cmpd_sample_id	inchi_key	smiles	cas_number	moa
JA-88-IO52				
FB-62-KB87				
KB-00-DM33				
PD-74-VS77				
QC-55-WY28				
QD-57-GT11				
XF-76-GE52				
GC-11-YA32				
AB-06-KB32				
TD-29-IN36				
BE-16-UV45				
BB-57-AZ77				
DD-85-WO51				
PA-40-HC94				
QF-05-OL72				
YB-30-EK42				
ED-62-DB62				
QB-00-CS87				
MA-20-ZI33				
UE-90-KK72				
YC-66-WR78				
NB-75-RF23				
FA-47-IB34				
MA-43-MR37				
AC-75-CE67				
DE-98-FC24				
HC-76-HU27				
DE-18-BC44				
YA-61-RR36				
YA-34-DT48				
NE-14-AO67				
SC-50-ME48				
LE-40-JW92				
AE-64-KN26				
LD-30-MF71				
ZF-10-JD55				
VB-88-YT38				
ME-54-JY76				
AB-14-QA30				
IC-72-TE79				
IF-87-AU84				
VF-79-GQ03				
WB-92-TT14				
UD-03-SW43				
BF-89-QD24				
LC-40-KC29				
CD-84-ET75				
GF-32-FY02				
AC-41-MB45				
LB-67-FA06				
YA-81-YH47				
WB-48-OF09				
GC-69-JF03				
BA-96-YB32				
JA-38-XE73				
IF-28-AV94				
DB-29-HQ45				
AB-61-FY15				
BD-81-FB30				
CE-36-HY42				
NF-10-JP55				
LE-83-PR92				
RA-01-US54				
SB-80-CR34				
AC-14-DG59				
FA-57-OP23				
RA-55-DY98				
PD-58-VA68				
UB-79-KN96				
FC-13-UF39				
UA-91-HL97				
EA-39-YN88				
SB-75-TY18				
FD-13-TF49				
GC-15-JX22				
NB-37-AN17				
GD-41-HR28				
FB-85-ND09				
UC-19-KX65				
CA-48-CT20				
DE-65-KO66				
OF-37-IT01				
MA-17-XU09				
SF-67-CJ22				
BB-83-OX58				
AC-38-WM38				
CC-18-YW57				
EF-82-OV15				
FE-61-DL94				
UE-01-HV71				
CF-44-NQ13				
SC-09-QD27				
XD-37-GI34				
DD-01-VE87				
CC-29-RG66				
VE-88-XW30				
HF-68-PM58				
TC-02-NZ28				
AA-94-TU18				
HC-49-RF93				
EB-08-WP80				
FE-49-ZJ78				
JE-43-OY99				
BB-32-IZ10				
BF-94-GX05				
GA-77-FY14				
EB-98-OI08				
CB-13-WC72				
KD-04-TL80				
MA-16-HJ95				
HF-67-IR57				
BD-70-EK54				
LC-62-AU42				
WB-33-KW88				
WD-86-NH64				
GE-72-PR35				
AC-84-QG99				
JD-47-WR37				
CB-45-VH79				
PC-49-XP02				
EA-33-QC97				
XA-35-DA85				
NC-05-TZ21				
ZB-72-PE17				
HD-19-IW09				
OD-30-UF61				
NE-94-VE83				
DB-41-IH69				
OB-44-HO47				
SE-81-RI20				
BF-32-CI54				
JA-23-RY79				
PA-70-ZC89				
EC-49-OQ85				
VD-08-YA83				
GE-98-ZI68				
NB-58-SA13				
ZB-42-PL54				
GA-77-MH38				
NB-21-MW29				
IA-41-VQ90				
IA-08-DE38				
HA-72-NR60				
BA-92-CZ75				
TD-91-KV46				
AB-86-XY72				
DD-58-HC29				
WD-08-QT63				
RA-25-VV91				
QC-49-CA55				
CB-99-OG76				
LC-54-XS57				
ZE-58-ZZ82				
DE-15-GD59				
LE-50-AP60				
DA-48-NC44				
AC-91-TS36				
DB-41-OE47				
BC-06-IL96				
LD-36-DG33				
MB-72-YK93				
ED-90-AH37				
GA-87-BR97				
BB-55-JH29				
BB-27-MC77				
RC-21-IF98				
RA-49-ZB08				
BC-61-ZY95				
HA-38-ML65				
LC-21-LG46				
HF-66-BD96				
LB-67-JK40				
EA-69-VJ68				
ZF-00-MX33				
QF-63-EA36				
HF-35-HT37				
KA-75-LP02				
EB-67-WB79				
EA-09-HM95				
AE-43-UJ94				
QF-00-NO42				
WA-15-KX40				
KB-46-EJ60				
NB-73-CA61				
OA-54-FL10				
OF-97-MQ74				
FF-76-LK08				
XD-53-KC50				
BD-82-NF37				
EA-73-UC67				
BE-48-IT75				
BE-66-UB12				
KC-86-UD16				
AE-56-RB57				
KB-56-XG08				
CB-16-JO93				
FF-96-HL81				
MB-95-VI30				
DC-01-WE57				
FD-25-KX07				
GC-57-HV87				
CB-84-FA85				
UC-48-CW55				
HE-84-SC79				
JD-62-TK68				
XB-53-OZ95				
BF-54-GX35				
IF-43-EO10				
AB-67-SF89				
SB-89-QK94				
RF-58-GQ76				
LA-96-VT14				
XC-86-SR58				
HD-16-HN20				
SC-59-TX35				
XD-08-ZW85				
AF-83-BX08				
AE-38-ZM08				
DF-95-CY55				
FD-55-XG26				
DC-93-RZ62				
DE-20-VX20				
FD-74-XT10				
TA-20-FO62				
AE-38-EW82				
MA-42-UX14				
SA-03-IQ14				
AC-12-PZ00				
AC-86-XI84				
MC-40-KF76				
CB-10-UX80				
AA-56-DV95				
VA-27-OT56				
MD-17-VD78				
RC-74-NK42				
CB-29-KG96				
AB-57-IZ37				
HA-29-ZM35				
AB-04-HG24				
GA-48-QI68				
UE-91-YV71				
AC-71-YF45				
OF-47-EQ74				
FE-12-TO68				
UB-40-NK72				
IA-28-VB61				
IC-83-DE66				
JA-77-UH38				
BD-70-PH02				
AC-00-BR21				
VB-76-UE47				
AB-64-HD87				
GE-53-SM76				
HB-01-ZU75				
RB-55-KL42				
XC-88-ZM66				
VC-94-CG67				
S0-EE-TZAB				
AA-83-YJ04				
FE-39-LJ73				
XA-12-UL84				
AA-49-HG46				
HB-75-KT12				
GF-14-RF56				
AC-95-NR38				
EB-07-JB09				
CA-61-VV83				
LC-78-EV09				
QC-63-VN72				
TD-17-NF32				
JA-63-WB39				
CC-37-QW80				
MB-15-ZF03				
BE-24-LQ28				
DD-10-NA60				
AE-80-WH32				
XA-88-GW50				
MF-81-RJ18				
XE-45-YU38				
S0-EE-WNJC				
JC-63-BE61				
CB-68-HM58				
AE-64-IK64				
WC-49-TQ48				
BB-36-LB57				
GB-14-AJ76				
AA-16-HV95				
DD-96-VY72				
RC-47-LT41				
BE-77-XF69				
DA-18-QP05				
CB-59-ZX97				
DF-26-EY87				
QC-76-GI57				
FA-63-WI26				
GA-18-KF56				
EA-93-KT88				
DE-27-WV67				
QD-75-XB03				
FD-48-HZ39				
FA-62-JE09				
AA-91-WB95				
CB-72-CP81				
IE-38-FB31				
CF-15-GU15				
LB-70-YM83				
GA-10-WX15				
BB-73-ZW70				
EA-67-SE76				
PA-75-VL17				
VA-15-ZR21				
BE-49-XN43				
RF-04-GI28				
DA-23-TZ42				
NF-51-FT62				
RD-96-AM02				
HF-82-PE14				
WE-97-CV00				
QA-73-SR92				
HE-18-HV99				
OD-78-OU01				
CC-06-WH01				
KA-52-MX24				
HC-92-HE59				
YE-80-LN04				
DB-54-ZQ73				
HC-06-EN50				
RA-18-CU16				
CB-83-SC82				
QC-80-MO42				
S0-EE-Y7SS				
PF-84-RH50				
DD-61-DY35				
NC-14-ES72				
ZA-25-KN86				
AB-32-QZ50				
HD-26-KX74				
CF-01-BY15				
TD-33-TT56				
GD-07-HO70				
AA-50-FY68				
BE-61-CB85				
PD-14-WO27				
FF-60-FQ28				
KE-91-GT92				
KC-35-MF93				
AA-70-VU13				
GB-56-TN25				
LE-50-NZ39				
AA-62-OC45				
SC-76-YF40				
EA-07-RB34				
GC-72-GY67				
PE-63-ER67				
CB-69-KJ83				
KB-59-KM40				
BB-78-LT85				
PD-31-RP17				
FD-63-JF34				
BC-69-CQ95				
FE-25-GD89				
VA-82-XZ88				
XD-03-FM54				
BA-30-VU53				
TF-43-DT71				
VD-09-SX75				
LF-18-HE58				
ZD-38-GI91				
XB-22-LI07				
PB-40-CS17				
IE-36-BO23				
IB-96-PK68				
BA-59-EN38				
PB-63-WH18				
ZB-67-SE99				
UB-41-DY23				
BE-57-VZ17				
BA-15-LA22				
AB-04-MQ83				
GF-35-IT27				
CE-68-CC69				
LB-72-WN85				
IB-80-NT65				
BC-15-BY15				
AE-89-KX47				
FC-68-LJ11				
AB-09-EA37				
CB-92-FS28				
CE-96-CZ90				
UB-62-DF90				
ZB-29-GC39				
OE-18-ZX28				
DD-89-WQ95				
FF-46-CU92				
LC-11-GG16				
RB-18-SX73				
NE-42-YQ17				
TC-22-OM27				
HC-48-BS22				
HA-99-UT82				
WA-53-FZ40				
HA-21-ND29				
XC-50-TN39				
HA-88-EI28				
TD-49-MO89				
TA-48-MG12				
ID-69-QF93				
CB-25-VR83				
HC-86-IA49				
BE-27-RQ61				
FB-94-TJ61				
BE-73-EJ14				
DA-97-MT18				
FB-86-FA19				
OA-62-NJ00				
RD-89-FH52				
HE-34-ZC14				
NB-05-VI80				
WE-69-LT10				
DB-42-PI54				
BD-34-PN26				
MA-96-GW26				
BF-69-DN58				
JD-26-QG88				
PE-58-WU11				
ZD-85-ND87				
JE-52-BH86				
CE-18-AP85				
KA-50-OP35				
UE-76-JL04				
AC-10-JK64				
AD-82-AM64				
DB-89-DT62				
BD-11-DV28				
OA-15-DB28				
UE-09-SD17				
DB-00-QN66				
CB-12-BV05				
BE-38-UW72				
HC-74-FM38				
EF-85-DA07				
OC-71-BZ81				
EA-17-BY69				
HB-92-PE54				
NA-07-JX31				
HE-64-VW17				
GB-46-CK08				
AB-35-RU30				
AD-84-LG49				
GD-66-XE49				
BB-26-JS03				
KD-88-RE18				
UE-90-AA63				
TC-66-CI47				
BE-51-FL19				
YF-00-IN39				
CA-31-EV03				
CC-04-YT10				
JA-42-MU37				
GA-66-XX49				
RF-95-QO64				
ID-00-IC14				
ND-48-XK57				
KB-04-AF26				
AB-41-IO16				
AA-12-SS68				
JF-25-NM40				
CF-82-FS38				
HE-15-UQ55				
CC-90-EX35				
EC-96-KI84				
SE-92-BP29				
DF-84-RT50				
NC-42-UX09				
CF-83-PM81				
JB-65-ON98				
BD-01-HE32				
AF-53-GC97				
PC-04-TO77				
TC-91-SL57				
NE-45-SF73				
AD-70-DU18				
ND-36-VC68				
AC-90-GY03				
HD-00-AG74				
ZD-78-BS65				
AB-33-EM56				
PF-72-IT39				
OF-05-CB18				
TD-57-NZ75				
XD-71-WI50				
OF-02-BG78				
EA-81-CR68				
FD-19-TD14				
BD-98-XW77				
AE-84-YK54				
XC-81-LR46				
VA-57-TF22				
CD-89-CG91				
FA-45-PN48				
KA-73-PR92				
FF-10-JX55				
DC-39-CT52				
EF-73-IP33	AAAQFGUYHFJNHI-SFHVURJKSA-N	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21	1260907-17-2	BRD2/3/4/T BET familiy inhibitor
DE-81-OY65	AAKJLRGGTJKAMG-UHFFFAOYSA-N	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1	1429636-49-6	Inhibitors of Signal Transduction Pathways;EGFR (HER1 or erbB1) Inhibitors
IC-57-ZA36	AAOYLOCWJSLLJU-UHFFFAOYSA-N	O=C(C(=O)c1cc(Br)ccc1O)c1cc(Br)ccc1O	523-88-6	Carboxylesterase Inhibitors
RA-81-JZ66	AASYYGYJPZBFKC-UHFFFAOYSA-N	O=C(O)Cc1c(C(=O)O)n(Cc2cccc3ccccc23)c2ccc(F)cc12	942191-15-3	Known Chymase inhibitor
BD-60-ZK54	AATHJLXYARFGKZ-UHFFFAOYSA-N	O=C(c1ccc(-c2cc[n+]([O-])cc2)cc1)N1CCN(S(=O)(=O)c2ccc3cc(Cl)ccc3c2)CC1	216957-20-9	Inhibitors of Blood Coagulation Pathways;Coagulation Factor Xa Inhibitors
EB-09-LQ45	AATPYXMXFBBKFO-UHFFFAOYSA-N	COc1cc(C(C)C)c(Oc2cnc(N)nc2N)cc1I	865305-30-2	P2RX2 and P2RX3 Purinergic Receptor Antagonist
DB-32-FS68	ABFMMCZFKUIJGQ-UHFFFAOYSA-N	O=[N+]([O-])c1cc(CNCP(=O)(O)O)c2nc(O)c(O)nc2c1	1230388-35-8	AMPA Antagonists
MA-45-US84	ABGOSOMRWSYAOB-UHFFFAOYSA-N	Clc1cc2c(NC3CCCC3)nnc(-c3ccncc3)c2cc1Cl		SUV420H1/H2 inhibitor;kmt5b and kmt5c inhibitor
JD-48-EV39	ABGYSGBNWQSGJD-UHFFFAOYSA-N	O=C(O)Cc1cccc2c(=O)c3ccccc3oc12		
AB-64-NN66	ABSJDZWNXDCDKP-UHFFFAOYSA-N	CCS(=O)(=O)c1ccc(Cn2c(C)c(CC(=O)O)c3cccnc32)c(Cl)c1		CRTh2 antagonist
HD-44-WW47	ABVSYWGFUNXYAC-UHFFFAOYSA-N	O=C1Nc2ccc(S(=O)(=O)NCc3ccc(F)cc3)cc2/C1=N/Nc1cccc(C(=O)O)c1	1051387-90-6	Protein Tyrosine Phosphatase SHP-2 (PTP2C) Inhibitors
BA-38-MT25	ABWOWIYOHHZBRY-QQHIZMLBSA-N	CCc1nn2c(C)cc(C)nc2c1Cc1ccc(/C=C/CN2CCN(C[C@@H](O)CO)CC2)cc1		
FD-77-ZV22	ABXIUYMKZDZUDC-UHFFFAOYSA-N	Cc1cncc(-c2nc(NCCc3c[nH]c4ccccc34)c3ncn(C(C)C)c3n2)c1	1227634-69-6	Aryl hydrocarbon receptor antagonist
EA-90-WH82	ABYSNRYCRYBNHA-UHFFFAOYSA-N	CC1(Nc2nc(-c3ccn[nH]3)nc3cnccc23)CC1		
AA-10-VR76	ACGUYXCXAPNIKK-UHFFFAOYSA-N	Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl	139411-96-4	Large Conductance K(Ca) 1.1 (BK, maxi K+) Channel Activators;Ectonucleotide Pyrophosphatase/Phosphodiesterase 2 (ENPP2;Autotaxin) Inhibitors
AB-02-CF97	ACLUEOBQFRYTQS-UHFFFAOYSA-N	CC(C)(C)C1CCc2c(sc(NC(=O)c3ccco3)c2C(=O)O)C1	407587-33-1	Calcium activated chloride channel 1 inhibitor
BA-38-XM43	ACNHBCIZLNNLRS-UBGQALKQSA-N	CC(C)(O)[C@H]1O[C@H]2CC[C@@]3(C)[C@@](O)(CC[C@H]4Cc5c([nH]c6ccccc56)[C@@]43C)C2=CC1=O	57186-25-1	
CE-69-HJ13	ACPOUJIDANTYHO-UHFFFAOYSA-N	O=C1c2ccccc2-c2n[nH]c3cccc1c23	120093-15-4	AP-1 Inhibitors;Inhibitors of Signal Transduction Pathways;Leucine-Rich Repeat Kinase 2 (LRRK2;Dardarin) Inhibitors;SAPK1a (JNK2) Inhibitors;SAPK1b (JNK3) Inhibitors;SAPK1c (JNK1) Inhibitors;AP-1 Inhibitors;Inhibitors of Signal Transduction Pathways;Leucine-Rich Repeat Kinase 2 (LRRK2;Dardarin) Inhibitors;SAPK1a (JNK2) Inhibitors;SAPK1b (JNK3) Inhibitors;SAPK1c (JNK1) Inhibitors
AD-10-ZS64	ACRHBAYQBXXRTO-OAQYLSRUSA-N	COc1cc2c(cc1OC)CC(=O)N(CCCN(C)C[C@H]1Cc3cc(OC)c(OC)cc31)CC2		
DC-13-RZ62	ACTIUHUUMQJHFO-UPTCCGCDSA-N	COC1=C(OC)C(=O)C(C/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CCC=C(C)C)=C(C)C1=O		
KC-71-KK26	ACVGNKYJVGNLIL-UHFFFAOYSA-N	COc1ccc(-c2ccc(=N)n(CCCC(=O)O)n2)cc1	104104-50-9	GABA(A) Receptor Antagonists
AF-72-PP21	ADEBPBSSDYVVLD-UHFFFAOYSA-N	COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2	110119-84-1	Acetylcholinesterase Inhibitors
OE-03-IU44	ADFGMTGMCUBKEF-GASCZTMLSA-N	Cc1nc2c(-c3cc(N4C[C@@H](C)O[C@@H](C)C4)ccc3F)cnn2c(N)c1-c1cccc(Cl)c1		
XF-97-DS48	ADLYBSSJKFIGDM-UHFFFAOYSA-N	Cc1cccc(C)c1-c1cccc(COc2ccc(CCC(=O)O)cc2)c1	691900-43-3	FFAR1 agonist;Free Fatty Acid Receptor 1 (FFAR1;GPR40) Agonists
KB-57-TK65	ADPBTBPPIIKLEH-UHFFFAOYSA-N	COc1cc(O)c(C(=O)O)c(-c2cc(O)c(O)cc2C)c1	1402-75-1	Neutral Sphingomyelinase (N-SMase) Inhibitors;HIV Integrase Inhibitors
CB-88-OC19	ADUKCCWBEDSMEB-NSHDSACASA-N	CC(C)NC[C@H](O)COc1ccc(O)cc1	57526-81-5	beta-Adrenoceptor Agonists
AE-57-PS55	ADZBMFGQQWPHMJ-WMLDXEAASA-N	CNC(=O)c1cc(Oc2ccc3nc(N[C@H]4CCCC[C@H]4O)sc3c2)ccn1		CSF1R gene antagonist
BC-76-HY47	AECDBHGVIIRMOI-UHFFFAOYSA-N	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCC2)C1	475488-34-7	MTH1 inhibitor;IGF1R inhibitor
AC-63-DM46	AEOCXXJPGCBFJA-UHFFFAOYSA-N	CCc1cc(C(N)=S)ccn1		
GD-79-JJ38	AEQDJSLRWYMAQI-UHFFFAOYSA-N	COc1cc2c(cc1OC)C1Cc3ccc(OC)c(OC)c3CN1CC2	10097-84-4	5-HT Release Inhibitors
FE-95-PU35	AEVGCUSOXYKFKL-UHFFFAOYSA-N	Cc1nc(-c2ccc(Cl)cc2)sc1-c1ccnc(N)n1		
OA-86-XP09	AEZZPAQOEUQNBB-UHFFFAOYSA-N	CC1CC(=O)NN=C1c1ccc(-n2ccnc2)cc1	109745-32-6	Phosphodiesterase III Inhibitors
LA-27-FR67	AFCGFAGUEYAMAO-UHFFFAOYSA-N	CC(=O)NCCCS(=O)(=O)O	56180-94-0	mgluR);NMDA Antagonists;Drugs Acting on Glutamate Receptors (Metabotropic;mgluR);NMDA Antagonists;Drugs Acting on Glutamate Receptors (Metabotropic
OE-67-XG40	AFMXVBAHMGWYAZ-UHFFFAOYSA-N	Cc1ccc(-c2ccnc(Nc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)n2)cn1	1032314-85-4	Inhibitors of Signal Transduction Pathways;KIT (C-KIT) Inhibitors
BC-87-ZP43	AFVLVVWMAFSXCK-VMPITWQZSA-N	N#C/C(=C\\c1ccc(O)cc1)C(=O)O	122520-77-8	Monocarboxylate Transporter 1 (MCT1) Inhibitors
EB-82-QI99	AFZWZVLPIMHLSE-UHFFFAOYSA-N	Cc1cc(C)c(S(=O)(=O)n2cc(C)cc2C)c(C)c1	885434-70-8	Guanine Nucleotide Exchange Factors (GEFs) Inhibitors
BC-01-VL44	AGBQKNBQESQNJD-SSDOTTSWSA-N	O=C(O)CCCC[C@@H]1CCSS1	1077-27-6	Pyruvate Dehydrogenase Activators
ND-68-CU31	AGKAAJMNNVUNDK-UHFFFAOYSA-N	O=C(NCCCN1CCCCCC1)C(c1ccccc1)C1CCCCC1	147614-21-9	Acetylcholine Release Enhancers
BC-52-NW28	AGLCGCXQQDBYKJ-UHFFFAOYSA-N	COc1cccc(NCCC2(c3ccccc3)CC(C)(C)OC(C)(C)C2)c1	1313603-22-3	Isoprenylcysteine Carboxyl Methyltransferase Inhibitors
GE-13-TV02	AGNFWIZBEATIAK-UHFFFAOYSA-N	NCCCCc1ccccc1	120375-45-3	Semicarbazide-Sensitive Amine Oxidase (SSAO| VAP-1)  Inhibitors
BD-19-MD69	AGPKZVBTJJNPAG-WHFBIAKZSA-N	CC[C@H](C)[C@H](N)C(=O)O	1160211-67-5	CRHR1 agonist;Apoptosis Inhibitors;Calcium Channels (Voltage-Gated) alpha2/delta Subunit Ligands;Branched Chain Amino Acid;CRHR1 agonist;Apoptosis Inhibitors;Calcium Channels (Voltage-Gated) alpha2/delta Subunit Ligands;Branched Chain Amino Acid
AC-47-ZI16	AGSPXMVUFBBBMO-UHFFFAOYSA-N	N#CCCN	1119-28-4	LOX inhibitor
GB-76-TN05	AGVNHDNTFYHZNL-QGZVFWFLSA-N	Cc1cccc(S(=O)(=O)N(C)[C@H](C)CCN2CCC(C)CC2)c1	1217674-10-6	5-HT7 Antagonists
GB-05-QT17	AGZMQTIIZFXACL-UHFFFAOYSA-N	NS(=O)(=O)c1ccc(NS(=O)(=O)c2ccc([N+](=O)[O-])cc2)cc1	7478-00-4	Carbonic anhydrase inhibitor
DA-87-JB14	AHGMXAFUHVRQAD-UHFFFAOYSA-N	COC(=O)c1cc(Oc2ccc(C(F)(F)F)cc2Cl)ccc1[N+](=O)[O-]	50594-67-7	Protoporphyrinogen oxidase inhibitor
KB-84-OL45	AHIFMZUYRNPRJK-MHZLTWQESA-N	O=P(CN[C@@H](Cc1ccc(-c2ccccc2)cc1)c1nn[nH]n1)(Oc1ccccc1)Oc1ccccc1	154116-34-4	Endothelin-Converting Enzyme (ECE) Inhibitors;Neprilysin (Enkephalinase, Neutral Endopeptidase, NEP) Inhibitors;Endothelin-Converting Enzyme (ECE) Inhibitors;Neprilysin (Enkephalinase, Neutral Endopeptidase, NEP) Inhibitors
AE-04-SN76	AHJRHEGDXFFMBM-UHFFFAOYSA-N	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O	1279034-84-2	CDK6 Inhibitors;CDK4 Inhibitors
CA-48-JF51	AHJRSKVOELIMOX-RVXWVPLUSA-N	CCCCC#Cc1nc(N)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1	90596-73-9	Adenosine A2A Agonists;Adenosine A3 Agonists
FE-16-UK58	AIBHLZVVPXCTKY-SRCQZFHVSA-N	CN1C[C@H](Cn2cncn2)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21	105579-47-3	Dopamine D1 Agonists;Dopamine D2 Agonists
BD-26-EO58	AIFRHYZBTHREPW-UHFFFAOYSA-N	c1ccc2c(c1)[nH]c1cnccc12	244-63-3	Indoleamine 2,3-dioxygenase Inhibitors;MAO-B Inhibitors
CB-05-AU50	AINBDMJFHOKBDF-UHFFFAOYSA-N	CC(=O)Nc1ccc2c(=O)n(O)c(=O)[nH]c2c1		Nucleotide Excision Repair Inhibitor
CA-17-XB39	AIONOLUJZLIMTK-AWEZNQCLSA-N	COc1ccc([C@@H]2CC(=O)c3c(O)cc(O)cc3O2)cc1O	41001-90-5	Lipid Lowering Agents;Antioxidants;Triglyceride Lowering Agents;Cytochrome P450 CYP1B1 Inhibitors;TRPM3 Antagonists
VF-19-KA00	AIXMJTYHQHQJLU-UHFFFAOYSA-N	COC(=O)CC1CC(c2ccc(O)cc2)=NO1	478336-92-4	Macrophage Migration Inhibitory Factor (MIF) Inhibitors
FA-20-GU88	AJBBEYXFRYFVNM-UHFFFAOYSA-N	CCCn1c(=O)c2[nH]c(-c3ccc(OCC(=O)Nc4ccc(C#N)cc4)cc3)nc2n(CCC)c1=O	264622-58-4	Adenosine A2B Antagonists
BD-48-ZT65	AJCDZIDKYKCOMZ-AATRIKPKSA-N	CN(C(=O)CNC(=O)/C=C/c1cccc(Cl)c1)C1CC[S@SP2](=O)(=O)CC1		
BB-08-WM33	AJFFBPZYXRNAIC-UHFFFAOYSA-N	Cc1c(C(=O)NN2CCOCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(I)cc1	202463-68-1	CNR1 antagonist
YF-47-HO48	AJFGLTPLWPTALJ-SSDOTTSWSA-N	N[C@@](CF)(Cc1c[nH]cn1)C(=O)O	70050-43-0	Histidine Decarboxylase Inhibitors
RA-03-RQ19	AJIAMIPUWJQSPR-UHFFFAOYSA-N	Cn1cnnc1C1CCN(c2ncccc2-c2ccc(F)nc2)CC1		QPCT inhibitor
PC-74-OR34	AJKSBVCOTKODMF-UHFFFAOYSA-N	O=C1CC(=O)N(C2CCCC2)C(=O)N1CCc1cccc(Cl)c1	1391385-57-1	CACNA1D calcium channel subunit inhibitor
JC-14-YI23	AJPSBXJNFJCCBI-YPLOISPCSA-N	C=CCN1CC[C@]23c4c5ccc(O)c4O[C@@H]2/C(=N/N=C2\\CC[C@@]4(O)C6Cc7ccc(O)c8c7[C@@]4(CCN6CC=C)[C@@H]2O8)CC[C@@]3(O)C1C5		
KE-47-IA01	AJRGHIGYPXNABY-UHFFFAOYSA-N	COc1ccc(Cn2ccc3ccc(C(=O)NO)cc32)cc1	950762-95-5	HDAC8 inhibitor
LB-55-UZ51	AKGUXECGGCUDCV-UXBLZVDNSA-N	NC(=O)N/N=C/c1ccccc1		
HC-83-TS50	AKJULTWNHWSAFM-UHFFFAOYSA-N	C[S@SP2](=O)(=O)c1ccc(CC(=O)Nc2cc(Cl)c(-c3ccccc3OC(F)(F)F)c(Cl)c2)cc1	1426803-07-7	RORC gamma t inhibitor
DF-32-EL16	AKMNUCBQGHFICM-UHFFFAOYSA-N	Cc1nc2ccc(NC(=O)Nc3ccnc4cccnc34)cc2o1	249889-64-3	HCRTR1 antagonist;Orexin OX-1 Antagonists
BD-85-VR28	ALAPXRDQVUXCMS-SFHVURJKSA-N	Cc1ccc(-c2cnc3c(N[C@H](CO)Cc4cccnc4)nccn23)cc1		
YE-02-BO16	ALBKMJDFBZVHAK-UHFFFAOYSA-N	CCOC(=O)c1ncc2[nH]c3ccc(OCc4ccccc4)cc3c2c1COC	83910-44-5	Anxiolytics
AA-84-BX70	ALDJQYJOXDCKFF-BHDDXSALSA-N	CCOC[C@@H](CC(C)C)NC(=O)[C@@H]1CNC[C@H](C(=O)N(c2cc(OCC)c(CC)cn2)C2CC2)C1	1093955-00-0	Renin Inhibitors
CC-51-KS26	ALFGDCNSEBJYSP-UHFFFAOYSA-N	CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12	160521-72-2	HTR2B agonist
AA-76-CL76	ALGFQPMFHIDLFQ-UHFFFAOYSA-N	Cc1ccc2oc(-c3cc(Br)ccc3O)cc(=O)c2c1	468060-99-3	
GC-90-GG29	ALHBJBCQLJZYON-ZQDZILKHSA-N	N[C@H]1CC[C@H](N[C@@H]2C[C@H]2c2ccccc2)CC1	1431303-72-8	KDM1A (LSD1) inhibitor
AC-06-FB12	ALMACYDZFBMGOR-UHFFFAOYSA-N	COc1ccccc1Oc1ccc(N(Cc2cccnc2)S(=O)(=O)CC(F)(F)F)cc1	353229-59-1	mgluR2 Agonists
OE-91-GF88	ALRYLNXZUBATMZ-UHFFFAOYSA-N	C=C(c1ccc(C(=O)O)cn1)c1cc2c(cc1C)C(C)(C)CCC2(C)C	1481629-73-5	Retinoid RXR Agonists
DE-57-XI06	ALSKYCOJJPXPFS-BBRMVZONSA-N	CO[C@H]1CC=C2CCN3CCC4=C(CC(=O)OC4)[C@]23C1	1328-90-1	Nicotinic alpha4beta2 Antagonists
AB-41-VZ28	ALWKGYPQUAPLQC-UHFFFAOYSA-N	CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1	114-80-7	Acetylcholinesterase Inhibitors
GD-59-QF63	AMAJXAHZCGMNST-UHFFFAOYSA-N	CC1=C2CC3(C)C(=CC(O)C(O)C3C)C=C2OC1=O		Progesterone Receptor Antagonists
DE-91-FH69	AMLKCBXPVBOXAU-UHFFFAOYSA-N	C#CCOc1ccc2c(c1)c(-c1ccc(C(C)C)cc1)nc(=O)n2Cc1cccc(OCCO)c1	478965-50-3	Calcium-Sensing Receptor (CaSR) Antagonists;Parathyroid Hormone Secretion Stimulants
AC-53-HJ29	AMLYAMJWYAIXIA-VWNVYAMZSA-N	CC(C)[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](Cc2ccccc2)C(=O)N1C	188968-51-6	Integrin binder;Integrin alphavbeta3 (Vitronectin) Antagonists;Integrin alphavbeta5 Antagonists;Integrin binder;Integrin alphavbeta3 (Vitronectin) Antagonists;Integrin alphavbeta5 Antagonists
QA-58-CX23	AMQMTWPTOJKPBV-UHFFFAOYSA-N	O=C(NO)c1cnc(NCC2CCCN(S(=O)(=O)c3ccc4ccccc4c3)C2)nc1		
CB-06-FE89	AMSOPBXQXSAAAC-PLZPTFKGSA-N	C[C@]12O[C@H](C[C@]1(O)C(=O)O)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		
MC-51-BT07	ANDGGVOPIJEHOF-UHFFFAOYSA-N	O=C(c1ccc2nccnc2c1)N1CCCCC1	154235-83-3	AMPA Receptor Modulators
BB-53-SW55	ANGKOCUUWGHLCE-UHFFFAOYSA-N	C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1	13283-82-4	Muscarinic Antagonists
HA-83-HZ77	ANJTVLIZGCUXLD-DTWKUNHWSA-N	O=c1cccc2n1C[C@@H]1CNC[C@H]2C1	115051-74-6	Nicotinic alpha4beta2 Partial Agonists
CF-92-QS83	ANMLJLFWUCQGKZ-UHFFFAOYSA-N	O=C1OC(OC(=O)c2cccnc2Nc2cccc(C(F)(F)F)c2)c2ccccc21	66898-62-2	Calcium-activated Chloride Channels 1 Blockers;Mucin Production, Inhibitors;Calcium-activated Chloride Channels 1 Blockers;Mucin Production, Inhibitors
BE-10-NK39	ANNRUWYFVIGKHA-UHFFFAOYSA-N	CCCN(CCC)c1cc(C)nc2c(-c3cnc(N(C)C)cc3C)c(C)nn12	195055-03-9	CRF1 Antagonists
GC-09-EG26	ANRUJJLGVODXIK-UHFFFAOYSA-N	NCCC(=O)NCCc1c[nH]cn1	56897-53-1	HRH3 antagonist
AC-91-AV48	ANYJUPCHANVRRC-DRGJWEBESA-N	Cn1nnc(N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)Cc2cc3cc(F)c(F)cc3nc2N2CCC[C@@H]2[C@H]2CC[C@H](C(=O)O)CC2)n1		
EB-44-GM58	ANZIISNSHPKVRV-UHFFFAOYSA-N	COc1cc2c(cc1OC)CN(c1cc(N)c3cc(OC)c(OC)cc3n1)CC2	90402-40-7	alpha1-Adrenoceptor Antagonists
CD-35-BD44	AOAQQNHWPKBKKP-LOSJGSFVSA-N	CCn1cnc2c(Nc3ccc(S(=O)(=O)N4CCN(c5ccccc5)CC4)cc3)nc(N[C@@H]3CCCC[C@@H]3C(N)=O)nc21		
BF-19-KU00	AOCCBINRVIKJHY-UHFFFAOYSA-N	CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O	61422-45-5	Pyrimidine Antagonists;Thymidylate Synthase Inhibitors
AD-09-TD34	AOJMWYPUZRQUTK-PWRODBHTSA-N	CCOC[C@@H](CC(C)C)NC(=O)[C@@H]1CNC[C@H](C(=O)N(c2cc(OC)c(C(C)C)cn2)C2CC2)C1	1093954-96-1	Renin Inhibitors
HE-94-WM93	AOPOCGPBAIARAV-OTBJXLELSA-N	CC[C@@H](O)/C=C/C=C\\C[C@@H](O)/C=C/C=C/C=C\\[C@@H](O)CCCC(=O)O	1309610-43-2	Leukotriene BLT1 Receptor Ligands;Chemokine-like Receptor 1 (CMKLR1, CHEMR23) Ligands
SB-09-JU93	AOUZPXZGMZUQQS-YPAWHYETSA-N	CC(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](Cc1ccccc1)C(N)=O	1809784-29-9	GADD45Beta/ MKK7 complex disruptor
EB-19-SM10	AOXOYUCWJCCUDO-CMDGGOBGSA-N	O=C(/C=C/c1cccc2ccccc12)NO		Histone Deacetylase 8 (HDAC8) Inhibitors
FB-42-IV40	AOZLMMDVJOGGEQ-UHFFFAOYSA-N	COc1ccc(S(=O)(=O)Nc2nc(-c3cccc([N+](=O)[O-])c3)c(CN3CCCCC3)s2)cc1OC		
YA-52-FO46	APARDBNFWVLXJI-UHFFFAOYSA-N	COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)ccc1OCC(C)C	1119103-46-6	BDKRB1 antagonist;Non-Opioid Analgesics
AA-67-JI21	APJYDQYYACXCRM-UHFFFAOYSA-N	NCCc1c[nH]c2ccccc12		
FC-22-ZV65	APQPRKLAWCIJEK-UHFFFAOYSA-N	NCCSSCCN	101418-33-1	Tissue Transglutaminase (TGM2) Inhibitors
AA-59-HG56	AQCHWTWZEMGIFD-UHFFFAOYSA-N	Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C	17560-51-9	Carbonic Anhydrase Type VII Inhibitors
FA-43-XS35	AQCULNMHTOBDQM-UHFFFAOYSA-N	CS(=O)(=O)Cc1noc(-c2ccc(C(=O)C(F)(F)F)s2)n1		Histone Deacetylase 6 (HDAC6) Inhibitors;Histone Deacetylase 4 (HDAC4) Inhibitors
CC-15-MK46	AQFFXPQJLZFABJ-UHFFFAOYSA-N	CC(C)Oc1ccc2c(=O)c3cc(C(=O)O)ccc3oc2c1	33458-93-4	PTGER2 antagonist
AA-70-DH87	AQGNHMOJWBZFQQ-UHFFFAOYSA-N	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1	252917-06-9	Glycogen Synthase Kinase 3 (GSK-3) Inhibitors
PE-39-HL72	AQMPIDSGLFVVPL-UHFFFAOYSA-N	COC(=O)CN1CN(c2ccccc2)C2(CCN(Cc3cccc4ccccc34)CC2)C1=O	250685-44-0	OPRL1 (Nociceptin Receptor) agonist
S0-EE-XMWH	AQTPWCUIYUOEMG-INIZCTEOSA-N	O=C(C1CC1)N1CC[C@@H](Cc2n[nH]c(=O)n2-c2ccc(-c3ccc4occc4c3)cc2)C1	1332331-08-4	FAS inhibitor
DD-41-AE67	ARAIBEBZBOPLMB-UFGQHTETSA-N	CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)OC(C(=O)O)=C[C@@H]1N=C(N)N	139110-80-8	inhibitor of neuraminidase and Sialidase
KE-74-EB71	ARIWANIATODDMH-UHFFFAOYSA-N	CCCCCCCCCCCC(=O)OCC(O)CO		
AD-10-TH32	ARJCBSRIPGJMAD-LLVKDONJSA-N	NC(=O)c1noc([C@H](CCCC2CCCCC2)CC(=O)NO)n1	348622-88-8	Inhibitor of the BMP1/TLL1/TLL2 family of Proteases
FB-60-JQ38	ASGIQUHBAVIOTI-UHFFFAOYSA-N	CN(CCc1ccc(Cl)c(Cl)c1)CCN1CCCC1	138356-08-8	sigma Receptor Antagonists
DA-76-NE84	ASKREEJRSDOYKI-MMZGTNPYSA-N	C/C(=N\\OCCO)c1ccc2nnc([C@@H](C)c3c(F)cc4ncccc4c3F)n2n1	1268260-39-4	HGFR (MET;c-Met) Inhibitors
ED-84-WW97	ASNFTDCKZKHJSW-UWTATZPHSA-N	N[C@H](Cn1oc(=O)[nH]c1=O)C(=O)O		GRM1 agonist;GRM5 agonist
AD-93-VC77	ASUHOMGTZLJQAK-UHFFFAOYSA-N	O=C(O)CCCSc1nc2ccccc2n1Cc1cccc2ccccc12	351520-39-3	Known Chymase inhibitor
EB-70-JQ38	ASXVEBPEZMSPHB-PKHIMPSTSA-N	CC(NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1)C(=O)CF		
UE-20-KA68	ASXVEBPEZMSPHB-YJBOKZPZSA-N	C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1)C(=O)CF	105637-38-5	Cathepsin B Inhibitors
HC-14-FM48	ATASNKKKUMVJNW-CYBMUJFWSA-N	C[C@@H](c1c(F)cc2ncccc2c1F)c1cnc2ccc(-c3cnn(CCO)c3)nn12	1185765-63-2	HGFR (MET;c-Met) Inhibitors
EC-09-DC91	ATEBXHFBFRCZMA-VXTBVIBXSA-N	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\\C=C\\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O	72559-06-9	DNA-Directed RNA Polymerase Inhibitors
S0-EE-X7LX	ATENFOTVOKHAOY-CQSZACIVSA-N	CC(C)Oc1ccc2c(c1)C(=O)N(c1cccc(-c3nncn3[C@H](C)CO)n1)C2		ASK1
GB-31-HY20	ATHGHQPFGPMSJY-UHFFFAOYSA-N	NCCCCNCCCN	1122077-27-3	Protein tyrosine phophatase N-like stimulator;Drugs Acting on NMDA Receptors
DD-38-MZ39	ATLZEZGQPAJHJZ-UHFFFAOYSA-N	CC(C)(C)c1ccc(Nc2ncc(-c3ccc4ncncc4c3)c3ccccc23)cc1		
AE-00-DK14	ATMHFQDWDFHUDF-TXLWKQMCSA-N	CN(C(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@@H](/C=C/C(=O)N[C@@H]1CCCCNC1=O)Cc1ccc(Cl)cc1		Tachykinin NK1 Antagonists;Tachykinin NK2 Antagonists
DF-45-GA42	ATQMRMGXINTJHV-UHFFFAOYSA-N	Cc1nc(-c2ccc(-c3ccc(C(=O)N4CCc5cc6c(cc54)C4(CCN(C)CC4)CO6)cc3)c(C)c2)no1	180083-23-2	HTR1B antagonist
ME-31-RM40	ATSUJKLLCSXMLV-BUHFOSPRSA-N	O=C(/C=C/c1ccc(CNCCn2c3ccccc3c3ccccc32)cc1)NO		Histone Deacetylase (HDAC) Inhibitors
GC-04-UF36	AUGQEEXBDZWUJY-NMAPUUFXSA-N	CC(=O)OC[C@]12CCC(C)=C[C@H]1O[C@@H]1[C@H](O)[C@@H](OC(C)=O)[C@@]2(C)[C@]12CO2	109547-11-7	Apoptosis Inducers;Translation inhibitor;SGLT-1 expression Inhibitors
EF-33-QP63	AUJDLGWTNPBCBU-UHFFFAOYSA-N	Cc1sc2ncnc(Nc3cccc(C(=O)O)c3)c2c1-c1ccccc1		Protein kinase CK2 inhibition
QF-55-QV81	AUJYBYKYNPGFMV-UHFFFAOYSA-N	CC(Sc1nc(-c2ccccc2)c(C#N)c(=O)[nH]1)C(=O)O		
FD-00-QG34	AUMDBEHGJRZSOO-UHFFFAOYSA-N	Nc1ncnc2c1c(COc1cccc(Cl)c1)nn2C1CCOCC1	1188296-52-7	Casein Kinase CK1epsilon Inhibitors
EC-26-KB37	AURFZBICLPNKBZ-FZCSVUEKSA-N	CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	516-55-2	GABA(A) Receptor Antagonists;11-beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Inhibitors
BC-65-QR83	AURFZBICLPNKBZ-YZRLXODZSA-N	CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	110350-90-8	GABA(A) Receptor Modulators
BE-79-QU25	AUVVAXYIELKVAI-CKBKHPSWSA-N	CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21	101077-19-4	Translation inhibitor
AA-94-OG89	AUYYCJSJGJYCDS-GFCCVEGCSA-N	N[C@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O	327-86-6	
BF-59-OR93	AUYYCJSJGJYCDS-LBPRGKRZSA-N	N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O	20196-64-9	Thyroid hormone receptor alpha agonist;Hormone replacement agent
BC-20-WA90	AVHFGSYJGSZHIC-UHFFFAOYSA-N	O=C(Nc1cc(C(F)F)ns1)Nc1cc(Cl)ncc1CO		ATPase SMARCA2, SMARCA4 Inhibitor
XD-27-EB72	AVNQVPDWFUNVON-MEMLXQNLSA-N	CCN(c1cc(Cl)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)[C@H]1CC[C@H](N(C)C)CC1		PRC2/EZH2
MD-70-GS72	AVZCPICCWKMZDT-UHFFFAOYSA-N	O=C(O)CCNc1cc(N2CCc3ccccc3CC2)nc(-c2ccccn2)n1		
AF-11-IL39	AWDORCFLUJZUQS-ZDUSSCGKSA-N	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12	451462-58-1	ROCK gene inhibitor;PKC Kinase nhibitor
AD-30-SU93	AWHNHDGHHNGACT-UHFFFAOYSA-N	CN1CCN(C2=Nc3cc(Cl)ccc3Oc3ccccc32)CC1	3527-47-7	Dopamine D2 Receptor Ligands;Dopamine D4 Receptor Ligands;Dopamine D1 Receptor Ligands;Dopamine D3 Receptor Ligands;5-HT2A Receptor Ligands
CC-90-NK44	AWIVHRPYFSSVOG-UHFFFAOYSA-N	Fc1ccc(CNc2ncnc3ccc(F)cc23)cc1	1262888-28-7	Autophagy Agonist;Phosphodiesterase V (PDE5A) Inhibitors
FF-34-KW62	AWNGTXBLNYSBDK-UHFFFAOYSA-N	CCN(CC)C1CCN(c2cccc(-c3cnn4c(N)c(-c5cccc(Cl)c5)c(C)nc34)c2)CC1		
TE-16-VT54	AWOPBSAJHCUSAS-UHFFFAOYSA-N	CN(C)C(=O)Nc1cccc(-c2ccc(N(C)C)cc2)c1	1469924-27-3	Patatin like phospholipase protein inhibitor
AB-43-XJ34	AWUGZGWYVVYYIP-ZDUSSCGKSA-N	Cc1cn2cc(-c3cc4ccc(N5CCN[C@@H](C)C5)cc4oc3=O)nc2c(C)n1	1446310-67-3	splicing modulator
JE-04-LS32	AWZFCQRICMFIES-AATRIKPKSA-N	O=c1[nH]cnc2[nH]c(-c3ccnc(/C=C/c4ccc(CN5CCOCC5)cc4)c3)cc12		
BE-66-GV20	AXKPFOAXAHJUAG-UHFFFAOYSA-N	NC(=O)C1(N2CCCCC2)CCN(CCCC(=O)c2ccc(F)cc2)CC1	1893-33-0	5-HT2 Antagonists;Dopamine D2 Antagonists
S0-EE-Y6Y9	AXLYOAXOIGRBKX-UHFFFAOYSA-N	CCN1CCC(Nc2c3c(nc4cc(Cl)ccc24)CCCC3)CC1		
BB-21-KE77	AXRCEOKUDYDWLF-UHFFFAOYSA-N	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21	170364-57-5	Inhibitors of Signal Transduction Pathways;Protein Kinase PKC beta Inhibitors;Angiogenesis Inhibitors
FC-67-SZ42	AXUZQJFHDNNPFG-UXBLZVDNSA-N	CN(C)C(=O)CCSC(SCCC(=O)O)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1	115103-85-0	Leukotriene CysLT1 (LTD4) Antagonists;Leukotriene Synthesis Inhibitors
RA-89-RR01	AYOUDDAETNMCBW-GSHUGGBRSA-N	CN1C(=O)[C@@H](NC(=O)[C@H](CCC(F)(F)F)[C@H](CCC(F)(F)F)C(N)=O)N=C(c2ccccc2)c2ccccc21	1401066-79-2	gamma secretase inhibitor;Gamma-secretase inhibitor
BC-55-CK01	AYQKIBOBFAZBCX-UHFFFAOYSA-N	C1=C(c2cc3ccccc3o2)C2CCN1CC2	154183-31-0	Muscarinic M1 Agonists
BE-17-CS60	AYUNIORJHRXIBJ-TXHRRWQRSA-N	C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\\C=C(/C)C(=O)NC(=CC1=O)C2=O	106-95-6	CHK1 Expression Inhibitors;Inhibitors of Signal Transduction Pathways;Heat Shock Protein 90 (hsp90) Inhibitors
IA-65-QX27	AYYCFGDXLUPJAQ-UHFFFAOYSA-N	COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1	1348935-37-4	5-HT1A Receptor Antagonists;alpha1D-Adrenoceptor Antagonists
GC-02-TV70	AZAANWYREOQRFB-SETSBSEESA-N	O=C(CN1C(=O)C2(CCCC2)NC[C@H]1c1cc(F)cc(F)c1)Nc1ccc2c(c1)C[C@@]1(C2)C(=O)Nc2ncccc21	957116-20-0	highly potent calcitonin gene-related peptide (CGRP) receptor antagonist;CGRP antagonist;highly potent calcitonin gene-related peptide (CGRP) receptor antagonist;CGRP antagonist
OB-01-DJ93	AZEXWHKOMMASPA-UHFFFAOYSA-N	Cn1cc(-c2ccncc2)c(-c2ccc(OCc3ccc4ccccc4n3)cc2)n1	1037309-45-7	Phosphodiesterase 10A Inhibitors
JD-50-EC04	AZGIWMKLPRJOPT-UHFFFAOYSA-N	Cc1nc2c(-c3cccc(N4CCN(C)CC4)c3)cnn2c(N)c1-c1ccc(F)cc1		Src Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Abl Kinase Inhibitors;EphB4 Inhibitors;Src Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Abl Kinase Inhibitors;EphB4 Inhibitors
JD-70-IC84	AZKVWQKMDGGDSV-BCMRRPTOSA-N	COC(=O)C1=CO[C@@H](O)[C@@H]2C(CO)=CC[C@H]12	1202641-87-9	UCP2 inhibitor;Apoptosis Inhibitors;Non-Steroidal Antiinflammatory Drugs;Free Radical Scavengers
FB-99-SM50	AZLAIMCFUUYCHB-UHFFFAOYSA-N	N#Cc1nccc(Oc2cccc(OCc3ccc(CN)cc3)c2)n1		
CE-21-UO81	AZLAMPLFUDZOPO-HSZRJFAPSA-N	CN(C(=O)c1cccc2ccccc12)[C@H](CCNC(=O)c1ccccn1)Cc1ccc(F)cc1	1238070-47-7	Orexin OX-1 Antagonists;Orexin OX-2 Antagonists
VE-46-XV53	AZNNFRBTUPHBIE-KSWRQPAISA-N	CCOC(=O)[C@@H]1C[C@H]2C[C@@H](CN3CC(F)(F)C[C@H]3C(=O)OCC)CC[C@H]2CN1		
KA-82-CN45	AZSXOQSYRMGNPE-VXKWHMMOSA-N	O=C(CF)[C@H](CCc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)N1CCOCC1		m-Calpain (Calpain-2) Inhibitors;Cathepsin B Inhibitors;Cathepsin L Inhibitors
IC-76-JU42	AZXXGVPWWKWGAE-IYARVYRRSA-N	Cn1nnc(-c2ccc3c(c2)[nH]c2nc(Cc4ccccc4)nc(N[C@H]4CC[C@H](N)CC4)c23)n1		
LE-65-RW44	AZYDQCGCBQYFSE-LBPRGKRZSA-N	CC(C)[C@H](C(=O)Nc1nccs1)c1ccc(Cl)cc1	1103523-24-5	Free Fatty Acid Receptor 2 (FFAR2|  GPR43) Agonists
GA-51-DD14	AZZRFSWIWLKNLQ-UHFFFAOYSA-N	COc1ccc(/N=C(\\N)Nc2ccc3c4c(cccc24)CC3)c2ccccc12		
BC-62-RZ55	BAALMEGRQMMBJQ-UHFFFAOYSA-O	CCc1ccc2c3[nH]c4ccccc4c3cc[n+]2c1	6784-38-9	DNA-Intercalating Drugs;5-HT Reuptake Inhibitors;Acetylcholinesterase Inhibitors;DNA-Intercalating Drugs;5-HT Reuptake Inhibitors;Acetylcholinesterase Inhibitors
FE-09-JD34	BAQOPDGRUNKWLM-KRWDZBQOSA-N	COc1nc(N)nc(Nc2cc(S(N)(=O)=O)ccc2N[C@@H](c2cccc3c2OC(F)(F)O3)c2ncccc2Cl)n1		
AD-19-GH34	BASFYRLYJAZPPL-UONOGXRCSA-N	c1ccc([C@@H]2C[C@H]2NC2CCNCC2)cc1	1431367-51-9	KDM1A/B
LD-14-PB06	BAWKQIKBNVOTQP-UHFFFAOYSA-N	c1ccc(-n2cnc3cnc4ccc(-c5cccc(N6CCNCC6)c5)cc4c32)cc1		RET inhibitor
KB-65-GP42	BBFVLRHCOLVFKU-UHFFFAOYSA-N	N#Cc1cnc(Nc2ccc(S(N)(=O)=O)cc2)nc1N		CDK2 Inhibitors
BE-41-UE67	BBLGCDSLCDDALX-LKGBESRRSA-N	C/C=C(\\C)[C@H](O)[C@H](C)/C=C(C)/C=C/C/C(C)=C/Cc1nc(OC)c(OC)c(O)c1C	19855-42-6	NADH oxidase inhibitors;Electron transport chain inhibitor
DD-96-DE39	BBMWKHMUUHQRIO-GFCCVEGCSA-N	NC(=O)c1cnc2ccc(N3CC(F)(F)C[C@@H]3c3cccc(F)c3)nn12		
ZB-12-BE52	BBRSCGBAIAKATH-UHFFFAOYSA-N	O=C(O)c1cc2cc(O)ccc2n1Cc1ccc(Cl)c(Cl)c1		Chemokine CCR2B Receptor Antagonists
GD-09-QJ83	BBTFKAOFCSOZMB-UHFFFAOYSA-N	CNc1nc(-c2cccc(NC(=O)c3ccc(C(=O)OC)cc3)c2)c2cc(OC)c(OC)cc2n1	947620-48-6	PDE4 inhibitor for topical application
NF-24-NB76	BBTMSQSMAGSWCB-UHFFFAOYSA-N	CC1(c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)COCC(N)=N1	1262855-87-7	beta-Secretase 1 (BACE1) Inhibitors;beta-Secretase 2 (BACE2) Inhibitors
CC-70-BD07	BCEHBSKCWLPMDN-QFYYESIMSA-N	C[C@@H](c1ncncc1F)[C@@](O)(Cn1cncn1)c1ccc(F)cc1F		
DA-80-IV36	BCFGMOOMADDAQU-UHFFFAOYSA-N	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1	1092929-10-6	EGFR (HER1;erbB1) Inhibitors;HER2 (erbB2) Inhibitors;Inhibitors of Signal Transduction Pathways
SB-16-SI72	BCGHHRAUZWOTNH-XNIJJKJLSA-N	CO[C@@H]1[C@@H]2OP(=O)(O)OC[C@H]2O[C@H]1n1c(Sc2ccc(Cl)cc2)nc2c(N)ncnc21	634207-53-7	Activator of Epac;PDE2A Inhibitor;RAPGEF3 activator
OA-73-DX11	BCGWQEUPMDMJNV-UHFFFAOYSA-N	CN(C)CCCN1c2ccccc2CCc2ccccc21	113-52-0	5-HT Reuptake Inhibitors;Sodium Channel  Blockers;Norepinephrine Reuptake Inhibitors
KA-71-CQ25	BCWCEHMHCDCJAD-UHFFFAOYSA-N	Cc1ccc(C(=O)C(=O)c2ccc(C)cc2)cc1	3457-48-5	Carboxylesterase Inhibitors
DD-89-HG56	BDGKKHWJYBQRIE-HHHXNRCGSA-N	Cc1c(C(=O)N2CCN(C(=O)c3ccc(Br)cc3)[C@@H](c3ccc(Cl)cc3)C2)cnn1-c1cccc(C#N)c1		
EC-70-XX20	BDILTKLWRMFCFO-UHFFFAOYSA-N	CCCn1c(-c2cnc(Nc3ccc(C)nc3)nc2)nc2cccc(Cl)c21	1072930-28-9	mgluR5 Antagonists
BD-62-ZF67	BDSYKGHYMJNPAB-LICBFIPMSA-N	CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	66852-54-8	Antiinflammatory Drugs
AB-63-UX23	BDVFVCGFMNCYPV-UHFFFAOYSA-N	CC1CNCCN1S(=O)(=O)c1cccc2cnccc12		
GF-16-RR50	BDYDINKSILYBOL-WMZHIEFXSA-N	COc1cc(C(=O)N2CC[C@@H](O)[C@@H](N)C2)cc2nc(-c3cc4ccccc4n3CC3CC3)n(C)c12	1652591-81-5	PAD4 (Protein-arginine deiminase type-4) substrate competitive reversible inhibitor
BE-49-AQ65	BDYHNCZIGYIOGJ-DUXPYHPUSA-N	C/C(=C\\C(N)C(=O)O)CP(=O)(O)O	127910-31-0	Glutamate Ionotropic Antagonists;NMDA Antagonists
GD-85-ST07	BDYHNCZIGYIOGJ-FYTLMZHYSA-N	C/C(=C\\[C@H](N)C(=O)O)CP(=O)(O)O		
AD-11-VE17	BDYHNCZIGYIOGJ-RQOWECAXSA-N	C/C(=C/C(N)C(=O)O)CP(=O)(O)O		Kainate receptor antagonist
IA-77-NA41	BEENXQCDTFXZSE-UHFFFAOYSA-N	CCN(CC)Cc1ccc(Cc2cc3cnc(C#N)nc3n2CC(C)(C)C)cc1		Cathepsin K Inhibitors
S0-EE-Y4UM	BEKCHDAUQRKKOP-QFIPXVFZSA-N	Cc1ccccc1Cn1c(=N)n(C[C@H](O)c2ccc(Cl)c(Cl)c2)c2ccccc21		small-molecule antogonist of CBX7ChD binding to H3K27me3 when the protein is bound to RNA
BB-62-SZ35	BEKCHDAUQRKKOP-UHFFFAOYSA-N	Cc1ccccc1Cn1c(=N)n(CC(O)c2ccc(Cl)c(Cl)c2)c2ccccc21		
CA-44-LT45	BEPGKLOHQTXUHX-UHFFFAOYSA-N	Nc1nc(-c2ccc(Cl)c(Cl)c2)c(-c2ccncc2)s1	252198-68-8	Adenosine A1 Antagonists;Adenosine A2B Antagonists;Adenosine A3 Antagonists;Phosphodiesterase IV Inhibitors;p38 MAPK Inhibitors
AA-86-YV75	BERLXWPRSBJFHO-UHFFFAOYSA-N	Fc1ccc(Cl)cc1-c1nc(Nc2ccncc2)c2nccnc2n1	1608481-61-3	Activin Receptor Like Kinase 5 (ALK5;TbetaR-I) Inhibitors
AD-31-GO06	BEXBLQHZZOBULC-UHFFFAOYSA-N	CN(C)CCCn1c(=S)[nH]c2cc(Cl)ccc2c1=O		
CE-09-ZT22	BFPYWIDHMRZLRN-SLHNCBLASA-N	C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C	1050678-65-3	Estrogen Receptor (ER) Agonists
BA-06-RE84	BFRCLEOOZWHYRB-UHFFFAOYSA-N	N#Cc1c(N2CCN(C(=O)c3cccs3)CC2)c2ccccc2n(CC(=O)c2ccccc2)c1=O		Macrophage Migration Inhibitory Factor (MIF) Inhibitors
AB-97-BI36	BFRIBJACCUKTCE-UHFFFAOYSA-N	CN(C)c1ccc(NC(=O)CCCCCCC(=O)NO)cc1		
BB-10-PR06	BFTKDWYIRJGJCA-CYBMUJFWSA-N	C[C@@H]1CC(=O)Nc2cccc(-c3ccc4c(c3)c(-c3cnn(C)c3)nn4C)c2N1		dual CBP/EP300 inhibitor
GA-94-MC54	BFTWJXMKBNDLCI-UHFFFAOYSA-N	N#Cc1c(N2CCCNCC2)n(CC=C(Cl)Cl)c2c(=O)n(Cc3nccc4ccccc34)cnc12		Autophagy agonist
KC-99-BS89	BFUSHSDZIILEJV-UHFFFAOYSA-N	NCc1c(-c2ccc(Cl)cc2Cl)cn2c(N3CC[S+]([O-])CC3)cnc2c1N		
FB-19-ZG81	BFXLAXBXCXOWNH-UHFFFAOYSA-N	O=C(Nc1ccc(Cl)cc1)c1cc(Cl)ccc1NS(=O)(=O)c1ccc(Cl)c([N+](=O)[O-])c1	136402-17-0	Phosphopantetheine Adenylyltransferase (PPAT) Inhibitors
CE-19-PD79	BGDKAVGWHJFAGW-UHFFFAOYSA-N	CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1	1508-75-4	CHRM4 antagonist;Anticholinergics;CHRM4 Antagonists
HC-43-CV47	BGEBZHIAGXMEMV-UHFFFAOYSA-N	COc1c2ccoc2cc2oc(=O)ccc12		
EF-83-OP68	BGFHMYJZJZLMHW-UHFFFAOYSA-N	CC(C)n1cnc2c(NCCc3ccc(O)cc3)nc(-c3csc4ccccc34)nc21	1227633-49-9	Stem cell expansion;Aryl hydrocarbon receptor antagonist
UE-58-EW15	BGLQTHFKBDXBFL-OUKQBFOZSA-N	COc1cc(/C=C/C(=O)CCCCc2ccccc2)cc(OC)c1O	179337-33-8	Lipoxygenase Inhibitors;Non-Steroidal Antiinflammatory Drugs
DE-85-LX22	BGQKEJPDGZHKNI-KFWWJZLASA-N	O=CN(O)C[C@@H](CC1CCC1)C(=O)N1C[C@H](F)C[C@H]1C(=O)Nc1cccnn1		Peptide Deformylase (PDF) Inhibitors
AD-51-ZE47	BGRJTUBHPOOWDU-UHFFFAOYSA-N	CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC	15676-16-1	Dopamine D2 Antagonists;Carbonic Anhydrase Type VII Inhibitors
BA-46-YF32	BGVCEGVSQDOGSB-UHFFFAOYSA-N	COc1ccc2c(c1)CN(C)CCS2	1357476-46-0	Ryanodine receptor modulator;RyR1/FKBP12 Complex Stabilzer;Drugs Acting on Ryanodine Receptor (RyR) Channels
AD-20-AA40	BGVLELSCIHASRV-QPEQYQDCSA-N	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21	300801-52-9	CDC-like kinase-1 inhibitors
CC-20-FN31	BHCJHYIMNHXLOM-WVDRJWPYSA-N	CN(C(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@@H](/C=C/C(=O)N[C@@H]1CCCCNC1=O)Cc1ccc(Cl)c(Cl)c1	398507-81-8	Tachykinin NK1 Antagonists;Tachykinin NK2 Antagonists
BE-29-DG26	BHLXTPHDSZUFHR-UHFFFAOYSA-N	CCc1c(C(=O)C(N)=O)c2c(OCC(=O)O)cccc2n1Cc1ccccc1	172732-68-2	Secretory Phospholipase A2 (sPLA2) Inhibitors
CB-11-GB40	BHNVQLOUIWHYIX-UHFFFAOYSA-N	Nc1cnc(Cl)cc1NC(=O)Nc1cc(C(F)F)ns1		ATPase SMARCA2, SMARCA4 Inhibitor
AA-87-MP18	BHPKEYRAZNXILG-UHFFFAOYSA-N	CCCn1c(-c2ccc(Nc3ccc(C)nc3)c(Cl)c2)nc2cccc(Cl)c21	1072930-44-9	mglu5 Receptor (mgluR5) Ligands
ED-92-AL11	BHQCQFFYRZLCQQ-OELDTZBJSA-N	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C	10321-98-9	Cholesterol-7-alpha-hydroxylase product and feedback inhibitor
KA-81-AG66	BIIVYFLTOXDAOV-YVEFUNNKSA-N	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1	131740-09-5	CDK9 inhibitor
LB-24-KP05	BIMZLRFONYSTPT-UHFFFAOYSA-N	O=C(O)CNC(=O)C(=O)O	5262-39-5	Prolyl 4-Hydroxylase Inhibitors
BF-31-BY55	BIQBRWYPZDSJSE-UHFFFAOYSA-N	CC(C)(CO)CCCc1ccc2cc(O)c(N3CC(=O)NS3(=O)=O)c(F)c2c1		
AA-15-VA57	BIWQNIMLAISTBV-UHFFFAOYSA-N	Cc1ccc(B(O)O)cc1	5720-05-8	Endothelial Lipase (EL) Inhibitors
DF-53-QT23	BJFSUDWKXGMUKA-UHFFFAOYSA-N	COc1cc(-c2cn(C)c(=O)c3cnccc23)c(OC)cc1CN(C)C		BRD7/9 inhibitor;BRD9 gene inhibitor
DF-70-CD57	BJMSUUATNLDQQZ-DGCLKSJQSA-N	CCCN1CCC[C@@H]2c3cccc(O)c3OC[C@H]21	100745-36-6	Dopamine Autoreceptor Agonists
OD-55-ZL32	BJXPIIDUCADEKU-UHFFFAOYSA-N	Nc1ccc(N2CCC(O)CC2)cc1	142752-12-3	CDK Inhibitors
JA-02-IU07	BJYYRCRVWTWSJI-UHFFFAOYSA-N	O=c1c2cnn(-c3ccccc3)c2ncn1C1CCCCCCC1	1056634-07-1	mglu1 Receptor (mgluR1) Ligands;mglu5 Receptor (mgluR5) Ligands
BB-83-ZM06	BJZSXNALNFWZMN-UHFFFAOYSA-N	CS(=O)(=O)c1ccc(Nc2nc(NCc3ccccn3)nc3c2ncn3-c2cscn2)cc1		Tyrosine Kinase Inhibitors
BD-90-DK64	BKCDJTRMYWSXMC-UHFFFAOYSA-N	COc1cc2c(cc1OCCCN1CCCC1)N=C(N)C21CCC1	1527503-11-2	EHMT1/2 inhibitor
VB-27-PZ25	BKJXSQXZIOTRTP-UHFFFAOYSA-N	Brc1cccc(-c2c[nH]nn2)c1	35225-02-6	Methionine Aminopeptidase-2 (MetAP2) Inhibitors;Angiogenesis Inhibitors
NA-42-JG03	BKUOEWUHERGWSO-DKIMLUQUSA-N	CN[C@@H](C)C(=O)N[C@H]1CC[C@H]2CC[C@@H](C(=O)NCCc3ccccc3)N2C1=O		
GF-03-HI41	BKVIWGRFRKLFIO-UHFFFAOYSA-N	COc1cc(COc2cc(N)c(Cl)cc2C(=O)CCC2CCN(CCNS(C)(=O)=O)CC2)cc(OC)c1	161362-65-8	HTR4 antagonist
JA-85-SW39	BKWJAKQVGHWELA-UHFFFAOYSA-N	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1	1075739-30-8	WEE1 gene inhibitor
BE-61-OB65	BLAFVGLBBOPRLP-UHFFFAOYSA-N	O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1	269390-77-4	VEGFR-2 (FLK-1/KDR) Inhibitors;Inhibitors of Signal Transduction Pathways;VEGFR-3 (FLT4) Inhibitors;Angiogenesis Inhibitors
BD-51-DB15	BLEWPNAUDGZWPU-UHFFFAOYSA-N	O=C(O)c1ccc(OCC(F)(F)C(F)(F)F)cc1O		
JF-45-JM50	BLGXFZZNTVWLAY-DIRVCLHFSA-N	COC(=O)[C@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@H]2CC[C@@H]1O	112350-93-3	alpha-Adrenoceptor Antagonists
ED-98-UI13	BLGXFZZNTVWLAY-SCYLSFHTSA-N	COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O	103834-06-6	alpha2-Adrenoceptor Antagonists
GB-93-CC27	BLLLAUHTNAVSQR-VXKWHMMOSA-N	N=C(N)NCCCCC(=O)Nc1ccc(C[C@H](NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccccc2)C(=O)O)cc1		alpha-v Beta1 integrin inhibitor
AB-18-YN11	BLMPQMFVWMYDKT-NZTKNTHTSA-N	CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1	868540-17-4	Proteasome inhibitor
AA-44-BX20	BLQAXSAXSUNGMZ-UHFFFAOYSA-N	COc1ccc(-c2cnc(Nc3ccc(CCN4CCC(C(=O)O)CC4)cc3)nc2)cc1		
BA-40-KU28	BLRWBQBUNHIMAF-CALCHBBNSA-N	CN1CCN([C@H]2CC[C@@H](n3cc(-c4ccc(N)c(F)c4)c4c(N)ncnc43)CC2)CC1		
ID-17-PL23	BLSNYSFLZAWBIV-SFHVURJKSA-N	O=C(C[C@@H](C(F)F)n1ccc(F)n1)N1CCC(O)(Cn2cnc3c(cnn3-c3ccc(F)cc3)c2=O)CC1		
FB-88-FZ09	BLSWPPPBUQFKHH-UHFFFAOYSA-N	CN1CCN(C(=O)c2[nH]c3ccc([N+](=O)[O-])cc3c2-c2ccccc2)CC1	459168-97-9	phenocopies NUCB1 shRNA. Compound is likely a NUCB1 inhibitor.
AB-87-KC82	BLTGDXMNAWRERE-UHFFFAOYSA-N	Cc1ccc(Oc2nc(-c3ccccc3)nc3ccsc23)cc1	691869-12-2	Prostanoid EP4 Agonists
OB-65-AI50	BLVQHYHDYFTPDV-VCABWLAWSA-N	Nc1cc(F)ccc1NC(=O)/C=C/c1cnn(C/C=C/c2ccccc2)c1	1357389-11-7	HDAC3;HDAC3 active-site competitive inhibitor
AA-39-BD24	BLZVCIGGICSWIG-UHFFFAOYSA-N	NCCOB(c1ccccc1)c1ccccc1	524-95-8	Inositol Triphosphate IP3 Receptor Antagonists;Gap junction modulators
BB-42-FF52	BMGQWWVMWDBQGC-IIFHNQTCSA-N	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4	120685-11-2	Inhibitors of Signal Transduction Pathways;Flt3 (FLK2/STK1) Inhibitors;Protein Kinase C (PKC) Inhibitors;Angiogenesis Inhibitors
GC-82-RV65	BMKDZUISNHGIBY-ZETCQYMHSA-N	C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1	149003-01-0	Topoisomerase II inhibitor
CE-95-YX02	BMSOUOUGKACGBB-UHFFFAOYSA-N	CC(=O)Nc1nc(-c2cc(C)cc(C)c2)c(-c2ccncc2)s1		Adenosine A3 Antagonists
DF-92-CF17	BMZRVOVNUMQTIN-UHFFFAOYSA-N	N#CC(C#N)=NNc1ccc(OC(F)(F)F)cc1		
RE-22-MW21	BMZWFSGTPJUKJR-UHFFFAOYSA-N	CCCN(CCC)C1Cc2c[nH]c3ccc(OC)c(c23)C1	98770-53-7	HTR1A agonist
S0-EE-X3ZT	BNDMVFTVBINJLL-KRWDZBQOSA-N	CCc1ccc(C(=O)N[C@@H](CC(C)C)C(=O)N2CCCC2)cc1		
AA-62-JP26	BNOYRDUPHFYYTI-GFCCVEGCSA-N	COc1nc(-c2cc(F)ccc2[C@H]2Cc3nc(N)nc(C)c3C(=O)N2)cs1		Heat Shock Protein 90 (hsp90) Inhibitors
BB-89-GD49	BNRNXUUZRGQAQC-UHFFFAOYSA-N	CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12	139755-83-2	phosphodiesterase PDE5A Inhibitors
IA-13-FI66	BNYDDAAZMBUFRG-ZDUSSCGKSA-N	N[C@@H](CC(=O)Nc1ccc(Oc2cc(F)c(F)cc2Br)cc1)C(=O)O	868359-05-1	Excitatory amino acid transporter 2 inhibitor
BB-25-NU80	BOBBYBHJYYJHHQ-UHFFFAOYSA-N	CC(C)(C)c1nc2[nH]c(=S)[nH]c(=O)c2cc1-c1ccc(Cl)cc1		TRPV1 (Vanilloid VR1 Receptor) Antagonists
DC-93-WC67	BOCUKUHCLICSIY-UHFFFAOYSA-N	NS(=O)(=O)c1cc2c(cc1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O	2259-96-3	AMPA Receptor Modulators
AB-53-AW00	BOFQWVMAQOTZIW-UHFFFAOYSA-N	O=C(O)c1ccc(-n2nc(-c3ccccc3O)nc2-c2ccccc2O)cc1		
HE-11-PK61	BOHKBSYMCUBXPE-UHFFFAOYSA-N	O=C1C=C(c2ccccc2)S(=O)(=O)c2c(O)cccc21	96156-26-2	Binds HSPA8 preveting it from binding to OCT4 which facilitates OCT4 binding to DNA
S0-EE-YRH3	BOOROEDYUBEHOH-UHFFFAOYSA-N	Cc1[nH]c2ncnc(N3CCC(CN)(C(=O)Nc4cccc(OC(=O)N(C)C)c4)CC3)c2c1C		LIMK1 gene inhibitor;LIMK2 gene inhibitor
EB-90-BR21	BOVGTQGAOIONJV-UHFFFAOYSA-N	Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1	21187-98-4	K(ATP) Channel Blockers
OF-63-KD88	BOVQARYZUMVBNE-UHFFFAOYSA-N	CCOC(=O)OCCOc1cc2cc(CC)nc(-c3cc(OC(C)C)cc(OC(C)C)c3)c2cc1OC		
DB-84-EQ63	BOWVQLFMWHZBEF-KTKRTIGZSA-N	CCCCCCCC/C=C\\CCCCCCCC(=O)NCCO	111-58-0	Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119)  Agonists;K(V)4.3 Channel Blockers
WB-17-DI74	BPBPYQWMFCTCNG-UHFFFAOYSA-N	CCC(C)SSc1ncc[nH]1	141400-58-0	Thioredoxin 1 competitive irrreversible inhibitor
BA-92-YC70	BPEGJWRSRHCHSN-UHFFFAOYSA-N	Cn1nnc2c(C(N)=O)ncn2c1=O		
RD-37-PW33	BPJKUWXILSKTLE-AZPGRJICSA-N	CCOc1ccccc1N/N=C1/C(=O)N(c2cc(O)cc(-c3ccc(N(C)C)cc3)c2)N=C1C		BAX activator
BB-86-BE19	BPNUQXPIQBZCMR-IBGZPJMESA-N	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12	552325-73-2	cAMP-Dependent Protein Kinase (PKA) Inhibitors;Inhibitors of Signal Transduction Pathways;PKB alpha/Akt1 Inhibitors
AD-91-FB70	BPRNMVDTWIHULJ-AWEZNQCLSA-N	Cc1csc2c(N[C@@H](C)CN3CCN(S(=O)(=O)c4ccc(Cl)c(Cl)c4)CC3)ncnc12	1017606-66-4	Lysophosphatidate-2 receptor antagonist
DB-62-ES23	BPSSRMKDODSXFM-UHFFFAOYSA-N	N#CC1=C(N)OC2=C(C(=O)CC(c3ccccc3)C2)C1c1cccnc1		
IC-07-VY79	BPZSYCZIITTYBL-UHFFFAOYSA-N	COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1	126587-85-7	ADRB2 agonist
OB-28-LD05	BQAGPJNWXSERCJ-UHFFFAOYSA-N	Nc1ccc(Cc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2)cc1		
PC-34-YF76	BQBVDVGDHJQNHX-UHFFFAOYSA-N	CC(C)(C)c1ccccc1Nc1ncccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1		P2Y Antagonist
BA-65-YU05	BQDUNOMMYOKHEP-UHFFFAOYSA-N	Cn1ncnc1COc1nn2c(-c3cc(F)ccc3F)nnc2cc1C(C)(C)C	286456-42-6	GABA(A) BZ Site Receptor Agonists;GABA(A) BZ Site Receptor Antagonists
EB-11-MR93	BQMSKLCEWBSPPY-CGSQRZAOSA-N	C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C		
FF-55-AD09	BQMSKLCEWBSPPY-IKVTXIKFSA-N	C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	64907-22-8	GPR183 activator;GPR183 Agonist;GPR183 agonist
KE-24-RZ94	BQNXBSYSQXSXPT-UHFFFAOYSA-N	Clc1cccc(Cl)c1CSc1nnc(-c2cnccn2)s1	448947-81-7	Piezo1 channel activator;GlyT-2 Inhibitors
VF-03-AC40	BQSAHQXKFMHFDM-YPXUMCKCSA-N	FC(F)(F)Oc1ccc(-n2cccc2/C=N/Nc2ncc(C(F)(F)F)cc2Cl)cc1		
WC-67-DI84	BRCWSGLQXAOWBL-UHFFFAOYSA-N	CC(=O)Nc1cc(Oc2ccc3c(C(=O)Nc4cc(N5CCN(C)CC5)cc(C(F)(F)F)c4)cccc3c2)ncn1		
AB-79-ZD24	BRLVOVGBNYPHBQ-UHFFFAOYSA-N	Clc1cccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)c1		DRD4 antagonist
EB-00-JQ48	BRPOADLGOFPKKJ-UHFFFAOYSA-N	CCn1c2c(c3ccccc31)CCSC2(C)CCN(C)C	42408-80-0	norepinephrine reuptake inhibitor;Drugs Acting on Adrenergic Transmission;norepinephrine reuptake inhibitor;Drugs Acting on Adrenergic Transmission
BA-65-YU25	BSCGZOZNKPEXSS-UHFFFAOYSA-N	Cc1ccc(Nc2ccc(Cl)c(C)c2Cl)c(CC(=O)O)c1	1000590-53-3	Cyclooxygenase-2 Inhibitors
AA-64-WG29	BSIZUMJRKYHEBR-QGZVFWFLSA-N	COc1ccc(S(=O)(=O)N(Cc2cccnc2)[C@@H](C(=O)NO)C(C)C)cc1	161314-70-1	MMP-2 (Gelatinase A) Inhibitors;MMP-9 (Gelatinase B) Inhibitors;MMP-8 (Neutrophil Collagenase) Inhibitors;Angiogenesis Inhibitors;Matrix metalloproteinase inhibitor;MMP-2 (Gelatinase A) Inhibitors;MMP-9 (Gelatinase B) Inhibitors;MMP-8 (Neutrophil Collagenase) Inhibitors;Angiogenesis Inhibitors;Matrix metalloproteinase inhibitor
ED-35-EX82	BSQHKYLMKDAHEX-GOSISDBHSA-N	C[C@@H]1CN(c2ccc3c(Nc4ccc(Cl)c(-c5ncc(-c6ccccc6)[nH]5)c4)nccc3n2)CCO1		Smoothened Antagonist
CA-39-ZJ18	BSYNRYMUTXBXSQ-UHFFFAOYSA-N	CC(=O)Oc1ccccc1C(=O)O	11126-35-5	Cyclooxygenase-2 Inhibitors;TP53 Expression Enhancers;Cyclooxygenase-1 Inhibitors;Nitric Oxide Donors;Non-Steroidal Antiinflammatory Drugs
AE-03-BM76	BTCSSZJGUNDROE-UHFFFAOYSA-N	NCCCC(=O)O	123774-72-1	
IC-96-AX39	BTGNGJJLZOIYID-UHFFFAOYSA-N	CC(C)(C)C(=O)Oc1ccc(S(=O)(=O)Nc2ccccc2C(=O)NCC(=O)O)cc1	127373-66-4	Leukocyte Elastase Inhibitors;Elastase inhibitor
BE-72-EW73	BTIHMVBBUGXLCJ-OAHLLOKOSA-N	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1	186692-46-6	CDK inhibitors
CA-17-QL18	BTNHEVIVMWRJSQ-CGAIIQECSA-N	O=C(O)[C@H](CCC1CCCCC1)NC1CCc2ccccc2N(Cc2ccc([N+](=O)[O-])cc2)C1=O		Angiotensin AT2 Antagonists
GC-40-VJ01	BUEHOQICFGQBNY-ACJLOTCBSA-N	O=C1C2=C(C(=O)c3ccccc31)[C@H]1Oc3ccccc3[C@H]1CO2		
DD-16-GL76	BUGYDGFZZOZRHP-UHFFFAOYSA-N	CC12CC3CC(C)(C1)CC(N)(C3)C2	19982-08-2	NMDA Antagonists
HE-10-QN66	BUIFCOFNXXUCMV-VHSXEESVSA-N	COc1ccc([C@H]2NC(=O)O[C@H]2CO)cc1		
HF-00-QG19	BUOWEYLLAFLKCW-FQEVSTJZSA-N	O=C(Nc1ccccc1)Nc1cnc2c(c1)C[C@@]1(CN3CCC1CC3)O2		Neuromedin U Receptor 2 (NMU2) Ligands
AF-67-LZ82	BURJZXYDAYWVQP-UHFFFAOYSA-N	Nc1ncc(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)c(N)n1		Phosphatidylinositol 3-Kinase alpha (PI3Kalpha) Inhibitors
CD-20-MH57	BVQCFCYPFJOOAV-UHFFFAOYSA-N	CCCCNNC(=O)c1ccc(Br)cc1	537672-41-6	HDAC3 gene inhibitor
XE-99-WG54	BVRYLTBIGIAADD-UHFFFAOYSA-N	CC(C)=CCC(OC(=O)C(C)C)C1=CC(=O)c2c(O)ccc(O)c2C1=O		
BD-31-AE17	BVSGXWCTWBZFEV-UHFFFAOYSA-N	OCc1cccc2[nH]ccc12	1074-85-7	OPRL1 antagonist
TA-19-YA45	BVWHOZYQECWMFG-UHFFFAOYSA-N	Cc1ccc(-c2nc3ccccc3[nH]2)cc1NC(=S)NC(=O)c1ccc2c(c1)OCCO2	832093-32-0	antagonist of neuropilin-1 receptor
AA-23-FM46	BWDQBBCUWLSASG-MDZDMXLPSA-N	O=C(/C=C/c1ccc(CN(CCO)CCc2c[nH]c3ccccc23)cc1)NO	404951-53-7	HDAC 1/2/3/6/8/10/11;Antimitotic Drugs;Apoptosis Inducers;Histone Deacetylase (HDAC) Inhibitors
BE-70-CU78	BWSWBMFOGKKNQV-UHFFFAOYSA-N	Nc1cc2cccnc2c(-c2ccc3nonc3c2)n1	426268-10-2	Phosphodiesterase IV Inhibitors;TNF-alpha Release Inhibitors
VE-59-SD17	BWUYGRHIDKUYBU-UHFFFAOYSA-N	Cc1ccc(-c2ccc(CNCCCP(=O)(O)O)nc2-c2ccccc2)cc1	1011302-24-1	Lysophospholipid edg3 (S1P3) Receptor Antagonists;Lysophospholipid edg1 (S1P1) Receptor Agonists
JF-76-BD96	BWZNJVZTAWBIFG-UHFFFAOYSA-N	Cc1c(C(=O)Nc2ccc(N3CCC(N4CCOCC4)CC3)c(C#N)c2)cnn1-c1ccc(Cl)cc1		
AE-65-KK96	BXBNADAPIHHXJQ-UHFFFAOYSA-N	O=C(c1ccc2c(c1)OCO2)N1CCCCC1	34023-62-6	AMPA Receptor Postiive Allosteric Modulators
DB-11-SS01	BXDZOYLPNAIDOC-UHFFFAOYSA-N	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCN(CC(=O)NCCOCCOCCOCCNc4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)s2)o1		
JB-74-LF71	BXMNCESJTBYMLU-UHFFFAOYSA-N	CCN(CC)c1ccc(-c2nc(Nc3ccc(N4CCOCC4)cc3)nc3[nH]cnc23)cn1	1042917-07-6	Jak3 Inhibitors
BD-41-DI77	BXNJHAXVSOCGBA-UHFFFAOYSA-N	COc1ccc2c(c1)[nH]c1c(C)nccc12	122992-92-1	CDK5 Inhibitors;Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (DYRK1A) Inhibitors;CDK2 Inhibitors
BD-59-MG06	BXNMTOQRYBFHNZ-UHFFFAOYSA-N	CCOCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)O	144875-48-9	Interferon Inducers;TLR7 Receptor Agonists;TLR8 Receptor Agonists;TNF-alpha Production Inducers
TD-36-JP74	BXVNPOBNVRBOOV-UHFFFAOYSA-N	Cc1cc(N2CCOCC2)nc2ccc(NC(=O)C3CCCCC3)cc12	442898-34-2	Glucosylceramidase inhibitor
BB-28-CT35	BYDKAYRDAFQMFD-ZMSDIMECSA-N	COc1ccc(-c2cc3c(cc2[C@@H]2CCN(C)C[C@@H]2C)N2C(=NNC(=O)[C@H]2C)CO3)c(F)c1	1613718-79-8	PKC theta inhibitor
GF-57-LR72	BYDKEYCXCIVOOV-JTSKRJEESA-N	N=C(N)N1CCC[C@@H](CNC(=O)C[C@H](NS(=O)(=O)c2ccc3ccccc3c2)C(=O)N(CC(=O)O)C2CC2)C1	154397-77-0	Known Thrombin inhibitor
IB-26-FG03	BYJPCXBLOMYOLW-UHFFFAOYSA-N	CC(C)(N)Cc1c[nH]c2ccc(O)cc12		
RF-47-PC15	BYLOIWCTRDPRTP-UHFFFAOYSA-N	O=[N+]([O-])c1cc([N+](=O)[O-])c2nsnc2c1		
BB-11-JI42	BYPBFDASESWSQG-CABCVRRESA-N	C[C@@H]1COCCN1c1nc(N2CCOC[C@@H]2C)nc2[nH]c(-c3cccc4[nH]ccc34)nc12	1392421-71-4	Mammalian Target of Rapamycin (mTOR;FRAP1) Inhibitors
BA-68-FJ41	BYPBFDASESWSQG-HUUCEWRRSA-N	C[C@@H]1COCCN1c1nc(N2CCOC[C@H]2C)c2nc(-c3cccc4[nH]ccc34)[nH]c2n1	1392421-43-0	Mammalian Target of Rapamycin (mTOR;FRAP1) Inhibitors
AA-09-HG96	BYPFEZZEUUWMEJ-UHFFFAOYSA-N	CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O	6493-05-6	Chitinase Inhibitors;Phosphodiesterase Inhibitors;TNF-alpha Production Inhibitors
CC-85-XK71	BYTNEISLBIENSA-MDZDMXLPSA-N	CC(C)c1onc(-c2c(Cl)cccc2Cl)c1COc1ccc(/C=C/c2cccc(C(=O)O)c2)c(Cl)c1	1089660-72-9	Farnesoid X Receptor (FXR) Agonists
HA-03-TL98	BYTVHKDJAGIKDO-IZLXSQMJSA-N	NO[C@H]1CC[C@H](N)CC1		Antimetabolites;Ornithine Decarboxylase Inhibitors
TA-25-ZO44	BYWWNRBKPCPJMG-UHFFFAOYSA-N	CCCCCCCCCCCCc1ccc(S(=O)(=O)Nc2nncs2)cc1	1191951-57-1	Protein Kinase B (PKB/Akt) Inhibitors;Phosphoinositide dependent Kinase (PDK) 1 Inhibitors
CC-15-HU70	BYXZFAIHAQVBAH-XYOKQWHBSA-N	O=C(O)CNC(=O)/C(=C\\c1cccc(Br)c1)NC(=O)c1ccco1		ADAM12 gene inhibitor
KE-02-TK48	BYYQYXVAWXAYQC-IBGZPJMESA-N	CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OCc1cc(C(F)(F)F)cc(C(F)(F)F)c1	148451-96-1	TACR1 antagonist
GB-16-SU72	BZCALJIHZVNMGJ-HSZRJFAPSA-N	Cc1cc(OCCCS(C)(=O)=O)cc(C)c1-c1cccc(COc2ccc3c(c2)OC[C@H]3CC(=O)O)c1	1000413-72-8	Free Fatty Acid Receptor 1 (FFAR1; GPR40) Agonists
S0-EE-Y7IR	BZFGYHOKTSIEDA-VMPREFPWSA-N	C=CCN1CC(=O)N2[C@@H](Cc3ccc(OP(=O)(O)O)cc3)C(=O)N(Cc3cccc4cn(C)nc34)C[C@@H]2N1C(=O)NCc1ccccc1		Wnt signaling inhibitor, Inhibitor of beta-catenin/TCF transcription
AF-81-IV73	BZKPWHYZMXOIDC-UHFFFAOYSA-N	CC(=O)Nc1nnc(S(N)(=O)=O)s1	124442-28-0	Carbonic Anhydrase Type II Inhibitors;Carbonic Anhydrase Type XIII Inhibitors;Carbonic Anhydrase Type VI Inhibitors;Carbonic Anhydrase Type XIV Inhibitors;Carbonic Anhydrase Type XV Inhibitors
CF-50-MN16	BZMKNPGKXJAIDV-VAWYXSNFSA-N	CCC(CC)(CC(=O)Nc1cccc(/C=C/c2nc(C3CCC3)cs2)c1)C(=O)O	128312-51-6	CYSLTR1 antagonist
ME-77-TQ29	BZVVANAWXKAZCB-UHFFFAOYSA-N	CC(C)(CCC(C)(C)NCc1ccccc1O)NCc1ccccc1O	67360-01-4	TRPA1 Antagonists
BE-04-AN21	BZZYIHQWCXHSMZ-FMSKOOSDSA-N	COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCNC(=O)C4)CC3)cc1)C(=O)C2		Mdm2 p53-binding protein inhibitor
DA-77-II31	CACMCLIHCDTJHL-IDTAVKCVSA-N	CCNC(=O)NCCSC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O		Dual PRMT5 and PRMT7 inhibitor
EF-30-GD67	CAOSCCRYLYQBES-UHFFFAOYSA-N	O=C(O)CNC(=O)c1c(O)c2ccccc2n(Cc2ccccc2)c1=O	931398-72-0	EGLN1 inhibitor;EGLN1 gene inhibitor;EGLN1 inhibitor;EGLN1 gene inhibitor
WB-43-IC00	CAOTVXGYTWCKQE-UHFFFAOYSA-N	O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2	915385-81-8	Sphingosine Kinase 2 (SphK2) Inhibitors;Angiogenesis Inhibitors
CE-09-HG76	CBEQULMOCCWAQT-WOJGMQOQSA-N	Cc1ccc(/C(=C\\CN2CCCC2)c2ccccn2)cc1	10191-42-1	HRH1 antagonist
AE-94-OX50	CBOJJLBUFHIFCB-UHFFFAOYSA-N	CN1CCN(C(=O)Cn2c(=O)c3ccccc3n(CC(=O)Nc3cc(Cl)nc(Cl)c3)c2=O)CC1	1052722-94-7	S1PR2 antagonist;S1PR4 antagonist
JA-32-HE94	CBSRETZPFOBWNG-UCORVYFPSA-N	N[C@H]1C[C@@H](C(=O)O)CC1=C(F)F	640897-20-7	Covalent inhibitor of GABA aminotransferase
CF-02-MS93	CCAWRGNYALGPQH-UHFFFAOYSA-N	O=C(Nc1cccc(C(F)(F)F)c1)Nc1cc(S(=O)(=O)NC2CC2)ccc1-c1ccsc1	1432660-47-3	Isocitrate Dehydrogenase (NADP+) (IDPm, IDH2) (Arg140Gln Mutant) Inhibitors
QC-22-LC33	CDIHUCDJCVAPSM-UHFFFAOYSA-N	O=C(Nc1ccc(C(=O)N2CCCCC2)cc1)c1ccc(F)cc1		
CA-53-TT18	CDJNNOJINJAXPV-UHFFFAOYSA-N	Cc1cc(-c2nc(-c3ccc(OC(F)(F)F)cc3)no2)nn1Cc1ccnc(N2CCN(C3CC3)CC2)c1	1227158-85-1	HIF-1 inhibitor;HIF target gene expression suppressor
AE-94-ZD47	CDMGBJANTYXAIV-UHFFFAOYSA-N	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1	152121-47-6	Stress-Activated Protein (SAP/Jun) Kinase Inhibitors;Calcium Channel Activators;p38 MAPK Inhibitors
VE-33-MT21	CDOOFZZILLRUQH-GDLZYMKVSA-N	Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccc([C@@H]3C(=O)N(C)CCN3C)cc2)n1	1133432-46-8	Bruton's Tyrosine Kinase (BTK) Inhibitors
FE-56-PV35	CDOVNWNANFFLFJ-UHFFFAOYSA-N	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1	1062368-24-4	Activin Receptor Like Kinase 3 (ALK3 BMPR-IA) Inhibitors;Activin Receptor Like Kinase 2 (ALK2 ActR-IA) Inhibitors
DB-33-TM61	CDOZDBSBBXSXLB-UHFFFAOYSA-N	CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21	1094-08-2	NMDA Antagonists;Butyrylcholinesterase Inhibitors
ID-26-HX79	CDQUJZKBRAFWNG-UHFFFAOYSA-N	O=[N+]([O-])c1c(Nc2cc(F)cc(Cl)c2)ccc2nonc12	1422955-31-4	HIF-2;HIF-2 Inhibitor
FF-01-OH44	CDSXVXMUMRBIGJ-UHFFFAOYSA-N	Cc1cc(NCc2c(Cl)ccc(Cl)c2Cl)c2cccc(C(N)=O)c2n1		CD38 inhibitor
AC-47-YZ27	CEDLXWRFEZCVEU-INIZCTEOSA-N	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)CC(C)C)c3)cc12		CDC-like kinase-2 inhibitors
DA-17-XI26	CEGSUKYESLWKJP-UHFFFAOYSA-N	c1ccc2c(CCNc3ccc(Nc4ccncc4)cc3)c[nH]c2c1	881202-16-0	MDM2 (hdm2) Inhibitors
FE-49-VJ28	CEIJFEGBUDEYSX-FZDBZEDMSA-N	O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCN1CCN(c2ncccn2)CC1	112457-95-1	5-HT1A Receptor Agonists
PC-68-HN64	CEKYOUIQCZPVSY-UHFFFAOYSA-N	COc1cc(-c2cnc(N)c(-c3nc4cc(F)ccc4[nH]3)n2)ccc1OCCN1CCCC1	1100094-16-3	HGFR (MET;c-Met) Inhibitors;AXL Kinase Inhibitors
BA-44-WG29	CEMAWMOMDPGJMB-UHFFFAOYSA-N	C=CCOc1ccccc1OCC(O)CNC(C)C	22972-96-9	beta-Adrenoceptor Antagonists
IC-08-NY46	CEUDWZXMLMKPNN-SOFGYWHQSA-N	CC(=O)N(O)C/C=C/c1cccc(Oc2ccccc2)c1		
RD-92-QT24	CEUMAXLRGBKFQP-UHFFFAOYSA-N	Cc1cc(Nc2cc(Cl)nc(Oc3ccc([N+](=O)[O-])cc3)n2)n[nH]1		
BC-19-GQ25	CEUORZQYGODEFX-UHFFFAOYSA-N	O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1	1026778-41-5	Dopamine D2 Receptor Partial Agonists;5-HT1A Receptor Partial Agonists;ADRA1B gene inhibitor;HTR2A gene inhibitor
FB-13-ES60	CFBUZOUXXHZCFB-OYOVHJISSA-N	COc1ccc([C@]2(C#N)CC[C@@H](C(=O)O)CC2)cc1OC1CCCC1	153259-65-5	IL-12 Production Inhibitors;Phosphodiesterase IV Inhibitors;TNF-alpha Production Inhibitors;IL-1beta Production Inhibitors
IA-00-RJ06	CFHPNABTZSOBQJ-UHFFFAOYSA-N	Cc1cccc(NC(=N)N=C(N)N)c1	19579-42-1	5-HT3 receptor agonist
SD-15-WR01	CFKHTEWRARJPEJ-SNVBAGLBSA-N	C[C@@](O)(C(=O)Nc1ccc(C(=O)O)cc1Cl)C(F)(F)F	243982-49-2	Pyruvate Dehydrogenase Kinase (PDHK;PDK) Inhibitors
BF-49-IA57	CFMZSMGAMPBRBE-UHFFFAOYSA-N	O=C1c2ccccc2C(=O)N1O	3229-40-1	Ribonucleoside-Diphosphate Reductase Inhibitors
DD-82-HB82	CFOOTBBXHJHHMT-UHFFFAOYSA-N	CC(C)N1CCC(c2ccccc2)(c2ccccc2)CC1	31314-38-2	
BB-75-YK01	CFOTUZHUTFRFQA-UHFFFAOYSA-N	O=C1OC2CN1CCC2OCc1ccccc1		
LA-86-XT29	CFSOJZTUTOQNIA-UHFFFAOYSA-N	CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(N=[N+]=[N-])ccc1-2	91917-65-6	GABA(A) BZ Site Receptor Inverse Agonists
FE-27-XB49	CGDZXLJGHVKVIE-DNVCBOLYSA-N	O=C(N[C@@H]1CC[C@@H](c2cccc(F)c2F)CN(CC(F)(F)F)C1=O)N1CCC(n2c(=O)[nH]c3ncccc32)CC1	781649-09-0	CGRP antagonist;Calcitonin gene peptide ligand inhibitor;CGRP antagonist;Calcitonin gene peptide ligand inhibitor
BA-41-QF30	CGGOJJPTDGHQBH-UHFFFAOYSA-N	O=C(Cc1ccccc1)NCc1ccc2c(c1)CN(C1CCC(=O)NC1=O)C2=O		
BC-95-MO06	CGIGDMFJXJATDK-UHFFFAOYSA-N	COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1	28751-45-3	Cyclooxygenase-3 Inhibitors;Cyclooxygenase-1 Inhibitors;Cyclooxygenase-2 Inhibitors;Non-Steroidal Antiinflammatory Drugs
BD-69-XG81	CGSGRJNIABXQJQ-CAAOHEDASA-N	C=C(C)[C@@]12OC3(/C=C/C=C/CCCCC)O[C@@H]1[C@@H]1[C@@H]4O[C@]4(CO)[C@@H](O)[C@]4(O)C(=O)C(C)=C[C@H]4[C@@]1(O3)[C@H](C)[C@H]2OC(=O)c1ccccc1	60195-70-2	DNA topoisomerase I inhibitor;PKC activator;Protein kinase C alpha stimulator
DE-81-PO11	CGWBJJZOKGZCSJ-UHFFFAOYSA-N	CCCOc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2CCN2CCOCC2)cc1		N-Ac Lysine competitive CREBBP/EP300 inhibitor
ME-14-LE68	CGWOMXNQGSNOHL-UHFFFAOYSA-N	Nc1ncnc2c1c(-c1ccccc1)nn2-c1ccccc1	129852-40-0	Tyrosine Kinase Inhibitors
MD-91-HM15	CGYJGYNVEBFJEL-AWRGLXIESA-N	CCO[C@H]1CC[C@@](CS)(C(=O)N[C@@H](Cc2ccccc2)C(=O)Nc2cccnc2)CC1		MMP-9 (Gelatinase B) Inhibitors
GC-35-PT27	CHAYRPTYNSHELC-JCYRPKCISA-N	CCO[C@H]1CC[C@@](CS)(C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccccc2)CC1		MMP-9 (Gelatinase B) Inhibitors
ZE-53-LS38	CHDGNNAJDRBUIH-UHFFFAOYSA-N	c1ccc(C(NCCNC2c3ccccc3-c3ccccc32)c2ccccc2)cc1		
LB-65-SM65	CHILCFMQWMQVAL-UHFFFAOYSA-N	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O	634914-41-3	IKK-2 (IKK-beta) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors
AF-42-MP86	CHMSTEQGSHSXDA-UHFFFAOYSA-N	O=C(Nc1ccc(-c2nc3cc(NC(=O)C4CC4)ccc3[nH]2)cc1)C1CC1		
FA-02-RV60	CHNUOJQWGUIOLD-SMTGYRLFSA-N	CC(=C\\c1ccccc1)/C=C1/SC(=S)N(CC(=O)O)C1=O	82159-09-9	Aldose Reductase Inhibitors
EB-92-TL51	CIJVRWOHLBHSJS-UHFFFAOYSA-N	COc1ccccc1C(=O)Nc1cc(Cl)ccc1O		
BD-18-MM33	CITNMKKLNPYCDV-OVCLIPMQSA-N	O=C(/C=C/c1ccc(NS(=O)(=O)c2ccc(-c3ccccc3)cc2)cc1)NO		Histone Deacetylase (HDAC) Inhibitors
GC-86-TD91	CJAWPFJGFFNXQI-UHFFFAOYSA-N	Clc1cncc(N2CCNCC2)n1	61655-58-1	5-HT2C Agonists
EA-95-OQ30	CJJOSEISRRTUQB-UHFFFAOYSA-N	COP(=S)(OC)SCn1nnc2ccccc2c1=O		
JF-55-EN33	CJLMANFTWLNAKC-UHFFFAOYSA-N	COc1cc(-c2cc(-c3cccc(O)c3)cnc2N)cc(OC)c1OC	1431985-92-0	ACVRL1 gene inhibitor
AC-20-SO29	CJOFXWAVKWHTFT-XSFVSMFZSA-N	COCCCC/C(=N\\OCCN)c1ccc(C(F)(F)F)cc1	54739-18-3	5-HT Reuptake Inhibitors
PB-18-HD85	CKCSOMMBIPJYSG-UHFFFAOYSA-N	COc1cc2nc(CN3CC=C(c4ccccc4)CC3)[nH]c(=O)c2cc1OC		
OA-80-YT10	CKFRXCBNKKOFGO-IGEOTXOUSA-N	C[C@H]1CC(=O)Nc2cc(C(=O)NCCC3CC3)ccc2N1C(=O)N1CC2CC2C1		
MA-58-RR04	CKLGZXFOLMHCMC-UHFFFAOYSA-N	COc1ccc(CN2C(=O)C(=O)c3cc(OC(F)(F)F)ccc32)cc1	1160247-92-6	M5 positive allosteric modulator
BB-01-IO76	CKLJMWTZIZZHCS-REOHCLBHSA-N	N[C@@H](CC(=O)O)C(=O)O		
HA-30-KD77	CKNAQFVBEHDJQV-UHFFFAOYSA-N	Cc1c(-c2cnccn2)ssc1=S	64224-21-1	AMPK Activator;Nuclear Factor, Erythroid Derived 2, Like 2 (Nrf2) Activators;S6K1 Inhibitor
MD-06-ZJ05	CKTSBUTUHBMZGZ-SHYZEUOFSA-N	Nc1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1		
HC-38-KI38	CLEDYXXBPZCGOA-WDNCENIBSA-N	CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1cncc(Oc2ccc(F)cc2)c1)C1CCCCC1	1005342-49-3	Inhibitor of Apoptosis Proteins (IAP) Inhibitors;Apoptosis Inducers
EB-33-ZP53	CLGRAWDGLMENOD-UHFFFAOYSA-N	CC(C)(O)C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1	1260181-14-3	Jak3 tyrosine kinase inhibitor
DC-22-HS83	CLPFFLWZZBQMAO-CQSZACIVSA-N	N#Cc1ccc([C@H]2CCCc3cncn32)cc1	102676-87-9	Cytochrome P450 11B2 (Aldosterone Synthase) Inhibitors
EE-32-EY37	CMCWWLVWPDLCRM-UHFFFAOYSA-N	O=C1CCN(c2ccccc2)N1	14776-33-1	Cyclooxygenase (COX) Inhibitors;Lipoxygenase Inhibitors;Antioxidants
LD-67-CX31	CMDFESOYJXRUSW-UHFFFAOYSA-N	COc1ccccc1N1CCN(CCCn2nnc3ccccc32)CC1	156007-21-5	5-HT1A Receptor Antagonists;ADRA1B gene modulator
BC-85-QR33	CMJCXYNUCSMDBY-ZDUSSCGKSA-N	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1	1269440-17-6	Mutant Raf kinase B Inhibitors
CE-39-DG56	CMNKCJOQYZYEJJ-HSZRJFAPSA-N	CCOC(=O)N1CCN(C(=O)CC[C@H](C(=O)NO)N(Cc2ccc3c(c2)OCO3)S(=O)(=O)c2c(C)cc(OC)c(C)c2C)CC1		Procollagen C-Proteinase Inhibitors
FD-37-GE41	CMSGWTNRGKRWGS-NQIIRXRSSA-N	CCOC(=O)N1c2ccc(C(F)(F)F)cc2[C@@H](N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C(=O)OC)C[C@H]1CC	262352-17-0	Cholesteryl Ester Transfer Protein (CETP) Inhibitors
EE-57-RZ27	CMWTZPSULFXXJA-VIFPVBQESA-N	COc1ccc2cc([C@H](C)C(=O)O)ccc2c1	131991-52-1	Non-Steroidal Antiinflammatory Drugs
JA-42-NH96	CMYCCJYVZIMDFU-UHFFFAOYSA-N	C=CCN(C)CCCCCCOc1ccc(C(=O)c2ccc(Br)cc2)c(F)c1	161582-11-2	lanosterol synthetase inhibitor
HC-01-FD24	CNBOKXFMODKQCT-UHFFFAOYSA-N	CC(C)(O)Cn1cnc2c(N)nc3ccccc3c21		
BB-69-WN73	CNIKCJIPPYDKEJ-LGCWNYSLSA-O	O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C(O)(c1ccccc1)c1ccccc1)C2)Nc1ccon1		Muscarinic M1 Antagonists;Muscarinic M2 Antagonists;Muscarinic M3 Antagonists
CF-46-PR45	CNJGWCQEGROXEE-UHFFFAOYSA-N	O=C(O)c1cc(Cl)cc(Cl)c1O	106086-54-8	Aldo keto reductase 1C1 inhibitor
BC-56-WO88	CNNZLFXCUQLKOB-BMRADRMJSA-N	CO/N=C1/C=C(C#Cc2cccc(C)n2)CCC1		mgluR5 Antagonists
EF-20-MG69	COCYGNDCWFKTMF-UHFFFAOYSA-N	O=c1cc(-c2ccccc2)oc2c(O)c(O)ccc12	38183-03-8	TRKB Activators
EC-95-BQ25	COFOABYDLYTAJX-UHFFFAOYSA-N	CC(C(=O)O)c1ccc2c(c1)C(=O)c1ccccc1CS2		DNA Polymerase Inhibitors;ATPase Inhibitors
LD-96-DG13	COFVZFLCAOUMJT-OAQYLSRUSA-N	COc1cc2c(cc1OC)CN(C(=O)[C@@H](NCc1ccncc1)C(C)(C)C)CC2	1610882-30-8	HCRTR2 antagonist;Orexin OX-2 Antagonists
EE-66-OE89	COKMIXFXJJXBQG-NRFANRHFSA-N	CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O	1331911-68-2	Integrin binder;Integrin alpha-2/beta-3 antagonist
BC-43-JW95	COLNVLDHVKWLRT-QMMMGPOBSA-N	N[C@@H](Cc1ccccc1)C(=O)O		
IF-86-OK88	COQPVKMATNFNLG-UHFFFAOYSA-N	COc1ccc(-n2cnc3c(sc4nccc(N(C)C)c43)c2=O)cc1		mgluR1 Antagonists
MD-84-YS12	COTBDKMEUUNJTI-UHFFFAOYSA-N	Cc1cc(C)nc(NS(=O)(=O)c2ccc(NC(=O)NC(=O)c3ccc(Cl)cc3Cl)cc2)n1	1267610-30-9	PCTP (StARD2) Inhibitor
DE-69-QQ25	COUMZXFUZDBRCZ-UHFFFAOYSA-N	COc1ccc(Cn2c3ncnc4c(ncn4Cc4ccc(OC)cc4)c-3nc2=O)cc1	1070773-09-9	DDX3X gene inhibitor
TD-09-SX65	CPJICALSLDLRJP-UHFFFAOYSA-N	Cc1nc(C)c(-c2ccnc(Nc3cccc(Cl)c3)n2)s1		CDK Inhibitors
HD-86-DD86	CPLWILRNNYRJLA-SWLSCSKDSA-N	Cc1c(CO)c2cnnc(OCc3ccc(F)cc3)c2n1C[C@H]1C[C@@H]1C		H+/K+-ATPase Inhibitors
CC-47-VS90	CPRAGQJXBLMUEL-UHFFFAOYSA-N	Cc1cc(C(C)Nc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1	663619-89-4	PI3Kbeta inhibitor
ZB-92-PL24	CPZBLNMUGSZIPR-NVXWUHKLSA-N	O=C1c2cccc3c2[C@H](CCC3)CN1[C@@H]1CN2CCC1CC2	1021481-16-2	5-HT3 Antagonists
FA-77-YL98	CQASZSQCUYWGME-CYBMUJFWSA-N	Nc1nccc(Sc2cnc(N3CCC4(CCC[C@H]4N)CC3)cn2)c1Cl		SHP2 allosteric inhibitor
EB-85-DG91	CQDWPOURVPAZAM-UHFFFAOYSA-N	N=C(N)NCCCCC(=O)NCC(=O)NC(CC(=O)O)c1cccnc1	181819-08-9	Inhibitors of Blood Coagulation Pathways;Integrin alphaIIbbeta3 (Fibrinogen gpIIb/IIIa) Antagonists;Integrin alphavbeta3 (Vitronectin) Antagonists
IF-23-HY54	CQGQVNKFCSRASR-UHFFFAOYSA-N	NS(=O)(=O)Oc1ccc(Cl)cc1	25998-89-4	Carbonic Anhydrase Type II Inhibitors;Carbonic Anhydrase Type I Inhibitors
BA-64-PX65	CQOVPNPJLQNMDC-ZETCQYMHSA-N	NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O		
GA-41-JD09	CQPMMSAANJNLLH-BDJLRTHQSA-N	C[C@@H]1CN(C(=O)[C@@](C)(O)C(F)(F)F)CCN1C(=O)c1ccc(C#N)cc1		Pyruvate Dehydrogenase Kinase (PDHK;PDK) Inhibitors
EF-80-OD07	CQVJHSRCERJIHG-UHFFFAOYSA-N	CN(c1nnc(-c2c(O)cc(-c3cn[nH]c3)c(F)c2F)s1)C1CC(C)(C)NC(C)(C)C1	1620515-56-1	splicing modulator
PE-00-US47	CQWDZNQKJPNNJB-SCRDCRAPSA-N	O=C(NC1=CC(=O)[C@]2(CO)O[C@@H]2[C@H]1O)c1cccc(Cl)c1O	200496-86-2	Histidine Decarboxylase Inhibitors;Antiinflammatory Drugs
BD-90-SE75	CQXADFVORZEARL-UHFFFAOYSA-N	C1COC(NC(C2CC2)C2CC2)=N1	207572-68-7	Imidazoline I1 Receptor Agonists
IF-81-QQ90	CRFFZGAVKNNBKJ-UHFFFAOYSA-N	CCCOc1ccc(NS(C)(=O)=O)cc1-c1nc2c(c(C)nn2C)c(=O)[nH]1	168464-34-4	Phosphodiesterase Inhibitors
RA-25-SB63	CRJDCNONHYCPDW-UHFFFAOYSA-N	N=C(N)c1ccc(CNC(=O)c2cnn(Cc3ccc4ccccc4c3)c2)cc1		Known PlasmaKallikrein inhibitor
AB-07-AZ97	CRXJBISLCDTJDM-UHFFFAOYSA-N	O=C(C1CCCCC1)N1CCN(S(=O)(=O)c2cccc(C(F)(F)F)c2)CC1		Pyruvate Kinase Isozyme M2 (PKM2) Activators
BD-60-XA25	CRZZRJJSUJLGGC-UHFFFAOYSA-N	CCCn1c(-c2ccc(Nc3ccc(C)nc3)nc2)nc2cccc(Cl)c21		
CE-35-LA42	CSPZFLWZGHVAPG-UHFFFAOYSA-N	O=C(Nc1cc(-c2ccccc2)n[nH]1)n1ccc2cc(Oc3ncnc4c3CCNC4)ccc21		
OB-46-IM27	CTBNDZPQBKVVNM-UHFFFAOYSA-N	CC(=O)NCCNc1ncccc1-c1ccnc(Nc2cccc(Cl)c2)n1		
CF-26-ME34	CTDQKZGWJQNLIZ-UHFFFAOYSA-N	O=S(=O)(NCCc1c[nH]c2ccccc12)c1ccccc1	32585-54-9	15-Lipoxygenase Inhibitors
AD-86-ES28	CTEGQKDJTBWFHW-UHFFFAOYSA-N	COc1nc2sc(C(=O)NC3CC3)c(N)c2c(C)c1Cl	886047-13-8	M4 positive allosteric modulator
BC-57-KZ72	CTESJDQKVOEUOY-UHFFFAOYSA-N	N#Cc1c(O)c2c(-c3ccc(-c4ccccc4O)cc3)csc2[nH]c1=O	844499-71-4	AMP-Activated Protein Kinase (AMPK) Activators
JA-01-GQ75	CTNQAPPDQTYTHM-UHFFFAOYSA-N	O=C(Nc1cccc(C(F)(F)F)c1)Nc1ccccc1C(=O)O	1566-81-0	Chloride Channel Blockers
BA-23-MC77	CTRLABGOLIVAIY-UHFFFAOYSA-N	NC(=O)N1c2ccccc2CC(=O)c2ccccc21	28721-07-5	Sodium Channel  Blockers
HE-99-KP87	CTXSAOLIPRDNRU-UHFFFAOYSA-N	Cc1cc(OCc2nc(-c3ccc(OC(C)C)cc3)c(-c3ccc(OC(F)(F)F)cc3)s2)ccc1OCC(=O)O		
DE-93-IC37	CUGFLOKHGAUBLN-UHFFFAOYSA-N	O=C1Nc2ccc(C(=O)O)cc2/C1=N/Nc1ccccc1C(=O)O		Protein Tyrosine Phosphatase PTP-1B Inhibitors;Protein Tyrosine Phosphatase SHP-2 (PTP2C) Inhibitors;Protein Tyrosine Phosphatase PTP-1C Inhibitors
CC-25-QN53	CUHVIMMYOGQXCV-UHFFFAOYSA-N	Cc1cccc(C(C)c2c[nH]cn2)c1C	106807-72-1	Extracellular-regulated kinase (ERK) Activators;alpha2-Adrenoceptor Agonists;ADRA2A agonist;ADRA2B agonist;ADRA2C agonist
BC-81-LO06	CUKGVKDSSJVBFD-UHFFFAOYSA-N	O=Cc1ccc(-n2ccnn2)cc1		
BD-44-FH87	CURUTKGFNZGFSE-UHFFFAOYSA-N	CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1	104959-55-9	Muscarinic M1 Antagonists
EC-71-PH39	CUTPLPKYQGWUBC-AWKYBWMHSA-N	CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccccc1		mutant selective IDH1 inhibitor
AC-83-LN99	CUWJDZXEDIUEEW-HLFHJSLSSA-N	CC1=CC[C@H](C)C(C)(C)[C@@H]1/C=C/C(C)=C/CC[C@@]1(CO)[C@H](CCCO)/C(=C(/C)C=O)CC[C@]1(C)O	86293-27-8	Lymphangiogenesis Inducer;Lymphangiogenesis Inducers;Lymphangiogenesis Inducer;Lymphangiogenesis Inducers
VE-11-PV61	CVBJUEIAUOTXLV-UHFFFAOYSA-N	CS(=O)(=O)c1ccc(Cl)cc1Cn1cc(Cl)cc(C(N)=O)c1=N	1192347-42-4	Orally Active α1D Adrenoceptor
CB-15-RU50	CVBJWCJYJMMHGC-UHFFFAOYSA-N	CC(C)(Oc1ccc(CCNC(=O)c2ccc(-c3ccc(Cl)cc3)o2)cc1)C(=O)O		
DE-28-ZP75	CVBMAZKKCSYWQR-WCGOZPBSSA-N	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5ccccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC		
BC-22-LS63	CVLONJGXRCEARL-UHFFFAOYSA-N	Cc1ccc(Cl)cc1N/C(S)=N/CC(C)C		
AB-90-NH82	CVOUSAVHMDXCKG-UHFFFAOYSA-N	O=C1Nc2c(ccc(Cl)c2Cl)/C1=N/O	18711-16-5	Intermediate Conductance K(Ca) 3.1 (IKCa1;Gardos channel, SK41, IK1) Channel Activators;Small Conductance SK(Ca) 2.1 (SK1, SKCa1) Channel Activators;Small Conductance SK(Ca) 2.2 (SK2, SKCa2) Channel Activators;Small Conductance SK(Ca) 2.3 (SK3, SKCa3, hKCa3) Channel Activators
ED-05-LQ40	CVRXLMUYFMERMJ-UHFFFAOYSA-N	c1ccc(CN(CCN(Cc2ccccn2)Cc2ccccn2)Cc2ccccn2)nc1		
DE-81-UE07	CVSVTCORWBXHQV-UHFFFAOYSA-N	CN(CC(=O)O)C(=N)N	1093737-19-9	ADP to ATP Phosphate donor;Creatine Kinase substrate
EA-30-DG14	CVXJAPZTZWLRBP-MUUNZHRXSA-N	COc1ccccc1CN(C[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CN1CCC(N2CCCCC2)CC1)C(C)=O	170566-84-4	Tachykinin NK1 Antagonists;Growth Hormone Secretagogues
KC-11-TJ63	CWRVKFFCRWGWCS-UHFFFAOYSA-N	C1CCc2nnnn2CC1	20192-24-9	GABA(A) Receptor Antagonists
AE-74-SQ33	CXAGHAZMQSCAKJ-WAHHBDPQSA-N	CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]1CCCN2C(=O)CC[C@H](NC(=O)c3nccc4ccccc34)C(=O)N12	192755-52-5	Caspase 1 (IL-1beta Converting Enzyme) Inhibitors
QD-39-YV36	CXGRSTBDABKESY-UCORVYFPSA-N	N[C@H]1C[C@@H](C(=O)O)CC1=C(C(F)(F)F)C(F)(F)F		OAT inhibitor
VD-08-TC47	CXGTZJYQWSUFET-IBGZPJMESA-N	CCO[C@@H](Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(=O)O	251565-85-2	Insulin Sensitizers;PPARalpha Agonists;PPARgamma Agonists
BA-10-WH12	CXHHBESKHSJGOL-UHFFFAOYSA-N	CC1(c2cc(NC(=O)n3ccc4cc(Oc5ncnc6c5CCNC6)ccc43)[nH]n2)CC1	1229450-33-2	VEGFR-2 (FLK-1/KDR) Inhibitors
OD-23-MK85	CXNKZFHCAXWXIJ-UHFFFAOYSA-N	CN(CC(=O)Nc1c2c(nc3ccccc13)CCC2)Cc1ccccc1	339310-56-4	Prostanoid EP4 Antagonists
FB-06-IU47	CXOCENPNQSXLGZ-UHFFFAOYSA-N	COC(=O)c1sccc1NC(=O)Cc1cccs1	676594-38-0	SAPK1a (JNK2) Inhibitors;SAPK1b (JNK3) Inhibitors;SAPK1c (JNK1) Inhibitors
YD-85-OD87	CXPCEXYLSIRLQJ-UHFFFAOYSA-N	Fc1cc(-c2cccc3ncc(-c4cn[nH]c4)nc23)cc(F)c1CN1CCOCC1		
HD-03-XB39	CXQRKICWSCAUGW-UHFFFAOYSA-N	Cc1ccc(Nc2cc(-c3ccccc3)ncn2)cc1NS(C)(=O)=O		CDK inhibitor
LB-04-KP05	CXUCKELNYMZTRT-UHFFFAOYSA-N	CCn1c(=O)[nH]c2ccccc21	10045-45-1	SK2 Potassium Channel Activators
BC-08-RC39	CYCBWXXBSATYMI-QZWVJJBASA-N	C[N+]1(CCc2ccccc2)CCC[C@@H]1COC(=O)C(O)(c1ccccc1)c1ccccc1		CHRM3 antagonist
CF-68-DM58	CYLYVXPHAQLXFG-UHFFFAOYSA-N	CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1	19077-98-6	tetrahydrobiopterin biosynthesis inhibitor;Anti-inflammatory
GE-44-AZ94	CYMHTKKOUMCVCF-RPBOFIJWSA-N	Cc1cccc(C[C@H](Nc2ccccc2)C(=O)N[C@H](C#N)COCc2ccc(C(=O)O)cc2)c1		
AA-85-KR83	CYNLZIBKERMMOA-AWQFTUOYSA-N	COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)NC(C)(C)C	264233-05-8	GPR35 antagonist
EB-30-VD02	CYOHGALHFOKKQC-UHFFFAOYSA-N	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21	606143-52-6	MEK1 Inhibitors;MEK2 Inhibitors;Inhibitors of Signal Transduction Pathways
CB-30-KN11	CYPGNVSXMAUSJY-CXUHLZMHSA-N	N=C(N)N/N=C1\\CCc2c(C(=N)N)cccc21	138794-73-7	SAMDC inhibitor
AD-54-FG24	CYXKNKQEMFBLER-UHFFFAOYSA-N	C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1	10118-35-1	Carnitine O-Palmitoyltransferase Inhibitors;NOX2 Inhibitors
FD-74-LD52	CZBFDKZEZLRXSZ-UHFFFAOYSA-N	Cn1ccc2cc(-c3nc4ccc(F)cc4s3)ccc21		
DA-33-CX68	CZCUSHJQJWKYTD-UHFFFAOYSA-N	Cc1nccc(-c2cn(Cc3ccccc3)c3cnccc23)n1		Dyrk1 inhibitor
IB-56-BR35	CZKPOZZJODAYPZ-LROMGURASA-N	N=C(N)NCCCC[C@@H]1NC(=O)CCSSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(=O)O)NC(=O)CNC1=O	1248559-53-6	Inhibitors of Blood Coagulation Pathways;Integrin alphaIIbbeta3 (Fibrinogen gpIIb/IIIa) Antagonists;Inhibitors of Blood Coagulation Pathways;Integrin alphaIIbbeta3 (Fibrinogen gpIIb/IIIa) Antagonists
FB-91-BU05	CZRCFAOMWRAFIC-UHFFFAOYSA-N	CCCCCCCCCCCCCCOc1ccc(C(=O)O)o1	54857-86-2	Acetyl-CoA Carboxylase 1 (ACC1) Inhibitors;Acetyl-CoA Carboxylase 2 (ACC2) Inhibitors
DC-17-EL33	CZSDJYXNNJQXBB-UHFFFAOYSA-N	C=CCC1Oc2cccc(OC)c2-c2ccc3c(c21)C(C)=CC(C)(C)N3	239066-73-0	Glucocorticoid Receptor (GR) Modulators
EB-89-KM10	CZTSOXCSVFEFIK-UHFFFAOYSA-N	Oc1c(Cc2ccccc2)ccc2ccccc12	36441-32-4	Lipoxygenase Inhibitors;Antiinflammatory Drugs
EC-47-EO60	CZWVHOJDIJIJOH-UHFFFAOYSA-N	O=C1c2ccccc2C(=O)N1c1ccc(S(=O)(=O)N2CCOCC2)cc1	92082-86-5	Phosphodiesterase IV Inhibitors;Phosphodiesterase V (PDE5A) Inhibitors;TNF-alpha Production Inhibitors
S0-EE-U3YG	DALBJAQPFUGPCJ-UHFFFAOYSA-N	N#Cc1c(-c2ccccc2)nc(SCc2ccc(C(=O)O)cc2)[nH]c1=O		ACMSD inhibitor
DA-79-ZD74	DANYIYRPLHHOCZ-UHFFFAOYSA-N	COc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1	480-44-4	Xanthine Oxidase Inhibitors;Melanin Inhibitors
ME-49-AE45	DAQJYQUHXSBGJM-VIFPVBQESA-N	CC(C)(C)NCC(=O)N1CCC[C@H]1C#N		
GE-29-ZM45	DAZCBQNFGSWSQG-UHFFFAOYSA-N	CC(C)COC(=O)Nc1ccc(-c2cnc3c(-c4ccc(N5CCN(C)CC5)cc4)cnn3c2N)cc1		Lck tyrosine kinase inhibitor
HA-10-LJ21	DAZSWUUAFHBCGE-KRWDZBQOSA-N	CC(C)[C@H](NC(=O)CCc1ccccc1)C(=O)N1CCCC1	566914-00-9	Myd88 Dimerization Inhibitors
AF-28-FX20	DBABZHXKTCFAPX-UHFFFAOYSA-N	CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1	57-66-9	MRP-1 Inhibitors;TRPV2 (Vanilloid VR2 Receptor) Agonists
AC-58-RM63	DBCKRBGYGMVSTI-UHFFFAOYSA-N	O=c1[nH]c2c(O)ccc(CCNCCS(=O)(=O)CCCOCCc3ccccc3)c2s1	154189-24-9	Dual acting dopamine D2 / beta-2 adrenoceptor agonist;Dopamine D2 Agonists;beta2-Adrenoceptor Agonists
CD-18-KC24	DBEPLOCGEIEOCV-WSBQPABSSA-N	CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C	140375-21-9	Steroid 5alpha-Reductase Inhibitors
AD-37-DF79	DBISXWCOHGUFSF-UHFFFAOYSA-N	c1ccc(Nc2nc3c(s2)CCCc2n[nH]cc2-3)nc1	1235325-16-2	MGLUR4 positive allosteric modulator
RB-55-WB28	DBUOUVZMYWYRRI-YWEKDMGLSA-N	O=C(O[C@H]1[C@@H]2C=CO[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]2[C@@]2(CO)O[C@@H]12)c1ccc(O)c(O)c1	50932-20-2	TRADD-TRAF2 PPI inhibitor;TNFa - NFkB pathway inhibitor
AD-82-OW73	DCAJEEHUEYUYHB-UHFFFAOYSA-N	COCCOc1cc2ncc(-c3cc(N)nc(Cl)c3)n2cc1S(=O)(=O)C(C)(C)C		SELECTIVE INHIBITOR OF RIPK2;Receptor-Interacting Serine/Threonine-Protein (RIP-2) Kinase 2 Inhibitors
WA-03-IF37	DCFKMXSEXOQIEJ-UHFFFAOYSA-N	CCc1ccc(Nc2nnc(Cc3ccc(=O)[nH]c3)c3ccccc23)cc1Br		VEGFR Inhibitors;Inhibitors of Signal Transduction Pathways;Cytochrome P450 CYP3A4 Inhibitors;Cytochrome P450 CYP2C9 Inhibitors;Angiogenesis Inhibitors;VEGFR Inhibitors;Inhibitors of Signal Transduction Pathways;Cytochrome P450 CYP3A4 Inhibitors;Cytochrome P450 CYP2C9 Inhibitors;Angiogenesis Inhibitors
KA-78-TY66	DCGOBPRQIYFVOD-UHFFFAOYSA-N	COc1cc2c(NC3CCN(CCCCCN)CC3)nc(NCCCN(C)C)nc2cc1OCCCCCN		Histone-Lysine N-Methyltransferase EHMT2 (H3-K9-HMTase 3;G9a) Inhibitors
GD-71-OU80	DCKZGFRFXGBGOQ-UHFFFAOYSA-N	O=S(=O)(Nc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)cc1)c1ccc(Cl)cc1	2654-68-4	Carboxylesterase Inhibitors
FB-32-PY27	DCMHHJQTRGXPBA-UHFFFAOYSA-N	Clc1ccc(Cn2cc(-c3ccncc3)cn2)c(Cl)c1	870863-02-8	Cytochrome P450 CYP3A4 Inhibitors;Cytochrome P450 CYP2C9 Inhibitors
AB-30-DA10	DCOPUUMXTXDBNB-UHFFFAOYSA-N	O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl	128402-48-2	Cyclooxygenase-3 Inhibitors;Cyclooxygenase-1 Inhibitors;Cyclooxygenase-2 Inhibitors;Non-Steroidal Antiinflammatory Drugs;Voltage-Gated K(V) 7.2 (KCNQ2) Channel Activators
QD-85-OO24	DCRFKOGBPXGTPM-UHFFFAOYSA-N	O=C1CSC(c2ccccc2)c2cc(Cl)ccc2N1	13540-43-7	L-Type Calcium Channel Blockers;Na+/Ca2+ Exchanger (NCX) Inhibitors;L-Type Calcium Channel Blockers;Na+/Ca2+ Exchanger (NCX) Inhibitors
YC-27-PB87	DCSCGGYEUWOGTN-UHFFFAOYSA-N	Cc1c(COC(C)(C)C(=O)NCc2ccc(C(=O)O)cc2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(C(F)(F)F)cc1		LPAR5 (alias GPR92) inhibitor
FA-90-DR66	DCSUBABJRXZOMT-IRLDBZIGSA-N	COc1cc(N)c(Cl)cc1C(=O)N[C@@H]1CCN(CCCOc2ccc(F)cc2)C[C@@H]1OC	104860-66-4	alpha-Adrenoceptor Antagonists
BE-45-UU35	DCVZSHVZGVWQKV-UHFFFAOYSA-N	NCCNS(=O)(=O)c1cccc2cnccc12	116700-36-8	cAMP-Dependent Protein Kinase (PKA) Inhibitors;Inhibitors of Signal Transduction Pathways
BB-28-MC54	DDAWTSCZLAACFR-GVUKDKGQSA-N	N#Cc1ccc(CCNC(=O)[C@@H]2CCN2c2cc(-c3ccc([C@H]4CC[C@H](C(=O)O)CC4)cc3)nc(C(F)(F)F)n2)cc1	1595145-44-0	GPBAR1 agonist
OD-09-LH57	DDIDOUDEMUIUGR-PMERELPUSA-N	CCOC(=O)C[C@H](NC(=O)CN(CCCOC)C(=O)Cc1ccc(NC(=O)Nc2ccccc2C)cc1)c1ccc(OC)cc1		
EC-60-IX15	DDKGKOOLFLYZDL-UHFFFAOYSA-N	O=c1c(-c2ccc(O)c(O)c2)coc2cc(O)ccc12	485-63-2	Macrophage Migration Inhibitory Factor (MIF) Inhibitors;Tyrosinase Inhibitors;Melanin Inhibitors
YD-71-BE10	DDKHTWASHUKHLD-UHFFFAOYSA-N	Nc1n[nH]c2nc(-c3ccc(NS(=O)(=O)c4cc(Cl)ccc4F)cc3)cnc12	1279829-87-6	Serum/Glucocorticoid-Regulated Kinase 1 (SGK1) Inhibitors
EB-98-LS52	DDKOMKXCUXCQBS-UHFFFAOYSA-O	C[N+](C)(C)CC#CCOC(=O)Nc1cccc(Cl)c1	50510-07-1	Muscarinic receptor agonist
EB-09-JJ93	DDNCQMVWWZOMLN-IRLDBZIGSA-N	CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c(n1c1ccccc41)[C@@H]32	115986-87-3	Nav1.8 (SNS/PN3) Sodium Channel Blockers;Phosphodiesterase I Inhibitors
AD-55-EA62	DDOQBQRIEWHWBT-GSVOUGTGSA-N	N[C@H](CCP(=O)(O)O)C(=O)O		
AF-65-CU85	DDOQBQRIEWHWBT-UHFFFAOYSA-N	NC(CCP(=O)(O)O)C(=O)O	20263-07-4	mgluR6 Antagonists
AE-21-BF25	DDOQBQRIEWHWBT-VKHMYHEASA-N	N[C@@H](CCP(=O)(O)O)C(=O)O	145236-29-9	mgluR4 Agonists;mgluR8 Agonists
S0-EE-XMXE	DDPFCUXJEFSBMK-FQEVSTJZSA-N	C[C@H]1CN(c2cncnc2)Cc2cc(C(=O)Nc3cc(CN4CCCN(C)CC4)cc(C(F)(F)F)c3)ccc21		
GD-39-YG36	DDPFCUXJEFSBMK-HXUWFJFHSA-N	C[C@@H]1CN(c2cncnc2)Cc2cc(C(=O)Nc3cc(CN4CCCN(C)CC4)cc(C(F)(F)F)c3)ccc21		
KB-45-CF78	DDRPLKODWUPIEW-UHFFFAOYSA-N	O=c1oc(Cc2ccccc2)nc2ccccc12		
DE-86-XV75	DDUHZTYCFQRHIY-RBHXEPJQSA-N	COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O	107912-37-8	Keratin 12 modulator
BF-69-DX62	DDVVRHNNOPQPGB-UHFFFAOYSA-N	Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1	470689-87-3	Chemokine CCR5 Antagonists
AF-00-QK19	DDYJDIHOSRTMSE-FLIBITNWSA-N	C=CCN1C(=O)CS/C1=N\\NC(=S)NC	87958-67-6	Apoptosis Inducers
UE-02-UW61	DETOMBLLEOZTMZ-UHFFFAOYSA-N	Cc1c(CN2CCC(Nc3ncnc4sc(CC(F)(F)F)cc34)CC2)ccc2c1cc(C#N)n2Cc1cn[nH]c1	1857417-13-0	Menin inhibitor
OB-17-DQ74	DEVSOMFAQLZNKR-RJRFIUFISA-N	O=C(/C=C\\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NNc1cnccn1	1393477-72-9	Exportin 1 inhibitor
PE-69-DO79	DEVUYWTZRXOMSI-UHFFFAOYSA-N	NS(=O)(=O)Nc1ccccc1	15959-53-2	carbonic anhydrase inhibitor
BA-84-WN26	DFBIRQPKNDILPW-KTGKZQHOSA-N	CC(C)[C@]12O[C@H]1[C@@H]1O[C@]13[C@]1(O[C@H]1CC1C4=C(CC[C@@]13C)C(=O)OC4)[C@@H]2O	38748-32-2	ERCC3 (TFIIH subunit)
BE-47-IP08	DFDGRKNOFOJBAJ-UHFFFAOYSA-N	CC1(c2ccccc2)OC(C(=O)O)=CC1=O	72420-38-3	GPR109A agonist
DE-80-BU08	DFNOJNBNTVQPCA-UHFFFAOYSA-N	Nc1c(C(=O)Nc2c(F)cc(F)cc2Br)sc2nc3c(cc12)CCC3	497061-48-0	ATOX1 inhibitor
HB-19-DP22	DFNZYFAJQPLJFI-UHFFFAOYSA-N	C=Cc1cncc2c1CCOC2=O	439-89-4	IL-6 Production Inhibitors;TNF-alpha Production Inhibitors;Glucocorticoid Receptor agonist;IL-6 Production Inhibitors;TNF-alpha Production Inhibitors;Glucocorticoid Receptor agonist
AD-88-WG84	DFOVLSMXPWPCFH-UHFFFAOYSA-N	CCCC(=O)Nc1cccc(NC(=O)c2ccccc2Br)c1	423735-93-7	PAR-1 antagonist
GF-73-HI61	DFQKZFFVISYVDA-YFBXQHAESA-N	CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)COC(=O)c1c(Cl)cccc1Cl	151594-01-3	Caspase 1 (IL-1beta Converting Enzyme) Inhibitors
CB-20-ND22	DFQQRCOUHDEARR-VXKWHMMOSA-N	CC(C)C[C@H](NP(=O)(O)CC1CCCCC1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O		Endothelin-Converting Enzyme (ECE) Inhibitors
CF-90-DA50	DFTOOBKXSNAAPW-ADTLFGHVSA-N	CC(C)C[C@H](NC(=S)Nc1ccccc1)C(=O)N[C@H]1CCOC1O	602307-45-9	mu-Calpain (Calpain-1) Inhibitors;m-Calpain (Calpain-2) Inhibitors
AC-91-WE67	DFYRUELUNQRZTB-UHFFFAOYSA-N	COc1cc(C(C)=O)ccc1O	16522-48-8	NADPH Oxidase Inhibitors
YA-71-LR91	DGCDINFBQBAGEV-DZGCQCFKSA-N	COCc1nnc(NC(=O)[C@H](c2ccc(-c3nnn(C)n3)cc2)[C@H]2CCC(F)(F)C2)s1		
AB-51-WV08	DGENZVKCTGIDRZ-UHFFFAOYSA-N	O=C(O)CCc1ccc(NCc2cccc(Oc3ccccc3)c2)cc1	885101-89-3	FFAR1 agonist;Free Fatty Acid Receptor 1 (FFAR1;GPR40) Agonists
DC-05-LU10	DGGLFHJMXJUSDG-HNNXBMFYSA-N	Cc1ccccc1[C@H](CC(=O)O)NC(=O)c1cc(=O)n(-c2ccccc2F)[nH]1		
BC-52-WF67	DGMKFQYCZXERLX-UHFFFAOYSA-N	CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1	24485-90-3	CCK2 (CCKB/Gastrin) Antagonists
CD-30-JO39	DHBIDMNRDQKQRD-UHFFFAOYSA-N	O=C(c1cccc(C(F)(F)F)c1Cl)N1CCc2c(nnn2-c2ncc(F)cn2)C1		P2RX7 antagonist
BD-69-YD09	DHEMNTLAGYUASY-BABZEESQSA-N	CO[C@H]1C[C@@H](C)C/C(C)=C/[C@@H](CC(C)=O)C(=O)C[C@H](O)[C@@H](C)[C@@H](/C(C)=C/[C@@H]2CC[C@@H](O)[C@H](OC)C2)OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@H]1[C@@H](OC)C[C@H]2C	124554-37-6	Neurotrophic Agents
FE-31-JU80	DHJQWBSZKBDBFP-UHFFFAOYSA-N	NC(CC1CCCCC1CCP(=O)(O)O)C(=O)O		
AC-55-CK61	DHKKONBXGAAFTB-OTYYAQKOSA-N	COc1cc(/C=C2\\CCC/C(=C\\c3ccc(O)c(OC)c3)C2=O)ccc1O	579-23-7	TNF Expression Inhibitors;Antiinflammatory Drugs;Breast Cancer-Resistant Protein (BCRP;ABCG2) Inhibitors
BD-59-TG01	DHMLNZRDVQLQBB-UHFFFAOYSA-N	COc1ccccc1N1CCN(CCN(C(=O)c2ccc(I)cc2)c2ccccn2)CC1	155204-23-2	alpha-Adrenoceptor Antagonists
XA-82-BM12	DHSASSJDMAHICE-UHFFFAOYSA-N	O=c1occ2c3c(ccc(O)c13)Oc1ccc(O)cc1-2		TLR2/4 pathway antagonist
GF-98-RS57	DHSUYTOATWAVLW-WFVMDLQDSA-N	CC1(C)C[C@@H]1C(=O)N/C(=C\\CCCCSC[C@H](N)C(=O)O)C(=O)O	81129-83-1	Dehydropeptidase I Inhibitors
RA-60-MZ29	DHXKRMSKXLDZGY-UHFFFAOYSA-N	CC(C)c1c(-c2ccccc2)[nH]c2c(C#N)cnn2c1=O		KDM5A pan Inhibitor
RB-06-YP44	DIHXJZHAIHGSAW-UHFFFAOYSA-N	N=C(N)NC(=N)Nc1cccc(Cl)c1	2113-05-5	5-HT3 receptor agonist
CA-66-YB17	DJBNUMBKLMJRSA-UHFFFAOYSA-N	O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F	54143-55-4	Nav1.5 (Cardiac/SkMII) Sodium Channel Blockers
MC-36-PM07	DJCVSFWGKYHMKH-YVMONPNESA-N	O=C(O)/C(S)=C/c1ccc(I)cc1	179528-45-1	Calpain Inhibitors
EE-13-PS05	DJLOPBNMNYCRDV-SQHAQQRYSA-N	Cc1cccc(C[C@H](Nc2ccc3c(c2)C(=O)OC3(C)C)C(=O)N[C@H](C#N)COCc2cccc(C(=O)O)c2)c1		Cathepsin L Inhibitors
BD-04-IN11	DJMHJHDYEXNPEH-UHFFFAOYSA-N	O=C1CN=C(c2ccccc2)c2oc3ccc(Br)cc3c2N1		P2X4 Receptor Antagonists
NA-30-EF36	DJOVLOYCGXNVPI-UHFFFAOYSA-N	CN1CCN(c2ccc(-c3cccc(CN4CCOCC4)c3)cc2NC(=O)c2c[nH]c(=O)cc2C(F)(F)F)CC1	1801787-56-3	WDR5 inhibitor;WDR5 Inhibitor
DA-28-TM43	DJWHAISGEPYECC-UHFFFAOYSA-N	N#Cc1ccc(-c2cnc3ccc(NC4CCCCC4)nn23)cc1	1012345-05-9	Interleukin-1 Receptor-Associated Kinase (IRAK) Inhibitors
AD-14-QD12	DKBJBZGJYZAELL-UHFFFAOYSA-N	CC(C)(O)CCCc1ccc2cc(O)c(N3CC(=O)NS3(=O)=O)c(F)c2c1		T-cell protein tyrosine phosphatase inhibitor;Protein tyrosine phosphatase-1B inhibitor
CB-24-FA25	DKGZKTPJOSAWFA-UHFFFAOYSA-N	O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1		
DD-31-LY65	DKHGMERMDICWDU-GHDNBGIDSA-N	CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC1=C(C)C(=O)c2ccccc2C1=O		
AA-56-KV80	DKMACHNQISHMDN-RPLLCQBOSA-N	CNC(=O)[C@@H](c1ccccc1)N1CCc2cc(OC)c(OC)cc2[C@@H]1CCc1ccc(C(F)(F)F)cc1	1266467-63-3	Orexin OX-1 Antagonists;Orexin OX-2 Antagonists
DA-39-AJ98	DKMFBWQBDIGMHM-UHFFFAOYSA-N	CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1	1622-79-3	DRD2 antagonist
EF-01-LB20	DKNWSYNQZKUICI-UHFFFAOYSA-N	NC12CC3CC(CC(C3)C1)C2	102395-13-1	Dopamine Receptor Agonists;NMDA Antagonists;M2 Channel Inhibitors
AD-92-QZ55	DKORMNNYNRPTBJ-UHFFFAOYSA-N	Cc1ccc(CCCO)c(NCc2ccc3nc(NCCCN4CCOCC4)n(Cc4nc(C)ccc4O)c3c2)c1		
JA-80-KW72	DKSWXNFPYZCJFU-UHFFFAOYSA-N	Cn1ncnc1COc1nn2c(-c3ccccc3)nnc2c2c1C1CCC2CC1		
S0-EE-YFM9	DKTDTIMJXXTKNI-UHFFFAOYSA-N	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3[nH]cnc23)c1	1351087-93-8	troponin 1 interacting kinase inhibitor
MA-06-DJ95	DKXHSOUZPMHNIZ-UHFFFAOYSA-N	O=C1NCCc2[nH]c(-c3ccncc3)cc21	845538-12-7	Inhibitors of Signal Transduction Pathways;Cell Division Cycle 7-Related Protein Kinase (CDC7) Inhibitors
AB-05-JR93	DKYWVDODHFEZIM-UHFFFAOYSA-N	CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1	154907-35-4	Non-Steroidal Antiinflammatory Drugs
XD-44-FJ34	DKZGKUZHMHEHBU-UHFFFAOYSA-N	Cc1nc(NC(=O)NCC(=O)N(C)C)sc1-c1ccc(S(C)(=O)=O)c(F)c1		Phosphatidylinositol 3-Kinase gamma (PI3Kgamma) Inhibitors
YD-49-HM53	DKZYXHCYPUVGAF-JCNLHEQBSA-N	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1	1431697-89-0	MELK inhibitor
KA-27-KH73	DLMBMHOJKBPKLK-UHFFFAOYSA-N	CCOc1ccc2cc(-c3nn(CC4CCNCC4)c4ncnc(N)c34)ccc2c1	1320266-08-7	camk1 gene inhibitor
BC-45-VY95	DMDGGSIALPNSEE-UHFFFAOYSA-N	NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O	135-09-1	Carbonic anhydrase inhibitor
DA-05-NN93	DMIDPTCQPIJYFE-UHFFFAOYSA-N	O=C(NCC(=O)N1CCCC1)Nc1ccc2cnccc2c1	1687736-54-4	protein arginine methyltransferase 3 inhibitor;PRMT3 inhibitor
OD-47-WT51	DMJWENQHWZZWDF-PKOBYXMFSA-N	CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccccc3CC[C@@H]21	112108-01-7	selective dopamine D1/D5 receptor antagonist
DE-48-HZ49	DMMILYKXNCVKOJ-UHFFFAOYSA-N	O=C(Nc1cccc(Nc2ncc(Br)c(NCCc3c[nH]cn3)n2)c1)N1CCCC1	702674-56-4	PKB beta/Akt2 Inhibitors
UF-06-JB00	DNBCCTCVENITSE-VAWYXSNFSA-N	CCOC(=O)Nc1ccc(C(=O)/C=C/c2cc(N3CCOCC3)c3ccccc3n2)cc1		Heat Shock Protein 70 (hsp70) Inducers;TNF-alpha Production Inhibitors;Heat Shock Protein 70 (hsp70) Inducers;TNF-alpha Production Inhibitors
GE-29-BW54	DNDWVUOVTWIWKZ-UHFFFAOYSA-N	COCCNc1cc(NC(=O)N2CCCc3cc(CN(C)C(C)=O)c(C=O)nc32)ncc1C#N		ATP competitive inhibitor
BA-44-SG89	DNHZIQUHIDDATB-UHFFFAOYSA-N	Cc1cc(OCc2nc(-c3ccc(OC(C)C)nc3)c(-c3ccc(OC(F)(F)F)cc3)o2)ccc1OCC(=O)O	870637-90-4	
EA-86-QK08	DNJCYUFEKRPSFY-UHFFFAOYSA-N	CC(=O)c1ccc(OCCCOc2cc(NC(=O)C(=O)O)c(C)cc2Br)c(CCC(F)(F)F)c1O	109683-31-0	Leukotriene Antagonists;Platelet-Activating Factor Receptor (PAFR) Antagonists;Phospholipase A2 (PLA2) Inhibitors;Non-Steroidal Antiinflammatory Drugs
TD-48-XJ84	DNLUVZFMNAQCGT-UHFFFAOYSA-N	COc1nc2cnc3ccc(C#Cc4cccnc4)cc3c2n1-c1ccc(C#N)cc1		
IA-97-VE31	DNODJHQYSZVNMH-UHFFFAOYSA-N	Nc1ccc(O)c2c1C(=O)N(C1CCC(=O)NC1=O)C2=O	1547162-46-8	CRBN neomorph;E3 ligase inhibitor
QC-10-TY16	DNORZUSMZSZZKU-UHFFFAOYSA-N	CCOC(=O)C1(CCCCCc2ccc(Cl)cc2)CO1	78573-55-4	Carnitine O-Palmitoyltransferase Inhibitors;Antioxidants;Carnitine O-Palmitoyltransferase Inhibitors;Antioxidants
VE-15-RK04	DNUXGDOJLQYUTO-UHFFFAOYSA-N	Brc1ccc2[nH]c3cnccc3c2c1	59444-69-8	
DA-19-AJ18	DOBMPNYZJYQDGZ-UHFFFAOYSA-N	O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O	66-76-2	NADPH Quinone Oxidoreductase 1 (NQO1) Inhibitors;Anticoagulant;Vitamin K Epoxide Reductase (VKER, VKOR) Inhibitors
NE-34-OZ69	DOKZLKDGUQWMSX-HKBQPEDESA-N	OC[C@H](Cc1ccccc1)Nc1nc(Oc2ccc3c(c2)CCC3)nc2c1ncn2Cc1ccc(-c2ccccc2)cc1	944328-88-5	ADP ribosylation factor 1 inhibitor
BA-70-LV41	DOUMFZQKYFQNTF-WUTVXBCWSA-N	O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O	20283-92-5	Angiogenesis Inhibitors;Antioxidants;4-aminobutyrate transaminase inhibitor;Angiogenesis Inhibitors;Antioxidants;4-aminobutyrate transaminase inhibitor
AA-42-JP76	DOUYETYNHWVLEO-UHFFFAOYSA-N	CC(C)Cn1cnc2c(N)nc3ccccc3c21	9050-31-1	TLR7 Receptor Agonists;Interferon Inducers
AA-14-SG39	DOWDJFVLAJDWNC-OAQYLSRUSA-N	O=C(O)[C@@H](CCCN1C(=O)c2ccccc2S1(=O)=O)NS(=O)(=O)c1ccc(Oc2ccccc2)cc1		
BA-09-ZX42	DPAMLADQPZFXMD-UHFFFAOYSA-N	O=C(O)c1ccc(Nc2ccccc2)cc1		
NE-27-MD08	DPBURRXPRULCQN-UHFFFAOYSA-N	O=C(Nc1ccccc1)N(CC1=CC(Cc2ccccc2)(NC(=O)C(Cl)(Cl)Cl)CC1)c1cccc(OCCN2CCOCC2)c1		Motilin Receptor Antagonist
CD-77-YB29	DPFHVUSPVHRVFL-YFKPBYRVSA-N	C[C@@H](NCc1cc(Br)cc2[nH]c(=O)c(=O)[nH]c12)P(=O)(O)O	206648-13-7	NMDA Glycine-Site Antagonists
HA-40-OT25	DPNOTBLPQOITGU-LDDQNKHRSA-N	CCCCC[C@H](O)/C=C/[C@H]1CCC(=O)[C@@H]1CCCCCCC(=O)O	37786-00-8	
HD-36-DK23	DPSIHWHXSJPPRA-UHFFFAOYSA-N	CC(=O)N1CCN(Cc2sc(NC(=O)C(C)(C)NC(=O)c3ccc(F)cc3)nc2C(F)(F)F)CC1		
BE-07-XF09	DQDBCHHEIKQPJD-ODKJCKIQSA-N	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O	60482-95-3	Neurotensin Agonists
OF-32-PT74	DQNIGNOPCIUNOF-UHFFFAOYSA-N	CN1CCC2=C(CC1)c1ccccc1Sc1ccccc12		
DB-28-SP20	DQTMJIUNXVVYJR-IDUWFGFVSA-N	COc1cc(OC)c(OC)cc1/C=C1\\Oc2cc(O)ccc2C1=O	256531-54-1	17beta-Hydroxysteroid Dehydrogenase (17beta-HSD)  Inhibitors
AC-94-JQ48	DRCHYIQEOVOYNJ-RDGATRHJSA-N	Cc1cccc(C[C@H](Nc2ccccc2)C(=O)N[C@H](C#N)COCc2ccc(F)c(C(=O)O)c2)c1		Cathepsin B Inhibitors
KE-89-DV96	DRCMAZOSEIMCHM-UHFFFAOYSA-N	Oc1cc2c(cc1O)CN(C(=S)NCCc1ccc(Cl)cc1)CCC2	138977-28-3	TRPV1 (Vanilloid VR1 Receptor) Antagonists
DB-69-JG66	DRDIHUMOFDGYRJ-UHFFFAOYSA-N	CCN(CC)CCCNC(=O)Cn1nc(C)n2c(cc3sccc32)c1=O		
CD-90-SN76	DREVJBVJBRSSDL-UHFFFAOYSA-N	CC(C)NCC(O)COc1nccs1	38241-39-3	Drugs Acting on Adrenoceptors;adrenoceptor beta 1 partial agonist;Drugs Acting on Adrenoceptors;adrenoceptor beta 1 partial agonist
EF-19-KJ63	DRHKJLXJIQTDTD-OAHLLOKOSA-N	CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1	106133-20-4	alpha1-Adrenoceptor Antagonists
BA-46-QO78	DRLADIVXUVDIQQ-UHFFFAOYSA-N	CCN1c2ccc(C(C)=O)cc2N=C(c2ccc(C(=O)O)cc2F)c2cc3c(cc21)C(C)(C)CCC3(C)C	777074-39-2	Retinoid RXR Antagonists
AC-31-SL44	DRLFMBDRBRZALE-UHFFFAOYSA-N	COc1ccc2[nH]cc(CCNC(C)=O)c2c1	51023-76-8	Antioxidants;Apoptosis Inducers;Free Radical Scavengers;NOS2 Expression Inhibitors;TH Expression Enhancers
EA-86-YK48	DRSJLVGDSNWQBI-SFHVURJKSA-N	COc1cccc(OC)c1-c1ccc(C[C@H](NC(=O)c2c(Cl)cccc2Cl)C(=O)O)cc1	232271-19-1	Integrin binder;Integrin alpha4beta1 (VLA-4) Antagonists;Integrin alpha4beta7 (LPAM-1) Antagonists
DA-17-YW85	DRTQHJPVMGBUCF-UHFFFAOYSA-N	O=c1ccn(C2OC(CO)C(O)C2O)c(=O)[nH]1		
AE-48-EW32	DSCFFEYYQKSRSV-KLJZZCKASA-N	CO[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O	10284-63-6	gamma-Secretase Inhibitors
GE-84-SM43	DSEIKQVUTKGLGT-UHFFFAOYSA-N	COC(=O)CN1CN(c2ccccc2)C2(CCN(Cc3ccc4ccccc4c3)CC2)C1=O	250685-44-0	OPRL1 agonist
PD-30-OV49	DSEJCLDJIFTPPH-FMIVXFBMSA-N	CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccc(C#N)c3)C3CCN(CCC4CCCC4)CC3)cc21	683746-68-1	Neuropeptide Y2 (NPY Y2) Antagonists
CA-96-KH56	DSEYBGDEFWSNEE-MRXNPFEDSA-N	CC1=CSC2=Nc3ccccc3[C@@H](c3ccccc3)N12		
QF-09-IK44	DSHOFHQFNJBXHY-UHFFFAOYSA-N	CN(C(=O)Oc1ccc(O)c(C(=O)NCc2cccnc2)c1)c1ccccc1		
FE-26-GO83	DSLGGWUUDXOOTH-MOSHPQCFSA-N	COC(=O)c1ccccc1-c1ccc(/C=C2\\SC(=S)N(Cc3ccccc3)C2=O)o1		
CF-15-FD69	DSLPMJSGSBLWRE-UHFFFAOYSA-N	NS(=O)(=O)Oc1ccc2c3c(c(=O)oc2c1)CCCCC3	288628-05-7	Carbonic Anhydrase Type II Inhibitors;Steryl Sulfatase Inhibitors
ID-12-NA84	DSQVFZCPRRLZSA-UHFFFAOYSA-N	COc1ccccc1N1CCN(CCCc2ccccc2)CC1	144146-63-4	alpha-Adrenoceptor Antagonists
FA-39-ZT32	DTEKTGDVSARYDS-NSHDSACASA-N	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)[C@@H]1C		Ribosomal protein S6 kinase inhibitor
AD-37-UF49	DTIZKDMQUYFSRE-ZDUSSCGKSA-N	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C2(C)CC2)c1	1217486-51-5	Phosphatidylinositol 3-Kinase alpha (PI3Kalpha) Inhibitors
FC-55-IG96	DTQNEFOKTXXQKV-HKUYNNGSSA-N	COc1ccccc1CN[C@H]1CCCN[C@H]1c1ccccc1	136870-97-8	Tachykinin NK1 Antagonists
DD-74-PJ26	DTZDSNQYNPNCPK-UHFFFAOYSA-N	c1ccc(C(NCCNC(c2ccccc2)c2ccccc2)c2ccccc2)cc1	83027-13-8	mgluR7 Agonists
HB-69-CT62	DUBPJEDOCJXVKG-UHFFFAOYSA-N	CCOC(=O)c1cc2ccccc2nc1C	15785-08-7	Histone N-Acetyltransferase (HAT) Inhibitors
HB-19-OF33	DUFKTZBQJIHIAQ-VGZDNEPHSA-N	CC(=O)Nc1cc(Cl)ccc1/C=C/C(=O)N1CCN(Cc2ccc(F)cc2)C[C@H]1C	685534-25-2	Chemokine CCR1 Antagonists
OD-77-AG95	DUIHHZKTCSNTGM-UHFFFAOYSA-N	CS(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1	1232410-49-9	ATR gene inhibitor
BA-13-CC32	DUXCHYYGLSQPPP-LWOCSEGBSA-O	O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C(O)(c1cccs1)c1cccs1)C2)Nc1ccncn1		Muscarinic M1 Antagonists;Muscarinic M2 Antagonists;Muscarinic M3 Antagonists
CA-60-RU13	DVDJVOXOGPLDLE-QGZVFWFLSA-N	COc1cccc(S(=O)(=O)N(Cc2cccnc2)[C@@H](C(=O)NO)C(C)C)c1		
DC-63-KC77	DVEXZJFMOKTQEZ-JYFOCSDGSA-N	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\\N)Sc1ccccc1N	109511-58-2	Apoptosis Inducers;Mitogen-Activated Protein (MAP) Kinase Kinase (MEK) Inhibitors;Extracellular-Regulated Kinase (ERK) Inhibitors;Jak2 Inhibitors
GD-70-NJ06	DVJAAHPCJYIXDE-VOQZNFBZSA-N	CC(C)C[C@H](NC(=O)c1ccc2c(c1)nc(Cc1ccco1)n2[C@@H]1CCCC[C@H]1C)C(=O)O	1586790-45-5	Apelin receptor agonist
BB-73-OX38	DVMCMTVFXINJGW-IRXDYDNUSA-N	O=C(Nc1ccc(Cl)cn1)[C@H]1CN(CC(F)F)C[C@@H]1C(=O)Nc1ccc(-n2ccccc2=O)cc1F		Known FactorXa inhibitor
TA-25-KO99	DVQKEPFWUFUQBY-UHFFFAOYSA-N	O=C(Nc1ccc(-n2c(C(F)(F)F)nc3ccccc32)cc1)c1cccc(F)c1F		TRPM4 Agonists;Cytokine Production Inhibitors
JB-09-SI50	DVXSJBDRMIDVMC-UHFFFAOYSA-N	CN(C)CCCn1nc(C2=C(c3cn(-c4csc5ccccc45)c4ccccc34)C(=O)NC2=O)c2ccccc21		Protein Kinase C (PKC) Inhibitors
AC-90-QA75	DVZMRTJKNJKEGV-UHFFFAOYSA-N	Nc1c(Cl)cc(S(N)(=O)=O)cc1Cl		
QF-97-LC45	DWGPHWOSZWVQQI-YDWXAUTNSA-N	O=C(O)/C=C/c1ccc(-c2nc[nH]c2-c2ccc(/C=C/C(=O)O)cc2)cc1		
ND-66-KW81	DWIYBCKFYUQVLU-UHFFFAOYSA-N	N#Cc1ccc(-c2ccc(OCCCCCCC(=O)NO)cc2)cc1	191228-04-3	TNF-alpha Production Inhibitors
BB-47-YI31	DWJXYEABWRJFSP-XOBRGWDASA-N	C[C@H](NC(=O)Cc1cc(F)cc(F)c1)C(=O)N[C@H](C(=O)OC(C)(C)C)c1ccccc1	208255-80-5	gamma-Secretase Inhibitors;Notch Signaling Inhibitors;Antiamyloidogenic Agents
AB-80-CK34	DWLMLPCWSGBXMZ-UHFFFAOYSA-N	Cn1cc(C2=C(c3cn(C)c4ccccc34)C(=O)NC2=O)c2ccccc21	125313-72-6	CDK4/Cyclin D1 Inhibitors;CDK2/Cyclin E Inhibitors;Protein Kinase C (PKC) Inhibitors
ED-79-EW79	DWPQODZAOSWNHB-UHFFFAOYSA-N	CN1CC(=O)N/C1=N\\C(=O)Nc1cccc(Cl)c1	57653-26-6	mgluR5 Antagonists;GRM5 antagonist
AB-55-DE17	DWRVMQXDTOSBGF-MRXNPFEDSA-N	CC(C)(O)[C@H](F)CNC(=O)c1cnc(Nc2ncc(C#N)cc2Cl)cc1NC1CC1	1609544-22-0	interleukin 1 receptor associated kinase 4
IE-49-AI35	DXPHNGAMYPPTBJ-TZMIJSMNSA-N	CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCC(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC	142569-99-1	EDNRB agonist
AE-06-FY47	DXPOSRCHIDYWHW-UHFFFAOYSA-N	O=C(NCCNCC(O)COc1ccc(O)cc1)N1CCOCC1	69630-08-6	ADRB1 agonist
EB-66-TU32	DXUDLEHAROCUHM-KYJUHHDHSA-N	CC(=O)N[C@@H](Cc1ccc(CP(=O)(O)O)cc1)C(=O)NC1(C(=O)N[C@@H](CC(N)=O)C(=O)NCCCc2c(O)ccc3ccccc23)CCCCC1		
DD-77-OI11	DYGBNAYFDZEYBA-UHFFFAOYSA-N	COc1ccc(C(=O)C2CCN(CC(=O)N(Cc3nc4c(c(=O)[nH]3)COCC4)CC3CC3)CC2)cc1	1419949-20-4	Tankyrase 1 (TNKS1;PARP5A) Inhibitors;Tankyrase 2 (TNKS2;PARP5B) Inhibitors
AC-22-PZ30	DYIRSNMPIZZNBK-UHFFFAOYSA-N	CS(=O)(=O)c1ccc(-c2cnc(NCc3ccco3)n3cnnc23)cc1		PRC2/EED
DC-91-ME12	DYKFCLLONBREIL-KVUCHLLUSA-N	CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O	10118-90-8	Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors;30S Ribosomal Protein Inhibitors;Protein Arginine Deiminase Inhibitors
IA-75-LQ65	DYLUUSLLRIQKOE-UHFFFAOYSA-N	CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1	1446502-11-9	IDH2 R140Q mutant inhibitor
QA-87-NQ04	DYXYXTDIFMDJIR-UHFFFAOYSA-N	CNc1oc(-c2cccc3ccccc23)nc1C#N	847163-28-4	ALOX15 gene inhibitor
AC-98-UW57	DYZJXZOQQRXDLE-UHFFFAOYSA-O	CCOCC(O)COc1ccc(NC(=O)CC[S+](C)C)cc1		
QE-03-UA61	DZACSLYTXLZAAF-UHFFFAOYSA-N	Cc1c(CN2CCC(Nc3ncnc4sc(CC(F)(F)F)cc34)CC2)ccc2[nH]c(C#N)cc12	1628317-18-9	Menin inhibitor
NE-00-JZ19	DZIUPOCVDSYPSY-UHFFFAOYSA-N	Cc1c(Nc2c(C#N)cncc2-c2cc3cc(CN4CCN(C)CC4)ccc3o2)ccc2[nH]ccc12	959969-71-2	Protein Kinase PKC theta Inhibitors
SD-69-IX30	DZLOHEOHWICNIL-QGZVFWFLSA-N	CCOC(=O)[C@@]1(CCCCCCOc2ccc(Cl)cc2)CO1		
SB-75-UH17	DZOJBGLFWINFBF-UMSFTDKQSA-N	CC(=O)N(C)C1(c2ccccc2)CCN(CCC[C@]2(c3ccc(Cl)c(Cl)c3)CCCN(C(=O)c3ccccc3)C2)CC1	160492-56-8	Tachykinin NK3 Antagonists
BC-46-DY47	FACMWMBWGSPRKO-UHFFFAOYSA-N	CN1CCN(C2=Nc3ccccc3Sc3nccn32)CC1	81382-51-6	Drugs Acting on Dopaminergic Transmission
BA-16-AB67	FAEKWTJYAYMJKF-QHCPKHFHSA-N	CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O	135062-02-1	Insulin Secretagogues
JB-01-MH79	FANMQRSNMHKZCR-BKUYFWCQSA-N	CC1(CN2C(=O)S/C(=C\\c3ccc(NS(=O)(=O)c4ccc([N+](=O)[O-])c(C(F)(F)F)c4)cc3)C2=O)CCCCC1	1290069-19-0	AMP-Activated Protein Kinase (AMPK) Activators
AB-66-IL06	FARMEEAGJWMFSZ-UHFFFAOYSA-N	Cc1cc(C)c(N(Cc2ccccc2)S(=O)(=O)c2ccc(OCCNC(=O)c3cc4ccccc4o3)cc2)c(C(=O)NO)c1	307002-73-9	MMP-13 (Collagenase 3) Inhibitors;Angiogenesis Inhibitors
PD-94-WO47	FASLEVZZILWGJD-UHFFFAOYSA-N	COc1cc(-c2ccc3c(c2)Nc2ccc(C(C)(C)C(=O)Nc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1[N+](=O)[O-]		Inhibitors of Signal Transduction Pathways;Checkpoint Kinase 1 (Chk1) Inhibitors
YD-21-ZR41	FATGTHLOZSXOBC-UHFFFAOYSA-N	Cc1c(Cc2ccc3ccccc3n2)c2cc(F)ccc2n1CC(=O)O	851723-84-7	CRTH2 Receptor Antagonists
NB-12-ZK38	FAWSUKOIROHXAP-NPMXOYFQSA-N	CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C	1300031-52-0	BET bromodomain inhibitor
EB-66-IH06	FAZZYPIBZBGQSH-UHFFFAOYSA-N	CCc1cccc2c1N(C)Cc1cc3c(cc1-2)OCO3	854847-61-3	AXIN auto-inhibition inhibitor;Wnt pathway activator;AXIN auto-inhibition inhibitor;Wnt pathway activator
BD-33-HT38	FBKMWOJEPMPVTQ-UHFFFAOYSA-N	NS(=O)(=O)NCCNc1nonc1/C(=N/O)Nc1ccc(F)c(Br)c1	1204669-37-3	Epacadostat is an investigational cancer drug.[1] Epacadostat is an inhibitor of indoleamine 2,3-dioxygenase-1) (IDO1).[1][2];Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immunooncolog
TF-23-DD23	FBLPQCAQRNSVHB-UHFFFAOYSA-N	CCc1cncnc1N1CCN(Cc2nc3cc(C(F)(F)F)ccc3[nH]2)CC1	1255517-76-0	Antagonist of S6K
HA-64-OZ89	FBPXLHRHDPRVOH-UHFFFAOYSA-N	Cc1ccc(NC(=O)c2sc3ccccc3c2Cl)c(C(=O)Nc2ccc(F)cc2)c1	216985-39-6	Coagulation Factor Xa Inhibitors;Inhibitors of Blood Coagulation Pathways
YB-01-IL62	FBRZJJQDBZRQKO-UHFFFAOYSA-N	Cc1c(Cc2cccc([N+](=O)[O-])c2)c(=O)oc2cc(Oc3ncccn3)ccc12		
IA-03-BO30	FBSFWRHWHYMIOG-UHFFFAOYSA-N	COC(=O)c1cc(O)c(O)c(O)c1	99-24-1	5-Lipoxygenase Inhibitors;Cyclooxygenase-2 Inhibitors;Antioxidants
EE-85-SK26	FBSRBPSSIDGSEB-UHFFFAOYSA-N	CN(c1ccc(-c2cc3c(=O)n(C)c(=O)n(C)c3cc2O)nn1)C1CC(C)(C)NC(C)(C)C1		splicing modulator
CD-41-RE87	FCCUUXVXNBHGAZ-YLJYHZDGSA-N	Cn1cc(-c2cc(Oc3ccc4nc(N[C@@H]5CCCC[C@H]5O)sc4c3)ccn2)cn1		Angiogenesis Inhibitors;CSF1R (c-FMS) Inhibitors
IB-34-OS52	FCFLRBRNNOEQMR-MRVPVSSYSA-N	N[C@H](CNC(=O)c1cc2c(Br)cccc2[nH]1)C(=O)O	1182349-05-8	NMDA Glycine-Site Modulators
EC-89-AJ93	FCFNRCROJUBPLU-DNDCDFAISA-N	CC(C)[C@@H]1NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC(=O)[C@H](C(C)C)NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC(=O)[C@H](C(C)C)NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC1=O		
MD-49-BL92	FCHPZRJYEBHTOH-UHFFFAOYSA-N	CC(=O)Nc1nnc(Sc2ccnc3cc(Cl)ccc23)s1		
AD-50-WA90	FDDDEECHVMSUSB-UHFFFAOYSA-N	Nc1ccc(S(N)(=O)=O)cc1	10103-15-8	MEK1 Inhibitors
QF-14-JU46	FDLOBNTWQDSHPF-UHFFFAOYSA-N	CC(C)c1cc(Oc2c(Br)cc(CC(=O)O)cc2Br)ccc1O	219691-88-0	Thyroid Hormone Receptor beta Agonists
FA-70-ZG69	FDLYAMZZIXQODN-UHFFFAOYSA-N	O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1	1021843-02-6	Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors;Poly(ADP-ribose)polymerase-2 (PARP-2) Inhibitors
AE-51-ZO26	FDTXHWQFIXYHCL-QGZVFWFLSA-N	O=C(c1ccc(-n2nnc3cccnc32)cc1)N(c1ncccc1Cl)[C@@H]1CCCNC1		pcsk9 translation inhbitor
RD-90-OY66	FDWQSLRDIBRKEI-UHFFFAOYSA-N	CC(C)(C)c1cnc(CSc2cnc(NC(=O)Cc3ccc(CNC(CO)CO)cc3)s2)o1	333389-24-5	CDK2/Cyclin E Inhibitors;CDK1 Inhibitors;CDK4 Inhibitors
AB-34-RQ73	FDXQKWSTUZCCTM-UHFFFAOYSA-N	CNCC(O)CC12CCC(c3ccccc31)c1ccccc12	39022-39-4	Norepinephrine Reuptake Inhibitors
DB-82-PI34	FECQXVPRUCCUIL-UHFFFAOYSA-N	Nc1nc2c(ccc3ccccc32)s1	111886-81-8	Intermediate Conductance K(Ca) 3.1 (IKCa1| Gardos channel, SK41, IK1) Channel Activators;Small Conductance SK(Ca) Channel Activators
EC-67-PV87	FEGRQUWSKADGSP-UHFFFAOYSA-N	O=C(Nc1cncnc1)c1c(Cl)ccc2c(Nc3cccc(C(F)(F)F)c3)noc12	1002106-17-3	PDGFRalpha Inhibitors;KIT (C-KIT) Inhibitors;Angiogenesis Inhibitors
DA-15-PU65	FELGMEQIXOGIFQ-UHFFFAOYSA-N	Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O	103639-04-9	5-HT3 receptor antagonist
CF-53-HM41	FERIKTBTNCSGJS-KIGHRTHISA-N	N[C@@]1(C(=O)O)C[C@H](C(=O)O)[C@H](C(=O)O)C1		GRM4 agonist;GRM6 agonist;GRM7 agonist;GRM8 agonist
DC-98-HC94	FEUMHQAIPUNRCH-ICQOZSIZSA-N	O=C(O)CCCCCCN1C(=O)CCC[C@@H]1/C=C/[C@@H](O)Cc1ccccc1		Prostanoid EP4 agonist
ME-42-RD46	FEWMVFZZCUSAMK-OAQYLSRUSA-N	Nc1cc(COc2ccccc2CC(=O)O)cc(-c2cccc([C@H](N)CO)c2)c1		Complement factor D inhibitor
BB-18-OM53	FFAJBRIJPGOECU-INIZCTEOSA-N	Cn1nc(C2CC2)cc1NC(=O)N[C@H](CO)CCN1CC(Oc2ccc(Cl)cc2)C1		Chemokine CCR3 Antagonists
DB-77-AV67	FFBGIFBVWIAEIA-UHFFFAOYSA-N	O=C(OC1CCCCC1N1CCC(c2ccccc2)CC1)c1ccccc1		
DF-41-HL79	FFEARJCKVFRZRR-SCSAIBSYSA-N	CSCC[C@@H](N)C(=O)O		
UF-28-DW05	FFGNNGLKJOEDAC-UHFFFAOYSA-N	N#Cc1cc(S(=O)(=O)N2C(=O)N(CCCCCN)C(=O)C2Cc2c[nH]c3ccccc23)ccc1Oc1ccc(N)cc1	528570-48-1	Somatostatin SRIF1A (sst2) Agonists
AA-31-NO26	FFGPTBGBLSHEPO-UHFFFAOYSA-N	NC(=O)N1c2ccccc2C=Cc2ccccc21	298-46-4	Sodium Channel  Blockers
BE-79-PQ70	FFHSQDAETWTILU-UHFFFAOYSA-N	COc1cc(-c2cnc(N)c(N3CCC(C(=O)O)CC3)n2)cc(OC)c1OC	1254327-52-0	NEK2 gene inhibitor
AE-18-RD27	FFNWMBDISAYHDC-UHFFFAOYSA-N	CCN(CC)CCOC(=O)c1cc(Cl)c(N)cc1OC	137196-67-9	5-HT4 and 5-HT3 antagonist
UB-21-MV06	FFQQVSHJKNRETB-UHFFFAOYSA-N	Nc1c(-c2nc3ccccc3[nH]2)c(=O)[nH]c2[nH]cnc12		VEGFR Inhibitors;Angiogenesis Inhibitors;VEGFR Inhibitors;Angiogenesis Inhibitors
AA-01-XV28	FFWUPFYTTMMSTH-UHFFFAOYSA-N	O=C(Oc1cccc2c(O)nccc12)c1ccccc1	370872-09-6	Poly(ADP-ribose)polymerase-2 (PARP-2) Inhibitors
ZC-09-IW47	FGLYBSVKXTWBRO-UHFFFAOYSA-N	COc1cccc(N2CCN(Cc3cc4cnc(C#N)nc4n3CC(C)(C)C)CC2)c1		
BA-75-VA57	FGPJLEXUYISLTH-UHFFFAOYSA-N	COc1ccc(Nc2ncc(Cl)c(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)c4c3C(=O)N(C)C4)n2)c(OC)c1	881414-87-5	FAK inhibitor
KD-31-TU05	FGQFOYHRJSUHMR-UHFFFAOYSA-N	O=C(O)CSc1nnc(Br)n1-c1ccc(C2CC2)c2ccccc12	1151516-14-1	
WC-59-RG09	FGTCROZDHDSNIO-UHFFFAOYSA-N	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12	728033-96-3	VEGFR-2 (FLK-1/KDR) Inhibitors;PDGFRbeta Inhibitors;KIT (C-KIT) Inhibitors;Angiogenesis Inhibitors
AE-95-ZK81	FGXWKSZFVQUSTL-UHFFFAOYSA-N	O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1	57808-66-9	Dopamine Receptor Antagonists
TC-69-EY43	FGYMJXFSHBLHLW-CYBMUJFWSA-N	COc1ncc(C)cc1CC[C@@](O)(CC(=O)O)C(=O)O		
JE-31-PK61	FHBANDDJQJAZOQ-CQSZACIVSA-N	C[C@H](c1nc2c(cnn2C2CCOCC2)c(=O)[nH]1)N1CC(Oc2ccccc2)C1	1236858-52-8	PDE9a inhibitor
UD-85-WR81	FHJATBIERQTCTN-UHFFFAOYSA-N	CCNCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)O		
XC-68-NP33	FHKSAMKFFJMXMV-BGERDNNASA-N	O=C([C@@H]1CSC(c2cccnc2)N1)N1CCN(CCCc2ccccc2)CC1		PTAFR antagonist
YB-31-TH67	FHXBMXJMKMWVRG-SLHNCBLASA-N	CC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12		
AD-24-KU93	FHYQVOOPAIKHLJ-UHFFFAOYSA-N	COc1ccc(Nc2nc(C(=O)N3CCc4cc(OC)c(OC)cc4C3)cs2)cc1		
LB-18-LH35	FIKVYIRIUOFLLR-UHFFFAOYSA-N	CC(CC(=O)c1ccc(-c2ccc(F)cc2F)cc1)C(=O)O	112344-52-2	Leukotriene BLT (LTB4) Antagonists;Cyclooxygenase (COX) Inhibitors;Lipoxygenase Inhibitors;Non-Steroidal Antiinflammatory Drugs;Leukotriene BLT (LTB4) Antagonists;Cyclooxygenase (COX) Inhibitors;Lipoxygenase Inhibitors;Non-Steroidal Antiinflammatory Drugs
DA-66-OE69	FIVPIPIDMRVLAY-RBJBARPLSA-N	CN1C(=O)[C@]23CC4=CC=C[C@H](O)[C@H]4N2C(=O)[C@@]1(CO)SS3	67-99-2	NF-kappaB (NFKB) Activation Inhibitors
AB-15-XR48	FJDDSMSDZHURBJ-UHFFFAOYSA-N	COc1ccc2[nH]c(I)c(CCNC(C)=O)c2c1	93515-00-5	MTNR1A agonist;MTNR1B agonist
AC-36-TL21	FJHBVJOVLFPMQE-QFIPXVFZSA-N	CCc1c2c(nc3ccc(O)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC	110714-48-2	Apoptosis Inducers;DNA Topoisomerase I Inhibitors
GF-46-FA29	FJHGPWNOEATILY-UHFFFAOYSA-N	NC(CNC(=O)C1(c2ccc(Cl)cc2)CC1)c1ccc(C(=O)Nc2ccncc2)cc1		Rho Kinase Inhibitors;Protein Kinase PKC theta Inhibitors;Protein Kinase PKC epsilon Inhibitors
UF-61-QB73	FJJLMFGGWNDUMR-SFHVURJKSA-N	COc1ccc2cc([C@](O)(c3c[nH]cn3)C(C)C)ccc2c1		Cytochrome P450 CYP17 (17alpha-Hydroxylase/C17-20 Lyase) Inhibitors
BB-00-UK69	FJLBFSROUSIWMA-UHFFFAOYSA-N	CC(C)(C(=O)c1cccnc1)c1cccnc1	22752-91-6	11-beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Inhibitors;Mineralocorticoid Receptor (MR) Antagonists;Cytochrome P450 CYP11B1 (Steroid 11-beta Hydroxylase) Inhibitors
ME-77-JX81	FJMQJSUOOGOWBD-UHFFFAOYSA-N	CC(F)(F)CN1CCOc2c(nn(-c3ccccc3Cl)c2-c2ccc(Cl)cc2)C1=O	851728-60-4	Cannabinoid CB1 Antagonists
JB-98-EB51	FJVQHTGEXYKKBS-CJRGTMQESA-N	C[C@@H]1C/C=C/CC/C=C/C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1	544712-82-5	Heat Shock Protein 90 (hsp90) Inhibitors
BB-86-UL91	FJWYXWJQDPCIEZ-UHFFFAOYSA-N	CN(C)C(=O)c1cc2cnc(Nc3ccc(C(=O)N4CC5CCC(C4)N5)cn3)nc2n1C1CCCC1	1331845-06-7	CDK4 Inhibitors
AA-22-PQ14	FJZKZLNJNRQYPS-TZMCWYRMSA-N	COc1ccc(I)c2c1C[C@@H]1[C@@H](C2)OCCN1C		ADRA1A agonist
HD-40-AK39	FJZZPCZKBUKGGU-AUSIDOKSSA-N	CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2c(c1)OCCO2	1000191-50-3	
EF-14-GN61	FKCMADOPPWWGNZ-YUMQZZPRSA-N	CC(C)[C@H](N)C(=O)N1CCC[C@H]1B(O)O	149682-77-9	Dipeptidyl Peptidase II (DPPII;DPP2;DPP7) Inhibitors;Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors;Dipeptidyl Peptidase IX (DPP9;DPRP2) Inhibitors;Dipeptidyl Peptidase VIII (DPP8) Inhibitors;Fibroblast Activation Protein-alpha (FAPalpha) Inhibitors
RB-56-FZ63	FKIAZUIISXQFHC-UHFFFAOYSA-N	Cc1c(COc2ccc(F)c(F)c2F)oc2cccc(OCCCNCc3cccnc3)c12		N-Myristoyltransferase  Inhibitors
CA-72-UL91	FKJMFCOMZYPWCO-HNNXBMFYSA-N	O=C(O)C[C@H](NC(=O)OCc1ccccc1)C(=O)COC(=O)c1c(Cl)cccc1Cl	153088-73-4	Caspase 1 (IL-1beta Converting Enzyme) Inhibitors
BF-81-KO31	FKSFKBQGSFSOSM-QFIPXVFZSA-N	CC[C@H](C)n1cc(C)c2c(C(=O)NCc3c(C)cc(C)[nH]c3=O)cc(-c3ccc(N4CCNCC4)nc3)cc21	1346574-57-9	PRC2/EZH2;EZH2 gene inhibitor
AF-62-PI84	FKULIXGXFMDTPC-UHFFFAOYSA-N	O=C(Cn1cncn1)c1ccc(-c2ccccc2)cc1	89082-08-6	Heme Oxygenase 1 (HO-1) Inhibitors
AC-92-ZW28			1228170-70-4	
NB-37-LA11	FLCRMGKKLKMMAE-UHFFFAOYSA-N	Cc1ccc(N2C(=O)C(O)=C(C(=O)c3ccc(Cl)cc3)C2c2cccc(F)c2)cc1Br		PLAUR gene inhibitor
CC-91-VE57	FLFWWGQQNBDVES-UHFFFAOYSA-N	Cc1cc(C)c(Nc2ccc(Cl)c(C(F)(F)F)c2)c(C)c1		RAPGEF4 inhibitor
CB-30-ND32	FLJVRWOWKXUFRB-UHFFFAOYSA-N	CCCCNS(=O)(=O)NCCCC		
CE-21-AY10	FLKRMXAWABTWSH-UHFFFAOYSA-N	NS(=O)(=O)N1CCCCC1	4108-90-1	Carbonic anhydrase inhibitor;Angiogenesis Inhibitors;Apoptosis Inducers;Nicotinamide Phosphoribosyltransferase (NMPRTase) Inhibitors;Carbonic anhydrase inhibitor;Angiogenesis Inhibitors;Apoptosis Inducers;Nicotinamide Phosphoribosyltransferase (NMPRTase) Inhibitors
BB-23-PM31	FLKSZJUIPRZEET-UHFFFAOYSA-N	CC(C)c1c(NCC2CCC3(CCC3)CC2)nc(C#N)nc1OC1CCN(C)CC1		Cathepsin S Inhibitors
BB-04-TN61	FLNXBVJLPJNOSI-UHFFFAOYSA-N	Clc1ccc(C(OCCN2CCCCC2)c2ccccc2)cc1		
WE-25-AN91	FLNYLINBEZROPL-NSOVKSMOSA-N	COc1ccccc1CN[C@H]1C2CCN(CC2)[C@H]1C(c1ccccc1)c1ccccc1	129912-34-1	Non-Steroidal Antiinflammatory Drugs;Tachykinin NK1 Antagonists
JE-55-OJ53	FLNZOSVLPXDSKI-UHFFFAOYSA-N	Cc1nc2cnc3ccc(Br)cc3c2n1-c1ccc(C(C)(C)C#N)cc1		
IB-88-LO32	FLTBEMVEAFMWDD-UHFFFAOYSA-N	CC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1	117796-52-8	Histamine H1 Receptor Antagonists;Platelet-Activating Factor Receptor (PAFR) Antagonists;Non-Steroidal Antiinflammatory Drugs
LD-48-CY61	FMACPFBCGJVLLZ-UHFFFAOYSA-N	Cc1cc(C)c(C(=O)Nc2ccc(-n3nc(C(F)(F)F)cc3C(F)(F)F)cc2)cn1		Calcium Release-Activated Channels (CRAC) Blockers
AD-07-YF79	FMASTMURQSHELY-UHFFFAOYSA-N	Cc1cc2c(CN(C(=O)c3ccncc3C)c3ccc(F)cc3C)cccc2[nH]1	951030-41-4	TGR5 agonist;GPBAR1 agonist
DD-43-WW40	FMTVWAGUJRUAKE-UHFFFAOYSA-N	CC(C)Oc1ccc(-c2c[nH]cc2CN(C)CCN)cc1	1831110-54-3	Type I PRMT inhibitor
AB-87-LJ34	FNGXWOIGFSRSSD-ZROIWOOFSA-N	O=C(O)CCN1C(=O)/C(=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)SC1=S		
GA-79-ZF28	FNICBGZPBTURDA-UHFFFAOYSA-N	Cc1ccc(S(=O)(=O)Nc2nnc(S(N)(=O)=O)s2)cc1	99179-22-3	Carbonic anhydrase inhibitor
AF-31-RV78	FNKQXYHWGSIFBK-RPDRRWSUSA-N	C[C@H](O)[C@H](O)[C@H]1CNc2[nH]c(N)nc(=O)c2N1	103130-44-5	
CB-87-GT98	FNPPHVLYVGMZMZ-XBXARRHUSA-N	COc1nccnc1NS(=O)(=O)c1ccc(NC(=O)/C=C/c2ccc([N+](=O)[O-])s2)cc1	1360614-48-7	Reduces sulfur mustard intoxication;Covalent Necroptosis Inhibitors
HB-45-XQ45	FNSJVQXUTIKAPS-UHFFFAOYSA-N	N#CC1=C2C(=NC1=O)c1cccc3c(Sc4ccc(N)cc4)ccc2c13	1265829-41-1	Apoptosis Inducers;Mcl-1 Inhibitors
TD-48-MJ89	FNTVKQKNZVAMJI-UHFFFAOYSA-N	O=C1CS(=O)(=O)C(c2ccccc2Cl)c2cc(Cl)ccc2N1	1011289-81-8	Na+/Ca2+ Exchanger (NCX) Inhibitors
AD-70-LA75	FOCVUCIESVLUNU-UHFFFAOYSA-N	S=P(N1CC1)(N1CC1)N1CC1	1631739-26-8	Cytochrome P450 Oxidase Inhibitors;DNA alkylating agent
BA-31-KY85	FOECKIWHCOYYFL-UHFFFAOYSA-N	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1	1160271-30-6	P2RY14 inhibitor
IA-76-ZU47	FOFHDVOENOAIGR-UHFFFAOYSA-N	CNC(=O)Nc1ccc(-c2cc(-c3ccnc(Nc4ccc(C)c(S(=O)(=O)N(C)C)c4)n3)ccn2)cc1	1402452-10-1	SMG1 gene inhibitor
CB-13-ZM26	FOIVPCKZDPCJJY-JQIJEIRASA-N	C/C(=C\\c1ccc(C(=O)O)cc1)c1ccc2c(c1)C(C)(C)CCC2(C)C	71441-28-6	Retinoid RAR Agonists
AB-63-OW35	FPCCSQOGAWCVBH-UHFFFAOYSA-N	O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1	74050-98-9	5-HT2 Antagonists
EC-31-MR88	FPGRARCGULBHOH-UHFFFAOYSA-N	CN(C)CCNC(=O)CN1CCN(C(=O)c2sc(C(C)(C)C)cc2NC(=O)Nc2cccc(Cl)c2Cl)C(C)(C)C1=O		p38alpha MAPK Inhibitors
CF-53-GP28	FPIPGXGPPPQFEQ-OVSJKPMPSA-N	CC1=C(/C=C/C(C)=C/C=C/C(C)=C/CO)C(C)(C)CCC1	11103-57-4	1 Epidermal  transglutaminase inhibitor
FE-94-WT30	FPNPSEMJLALQSA-MIYUEGBISA-N	Nc1ccn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@H](O)[C@@H]3O)O2)c(=O)n1	211448-85-0	Mucin Production, Enhancers;P2Y2 Agonists
BC-09-JG96	FPOBKZCHKXONBB-UHFFFAOYSA-N	NC(=O)N(O)CC1=Cc2cc(Oc3ccccc3)ccc2OC1	134822-78-9	Lipoxygenase Inhibitors;Non-Steroidal Antiinflammatory Drugs
AE-38-LX10	FPQNRXITKTZFMF-NWDGAFQWSA-N	NC(=O)c1nnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc2cc[nH]c12		Syk tyrosine kinase inhibitor;selective SYK inhibitor
AB-25-MR13	FPQQERRFPULCIK-UHFFFAOYSA-N	COc1cncc(-c2cnc(NC3CCNCC3)c3[nH]c(=O)c(C)cc23)c1		ATAD2 inhibitor
DE-10-AU63	FPVKHBSQESCIEP-JQCXWYLXSA-N	OC[C@H]1O[C@@H](n2cnc3c2N=CNC[C@H]3O)C[C@@H]1O	53910-25-1	Antimetabolites;Adenosine Deaminase Inhibitors;Antimetabolites;Adenosine Deaminase Inhibitors
FA-39-KG56	FPVZRTFTMXAZJO-UHFFFAOYSA-N	CCOC(=O)Cn1c(=O)c2c(ncn2C)n(C)c1=O		
AB-25-NK66	FQVLRGLGWNWPSS-BXBUPLCLSA-N	CC(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc2c[nH]cn2)NC1=O	229971-81-7	N-cadherin Inhibitor
JD-87-MR82	FQWDVNSBYDXPIO-CQSZACIVSA-N	COc1ccccc1C(=O)Nc1cc2c(cc1N1CCNC[C@H]1C)n(C)c(=O)n2C		BRPF1 inhibitor;BRPF1 inhibitors
OA-74-FH10	FQZSMTSTFMNWQF-UHFFFAOYSA-N	CCCCc1nc(Cl)c(C=O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1	114798-36-6	Cyclooxygenase-2 Inhibitors;Angiotensin AT1 Antagonists
CE-14-SQ43	FRPJGTNLZNXQEX-UHFFFAOYSA-N	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1	587870-77-7	Dopamine D4 Agonists
DE-65-KO26	FRPJSHKMZHWJBE-UHFFFAOYSA-N	O=C(Nc1ccncc1)c1cc([N+](=O)[O-])ccc1Cl	313516-66-4	PPARgamma antagonist
QE-93-PG25	FRWXXAYVHFLWCV-UHFFFAOYSA-N	Cn1cc(C2=C(c3c4n(c5ccccc35)CCC(CO)C4)C(=O)NC2=O)c2ccccc21	131848-12-9	Protein Kinase C (PKC) Inhibitors
HC-11-RK51	FSEZESVJDPKRDS-UWJYYQICSA-N	CN1CC(=O)N2[C@H](c3c[nH]c4ccc(Cl)cc34)c3cc4c(cc3C[C@H]2C1=O)OCO4		PIP5K1alpha inhibitor
BE-36-XE09	FSFMFLKTKIVZGE-UHFFFAOYSA-N	Nc1n[nH]c2nc(N3CCOCC3)c3c(c12)CCN(Cc1ccccc1)C3		
FD-62-ZB67	FSIRXIHZBIXHKT-MHTVFEQDSA-N	CCC(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1	80576-83-6	Antimetabolites;Dihydrofolate Reductase (DHFR) Inhibitors
BC-60-TS99	FSRBEBAWESSVKK-LJQANCHMSA-N	C[C@@H](OC(=O)Nc1c(-c2ccc(-c3ccc(C4(C(=O)O)CC4)cc3)cc2)cnn1C)c1ccccc1	1396007-05-8	Lysophospholipid edg2 (LPA1) Receptor Antagonists
WC-23-DZ10	FSRSEANZUZHDHK-UHFFFAOYSA-N	CN1CCN(C2=Nc3ccc(Cl)cc3Oc3ccccc32)CC1	3455-10-5	Histamine H4 Receptor Agonists;Histamine H1 Receptor Ligands
RE-35-JB13	FSZPIAXLCCQFCM-FCQUAONHSA-N	CN(C)Cc1cccc(N/C(=C2\\C(=O)Nc3cc(C(N)=O)ccc32)c2ccccc2)c1	1094614-84-2	MEK5/ERK5 Inhibitor
BC-11-LL59	FTALBRSUTCGOEG-UHFFFAOYSA-N	Nc1nc2ccc(OC(F)(F)F)cc2s1	1744-22-5	Glutamate Release Inhibitors;K(V)4.3 Channel Blockers;Sodium Channel  Blockers;Cystine Glutamate Transporter Inducer
AE-41-GB05	FTLQSQQQFMZPKO-UHFFFAOYSA-N	NCc1cccc(C2CCN(C(=O)c3ccc(C#Cc4ccccc4F)o3)CC2)c1	725228-45-5	Known Tryptase inhibitor
JE-47-FU54	FTVWIRXFELQLPI-ZDUSSCGKSA-N	O=C1C[C@@H](c2ccc(O)cc2)Oc2cc(O)cc(O)c21	13308-00-4	Apoptosis Inducers;Cytochrome P450 CYP3A4 Inhibitors;Antioxidants;Cell Adhesion Inhibitors
BF-61-IO76	FUBBWDWIGBTUPQ-UHFFFAOYSA-N	CCOC(=O)C(=O)Nc1cc(C)c(Oc2ccc(O)c(C(O)c3ccc(F)cc3)c2)c(C)c1	156740-57-7	Thyroid Hormone Receptor beta Agonists
JB-62-SR15	FUBNLFDSTCWVKM-OALUTQOASA-N	O=C(O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1Cc2ccccc2CN1		
CD-70-GD72	FUGQNAUKABUDQI-UHFFFAOYSA-N	CC(C)c1cc2c(N3CCN(C4=NCC(C)(C)S4)CC3)ncnc2s1	1271738-59-0	Inhibitor of MEN1 (Menin);MEN1 inhibitor
BF-77-FT23	FUHCEERDBRGPQZ-LBNVMWSVSA-N	COc1ccc([C@H]2N[C@H](C(=O)O)Cc3c2[nH]c2ccccc32)cc1CN1CCN(c2ccccc2F)CC1	1354235-96-3	Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) Antagonists
GA-66-IX54	FUPKFFJNRCYVCY-AREMUKBSSA-N	O=C([C@H](NS(=O)(=O)c1ccc2[nH]c(=O)ccc2c1)c1ccccc1)N(Cc1ccco1)Cc1cccs1		OGT (O-linked N-acetylglucosamine (GlcNAc) transferase) inhibitor
AA-99-OX27	FUSNMLFNXJSCDI-UHFFFAOYSA-N	Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1	2398-96-1	Fungal Squalene Monooxygenase Inhibitors
EC-17-MF19	FUZYTVDVLBBXDL-UHFFFAOYSA-N	NC(=O)C1CCCc2c1[nH]c1ccc(Cl)cc21	49843-98-3	SIRT1;Histone Deacetylase SIRT1 Inhibitors
KD-36-KT24	FVBBTOIQETYGOA-SDNORSGYSA-N	CO[C@@H](C(=O)N[C@H]1CC[C@@H](O)CNC1=O)[C@H](O)[C@@H](O)[C@H](O)/C=C/C(C)(C)C		
EB-83-IM06	FVKOFZKSMMIUTL-UHFFFAOYSA-N	O=c1c2cc(F)ccc2sn1-c1cc(S(=O)(=O)N2CCOCC2)ccc1N1CCOCC1	1632125-79-1	Insulin degrading enzyme inhibitor
EC-90-QX75	FVRLVWVKWXERPU-KRWDZBQOSA-N	CO[C@@H](C)COc1cc(NC(=O)N2CCCc3cc(CN4CCN(C)CC4=O)c(C=O)nc32)ncc1C#N		FGFR4 gene inhibitor
BF-29-LU75	FWCVZAQENIZVMY-UHFFFAOYSA-N	CC(C)n1nccc1-c1ncccc1COc1cccc(O)c1C=O	1446321-46-5	Hemoglobin Subunit beta (Sickle Cell Anemia Variant) Polimerization Inhibitors
CA-65-MK91	FWFGIHPGRQZWIW-SQNIBIBYSA-N	CC(C)C[C@@H](C(=O)N[C@H](C(=O)OC1CCCC1)c1ccccc1)[C@H](O)C(=O)NO	238750-77-1	
GA-27-MH98	FWFSAHWQTKFKBC-UHFFFAOYSA-N	CCn1c(=O)ccc2cnc([S+](C)[O-])nc21	211244-83-6	CDK Inhibitors
AD-72-RI24	FXGHOAZJQNLNFD-UHFFFAOYSA-N	CN(C)CC1CCn2c(c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c3ccccc32)C1	131848-98-1	Protein Kinase C (PKC) Inhibitors
DF-80-HY53	FXNFHKRTJBSTCS-UHFFFAOYSA-N	O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12		
AE-00-YK74	FXVFHUCFWMFLSG-UHFFFAOYSA-N	O=C(Nc1ccc2c(c1)CCN2CCc1ccccn1)c1ccccc1-c1ccc(C(F)(F)F)cc1		ApoB Secretion Inhibitors
S0-EE-YMWJ	FYICDSWKKFSYOM-UHFFFAOYSA-N	C=CC(=O)Nc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1Oc1ccccc1	1603845-32-4	ERBB3 covalent inhibitor
AA-69-TD29	FYNMINFUAIDIFL-UHFFFAOYSA-N	Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cnc(OC2CCOCC2)c(N2CCOCC2)c1		
AD-94-TN76	FYPMFJGVHOHGLL-UHFFFAOYSA-N	CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1	23288-49-5	Antioxidants;ABCA1-mediated cellular lipid efflux inhibitor;Serine Protease Hepsin Inhibitors
DC-59-NQ20	FYSRKRZDBHOFAY-UHFFFAOYSA-N	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F	479543-46-9	P38a kinase inhibitor
KB-25-KP22	FZFOTSIMQZCSAS-UHFFFAOYSA-N	COc1cc2cc(C3CCNCC3)oc2cc1OC	54477-07-5	Serotonin Antagonists
EE-60-CG74	FZHHRERIIVOATI-UHFFFAOYSA-N	OC(CNc1ccccc1)Cn1c2ccc(Br)cc2c2cc(Br)ccc21	301353-96-8	Neuroprotective;Neuroprotectant;Nicotinamide Phosphoribosyltransferase (NAmPRTase;Nampt) Activators
JD-78-FE08	FZKFBGXSXUYBMX-FQEVSTJZSA-N	O=C(NCc1cccc(O)c1)c1cc(Cl)c(C(=O)N[C@@H](CNC(=O)c2cc(O)cc(O)c2)C(=O)O)c(Cl)c1		Integrin alphaLbeta2 (LFA-1) Antagonists;Anti-ICAM-1 (CD54) Agents
RE-51-AF63	FZNCGRZWXLXZSZ-CIQUZCHMSA-N	OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O	83480-29-9	alpha-Glucosidase Inhibitors;inhibits digestion and absorption of glucose from intestine
GA-81-DL34	FZOFDZMKSAUTHT-NRFANRHFSA-N	O=C1Nc2ccccc2C2(CCN(C[C@H](Cc3ccccc3)Nc3nc4ccc(F)cc4s3)CC2)N1		Notch Pathway Antagonist;ER Stress Inducer;ZIP7 modulator
GC-06-BU42	FZWTUTSNVNMLPN-UHFFFAOYSA-N	Cc1nc(-n2ccc(O)cc2=O)sc1C(=O)NCc1ccccc1	1105690-38-7	SCD inhibitor
RB-42-MC53	FZXZDHDSQPECTD-UHFFFAOYSA-N	Cn1cc(C2=C(c3cn(C4CCN(C(=O)OC(C)(C)C)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21	170364-25-7	Protein Kinase C (PKC) Inhibitors
BD-96-HO33	FZZIIAUJWUWYCF-UHFFFAOYSA-N	Cc1ccc(N2CC(=O)N(S(=O)(=O)c3ccc(Cl)cc3)C2=O)cc1C		Known Chymase inhibitor
KC-48-OO62	GAANRNOWRTWFGY-MXVIHJGJSA-N	Cc1c(CNc2ncc([N+](=O)[O-])c(NC[C@H]3CC[C@H](CN)CC3)n2)cccc1-c1cccc(CN)c1	943721-41-3	PKC theta inhibitor
JB-82-SK68	GABNAHQQEVWYNS-UHFFFAOYSA-N	O=S1(=O)C=C(c2ccccc2)S(=O)(=O)CC1		
JC-96-ID26	GACCZOWWEMDUMW-JWQCQUIFSA-N	CC(C)N1C(=O)[C@H](NC(=O)[C@@H](Cc2ccccc2F)NC(=O)c2ccc(F)cc2C(F)(F)F)CCc2cc(Cl)ccc21		Nav1.7 ( PN1/hNE-Na) Sodium Channel Blockers
AE-00-NY23	GACOFEKSDCOVMV-RRYXBOBMSA-N	CC(C)[C@@]12C[C@@H](OC(=O)CO)[C@@](C)(O1)[C@@H]1CC[C@@H](C)[C@H]1[C@@H]2OC(=O)/C=C/c1ccccc1	1094250-15-3	TRPC4 gene stimulator
IB-89-RS34	GADIKQPUNWAMEB-UHFFFAOYSA-N	CCc1c(C(=O)OC)ncc2[nH]c3cc(OC)c(OC)cc3c12	1215833-62-7	Ligand of the GABAA receptor subtypes
BC-75-CK91	GAEUGYYJXUTOSY-UHFFFAOYSA-N	CNc1cc(Nc2nccc(Nc3cccc(OC)c3S(N)(=O)=O)n2)ccc1C		ALK Inhibitors;ZAP70 Kinase Inhibitors
MB-13-WR12	GAGLCVGNZGLPTE-UHFFFAOYSA-N	COc1cccc(NC(=O)CSC2=Nc3ccccc3C3=NC(CC(=O)NCc4ccc5c(c4)OCO5)C(=O)N23)c1		
CA-07-KS70	GAIGXSIJEITWDD-UHFFFAOYSA-N	Clc1cccc(-c2cnc3sc(NCCc4ccccn4)nn23)c1	1137143-44-2	Pim-1 Kinase Inhibitors
VD-88-MW70	GAKKPKBEHVIOLH-UHFFFAOYSA-N	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1		CDK Inhibitor;Pan Kinase Inhibitor
AF-87-II41	GAMRBCZMOOMBSQ-CCEZHUSRSA-N	CCCCCc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1	110683-10-8	TRPM8 (TRP-p8| CMR1)  Antagonists;TRPM2 Antagonists;TRPC6 Inhibitors;Phospholipase A2 (PLA2) Inhibitors
CB-24-AT90	GAOZTHIDHYLHMS-KEOBGNEYSA-N	CC[C@@]1([C@@H]2O[C@@H]([C@H]3O[C@@](O)(CO)[C@H](C)C[C@@H]3C)C[C@@H]2C)CC[C@H]([C@]2(C)CC[C@]3(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(=O)O)O3)O2)O1		
UF-86-ME07	GAPFINWZKMCSBG-UHFFFAOYSA-N	N=C(N)NCCS	1190-74-5	Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Cyclooxygenase (COX) Inhibitors;Antiinflammatory Drugs;Free Radical Scavengers
IB-90-MD82	GAQWKARFCURWKO-HNNXBMFYSA-N	COc1cccc(NC[C@H](F)Cn2c3ccc(Br)cc3c3cc(Br)ccc32)n1		
DB-56-XL71	GBABOYUKABKIAF-IELIFDKJSA-N	CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2	71486-22-1	Antimitotic Drugs;Tubulin polymerization inhibitors
RC-14-PH60	GBHKWXUSQTVIBN-UHFFFAOYSA-N	CC1(C)Oc2cc(N3CCN(C(=O)OCc4ccccc4)CC3)c([N+](=O)[O-])cc2-c2c1cnn2-c1ccc(C(=O)O)cc1		
BA-02-FS63	GBLVWAKPJGOHBU-NTKDMRAZSA-N	CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C(=O)N(C)c2ccccc2)C1		
HC-97-AH03	GBTYEOLOCAQPPZ-MHZLTWQESA-N	COCCCN(CC(=O)N[C@@H](CC(=O)O)c1ccc(OC)c(OC)c1)C(=O)Cc1ccc(NC(=O)Nc2ccccc2C)cc1		Integrin binder;Cell Adhesion Inhibitors;Integrin alpha4beta1 (VLA-4) Antagonists
CA-23-BW20	GCBKYZIVRCZIQF-UHFFFAOYSA-N	COc1cc(OC)c(NC(=O)Cn2c(=O)n(CC(=O)O)c(=O)c3ccccc32)cc1Cl	1052722-45-8	S1PR2 antagonist
DA-30-HN81	GCLYTVBHDAOFHM-YOEHRIQHSA-N	C[C@H]1CCCN(C(=O)[C@@H]2Cc3ccccc3N2c2ccc(=O)n(C)n2)C1		Peripheral Benzodiazepine Receptor (PBR) Ligands
OD-39-RY38	GCSZJMUFYOAHFY-SDQBBNPISA-N	CCN1/C(=C/C(C)=O)Sc2ccc(O)cc21		
CA-32-XV05	GCUCIFQCGJIRNT-UHFFFAOYSA-N	O=C(O)CN1C(=O)c2cccc3cccc(c23)C1=O	51411-04-2	Aldose Reductase Inhibitors
LB-60-OF61	GCWGKOCPENDNLZ-UHFFFAOYSA-N	N#Cc1ncc2cc(COc3ccc(C(=O)NCc4cccnc4)cc3)n(CCC3CCCCC3)c2n1		
FB-75-YG01	GCWIICJLIHIUNY-UHFFFAOYSA-N	O=C1OC2CN1CCC2Oc1ccccc1		Cathepsin inhibitor
CF-50-QK79	GCZHKZTYTMTFGU-JHOUSYSJSA-N	COCc1cc2cc(c1)C(=O)N[C@H]([C@H](O)CNC1(c3cccc(C(C)C)c3)CC1)Cc1cccc(c1)OCCCCN2		beta-Secretase 1 (BACE1) Inhibitors;beta-Secretase 2 (BACE2) Inhibitors;Cathepsin E Inhibitors;Cathepsin D Inhibitors
SF-77-LC15	GDGYMKPSHGCUMS-MPXUKUPWSA-N	CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@]2(C[C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C(C)(C)C21COC1)C(C)(C)C		
HF-36-FK93	GDJANRNMFHNVOW-DCPHZVHLSA-N	C[C@H](NC(=O)[C@H]1NCC[C@@H]1O)c1ccc(-c2noc(CCC3CCCC3)n2)cc1	1218816-71-7	SPHK1 inhibitor
BB-41-XE67	GDJTWWGJXFJUTQ-KRWDZBQOSA-N	Cc1ccc(-c2ccc(O[C@H]3CN4CCC3CC4)nn2)c(F)c1		Nicotinic alpha7 Agonists
AF-33-GW65	GDLBFKVLRPITMI-UHFFFAOYSA-N	CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1	1098065-76-9	potassium channel activator;K(ATP) Channel Activators
AC-50-JK54	GDLIGKIOYRNHDA-UHFFFAOYSA-N	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	17321-77-6	Serotonin Transporter (SERT) Inhibitors
TD-35-IE25	GDOVFSONSLOIAK-KRWDZBQOSA-N	O=C([C@@H]1CSCN1C(=O)CC1Cc2ccccc2C1)N1CCCC1	130849-58-0	Prolyl Endopeptidase (prolyl oligopeptidase;POP) Inhibitors
KA-46-YG68	GDQXJQSQYMMKRA-UHFFFAOYSA-N	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21	221244-14-0	Extracellular-Regulated Kinase (ERK) Inhibitors;Calmodulin-Dependent Protein Kinase II (CaMK-II) Inhibitors;Extracellular-Regulated Kinase (ERK) Inhibitors;Calmodulin-Dependent Protein Kinase II (CaMK-II) Inhibitors
WD-15-WN01	GDZMTYCCFDKAOL-UHFFFAOYSA-N	CC(C)(C)OC(=O)NCCc1ccc(NC(=O)c2ccccc2-c2ccc(C(F)(F)F)cc2)cc1		ApoB Secretion Inhibitors
AD-20-KA75	GEHJIACZUFWBTK-UHFFFAOYSA-N	O=S(=O)(c1cccc2c(I)cccc12)N1CCCNCC1	109376-83-2	Myosin Light Chain Kinase (MLCK) Inhibitors
IE-80-DC24	GEIYYAQWCIOURN-UHFFFAOYSA-N	CC(C)C(N)C(=O)NCc1cc([N+](=O)[O-])cc2[nH]c(=O)c(=O)[nH]c12		
ED-33-YZ72	GEPYBHCJBORHCE-SFHVURJKSA-N	COc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2C[C@H](C)N2CCOCC2)cc1Cl	1613695-14-9	CREBBP / CBP / KAT3A;N-Ac Lysine competitive CREBBP inhibitor
MC-43-PK30	GERJIEKMNDGSCS-DQEYMECFSA-N	O=C(O)c1ccc(CN2C[C@@H]3C[C@H]2CN3Cc2ccc(Oc3ccc(-c4ncco4)cc3)cc2)cc1	943764-99-6	inhibition of leukotriene A4 hydrolase
JB-82-MH86	GEVVQZHMFVFGLN-HDJSIYSDSA-N	Nc1ncnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)CCO2	1109276-89-2	Diacylglycerol Acyltransferase type 1 (DGAT-1) Inhibitors
OA-10-AB96	GEWCGOGVWLUKRX-LOACHALJSA-N	CC(C)C[C@H](NC(=O)C(CS)CCc1ccccc1)C(N)=O		Collagenase Inhibitors
BE-89-DG86	GFBPVYVWAHGFJY-UHFFFAOYSA-N	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nccn1-c1cc(NN2CCN(C)CC2)ncn1		
LE-80-QM43	GFCFHPBOVAMCFA-VMDCBLMVSA-O	CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc(Br)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCC[N+](C)(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(N)=O		CBX6 inhibitor
AD-00-WA10	GFFPVFWRCCFTOC-UHFFFAOYSA-N	CC(C)OCCN(C(=O)CCl)c1ccc(C(=O)N2CCN(CCc3ccc(Cl)cc3)CC2)cc1		
CB-10-YX20	GFGMISOSPOPSHN-NOCYUORASA-N	O=C1OC(/C=C/c2ccccc2)=N/C1=C\\c1cccnc1	315694-89-4	DAPK1/3 inhibitor
DA-58-LZ09	GFMMXOIFOQCCGU-UHFFFAOYSA-N	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl	212631-79-3	Mitogen-Activated Protein (MAP) Kinase Kinase (MEK) Inhibitors;Extracellular-Regulated Kinase (ERK) Inhibitors;Inhibitors of Signal Transduction Pathways
GE-84-VZ24	GFWPWSNIXRDQJC-UHFFFAOYSA-N	O=C1c2c(O)cc(O)cc2OC(c2ccc(O)cc2)C1c1c(O)cc(O)c2c(=O)cc(-c3ccc(O)c(O)c3)oc12	417703-47-0	Phospholipase A2 (PLA2) Inhibitors;Non-Steroidal Antiinflammatory Drugs
FD-91-OK66	GFXMFSCCEVADLF-UHFFFAOYSA-N	CC(=O)Nc1ncc(SCc2ncc(C(C)(C)C)o2)s1	224435-04-5	CDK2/Cyclin E Inhibitors
IA-10-ET40	GGALEXMXDMUMDM-UHFFFAOYSA-N	Clc1cccc(SC2CCNCC2)n1	98330-05-3	5-HT1B Agonists
DD-93-NF74	GGJXMJDJTXWIKJ-JOCHJYFZSA-N	N[C@H](Cc1ccc(Cl)cc1Cl)C(=O)N1Cc2ccc(NC(=O)c3ccccc3)cc2C1		
ED-62-GS43	GGMAXEWLXWJGSF-PEWBXTNBSA-N	CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O	217082-60-5	APLNR agonist
RC-52-AC88	GGMKSZQCUBFLME-HJWRWDBZSA-N	O=C(/C=C\\C(=O)Nc1cccc(Cl)c1)Nc1ccc(Br)cc1		XPO1 (CRM1) inhibitor
AC-44-UR36	GGPZCOONYBPZEW-UHFFFAOYSA-N	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1	269390-69-4	VEGFR-1 (Flt-1) Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;KIT (C-KIT) Inhibitors;Angiogenesis Inhibitors
DD-68-ZP95	GGQCWUKLPMFTDA-UHFFFAOYSA-N	CC(C)n1cc(-c2cncc(-c3ccc4c(c3)CC(=O)N4C)c2)ccc1=O		Ossification inhibitor;Kinase inhibitors;Inhibitor of bone morphogenetic protein kinases
AA-13-DN24	GGUSQTSTQSHJAH-UHFFFAOYSA-N	OC(CN1CCC(Cc2ccc(F)cc2)CC1)c1ccc(Cl)cc1	119431-25-3	NMDA Antagonists
S0-EE-XPGU	GGVFBUYNEPBFQT-UHFFFAOYSA-N	O=C(O)c1c(O)cccc1CCc1ccc2ccccc2c1	365542-77-4	
BA-39-LQ60	GGWIGGMSOWGWLR-UHFFFAOYSA-N	O=c1oc2ccccc2c(O)c1C(c1ccccc1)c1c(O)c2ccccc2oc1=O		
DA-49-ZD74	GGXICVAJURFBLW-CEYXHVGTSA-N	CC(C)OC(=O)CCC/C=C\\C[C@@H]1[C@@H](CC[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O	130209-82-4	Prostaglandin F agonists
RE-62-FC93	GGXYSIWKDNGCRS-UHFFFAOYSA-N	CCN(CC)C1CCN(c2ccc(OC)c(-c3cnn4c(N)c(-c5cccc(Cl)c5)c(C)nc34)c2)CC1		
AA-45-AA67	GHASVSINZRGABV-UHFFFAOYSA-N	O=c1[nH]c(O)ncc1F	1004-03-1	thymidylate synthase
GE-74-KC09	GHBUMWHHZFGRDI-AWEZNQCLSA-N	COc1cc(OC)cc(C2=N[C@H](CO)Cc3cc(OC)c(OC)cc32)c1	143526-87-8	Phosphodiesterase III Inhibitors;Phosphodiesterase IV Inhibitors;Nucleoside-Diphosphate Kinase Inhibitors;Phosphodiesterase III Inhibitors;Phosphodiesterase IV Inhibitors;Nucleoside-Diphosphate Kinase Inhibitors
CC-17-JL38	GHBUPSVATJKTRR-UHFFFAOYSA-N	CNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(N3CCNCC3)cc2)n1	1333146-24-9	
AA-19-SX47	GHCCBWMZKJQGLS-UHFFFAOYSA-N	O=C(Cc1ccc(Cl)c(Cl)c1)N1CCCCC1CN1CCCC1	112282-24-3	OPRK1 agonist
XF-42-ES96	GHESWKCVPRIYLS-UHFFFAOYSA-N	O=[N+]([O-])c1ccc(N2CCCC(CO)C2)cc1	166438-83-1	CDK Inhibitors
VD-76-SO91	GHMKQBWHPQMXSH-UHFFFAOYSA-N	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cnc(Cl)nc1C(F)(F)F	154563-54-9	Antiinflammatory Drugs;NF-kappaB (NFKB) Activation Inhibitors
JA-52-PL41	GHNVVDAQSLCEMR-UHFFFAOYSA-N	C#CCOC(=O)Nc1ccc(Cl)c(-c2nc3cc(Cl)ccc3s2)c1		Lysophosphatidic Acid-Acyltransferase beta (LPAAT-beta) Inhibitors
IA-41-GR68	GHOHRLXVWJYYKJ-BYPYZUCNSA-N	N[C@H](CS)CCS(=O)(=O)O	232261-88-0	Glutamyl Aminopeptidase (Aminopeptidase A) Inhibitors
FC-11-YA62	GHOSNRCGJFBJIB-UHFFFAOYSA-N	CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1	139481-59-7	Angiotensin AT1 Antagonists
OE-23-XH48	GHTGYZMBQPXTCQ-UHFFFAOYSA-N	CC1(C)Cc2c(sc(NC(=O)c3ccn[nH]3)c2C(N)=O)C(C)(C)O1		CFTR modulator
SB-87-LQ34	GHVMTHKJUAOZJP-CGTJXYLNSA-N	CNC(=O)[C@@H](NC(=O)[C@H](CCCc1ccccc1)[C@H](C)N(O)C=O)C(C)(C)C	260264-93-5	ADAM10 gene inhibitor
CC-62-XM29	GHWJEDJMOVUXEC-UHFFFAOYSA-N	Oc1cc2c(c(Cl)c1O)CCNCC2c1ccccc1	67287-39-2	DRD1 agonist
HE-43-BS90	GIJDWRLMGLMKPQ-UHFFFAOYSA-N	NC(=O)c1nc(-c2cccnc2)nc2c1[nH]c(=O)n2C1CCN(C(=O)OCc2ccccc2)CC1	1022155-50-5	Mammalian Target of Rapamycin (mTOR;FRAP1) Inhibitors
CB-42-EI79	GIUYCYHIANZCFB-FJFJXFQQSA-N	Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@@H]1O	75607-67-9	Purine Antagonists
BF-03-RM76	GJINDJNJRPIQNH-UHFFFAOYSA-N	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(NC(=O)N(C)c4ncnc5[nH]ccc45)c3)cc2C(F)(F)F)CC1		Inhibitors of Signal Transduction Pathways;Flt3 (FLK2/STK1) Inhibitors;FGFR3 Inhibitors;Bcr-Abl Kinase Inhibitors;Angiogenesis Inhibitors;Inhibitors of Signal Transduction Pathways;Flt3 (FLK2/STK1) Inhibitors;FGFR3 Inhibitors;Bcr-Abl Kinase Inhibitors;Angiogenesis Inhibitors
MC-40-IP75	GJJFMKBJSRMPLA-HIFRSBDPSA-N	CCN(CC)C(=O)[C@]1(c2ccccc2)C[C@@H]1CN	101152-94-7	5-HT Reuptake Inhibitors;Norepinephrine Reuptake Inhibitors
FE-18-SS57	GJNDXQBALKCYSZ-RYUDHWBXSA-N	CC(C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O	3918-92-1	Calpain Inhibitors
DA-59-ZD74	GJPICJJJRGTNOD-UHFFFAOYSA-N	COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO	1174918-31-0	Endothelin ETA Receptor Antagonists;Endothelin ETB Receptor Antagonists
AE-52-XF72	GJQPMPFPNINLKP-UHFFFAOYSA-N	NS(=O)(=O)c1cc(Cl)c(Cl)c(S(N)(=O)=O)c1	120-97-8	Carbonic Anhydrase Inhibitors
LF-35-CP32	GJSLOMWRLALDCT-UHFFFAOYSA-N	CN(C)Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2	37115-32-5	Peripheral-type benzodiazepine receptors potentiator
AE-37-KS50	GJZVQXWEIYRHBE-UHFFFAOYSA-N	CCOC(OCC)P(=O)(O)CCCNCc1ccc(Cl)c(Cl)c1		
EA-73-MI41	GKCBAIGFKIBETG-UHFFFAOYSA-N	CCCCNc1ccc(C(=O)OCCN(C)C)cc1	100311-22-6	
LF-64-NB46	GKFPROVOIQKYTO-UZLBHIALSA-N	COC(=O)[C@H](CCSC)NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1ccccc1	1217447-06-7	Inhibitors of Signal Transduction Pathways;Farnesyltransferase (geranylgeranyl pyrophosphate synthase) Inhibitors
AB-23-UX23	GKJZEKSHCJELPL-UHFFFAOYSA-N	Cn1cc(C(F)(F)F)nc1-c1ccc(OCC(O)CNCCOc2ccc(O)c(C(N)=O)c2)cc1	105737-62-0	ADRB1 antagonist
FF-07-FL63	GKTWGGQPFAXNFI-HNNXBMFYSA-N	COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1	113665-84-2	P2Y12 (P2T) Antagonists
AE-39-SG01	GKTWGGQPFAXNFI-UHFFFAOYSA-N	COC(=O)C(c1ccccc1Cl)N1CCc2sccc2C1	113665-84-2	P2RY12 antagonist
VA-03-RM19	GKWHICIUSVVNGX-MRXNPFEDSA-N	CN(C)[C@@H]1CCc2[nH]c3ccc(NC(=O)c4ccc(F)cc4)cc3c2C1	1217756-94-9	5-hydroxytryptamine receptor 1F receptor agonist
LB-58-WE43	GKWPCEFFIHSJOE-UHFFFAOYSA-N	CCN(C(=O)c1c(O)c2c(Cl)cccc2n(C)c1=O)c1ccccc1	248281-84-7	Immunomodulator
ZA-28-BF44	GLBZSOQDAOLMGC-UHFFFAOYSA-N	COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)nc3)ccnc2c1	913376-83-7	c-Met) Inhibitors;HGFR (MET
ED-26-RU42	GLLPUTYLZIKEGF-HAVVHWLPSA-N	O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1	110140-89-1	Prostanoid TP Antagonists;Thromboxane Synthase Inhibitors
AD-26-RY42	GLLPUTYLZIKEGF-QJOMJCCJSA-N	O=C(O)CCCCO/N=C(\\c1cccnc1)c1cccc(C(F)(F)F)c1		
ID-05-KT67	GLRHIFIUOXQKIX-CJLVFECKSA-N	C(=N/N(Cc1ccccc1)Cc1ccccc1)\\c1ccccc1		
ED-02-CL76	GLVAUDGFNGKCSF-UHFFFAOYSA-N	S=c1[nH]cnc2[nH]cnc12	1194-62-3	Immunosuppressive;Purine Antagonists
LE-31-QT97	GLXSBZGTGMPDKH-UHFFFAOYSA-N	O=C(NCCc1cccc2ccccc12)C1CCC1	152302-33-5	Melatonin Antagonists
BE-68-PM13	GMGMDWSPSKXMJH-OAQYLSRUSA-N	COc1ccc2nc(NC(=O)[C@H](CC3CCCC3)c3ccc(S(=O)(=O)N4CCN(C)CC4)cc3)sc2n1	866772-52-3	Glucokinase Activators
FC-22-VC55	GMJJUIPOBZLSRJ-MRXNPFEDSA-N	C[C@@H]1COCCN1c1cc(C2(S(C)(=O)=O)CCOCC2)nc(-c2cccc3[nH]ccc23)n1	1233339-29-1	ATR gene inhibitor;Chemosensitizer;DNA damage reversal pathway modulator
DC-08-CM08	GMLKJSOWCKBKLX-UHFFFAOYSA-N	c1cc2c(N3CCNCC3)nc(-c3ccc4[nH]ncc4c3)nc2cn1		Rho Kinase Inhibitors
IF-00-FW22	GMNKEZBZYKGPTL-LUAWRHEFSA-N	CCc1cccc2c(/C=C(/C)C(=O)O)cc(OC)c(OC(C)=O)c12		
FD-81-SU40	GMPKIPWJBDOURN-UHFFFAOYSA-N	CON		
S0-EE-WW96	GMPQGWXPDRNCBL-UHFFFAOYSA-N	COc1cc(-c2nn(CCN3CCC(N(C)C)CC3)c3ncnc(N)c23)ccc1NC(=O)OC(C)(C)C		
BB-36-JL06	GMQJALWDENUKHB-UHFFFAOYSA-N	CCS(=O)(=O)NCc1cncc(-c2cc3ccc(Cl)cc3n2C)c1	1202551-28-7	Cytochrome P450 11B2 (Aldosterone Synthase) Inhibitors
DB-87-WL13	GMQUVXSLXJHXLX-URLMMPGGSA-N	CC(C)(C)OC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)C1CCN(S(=O)(=O)c2ccccc2)CC1		Somatostatin SRIF1A (sst2) Antagonists
AA-07-FZ97	GMRQFYUYWCNGIN-NKMMMXOESA-N	C=C1/C(=C\\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O	1000873-74-4	CYP27B1 metabolite
BD-66-QO48	GMTAOJMPNXLKJI-UHFFFAOYSA-N	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1		DLK Inhibitor
AD-91-FZ23	GMZVRMREEHBGGF-UHFFFAOYSA-N	NC(=O)CN1CCCC1=O	7491-74-9	Nootropic;AMPA Receptor Postiive Allosteric Modulators
ND-54-FY31	GNDKYAWHEKZHPJ-UHFFFAOYSA-N	NS(=O)(=O)c1ccccc1[N+](=O)[O-]		
EE-23-MF14	GNKAYRQCODZPBL-HSZRJFAPSA-N	CCc1ccc2nc(NC(=O)[C@H](CC3CCCC3)c3ccc(S(=O)(=O)N(CCOC)CCC(=O)O)cc3)sc2n1		
YB-58-IZ37	GNMUEVRJHCWKTO-HXUWFJFHSA-N	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2		N-Ac Lysine competitive BET family inhibitor BRD4
PD-60-FM93	GNOZQRKYZJSIPZ-UHFFFAOYSA-N	CN(C(=O)c1cc2ccccc2cc1C(=O)C(c1cccc2ccccc12)P(=O)(O)O)C1CCN(C(=O)c2ccccc2)CC1	429676-93-7	Dual mast cell chymase, Cathepsin G inhibitor
JD-94-BC04	GNRIZKKCNOBBMO-UHFFFAOYSA-N	COc1c(O)cc2oc3cc(O)c(CC=C(C)C)c(O)c3c(=O)c2c1CC=C(C)C	6147-11-1	Fatty Acid Synthase Inhibitors;Acidic Sphingomyelinase (A-SMase) Inhibitors;Antioxidants
GB-86-PE04	GNZCSGYHILBXLL-UHFFFAOYSA-N	CC(C)(C)Nc1nc2cc(Cl)c(Cl)cc2nc1S(C)(=O)=O	281209-71-0	GLP-1 Receptor Agonists;positive allosteric modulator of GLP1R
AE-07-IZ32	GODKPWYLLOOFQL-KDURUIRLSA-N	C[C@@H]1CN(c2ccc(Nc3ncc4ccn(-c5cc(F)c(CN6CCOCC6)c(F)c5)c4n3)cn2)C[C@H](C)N1	1180158-99-9	
AD-34-TG29	GOLXRNDWAUTYKT-UHFFFAOYSA-N	O=C(O)CCc1c[nH]c2ccccc12	10265-77-7	Free Radical Scavengers;beta-Amyloid (Abeta) Protein Neurotoxicity Inhibitors
AD-85-ME82	GORPFHTVXJBJQH-XJYRRQLNSA-N	CC[C@@H]1/C=C(\\C)C[C@H](C)C[C@H](O)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC		
AE-04-DX45	GOTMKOSCLKVOGG-OAHLLOKOSA-N	CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1	125941-87-9	Dopamine D1 Antagonists;Dopamine D5 Antagonists;DRD1 antagonist;DRD5 antagonist
JD-04-UT85	GOTYRUGSSMKFNF-UHFFFAOYSA-N	Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O	1243329-97-6	DDB1-CRBN modulator;Angiogenesis Inhibitors;TNF-alpha Production Inhibitors
GA-47-CH23	GOVANMMKAZSZDV-OAHLLOKOSA-N	CCC(=O)Nc1cccc(-c2cc3c(N[C@H](C)c4ccccc4)ncnc3[nH]2)c1		EGFR (HER1;erbB1) Inhibitors
AE-72-UP91	GOVVZKTWJFVEFJ-MPKXVKKWSA-N	CC[C@@H](Nc1c(Nc2ccc(Cl)c(S(=O)(=O)N(C)OC)c2O)c(=O)c1=O)[C@H]1CC[C@@H](C)O1	1206894-97-4	Chemokine CXCR2  (IL-8 beta Receptor) Antagonists
AE-05-CB45	GOVYBPLHWIEHEJ-UHFFFAOYSA-N	CN1CCc2c(c3ccccc3n2Cc2ccc(C(=O)NO)cc2)C1	1239262-52-2	HDAC 6/8;Histone deacetylase-6 inhibitor
SC-71-IB68	GOWDFSKVUJAHJJ-UHFFFAOYSA-N	NS(=O)(=O)N1CCCCCC1	4108-89-8	Carbonic anhydrase inhibitor
EC-14-UM93	GPDKREBNFFEDHW-UHFFFAOYSA-N	O=C(C(=O)c1ccc([N+](=O)[O-])cc1)c1ccccc1	22711-24-6	Carboxylesterase Inhibitors
BD-45-EU45	GPEJLSOTBIROAY-QHCPKHFHSA-N	CCC[C@]1(c2ccc(C#N)cc2F)C(=O)N(Cc2ccc(F)cc2)Cc2cncn21		
CA-38-JF31	GPFXZYJYVUTNSE-LCPICFLISA-N	C=CC1=CC[C@H]2[C@@H](C[C@@H](O)[C@@]3(O)[C@@]4(C)C(=O)O[C@H]4CC[C@]23C)[C@H]1C		covalent HSP70 inhibitor
AB-64-ZX70	GPKJTRJOBQGKQK-UHFFFAOYSA-N	CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12	130-42-7	TP53 Expression Enhancers;Secretory Phospholipase A2 (sPLA2) Inhibitors;Cytokine Production Inhibitors;NF-kappaB (NFKB) Activation Inhibitors
JB-37-OU59	GPLUUMAKBFSDIE-KRWDZBQOSA-N	NC(=O)c1ccc(CNC(=O)NC[C@H]2CN(Cc3ccc(Cl)c(Cl)c3)CCO2)cc1	408303-43-5	Chemokine CCR3 Antagonists
AE-70-QB23	GPMXUUPHFNMNDH-UHFFFAOYSA-N	O=C(CCCN1CCC(O)(c2cccc(C(F)(F)F)c2)CC1)c1ccc(F)cc1	2062-77-3	
EA-95-YQ95	GPTFURBXHJWNHR-UHFFFAOYSA-N	CN1CCc2cc3c(cc2C(=O)Cc2ccc4c(c2C1)OCO4)OCO3	130-86-9	Acetylcholinesterase Inhibitors;Norepinephrine Transporter (NET) Inhibitors;Serotonin Transporter (SERT) Inhibitors;Inhibits LPS induced cytokine secretion
EA-40-KQ08	GPTKKIOZEZUGBH-RTWAWAEBSA-N	CC1(C)Oc2ccc(S(=O)(=O)Nc3ccccc3)cc2[C@@H](N2CCCCC2=O)[C@@H]1O	185695-83-4	K(ATP) Channel Activators
JD-54-BS97	GPWMBZKWWUXUPP-HDICACEKSA-N	Cc1c(C(=O)Nc2ccc(N3C[C@@H](C)O[C@@H](C)C3)nc2)cccc1-c1ccc(C#N)cc1	956698-43-4	smoothened antagonist
DB-98-LQ88	GPXBXXGIAQBQNI-UHFFFAOYSA-N	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F	1029872-54-5	Inhibitors of Signal Transduction Pathways;Raf kinase B Inhibitors
ZE-79-HJ46	GQEAQQLZXOTRPN-UHFFFAOYSA-N	Cc1cc(C)c(CNC(=O)c2ccnc3c2cnn3C(C)C)c(=O)[nH]1		
AA-99-HO76	GQEOCXVLXYTOAW-HSZRJFAPSA-N	CO[C@@H]1CCN(c2nc(-c3c(C)ccc4[nH]nc(C)c34)nc3c2CN(c2c(Cl)c(C4CC4)nn2C)CC3)CC1(C)C		C5a Receptor antagonist
GE-29-BW04	GRHBODILPPXVKN-UHFFFAOYSA-N	CCCCOc1cccc(CCNCC(=O)N(C)C)c1	1092977-06-4	Nav1.3 (Brain Type III) Sodium Channel Blockers;Nav1.7 (PN1/hNE-Na) Sodium Channel Blockers;Nav1.8 (SNS/PN3) Sodium Channel Blockers
NC-76-YX69	GRIATXVEXOFBGO-UHFFFAOYSA-N	Cc1cccc2sc(N)nc12		
FC-15-XG61	GRPDJYSPOSONBX-CXXVJMAYSA-O	O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C(O)(c1cccs1)C1CCCCC1)C2)Nc1ccon1		Muscarinic M1 Antagonists;Muscarinic M2 Antagonists;Muscarinic M3 Antagonists
GB-01-UN23	GRPDTQVFLZSLBL-FRFSOERESA-N	CN1C[C@H](CSc2nccn2C)C[C@@H]2Cc3c(O)cccc3C[C@H]21		
ED-14-GQ53	GRUODACYFFPYCV-UHFFFAOYSA-N	Cc1ccc(Oc2ccccc2C(=O)O)cc1		
SA-63-NG30	GRWNPFJXINLSNF-UHFFFAOYSA-N	CCS(=O)(=O)c1ccc(CC(=O)Nc2nc(-c3cccc(Cl)c3)c(C(=O)c3ccccc3Cl)s2)cc1	1361413-10-6	Retinoid receptor modulator
S0-EE-Y9S3	GRXCLNMCJWKTAT-UHFFFAOYSA-N	COc1cccc(CC(=O)N2Cc3ccc([S@SP3](=O)(=O)Nc4cnn(C5CCC5)n4)cc3C2)c1		MOGAT 3 inhibitor
BF-94-NX85	GRZXWCHAXNAUHY-NSISKUIASA-N	CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@H]3O)CC1)c1ccc(Cl)cc1	1001264-89-6	AKT inhibitor
CC-67-LI41	GSCPDZHWVNUUFI-UHFFFAOYSA-N	NC(=O)c1cccc(N)c1	3544-24-9	NAD+ ADP-Ribosyltransferase (poly(ADP-ribose)polymerase;PARP) Inhibitors;Free Radical Scavengers
EE-08-FF71	GSDSWSVVBLHKDQ-JTQLQIEISA-N	C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23		
MA-08-KH70	GSFDFZOSYZNZOA-ROMNCUSUSA-N	C=CC[C@@H]1[C@H](O)CC[C@@]2(C)[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12	152755-31-2	INSIG-1 Expression Enhancers;LDL-Receptor Up-Regulators
EC-42-DO33	GSLWRDKYYIQKIM-TZMCWYRMSA-N	CCCN1CCC[C@@H]2c3cc(O)ccc3OC[C@H]21	100745-12-8	Dopamine Autoreceptor Agonists;Prolactin Secretion Inhibitors
JC-03-OI01	GSNOZLZNQMLSKJ-UHFFFAOYSA-N	CCN(CC)c1cc(C)nc2ncnn12	15421-84-8	Platelet activating factor receptor antagonist
BD-29-IQ20	GSQOBTOAOGXIFL-LFIBNONCSA-N	N#C/C(=C\\c1ccc(O)c(O)c1)C(=O)NCCCc1ccccc1	133550-34-2	Tyrosine Kinase Inhibitors;CDK2 Inhibitors
AC-94-SN51	GSQOTVHUYJQPDR-UHFFFAOYSA-N	CC(C)c1c(NC(=O)Nc2cnc(-n3nccn3)c(Cl)c2)cnc2cc(Cl)nn12		MALT1 protease inhibitor
OC-41-DF58	GSRTWXVBHGOUBU-UHFFFAOYSA-N	O=c1[nH]c(=S)[nH]c2nc(-c3ccccc3)c(-c3ccccc3)nc12	14892-97-8	inhibitor of dna ligase IV
QE-48-NG07	GTDABJYBDINOEI-UHFFFAOYSA-N	CC(C)CC1C(=O)NC(=N)N1c1nc(NC(=N)N)nc(Nc2ccc(Nc3nc(NC(=N)N)nc(N4C(=N)NC(=O)C4CC(C)C)n3)cc2)n1		NPR1 agonist of the extracellular domain
RF-36-EI47	GTTZQULJQRNNER-HNNXBMFYSA-N	CC(C)(Cc1ccccc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12	862594-15-8	beta1-Adrenoceptor Ligands;beta2-Adrenoceptor Ligands
BC-53-HT63	GTVPOLSIJWJJNY-UHFFFAOYSA-N	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21	101622-51-9	CDK5 Inhibitors;Inhibitors of Signal Transduction Pathways;CDK1 Inhibitors;CDK2 Inhibitors
GE-26-BO33	GUDJFFQZIISQJB-UHFFFAOYSA-N	CS(=O)(=O)c1ccc(NC(=O)c2cc(C#N)c(Sc3c(Cl)cncc3Cl)s2)cc1	1247825-37-1	
KA-92-WY22	GUDVQJXODNJRIJ-CALCHBBNSA-N	C[C@@H]1CN(CCCn2c3ccccc3c3ccccc32)C[C@H](C)N1	207233-98-5	sigma Receptor Antagonists
QA-07-KC40	GUGBOAVFOFNJFG-VAWYXSNFSA-N	O=C(/C=C/c1ccc(CNCCCc2c[nH]c3ccccc23)cc1)NO		Histone Deacetylase (HDAC) Inhibitors
AD-29-MQ00	GUHYXMDFXOUTTG-CSPPYYTDSA-N	CC(NC(=O)c1ccc(C(=O)N[C@@H](CC(N)=O)C(=O)O)c(Cl)c1)c1cccc(O)c1		
RA-44-SU16	GUJLUPNSRRNJKP-UHFFFAOYSA-N	Cc1nc(N2CCN(C)CC2)c2oc3ccc(Cl)cc3c2n1	848217-00-5	HRH4 antagonist
VA-39-AQ18	GULVVTHHUIIMRL-WUFINQPMSA-N	CCCC(=O)C1(c2ccccc2)CCN(C(=O)[C@@H](Cc2ccc(OC)cc2)NC(=O)[C@@H](N)Cc2cncn2C)CC1	457893-92-4	Melanocortin MC1 Receptor Agonists
LF-37-AX51	GUNGQVJAKLIYDG-JXMROGBWSA-N	COc1ccc(C(=O)/C=C/c2ccccc2)c(O)c1		
VA-71-JY23	GUOCQDADKJJVBQ-NMWGTECJSA-N	O=C1/C(=N\\c2cc(Cl)cc(Cl)c2)c2ccccc2N1c1ccccc1	303984-51-2	
IB-92-XA34	GUOQUXNJZHGPQF-UHFFFAOYSA-N	Cc1nnc2ccc(-c3cccc(C(F)(F)F)c3)nn12	66548-69-4	Anxiolytics
UE-11-OB38	GVCWUAXAZPVAER-IXZFBDPMSA-N	CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)O		Anti-CEACAM5 (CD66e)
BD-58-PT20	GVGVYDCVFBGALZ-UHFFFAOYSA-N	Cc1ccc2cccc(NC(=O)c3ccc(OC(C)C)cc3)c2n1	892711-75-0	activator of ATP2A2 (SERCA2)
SD-51-LL22	GVIFMXAPEOVXKO-UHFFFAOYSA-N	COc1ccc(Cn2nc(CCN3CCN(c4cccc(Cl)c4C)CC3)c3cc(OC)c(OC)cc32)cc1OC		Calmodulin Antagonists
ZE-11-HK24	GVKXFVCXBFGBCD-BDHYPIEDSA-N	COC(=O)[C@H]1[C@@H](O)[C@@]2(O)c3c(OC)cc(O[C@H]4O[C@@H]([C@@H](O)CO)CO[C@H]4OC)cc3O[C@@]2(c2ccc(OC)cc2)[C@@H]1c1ccccc1		EIF4A gene modulator
HC-74-HM63	GVKXFVCXBFGBCD-JRPGFILLSA-N	COC(=O)[C@H]1[C@@H](O)[C@@]2(O)c3c(OC)cc(O[C@@H]4O[C@@H]([C@@H](O)CO)CO[C@H]4OC)cc3O[C@@]2(c2ccc(OC)cc2)[C@@H]1c1ccccc1	697235-39-5	Elongation factor 1 alpha inhibitor;Translation Inhibitor
BA-95-YU85	GVPAGJWVBUZHNQ-UHFFFAOYSA-N	Cc1nc2cnc3ccc(C#Cc4cccnc4)cc3c2n1-c1ccc(C(C)(C)C#N)cc1	853910-02-8	Phosphoinositide dependent Kinase (PDK) 1 Inhibitors;Phosphatidylinositol 3-Kinase (PI3K) Inhibitors;Phosphoinositide dependent Kinase (PDK) 1 Inhibitors;Phosphatidylinositol 3-Kinase (PI3K) Inhibitors
RC-18-AD40	GVWNNKNAVOPJNV-UHFFFAOYSA-N	Cc1cc(C)cc(Nc2nccc(-c3nccs3)n2)c1	477769-78-1	Glycogen Synthase Kinase 3 (GSK-3) Inhibitors;Syk Kinase Inhibitors;Aurora-B (ARK2) Kinase Inhibitors;Antimitotic Drugs;Glycogen Synthase Kinase 3 (GSK-3) Inhibitors;Syk Kinase Inhibitors;Aurora-B (ARK2) Kinase Inhibitors;Antimitotic Drugs
KB-37-OO25	GWGNPYYVGANHRJ-GDBMZVCRSA-N	C[C@@H]1CN(Cc2ncccn2)C[C@H]1c1cn2c(C3CCOCC3)ncc2c(=O)[nH]1		
AE-67-FF84	GWHSPAGSUKYSEY-UHFFFAOYSA-N	O=C(O)c1ccc(-c2nc(-c3cccc(C(F)(F)F)c3)cs2)cc1		Retinoid RXRalpha Agonists;Retinoid RARalpha Agonists
RB-22-TT44	GWKQRNXTGAHPBR-GINUTJKVSA-N	O=C(O)/C=C/c1ccc(C(=C2C3CCCC2CCC3)c2ccc(O)cc2)cc1		Estrogen Receptor (ER) alpha Ligands;Estrogen Receptor (ER) beta Ligands;Selective Estrogen Receptor Destabilizers (SERD)
TC-95-IR96	GXAQELJVODWLDD-UHFFFAOYSA-N	CN(C)CC1CCc2cc(NC(=O)c3ccc(-c4ccc(F)cc4)cc3)ccc2C1	331758-35-1	Melanin-Concentrating Hormone MCH-R1 (SLC-1) Receptor Antagonists
EB-44-OW82	GXFWOMYQHNODFA-UHFFFAOYSA-N	c1ccc2c(c1)Cc1ccccc1-n1c-2nnc1N1CCNCC1	90685-01-1	Glycine Receptor Antagonists;GABA(A) Receptor Antagonists;Glycine Receptor Antagonists;GABA(A) Receptor Antagonists
AC-30-XU83	GXJABQQUPOEUTA-RDJZCZTQSA-N	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O	179324-69-7	Proteasome inhibitor;Proteasome Inhibitors;Apoptosis Inducers;Caspase 3 Activators;NF-kappaB (NFKB) Activation Inhibitors
GE-25-YQ75	GXPHKUHSUJUWKP-UHFFFAOYSA-N	Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2	97322-87-7	Insulin Sensitizers;PPARgamma Agonists;CCL2 Expression Inhibitors;EGR1 Expression Enhancers
S0-EE-WYIH	GXUZUPUMLJASRP-AWEZNQCLSA-N	O=C(O)C[C@@H]1COC2(CCN(c3ccc(-c4nc5ccc(C(F)(F)F)cc5[nH]4)cn3)CC2)C1	1356470-43-3	
CA-64-LT35	GXWKSXUPEFVUOO-UHFFFAOYSA-N	Cc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1Br	300842-64-2	Angiogenesis Inhibitors;Inhibitors of Signal Transduction Pathways;VEGFR-2 (FLK-1/KDR) Inhibitors
CC-05-MK46	GXZSAQLJWLCLOX-UHFFFAOYSA-N	NC(C(=O)O)c1ccc(C(=O)O)c(O)c1		
DA-60-KU38	GYAVBQCESJPOKV-UHFFFAOYSA-N	CCc1cc2[nH]c(=O)n(N(C(C)=O)S(C)(=O)=O)c(=O)c2cc1-c1ccnn1C		
GC-21-IX32	GYBXWOPENJVQKE-UFYCRDLUSA-N	CSCC[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O	67247-12-5	FPR1 antagonist
GB-33-FW25	GYDJEQRTZSCIOI-LJGSYFOKSA-N	NC[C@H]1CC[C@H](C(=O)O)CC1	1197-18-8	Tissue-Type Plasminogen Activator (t-PA) Inhibitors
GD-69-GP37	GYFRQCMDLBNZSF-UHFFFAOYSA-N	CCc1nc(C)cn2nc(-c3cc(=O)n4cc(C5CCN(C)CC5)cc(C)c4n3)cc12		splicing modulator
DD-95-TY80	GYHCTFXIZSNGJT-UHFFFAOYSA-N	Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cc(Cl)ccc32)c(C)c1	150683-30-0	antagonist of AVPR2
UE-41-CL72	GYHZBYPKMNZJKG-UHFFFAOYSA-N	CSc1cccc(NC(=O)Nc2cccc3ccc(O)cc23)c1	199929-52-7	TRPV1 (Vanilloid VR1 Receptor) Antagonists
FC-11-WH14	GYKLFBYWXZYSOW-UHFFFAOYSA-N	CCCC(=O)OCOC(=O)C(C)(C)C	122110-53-6	Apoptosis Inducers;Histone Deacetylase (HDAC) Inhibitors;Angiogenesis Inhibitors
GC-46-AX49	GYKMAWIYKPLMGN-LADGPHEKSA-N	CC1(C)COC(=O)[C@H]1NC(=O)[C@@H](CC(=O)O)c1ccn(-c2ccc(-c3ccc(C#N)cc3)cc2)c1	207118-71-6	Matrix Metalloproteinase Inhibitors;Angiogenesis Inhibitors
AA-62-HP31	GYLDXIAOMVERTK-UHFFFAOYSA-N	CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21	1224844-38-5	Mammalian Target of Rapamycin (mTOR;FRAP1) Inhibitors;Phosphatidylinositol 3-Kinase delta (PI3Kdelta) Inhibitors;Phosphatidylinositol 3-Kinase alpha (PI3Kalpha) Inhibitors;Phosphatidylinositol 3-Kinase gamma (PI3Kgamma) Inhibitors
CA-90-RU33	GYNZGXINUJMHPX-UHFFFAOYSA-N	CN(C)C1CCN(c2ccc(Nc3ncc4cc(C#N)n(C5CCCC5)c4n3)nc2)CC1	1211441-32-5	CDK4 Inhibitors
EA-02-ZO63	GYQYAJJFPNQOOW-UHFFFAOYSA-N	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1	1254053-43-4	FLT3/AXL inhibitor
FA-91-OA82	GYRDYYGMGMDTQH-UHFFFAOYSA-N	O=C(CNCc1ccccc1Br)N(c1ccccc1)c1ccccc1		GRM7 agonist
AA-56-QO38	GYSZUJHYXCZAKI-UHFFFAOYSA-N	COc1cccc(OC)c1OCCNCC1COc2ccccc2O1	2170-58-3	alpha1-Adrenoceptor Antagonists
UE-50-KK32	GYVYUQVVKBZPRY-UHFFFAOYSA-N	N#Cc1ccc(NCCc2nc3cc(Cl)ccc3c3nn(-c4ccccc4)cc23)cc1		
ZE-61-GA95	GYWQBPYNAGLBSC-UHFFFAOYSA-N	O=C(NCc1ccncc1)C12CC3CC(CC(C3)C1)C2		
PA-63-TR22	GYZCDPYMSMUVHN-UKTHLTGXSA-N	CCOc1cc(C(=O)Nc2nc3cccc(C)c3n2C2CCCCN(C(=O)/C=C/CN(C)C)C2)ccn1		
VC-19-YG34	GZGLPBNOIFLLRE-UHFFFAOYSA-N	COc1cccc2nc(-c3cccs3)nc(NN3C(=O)C=C(C)C3=O)c12	219773-55-4	IKK-2 (IKK-beta) Inhibitors;Flt3 (FLK2/STK1) Inhibitors
BC-09-XN48	GZHYLNMRATZHOJ-YADHBBJMSA-N	CN1CCN(C(=O)CN[C@H]2C[C@@H]2c2ccc(OCc3ccc(Cl)cc3)cc2)CC1		KDM1A/B
TD-31-KS49	GZKLJWGUPQBVJQ-UHFFFAOYSA-N	O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1	106516-24-9	5-HT2A Antagonists;Dopamine D2 Antagonists
EE-02-BO83	GZOFTOHENYHNMS-UHFFFAOYSA-N	COC(=O)c1cc(CCc2cc(OC)ccc2OC)ccc1O	150779-71-8	Cytoskeleton inhibitors;Tubulin Polymerization Inhibitors;Cytoskeleton inhibitors;Tubulin Polymerization Inhibitors
KB-58-XI48	GZSOSUNBTXMUFQ-YFAPSIMESA-N	COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1O	520-27-4	Aryl Hydrocarbon Receptor (AhR) Agonists
AA-27-LG62	GZUITABIAKMVPG-UHFFFAOYSA-N	O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12	1020061-04-4	ENG Expression Enhancers;ACVRL1 Expression Enhancers;Selective Estrogen Receptor Modulators (SERM)
IC-05-WD74	GZUVCNPDJISLKF-UHFFFAOYSA-N	COc1cc2c(cc1OC)-c1[nH]nc(NCc3c(C)cccc3C)c1C2	1201944-86-6	HRI Kinase inhibitor
DE-11-PO61	GZYGRXMERWMSTJ-INIZCTEOSA-N	CC(C)C[C@H](N)COc1ccc2c(c1)OCc1cnc(NC(=O)C3CC3)cc1-2	1454913-31-5	AP2-Associated Protein Kinase 1 (AAK1) Inhibitors
IE-44-DP45	HAQIRIMIVLFYIX-ZFWWWQNUSA-N	CCCCNC(=O)[C@@H]1Cc2ccccc2N1C(=O)[C@@H](N)CC	175553-48-7	Tripeptidyl Peptidase II Inhibitors
PA-64-LE28	HAQOEWGSBVQDHB-UHFFFAOYSA-N	CC(C)(C)c1cc(-c2csc(CN)n2)cc(C(C)(C)C)c1O	335242-75-6	Sodium Channel  Blockers;Cyclooxygenase (COX) Inhibitors;Antioxidants;Lipid Peroxidation Inhibitors;Sodium Channel  Blockers;Cyclooxygenase (COX) Inhibitors;Antioxidants;Lipid Peroxidation Inhibitors
CD-88-UF56	HASGWVOTHYCRIP-UHFFFAOYSA-N	N=C(N)Nc1ccc(Cl)c(C(F)(F)F)c1		5-HT3 receptor agonist
QE-79-XO29	HAVJATCHLFRDHY-KSZYUSJVSA-N	COC(=O)C[C@](O)(CCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4	25302-09-4	Translation Inititiation Inhibitor
HD-51-KD29	HBMFSXMMRNCYAR-UHFFFAOYSA-N	CC(C)NCCCNc1ccc(Nc2ncc(Br)c(Nc3ccccn3)n2)cc1		Cyclin-Dependent Kinase Inhibitors
MD-91-JM80	HBOJWAYLSJLULG-UHFFFAOYSA-N	CNCCN1CCC(OCc2ccccc2)CC1		PRMT4/6 inhibitor;PRMT4 and PRMT6 inhibitor
IB-14-XS97	HBPNHPWPUQVWIY-UHFFFAOYSA-N	Nc1cc(O)cc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O	1547162-44-6	CRBN neomorph;E3 ligase inhibitor
BC-94-PR16	HBYORZQNJPQOQI-UHFFFAOYSA-N	COc1ccc(S(=O)(=O)NC(=O)c2sccc2SCc2ccc(Cl)c(Cl)c2)cc1C(=O)O	1336982-56-9	
CE-18-ZM38	HBZPKPRLRQUIHK-UHFFFAOYSA-N	CCN(CC)CCCNc1ccc2ncc(-c3cccc(Cl)c3)n2n1		Protein Kinase PKC theta Inhibitors;IL-2 Production Inhibitors
LD-12-GA99	HCAQGQIHBFVVIX-LYXAAFRTSA-N	C/C(=N\\NC(=N)N)c1ccc(NC(=O)Nc2ccc(/C(C)=N/NC(=N)N)cc2)cc1	1048364-29-9	Ribonuclease P Inhibitors;Checkpoint Kinase 2 (Chk2) Inhibitors
LB-00-NP55	HCBULGQMULJTCM-ZSOIEALJSA-N	O=C1/C(=C/c2ccc(O)c(O)c2)Oc2ccccc21	24418-86-8	Sphingosine Kinase Inhibitors
IF-45-JC86	HCGFLVDMFDHYJD-UHFFFAOYSA-N	c1cnc(N2CCNCC2)cn1		
GC-42-LL86	HCGJPCCNPPBVAZ-UHFFFAOYSA-N	Cc1cc2nc(-c3ccc(NC(=O)Nc4ccc(-c5nc6cc(C)c(C)cc6[nH]5)cc4)cc3)[nH]c2cc1C		Angiogenesis Inhibitors;Heparanase Inhibitors
AB-00-VH52	HCIUDAYJRVRACO-UHFFFAOYSA-N	CN1CC(CS(=O)(=O)N2CCN(c3cnc(OCC4CCN(C(=O)OC5(C)CC5)CC4)cn3)C(=O)C2)C1	1134108-76-1	
CB-05-UD24	HCKUBNLZMKAEIN-GSVOUGTGSA-N	N[C@@H]1CCN(O)C1=O	123931-04-4	NMDA Glycine B Receptor Partial Agonists
WC-89-JT40	HCODCRHNVCTCTR-UHFFFAOYSA-N	Nc1ccc(S(N)(=O)=O)cc1I	1350027-80-3	Carbonic anhydrase inhibitor
DE-34-DT75	HCSMRSHIIKPNAK-LSAVBLLPSA-N	CN[C@@H](C)C(=O)N[C@H](C(=O)N1CC[C@H]2CCN(CCc3ccccc3)C[C@H]21)C1CCCCC1	867324-12-7	Inhibitor of Apoptosis Proteins (IAP) Inhibitors;Angiogenesis Inhibitors;Apoptosis Inducers;Caspase 3 Activators;Caspase 8 Activators;Caspase 9 Activators
AE-53-IJ74	HCYAFALTSJYZDH-UHFFFAOYSA-N	CNCCCN1c2ccccc2CCc2ccccc21	50-47-5	Sodium Channel  Blockers;Norepinephrine Transporter (NET) Inhibitors
TA-36-GV23	HCZHHEIFKROPDY-UHFFFAOYSA-N	O=C(O)c1cc(=O)c2ccccc2[nH]1	13593-94-7	NMDA Antagonists;AMPA Receptor Modulators;a7 nicotinic acetylcholine receptor Inhibitor
ID-70-SM63	HCZKYJDFEPMADG-TXEJJXNPSA-N	C[C@H](Cc1ccc(O)c(O)c1)[C@@H](C)Cc1ccc(O)c(O)c1	1050512-02-1	ER stress inducer;IGF-1R Phosphorylation Inhibitors;Lipoxygenase Inhibitors
CA-25-LR28	HDACQVRGBOVJII-JBDAPHQKSA-N	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21	1028843-43-7	Angiotensin-I Converting Enzyme (ACE) Inhibitors
QE-83-LG95	HDOZVRUNCMBHFH-UHFFFAOYSA-N	CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21	1200591-33-8	Adrenergic receptor modulator;Dopamine D2 Antagonists;Serotonin Antagonists
CF-97-KZ12	HDTKLZINZGEPFG-UHFFFAOYSA-N	COc1ccc(S(=O)(=O)N2CCCCC2)cc1C	457961-34-1	Melanopsin Antagonist
AF-16-GB72	HDZWHJYZJWLTAG-UHFFFAOYSA-N	CCOC(=O)c1ccc(CN(Cc2ccc(-c3cccc(S(C)(=O)=O)c3)cc2)S(=O)(=O)c2c(C)cc(C)cc2C)o1	1416153-62-2	LXR inverse agonist;Inverse agonist of LXR;NR1H3 gene modulator
KE-73-XV62	HDZZVAMISRMYHH-KCGFPETGSA-N	Nc1ncnc2c1ccn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		
EC-00-KR26	HEFNNWSXXWATRW-JTQLQIEISA-N	CC(C)Cc1ccc([C@H](C)C(=O)O)cc1	113403-10-4	Cyclooxygenase (COX) Inhibitors;Non-Steroidal Antiinflammatory Drugs
AA-98-MW52	HEFNNWSXXWATRW-UHFFFAOYSA-N	CC(C)Cc1ccc(C(C)C(=O)O)cc1	1010396-31-2	Cyclooxygenase-3 Inhibitors;Cyclooxygenase-1 Inhibitors;Cyclooxygenase-2 Inhibitors;Non-Steroidal Antiinflammatory Drugs;NF-kappaB (NFKB) Activation Inhibitors
BC-39-JG96	HEMJJKBWTPKOJG-UHFFFAOYSA-N	Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1	114413-98-8	PPARalpha Agonists
CE-17-FI51	HEMJMIZAXNWBAM-PKTZIBPZSA-N	CC[C@@H]1C[C@H](N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c2ncc(-c3cnn(C)c3)cn2)CN1C(=O)OC(C)C	1160064-67-4	CETP inhibitor
JE-61-XN48	HEQDZPHDVAOBLN-UHFFFAOYSA-N	CC(C)c1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1	349085-38-7	TRPA1 Antagonists
ME-61-RC56	HERUZAOANPGYSY-UHFFFAOYSA-N	OC1CCCc2nc3ccccc3c(NCc3ccccc3)c21	104675-35-6	Acetylcholinesterase Inhibitors;Norepinephrine Reuptake Inhibitors
BC-07-FZ32	HESLKTSGTIBHJU-UHFFFAOYSA-N	CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4c(c3)CCC(=O)N4)ncc2C(F)(F)F)c1	869288-64-2	FAK inhbitor;Inhibitor of fibronectin-directed migration;Co-Inducer of apoptosis in pancreatic cancer
DA-10-ZX00	HFVLFLKYVBPGSN-HNAYVOBHSA-N	O=C(N[C@H]1CCC[C@@](O)(C#Cc2cccc(Cl)c2)C1)c1ccc(Cl)o1		mgluR5 Antagonists
MB-01-IW99	HGCAUCAWEADMPM-UHFFFAOYSA-N	CC(C)CC(N)P(=O)(O)O	20459-60-3	
HA-27-FV67	HGEYJZMMUGWEOT-UHFFFAOYSA-N	Oc1ccc2[nH]cc(CCCCN3CC=C(c4ccccc4)CC3)c2c1	108050-82-4	Dopamine Autoreceptor Agonists
CB-87-RB49	HGFOOLONGOBCMP-IBGZPJMESA-N	COc1ccc([C@H](CC(=O)O)N2CCN(CCCc3ccc4c(n3)NCCC4)C2=O)cn1	227963-15-7	Integrin alpha-V/beta-3 antagonist, Integrin alpha-V/beta-5 antagonist
DF-46-QE34	HGHFHFDOPKORCS-TVNUBGQTSA-N	COCCCN1CCOc2ccc(CO[C@H]3CNC[C@@H](CO)[C@@H]3c3ccc(COC[C@@H](C)COC)cc3)cc21		beta-Secretase (BACE) Inhibitors;Plasmepsin II Inhibitors;Cathepsin D Inhibitors;HIV Protease Inhibitors
MB-93-BH38	HHBOWXZOLYQFNY-UHFFFAOYSA-N	CCCOc1ccc(Br)cc1-c1cc(-c2ccc(Cl)cc2)[nH]c1-c1ccncc1	191034-25-0	GCGR antagonist;Glucagon Receptor (GCGR) Antagonists
PD-34-SO87	HHKGVQGXRGQBBA-UHFFFAOYSA-N	CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N(C)CCCN(C)C)c2)n1		Tie2 Receptor Inhibitors;Inhibitors of Signal Transduction Pathways;Angiogenesis Inhibitors
CB-49-OG36	HHOVRZGUSBMKKU-ZDUSSCGKSA-N	CNc1nccc(-c2ccc(C(=O)N[C@H](CN)Cc3ccc(Cl)cc3Cl)s2)n1		PKA and AKT (a.k.a. PKB)
EF-43-OP88	HHRPVOWUBGBVDY-UHFFFAOYSA-N	O=C(NCc1ccccn1)c1ccnc(N2CCN(Cc3ccc(C(F)(F)F)cc3)C2=O)c1	1202927-55-6	SCD inhibitor
EA-06-CH36	HHXQMLIHQFHIJU-UHFFFAOYSA-N	CCN(CC)C(=O)C(c1ccccc1)C1CCN(c2ccc(NC(=O)Nc3c(C)noc3C)cc2F)CC1		Neuropeptide Y2 (NPY Y2) Antagonists
FA-30-KQ38	HHZIURLSWUIHRB-UHFFFAOYSA-N	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1	1353151-22-0	Apoptosis Inducers;Inhibitors of Signal Transduction Pathways;Bcr-Abl Kinase Inhibitors
BE-74-SX40	HHZLKORDNNRTRS-UHFFFAOYSA-N	Cc1ccn2cc(-c3ccc(OCCCN4CCCCC4)cc3)nc2c1	365565-36-2	HRH3 antagonist
EB-18-PP65	HHZQETZZACUFHE-UHFFFAOYSA-N	Nc1cc(Cl)cc2c1[nH]c1cnccc12	361202-25-7	
AA-43-TW35	HIHZDNKKIUQQSC-UHFFFAOYSA-N	COc1ccccc1N1CCN(CCCNc2c(C)c(=O)n(C)c(=O)n2C)CC1	34661-85-3	alpha1A-Adrenoceptor Antagonists
LA-42-CN75	HINVYDRMYARWQP-UHFFFAOYSA-N	O=C1CN(c2cc3cc(CCCc4c(F)c(F)c(F)c(F)c4F)ccc3cc2O)S(=O)(=O)N1		
KA-00-HF91	HIPWSQSREBIBSE-PPSBJXRFSA-N	COC(=O)[C@@]1(OC(=O)c2sccc2C)[C@H](C)CC2C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C		
FB-39-VW14	HIUOABSWQSUEGK-UHFFFAOYSA-N	Cc1nc(-c2ccccn2)nc(NCCc2ccccc2)c1Cl		MetAPN inhibitor;Plasmodium falciparum Methionine Aminopeptidase-1b (PfMetAP1b) Inhibitors
HA-83-MI31	HIVBATDUVFEJFZ-UHFFFAOYSA-N	CN(C)CCC1(c2ccc(Cl)cc2)Cc2ccccc2C(=O)O1	477313-09-0	UTS2R agonist
LC-96-WR85	HIWKGPKZDUQDKF-UHFFFAOYSA-N	COc1ccc(N(C(=O)Cn2nnc3ccccc32)C(C(=O)NCC2CCCO2)c2ccc(F)cc2)cc1	1032892-26-4	UDP/CysLT Receptor (GPR17, P2Y-like) Modulators
QB-06-VC83	HIWQJAGWEWRIIP-UHFFFAOYSA-N	CC1=C(C(=O)Nc2ccccc2C)C(c2ccco2)C2=C(CCCC2=O)N1	886358-51-6	GPR41 agonist
SA-37-YW78	HIWUTKCNKODAMJ-UHFFFAOYSA-N	O=C(c1ccc(C(=O)N2CCC(N3CCCC3)CC2)cc1)N1CCC(N2CCCC2)CC1		Selective antagonist of L3MBTL3
CF-83-HM41	HIXSPVQXXDULHS-UHFFFAOYSA-N	COc1cc2c(cc1OC)-c1cc3nc4ccccc4nc3n1C(C)(C)C2	163769-88-8	IL-5 Receptor Antagonists
DD-30-NA60	HIYANFJZDCBRGH-UHFFFAOYSA-N	CN(C)C(=O)Cc1cn(-c2cccc(C(F)(F)F)c2)nc1-c1ccc(-c2ccccc2)cc1		
BC-01-JL64	HIYAVKIYRIFSCZ-CYEMHPAKSA-N	CNc1ccc2oc(C[C@H]3O[C@@]4(CC[C@H]3C)O[C@H]([C@H](C)C(=O)c3ccc[nH]3)[C@H](C)C[C@H]4C)nc2c1C(=O)O		
RD-50-EO07	HIZOPJQOPKRKFM-UHFFFAOYSA-N	O=C(O)c1ccc(CCCc2c(CCNS(=O)(=O)Cc3ccc(Cl)c(Cl)c3)n(C(c3ccccc3)c3ccccc3)c3ccc(Cl)cc23)cc1	241498-09-9	Cytosolic Phospholipase A2 (cPLA2) Inhibitors
JB-91-QG66	HJFDTNBKNJFDQP-UHFFFAOYSA-N	Nc1cc(Oc2ccc3c(C(=O)Nc4ccc(F)c(C(F)(F)F)c4)cccc3c2)ncn1		VEGFR-2 (FLK-1/KDR) Inhibitors
BE-34-JO19	HJGMCDHQPXTGAV-IYARVYRRSA-N	O=C(COc1ccc(Cl)cc1)N[C@H]1CC[C@H](NC(=O)COc2ccc(Cl)cc2)CC1	1597403-47-8	Inhibits UPR, reactives translation;EIF2B4 modulator
AD-18-VX25	HJJPJSXJAXAIPN-UHFFFAOYSA-N	COC(=O)C1=CCCN(C)C1	131448-18-5	Muscarinic Receptor Agonists;Potassium Channel Subfamily K Member 18 (TRESK KCNK18) Blockers
AA-47-BS40	HJMQDJPMQIHLPB-UHFFFAOYSA-N	COc1cc(-c2ccc(=O)[nH]n2)ccc1OC(F)F	101975-10-4	Phosphodiesterase III Inhibitors;Phosphodiesterase IV Inhibitors
AA-68-MW92	HJORMJIFDVBMOB-UHFFFAOYSA-N	COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1	61413-54-5	Phosphodiesterase IV Inhibitors
DF-75-MR73	HJPRDDKCXVCFOH-UHFFFAOYSA-N	CCCCn1c(=O)c2c(ncn2CC(C)=O)n(CCCC)c1=O	57076-71-8	Phosphodiesterase IV Inhibitors
EA-41-GV68	HJPXZXVKLGEMGP-YUMQZZPRSA-N	N[C@@H](CCS(=O)(=O)O)CSSC[C@@H](N)CCS(=O)(=O)O	1601301-49-8	Known aminopeptidase A inhibitor
KB-72-ID36	HJQILFPVRNHTIG-UHFFFAOYSA-N	Cc1cccc(Oc2cnc(=O)[nH]c2)c1	41964-07-2	Lyn Kinase Activators;Lyn kinase activator
DD-28-MZ39	HJSQVJOROCIILI-UHFFFAOYSA-N	CN(C)C(=O)Cc1nn(-c2ccccc2)c(=O)c2c1c1ccc(Cl)cc1n2C	220448-02-2	Peripheral Benzodiazepine Receptor (PBR) Ligands
UA-44-EN14	HJUKQFCXOYBYRN-UHFFFAOYSA-N	O=C(C1CCCCC1)N1CCN(S(=O)(=O)c2ccc3ccccc3c2)CC1		
BF-72-LI04	HKBSINOBYAPKIH-RWUOKQAASA-N	N#C[C@@H]1CCCN1C(=O)CNC1C2CC3CC(C2)CC1C3		Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors
BC-02-SI44	HKGJEZIGDHFJFL-UHFFFAOYSA-N	CC(Nc1nc(N2CCCC2)nc2ccccc12)c1ccccc1	662163-81-7	Importin beta inhibitor
AA-57-FZ47	HKGVZNNJDXEJQC-UHFFFAOYSA-N	CSc1ncc(CO)c(NC2CCCC2)n1	211245-63-5	CDK Inhibitors
NC-54-XY91	HKLFGFFVVQJOPT-UHFFFAOYSA-N	O=c1c2cnn(-c3ccc(Cl)cc3)c2ncn1C1CCCCC1		
SC-68-JQ26	HKPHVFFQXHMOHX-UHFFFAOYSA-N	N=C(N)Nc1ccccc1Cl	24067-11-6	5-HT3 receptor agonist
BD-47-NP88	HKROEBDHHKMNBZ-CHBKHGQFSA-N	CCC(=N\\O)/C(C)=C/c1ccc(F)cc1	1170613-55-4	TRPA1 Antagonists
AA-58-FJ71	HKSZLNNOFSGOKW-FYTWVXJKSA-N	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4	109189-95-9	Signal transduction modulator;Protein Kinase C (PKC) Inhibitors;Signal transduction modulator;Protein Kinase C (PKC) Inhibitors
CE-72-GF32	HKVAMNSJSFKALM-GKUWKFKPSA-N	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C	159351-69-6	Inhibitors of Signal Transduction Pathways;Mammalian Target of Rapamycin (mTOR;FRAP1) Inhibitors;Rotamase (FKBP12) Inhibitors;Angiogenesis Inhibitors;mTOR inhibitor
UD-27-FS48	HKVWLCPNTJYNBO-IVHGUIJPSA-N	CCOc1cccc([C@]2(N3CCN(c4ccccc4)CC3)CC[C@@H](C)CC2)c1		NPY1R antagonist;Neuropeptide Y1 (NPY Y1) Antagonists
FB-20-YQ23	HLCHESOMJVGDSJ-LOYHVIPDSA-N	O=C(N[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCC(Cn2cncn2)(C2CCCCC2)CC1)[C@H]1Cc2ccccc2CN1	312637-48-2	Melanocortin MC4 Receptor Agonists
JB-48-TL55	HLFSDGLLUJUHTE-SNVBAGLBSA-N	c1ccc([C@H]2CN3CCSC3=N2)cc1	14769-73-4	Nicotinic Receptor Agonists
GB-92-MH66	HLKXYZVTANABHZ-UHFFFAOYSA-N	NC(=O)NC(CC(=O)O)C(=O)O		
FD-75-PQ00	HLQJSHIGILQGLM-UHFFFAOYSA-N	COC(=O)c1cncn1C1CCC(C)(C)c2ccccc21		
AA-30-BE85	HLXSCTYHLQHQDJ-UHFFFAOYSA-N	COc1ccc(C(=O)CC2(O)C(=O)Nc3c(Cl)ccc(Cl)c32)cc1	1037184-44-3	EWS-FLI1 Inhibitors
HB-90-QG69	HMABYWSNWIZPAG-UHFFFAOYSA-N	CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1	283173-50-2	Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors;Poly(ADP-ribose)polymerase-2 (PARP-2) Inhibitors;DNA Repair Inhibitors
GD-07-XY44	HMGQCYBBVBPNIE-DLRXVWRPSA-N	C[C@H]1CCN(C(=O)[C@@H](CCC2CCNCC2)NS(C)(=O)=O)[C@@H]1C(=O)N[C@@H](CCCCN)C(=O)c1nc2ccccc2o1		
MD-61-RW54	HMHVCUVYZFYAJI-UHFFFAOYSA-N	NS(=O)(=O)c1ccc(N2CCCCS2(=O)=O)cc1	61-56-3	Carbonic Anhydrase Type II Inhibitors;Carbonic Anhydrase Type IX Inhibitors;Carbonic Anhydrase Type VII Inhibitors;Carbonic Anhydrase Type XII Inhibitors
BE-07-NI91	HMJIYCCIJYRONP-UHFFFAOYSA-N	COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc2nonc12	131970-21-3	Calcium Channel Blockers
LF-86-EA69	HMKZVAZQKOKXRZ-UHFFFAOYSA-N	O=S(=O)(Nc1cc(Cl)cc(Cl)c1)c1ccccc1	54129-15-6	Dedicator of cytokenesis protein 5 inhibitor
FD-20-DQ38	HMNLZWPYRJAJHG-UHFFFAOYSA-N	C#CCOc1ccc2c(c1)c(-c1ccc(C(C)C)cc1)nc(=O)n2Cc1cccc(OCCOC)n1		Calcium-Sensing Receptor (CaSR) Antagonists;Parathyroid Hormone Secretion Stimulants
UD-50-IU51	HMRLDZHPNDPQNS-JXMROGBWSA-N	CC(C)=CCC/C(C)=C/CC(P(=O)(O)O)P(=O)(O)O		
GE-01-QX17	HMYBVYBHZVQZNH-AEFFLSMTSA-N	CC[C@@H]1c2ccc3cc(O)ccc3c2CC[C@]1(C)C(=O)O	17659-99-3	Estrogen receptor beta modulator
CA-37-NI01	HNHUNRACMOTTER-UHFFFAOYSA-N	Cc1cc(C)c(CNC(=O)c2cc(C3CC3)nc3c2cnn3C(C)C)c(=O)[nH]1	923894-97-7	PRC2/EZH2;EZH2
IE-28-SY71	HNIIBDFHTBZSEU-UHFFFAOYSA-N	O=C1c2ccccc2-c2nc3cc4ccccc4cc3nc21		
EB-55-VD69	HNLJEOAFXYIQQM-YYIAUSFCSA-N	O=C(Nc1ccc(Cl)c(Cl)c1)[C@H]1[C@H](c2ccncc2)[C@H]2CC[C@@H]1O2		
BF-94-CQ58	HNXCBYBLDPXLMN-UHFFFAOYSA-N	COCCn1c(-c2ccc(C(C)C)cc2)nc2c(Br)c(Cc3cccnc3SC)cc(OC)c21		Calcium-Sensing Receptor (CaSR) Antagonists;Parathyroid Hormone Secretion Stimulants
GF-92-IR00	HOFGTYCLOKDAES-UHFFFAOYSA-N	Cc1c(C(=O)NCCCO)cnn1-c1nc(-c2cccc(C(F)(F)F)c2)cs1	162112-37-0	LFA-1/ICAM-1 Interaction Inhibitors
AF-06-AY37	HOLWINOWZVORSA-UHFFFAOYSA-N	O=C(O)CCn1c2c(c3ccccc31)CCCC2		
BE-29-HA72	HOMGKSMUEGBAAB-UHFFFAOYSA-N	O=P1(NCCCl)OCCCN1CCCl		
BB-03-FT18	HORXBWNTEDOVKN-UHFFFAOYSA-N	O=C(NCC1(c2nc(-c3ccccc3)cs2)CCOCC1)c1cccc(-c2noc(C(F)(F)F)n2)c1	1314890-29-3	
DF-40-CD57	HOSPRUSAKFDVHP-GOSISDBHSA-N	C[C@@H](Nc1ncnc2[nH]c(-c3ccc(CN4CCNCC4)cc3)cc12)c1ccccc1	803706-07-2	EGFR (HER1;erbB1) Inhibitors;VEGFR Inhibitors;Angiogenesis Inhibitors
MB-35-NZ76	HOUMUCTZMMLNTR-UHFFFAOYSA-N	O=C(c1ccc(C(=O)N2CCC(N3CCCCC3)CC2)cc1)N1CCC(N2CCCCC2)CC1		
VD-14-CD80	HOVMHIRTZYQSKM-UHFFFAOYSA-N	Cc1cc2c(cc1Cl)N(C(=O)Nc1cccc3ncccc13)CC2		5-HT2B Antagonists
HC-76-PX74	HOWPQHHSDDSJSQ-UHFFFAOYSA-N	CCCCCS(=O)(=O)NC(=O)C1(NC(=O)c2ccc(C#Cc3cccc(C(F)(F)F)c3)cc2)CCCCC1		
AA-87-EI21	HPHUVLMMVZITSG-LURJTMIESA-N	CC[C@@H](C(N)=O)N1CCCC1=O	102767-28-2	Synaptic vesicle glycoprotein 2A modulator
CF-48-QD87	HPLNQCPCUACXLM-PGUFJCEWSA-N	CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]	852808-04-9	Apoptosis Inducers;Bcl-2 Inhibitors;Bcl-xl Inhibitors;Bcl-w Inhibitors
LD-37-KX01	HPMIIRRRPQSYSS-JOCHJYFZSA-N	Cc1oc(-c2ccc(Cl)c(F)c2)nc1COc1cccc(C(C)(C)C(=O)N2CCC[C@@H]2C(=O)O)c1		PPARalpha Agonists
AC-31-PL89	HPNSFSBZBAHARI-RUDMXATFSA-N	COc1c(C)c2c(c(O)c1C/C=C(\\C)CCC(=O)O)C(=O)OC2	1162256-90-7	Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors;Immunosuppressant;IMPDH inhibitor;antiviral
NF-77-LG65	HPOHWZYSJMJZSA-VXKWHMMOSA-N	CC(C)[C@H](S)C(=O)NC1(C(=O)N[C@@H](Cc2ccc(-c3ccccc3)cc2)C(=O)O)CCCC1		Endothelin-Converting Enzyme (ECE) Inhibitors;Neprilysin (Enkephalinase, Neutral Endopeptidase, NEP) Inhibitors;Endothelin-Converting Enzyme (ECE) Inhibitors;Neprilysin (Enkephalinase, Neutral Endopeptidase, NEP) Inhibitors
LE-01-MT37	HPTMTYKYKUKYCQ-UHFFFAOYSA-N	Cc1ccc(Nc2cc(-c3ccccc3O)ncn2)cc1NS(C)(=O)=O		CDK1/2 inhibitor
AC-11-BO01	HPTXLHAHLXOAKV-INIZCTEOSA-N	O=C(O)[C@H](Cc1c[nH]c2ccccc12)N1C(=O)c2ccccc2C1=O	32675-71-1	DNMT direct inhibitor
HB-24-AP80	HPXDJZWNAJAQFG-UHFFFAOYSA-N	Clc1ccc(-c2cccn3cncc23)cc1		
AC-93-LT43	HQFDCITUHVQXEV-UHFFFAOYSA-N	Cc1[nH]ncc1-c1nc(NC2(C)CC2)c2ccncc2n1		LATS inhibitor;Yap pathway activator
TC-25-MR66	HQFNFOOGGLSBBT-AWNIVKPZSA-N	COc1cc(/C=C(\\C#N)C(=O)Nc2nnc(C(F)(F)F)s2)ccc1OCc1ccc(C(F)(F)F)cc1C(F)(F)F	725247-18-7	Estrogen-Related Receptor alpha (ERRalpha, ERR1) Inverse Agonists
CD-05-PU90	HQHSJJZIICGOIX-UHFFFAOYSA-N	Nc1nccc(-c2c[nH]c3ncccc23)n1	341998-55-8	CDK inhibitors
CC-58-JZ09	HQPIKMNKCMXJQC-ONEGZZNKSA-N	CO/C=C/C(=O)c1cc2c3c(c(N)cc(NC(C)=O)c3n1)N=C2		LCK and PI3K dual inhibitor, also targets mTOR
BA-06-GI09	HQTBIZDUNOAXTD-UHFFFAOYSA-N	NCc1cc(-c2cccnc2)no1	543713-43-5	Cytochrome P450 CYP2A6 Inhibitors
QE-11-DP47	HQWHKELJHUFLGD-UHFFFAOYSA-N	COc1c(O)cc2oc3cc4c(c(O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4		
EA-62-MI89	HQWTUOLCGKIECB-XZWHSSHBSA-N	O=C1[C@H](Cc2ccc(O)cc2)N2C(=O)CCN(C(=O)NCc3ccccc3)[C@H]2CN1Cc1cccc2ccccc12	780757-88-2	CREBBP - beta-catenin interaction inhibitor;Apoptosis Inducers;Wnt Signaling Inhibitors
XD-01-OY13	HRAQDVZJYIAWOV-UHFFFAOYSA-N	Cc1nc2ccc(NCc3cccc(C(F)(F)F)c3)cc2n(CCNC(=O)CO)c1=O	1018675-35-8	Stearoyl-CoA Desaturase (delta-9 Desaturase;SCD;SCD1) Inhibitors
HD-29-LW24	HRNLUBSXIHFDHP-UHFFFAOYSA-N	Nc1ccccc1NC(=O)c1ccc(CNc2nccc(-c3cccnc3)n2)cc1	726169-73-9	HDAC1/2;Apoptosis Inducers;Histone Deacetylase 1 (HDAC1) Inhibitors
BA-87-NF64	HRRBJVNMSRJFHQ-UHFFFAOYSA-N	COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1	1164469-60-6	alpha1D-Adrenoceptor Antagonists
JC-51-JD64	HRWCVUIFMSZDJS-SZMVWBNQSA-N	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(=O)O)SCCS2	200872-06-6	Angiotensin-I Converting Enzyme (ACE) Inhibitors
EC-01-PH79	HSKAZIJJKRAJAV-KOEQRZSOSA-N	Cc1cccc(/C=N/Nc2cc(N3CCOCC3)nc(OCCc3ccccn3)n2)c1	541550-19-0	PIKFYVE inhibitor;IL-12 Production Inhibitor;PIKFYVE enzyme inhibitor
FA-14-WC79	HSNUXANXVHLGQT-HXUWFJFHSA-O	CCCCCCCCCCCCCCOP(=O)(O)O[C@H](CC(=O)O)C[N+](C)(C)C		Carnitine O-Palmitoyltransferase 1 (CPT-1) Inhibitors
CD-62-GL56	HSRJKNPTNIJEKV-MRVPVSSYSA-N	COc1ccccc1OC[C@H](O)CO		
DB-01-BR68	HSRJKNPTNIJEKV-UHFFFAOYSA-N	COc1ccccc1OCC(O)CO		
RD-39-ZE95	HSSHUDKWJRJKPV-UHFFFAOYSA-N	NNC(=O)c1sc2cccc(Cl)c2c1Cl	350997-39-6	inhibitor of OGG1
DD-34-AN51	HSTZMXCBWJGKHG-CUYWLFDKSA-N	OC[C@H]1O[C@@H](Oc2cc(O)cc(/C=C/c3ccc(O)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O	148766-36-3	VCAM1 Expression Inhibitors;ICAM1 Expression Inhibitors;Xanthine Oxidase Inhibitors
AF-33-AM86	HSUGRBWQSSZJOP-RTWAWAEBSA-N	COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1	103532-26-9	L-Type Calcium Channel Blockers
NA-00-YS67	HSZIWISHLSFWJO-PRABLTMGSA-N	O=C(N[C@H](/C=C/S(=O)(=O)c1ccccc1)CCc1ccccc1)[C@H](Cc1ccccc1)NC(=O)N1CCOCC1	1348565-08-1	Cysteine Protease Inhibitors
FD-72-CE19	HTGCJAAPDHZCHL-UHFFFAOYSA-N	CC1(CN2CCC(n3c(=O)[nH]c4ccccc43)CC2)OCc2ccccc2-n2cccc21	109826-26-8	Calmodulin Antagonists
AB-11-VI02	HTIQEAQVCYTUBX-UHFFFAOYSA-N	CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl		
FC-08-PZ84	HTJWLEGCECXGSQ-UHFFFAOYSA-N	O=C(Nc1ccc(O)c(C(=O)O)c1)c1cccc(NC(=O)c2ccco2)c1	887686-02-4	SIRT6 inhibitor
DD-47-GB64	HTTJCVMWSJWZID-UHFFFAOYSA-N	Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1	678974-63-5	CCR5 antagonist
CF-98-GZ19	HTTLBYITFHMYFK-UHFFFAOYSA-N	O=c1oc(-c2ccccc2)nc2ccccc12	1022-46-4	Elastase inhibitor
QA-98-TQ46	HTWDCJWXQKOQPP-UHFFFAOYSA-N	Nc1ccc2[nH]nc3c2c1C(=O)c1ccccc1-3		
ND-20-AS37	HTYFFCPFVMJTKM-UHFFFAOYSA-N	N=C(N)NC(=N)Nc1ccc(Cl)cc1	4022-81-5	5-HT3 receptor agonist
FD-15-HD09	HUASEDVYRABWCV-NDEPHWFRSA-N	CCOC(=O)N1CCN(C(=O)[C@H](Cc2cccc(C(=N)NO)c2)NS(=O)(=O)c2c(C(C)C)cc(C(C)C)cc2C(C)C)CC1	1191101-18-4	Urokinase (u-PA) Inhibitors
AC-85-MR73	HUCJFAOMUPXHDK-UHFFFAOYSA-N	Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1	1218-35-5	alpha2A(2D)-Adrenoceptor Agonists;alpha2B-Adrenoceptor Agonists;alpha2C-Adrenoceptor Agonists
ZD-23-ZF57	HUEKBQXFNHWTQQ-UHFFFAOYSA-N	CNc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]cc(Cl)c12	1700693-08-8	LRRK2 inhibitor
DD-26-VR55	HUGUNJBGJZFIKW-UHFFFAOYSA-N	COc1cccc(Nc2nccc(Nc3ccc4c(c3S(N)(=O)=O)OCCO4)n2)c1		ZAP70 Kinase Inhibitors;ALK Inhibitors
DE-79-FD94	HUJRVZPZMDVSSK-VJBMBRPKSA-N	COCCc1ccc(-c2[nH]c3cc(S(=O)(=O)N[C@H]4CC[C@H](C(=O)N5CCOC[C@@H]5C)CC4)ccc3c2Cl)cc1		Acetyl-CoA Carboxylase 1 (ACC1) Inhibitors;Acetyl-CoA Carboxylase 2 (ACC2) Inhibitors
AD-86-OB87	HUNGUWOZPQBXGX-UHFFFAOYSA-N	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1	1038395-65-1	c-src allosteric inihitor;allosteric Src inhibitor;Src Kinase Inhibitors;Antimitotic Drugs;Inhibitors of Signal Transduction Pathways;Tubulin polymerization inhibitors
CC-91-RO81	HUUSXLKCTQDPGL-UHFFFAOYSA-N	CC(C)(O)c1coc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)c1	210826-40-7	NRLP3 inflammasome inhibitor;inhibits NLRP3 inflammasome (exact target/mechanism unknown). Shows reduction of IL-1B in vivo in EAE expt models of MS.
HA-51-DA67	HUWKQQZKKYNSIW-DJUMBFHZSA-N	CN1CC(c2ccc(F)cc2)C2(CCCN(C(=O)[C@@H](COCc3ccccc3)NC(=O)C(C)(C)N)C2)C1=O	1415234-45-5	Growth hormone secretagogue receptor (ghrelin) agonist
EE-01-DO31	HUWWIHVYVDAXCT-UHFFFAOYSA-N	N#Cc1nc2c(nc1C#N)-c1ccccc1C2=O	40114-84-9	Caspase 3 Inhibitors;Ubiquitin Carboxyl-terminal Hydrolase Inhibitors;Cathepsin B Inhibitors
RC-65-VL12	HVEFZPHPECITAC-WOMSROEHSA-N	C[C@@H](NS(=O)(=O)CC/C=C/Cn1ccc(=O)[nH]c1=O)c1cccc(OCC2CC2)c1	1198222-30-8	Deoxyuridine Nucleotidohydrolase (dUTPase) Inhibitors
CA-73-TP18	HVFDPAQZZZVGNB-UHFFFAOYSA-N	COc1ccc(C2COc3cc(O)c(O)cc3C2)cc1OC		Lipoxygenase Inhibitors;Antiinflammatory Drugs;Lipoxygenase Inhibitors;Antiinflammatory Drugs
AB-34-DD27	HVQAJTFOCKOKIN-UHFFFAOYSA-N	O=c1c(O)c(-c2ccccc2)oc2ccccc12	142416-04-4	Drugs Acting on Beta-Amyloid;DNA binder;Drugs Acting on Beta-Amyloid;DNA binder
CD-96-HO43	HVSILNVTAWKPSC-ICSRJNTNSA-N	N[C@@H](CS)C(=O)N1CCn2cc(-c3ccccc3)nc2[C@@H]1CC1CCCCC1	195450-11-4	Inhibitor of Gq (GNA11) mediated GPCR signaling;G protein inhibitor - preferentially blocking Gq.;Inhibitor;Inhibitor of Gq (GNA11) mediated GPCR signaling;G protein inhibitor - preferentially blocking Gq.;Inhibitor
AA-52-JS03	HVXBOLULGPECHP-WAYWQWQTSA-N	COc1ccc(/C=C\\c2cc(OC)c(OC)c(OC)c2)cc1O	117048-59-6	Microtubule Polymerization Inhibitors
CD-91-MI27	HWKROQUZSKPIKQ-MRXNPFEDSA-N	CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc(O)c2)CC1	201038-74-6	5-HT7 Antagonists
RC-92-EM42	HWOAQZBIJPMRLH-UHFFFAOYSA-N	S=c1[nH]n2c(COc3ccc(Cl)cc3)nnc2s1		CDK1 Inhibitors;CDK2 Inhibitors;CDK4 Inhibitors
HB-95-ZG66	HWPGRFRXZNLZEX-UHFFFAOYSA-N	Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1	847375-16-0	Oxytocin agonist
CD-10-LX95	HWPXBWNLCZPRCW-RVDMUPIBSA-N	CCN(CC)C(=O)/C=C(\\C)c1ccc(OCc2c(F)cccc2F)c(CC(=O)O)c1		Leukotriene BLT (LTB4) Antagonists
FE-29-XM40	HWSHOMMVLGBIDN-UHFFFAOYSA-N	CC(C)(C)NC(=O)c1cncn1C1CCN(c2ccc(-c3nnc(C(F)(F)F)o3)cn2)CC1		WNK1/2/3/4 inhibitor;WNK1 gene inhibitor
DA-19-JA87	HWXIGFIVGWUZAO-UHFFFAOYSA-N	Cn1c(=O)c2c(ncn2CC2OCCO2)n(C)c1=O	69975-86-6	Adenosine A1 Antagonists
LA-64-ZV04	HWXVDEAMULKKDC-UHFFFAOYSA-N	CCCCNC(=O)Oc1ccc(OCc2ccccc2)cc1	195140-79-5	Fatty Acid Amide Hydrolase (FAAH) Inhibitors
LE-08-BO67	HXGBXQDTNZMWGS-UHFFFAOYSA-N	NC(=O)C(c1ccccc1)(c1ccccc1)C1CCN(CCc2ccc3c(c2)CCO3)C1	133099-04-4	Muscarinic M5 receptor antagonist
KD-75-HW99	HXHAJRMTJXHJJZ-UHFFFAOYSA-N	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1	252003-65-9	EGFR (HER1| erbB1) Inhibitors;PDGFR Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;Inhibitors of Signal Transduction Pathways;Angiogenesis Inhibitors
OD-13-IE31	HXHYZXUIKFXLHE-JTQLQIEISA-N	C[C@@H](CO)NC(=O)c1cnn2c(O)cc(-c3ccccc3)nc12		
RB-61-DW99	HXIMTHFWUCSQRF-UHFFFAOYSA-N	CNCc1cc(-c2ccccc2)n(S(=O)(=O)c2ccccc2)c1	881678-78-0	ATP4A blocker, ATP4B blocker
AC-36-SY22	HXITXNWTGFUOAU-UHFFFAOYSA-N	OB(O)c1ccccc1	98-80-6	Carbonic anhydrase inhibitor
ID-43-YL08	HXNBAOLVPAWYLT-NVNXTCNLSA-N	O=C1NC(=S)S/C1=C\\c1cc(Br)ccc1OCc1ccccc1Br	893449-38-2	PTP4A3 inhibitor/antagonist
DB-73-BC12	HXPQWNPLNIEJOW-UHFFFAOYSA-N	CCc1nn2c(C)cc(C)nc2c1Cc1ccc(-c2nnc(C3CCNCC3)o2)cc1	1401728-56-0	GPR4 antagonist
FC-62-AI14	HXWARSZQGAFXJM-MGPUTAFESA-N	CC(C)[C@@](C)(O)[C@@H]1CN(c2nc(-c3n[nH]c4ncccc34)c(F)cc2Cl)CCN1	1321924-70-2	Protein kinase C theta inhibitor
CB-12-HC20	HXYVTAGFYLMHSO-UHFFFAOYSA-N	CCCCCCCCCCCCCCCC(=O)NCCO	544-31-0	Cannabinoid CB2 Agonists
DB-51-UO66	HYAFETHFCAUJAY-UHFFFAOYSA-N	CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1	105355-27-9	Insulin Sensitizers;PPARgamma Agonists
HA-48-LV39	HYBRYAPKQCZIAE-UHFFFAOYSA-N	COc1ccc2c(c1OC)CN(C)CCc1cc3c(cc1C(=O)C2)OCO3		
EA-18-FP00	HYFHYPWGAURHIV-JFIAXGOJSA-N	COC(=O)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4	26833-87-4	Translation inhibitor;treatment of orphan leukemia;Elongation inhibitor;Treatment of orphan leukemia;Translation inhibitor;treatment of orphan leukemia;Elongation inhibitor;Treatment of orphan leukemia
AD-38-OG44	HYHMLYSLQUKXKP-UHFFFAOYSA-N	CC(C)(CCCCCC(O)CCCCCC(C)(C)C(=O)O)C(=O)O	738606-46-7	ATP citrate lyase inhibitor
AB-78-RM53	HYIMSNHJOBLJNT-UHFFFAOYSA-N	COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]	101539-70-2	Calcium Channel Blockers;Antioxidants;Calcium Channel Blockers;Antioxidants
GB-11-PX47	HYJRTXSYDAFGJK-UHFFFAOYSA-N	C[N+]1(C)CCC(OC(=O)C(c2ccccc2)c2ccccc2)CC1	106458-69-9	CHRM3 antagonist
KA-54-MB31	HYTRYTZFJVVZAF-UHFFFAOYSA-N	NC1Cc2ccccc2N(O)C1=O	25263-70-1	Kynurenine Aminotransferase II (KAT II) Inhibitors
SC-72-YW56	HYWDWAXZNWIOQW-UHFFFAOYSA-N	CN1CCOc2cc(-c3cc4c(cn3)CCc3c-4[nH]c4c3C(=O)NCC43CC3)ccc21	1105658-32-9	MAPKAPK5 inhibitor
BE-18-EM88	HYWYRSMBCFDLJT-UHFFFAOYSA-N	CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1	1364966-82-4	Cyclooxygenase-2 Inhibitors
NE-20-WM78	HZASIAXCPXTISQ-NVXWUHKLSA-N	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC	1262849-73-9	Checkpoint Kinase 2 (Chk2) Inhibitors
LF-56-QX74	HZBABTUFXQLADL-UHFFFAOYSA-N	CCCCCCCOc1ccc(O)cc1	13037-86-0	steroidogenic factor inhibitor
KC-54-AS32	HZLAWYIBLZNRFZ-VXGBXAGGSA-N	O=C(O)[C@H]1CCCN1C(=O)CCCCC(=O)N1CCC[C@@H]1C(=O)O	224624-80-0	Antiamyloidogenic Agents;Anti-Human Serum Amyloid P (Anti-SAP)
EA-30-ZX90	HZMAFSFOEIRHAL-UHFFFAOYSA-N	CCC(CC)Nc1c(Nc2ccc(Cl)c(S(=O)(=O)N(C)OC)c2O)c(=O)c1=O	1206894-99-6	Chemokine CXCR2  (IL-8 beta Receptor) Antagonists
JD-12-YK78	HZOPLJHDBHXQFB-JOCHJYFZSA-N	Cc1oc(-c2ccc(Cl)cc2)nc1COc1cccc(C(C)(C)C(=O)N2CCC[C@@H]2C(=O)O)c1		
AB-33-VM36	HZQDCMWJEBCWBR-UUOKFMHZSA-N	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1O	50524-49-7	Immunosuppressive
CC-85-AY05	HZZVJAQRINQKSD-PBFISZAISA-N	O=C(O)[C@H]1/C(=C/CO)O[C@@H]2CC(=O)N21	1365254-41-6	beta-Lactamase Inhibitors
GE-17-WR07	HZZZZODVDSHQRG-UHFFFAOYSA-N	COc1cc(OC)c(C(=O)CCCCN2CCC3(CC2)NC(=O)NC3=O)cc1NS(=O)(=O)c1ccc(C(F)(F)F)cc1	185376-97-0	5-HT2C Antagonists;HTR2C antagonist
IF-72-BO18	IAASQMCXDRISAV-CYBMUJFWSA-N	O=C(N[C@H](Cc1ccccc1)C(=O)O)c1sc2cc(F)ccc2c1Cl	1279713-77-7	TLR3 gene inhibitor
CC-48-ZJ56			1098979-63-5	
BB-86-BE39	IAKHMKGGTNLKSZ-INIZCTEOSA-N	COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2	30512-31-3	Tubulin Polymerase Inhibitors
KF-07-OX36	IALXIRPKVRUJQO-UHFFFAOYSA-N	O=C(O)c1ccc(-c2cc3cccnc3c(-c3ccc4nonc4c3)n2)cc1	426268-06-6	Phosphodiesterase IV Inhibitors
EE-78-ES92	IANOEARWEWNMSC-UHFFFAOYSA-N	O=C(O)C(=O)c1ccc(OCCOc2ccc3ccccc3c2)s1	145794-08-7	Carnitine O-Palmitoyltransferase 1 (CPT-1) Inhibitors
GD-79-TW34	IASPBORHOMBZMY-UHFFFAOYSA-N	O=C(Nc1ccccc1-c1cn2c(CN3CCNCC3)csc2n1)c1cnc2ccccc2n1	1001645-58-4	SIRT1;Histone Deacetylase SIRT1 Activators
CE-74-KU68	IAVUPMFITXYVAF-XPUUQOCRSA-N	CCN[C@H]1C[C@H](C)S(=O)(=O)c2sc(S(N)(=O)=O)cc21	120279-96-1	Carbonic Anhydrase Type II Inhibitors
BD-04-NG34	IAYGCINLNONXHY-LBPRGKRZSA-N	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1	1019773-80-8	Checkpoint Kinase 1 (Chk1) Inhibitors;Checkpoint Kinase 2 (Chk2) Inhibitors;DNA Repair Inhibitor
CB-43-EP73	IAZDPXIOMUYVGZ-UHFFFAOYSA-N	C[S+](C)[O-]		
BE-41-AV63	IBAQFPQHRJAVAV-ULAWRXDQSA-N	OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO	1204250-58-7	SGLT-3 Activators;alpha-Glucosidase Inhibitors
AB-85-JR73	IBCXZJCWDGCXQT-UHFFFAOYSA-N	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1	396129-53-6	Inhibitors of Signal Transduction Pathways;Activin Receptor Like Kinase 5 (ALK5;TbetaR-I) Inhibitors;p38 MAPK Inhibitors
ID-55-OJ03	IBGLGMOPHJQDJB-IHRRRGAJSA-N	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1	899805-25-5	JNK inhibitor
SE-21-NB93	IBLNKMRFIPWSOY-FNORWQNLSA-N	CC(C)(C)C(O)/C=C/c1ccc2c(c1)OCO2	1185239-64-8	GABA Reuptake Inhibitors;GABA Aminotransferase Inhibitors
WE-43-PZ45	IBMFMQONAHFJRX-UHFFFAOYSA-N	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4c(Cl)cncc4Cl)s3)cc2)CC1		
BB-11-XO81	IBMJKJJMRYHRNQ-UHFFFAOYSA-N	COc1ccc(N2Cc3ccc(O)cc3OC2=O)cc1		Macrophage Migration Inhibitory Factor (MIF) Inhibitors
AB-12-PP61	IBPVXAOOVUAOKJ-UHFFFAOYSA-N	Fc1cc(-c2cccc3ncc(-c4cnn(C5CCNCC5)c4)nc23)cc(F)c1CN1CCOCC1	1092499-93-8	Jak2 Inhibitors
ME-60-RF56	IBQJWZNNSYUOII-UHFFFAOYSA-N	N#Cc1c(NC(=S)NC(=O)c2ccccc2)sc2c1CCCC2	121746-08-5	Serotonin Antagonists
QA-67-IM54	ICLUPJSFAFLDLR-AREMUKBSSA-N	O=C([C@@H](Cc1ccccc1)NS(=O)(=O)c1ccc2[nH]c(=O)ccc2c1)N(Cc1ccco1)Cc1cccs1		
BC-87-PJ84	ICMGLRUYEQNHPF-UHFFFAOYSA-N	COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1	102411-11-0	alpha1-Adrenoceptor Antagonists
KA-60-LC14	ICVDGTYUNLLBJC-RWDQXUKUSA-N	CC(C)(C)[C@H](Nc1nc(CC(=O)N2CCOCC2)cs1)C(=O)N1C[C@]2(C[C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C(C)(C)C21CCC1		
GE-40-VJ66	ICWBFSCBEZAOCT-UHFFFAOYSA-N	COc1ccc(NS(N)(=O)=O)cc1	10539-83-0	carbonic anhydrase inhibitor
FF-22-NB12	IDBCUMFOZBUJCL-UHFFFAOYSA-N	Cc1cc(-c2nc3ccccc3s2)ccc1N	178804-04-1	Aryl Hydrocarbon Receptor (AhR) Agonists
BB-40-KK84	IDEHCMNLNCJQST-UHFFFAOYSA-N	NCCCCCCNS(=O)(=O)c1cccc2c(Cl)cccc12	61714-27-0	K(V)11.1 (erg1) Channel Blockers;K(V)1.5 Channel Blockers;Calmodulin Antagonists
BD-85-GY20	IDFOCEQDKOOOER-UHFFFAOYSA-N	Cc1c(Cc2ccccc2)c(=O)oc2cc(O)ccc12	86-44-2	17beta-Hydroxysteroid Dehydrogenase Type 3 (17beta-HSD3) Inhibitors
VB-48-KG22	IDHADZLSPDGLOW-UHFFFAOYSA-N	Oc1nc(S)c2nc(S)[nH]c2n1		
IF-22-EA89	IDINUJSAMVOPCM-UHFFFAOYSA-N	N=C(N)NCCCCCCC(=O)NC(O)C(=O)NCCCCNCCCN		
HE-09-WC21	IDWSNQSNHQTUQD-TZBSWOFLSA-N	O=C([C@H]1CC[C@H](NS(=O)(=O)c2ccc(-c3cocn3)cc2)CC1)N1CCNC[C@@H]1c1ccccc1	1310475-39-8	Acetyl-CoA Carboxylase 1 (ACC1) Inhibitors;Acetyl-CoA Carboxylase 2 (ACC2) Inhibitors
ME-90-FS02	IEENMDADGAZPAM-UHFFFAOYSA-N	CCC(C)C1C(=O)N2NCCCC2C(=O)N2NCCCC2C(=O)N(C)C(Cc2ccccc2)C(=O)N2CCCC2C(=O)NC(Cc2ccccc2)C(=O)N1O	122211-29-4	Vasopressin (AVP) V1a Antagonists;Vasopressin (AVP) V2 Antagonists
BB-39-YQ35	IEJXVRYNEISIKR-UHFFFAOYSA-N	Nc1cc(Cl)c(N=C2NCCN2)c(Cl)c1	66711-21-5	alpha2-Adrenoceptor Agonists
CA-26-BI29	IEKOTSCYBBDIJC-UHFFFAOYSA-N	CCCCCN(CCCCC)C(=O)C(CCC(=O)O)NC(=O)c1ccc(Cl)c(Cl)c1	1021868-76-7	CCK1 (CCKA) Antagonists
LC-43-SE41	IENZFHBNCRQMNP-UHFFFAOYSA-N	N#Cc1cc(CN2CCC(Nc3ncnc4sc(Cl)cc34)CC2)ccc1F	866206-54-4	5-HT2B Antagonists
AB-90-YR46	IENZQIKPVFGBNW-UHFFFAOYSA-N	COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC	19216-56-9	CDK1 Inhibitors;Apoptosis Inducers;ADRA1B antagonist
HC-04-ZM18	IFDGQFUYOOYEGE-UHFFFAOYSA-N	CN1CCC(c2ccc(CN(C)Cc3ccc(Cl)cc3)cc2)CC1		LSS gene inhibitor
EC-85-CG61	IFLIQLQVUMXNFU-IAPPQJPRSA-N	CCCCS(=O)(=O)NC(=O)[C@@H](NC(=O)[C@@H](Cc1ccc(-c2ccno2)cc1)N(C)C(=O)c1cc(C)cc(C)c1)C(C)C		Endothelin ETA Receptor Antagonists;Endothelin ETB Receptor Antagonists
GA-48-JB51	IFLVGRRVGPXYON-UHFFFAOYSA-N	NC(=O)C12NC(Cc3ccccc31)c1ccccc12	124070-15-1	NMDA Antagonists;Sodium Channel  Blockers
BC-36-PL31	IFSDAJWBUCMOAH-HNNXBMFYSA-N	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1	1146702-54-6	lipid kinase inhibitor;Phosphatidylinositol 3-Kinase delta (PI3Kdelta) Inhibitors
LE-48-SO37	IFSKWRRSOAKRFM-UHFFFAOYSA-N	CN1C(=O)Cc2c1ccc(-c1cccnc1)c2OCc1cccc(Cl)c1		
IF-83-OL68	IFTVRWXKABDXQE-UHFFFAOYSA-N	CC(C)n1cnc2c(NCCc3c[nH]c4ccccc34)nc(-c3csc4ccccc34)nc21		
AC-49-NG46	IFWMVQUGSGWCRP-UHFFFAOYSA-N	COc1c(OC)c(OC(C)=O)c2cc(Cl)ccc2c1OC(C)=O	91431-42-4	Lipoxygenase Inhibitors
DB-83-LM41	IFWNPAWLKUVJGK-UHFFFAOYSA-N	O=C(Nc1cc(C2CC2)on1)n1ccc2cc(Oc3ncnc4c3CNC4)ccc21		VEGFR-2 (FLK-1/KDR) Inhibitors
PC-63-CH43	IFWUBRBMMNTBRZ-UHFFFAOYSA-N	Cc1cc(Cn2c(=O)n(Cc3cnc(C)s3)c(=O)c3cc(S(=O)(=O)NC4(C)CC4)ccc32)n(C)n1		PARG inhibitor
MA-31-VM30	IGMKTIJBFUMVIN-UHFFFAOYSA-N	CN(c1nc2ccccc2s1)C1CCN(CC(O)COc2ccc(F)cc2)CC1		
KA-51-CQ55	IGMSBHBHVCLQBH-UHFFFAOYSA-N	c1ccc(-c2c(-c3ccnc(NC4CCCCC4)c3)nc(N3CCNCC3)c3ccncc23)cc1	1071136-06-5	PKD inhibitor
S0-EE-XKW4	IGRCFOGPIJEESA-UHFFFAOYSA-N	O=C(Nc1ccc(I)cc1F)c1cc(F)ccc1O		RANKL inhibitor
AA-77-MP68	IGTAPYSCLKXXSC-UHFFFAOYSA-N	CC(C)Oc1ccc(-c2nc(-c3ccc(C4(N)COC4)cc3)no2)cc1C#N	1158098-53-3	Lysophospholipid edg1 (S1P1) Receptor Agonists;Lysophospholipid edg8 (S1P5) Receptor Agonists
JF-39-BZ76	IGUBBWJDMLCRIK-UHFFFAOYSA-N	CNC(=O)c1ccccc1Nc1cc(Nc2ccc(N3CCOCC3)cc2OC)ncc1C(F)(F)F	1061353-68-1	FAK inhibitor
JB-28-VO37	IHESCUFUOPLPNI-SUMDDJOVSA-N	CCOc1cccc([C@H]2CCC[C@H]2NC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1		
AA-36-YV45	IHFRMUGEILMHNU-UHFFFAOYSA-N	O=Cc1cc([N+](=O)[O-])ccc1O	58983-36-1	Glucose-6-phosphatase Inhibitors
EA-96-QK68	IHJCXVZDYSXXFT-UHFFFAOYSA-N	Nc1cc(Cl)c(S(N)(=O)=O)cc1S(N)(=O)=O	1184995-49-0	Carbonic Anhydrase Type II Inhibitors
EE-04-QG34	IHLWXZNPOVMUFQ-UHFFFAOYSA-N	CC(=O)NCCc1ccc(O)c(-c2c(O)c(O)c3c(c2O)C(=O)c2c(cc(O)c(C(=O)O)c2C(=O)O)C3=O)c1	15979-35-8	Direct competitive inhibitor of DNMT1
XA-36-WV33	IHZDCGSHXDMDGU-UHFFFAOYSA-N	CCOC(=O)C1=C(C)NC(=S)NC1c1cccc(OC)c1		Antimitotic Drugs;Kinesin-Like Spindle Protein  KIF11 (KSP, Eg5) Inhibitors
BF-63-DQ96	IIBBJCNVTRCTDV-QYQHSDTDSA-N	CC1=NN(c2ccc(C)c(C)c2)C(=O)/C1=N\\Nc1cccc(-c2cccc(-c3nnn[nH]3)c2)c1O		Signal Transduction Modulators;Thrombopoietin Receptor (TpoR) Agonists
BD-06-VI74	IIBYAHWJQTYFKB-UHFFFAOYSA-N	CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O	41859-67-0	11-beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Inhibitors;HSD11B1 Expression Inhibitors;PPARalpha Agonists;PPARdelta Agonists;PPARgamma Agonists
AE-05-GR23	IIQUYGWWHIHOCF-UHFFFAOYSA-N	O=C(NCCO)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1	778277-15-9	Inhibitors of Signal Transduction Pathways;Bcr-Abl Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Bcr-Abl Kinase Inhibitors
AC-67-PZ77	IIXWYSCJSQVBQM-LLVKDONJSA-N	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21	1454846-35-5	inhibitor of ALK
BE-58-FC64	IJALVDBOEUTVBN-UHFFFAOYSA-N	N#Cc1cccc(-c2nc(N3CCC(C(=O)O)CC3)cc3cccnc23)c1	713145-09-6	Phosphodiesterase PDE4D Inhibitors
GA-61-GX82	IJBNWYRAKMOUIC-JKSUJKDBSA-N	CCC[C@H]1c2cccc3c2[C@@H](Cc2ccc(O)c(O)c2-3)N1CC		
TD-69-UA90	IJHSPFFWIXGDBB-UHFFFAOYSA-N	O=C(CO)NC1CCN(Cc2ccc(Oc3nc4ccccc4s3)cc2)CC1		Leukotriene A4 Hydrolase Inhibitors
TD-40-ZR64	IJHSSZSLWCDQTQ-UHFFFAOYSA-N	CC(=O)Nc1cc(Oc2ccc3c(C(=O)Nc4ccc(CN5CCN(C6CC6)CC5)c(C(F)(F)F)c4)cccc3c2)ncn1		
UF-43-HT41	IJVMOGKBEVRBPP-ZETCQYMHSA-N	N[C@H](C(=O)O)c1ccc(C(=O)O)c(C(=O)O)c1	201730-11-2	mgluR8 Agonists
GD-90-RA90	IJYPHMXWKKKHGT-VAWYXSNFSA-N	COc1cc2c(cc1OC)CN(C(=O)/C=C/c1c(-c3ccccc3)n(C)c3ncccc13)CC2	1009104-85-1	
ME-36-FM27	IKDSTUUOAQZAFI-UHFFFAOYSA-N	Cn1c(=O)c2c(ncn2CCN2CCN(C(c3ccccc3)c3ccccc3)CC2)n(C)c1=O		HRH1 antagonist
AC-24-QG69	IKMDFBPHZNJCSN-UHFFFAOYSA-N	O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12	529-44-2	Androgen Receptor Ligands;Cytochrome P450 CYP3A4 Inhibitors;Antioxidants
FB-67-OY39	IKNOZZKXIDSTRN-PXLJZGITSA-N	Cc1cc(=O)oc2cc(NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC3CCCCC3)NC(=O)OCC3c4ccccc4-c4ccccc43)ccc12	475115-35-6	GALR2 agonist
ID-12-GA19	IKSQCMLJDHRWOA-UHFFFAOYSA-N	C=C=CCNCCCCNCC=C=C	93565-01-6	Apoptosis Inducers;Polyamine Oxidase Inhibitors
ND-35-VF18	IKSUABKMJZDCNQ-UHFFFAOYSA-N	Cc1cc(CC(=O)O)ccc1NC(=O)c1cc(OCc2cccc(Cl)c2)ccc1C	1034025-63-2	Prostanoid EP4 Agonists;PTGER4 agonist
DD-44-OX00	IKUBXUCJQADOPH-UHFFFAOYSA-N	CCN1CCN(c2cc(C)c3cc(NC(=O)Cc4ccc(Cl)c(Cl)c4)ccc3n2)CC1		
HE-55-AG11	IKUFKDGKRLMXEX-UHFFFAOYSA-N	CN1CCN(c2ccc(-c3ccncc3-c3cc(F)c(O)c(F)c3)cc2)CC1		Ribosomal protein S6 kinase inhibitor
EC-62-OE64	ILAZEUQGANOTAY-VAWYXSNFSA-N	CC(C)N(CCc1c[nH]c2ccccc12)Cc1ccc(/C=C/C(=O)NO)cc1		Histone Deacetylase (HDAC) Inhibitors
QA-34-BH60	ILCJEENXGVKZEJ-UHFFFAOYSA-N	CC(C)C(C(=O)Nc1cccnc1)c1ccc(Cl)cc1		
LB-03-JV32	ILEIGUXOYKZHRK-UHFFFAOYSA-N	Cc1ccc(NC(=N)N=C(N)N)cc1	15233-33-7	5-HT3 receptor agonist
RE-99-TA30	ILJDAFPFCCVDKU-UHFFFAOYSA-N	NCC1OCCc2ccccc21	19158-90-8	MC4R antagonist
CD-01-ZO61	ILOIOIGZFHGSMS-UHFFFAOYSA-N	O=C(CCCCCCc1ccccc1)c1ncc(-c2ccccn2)o1	681135-77-3	Fatty Acid Amide Hydrolase (FAAH) Inhibitors
FF-54-JC89	IMONEMVSDGNYHY-YSURURNPSA-N	N/C(=N/N=C/c1c[nH]c2ccc(O)cc12)NCCc1ccc(Cl)c(Cl)c1		
OC-36-DG23	IMOQEWXBWXGJOX-CQSZACIVSA-N	N#CC1(c2cc(C[C@@H](O)CO)cc(-c3ccnc4[nH]nc(C(F)(F)F)c34)c2)CC1	1620328-15-5	PKC epsilon inhibitor
BC-06-OP01	IMXKHFILKMPFGB-ZWYWTTNJSA-N	C=C1C(=O)N[C@@H](C)C(=O)N(C)[C@@H](C)C(=O)N[C@@H]([C@H](OC(=O)[C@@H](NC(=O)CC)[C@H](O)C(C)C)C(C)C)C(=O)N(C)[C@@H]([C@@H](C)OC)C(=O)O[C@H](C(C)C)[C@H](NC(C)=O)C(=O)O[C@H](Cc2ccccc2)C(=O)N1C		
CC-15-TX17	IMYZQPCYWPFTAG-UHFFFAOYSA-N	CNC1(C)C2CCC(C2)C1(C)C	107538-05-6	Nicotinic Receptor Antagonists
AA-28-PM33	IMZMKUWMOSJXDT-UHFFFAOYSA-N	O=C(O)c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1	105878-73-7	Mediator Release Inhibitors
AA-56-AB37	INAICWLVUAKEPB-QSTFCLMHSA-N	O=C(/C=C/N1C[C@H]2C[C@@H]1CN2c1ccccn1)c1ccccc1O		SMARCA2/4;SMARCA2 gene inhibitor;Protein Polybromo-1 (PBRM1; hPB1; BAF180) Inhibitors
FC-05-LX47	INASOKQDNHHMRE-UHFFFAOYSA-N	CC(C)OC(=O)C1=CN(C(=O)c2ccc(F)c(F)c2)CC(C)(C)c2c1[nH]c1ccccc21	629664-81-9	Farnesoid X Receptor (FXR) Agonists
AC-41-IB85	INBGSXNNRGWLJU-ZHHJOTBYSA-N	C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	2140-46-7	Apoptosis Inducers;IL-8 Modulators;TNF-alpha Release Inhibitors;Cholesterol Biosynthesis Inhibitors;3-hydroxy-3-methylglutaryl-CoA reductase Inhibitors
EF-89-OM00	INFDPOAKFNIJBF-UHFFFAOYSA-N	C[n+]1ccc(-c2cc[n+](C)cc2)cc1		
FF-90-JK74	INJOMKTZOLKMBF-UHFFFAOYSA-N	N=C(N)NC(=O)Cc1c(Cl)cccc1Cl	29110-47-2	alpha2-Adrenoceptor Agonists
BF-02-AC95	INRRBCBUMMJGOS-UHFFFAOYSA-N	CC(C)(c1cc(Br)c(OCC(O)CN2CCOCC2)c(Br)c1)c1cc(Br)c(OCC(O)CN2CCOCC2)c(Br)c1	299420-64-7	beta-Amyloid (Abeta) Aggregation Inhibitors
CA-54-WJ96	INSBKYCYLCEBOD-UHFFFAOYSA-N	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12	391670-48-7	Casein Kinase II (CK2) Inhibitors
LC-05-JF28	INULNSAIIZKOQE-YOSAUDMPSA-N	COc1cccc2c1C[C@H]1C[C@@H](C(=O)N3CCN(c4ccc([N+](=O)[O-])cc4)CC3)CN(C)[C@@H]1C2	187218-90-2	Somatostatin SRIF2A (sst1) Antagonists
PA-57-FX61	INWHWNYXZBIOFV-UHFFFAOYSA-N	O=C(NCCc1nc(-c2ccccc2)no1)c1cccc(-c2noc(C(F)(F)F)n2)c1		
RB-43-AX96	INYJNSBDHOVLAH-UHFFFAOYSA-N	NC(=O)c1c(F)ccc(OCc2nc3cc(Cl)cnc3s2)c1F		
AB-13-HC37	INZHOKAGODFSQH-UHFFFAOYSA-N	COc1ccc(CN(CC(=O)NO)S(=O)(=O)c2ccc(OCCCCl)cc2)cc1		
KE-30-PJ81	IODOBBFRLZLCJR-UHFFFAOYSA-N	Cc1ccc(-c2ccc(S(C)(=O)=O)cc2)n1-c1ccc(F)cc1	189500-90-1	Cyclooxygenase-2 Inhibitors;Non-Steroidal Antiinflammatory Drugs
BB-51-DP49	IOINWGCMLYSPAK-UHFFFAOYSA-N	C=CCCOc1ccc(S(=O)(=O)N(CC(=O)NO)Cc2ccc(-n3cncn3)cc2)cc1		MMP-2 (Gelatinase A) Inhibitors;MMP-9 (Gelatinase B) Inhibitors
FE-29-HC66	IOLRUMINDIUCLJ-RRFJBIMHSA-N	CNC(=O)[C@@H](NC(=O)[C@H](c1ccc(OC)cc1)[C@H](CO)C(=O)NO)C(C)(C)C	205807-59-6	ADAM17 (TNF-alpha-Converting Enzyme (TACE) Inhibitors);MMP-13 (Collagenase 3) Inhibitors;MMP-1 (Interstitial Collagenase) Inhibitors;MMP-2 (Gelatinase A) Inhibitors;MMP-3 (Stromelysin 1) Inhibitors;MMP-9 (Gelatinase B) Inhibitors
CE-70-RN96	IOUVKUPGCMBWBT-QNDFHXLGSA-N	O=C(CCc1ccc(O)cc1)c1c(O)cc(O)cc1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O	112318-65-7	SGLT-1 Inhibitors;SGLT-2 Inhibitors
KC-96-UA29	IOVGROKTTNBUGK-SJCJKPOMSA-N	C[C@H](NCCc1ccc(O)cc1)[C@H](O)c1ccc(O)cc1	23239-51-2	ADRB3 agonist
CA-26-UY62	IOYGAWXBNPFOKF-UHFFFAOYSA-N	Nc1cc(Oc2ccc3c(C(=O)Nc4cccc(C(F)(F)F)c4)cccc3c2)ncn1		VEGFR-2 (FLK-1/KDR) Inhibitors
CE-42-GB12	IPFOUKVHPIKUEI-UHFFFAOYSA-N	Nc1ncnc2c1c(-c1ccccc1)nn2Cc1ccccc1		
HE-55-NT77	IPJXSSVITPAERU-RHSMWYFYSA-N	CCC(=O)c1ccc(OC)c2c1C[C@H]1OCCN(C)[C@@H]1C2		5-HT1D Agonists
AA-90-YI00	IPSGOMWAGOYNKO-UHFFFAOYSA-N	NCc1ccc2c(c1)CN(C1CCC(=O)NC1=O)C2=O		
AB-92-GP61	IPSSXIMJJXSJQB-FQEVSTJZSA-N	CCOC(=O)[C@H](Cc1ccccc1)NC(=O)c1cc(Cl)c(OCCN2CCN(C)CC2)c(Cl)c1O		
DA-32-QL71	IPSYPUKKXMNCNQ-PFHKOEEOSA-N	CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)nc(Cl)nc32)[C@H](O)[C@@H]1O	163042-96-4	Adenosine A3 Agonists
BE-54-BG59	IQCKJUKAQJINMK-HUBRGWSESA-N	CC(C)N(CCCNC(=O)Nc1ccc(C(C)(C)C)cc1)C[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O	1561178-17-3	Dot1L inhibitor
HE-22-JR80	IQFYYKKMVGJFEH-CSMHCCOUSA-N	Cc1cn([C@@H]2C[C@@H](O)[C@H](CO)O2)c(=O)[nH]c1=O		
JB-58-VY51	IQFYYKKMVGJFEH-XLPZGREQSA-N	Cc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O	1211376-53-2	Thymidine kinase 1 ligand;Thymidine kinase 2 ligand
UC-38-AA43	IQGJUDFNHPTCGC-UHFFFAOYSA-N	Cc1nc(-n2cnn(Cc3ccc(C(F)(F)F)cc3)c2=O)sc1C(=O)NCc1cccnc1	1072804-24-0	SCD inhibitor
IF-03-OL58	IQIBKLWBVJPOQO-UHFFFAOYSA-N	CC1(C)CCSc2ccc(C#Cc3ccc(C(=O)O)cn3)cc21	118292-41-4	Drugs Acting on Retinoid Receptors
EC-60-CX20	IQVDLEXWAPYWDT-LJQANCHMSA-N	Cc1ccc(-c2ncc(OC[C@@H]3CCNC3)cc2-c2ccc(C#N)cc2)cc1		
JA-24-VW07	IQVRBWUUXZMOPW-PKNBQFBNSA-N	CCn1c(=O)c2c(nc(/C=C/c3ccc(OC)c(OC)c3)n2C)n(CC)c1=O	155270-99-8	Adenosine A2A Antagonists
DB-40-HA40	IRERRFYLRIBFMB-UHFFFAOYSA-N	CC1(C)CC(Nc2ccc(-c3cc4ccccc4s3)nn2)CC(C)(C)N1	1562332-79-9	Splicing modulator
JE-72-KV75	IRGAIDAWHGYOKD-UHFFFAOYSA-N	COc1cc(F)c(-c2nc3c(NCC4CCNCC4)c(Cl)cnc3[nH]2)cc1OC		JAK1 selective inhibitors
EC-37-MB09	IRGYSXZCDAWOOC-UHFFFAOYSA-N	Cc1ccc(S(=O)(=O)Nc2ccccc2N2CCCCC2)s1	1062271-24-2	Mucolipin agonist
BC-28-NG89	IRLWJILLXJGJTD-UHFFFAOYSA-N	COc1ccc(OC(=O)N(CC(=O)O)Cc2ccc(OCCc3nc(-c4ccccc4)oc3C)cc2)cc1	331741-94-7	Insulin Sensitizers;PPARalpha Agonists;PPARgamma Agonists
BE-51-JY70	IRWDVLZZYSYUAI-UHFFFAOYSA-N	CN1CCN(c2ccc(C(=O)NCc3cnc(C#N)nc3NCC(C)(C)C)cc2)CC1	501000-36-8	Cathepsin K Inhibitors
ND-56-OT44	IRXNZDLBTXVBDW-STEQJIOHSA-N	NC1CC1c1ccc(OCC[C@H](NC(=O)c2ccccc2)C(=O)NCc2ccccc2)cc1	1196053-11-8	Lysine-Dependent Demethylase 1A (LSD1) Inhibitors
AA-83-TW85	ISFPDBUKMJDAJH-UHFFFAOYSA-N	O=C1CCc2c(ccc3ccccc23)O1	5690-03-9	Histone Deacetylase SIRT2 Inhibitors
BB-79-AG41	ISHNPDWTQUXPSY-UHFFFAOYSA-N	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(C#Cc4cccnc4)ccc3ncc21	853910-61-9	Phosphatidylinositol 3-Kinase (PI3K) Inhibitors
AA-81-IB40	ISHUULBGXOVLLF-UHFFFAOYSA-N	Nc1ncc(-c2ncccc2OC(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		PKC inhibitor;Kinase inhibitors;PKC inhibitor;Kinase inhibitors
PA-53-BA36	ISJSHQTWOHGCMM-NDEPHWFRSA-N	CCOC(=O)N1CCN(C(=O)[C@H](Cc2cccc(C(=N)N)c2)NS(=O)(=O)c2c(C(C)C)cc(C(C)C)cc2C(C)C)CC1	255374-84-6	Urokinase (u-PA) Inhibitors
CA-60-LK14	ISMFHXHTOAYRLV-ZEQRLZLVSA-N	COCCCOc1cc(C(=O)N(C[C@@H]2CNC[C@H]2CN(C(=O)OC2CCOCC2)C2CC2)C(C)C)ccc1OC		
BD-47-DS20	ISMHAZMNDUAHLK-UHFFFAOYSA-N	O=C(O)CCC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)CCCc1cccnc1	134235-78-2	Prostanoid TP Antagonists;Thromboxane Synthase Inhibitors
ZD-84-PM36	ISTCAWFMNVHHRU-UHFFFAOYSA-N	COc1cccc(Oc2ccc(NC(=O)C3CC3)cc2)c1		Melatonin MT2 Receptor Ligands
AB-55-HO71	ISWRGOKTTBVCFA-UHFFFAOYSA-N	Cc1ccc(=O)n(-c2ccccc2)c1	53179-13-8	TNF alpha synthesis inhibitor;TGFb pathway inhibitor;antifibrotic
BC-22-RZ85	ITACCRHKSPSKKL-UHFFFAOYSA-N	CCCCn1c(-c2ccccc2)nc(-c2ccccc2)c1CN(Cc1ccc2c(c1)OCO2)Cc1ccc2c(c1)OCO2	439571-48-9	C5a Antagonists
DE-14-EG14	ITAVYEBJUXADGU-UHFFFAOYSA-N	CC(=O)N(n1c(=O)[nH]c2cc(C(C)C)c(-c3ccnn3C)cc2c1=O)S(C)(=O)=O		
JC-06-ED36	ITFBYYCNYVFPKD-FMIDTUQUSA-N	CC1(C)CC[C@]2(C(=O)n3ccnc3)CC[C@]3(C)[C@H](C(=O)C=C4[C@@]5(C)C=C(C#N)C(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1	443104-02-7	Apoptosis Inducers;Nitric Oxide Production Inhibitors;Nuclear Factor, Erythroid Derived 2, Like 2 (Nrf2) Activators;Antiinflammatory Drugs;PPARgamma Agonists;Apoptosis Inducers;Nitric Oxide Production Inhibitors;Nuclear Factor, Erythroid Derived 2, Like 2 (Nrf2) Activators;Antiinflammatory Drugs;PPARgamma Agonists
QB-72-LM87	ITPRBCDKYPSWNW-UHFFFAOYSA-N	COc1ccc(Cc2cccc(-c3c(O)c4ccc(Cl)cc4[nH]c3=O)c2)cc1	142326-92-9	NMDA Glycine B Receptor Antagonists
DD-66-VY52	IUMQXQJZIHWLIN-HSZRJFAPSA-N	COC(=O)[C@H](NC(=O)c1cc(-c2ccccc2)nc2ccccc12)c1ccccc1	174635-53-1	Tachykinin NK3 Antagonists
S0-EE-WHDK	IUMRIDAXKLGCQO-UHFFFAOYSA-N	Nc1ncnc2c1ncn2CC(=O)NCc1ccc(S(N)(=O)=O)cc1		
UC-83-VC55	IUNFWMWQNWQIFS-UHFFFAOYSA-N	N=C(N)Nc1ccc(C(F)(F)F)cc1	130066-24-9	5-HT3 receptor agonist
LD-98-VO32	IVDUVEGCMXCMSO-FQEVSTJZSA-N	Cc1ncc(Cl)cc1NCc1ccc(C(=O)N[C@@H](CC2CCCC2)C(=O)NC2CC2)s1	1404456-53-6	WIP1 inhibitor
FD-43-EF54	IVQVBMWPWPTSNO-UHFFFAOYSA-N	CN1CCN(C(=O)c2ccc(-c3ccc4c(C=O)c(O)ccc4c3)s2)CC1	1093119-54-0	IRE1 protein kinase inhibitor
JD-12-CE09	IVRXNBXKWIJUQB-UHFFFAOYSA-N	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1	700874-72-2	Inhibitors of Signal Transduction Pathways;Activin Receptor Like Kinase 5 (ALK5;TbetaR-I) Inhibitors
IB-06-YD91	IVTVGDXNLFLDRM-HNNXBMFYSA-N	Cc1nc(=O)c2cc(CN(C)c3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)s3)ccc2[nH]1	112887-68-0	dual thymidylate synthase and dihydrofolate reductase inhibitors
BC-56-BB82	IVUGBSGLHRJSSP-UHFFFAOYSA-N	CC(C)C(=O)Nc1ncc(-c2cc(C(F)F)nn2-c2c(Cl)cccc2Cl)s1	1338247-35-0	LIM kinase-1 inhibitor;LIM kinase-2 inhibitor
HA-36-JX64	IVULCMPTMXWZEU-UHFFFAOYSA-N	CC(=O)c1ccc2c(c1)N=C(c1ccc(C(=O)O)cc1F)c1cc3c(cc1N2C)C(C)(C)CCC3(C)C		
DB-18-UF01	IVYQPSHHYIAUFO-VXKWHMMOSA-N	CC(C)C[C@H](NC(=O)c1cc2ccccc2s1)C(=O)N1CCN(C(=O)[C@H](CO)NS(=O)(=O)c2ccc(Cl)cc2Cl)CC1	942206-85-1	TRPV4 gene stimulator
QB-42-ET79	IWCWQNVIUXZOMJ-MISYRCLQSA-N	CC(C)c1cc2c(cc1S(=O)(=O)O)[C@@]1(C)CCC[C@@](C)(C(=O)O)[C@@H]1CC2	33159-27-2	Urease Inhibitors;Mucin Production, Enhancers
LB-01-DD09	IWQKAMJGVIHECB-UHFFFAOYSA-N	O=[N+]([O-])c1cccc2nsnc12	6583-06-8	Thioredoxin Reductase Inhibitors
AB-99-PR28	IWUCXVSUMQZMFG-AFCXAGJDSA-N	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1	252269-50-4	Hepatitis C virus inhibitor;Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors
OC-14-JE78	IWWXIZOMXGOTPP-ZWKOTPCHSA-N	O=C(O)[C@H]1NCCN(C(=O)c2ccc3c(ccc4ccccc43)c2)[C@H]1C(=O)O	858131-67-6	NR2C Antagonists;NR2D Antagonists
ND-35-ZI55	IWXNYAIICFKCTM-UHFFFAOYSA-N	CC(C)c1ccc(C(=O)N=C(N)N)cc1S(C)(=O)=O	159138-73-5	Na+/H+ Exchanger type 1 (NHE-1) Inhibitors
KE-89-TF43	IWXUVYOOUMLUTQ-CZUORRHYSA-N	C[C@@H]1CN(Cc2ncccn2)C[C@H]1c1nc2c(cnn2C2CCOCC2)c(=O)[nH]1	1082744-20-4	PDE9A gene inhibitor
AC-53-YM36	IWZIDQPPNCCYAC-UHFFFAOYSA-N	COCCN1CCC(c2ccc(C(=O)NC3(C(=O)NCC#N)CCCCC3)cc2)CC1	354813-34-6	Cathepsin K Inhibitors
IA-94-MZ54	IXEPQJQQSLMESJ-UHFFFAOYSA-N	c1ccc(-c2ccc(CNCCNCc3ccc(-c4ccccn4)cc3)cc2)nc1	1507370-20-8	FBXO3 gene inhibitor
FE-48-QP65	IXJCHVMUTFCRBH-SDUHDBOFSA-N	CCCc1c(OCCCC/C=C\\C=C\\[C@H](Sc2ccc3c(=O)cc(C(=O)O)oc3c2)[C@H](O)c2cccc(C(F)(F)F)c2)ccc(C(C)=O)c1O	151581-24-7	Leukotriene Antagonists;Leukotriene CysLT1 (LTD4) Antagonists;Leukotriene Antagonists;Leukotriene CysLT1 (LTD4) Antagonists
VE-22-XI52	IXMQNMIYTMPPQN-UHFFFAOYSA-N	CNC(=O)c1cc(Cc2nnc(Nc3ccc(Cl)cc3)c3ccccc23)ccn1	325781-16-6	VEGFR-2 (FLK-1/KDR) Inhibitors;Inhibitors of Signal Transduction Pathways;Angiogenesis Inhibitors
BE-07-IS45	IXPROWGEHNVJOY-UHFFFAOYSA-N	CCCCN(CC)c1nc(C)nc2c1c(C)c(C)n2-c1c(C)cc(C)cc1C	157284-96-3	CRHR1 antagonist
EE-18-HW72	IXTMWRCNAAVVAI-UHFFFAOYSA-N	CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1	115256-11-6	K(V)11.1 (erg1) Channel Blockers
BE-50-RK99	IXXYIIXBZSGESQ-UHFFFAOYSA-N	CC(C)(C)c1ccc(Nc2ncc(-c3ccc4ccncc4c3)c3ccccc23)cc1		
S0-EE-XYMJ	IXXZGBOSQDVMTC-UHFFFAOYSA-N	Cn1c(CN2CCN(c3ncc(Cl)cn3)CC2)nc2ccccc21	1207197-70-3	postive allosteric modulator;mgluR2 Positive Allosteric Modulator
EF-33-IW50	IYAYHZZWYNXHEQ-UHFFFAOYSA-N	O=C(Nc1cccc(Br)c1)c1cccc(S(=O)(=O)N2CCCCCC2)c1	420831-40-9	SIRT2;SIRT2 gene inhibitor
GB-33-SS25	IYBLVRRCNVHZQJ-UHFFFAOYSA-N	O=c1cc(-c2ccccc2)oc2cccc(O)c12	491-78-1	
CA-67-IB54	IYIGLWQQAMROOF-HHHXNRCGSA-N	COc1ccccc1[C@@H](NS(=O)(=O)c1ccc2[nH]c(=O)ccc2c1)C(=O)N(Cc1ccco1)Cc1cccs1		OGT (O-linked N-acetylglucosamine (GlcNAc) transferase) inhibitor
HD-22-KR30	IYMWLYWBYFPVAA-IHRKKFBRSA-N	CCCNC(=O)O[C@H]1CC[C@@](CNC(=O)c2ccccc2OC)(c2ccccc2)CC1		K(V)1.5 Channel Blockers;K(V)1.3 Channel Blockers
BD-49-MD69	IYNDTACKOAXKBJ-UHFFFAOYSA-N	OCCCNc1cc(-c2ccnc(Nc3cccc(Cl)c3)n2)ccn1	164658-13-3	Protein Kinase C (PKC) Inhibitors;CDK1 Inhibitors;CDK2 Inhibitors
DE-00-JU18	IYOZTVGMEWJPKR-IJLUTSLNSA-N	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1	129830-38-2	Calcium Sensitizers;Rho Kinase 2 (ROCK 2| ROCKalpha) Inhibitors;Rho Kinase 1 (ROCK 1| p160-ROCK) Inhibitors;Leucine-Rich Repeat Kinase 2 (LRRK2| Dardarin) Inhibitors
KC-97-AA46	IYQLPINCUIRXCU-DGGSEBSFSA-N	CC1(C)CC(=O)N(C[C@@H](NC(=O)N[C@H](C(=O)N2C[C@]3(C[C@H]2C(=O)NC(CC2CCC2)C(=O)C(N)=O)C(C)(C)C32CCC2)C(C)(C)C)C(C)(C)C)C(=O)C1		
EC-22-ZY92	IYSYLWYGCWTJSG-XFXZXTDPSA-N	CC(C)(C)/[N+]([O-])=C/c1ccccc1		
AA-99-HG56	IYSYPCSSDZBWHN-UHFFFAOYSA-N	O=C1Cc2ccccc2C(=C2CCNCC2)c2ccsc21	34580-20-6	Histamine Receptor Antagonists
LC-12-VN85	IYVIAGDMQOYYQC-OUKQBFOZSA-N	O=C(/C=C/c1ccc(CNCCCc2ccccc2)cc1)NO		Histone Deacetylase (HDAC) Inhibitors
EC-86-EK93	IYZXGLGVLYBKAI-UHFFFAOYSA-N	Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Nc4ccc(S(=O)(=O)O)cc4)n3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O	72696-54-9	P2Y4 Receptor Ligands;P2Y2 Antagonists;P2Y4 Receptor Ligands;P2Y2 Antagonists
GD-96-AK08	IZAOBRWCUGOKNH-OAHLLOKOSA-N	C[C@H](c1ccc(F)cc1CCCC(=O)O)N(c1cc(F)ccc1F)S(=O)(=O)c1ccc(Cl)cc1	290315-45-6	gamma-Secretase Inhibitors;Antiamyloidogenic Agents
AE-71-VB70	IZEKFCXSFNUWAM-UHFFFAOYSA-N	OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1	58-32-2	Adenosine Transporter Inhibitor;Phosphodiesterase III Inhibitors;Phosphodiesterase V (PDE5A) Inhibitors
VA-48-TW80	IZJBLVOLKKCYQF-UHFFFAOYSA-N	Cc1[nH]cc2c(=O)n(-c3ccc(Cl)cc3)nc-2c1I	244637-95-4	GABA receptor ligand
ME-47-KQ59	IZPMWFSVTDOCDI-HAVVHWLPSA-N	O=C(O)c1ccc(N2N=C(Cc3ccccc3)/C(=C\\c3ccc(-c4ccccc4F)o3)C2=O)cc1		
LC-11-KD29	IZPNVUYQWBZYEA-UHFFFAOYSA-N	Cc1cc[n+](C)cc1		
JE-61-EQ70	IZVNOOHIAZYNQG-UHFFFAOYSA-N	CCCN(CC1CC1)c1nc(C)nc(Nc2c(Cl)cc(C)c3nccnc23)c1C		
FD-69-CC31	JABSKGQQWUDVRU-UHFFFAOYSA-O	CCN(c1ccccc1)c1cc(NC)[n+](C)c(C)n1	133059-95-7	HCN [I(h)] Blockers
DE-27-WV87	JABSMABHPFQNPH-FXQIFTODSA-N	C[C@H]1CC(N)=N[C@H]2CCC[C@H]21		Inducible Nitric Oxide Synthase (NOS-2) Inhibitors
DD-24-TT70	JACAAXNEHGBPOQ-LLVKDONJSA-N	CC(=O)N1N=C(c2ccc(N)cc2)c2cc3c(cc2C[C@H]1C)OCO3	161832-65-1	AMPA Non-Competitive Antagonists;Kainate Antagonists
CF-22-IS33	JAHGNOXPMXOEJS-BSPLYONXSA-N	C=C(CC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)C[C@@H](O)[C@@]13C[C@@]14C(=O)C[C@H](O)[C@@](C)(C(=O)O)[C@@H]4C(=O)C[C@]23O)C(C)C		Cholesterol synthesis inhibitor
BC-84-BQ58	JAKAFSGZUXCHLF-LSCFUAHRSA-N	CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(NC3CCCCC3)ncnc21	130714-47-5	Adenosine A1 Agonists;ADORA1 agonist
FA-03-CZ62	JAUOIFJMECXRGI-UHFFFAOYSA-N	Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1	100643-71-8	Histamine H1 Receptor Antagonists
AD-52-UZ45	JAXBMKIHTZGIMY-FMQCOBDLSA-N	C[C@H]1CN(CC[C@]2(O)CC[C@@H](NC(=O)c3cc4c(OCc5coc6cc(OCC7CC7)ccc56)cccc4[nH]3)CC2)CC[C@@H]1O		Chemokine CCR2 (MCP-1 Receptor) Antagonists;Chemokine CCR5 Antagonists
BD-94-KU93	JBDGDEWWOUBZPM-XYPYZODXSA-N	Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1	107814-37-9	Pulmonary surfactant;lysosomal exocytosis
JB-60-JM38	JBHLYIVFFLNISJ-UHFFFAOYSA-N	CCCCN1CCC(CCC(=O)c2cc(Cl)c(N)cc2OC)CC1	160845-95-4	5-HT4 Partial Agonists
GA-85-SJ43	JBHUBOISLBWHAR-UHFFFAOYSA-N	Cc1cc2c(s1)Nc1ccc(F)cc1N=C2N1CCN(C)CC1	61325-80-2	DRD1 antagonist
LE-39-LB33	JBMKAUGHUNFTOL-UHFFFAOYSA-N	NS(=O)(=O)c1cc2c(cc1Cl)N=CNS2(=O)=O	58-94-6	SLC12A3 inhibitor;CA1 inhibitor;CA2 inhibitor;CA4 inhibitor
BA-28-XM73	JBNKSLCTVLKCIV-UHFFFAOYSA-N	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nccn1-c1cc(NN2CCN(C)CC2)ncn1		
GA-88-PV69	JBXMHSUKOHUKAV-KIFIMYBHSA-N	COC(=O)[C@@]1(OC(=O)c2ccco2)[C@H](C)CC2C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C		Glucocorticoid Receptor (GR) Ligands
DA-91-RR73	JCBQCKFFSPGEDY-UHFFFAOYSA-N	c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2	31721-17-2	Drugs Acting on 5-Hydroxytryptamine Receptors
AC-94-YX80	JCCNYMKQOSZNPW-UHFFFAOYSA-N	CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1		
JC-52-RH51	JCFYHERKXJTSGF-UHFFFAOYSA-N	Cc1noc(C)c1-c1cc(COc2ccc(CCC(=O)O)c(F)c2)ccc1Cl		GPR40 agonist
S0-EE-YAXR	JCINCSYDDSRQQC-UHFFFAOYSA-N	CCCCCCCCCc1cc(O)cc(O)n1		Potent GPR84 Agonists;GPR84 agonist
DA-09-XJ53	JCKGSPAAPQRPBW-OAQYLSRUSA-N	O=C([C@@H](Cc1cccc(C(F)(F)F)c1)NS(=O)(=O)c1cc(F)c2c(c1)CCNC2)N1CCCC1	1627607-87-7	Substrate competitive SET7/9 inhibitor;SET7/9 Inhibitor
AA-51-RY00	JCKYGMPEJWAADB-UHFFFAOYSA-N	O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1		
BA-15-VE07	JCSGFHVFHSKIJH-UHFFFAOYSA-N	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21	280744-09-4	Glycogen Synthase Kinase 3 (GSK-3) Inhibitors
CB-29-AX17	JCSXUHWHPBQRET-JRGCBEDISA-N	OC[C@H]1OC[C@H](Oc2nc3c(F)c(-c4ccc(-c5ccccc5)cc4)c(F)cc3[nH]2)C[C@@H]1O		
HE-68-XL70	JCVGLWTXHBOEKI-UHFFFAOYSA-N	O=C1CN(c2c(O)cc(CC3CCCCC3)cc2F)S(=O)(=O)N1	941607-78-9	Protein Tyrosine Phosphatase PTP-1B Inhibitors
CE-52-SB42	JCXKHYLLVKZPKE-UHFFFAOYSA-N	Nn1nnc2ccccc21	1614-12-6	Cytochrome P450 Inhibitors
FA-71-QH69	JDBSZVDIUIRSDG-DAFODLJHSA-N	Fc1ccc2c(/C=C/c3nnn[nH]3)c[nH]c2c1	1316695-35-8	Tryptophan 2,3 dioxygenase inhibitor;Immunosuppressant
KC-93-NH98	JDCKMCIQUXTYQI-UHFFFAOYSA-N	O=c1[nH]c2cc(C(F)(F)F)cc(Cl)c2[nH]c1=O	153504-72-4	Glutamate Ionotropic Antagonists;NMDA Antagonists
PB-13-ZD03	JDJGAAQTPZJIDZ-UHFFFAOYSA-P	C[n+]1cccc2cc(NC(=O)c3cccc(C(=O)Nc4ccc5c(ccc[n+]5C)c4)c3)ccc21		Telomerase Inhibitors;DNA G-quadruplex (G4) Ligands
OD-48-HX53	JDVVGAQPNNXQDW-TVNFTVLESA-N	O[C@H]1[C@H](O)[C@@H](O)CN2CC[C@H](O)[C@H]12	107244-34-8	Alpha glucosidase inhibitor
QD-32-CW16	JDXVNCOKDAGOAM-UHFFFAOYSA-N	Cc1nc(-c2ccc(OCCCCCOc3ccc(/C(N)=N/O)cc3)cc2)c(C(C)C)s1	491577-61-8	Leukotriene BLT (LTB4) Antagonists
CC-03-PW00	JECYVXQBWWWXJR-FQEVSTJZSA-N	CC(C)C[C@H]1c2[nH]c3ccc(Cl)cc3c2CCN1C(=O)CCN1CCC(F)(F)CC1	1432663-54-1	Inhibitor of pyrimidine biosynthesis;Antimicrobial
HC-09-KP12	JEDJMKTVUPSHFW-ABAIWWIYSA-N	C[C@H](Cc1ccc2c(c1)OC(C(=O)O)(C(=O)O)O2)NC[C@H](O)c1cccc(Cl)c1	138908-40-4	beta3-Adrenoceptor Agonists;ADRB3 agonist
BF-26-MB27	JEGHXKRHKHPBJD-UHFFFAOYSA-N	CS(=O)(=O)N1CCc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc21	1007207-67-1	Phosphatidylinositol 3-Kinase beta (PI3Kbeta) Inhibitors;Phosphatidylinositol 3-Kinase alpha (PI3Kalpha) Inhibitors;Phosphatidylinositol 3-Kinase gamma (PI3Kgamma) Inhibitors
UC-00-QA88	JFKJUTFJFHKGKQ-UHFFFAOYSA-N	Nc1ncnc2c1c(-c1ccccc1)cn2-c1ccc(CCO)cc1		
OC-56-RM62	JFLQYBGXCJOSFW-UHFFFAOYSA-N	CCOC(=O)C1=CN(Cc2ccccc2)c2ccccc2C1c1ccc(OC)c(OC)c1		
EE-45-VG61	JFNANCYIHVAEQV-RRPNLBNLSA-N	Cc1cc(C)cc(C(=O)N(C)[C@H](Cc2ccccc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)c1	169544-71-2	EDNRB gene inhibitor
AA-91-SB25	JFOAJUGFHDCBJJ-UHFFFAOYSA-N	CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC(F)(F)F)nc1-2	1202055-32-0	Ttk protein kinase inhibitor
CA-43-WF29	JFTJDUMMWOSHFL-RXMQYKEDSA-N	O=C(O)[C@H]1CCCN1C(=O)COP(=O)(O)OP(=O)(O)O		Cholesterol Biosynthesis Inhibitors
GA-01-EO66	JFUAWXPBHXKZGA-IBGZPJMESA-N	CC(C)(C[C@@](O)(Cc1cc2ccncc2[nH]1)C(F)(F)F)c1cc(F)ccc1O	1245526-82-2	Glucocorticoid Receptor (GR) Ligands;TNF-alpha Production Inhibitors
KB-49-NF63	JFULSLXRHNJOEO-UHFFFAOYSA-N	N#Cc1c(NC(=O)CCc2ccccc2)sc2c1CCCC2	321945-24-8	VPAC1 (VIP1) Antagonists
RC-62-LC43	JFWNERIMAUEHNN-MRXNPFEDSA-N	N[C@H](Cc1ccc(Cl)cc1Cl)C(=O)N1Cc2ccccc2C1		
DE-23-IF54	JGAPWJRMEQDHGG-JOCHJYFZSA-N	CCOCC1(COCC)N[C@@H](c2nc(-c3ccccc3)c[nH]2)Cc2c1[nH]c1ccccc21	469874-15-5	Somatostatin srif1C (sst3) Antagonists
LA-42-ER00	JGDCRWYOMWSTFC-AZGSIFHYSA-N	C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2[C@H](O)C(=O)[C@]2(C)[C@@H](c3ccc(=O)oc3)CC[C@]12O	464-74-4	Arenobufagin, SMUT
AB-04-NN16	JGFDHSBAZUPYQN-UHFFFAOYSA-N	N/C(=N\\C(=O)c1nc(Cl)c(N)nc1N)NC1CCN(C(=O)NCCCCNC(=O)N2CCC(N/C(N)=N/C(=O)c3nc(Cl)c(N)nc3N)CC2)CC1	1080018-64-9	Epithelial Sodium Channels (ENaC) Blockers
DB-18-IF31	JGLXEUNGCCJCDK-UPHHSBJESA-N	CC#C[C@@]1(O)CC[C@@]2(Cc3ccccc3)c3ccc(C(=O)NCc4ccncc4)cc3CC[C@@H]2C1		Glucocorticoid Receptor (GR) Modulators
DE-48-PP80	JGPJQFOROWSRRS-UHFFFAOYSA-N	Cc1nnc2n1-c1sc(CCC(=O)N3CCOCC3)cc1C(c1ccccc1Cl)=NC2	105219-56-5	PTAFR antagonist;Platelet-Activating Factor Receptor (PAFR) Antagonists
BF-79-GG96	JGPMMRGNQUBGND-UHFFFAOYSA-N	COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O	58186-27-9	Calcium Channel Modulators;Antioxidants;Calcium Channel Modulators;Antioxidants
QA-14-AU91	JGQBYBXYRUCBQY-UHFFFAOYSA-N	CC1CC(=O)c2c(cc3c(-c4c(O)cc(O)c5c(O)c6c(cc45)OC(C)CC6=O)c(O)cc(O)c3c2O)O1	25908-26-3	NOS2 Expression Inhibitors;Phosphodiesterase Inhibitors
FC-56-ZH16	JGRPKOGHYBAVMW-UHFFFAOYSA-N	O=C(O)c1ccc(O)c2ncccc12	5852-78-8	broad-spectrum inhibitor of 2OG oxygenases
BA-89-SR63	JGWRKYUXBBNENE-UHFFFAOYSA-N	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1	1029044-16-3	CSF1R inhibitor
GC-83-NL88	JHBIMJKLBUMNAU-UHFFFAOYSA-N	CS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(F)cc2)cc1	162054-19-5	Cyclooxygenase-2 Inhibitors;Non-Steroidal Antiinflammatory Drugs
AC-11-SE07	JHLHNYVMZCADTC-LOSJGSFVSA-N	CN(C(=O)C(c1ccccc1)c1ccccc1)[C@H](CN1CC[C@H](O)C1)c1ccccc1	153205-46-0	kappa-Opioid Agonists
ED-83-GF49	JHSXDAWGLCZYSM-UHFFFAOYSA-N	Cc1cc(Cl)ccc1OCCCC(=O)NO		
AD-70-TH82	JIBQVJZSWQNHLX-HSZRJFAPSA-N	COc1ccc([C@]2(c3ccc(F)c(-c4cccnc4F)c3)N=C(N)N(C)C2=O)cc1C		beta-Secretase 1 (BACE1) Inhibitors
CF-97-AV07	JICJBGPOMZQUBB-UHFFFAOYSA-N	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	1159812-13-1	5-HT Reuptake Enhancers
AC-45-EE32	JICKJYGLSKDGIC-UHFFFAOYSA-N	CC(C)CCCCCCCCCCCC(=O)NC(CS(=O)(=O)O)C(O)CCCCCCCCCCCC(C)C		
ED-81-ZH14	JIFCFQDXHMUPGP-UHFFFAOYSA-N	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cc2)n1	910232-84-7	
AF-01-FE42	JIGIIKUAFNUTGA-UHFFFAOYSA-N	CCCN(CCC)C1CSc2cccc(OCC)c2C1		5-HT1A Receptor Agonists
GE-17-FE71	JIMHYXZZCWVCMI-RIYZIHGNSA-N	O=C(O)c1ccc(/C=C2/SC(=S)N(c3cccc(C(F)(F)F)c3)C2=O)cc1	307510-92-5	CFTR Channel Inhibitors
DF-37-AV77	JIVPVXMEBJLZRO-UHFFFAOYSA-N	NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl	74658-80-3	Carbonic Anhydrase Type VII Inhibitors
AF-13-LM61	JJCFRYNCJDLXIK-UHFFFAOYSA-N	CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1	129-03-3	Histamine H1 Receptor Antagonists;5-HT2B Antagonists
LA-69-OL77	JJEXWPHPFZLTCU-UHFFFAOYSA-N	O=c1[nH]c2ccc(C#CCN3CCC(Cc4ccccc4)CC3)cc2[nH]1	302799-86-6	NR2B Antagonists
EC-55-XG31	JJKOTMDDZAJTGQ-DQSJHHFOSA-N	CC/C(=C(\\c1ccc(I)cc1)c1ccc(OCCN2CCCC2)cc1)c1ccccc1	116057-75-1	Selective Estrogen Receptor Modulators (SERM)
AD-06-OB47	JJQKICOADUKSNS-UHFFFAOYSA-N	NCCCCNS(=O)(=O)c1ccc2c(Cl)cccc2c1	81705-04-6	CYP2C19 gene modulator
AA-33-TW45	JKAHWGPTNVUTNB-IXPVHAAZSA-N	CN1C[C@H](CC#N)C[C@@H]2c3cccc4[nH]c(Cl)c(c34)C[C@H]21	36945-03-6	Prolactin Secretion Inhibitors
LE-41-QT17	JKGFOIGGPUTHIY-UHFFFAOYSA-N	CC1(C)Cc2c(c(N3CCOCC3)nc3sc4c(NCc5cccnc5)ncnc4c23)CO1	848057-26-1	Phosphodiesterase PDE4A Inhibitors;Phosphodiesterase PDE4B Inhibitors;Phosphodiesterase PDE4D Inhibitors
CC-58-RP30	JKHYOWBRQRJSTQ-OAQYLSRUSA-N	COC(=O)N[C@@H]1Cc2ccc(NC(=O)c3cccc(C)c3-c3ccc(C(F)(F)F)cc3)cc2C1	256397-11-2	Microsomal Triglyceride Transfer Protein (MTTP) Inhibitors;ApoB Secretion Inhibitors
HC-96-WV85	JKKKHIBCTKIWFJ-UHFFFAOYSA-N	COCCn1nnnc1C(c1cc2cc(OC)ccc2[nH]c1=O)N(CCc1ccccc1)Cc1ccccc1	570365-12-7	UDP/CysLT Receptor (GPR17, P2Y-like) Modulators
DA-81-VY50	JKMWINSPNJPJSO-UHFFFAOYSA-N	Cc1nn(C)cc1-n1c(=O)n(C)c2cnc3ccc(-c4cncc(OC(C)C)c4)cc3c21	1257546-73-8	Mammalian Target of Rapamycin (mTOR;FRAP1) Inhibitors;PI3K inhibitors
JB-61-UQ50	JLCDKDGHTWGGQM-UHFFFAOYSA-N	CC(Cc1ccccc1)NCc1ccccc1	1085-42-3	
HC-19-UZ81	JLJAVUZBHSLLJL-DQEHQXCCSA-N	COc1ccc([C@H]2O[C@@H](c3ccc(OC)c(OC)c3)[C@H](C)[C@@H]2C)cc1OC		
BA-55-OU30	JLSVDPQAIKFBTO-AYGDVHJDSA-N	COc1cc(=O)oc(/C=C/C=C/C=C/C(C)=C/[C@@]2(C)O[C@@H](C)[C@@](C)(O)[C@@H]2O)c1C	25425-12-1	Inhibitor of mitochondrial ATPase
CC-50-FK24	JLYAXFNOILIKPP-KXQOOQHDSA-N	CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1	1093851-28-5	BCL-2/xL inhibitor;Apoptosis Inducers;Bcl-2 Inhibitors;Bcl-xl Inhibitors;Bcl-w Inhibitors
S0-EE-YC7H	JMBODOHYRWZQEW-UHFFFAOYSA-N	CC1(Nc2ccc(C(=O)NO)cc2)CCN(c2ccc(Cl)cc2)C1=O	1390618-15-1	
HD-28-QL60	JMIQFISPBOHMQG-UHFFFAOYSA-N	Clc1cccc(Cl)c1Nc1ncc[nH]1	21714-22-7	Na+/H+ Exchanger type 3 (NHE-3) Inhibitors
AA-48-GT70	JMIYTUHCNXXODK-UHFFFAOYSA-N	Nc1ccc(CNC(=O)Nc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)cn1		NAMPT Inhibitor
OB-61-XZ91	JMPOIZCOJJMTHI-UHFFFAOYSA-N	O=C(CCn1cnc2c(=O)[nH]cnc21)Nc1ccc(C(=O)O)cc1	138117-50-7	Neurotrophic Agents
DA-10-VU83	JMSUDQYHPSNBSN-UHFFFAOYSA-N	O=C(CCN1CCN(C(=O)OCc2cc(Cl)cc(Cl)c2)CC1)c1ccc2[nH]c(=O)oc2c1	1144035-53-9	Ectonucleotide Pyrophosphatase/Phosphodiesterase 2 (ENPP2;Autotaxin) Inhibitors
BD-93-AM31	JNAHVYVRKWKWKQ-CYBMUJFWSA-N	C[C@]1(c2nc3c(C(N)=O)cccc3[nH]2)CCCN1	912444-00-9	
HA-99-PM50	JNEXVTRXIDHXHP-UHFFFAOYSA-N	Cc1c(Nc2ccc(Br)cc2F)c(C(=O)NOCCO)c2n(c1=O)CCC2		
DD-26-RY82	JNGVJMBLXIUVRD-SFHVURJKSA-N	C[C@](O)(COc1ccc(C#N)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	1202044-20-9	Selective Androgen Receptor Modulator
BE-46-FY47	JNNOSTQEZICQQP-UHFFFAOYSA-N	Clc1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2	6104-71-8	Muscarinic M1 Agonists;5-HT2A Inverse Agonists;Dopamine D3 Partial Agonists;Dopamine D2 Receptor Partial Agonists
HF-29-JW14	JNODQFNWMXFMEV-UHFFFAOYSA-N	Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1	1186653-04-2	NMDA Antagonists;5-HT6 Antagonists
AE-95-UU45	JOAHPSVPXZTVEP-YXJHDRRASA-N	CCN(CC)C(=O)N[C@H]1C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1	106347-60-8	5-HT2A Antagonists;5-HT2B Antagonists;Prolactin Secretion Inhibitors
WC-75-IK59	JOEYVYNGBCYTGH-UHFFFAOYSA-N	Cn1c(=O)[nH]c(=O)c2c1nc1n(CCCCO)c(-c3ccccc3)cn21	633281-74-0	EphB4 Inhibitors
CC-58-DF11	JOLJIIDDOBNFHW-UHFFFAOYSA-N	CCCCCCOc1nsnc1C1=CCCN(C)C1	1018845-70-9	Muscarinic M1 receptor agonist;Muscarinic M4 receptor agonist;Muscarinic M5 receptor agonist;Cholinergic Muscarinic 1-4 agonist
DE-62-FI29	JOOXLOJCABQBSG-UHFFFAOYSA-N	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1	1374744-69-0	Jak2 Inhibitors;Flt3 (FLK2/STK1) Inhibitors
AC-40-DU58	JOPNHSIHFSZJMB-UHFFFAOYSA-N	CCOC(=O)C1=C(N)Oc2cc(O)ccc2C1c1cccnc1	332164-34-8	Known LNPEP
TF-60-NH65	JOWMTYWOBJALGB-KYZUINATSA-N	C[C@H]1CC[C@H](C(=O)CCC(=O)O)CC1	195137-72-5	K(ATP) Channel Blockers;Insulin Secretagogues;K(ATP) Channel Blockers;Insulin Secretagogues
AA-33-DN24	JPAWFIIYTJQOKW-UHFFFAOYSA-N	Cc1[nH]c(=O)c(C#N)cc1-c1ccc2nccn2c1		
EE-66-CK83	JPEXLYQOPMWVGZ-UHFFFAOYSA-N	CC(C)N1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		Protein Kinase C (PKC) Inhibitors
CD-63-FZ67	JPPYWKVKLSBQJM-UHFFFAOYSA-N	CCCc1cc(C(=O)O)ccc1OC(C(=O)NS(=O)(=O)c1ccc(C(C)C)cc1)c1ccc2c(c1)OCO2	159590-37-1	Endothelin Receptor Antagonists;Endothelin ETA Receptor Antagonists;Endothelin ETB Receptor Antagonists
DD-91-OY40	JPSGQGNOUABQDF-PRVBGKCFSA-N	Cn1c(-c2ccc(CCC(=O)O)cc2)c(Cl)c2ccc(S(=O)(=O)N[C@H]3CC[C@H](C(=O)N4CCOC[C@@H]4C4CC4)CC3)cc21		Acetyl-CoA Carboxylase 1 (ACC1) Inhibitors;Acetyl-CoA Carboxylase 2 (ACC2) Inhibitors
ZB-93-OS38	JPSZEXYTKSIPDW-UHFFFAOYSA-N	COc1ccc(-n2cnc3cc(NCc4ccc(C(C)C)cc4)ccc32)cc1		
TC-80-LY86	JQICCWXEQVMHDM-ZSOIEALJSA-N	O=C(O)c1ccc(/C=C2\\SC(=O)N(c3cccc(C(F)(F)F)c3)C2=O)cc1		
AA-40-IA00	JQSAYKKFZOSZGJ-UHFFFAOYSA-N	COc1ccc(CN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)c(OC)c1OC	101477-54-7	P-Glycoprotein (MDR-1) Inhibitors;Calcium Channel Blockers
CC-04-FJ21	JQSJAVBMIMDUFO-UHFFFAOYSA-N	Clc1cc(Cl)cc(CNc2ncncc2-c2ccc3c(c2)OCO3)c1	1440251-53-5	CLK4 inhibitor
AC-79-CQ25	JQUJTHQSFVWZEH-UHFFFAOYSA-N	CSc1sc(-c2ccn(C(C)=O)n2)c2c1C(=O)CC(C)(C)C2		
CB-36-TO28	JQXXHWHPUNPDRT-AHYHWTFRSA-N	COC1/C=C\\OC2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\\C=C/C(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C		
AA-50-HR61	JQXXHWHPUNPDRT-WLSIYKJHSA-N	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\\C=C\\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C	13292-46-1	DNA-Directed RNA Polymerase Inhibitors;Enzyme Inducers;RNA Polymerase (Bacterial) Inhibitors
CB-00-BH77	JRCFAROYAPNJQJ-UHFFFAOYSA-N	NC(=O)c1nc(-c2cccnc2)nc2c1[nH]c(=O)n2Cc1ccccc1		
JD-58-MV19	JROFGZPOBKIAEW-HAQNSBGRSA-N	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12	1187559-66-5	mTOR Complex 1 (mTORC1) Inhibitors;mTOR Complex 2 (mTORC2) Inhibitors
GB-84-KP45	JRQRKFDFHAPMGQ-UHFFFAOYSA-N	NC(C(=O)O)c1ccc(P(=O)(O)O)cc1	120667-15-4	mgluR8 Agonists
BB-62-MS83	JRSGZNKDLJKFKK-XMMPIXPASA-N	CN1CCN(S(=O)(=O)c2ccc([C@@H](CC3CCCC3)C(=O)Nc3nc4ccc(N5CCOCC5)nc4s3)cc2)CC1		
AD-54-IH37	JRURYQJSLYLRLN-BJMVGYQFSA-N	CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1	1047659-02-8	COMT Inhibitors
XD-62-HM52	JRVXFGNCHKHBPA-UHFFFAOYSA-N	COc1ccc(C2Nc3cccc(O)c3C(=O)N2Cc2ccccc2)cc1COc1ccc(NC(C)=O)cc1	1186649-91-1	Thyroid stimulating hormone receptor antagonist
AA-22-SF72	JRWCBEOAFGHNNU-UHFFFAOYSA-N	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1	943540-75-8	Inhibitors of Signal Transduction Pathways;HGFR (MET;c-Met) Inhibitors
JE-63-IE01	JRWROCIMSDXGOZ-UHFFFAOYSA-N	CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(Cl)cc2C(=O)c2cc[n+]([O-])cc2)cc1	698394-73-9	CCR9 chemokine antagonist
WC-81-BR91	JRXBMCCODQDYEB-UHFFFAOYSA-N	O=C(O)c1ccccc1Nc1ccnc(Nc2ccccc2C(=O)O)n1		
EE-45-YQ15	JSAGVMATNVPFMK-OKZBNKHCSA-N	CC[C@H](C(=O)NO)[C@H](C(=O)N1CCCC[C@H]1C(=O)NC(C)C)c1ccc(Cl)cc1		MMP-7 (Matrilysin) Inhibitors
GE-14-EF51	JSPPDMSCDGJJOM-YDMRWXCBSA-N	C/C(=C\\Cc1c(O)cc(C)c(C=O)c1O)CC[C@@]1(C)[C@H](C)CCC(=O)[C@@H]1C	22562-68-1	
PC-80-LV29	JSTRDQJVSSAHTB-UHFFFAOYSA-N	Cc1cc(-c2ccccc2)nc2cc(C(=O)Nc3ccc(O)cc3)nn12		
DA-54-NN76	JSVNNLRZCJAYTQ-ORYQWCPZSA-N	C[C@@H](CN1CCC(n2c(=O)[nH]c3cc(Br)ccc32)CC1)NC(=O)[C@@H]1C[C@H]1c1ccccc1	1246303-14-9	PLD1 Inhibitor
LF-45-MW04	JTARFZSNUAGHRB-UHFFFAOYSA-N	Cc1cc(NC(=O)Nc2ccc(N(C)C)cc2)c2cc(F)cc(F)c2n1	1431697-90-3	Orexin 1 receptor antagonist
DA-20-VR86	JTEGQNOMFQHVDC-NKWVEPMBSA-N	Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1	1117764-41-6	Reverse Transcriptase Inhibitors
FA-45-XX32	JTLXCMOFVBXEKD-FOWTUZBSSA-N	C/C(=C(/CCO)SSCC1CCCO1)N(C=O)Cc1cnc(C)nc1N	10238-39-8	Hepcidin antagonist
IB-56-JN40	JTVBXQAYBIJXRP-SNVBAGLBSA-N	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1	173897-44-4	Rho Kinase Inhibitors
CD-49-HJ53	JTVCWQUNPMKMER-BQYLNSIHSA-N	CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1	313664-40-3	SPPL1 inhibitor
UF-98-OM26	JTVWJXUGGJTGDA-IBGZPJMESA-N	Cc1cccc(Cl)c1C(=O)N[C@@H](Cc1ccc(NC(=O)c2c(Cl)cccc2Cl)cc1)C(=O)O	220846-33-3	Integrin alpha4beta7 (LPAM-1) Antagonists;Cell Adhesion Inhibitors;Integrin alpha4beta1 (VLA-4) Antagonists
DA-23-IF64	JUCNGMPTCXPMNB-UHFFFAOYSA-N	COCCNC(=O)c1ccnc(C(=O)NCCOC)c1	128075-79-6	Prolyl 4-Hydroxylase Inhibitors
CB-52-IL46	JUDLSYDCHAYGRJ-UHFFFAOYSA-N	O=C(O)CCCC(CNS(=O)(=O)c1ccc(Cl)cc1)c1cccnc1		
NC-94-LE33	JUJPKFNFCWJBCX-UHFFFAOYSA-N	Nc1nc(OCc2cc(Br)cs2)c2[nH]cnc2n1	192441-08-0	MGMT gene inhibitor
QB-69-AR11	JUKNQANCSAMREP-DRABBMOASA-N	CCC(=O)N[C@H]1C[C@@H](n2cnc3c(NC4CCCC4)nc(Cl)nc32)[C@H](O)[C@@H]1O	1144045-82-8	Adenosine A1 Agonists
IB-08-VY61	JUOSGGQXEBBCJB-GORDUTHDSA-N	CNCC/C=C/c1cccnc1	1129-68-6	Nicotinic Receptor Agonists;Nicotinic alpha4beta2 Agonists
EA-67-CO00	JUUFBMODXQKSTD-UHFFFAOYSA-N	CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N	1198579-27-9	Voltage-Gated K(V) 7 (KCNQ) Channel Activators
AD-30-VB23	JUVIOZPCNVVQFO-HBGVWJBISA-N	C=C(C)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4[C@@H]2C3=O)O1	12679-58-2	Electron transport chain inhibitor;Apoptosis Inducers;NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitors;Non-Steroidal Antiinflammatory Drugs;Electron Transport Chain Inhibitors;Electron transport chain inhibitor;Apoptosis Inducers;NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitors;Non-Steroidal Antiinflammatory Drugs;Electron Transport Chain Inhibitors
AD-59-IN33	JUWDSDKJBMFLHE-UHFFFAOYSA-N	Cc1cc(C(=O)CN2CCCC2)c(C)n1-c1ccc(F)cc1	314245-33-5	Ubiquitin C-terminal Hydrolase 14 (USP14) Inhibitors
CA-73-BW50	JVDOKQYTTYUYDV-UHFFFAOYSA-N	Cc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1	936091-14-4	Apoptosis Inducers;Jak2 Inhibitors
UD-99-XG44	JVQDGCHIZJMTFB-UHFFFAOYSA-N	O=P(O)(O)C(Cc1ccccc1)c1ccccc1		
WA-06-QR58	JWBOOOYVKSNBFU-CXUHLZMHSA-N	NC(=S)N/N=C/c1cc(-c2ccccc2)ccc1O		
BF-18-MJ41	JWCUSQCZMQIBMR-UHFFFAOYSA-N	Cc1cccc(NC(=O)c2ccc(C(F)(F)F)cc2C(=O)O)n1	1531634-31-7	sortilin inhibitor (SORT1)
LB-17-PD08	JWIYKMOFSFOAAZ-UHFFFAOYSA-N	O=c1[nH]nc2c3c(cccc13)Oc1ccccc1-2	220938-23-8	Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors
LF-94-HB11	JWOGUUIOCYMBPV-GMFLJSBRSA-N	CCC(=O)CCCCC[C@@H]1NC(=O)[C@H]2CCCCN2C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC1=O	183506-66-3	HDAC inhibitor
AC-56-ZV05	JWQOJVOKBAAAAR-UHFFFAOYSA-N	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC	648903-57-5	Syk Kinase Inhibitors
AD-42-US78	JWZZKOKVBUJMES-UHFFFAOYSA-N	CC(C)NCC(O)c1ccc(O)c(O)c1	114-45-4	beta-Adrenoceptor Agonists
DB-28-ZJ81	JXAGDPXECXQWBC-LJQANCHMSA-N	O=C(C[C@H](CSc1ccccc1)C(=O)O)c1ccc(-c2ccc(Cl)cc2)cc1	179545-76-7	MMP-2 (Gelatinase A) Inhibitors;MMP-9 (Gelatinase B) Inhibitors;MMP-3 (Stromelysin 1) Inhibitors;Angiogenesis Inhibitors
CD-30-AD57	JXTHNDFMNIQAHM-UHFFFAOYSA-N	O=C(O)C(Cl)Cl	13425-80-4	Apoptosis Inducers;Pyruvate Dehydrogenase Kinase (PDHK;PDK) Inhibitors
BA-23-XC02	JXZZEXZZKAWDSP-UHFFFAOYSA-N	O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1	26844-12-2	alpha1-Adrenoceptor Antagonists
AB-50-OH27	JYLNHIJYZROVQX-NKNVEYFZSA-N	COC(=O)C[C@@H]1C/C=C/C(=O)O[C@H]([C@H](C)[C@@H](OC)/C(C)=C/C=C/C(C)=C/c2coc(C)n2)C[C@H](O)[C@@]2(C)O[C@@H]2/C=C/[C@@H](C)[C@H](O)C1		tubulin antagonist
GF-16-AN80	JYSLFQTWNRYWJT-UHFFFAOYSA-N	CC(C)NCCCn1c(Sc2cc(Cl)cc(Cl)c2)nc2c(N)ncnc21	1454619-14-7	inhibitor of Grp94
PB-40-YB26	JZALJKMCUUXBKR-UHFFFAOYSA-N	O=C1NC(=S)NC(=O)C1=Cc1cc2ccccc2[nH]1	69008-58-8	Histone Deacetylase SIRT2 Inhibitors;SIRT1 gene inhibitor
AA-67-TP08	JZCPYUJPEARBJL-UHFFFAOYSA-N	Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1	158681-13-1	CNR1 antagonist;Cannabinoid CB1 Inverse Agonists;IL-6 production inhibitor
DD-99-WQ55	JZCVYBQWYSYJEA-WPCRTTGESA-N	C[C@H]1Cc2c([nH]c3cc(F)c(F)cc23)[C@@]2(N1)C(=O)Nc1ccc(Cl)cc12		
AC-43-YW30	JZQKKSLKJUAGIC-UHFFFAOYSA-N	CC(C)NCC(O)COc1cccc2[nH]ccc12	13523-86-9	beta-Adrenoceptor Antagonists
GE-11-ZR43	JZRASOCKVGXGDR-CTYIDZIISA-N	COC(=O)Nc1cnc(NC[C@H]2CC[C@H](Nc3ccc4ccnc(Cl)c4n3)CC2)nc1		
BC-30-IU38	JZRMBDHPALEPDM-UHFFFAOYSA-N	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1	1049743-58-9	Apoptosis Inducers;IKK-2 (IKK-beta) Inhibitors
OC-53-QX76	JZSPAHAWDCQCEX-UHFFFAOYSA-N	N=C(N)NCCc1cccc(Cl)c1	55154-94-4	5-HT3 receptor agonist
BE-67-QZ92	JZUFKLXOESDKRF-UHFFFAOYSA-N	NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O	125727-50-6	SLC12A3 gene inhibitor
ED-12-QV45	JZWUKILTKYJLCN-XEGCMXMBSA-N	Nc1nc(OC(c2ccc(-c3cccc(F)c3)cc2)C(F)(F)F)cc(-c2ccc(C[C@H](N)C(=O)O)cc2)n1	1040526-12-2	Tryptophan Hydroxylase 1 (TPH1) Inhibitors;Tryptophan Hydroxylase 2 (TPH2) Inhibitors
QC-95-TO14	JZXRLKWWVNUZRB-UHFFFAOYSA-N	NCCNC(=O)c1ccc(Cl)cn1	103878-83-7	MAO-B Inhibitors
QE-00-EB96	KAAPXWSYROPAEL-MXVIHJGJSA-N	CCCCNc1ncc2c(-c3ccc(S(=O)(=O)N4CCOCC4)cc3)nn([C@H]3CC[C@H](O)CC3)c2n1		MERTK gene inhibitor
ID-90-NM43	KAKPGJJRYRYSTP-UHFFFAOYSA-N	COc1cc(OC)cc(N2CCN(C(=O)Nc3nc4cc(F)ccc4nc3OC)CC2)c1	888478-45-3	phosphorylated-p68 RNA helicase inhibitor
S0-EE-XGII	KAQSSNYVMPKBOO-UHFFFAOYSA-N	CCOc1cc(OC(C)C)c(F)c(C(Nc2ccc(C(=N)N)cc2)c2nc(-c3ccccc3C(N)=O)c[nH]2)c1		F7 gene inhibitor
BA-85-ZA57	KASDHRXLYQOAKZ-XDSKOBMDSA-N	CC[C@@H]1/C=C(\\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@H](Cl)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC	1000802-56-1	Calcineurin inhibitor;Rotamase (FKBP12) Inhibitors;Calcineurin inhibitor;Rotamase (FKBP12) Inhibitors
PD-71-MW24	KAXNDTMKFONXJM-UHFFFAOYSA-N	COc1ccc(-c2sc(NC(=O)C3CCCC3)nc2C)cc1[S@SP3](=O)(=O)Nc1ccc(O)cc1	1429624-84-9	PI4K inhibitor
JC-22-WH91	KAXYUIACJONUCH-UHFFFAOYSA-N	Cc1nc(C(N)=O)nn1-c1ccc(C(C)(C)c2ccc(Cl)cc2)cc1		
TC-16-ZS56	KBEKQQJUNVQLDZ-MDZDMXLPSA-N	O=C(O)c1ccc(/C=C/S(=O)(=O)Cc2ccc(Cl)cc2)cc1		
BA-16-GI09	KBFUQFVFYYBHBT-UHFFFAOYSA-N	Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1cccn1	289905-88-0	Intermediate Conductance K(Ca) 3.1 (IKCa1;Gardos channel, SK41, IK1) Channel Blockers
BD-65-VV48	KBOPZPXVLCULAV-UHFFFAOYSA-N	Nc1ccc(O)c(C(=O)O)c1	1261398-47-3	Non-Steroidal Antiinflammatory Drugs;PPAR Gamma Inhibitor
UF-44-NQ36	KBZOIRJILGZLEJ-UHFFFAOYSA-N	N=C(N)NCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O	113-79-1	AVPR1A agonist
GB-90-VQ08	KCAJXIDMCNPGHZ-UHFFFAOYSA-N	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1	1073667-47-6	P38a inhibitor
JF-74-GS02	KCCGYHFRRRMLAU-UHFFFAOYSA-N	NC(=O)C(O)(c1ccccc1)C(F)(F)F	20445-34-5	T-Type Calcium Channel Blockers
KC-95-ZW49	KCGLTUBCAGZLHP-XYOKQWHBSA-N	N#C/C(=C\\c1ccc(O)c(O)c1)C(=O)OCCc1cccs1	132465-10-2	12-Lipoxygenase Inhibitors
BA-77-IP18	KCHHHGRFMSWSFF-GOSISDBHSA-N	CCS(=O)(=O)N[C@@H](c1cncc(-c2ccc(C#N)c(Cl)c2)c1)C1CC1	1255870-79-1	CYP11B2 gene inhibitor
BB-80-NH42	KCWGETCFOVJEPI-UHFFFAOYSA-N	COc1ccc2c(c1)CN(C(=O)CCN1CCC(Cc3ccccc3)CC1)CCS2	1038410-88-6	RyR2/FKBP12.6 Complex Antagonists;Calcium Channel Blockers
BF-76-AO03	KDDHBJICVBONAX-UHFFFAOYSA-N	CC1CC(C)(C)N(C(=O)CN2C(=O)c3ccccc3C2=O)c2ccccc21		
FE-59-BC81	KDFQABSFVYLGPM-QFIPXVFZSA-N	Cc1cccc(NC(=O)N[C@@H]2N=C(c3ccccc3)c3ccccc3N(C)C2=O)c1	118101-09-0	CCK2 (CCKB/Gastrin) Antagonists
AF-25-BS76	KDGFLJKFZUIJMX-UHFFFAOYSA-N	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O	1256580-46-7	ALK Tyrosine Kinase Receptor Inhibitors;Echinoderm Microtubule-Associated Protein-like 4-ALK Tyrosine Kinase Receptor (EML4- ALK) Inhibitors
JD-81-YX02	KDKUVYLMPJIGKA-UHFFFAOYSA-N	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F	443797-96-4	Antimitotic Drugs;Apoptosis Inducers;Aurora Kinase Inhibitors;CDK1/Cyclin B Inhibitors;CDK2/Cyclin A Inhibitors;Inhibitors of Signal Transduction Pathways
WA-43-MP01	KDMQSUUXKLZVNU-UHFFFAOYSA-N	O=c1c2ccccc2sn1-c1ccccc1		
DB-63-TM61	KEDQCFRVSHYKLR-UHFFFAOYSA-N	COc1ccc(CCN(C)CCCN2CCc3cc(OC)c(OC)cc3CC2=O)cc1OC	125846-52-8	HCN [I(f)] Blockers
KC-07-HN67	KEEYRKYKLYARHO-UHFFFAOYSA-N	COc1cc(C)c(Cc2cnc(N)nc2N)cc1OC	6981-18-6	P2X3 Receptor Antagonists;P2X2/3 Receptor Antagonists
AA-74-ON06	KFCQBQPVOJXMQD-QCOJBMJGSA-N	COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)N[C@H]2CCC[C@@H]2O)C(C)C)C(C)C)ccc1OC		
BB-57-NT83	KFQYTPMOWPVWEJ-UHFFFAOYSA-N	CCCN(CCc1cccs1)C1CCc2c(O)cccc2C1	102120-99-0	DRD2 agonist
MB-78-HH35	KFRKRECSIYXARE-HYARGMPZSA-N	O=C(O)/C(Cc1ccccc1[N+](=O)[O-])=N/Nc1nc(-c2ccc(Cl)c(Cl)c2)cs1	315706-13-9	EIF4E-EIF6G interaction inhibitor;eiF4F complex assembly inhibitor
KE-97-TA46	KGFYHTZWPPHNLQ-CQSZACIVSA-N	O=C(NC[C@@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1	865479-71-6	Known FactorXa inhibitor
JF-16-BD66	KGPGFQWBCSZGEL-ZDUSSCGKSA-N	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21	937174-76-0	Inhibitors of Signal Transduction Pathways;PKB alpha/Akt1 Inhibitors;PKB beta/Akt2 Inhibitors;PKB gamma/Akt3 Inhibitors
ND-06-AJ85	KGSREKFQOUTIEA-JGCGQSQUSA-N	CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ncnc3c2CCN(C2CCN(Cc4c(F)cccc4-c4ccc(Cl)cc4)CC2)C3)cc1S(=O)(=O)C(F)(F)F	1274802-68-4	BCL2 gene inhibitor;Apoptosis Inducers
QE-98-XD90	KHARTKZTHPGVTE-UHFFFAOYSA-N	Cc1cccc(-c2cc(-c3cncc(C#CCN(C)C)c3)c3cc[nH]c3n2)n1		
IC-15-FM25	KHEDUPJKNPEZBB-UHFFFAOYSA-N	O=C(Nc1ccccc1)c1c(Nc2ccccc2)[nH]c(=O)[nH]c1=O		SAPK1b (JNK3) Inhibitors
GA-04-SF76	KHPKQFYUPIUARC-UHFFFAOYSA-N	Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1	220991-20-8	Cyclooxygenase-2 Inhibitors
DE-28-XP50	KHWCPNJRJCNVRI-UHFFFAOYSA-N	CCCOc1ccn2c(C(C)=O)cc(-c3ccccc3S(C)(=O)=O)c2c1	1619994-68-1	BAZ2A, BAZ2B dual inhibitor;Dual BAZ2A/BAZ2B inhibitor;BAZ2A/B dual inhibitor
BA-72-YP01	KIAPWMKFHIKQOZ-UHFFFAOYSA-N	COC(=O)c1ccccc1NC(=O)c1ccc(F)cc1	461681-88-9	Golgi ARF 1 (ADP-Ribosylation Factor) GTPase activator
KB-71-QJ23	KIDSRUSWXRTAQB-UHFFFAOYSA-N	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N3CCC4(CC3)OCCO4)nc21		
RA-00-KI98	KIEXMVITNVJBEJ-NBILRRPASA-N	COc1cncc(C(=O)Nc2nc3cccc(C)c3n2[C@@H]2CCCCN(C(=O)/C=C/CN(C)C)C2)c1		Blk tyrosine kinase inhibitor
GB-06-BA49	KILIYQSGUAKAHL-UHFFFAOYSA-N	Cc1cccc(-c2cc(-c3cncc(-c4ccc(C(C)N)cc4)c3)c3cc[nH]c3n2)n1	1171894-79-3	Activin receptor antagonist
FB-31-TA57	KINMYBBFQRSVLL-UHFFFAOYSA-N	O=c1ccc2c(OCCCCOc3ccccc3)c3ccoc3cc2o1	870653-45-5	K(V)1.3 Channel Blockers
CC-61-HH09	KIVUHCNVDWYUNP-UHFFFAOYSA-N	Nc1cc2c3ccccc3ccc2c2ccccc12	2642-98-0	
FC-13-VS25	KJADKKWYZYXHBB-XBWDGYHZSA-N	CC1(C)O[C@@H]2[C@@H](CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@H]23)O1	122-09-8	Carbonic Anhydrase Type II Inhibitors;Kainate Receptor Antagonists;AMPA Receptor Antagonists;Carbonic Anhydrase Type II Inhibitors;Kainate Receptor Antagonists;AMPA Receptor Antagonists
AC-14-FX35	KJPHTXTWFHVJIG-UHFFFAOYSA-N	CCN(Cc1cccnc1)C(=O)CN(c1ccc(OC)nc1)S(=O)(=O)c1ccccc1C	680590-49-2	Orexin OX-2 Antagonists
FC-61-BK21	KJPRLNWUNMBNBZ-QPJJXVBHSA-N	O=C/C=C/c1ccccc1	104-55-2	TRPA1 Agonists;Aldose Reductase Inhibitors
GF-19-NZ91	KKBIUAUSZKGNOA-HNAYVOBHSA-N	CC(=O)SC[C@@H](Cc1ccc2c(c1)OCO2)C(=O)N[C@@H](C)C(=O)OCc1ccccc1	135038-57-2	Angiotensin-I Converting Enzyme (ACE) Inhibitors;Neprilysin (Enkephalinase, Neutral Endopeptidase, NEP) Inhibitors
FF-46-OR35	KKEMGRLKOQAUBU-KRWDZBQOSA-N	COc1ncc([C@@H](CCCCCCc2ccc3c(n2)NCCC3)CC(=O)O)cn1		Integrin alpha-V/beta-3 antagonist, Integrin alpha-V/beta-5 antagonist
FE-82-WB22	KKISLZKMBSCLSS-UHFFFAOYSA-N	CN1CCc2cc(Nc3ncc(C4CC4)c(NCCCNC(=O)C4CCC4)n3)ccc2C1	1190379-70-4	
LF-30-FP85	KKJQZCUARAVZRB-UHFFFAOYSA-N	COc1cc(-c2c[nH]c3cc(C(=O)c4ccc(Cl)c(S(N)(=O)=O)c4)ccc23)c(Cl)cn1		
DC-82-AV25	KKLMRJSMWOEEFA-OAQYLSRUSA-N	CN(C(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1)N(CCC(=O)N[C@@H]1CCCCNC1=O)Cc1ccc(Cl)c(Cl)c1		Tachykinin NK1 Antagonists;Tachykinin NK2 Antagonists
YB-61-MY23	KKTZALUTXUZPSN-UHFFFAOYSA-N	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12	154447-35-5	DNA-PK inhibitor
ED-27-OE11	KKVYOWPPMNSLCP-UHFFFAOYSA-N	S=C(SSC(=S)N1CCOCC1)N1CCOCC1	729-46-4	PDK1 gene inhibitor
EA-32-CY22	KKYOZZAUCIMAQW-IBGZPJMESA-N	CC1(C)CNc2c(cccc2S(=O)(=O)N[C@@H](CCCNC(=N)N)C(=O)N2CCC(CCO)CC2)C1		Inhibitors of Blood Coagulation Pathways;Thrombin Inhibitors
BB-74-RX30	KLADKEUPPHQHDN-HDUJCMOOSA-N	CN[C@@H](C)C(=O)N[C@@H](CCCCNC(=O)c1ccc(-c2ccc(C(=O)NCCCC[C@H](NC(=O)[C@H](C)NC)C(=O)N3CCC[C@H]3c3cncc(C(=O)c4ccc(F)cc4)c3)cc2)cc1)C(=O)N1CCC[C@H]1c1cncc(C(=O)c2ccc(F)cc2)c1		Inhibitor of Apoptosis Proteins (IAP) Inhibitors
AA-62-XS38	KLBQZWRITKRQQV-UHFFFAOYSA-N	CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2	107388-89-6	Dopamine D2 Antagonists
BF-63-NG22	KLGQSVMIPOVQAX-UHFFFAOYSA-N	Oc1nc(-c2ccc(C(F)(F)F)cc2)nc2c1CSCC2	284028-89-3	Tankyrase 1 (TNKS1) Inhibitors;Tankyrase 2 (TNKS2) Inhibitors
NF-21-HQ00	KLHOCHQJHXNKAS-UHFFFAOYSA-N	Cc1ccc(NC(=O)c2ccc3c(c2)OCCO3)cc1NC(=O)c1ccc2nc(OCCN3CCCC3)ccc2c1		
YA-82-VS66	KLJQHLQVCFUHRQ-UHFFFAOYSA-N	COc1ccc(OCC2c3cc(OC)c(OC)cc3CCN2C(=O)c2ccc(Cl)cc2)cc1	486427-18-3	NMDA NR2C Receptor Ligands;NMDA NR2D Receptor Ligands
MF-65-HS14	KLONBAQEOKQUTQ-GHXNOFRVSA-N	CCN1/C(=C/C(=O)C(F)(F)F)Sc2ccc(OC)cc21		
FD-49-XC21	KLSCBNKMNKJFBO-UHFFFAOYSA-N	Cc1cccc2c(C3=C(c4nc(N5CCNC6(CC6)C5)cc5ccccc45)C(=O)NC3=O)c[nH]c12		Protein Kinase C (PKC) Inhibitors;IL-2 Production Inhibitors
WC-09-GD62	KLSIFOJPWJBRFH-GWNOIRNCSA-N	CONC(=O)[C@H]1[C@@H](O)[C@@]2(O)c3c(OC)cc(OC)cc3O[C@@]2(c2ccc(OC)cc2)[C@@H]1c1ccccc1	1352914-52-3	EIF4A1 gene inhibitor
AA-27-TF89	KLSRELDSEJWOAS-UHFFFAOYSA-N	CN1CCN(c2ccc(NCCNc3ccc([N+](=O)[O-])c(N)n3)nc2-c2ccc(Cl)cc2Cl)C(=O)C1	403808-62-8	
FD-77-DL33	KLZWOWYOHUKJIG-BPUTZDHNSA-N	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1C(=O)N(C)C[C@H]1C(=O)O		
CA-10-RU23	KMKBEESNZAPKMP-UHFFFAOYSA-N	Cc1c(OCc2cccc(-c3ccc(C(=O)O)cc3)c2)cc2c(c1C)C(=O)C(C1CCCC1)C2	866823-73-6	mgluR2 Positive Allosteric Modulator;GRM2 agonist
ED-11-KK36	KMWOUFLMUAYYDF-CAOOACKPSA-N	O=C(CNC(=O)c1cccs1)N/N=C/c1ccc(C(=O)O)cc1		Methionyl-tRNA Synthetase Inhibitors
WD-65-PA90	KMZQAVXSMUKBPD-DJWKRKHSSA-N	O=C(C[S+]([O-])Cc1ccco1)NC/C=C\\COc1cc(CN2CCCCC2)ccn1	118288-08-7	Histamine H2 Receptor Antagonists
CE-73-XC72	KNAHARQHSZJURB-UHFFFAOYSA-N	CCCc1cc(=O)[nH]c(=S)[nH]1	500-50-5	Thyroid peroxidase inhibitor;Type 1 deiodinase inhibitor;Thyroid peroxidase inhibitor;Type 1 deiodinase inhibitor
OD-96-ZC58	KNBSYZNKEAWABY-UHFFFAOYSA-N	O=C(O)CCc1c(C(=O)O)[nH]c2cc(Cl)cc(Cl)c12	101861-63-6	Fructose-1,6-Bisphosphatase Inhibitors;NMDA Glycine-Site Antagonists;GPR17 gene modulator
CC-84-JQ48	KNBWKJBQDAQARU-KSSCSKLYSA-N	O=C(NC12CC3CC(CC(C3)C1)C2)N[C@H]1CC[C@H](Oc2ccc(C(=O)O)cc2)CC1	885012-33-9	Soluble Epoxide Hydrolase Inhibitors
DA-75-KD59	KNCYWVRUUBOHGE-RRFJBIMHSA-N	CNC(=O)[C@@H](NC(=O)[C@H](c1ccc(C)cc1)[C@H](CO)C(=O)NO)C(C)(C)C	205807-58-5	ADAM17 (TNF-alpha-Converting Enzyme (TACE) Inhibitors);MMP-13 (Collagenase 3) Inhibitors;MMP-1 (Interstitial Collagenase) Inhibitors;MMP-2 (Gelatinase A) Inhibitors;MMP-9 (Gelatinase B) Inhibitors
AW-10-0667	KNHUKKLJHYUCFP-UHFFFAOYSA-N	CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1		
FE-72-KZ75	KNLROUBMVYVLGX-UHFFFAOYSA-N	C=CC(=O)Nc1ccc(F)c(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		irreversible covalent inhibitor of JAK3
QE-18-WG07	KNPLCJZGNRGZAN-UHFFFAOYSA-N	COc1ccccc1NC(=O)Nc1ccc([N+](=O)[O-])cc1O	182498-30-2	Chemokine CXCR1 (IL-8 alpha Receptor) Antagonists;Chemokine CXCR2  (IL-8 beta Receptor) Antagonists
AC-61-ZY25	KNURFLJTOUGOOQ-UHFFFAOYSA-N	CC(=O)NNC(=O)N1Cc2ccccc2Oc2ccc(Cl)cc21	19395-87-0	EP (PGE2) Receptor Antagonists;EP (PGE1) Receptor Antagonists;EP (PGE2) Receptor Antagonists;EP (PGE1) Receptor Antagonists
OD-32-FK33	KNVIUMWNYXDULF-UHFFFAOYSA-N	COc1ccc(Oc2cc3c(cc2NS(=O)(=O)c2ccc(OC)c(OC)c2)n(C)c(=O)n3C)cc1		TRIM24/BRPF1/2 dual inhibitor;TRIM24/BRPF1B dual inhibitor
BE-90-IY33	KNYVRFXIVWUGBZ-UHFFFAOYSA-N	O=C(NCc1ncccc1F)c1coc(CCNCCc2nc3ccccc3[nH]2)n1		Ferroportin inhibitor
MD-40-FM63	KOBHCUDVWOTEKO-VKHMYHEASA-N	N/C(=N\\O)NCC[C@H](N)C(=O)O	189302-40-7	
AA-10-BH32	KOEJPVOFYIFFSM-UQAQOTMJSA-N	CN[C@@H](C)C(=O)N[C@H](C(=O)N1CC[C@H]2CCN(CCc3ccccc3)C(=O)[C@H]21)C1CCCCC1		Apoptosis Inducers;Inhibitor of Apoptosis Proteins (IAP) Inhibitors
NC-29-PY58	KOODMIUJLQTAQY-UHFFFAOYSA-N	Cc1ccc(Nc2cc(-c3cccc(N)c3)ncn2)cc1NS(=O)(=O)c1cn(C)cn1		CDK inhibitor
JC-57-DO70	KORNTPPJEAJQIU-KJXAQDMKSA-N	C=CCN1C[C@H](C(=O)N(CCCN(C)C)C(=O)NCC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21	81409-90-7	Dopamine D2 Agonists;Prolactin Secretion Inhibitors
LA-93-IR67	KOUHBMWJVVCBCI-UHFFFAOYSA-N	CCCCCCCCCCCCCC(=O)Nc1ccc2nc(NC(=O)c3ccccc3)sc2c1	952036-51-0	Ceramide Kinase Inhibitors
AD-89-XG11	KOVRZNUMIKACTB-UHFFFAOYSA-N	CCOC(=O)c1cc2c(cn1)[nH]c1ccccc12	124475-91-8	receptor blocker
DC-93-NP78	KOZFSFOOLUUIGY-SOLYNIJKSA-N	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4	97161-97-2	Leucine-Rich Repeat Kinase 2 (LRRK2;Dardarin) Inhibitors;Leucine-Rich Repeat Kinase 2 (LRRK2;Dardarin) Inhibitors
ED-12-PB22	KPBNHDGDUADAGP-VAWYXSNFSA-N	O=C(/C=C/c1cccnc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1	1785666-54-7	Angiogenesis Inhibitors;Apoptosis Inducers;Nicotinamide Phosphoribosyltransferase (NMPRTase) Inhibitors
DB-47-QB24	KPOFHQYXIHSODO-UHFFFAOYSA-N	CC1(OC(=O)N2CCC(COc3cnc(N4CCN(S(C)(=O)=O)CC4)cn3)CC2)CC1	1134104-82-7	Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119) Ligands
KC-67-HN97	KPQMGPINRWJVQJ-UHFFFAOYSA-N	CC(C)(CCCCOc1cc(-c2ccccc2)cc(-c2ccccc2)n1)C(=O)O	141747-27-5	Leukotriene Antagonists;Leukotriene BLT (LTB4) Antagonists
JE-86-QG78	KPRTURMJVWXURQ-UHFFFAOYSA-N	CCOP(=O)(Cc1ccc(C(=O)Nc2ccc(Br)cc2C#N)cc1)OCC		
BA-77-US35	KPTMSQHTGZMEFU-UHFFFAOYSA-N	COc1cc(OC)cc(C(=O)NNC(=O)Nc2cccc3ccccc23)c1	444932-31-4	GPR139 agonist;Drugs Acting on Orphan G-Protein Coupled Receptors (GPR)
FA-48-FF91	KPTUKANGPPVLMD-UHFFFAOYSA-N	O=C(O)c1ccnc2c(O)cccc12		
YB-74-BG62	KPWSJANDNDDRMB-QAQDUYKDSA-N	CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1	1083076-69-0	Dopamine D2/3 receptor partial agonist
AB-22-AI49	KPYSYYIEGFHWSV-QMMMGPOBSA-N	NC[C@H](CC(=O)O)c1ccc(Cl)cc1	63701-55-3	GABA(B) Agonists
AF-10-QK79	KPYSYYIEGFHWSV-UHFFFAOYSA-N	NCC(CC(=O)O)c1ccc(Cl)cc1	1134-47-0	GABA(B) Agonists
LD-23-UR32	KPZQRBACZSLMPH-SSEXGKCCSA-N	Cc1c(C)c2c(c(C)c1O)CC[C@](C)(CN1CCN(c3cc(N4CCCC4)nc(N4CCCC4)n3)CC1)O2		
FF-06-MA64	KQEPIRKXSUIUTH-UHFFFAOYSA-N	O=C1CSC(c2ccccc2Cl)c2cc(Cl)ccc2N1	75450-34-9	Na+/Ca2+ Exchanger (NCX) Inhibitors;SERCA Inhibitors
DE-05-NX87	KQFCUHYPLSEMSA-UHFFFAOYSA-N	c1ccc(-c2cccn3cncc23)cc1	1059098-36-0	Glutaminyl Cyclase Inhibitors
HA-33-ZI46	KQFRTJUIRPBBAB-UHFFFAOYSA-N	Clc1cccc(N2CCNCC2)n1	87394-54-5	alpha-Adrenoceptor Antagonists
ZC-12-OO11	KQGPQDMPQIWCMX-UHFFFAOYSA-N	S=c1[nH]cc(-c2ccncc2)[nH]1	146366-04-3	Histone Deacetylase 8 (HDAC8) Inhibitors
S0-EE-X9NZ	KQGWZWJXRAHHCY-UHFFFAOYSA-N	COC(=O)c1ccccc1NC(=O)N1CCC(c2ccccc2C(F)(F)F)CC1	1482429-12-8	Retinol-Binding Protein 4 Inhibitors
DD-75-HY40	KQJSQWZMSAGSHN-JJWQIEBTSA-N	CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)O)CC[C@]3(C)CC[C@]12C		
AA-90-AU53	KQKPFRSPSRPDEB-UHFFFAOYSA-N	CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1	103628-46-2	5-HT1B Agonists;5-HT1D Agonists
NB-92-BG38	KQLDNWDJVNJTQQ-UHFFFAOYSA-N	COc1ccc(C(C)C)cc1CN1CCN(c2cccc3[nH]ccc23)CC1	1206846-61-8	HTR7 agonist
S0-EE-XFA6	KQNMJCHKXJCRRS-UHFFFAOYSA-N	CN(C)c1ncc(CN2CCC(c3cc(O)nc(N4CCOCC4)n3)CC2)cn1		P2Y13 (GPR86; GPR94) Receptor Agonists
GB-57-XV52	KQNZDYYTLMIZCT-KQPMLPITSA-N	C[C@H]1CCC/C=C/[C@@H]2C[C@H](O)C[C@H]2[C@H](O)/C=C/C(=O)O1	11006-23-8	Apoptosis Inducers;Caspase 3 Activators;Autophagy inducer;Apoptosis Inducers;Caspase 3 Activators;Autophagy inducer
FF-28-ES17	KQNZDYYTLMIZCT-LIQIAJTGSA-N	C[C@H]1CCC/C=C\\[C@@H]2C[C@H](O)C[C@H]2[C@H](O)/C=C/C(=O)O1		
EC-96-OH91	KQSPAAPFKIEUGH-UHFFFAOYSA-N	COc1cccc(Cn2cc(C(=O)Nc3ccc(C)c(S(=O)(=O)N4CCOCC4)c3)c(-c3ccc(C)cc3)n2)c1	1609564-75-1	NR1H4 gene inhibitor
DA-63-NP63	KQZKQPCMHFSLEK-ITINGCSBSA-N	C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(C)[C@@H]([C@H](C)CN2CCN(CCOC)CC2)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C		Cyclophilin inhibitor
IC-07-AK50	KRCUWCAUDKTMPB-UHFFFAOYSA-N	O=C(O)c1ccc(CN(Cc2cccc(F)c2)c2ccc(OCc3ccc4ccccc4n3)cc2)cc1	133430-69-0	Lipoxygenase Inhibitors;Non-Steroidal Antiinflammatory Drugs
BC-06-CP81	KRMDCWKBEZIMAB-UHFFFAOYSA-N	CN(C)CCC=C1c2ccccc2CCc2ccccc21	30227-34-0	5-HT Reuptake Inhibitors;Nav1.4 (SkM1) Sodium Channel Blockers;Norepinephrine Reuptake Inhibitors
OD-96-OP94	KRSPPNURDWHDSQ-UHFFFAOYSA-N	Nc1nc2c(C(CO)c3ccccc3)c[nH]c2c(=O)[nH]1	216754-04-0	Purine-Nucleoside Phosphorylase Inhibitors
ID-13-PY29	KRVMLPUDAOWOGN-UHFFFAOYSA-N	COc1ccc2[nH]cc(C3=CCNCC3)c2c1	107008-28-6	5-HT1A Receptor Agonists;5-HT1B Agonists
ED-00-OH22	KRWMERLEINMZFT-UHFFFAOYSA-N	Nc1nc(OCc2ccccc2)c2[nH]cnc2n1	1000874-21-4	O6-Alkylguanine-DNA Alkyltransferase (MGMT) Inhibitors
BD-60-DR81	KRXWJZIHQRIGSJ-UHFFFAOYSA-N	CC(C)c1c(-c2cnn(C(C)(C)C)c2)[nH]c2c(C#N)cnn2c1=O		KDM5A inhibitor
AA-76-VE74	KSEJZTWORQXILM-UHFFFAOYSA-N	C[S+]([O-])c1ccc(-c2nc3n(c2-c2ccncc2)CCC3)cc1	122454-69-7	Cyclooxygenase (COX) Inhibitors;Lipoxygenase Inhibitors;Non-Steroidal Antiinflammatory Drugs;Cyclooxygenase (COX) Inhibitors;Lipoxygenase Inhibitors;Non-Steroidal Antiinflammatory Drugs
ND-85-OJ63	KSGCNXAZROJSNW-UHFFFAOYSA-N	CCS(=O)(=O)c1ccc2oc(-c3ccc4ccccc4c3)nc2c1	945531-77-1	UTRN (Utrophin gene) Expression Enhancers
IB-30-KN41	KSGXQBZTULBEEQ-UHFFFAOYSA-N	CCCCCCOC(=O)/N=C(\\N)c1ccc(NCc2nc3cc(C(=O)N(CCC(=O)OCC)c4ccccn4)ccc3n2C)cc1	1019206-66-6	Known Thrombin inhibitor
KE-58-BO47	KSHJXDWYTZJUEI-UHFFFAOYSA-N	O=c1n(Cc2nc3ccccc3n2CCCCO)c2cnccc2n1C1CC1		
BE-45-XA42	KSISWIVDFITFKQ-UHFFFAOYSA-N	COC(=O)c1ccc(COc2ccccc2CN2CCN(C(=O)CNC(=O)CC34CC5CC(CC(C5)C3)C4)CC2)cc1	1335113-30-8	Niemann-Pick C1 inhibitor
HA-57-XH23	KSKRJZMRHSNRBX-UHFFFAOYSA-N	COc1ccc(-n2nc3c4ccccc4[nH]cc-3c2=O)cc1		
CB-47-SB29	KSNUCNRMDYJBKT-UHFFFAOYSA-N	CC(=O)NCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1	1262770-69-3	Vasopressin (AVP) V1a Antagonists
UD-09-TN01	KSWYJUIFHPSZOL-UHFFFAOYSA-N	CC(C)(O)c1ccc(N2CCN(c3nnc(Cc4ccccc4)c4ccccc34)CC2)nc1	1057677-92-5	Hedgehog Signaling Inhibitors
AC-65-TK51	KTDZCOWXCWUPEO-UHFFFAOYSA-N	CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1OC1CCCCC1	123653-11-2	Cyclooxygenase-2 Inhibitors
LD-22-SA99	KTEIFNKAUNYNJU-LBPRGKRZSA-N	C[C@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl	1374356-45-2	NUDT1 gene inhibitor;ALK gene inhibitor,ROS1 gene inhibitor, MET gene inhibitor, NUDT1 gene inhibitor
AB-37-JM16	KTEXNACQROZXEV-SLXBATTESA-N	C=C1C(=O)O[C@H]2[C@H]1CC/C(C)=C/CC[C@@]1(C)O[C@@H]21	20554-84-1	NF-kappaB (NFKB) Activation Inhibitors
BD-83-QC82	KTTVZVHKLPCAFP-SFTDATJTSA-N	CCOC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)C1(NC(=O)[C@@H](SC(C)=O)C(C)C)CCCC1	169319-62-4	Angiotensin-I Converting Enzyme (ACE) Inhibitors;Neprilysin (Enkephalinase, Neutral Endopeptidase, NEP) Inhibitors
BA-04-IG64	KTUCUQYEWVGDDQ-ANYOKISRSA-N	CC(C)[C@H](S)C(=O)NC1(C(=O)NC(Cc2ccc(-c3cncnc3)cc2)C(=O)O)CCCC1		Endothelin-Converting Enzyme (ECE) Inhibitors
BA-28-JD87	KTUFNOKKBVMGRW-UHFFFAOYSA-N	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1	1080014-82-9	Abl Kinase Inhibitors;Bcr-Abl Kinase Inhibitors;Inhibitors of Signal Transduction Pathways
NE-37-JX51	KTUHLWXKRMAAAZ-CNBUXVLOSA-N	CCCC[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CCC(=O)N2)CCSSCC[C@@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)O)NC1=O		
QD-61-CS49	KTVZFOCUPRUEJP-HYHJDXDTSA-N	CCCCCCCCCCCCCCCCOC[C@H]1O[C@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](O)[C@@H](O)[C@@H]1O		E-Selectin Inhibitors
GB-48-YF11	KTXBOOWDLPUROC-UHFFFAOYSA-N	CC(CNC(=O)c1cccnc1)NC(=O)c1cccnc1	1158520-62-7	NAD+ ADP-Ribosyltransferase (poly(ADP-ribose)polymerase;PARP) Inhibitors;Lipid Peroxidation Inhibitors;Free Radical Scavengers;NAD+ ADP-Ribosyltransferase (poly(ADP-ribose)polymerase;PARP) Inhibitors;Lipid Peroxidation Inhibitors;Free Radical Scavengers
LC-20-LZ39	KTXXYZBSQYXMPO-UHFFFAOYSA-N	N=C(N)SCc1ccc(Cl)cc1Cl	1073-70-7	MreB Polymerization Inhibitors;Angiogenesis Inhibitors
LD-69-ZV56	KUDUHLYXWIVQRQ-HKBQPEDESA-N	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3cc(OC(=O)N4CCC(N5CCCCC5)CC4)ccc3nc2-1		
FA-67-MV22	KUFRCLRVAYJMCG-UHFFFAOYSA-N	O=C(c1ccc(CN(Cc2ccc(F)cc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)cc1)N(Cc1ccc(F)cc1)Cc1cc(Cl)cc(Cl)c1	1201661-44-0	Apoptosis Inducers;Bcl-2 Inhibitors;Mcl-1 Inhibitors
ID-96-UX79	KUQWGLQLLVFLSM-ONAXAZCASA-N	CC[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)OCC(C)(C)CCCCc1cccc3c1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1		
IB-33-TE51	KURWKDDWCJELSV-UHFFFAOYSA-O	C[n+]1c2ccccc2cc2[nH]c3ccccc3c21		
ME-93-CO85	KUYNWRIOSPPTQL-UHFFFAOYSA-N	NC1(c2ccc(-c3nc4ccn5c(C(F)F)nnc5c4cc3-c3ccccc3)cc2)CCC1		
DD-34-TT70	KVDWOQGDMAEJLM-UHFFFAOYSA-N	Cc1c(-c2ccccc2F)[nH]c(N)c1C#N	186033-14-7	Large Conductance K(Ca) 1.1 (BK, maxi K+) Channel Activators
UD-70-IO77	KVHRYLNQDWXAGI-UHFFFAOYSA-N	COc1cn(-c2ccc(-n3cccn3)cc2F)nc(-c2ccnn2-c2ccccc2)c1=O	1238697-26-1	PDE10A inhibitor
BA-84-TD72	KVLFRAWTRWDEDF-IRXDYDNUSA-N	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO	1009298-09-2	mTOR Complex 1 (mTORC1) Inhibitors;mTOR Complex 2 (mTORC2) Inhibitors;catalytic mTOR inhibitor
HA-22-YE24	KVLLHLWBPNCVNR-SKCUWOTOSA-N	CN1N=C2CCN(C(=O)[C@@H](COCc3ccccc3)NC(=O)C(C)(C)N)C[C@@]2(Cc2ccccc2)C1=O	193273-66-4	GHS Receptor Agonists;Growth Hormone Secretagogues;Growth hormone secretagogue receptor (ghrelin) agonist
BA-74-BQ33	KVVODNUBDFULSC-XMMPIXPASA-N	Cc1oc(-c2ccc(C(F)(F)F)cc2)nc1COc1ccc(S(=O)(=O)N2c3ccccc3C[C@@H]2C(=O)O)cc1	839673-52-8	PPARalpha Agonists;PPARgamma Agonists
BA-94-PX65	KVWDHTXUZHCGIO-UHFFFAOYSA-N	Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1	132539-06-1	Dopamine D2 Antagonists;5-HT2A Inverse Agonist;ADRA1B gene inhibitor
AC-00-KV26	KWIUHFFTVRNATP-UHFFFAOYSA-O	C[N+](C)(C)CC(=O)O		
JB-99-UC61	KWJDHELCGJFUHW-LEWJYISDSA-N	COC(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(NS(=O)(=O)O)cc1)c1csc(-c2cccs2)n1		
NB-62-DN30	KWJDHELCGJFUHW-SFTDATJTSA-N	COC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(NS(=O)(=O)O)cc1)c1csc(-c2cccs2)n1	1008510-37-9	Protein Tyrosine Phosphatase beta (PTPRB) Inhibitors
AC-09-DD24	KWJRSHZSULRJHE-UHFFFAOYSA-N	Cc1ccc(OCCSc2ncccn2)c(Br)c1	723249-01-2	AMP-Activated Protein Kinase (AMPK) Activators;PRKA gene stimulator;AMP-Activated Protein Kinase (AMPK) Activators;PRKA gene stimulator
HF-57-QB74	KWMBIIQCLUIHDI-UHFFFAOYSA-N	CCOC(=O)C(C)Oc1cccc2c(=O)n(CC(=O)Nc3ccc4c(c3)OCCO4)ccc12	868224-64-0	NR5A1 inhibitor;steroidogenic factor 1 inhibitor
ED-91-LA02	KWQWBZIGHIOKIO-UHFFFAOYSA-N	CCCOc1ccc2[nH]cc(C3=CCNCC3)c2n1	131084-35-0	HTR1B agonist
GC-08-VP20	KXDROGADUISDGY-UHFFFAOYSA-N	N/C(=N\\C(=O)c1nc(Cl)c(N)nc1N)NCc1ccccc1	161804-20-2	PKD2L2 gene inhibitor;Sodium calcium exchanger 1 inhibitor;;PKD2L2 gene inhibitor;Sodium calcium exchanger 1 inhibitor;
CD-20-GE75	KXMZDGSRSGHMMK-VWLOTQADSA-N	Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2	1037624-75-1	Axl tyrosine kinase receptor inhibitor
EA-43-XP68	KXSNSVDPSDYDHW-HXUWFJFHSA-N	COCCN(CCC(=O)O)S(=O)(=O)c1ccc([C@@H](CC2CCCC2)C(=O)Nc2nc3ccc(Cl)nc3s2)cc1		
EC-34-FT85	KYHUARFFBDLROH-MOPGFXCFSA-N	Cc1cc([C@@H](C)Nc2cccc(-c3cc(C)c(C(=O)N[C@@H](C)C(=O)O)c(C)c3)c2)ccc1Cl	1233332-14-3	
FB-66-UU47	KYHUYMLIVQFXRI-SJPGYWQQSA-N	CC[C@H](C)[C@H]1NC(=O)[C@@H](NC(=O)[C@@H](CC(C)C)N(C)C(=O)[C@@H]2CCCN2C(=O)[C@H](C)O)[C@@H](C)OC(=O)[C@H](Cc2ccc(OC)cc2)N(C)C(=O)[C@@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)C(=O)[C@H](C(C)C)OC(=O)C[C@@H]1O	114607-50-0	binding to EF-1_ mediates inhibition of translocation
AC-42-LW33	KYPYKOKSZYHQII-HSZRJFAPSA-N	CS(=O)(=O)CCN1C[C@H](c2cccc(C(F)(F)F)c2)N(c2ccc(Oc3ccc(Cl)cc3)cc2)C1=O		
BC-00-YH62	KYRVNWMVYQXFEU-UHFFFAOYSA-N	COC(=O)Nc1nc2cc(C(=O)c3cccs3)ccc2[nH]1	31430-18-9	Tubulin polymerization inhibitor;Antimitotic Drugs;Tubulin polymerization inhibitors;Tubulin modulator;Tubulin polymerization inhibitor;Antimitotic Drugs;Tubulin polymerization inhibitors;Tubulin modulator
NB-06-IJ80	KYUFGGNCJRWMDN-GOYXDOSHSA-N	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(C)=O)C(C)C)C(=O)N[C@H](C=O)CC(=O)O	319494-39-8	CASP6 Inhibitor
CC-00-ZO24	KYWCWBXGRWWINE-UHFFFAOYSA-N	COc1ccc(C(=O)NCc2cccnc2)cc1C(=O)NCc1cccnc1	1085306-93-9	Prostanoid TP Antagonists
BB-75-UH54	KYWWJENKIMRJBI-UHFFFAOYSA-N	Fc1ccc(-c2c3cccc(C(F)(F)F)c3nn2Cc2ccc(F)cc2Cl)cc1	875787-07-8	Liver X Receptor (LXR) Agonists;ABCA1 Expression Enhancers
DE-37-JV37	KZENBFUSKMWCJF-UHFFFAOYSA-N	OCc1ccc(-c2ccc(-c3ccc(CO)s3)o2)s1	213261-59-7	Antiinflammatory Drugs;Cytokine Production Inhibitors;SULT1A1 prodrug;Chemical crosslinker;Antiinflammatory Drugs;Cytokine Production Inhibitors;SULT1A1 prodrug;Chemical crosslinker
BC-61-BE07	KZYCUCAZAITGMW-UHFFFAOYSA-N	Cc1ccc(C2=CS(=O)(=O)CCCS2(=O)=O)cc1		Galanin GAL1 Antagonists
BB-04-KA05	LAHVQXKWWOOVLX-UHFFFAOYSA-N	Cc1noc(C)c1C(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2C(F)(F)F)cc1		IL-4 Production Inhibitors;IL-2 Production Inhibitors;IL-5 Production Inhibitors
BF-24-JN36	LARFZNXVNANWFD-MRXNPFEDSA-N	O=C(Nc1ccc(OC(F)(F)F)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2cncnc2)c1		Allosteric ABL1 inhibitor
CD-59-MG26	LAYAEBGGDTWXAZ-RUZDIDTESA-N	CN1CCN(S(=O)(=O)c2ccc([C@@H](CC3CCCC3)C(=O)Nc3nc4ccc(-c5ccncc5)nc4s3)cc2)CC1		
AB-11-AY75	LBDOGIZEEBHJSE-UHFFFAOYSA-N	Cc1ccc(C)n1-c1ccc(O)c(C(=O)O)c1	313701-92-7	Pin1 Inhibitors
ZE-14-BN99	LBFYQISQYCGDDW-UHFFFAOYSA-N	Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1		Wnt signalling inhibitor;Wnt Pathway Inhibitor;type I inhibitor of CDK8 and CDK19
AE-97-TS20	LBHIOVVIQHSOQN-UHFFFAOYSA-N	O=C(NCCO[N+](=O)[O-])c1cccnc1	65141-45-9	Nitrate;Natriuretic peptide receptor A agonist;Vasodilator;K(ATP) Channel Activators;Nitrate;Natriuretic peptide receptor A agonist;Vasodilator;K(ATP) Channel Activators
XB-39-YT35	LBLDMHBSVIVJPM-CFNLWSCMSA-N	C=CCN1C[C@H](C)N(C(c2ccc(C(=O)N(CC)CC)cc2)c2cccc(O)c2)C[C@H]1C		OPRD1 agonist
JB-89-SI60	LBPUIWQYAGTBDC-LOSJGSFVSA-N	COCCCCC1(CNC(=O)[C@@H]2CNC[C@H](NS(=O)(=O)c3ccc(C)cc3)C2)c2ccccc2Oc2ccccc21		Renin Inhibitors
NF-27-AQ24	LBVZWEWTNUDWNS-YRNVUSSQSA-N	COc1ccc(CNC(=O)/C=C/c2ccc3[nH]cc(CCN(C)C)c3c2)cc1	185259-85-2	HTR1D agonist
IA-37-FR87	LBWQSAZEYIZZCE-SNVBAGLBSA-N	CC[C@@H](C)Nc1nc(C)nc2c(-c3ccc(OC)nc3C)c(C)nn12	459856-18-9	CRF1 Antagonists
GC-73-YI26	LBZZVBOHWAZYRL-UHFFFAOYSA-N	CN1CCN(c2ccc(-c3cnc4cccc(-c5cc(F)c(CN6CCOCC6)c(F)c5)c4n3)cc2)CC1	1092499-82-5	Jak2 Inhibitors;Jak1 Inhibitors
WA-00-QY36	LCFQGSRRJKESSW-UHFFFAOYSA-N	Cc1c(-c2ccccc2)nc2ccc(Br)cc2c1C(=O)Nc1ccc(C(=O)O)cc1F		Prostaglandin F2a receptor (PGF2a-DP aka PTGFR) antagnoist
DC-84-GJ21	LCMWDFXRHRLQPG-MXVIHJGJSA-N	CN1CCN([C@H]2CC[C@H](n3cc(-c4ccc(NS(=O)(=O)c5cccc(Cl)c5Cl)c(F)c4)c4c(N)ncnc43)CC2)CC1	262442-90-0	Tie2 Receptor Inhibitors;Inhibitors of Signal Transduction Pathways;Angiogenesis Inhibitors
BB-39-DQ95	LCNDUGHNYMJGIW-UHFFFAOYSA-N	Cn1c(-c2ccccc2)cc2onc(-c3ccccc3)c2c1=O	60986-80-3	mgluR7 Antagonists
AA-56-JY17	LCQLHJZYVOQKHU-VKHMYHEASA-N	NC(=O)N[C@@H](CCC(=O)O)C(=O)O	1188-38-1	Carbamoyl Phosphate Synthetase 1 (CPS1) Activators
BE-15-IE57	LCYAYKSMOVLVRL-UHFFFAOYSA-N	CCCC[S+]([O-])c1sc2nc(-c3cccs3)cc(-c3ccccc3)c2c1N	459147-39-8	Prostaglandin-degrading enzyme 15-PGDH inhibitor;inhibitor of the prostaglandin-degrading enzyme 15-PGDH
DC-96-HY67	LDCRTTXIJACKKU-ONEGZZNKSA-N	COC(=O)/C=C/C(=O)OC	12287-98-8	Nuclear Factor, Erythroid Derived 2, Like 2 (Nrf2) Activators;NF-kappaB (NFKB) Activation Inhibitors;Kelch-like ECH-Associated Protein 1 (Keap1, INrf2) Ligands
ND-15-RC31	LDGIHZJOIQSHPB-UHFFFAOYSA-N	O=C(O)c1ccc2cc(-c3ccc(O)c(C45CC6CC(CC(C6)C4)C5)c3)ccc2c1	125316-60-1	POLA1 inhibitor
GB-27-AY54	LDIOUQIXNSSOGU-UHFFFAOYSA-N	CCC(CC)Nc1c2c(nc3c(-c4ccc(OC)cc4Cl)c(C)nn13)CCC2	441060-02-2	CRF Receptor Antagonists
FB-33-LI31	LDQYATFLTIHISD-UHFFFAOYSA-N	COc1cc(C2C(C#N)=C(N)Oc3cc(N(C)C)ccc32)cc2c1OCO2		
DC-78-CM38	LDTAHRLHGHFHKP-UHFFFAOYSA-N	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC	862812-98-4	TBK1 gene inhibitor;IKBKE (IKK-epsilon;IKK-i) Inhibitors
BF-55-JR43	LDTLKRAZKQLFKD-UTKZUKDTSA-N	Cc1cc([C@H](Nc2ccc(C)c(CN3CC[C@@H](C(=O)O)C3)c2C)C(F)(F)F)ccc1Cl		S1PR1 antagonist
FB-43-LF24	LDUHDPXRHWESEJ-UHFFFAOYSA-N	Cc1ccc(-c2cc3c(=O)[nH]c(=O)[nH]c3nc2C(C)(C)C)cc1		
DB-36-TR95	LDXDSHIEDAPSSA-OAHLLOKOSA-N	O=C(O)CCn1c2c(c3ccccc31)C[C@H](NS(=O)(=O)c1ccc(F)cc1)CC2	116649-85-5	GPR44 antagonist;PTGDR antagonist;CRTH2 Receptor Antagonists;CCL2 Expression Inhibitors;Prostanoid TP Antagonists
DE-17-IZ77	LEBVLXFERQHONN-UHFFFAOYSA-N	CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C	119427-31-5	Sodium Channel Blocker; anaesthetic;Sodium Channel Blocker; anaesthetic
HD-35-ZQ35	LEJPKWXGQFBXRX-VZUCSPMQSA-N	Fc1ccc2c(c1)CC/C2=C\\c1cncnc1		Cytochrome P450 11B2 (Aldosterone Synthase) Inhibitors
PB-09-OE00	LEOIKBCGRYIEBD-UHFFFAOYSA-N	CNC(=O)c1ccc(-c2ccc3ncc4c(c3c2)n(-c2cn(C)nc2Cl)c(=O)n4C)cc1	1257546-19-2	Mammalian Target of Rapamycin (mTOR;FRAP1) Inhibitors;Phosphatidylinositol 3-Kinase beta (PI3Kbeta) Inhibitors;Phosphatidylinositol 3-Kinase delta (PI3Kdelta) Inhibitors;Phosphatidylinositol 3-Kinase alpha (PI3Kalpha) Inhibitors
DA-62-XV25	LEUQBJWNAXGICB-APWZRJJASA-N	c1cc2cc(-c3cnc(O[C@H]4CCN5CCC[C@@H]4C5)nc3)ccc2[nH]1		Nicotinic alpha7 Agonists
AA-24-EN31	LFKCJRRKCGWJCA-OXMZGPKHSA-N	CCC[C@H](NC(=O)[C@@H]1C[C@@]2(CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCCN1C(C)C)C(C)(C)C)C(C)(C)C)C(C)(C)C21CCC1)C(=O)C(=O)NC1CC1		
PC-05-MI00	LFQDNHWZDQTITF-UHFFFAOYSA-N	OB1OCc2cc(F)ccc21	174671-46-6	Leucyl-tRNA Synthetase Inhibitors
HA-88-JB21	LFUJIPVWTMGYDG-UHFFFAOYSA-N	O=c1[nH]ccc2c(O)cccc12	5154-02-9	NAD+ ADP-Ribosyltransferase (poly(ADP-ribose)polymerase;PARP) Inhibitors
TD-18-FT48	LFVUSUBWLODHOV-UHFFFAOYSA-N	CCOC(=O)C1CCCCN1C(=O)c1cc2nc(-c3ccccc3)cc(C(F)(F)F)n2n1		F2RL1 antagonist
DC-04-FQ48	LGBAQQMSODJFGN-GFCCVEGCSA-N	C[C@@H](c1c(F)cc2ncccc2c1F)c1cnc2ccc(N3CCNC(=O)C3)nn12	1264837-78-6	HGFR (MET;c-Met) Inhibitors
AA-38-TT50	LGEQQWMQCRIYKG-DOFZRALJSA-N	CCCCC/C=C\\C/C=C\\C/C=C\\C/C=C\\CCCC(=O)NCCO	94421-68-8	Cannabinoid CB1 Agonists;TRPV1 (Vanilloid VR1 Receptor) Agonists;K(V)4.3 Channel Blocker
YB-18-SI56	LGFJHIPRKAWWCI-UHFFFAOYSA-N	NCCc1c[nH]c2ccc(CN)cc12		
AD-18-XC14	LGFLRHWJJKLPCC-ZDUSSCGKSA-N	Nc1nc(N)c2nc(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2n1	52454-37-2	Folate Antagonists
EC-62-NP61	LGGNGJGQVBUVOE-UHFFFAOYSA-N	C#CCOCCOCCOCCOCCOc1ccc(-c2ccc(OS(=O)(=O)F)cc2)cc1		CRABP2 inhibitor
XE-69-AT35	LGOZXNLEMXJIMS-UHFFFAOYSA-N	CCCCCCCCCC(OC(=O)C(CCCCN(O)C(C)=O)NC(=O)c1coc(-c2ccccc2O)n1)C(C)C(=O)NC1CCCCN(O)C1=O		
BF-02-AC35	LGUYVFVZZRHOGY-UHFFFAOYSA-N	O=C(Nc1cc(-c2cn(-c3ccccc3)c3cnccc23)ccn1)NC1CC1		
BC-75-FA82	LHBBUGLYVFZUTH-GXVHRJHYSA-N	CC(C)c1cccc(CNC[C@@H](O)[C@@H]2C[C@H](C)CCCCCCCCC(=O)N(C)[C@@H](C)C(=O)N2)c1		beta-Secretase 1 (BACE1) Inhibitors
UB-28-WW60	LHBGDHWKCNHDBV-UHFFFAOYSA-N	Oc1noc2cc(C(F)(F)F)ccc12		
AE-88-WQ63	LHNIIDJUOCFXAP-UHFFFAOYSA-N	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1	957054-30-7	panPI3K inhibitor
FD-06-CV80	LHVFMWFHUOJTAG-HXUWFJFHSA-N	O=C(N[C@H](Cc1ccccc1)C(=O)O)c1ccc2c(c1)C(=O)c1ccccc1C2=O		
IF-86-JG83	LHXDBXYWIPUULZ-INIZCTEOSA-N	OC[C@H](Cc1ccccc1)NCc1ccccc1		
CF-55-OA12	LIBVHXXKHSODII-UHFFFAOYSA-N	O=C1COc2c(CCNCCN(C(=O)CCNCCc3ccc(Cl)c(Cl)c3)C3CCCCC3)ccc(O)c2N1	1035227-43-0	SMYD2 / KMT3C;SMYD2 gene inhibitor
DB-40-GN91	LIBVXZDYNVKVMR-OAGGEKHMSA-N	O=CN(O)C[C@@H](CC1CCCC1)C(=O)N1C[C@H](F)C[C@H]1C(=O)Nc1cnccn1	949197-97-1	Peptide Deformylase (PDF) Inhibitors
HB-03-JZ32	LIIRNJNGOKYCIP-UHFFFAOYSA-N	Cc1ccc(NC(=N)N=C(N)N)cc1Cl	114133-93-6	5-HT3 receptor agonist
BF-49-KQ10	LIWXQSMSAZJCQT-LBPRGKRZSA-N	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C)n1		Selective PI3Kalpha inhibitor
JC-19-ST72	LJALYPZMAKFPSM-HNNXBMFYSA-N	CN(C(=O)[C@@H]1CCCN1C#N)c1nc(-c2cccc(C#N)c2)cs1		
JB-23-ZE86	LKAMKJDBXSPXDT-UHFFFAOYSA-N	c1ccc(CNc2ccc3ncc(-c4ccncc4)n3n2)cc1		Lck Kinase Inhibitors
OA-16-KC73	LKBFFDOJUKLQNY-UHFFFAOYSA-N	O=C(O)Cc1nn(Cc2ccc(Br)cc2F)c(=O)c2ccccc12	72702-95-5	Aldose Reductase Inhibitors
ED-10-ED67	LKHRMULASXZCLG-UHFFFAOYSA-N	CCn1c(=O)[nH]c2cc(Cl)c(Cl)cc21		
BD-66-TZ80	LKJPYSCBVHEWIU-UHFFFAOYSA-N	CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	90357-06-5	Androgen Receptor Antagonists
KB-85-KP82	LKJRSIKJPNFWNO-UHFFFAOYSA-N	C=CCc1c(OC(C)=O)c2cccnc2n(-c2ccccc2)c1=O	89108-58-7	Leukotriene Antagonists;Leukotriene Synthesis Inhibitors;Mediator Release Inhibitors;Leukotriene Antagonists;Leukotriene Synthesis Inhibitors;Mediator Release Inhibitors
DA-75-NX57	LKJVGMXETAHJKU-AVRDEDQJSA-N	CC(=O)N[C@@H]1CN2C(=O)N(c3cc(Cl)cc(Cl)c3)C(=O)[C@]2(Cc2ccc(C#N)cc2)C1		Cell Adhesion Inhibitors;Integrin alphaLbeta2 (LFA-1) Antagonists;Tachykinin NK1 Antagonists
CA-11-KY95	LKZLGMAAKNEGCH-UHFFFAOYSA-N	CC(=O)c1cc([N+](=O)[O-])c(Sc2cccc(Cl)c2Cl)s1	882257-11-6	Ubiquitin C-terminal Hydrolase Inhibitors 7 (USP7| HAUSP) Inhibitors
AC-70-KV26	LLBLNMUONVVVPG-UHFFFAOYSA-N	OC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1	81226-60-0	Dopamine D2 Antagonists
AD-11-HV98	LLCRBOWRJOUJAE-UHFFFAOYSA-N	CCCN1CCN(c2ccc(C(=O)NC3(C(=O)NCC#N)CCCCC3)cc2)CC1	354813-19-7	Cathepsin K Inhibitors
BD-38-QC39	LLEJIEBFSOEYIV-UHFFFAOYSA-N	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC	34316-15-9	Bcl-xl Inhibitors;P2X7 Receptor Antagonists;Apoptosis Inducers;Rho GTPase Inhibitors;Protein Kinase C (PKC) Inhibitors
BD-12-CM09	LLIFMNUXGDHTRO-UHFFFAOYSA-N	Cc1noc(-c2ccc(CSCCC(=O)O)cc2)c1NC(=O)OC(C)c1ccccc1Cl	355025-24-0	Lysophospholipid edg2 (LPA1) Receptor Antagonists;Lysophospholipid edg7 (LPA3) Receptor Antagonists;LPAR1 antagonist;LPAR3 antagonist
PB-05-XP37	LLJYFDRQFPQGNY-QINSGFPZSA-N	O=C(O)/C=C(/CCc1ccc(Cl)cc1)c1ccccc1	1180676-32-7	allosteric PDK1 activator
CE-85-KN13	LLUTXPSOQPJMQA-UHFFFAOYSA-N	COc1ccccc1NC(=O)C(C)(O)C(F)(F)F		
DB-06-HE04	LLVPDBRSUHNJQQ-UHFFFAOYSA-N	COC(=O)c1cccc(NC(=O)NC2CCN(c3ccnc(Nc4ccc(F)cc4)n3)C2)c1		BPTF gene inhibitor
S0-EE-WW6E	LLZBQBVJQFUAEA-UHFFFAOYSA-N	COc1ccc(NC(=N)c2ccccc2)cc1CSC1CCCC1	1569735-58-5	
MA-32-UX14	LMAYILTVNBZXSW-QFIPXVFZSA-N	N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NC1CCN(Cc2c[nH]c3ccc(Cl)cc23)CC1		RAS-SOS molecular glue
FA-88-PW92	LMFWCWAOQYNELV-LUAWRHEFSA-N	O=C(/N=C1\\SSC2=NCCN21)c1cccs1		
GC-81-IA52	LMGQGPVCSYOMNS-UHFFFAOYSA-N	N=C(N)c1ccc2[nH]c(-c3cccc(-c4ccccc4)c3O)nc2c1		Urokinase (u-PA) Inhibitors;Tissue-Type Plasminogen Activator (t-PA) Inhibitors
CF-82-LL11	LMLDPXXCYIXDSG-MDZDMXLPSA-N	CC(C)(C)c1cc(/C=C/c2cccnc2)cc(C(C)(C)C)c1O	116376-62-6	Cyclooxygenase (COX) Inhibitors;Lipoxygenase Inhibitors;Non-Steroidal Antiinflammatory Drugs
AD-40-WB93	LMMJFBMMJUMSJS-UHFFFAOYSA-N	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F	946128-88-7	MEK1 Inhibitors
AA-24-SQ13	LMPZHLXYBWGGNT-UHFFFAOYSA-N	O=C(O)c1ccccc1Nc1cccc(OCc2ccc3ccccc3n2)c1	105350-26-3	Leukotriene Antagonists
AC-51-PY70	LMQBMWHHGVZWMR-UHFFFAOYSA-N	CCCc1c(OCC(O)COc2ccc3c(=O)cc(C(=O)O)oc3c2CCC)ccc(C(C)=O)c1O	40785-97-5	Leukotriene Antagonists;Leukotriene Synthesis Inhibitors
LA-36-XT39	LMYRWZFENFIFIT-UHFFFAOYSA-N	Cc1ccc(S(N)(=O)=O)cc1	12552-95-3	Carbonic Anhydrase Type II Inhibitors;Carbonic Anhydrase Type III Inhibitors
JF-37-AR97	LNDDRUPAICPXIN-SFHVURJKSA-N	Cc1noc(-c2ccc(-c3ccc(CC(=O)O)cc3)cc2)c1NC(=O)O[C@@H](C)c1ccccc1		
AA-77-RI81	LNEPOXFFQSENCJ-UHFFFAOYSA-N	O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1	1511-16-6	Dopamine D2 receptor inverse agonist;Dopamine D3 receptor inverse agonist;ADRA1B antagonist
YA-44-LW45	LNLBXZVRJITCST-UHFFFAOYSA-N	OC1(c2ccc(Cl)cc2)CCN(CCCC2c3ccccc3CCc3ccccc32)CC1		Antiinflammatory Drugs;Chemokine CC Antagonists;Antiinflammatory Drugs;Chemokine CC Antagonists
JD-00-YJ41	LNMRSSIMGCDUTP-UHFFFAOYSA-N	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1	1073667-64-7	Tie-2   p38 MAPK dual inhibitor
FA-17-JZ87	LNPDTQAFDNKSHK-UHFFFAOYSA-N	Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1	181695-72-7	Cyclooxygenase-2 Inhibitors;Non-Steroidal Antiinflammatory Drugs
AD-65-WK61	LNRUTWQSWUTEMQ-RDGATRHJSA-N	Cc1cccc(C[C@H](NC(=O)c2ccc(F)cc2F)C(=O)N[C@H](C#N)COCc2cccc(C(=O)O)c2)c1		Cathepsin B Inhibitors
CE-69-VJ68	LNTHITQWFMADLM-UHFFFAOYSA-N	O=C(O)c1cc(O)c(O)c(O)c1	137657-43-3	Apoptosis Inducers;beta-Amyloid (Abeta) Aggregation Inhibitors;Antioxidants;PPARgamma Agonists;beta-Amyloid (Abeta) Protein Neurotoxicity Inhibitors
VD-20-SR39	LNUYTUZRQGHPMJ-UHFFFAOYSA-N	Oc1ccc(Nc2nc(-c3ccc(F)cc3F)cs2)cc1		
FC-98-AJ86	LORDFXWUHHSAQU-UHFFFAOYSA-N	CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C		
CA-68-TC79	LOUPRKONTZGTKE-LHHVKLHASA-N	C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12	101143-86-6	P-Glycoprotein (MDR-1) Inhibitors;Sodium channel inhibitor
BA-98-JJ31	LOUPRKONTZGTKE-WZBLMQSHSA-N	C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12		
EA-40-GQ08	LPAHKJMGDSJDRG-RJTBUBHNSA-N	CCCC[C@@H](NC(=O)[C@@H](Cc1cn(C(=O)OC)c2ccccc12)NC(=O)[C@H](CC(C)(C)C)NC(=O)N1C(C)CCCC1C)C(=O)O	156161-89-6	Endothelin ETB Receptor Antagonists
FA-06-GA39	LPAQYRVMHQPHSA-UHFFFAOYSA-N	CCN(CC)CCN1C(=O)C2C(C(=O)Nc3ccc(Cl)c(Cl)c3)C3C=CC2(O3)C1C(=O)NC1CCCCC1	1044597-57-0	GHSR antagonist
CD-44-XT40	LPLVUJXQOOQHMX-QWBHMCJMSA-N	CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12	132215-36-2	Inhibitors of Blood Coagulation Pathways;Thrombin Inhibitors;Antioxidants;Cell Adhesion Inhibitors
EC-07-AO30	LPPRLWFUMJHAKF-UHFFFAOYSA-N	COC(=O)c1cc2c(N3CCN(CCCCN4C(=O)c5ccccc5S4(=O)=O)CC3)cccc2[nH]1	141533-35-9	ADRA1B gene modulator;5-HT1A Receptor Antagonists
ZB-54-WT28	LPUCBGGXXIUBAZ-UHFFFAOYSA-N	O=C(NC1CCN(CC(F)(F)F)CC1)c1ccc(-c2cccc(F)c2)nc1	1033836-12-2	Hematopoietic Prostaglandin D Synthase Inhibitor
PA-31-HP87	LQPGVGSKBNXQDU-UHFFFAOYSA-N	CCOC(=O)CCNc1cc(N2CCc3ccccc3CC2)nc(-c2cccnc2)n1	1394854-51-3	KDM6 inhibitor
GC-46-CA74	LQVXSNNAFNGRAH-QHCPKHFHSA-N	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)[nH]n2)c2cccn2n1	1001350-96-4	IGF-1R Inhibitors
NE-37-BQ24	LRFKWQGGENFBFO-IBGZPJMESA-N	CCCCCCCCc1ccc(CC[C@](N)(CO)COP(=O)(O)O)cc1	402616-26-6	S1PR3 agonist
JD-38-MY26	LRFKWQGGENFBFO-LJQANCHMSA-N	CCCCCCCCc1ccc(CC[C@@](N)(CO)COP(=O)(O)O)cc1	402616-23-3	Lysophospholipid edg3 (S1P3) Receptor Antagonists;Lysophospholipid edg1 (S1P1) Receptor Agonists;Lysophospholipid edg6 (S1P4) Receptor Agonists
BD-38-GC64	LRFKWQGGENFBFO-UHFFFAOYSA-N	CCCCCCCCc1ccc(CCC(N)(CO)COP(=O)(O)O)cc1	402615-91-2	Lysophospholipid edg1 (S1P1) Receptor Agonists;Lysophospholipid edg6 (S1P4) Receptor Agonists;Lysophospholipid edg8 (S1P5) Receptor Agonists;Lysophospholipid edg3 (S1P3) Receptor Agonists
CE-24-LQ98	LRGVDHZAEYAHLG-UHFFFAOYSA-N	O=C(NCCCn1ccnc1)c1cc(-c2cccs2)on1		
RE-72-IT14	LRJUQKWYFPRDIA-CMDGGOBGSA-N	CCc1nc2c(C)cc(C)nc2n1Cc1ccc(/C=C/CN2CCN(C(C)(C)C)CC2)cc1		
BA-39-OX47	LRKZZGJFTIVZRE-RUZDIDTESA-N	CN(C(=O)c1ccccc1)[C@H](CCNC(=O)c1cc2ccccc2cn1)Cc1ccccc1		
VB-92-JQ72	LSCNJMXUVMRNQD-UHFFFAOYSA-N	CC1(C)CCc2c(C(=O)Nc3cnn(C(c4ccccc4)C4CCN(CCF)CC4)c3)n[nH]c2C1		ITK (EMT) Kinase Inhibitors
AA-03-QM41	LSFLAQVDISHMNB-AFARHQOCSA-N	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](CN2CCCC2)C1	475488-23-4	IGF-1R Inhibitors;Inhibitors of Signal Transduction Pathways;Angiogenesis Inhibitors
EC-08-AP40	LSXUTRRVVSPWDZ-MKKUMYSQSA-N	CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CC(C)C)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O	1071992-57-8	Apoptosis Inducers;Inhibitor  of Apoptosis Protein 1 (IAP1) Inhibitors;Inhibitor  of Apoptosis Protein 2 (IAP2) Inhibitors;Signal Transduction Modulators;X-Chromosome-Linked Inhibitor of Apoptosis Protein (XIAP) Inhibitors
XA-39-SG64	LTQYSJKGRPGMPO-UHFFFAOYSA-N	C1Cc2[nH]nc(-c3nn[nH]n3)c2C1	851776-28-8	GPR109a partial agonist
EA-60-LN91	LTUGYAOMCKNTGG-UHFFFAOYSA-N	COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCCC1)n(C)c(=O)n2C	901245-65-6	BRPF1 inhbitor;BRPF1 inhibitor
AF-12-IW93	LUGXKWLXOYRDIS-UHFFFAOYSA-N	Nc1nc(-c2ccccn2)nc(N)c1Cc1ccc(Cl)cc1Cl	338965-09-6	Hepcidin (LEAP-1) Antagonists;Antianemic;Ferroportin antagonist;Hepcidin (LEAP-1) Antagonists;Antianemic;Ferroportin antagonist
XF-24-NT53	LUJZZYWHBDHDQX-QFIPXVFZSA-N	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12	714971-09-2	EGFR (HER1;erbB1) Inhibitors;HER2 (erbB2) Inhibitors;HER3 (erbB3) Inhibitors;HER4 (erbB4) Inhibitors
BB-44-CQ48	LUKBXSAWLPMMSZ-OWOJBTEDSA-N	Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1	31100-06-8	Anti-inflammatory;Antioxidant
GB-11-TA37	LUKNJAQKVPBDSC-SFHVURJKSA-N	c1cc2cc(-c3ccc(O[C@H]4CN5CCC4CC5)nn3)ccc2[nH]1	855291-54-2	Nicotinic alpha7 Agonists
KD-14-RS67	LUMCNRKHZRYQOV-UHFFFAOYSA-N	COc1cccc(C(=O)N2CCN(C(=O)COc3cccc(C)c3)CC2)c1OC	423748-02-1	antagonist of CBX7ChD/methyl-lysine binding by blocking H3K27me3 binding;CBX7ChD antagonist
DE-03-BW70	LUTPUCJIKBULCQ-UHFFFAOYSA-N	CC1CCc2cc(F)ccc2N1C(=O)COc1cccc2cnccc12	878292-01-4	Bile Acid Responsive TGR5 Receptors (GPBAR1, AXOR 109, GPCR19) Agonists
EE-01-FB85	LUZOFMGZMUZSSK-LRDDRELGSA-N	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C	132341-58-3	PKC agonist
CB-16-SY72	LVASCWIMLIKXLA-CABCVRRESA-N	O=C(C[C@H]1NCCC[C@@H]1O)Cn1cnc2cc(Br)c(Cl)cc2c1=O	1217623-74-9	glutamyl-prolyl-tRNA synthetase inhibitor
MB-86-VG83	LVDRREOUMKACNJ-BKMJKUGQSA-N	Cc1cc(=O)n(C)c2cc(N3C(=O)CC[C@H](NS(=O)(=O)CC(C)C)[C@H]3c3ccc(Cl)cc3)ccc12	1808951-93-0	BRD7/9 inhbitor;BRD9 inhibitor;BRD7/9 Bromodomain Inhibitor
JD-00-TT75	LVPYVYFMCKYFCZ-UHFFFAOYSA-N	CCCc1c(O)c(O)c(C(=O)O)c2cc(Cc3ccccc3)c(C)cc12	213971-34-7	Lactate dehydrogenase inhibitor
CB-68-SP90	LVRLSYPNFFBYCZ-VGWMRTNUSA-N	O=C(N[C@H]1CCS[C@H]2CCC[C@@H](C(=O)O)N2C1=O)[C@@H](S)Cc1ccccc1	159317-63-2	Angiotensin-I Converting Enzyme (ACE) Inhibitors;Neprilysin (Enkephalinase, Neutral Endopeptidase, NEP) Inhibitors
HB-96-QD61	LWHFQGYFXFQRAC-UHFFFAOYSA-N	CCNC(=O)N1CCCC(c2nc(-c3cccc(OC)c3)c3ccccn23)C1		CDK4 Inhibitors
ED-03-IP48	LWJKSVUJZBEXCH-UHFFFAOYSA-N	O=C(Nc1cnc(-c2cc(C(F)(F)F)ccc2Cl)cn1)c1c(F)cccc1F		Calcium Release-Activated Channels (CRAC) Blockers;IL-2 Production Inhibitors
PD-50-SI33	LWJOLPZGUNUJFV-UHFFFAOYSA-N	COCCCn1c(NC(=O)c2ccno2)nc2cc(CNc3ccccc3)ccc21		ITK (EMT) Kinase Inhibitors
CF-91-JY05	LWLBVIFUVSUSAY-UHFFFAOYSA-N	c1ccc2cc(N3CCNCC3)ccc2c1	104090-87-1	5-HT3 receptor agonist
BD-63-KJ69	LWQQLNNNIPYSNX-UROSTWAQSA-N	C=C1/C(=C\\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/[C@@H](O)C4CC4)CC[C@@H]23)C[C@@H](O)C[C@@H]1O	112828-00-9	Vitamin D analog
KC-77-HN47	LWUDDYHYYNNIQI-ZDUSSCGKSA-N	CC(C)(C)OC(=O)c1ncn2c1[C@@H]1CCCN1C(=O)c1c(Br)cccc1-2	84379-13-5	GABA(A) BZ Site Receptor Partial Agonists
TA-21-GI75	LWULHXVBLMWCHO-UHFFFAOYSA-N	COc1cccc(OC)c1-c1cc(C(=O)NC2(C(=O)O)C3CC4CC(C3)CC2C4)nn1-c1ccc(C(=O)N(C)CCCN(C)C)cc1C(C)C	184162-21-8	NTSR1 antagonist;NTSR2 antagonist;Neurotensin Antagonists
FE-37-OL13	LXBIFEVIBLOUGU-DPYQTVNSSA-N	OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O	108147-54-2	an oral pharmacologic chaperone, stabilizes specific mutant forms of α-galactosidase, increasing enzyme trafficking to lysosomes;Pharmacological Chaperones
GB-62-IH36	LXFHSCDLMBZYKY-UHFFFAOYSA-N	CN1CCN(c2nc3cc(C(F)(F)F)ccc3n3cccc23)CC1	109028-09-3	5-HT1B Agonists
MB-49-LL22	LXFOLMYKSYSZQS-XKHGBIBOSA-N	CC(C)N(C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C1CC(CCc2nc3cc(C(C)(C)C)ccc3[nH]2)C1	1380288-87-8	Dot1L / KMT4;Dot1L inhibitor
BA-90-AA10	LXMSZDCAJNLERA-LJODGORCSA-N	CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)C2CC[C@@]3(C)C(CC[C@@]34CCC(=O)O4)C21		
YB-80-KQ31	LXMUDYGEHZVOAZ-UHFFFAOYSA-N	O=C(O)c1ccc(-n2nc3c4ccccc4[nH]cc-3c2=O)cc1	77779-58-9	CD80 (B7-1) Inhibitors
DA-07-LL18	LXQPWBFVIIXOMV-OLZOCXBDSA-N	C[C@@H]1COCCN1c1cc(N2CCOC[C@@H]2C)nc2[nH]c(-c3cc[nH]n3)nc12		
YF-46-CA32	LXZPELBBMPKUJF-UHFFFAOYSA-N	O=c1c2c[nH]c3c(c-2nn1-c1ccccc1)CCCC3		
GB-72-BR65	LYAUICDWKQJAGX-UHFFFAOYSA-N	COc1cccc(N2CCN(CC(=O)NC3c4c(O)c(C)cc(C)c4CC3(C)C)CC2)c1		
AA-13-FM86	LYLFQLCLUXOFOL-UHFFFAOYSA-N	Cc1sc[n+](CC(=O)c2ccccc2)c1C		
CD-08-MF16	LYMSPQZKBVKSAH-UHFFFAOYSA-N	NS(=O)(=O)Oc1ccc(-c2ccccc2)cc1	25999-01-3	Carbonic anhydrase inhibitor
AD-79-UU60	LYNOGBKNFIHKLE-UHFFFAOYSA-N	CCCCc1ccc(/N=C/NO)c(C)c1	339068-25-6	20-HETE receptor antagonist
DD-89-MJ03	LYPFVIYNUQCDPM-HIFRSBDPSA-N	CCCC[C@H](CN(O)C=O)C(=O)N1CCC[C@H]1C(=O)Nc1ccc(F)c[n+]1[O-]	478913-91-6	Peptide Deformylase (PDF) Inhibitors
GE-32-JR10	LYUQWQRTDLVQGA-UHFFFAOYSA-N	NCCCc1ccccc1		
AC-24-NX95	LZAXPYOBKSJSEX-GOSISDBHSA-N	Cc1ccc2c(c1)C(=O)[C@]1(O)CCN(c3ccccc3)C1=N2	856925-71-8	MYH9 gene inhibitor;MYH10 gene inhibitor;MYH9 gene inhibitor;MYH10 gene inhibitor
YF-35-FN16	LZEUKTATKCFQHI-UHFFFAOYSA-N	CS(=O)(=O)Nc1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCNCC2)c1		
FE-36-JU27	LZGAYELMXYIELY-NSOVKSMOSA-N	CCc1ccc(C(=O)N(C[C@@H]2CNC[C@H]2CN(C)C(=O)Cc2ccccc2)C(C)C)cc1OCCCOC		Renin Inhibitors
AB-36-NS83	LZGUCCWQDOHAIL-UHFFFAOYSA-N	N#Cc1c(NC(=O)c2nn3c(C(F)(F)F)cc(-c4cccs4)nc3c2Cl)sc2c1CCCC2		Nav1.8 (SNS/PN3) Sodium Channel Blockers
CF-01-IO46	LZMHWZHOZLVYDL-UHFFFAOYSA-N	O=c1onc2cnc3ccccc3n12	41443-28-1	Potassium Channel Blockers;Soluble Guanylyl Cyclase (sGC) Inhibitors
NB-79-SE70	LZVYYWCYKXAVES-UHFFFAOYSA-N	Cc1nc(C)c(-c2ccnc(Nc3ccc(Cl)cc3)n2)s1		
BD-97-PP33	LZYWLEPSQNXESC-KUHUBIRLSA-N	Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(C(=O)N[C@@H]1CCCNC1)O2		
CB-83-ZW70	MAEIEVLCKWDQJH-UHFFFAOYSA-N	CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1	28395-03-1	Inhibits the sodium-potassium ATPase pump
AC-76-BB02	MAOSUPNJVJGJEU-UHFFFAOYSA-N	Fc1ccc(-c2[nH]cnc2-c2ccncc2)cc1	181630-93-3	p38alpha MAPK Inhibitors;Non-Steroidal Antiinflammatory Drugs
CA-63-LW25	MBAFFKJSYQWZHU-UHFFFAOYSA-N	COc1ccc(-c2cc3c(ccc4c5c([nH]c43)CCC5=O)cn2)cc1F	1010103-96-4	MAPKAP-K2 (MK2) Inhibitors;TNF-alpha Release Inhibitors
AF-41-QY60	MBBCVAKAJPKAKM-UHFFFAOYSA-N	O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1	182431-12-5	Microsomal Triglyceride Transfer Protein (MTTP) Inhibitors
UD-04-WN64	MBEUGCCHNAXERV-RUZDIDTESA-N	CC(C)(C)NC(=O)OC1CCN(c2cccc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)n2)CC1		
BE-08-QT65	MBGGBVCUIVRRBF-UHFFFAOYSA-N	O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1	57-96-5	URAT1 Inhibitors;OAT4 Inhibitors;Multidrug resistance-associated protein inhibitors
BA-69-DU95	MBMBGCFOFBJSGT-KUBAVDMBSA-N	CC/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\CCC(=O)O	1024594-51-1	PPARalpha Agonists
BF-12-AC65	MBRLOUHOWLUMFF-UHFFFAOYSA-N	COc1ccc2ccc(=O)oc2c1CC=C(C)C	1440642-68-1	ACAT Inhibitors
FD-35-PQ00	MBWXNTAXLNYFJB-NKFFZRIASA-N	CC1=C(C/C=C(\\C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=O)c2ccccc2C1=O	10485-69-5	Cytochrome P450 CYP4F2 Inhibitors;Vitamin K analogs
IC-80-CT90	MBXFSGLROPUBQC-UHFFFAOYSA-N	Cc1c(NC(=O)Nc2ccc(C#N)cc2)c(=O)n(-c2ccccc2)n1C		
BB-29-VD14	MCBBKIXEHFOEKH-UHFFFAOYSA-N	CCCCCC(=O)Nc1c(C)cc(Br)cc1C		Voltage-Gated K(V) 7.2 (KCNQ2) Channel Activators
FC-36-SU62	MCBDFKKRYBVIAV-JOCHJYFZSA-N	Cc1oc(-c2ccc(F)cc2)nc1COc1cccc(C(C)(C)C(=O)N2CCC[C@@H]2C(=O)O)c1		
GE-22-ME44	MCBPHFHTGOTFPN-UHFFFAOYSA-N	Cc1cn(-c2cc(NC(=O)c3cccc4cc(Oc5ccnc(NC(=O)C6CC6)c5)ccc34)cc(C(F)(F)F)c2)cn1	1072710-72-5	VEGFR-2 (FLK-1/KDR) Inhibitors;Bcr-Abl Kinase Inhibitors;Angiogenesis Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;Bcr-Abl Kinase Inhibitors;Angiogenesis Inhibitors
BA-75-MA47	MCECSFFXUPEPDB-UHFFFAOYSA-N	CC(C)c1cc2[nH]c(=O)n(NS(C)(=O)=O)c(=O)c2cc1-c1ccnn1C	912574-69-7	AMPA Antagonists
BB-23-AJ69	MCMSJVMUSBZUCN-YYDJUVGSSA-N	COc1cc2c(cc1OC)-c1c/c(=N\\c3c(C)cc(C)cc3C)n(C)c(=O)n1CC2		
XE-18-BC97	MCNPUZVCJKOYIZ-UHFFFAOYSA-N	Cc1nc(-c2ccc3c(C=O)c(O)ccc3c2)sc1C(=O)N1CCN(C)CC1		
AA-31-OE22	MCNZISFQKMPWRJ-TWLXKFCOSA-N	C[C@]12CCC(=O)C=C1C=CC1C2=CC[C@@]2(C)C1CC[C@@]21CCC(=O)O1		
DE-85-FR73	MCUJKPPARUPFJM-UWCCDQBKSA-N	N[C@@H]1CCCN(c2c(/C=C3\\SC(=O)NC3=O)cccc2-c2ccccc2)C1	1204144-28-4	PIM1, PIM2 and PIM3 inhibitor
FE-03-MI11	MCVDOHRUKGRVJP-UHFFFAOYSA-N	O=S(=O)(c1ccc(F)cc1)n1cnc2ccccc21		
EE-03-SG02	MDCJMRUYCBMNJG-ZBWUASRJSA-N	Cc1nn(C)c(C)c1CCN1CCC[C@H]1c1ccc(/C=C/C(=O)NO)cc1		
GC-07-UO80	MDGIEDNDSFMSLP-UHFFFAOYSA-N	Nc1nc(NCc2ccccc2)nc(-c2ccccc2CO)n1	1309198-71-7	positive allosteric modulator of GPR68
DC-31-WP64	MDMLFHGEDDZHNU-UHFFFAOYSA-N	CCS(=O)(=O)c1ccc(CC(=O)Nc2nc(-c3ccccc3)c(C(=O)c3ccccc3)s2)cc1		
BB-86-MY27	MDMWHKZANMNXTF-UHFFFAOYSA-N	COC(=O)c1c(C)[nH]c(C)c1C(=O)c1ccccc1Cc1ccccc1	120934-96-5	Calcium channel stimulator L-type;L-Type Calcium Channel Activators;Calcium channel stimulator L-type;L-Type Calcium Channel Activators
QB-29-GK19	MDOJEACSAMCINM-UHFFFAOYSA-N	CCOP(=O)(OCC)Oc1ccc2oc(-c3ccccc3)cc(=O)c2c1	1294512-63-2	Cholesterol Esterase Inhibitors
XD-50-BD50	MDVFITMPFHDRBZ-JLHYYAGUSA-N	CCCCCc1ccc(/C=C/C(=O)Nc2cc(Cl)ccc2C(=O)O)cc1	99754-06-0	Phospholipase A2 (PLA2) Inhibitors
IE-34-IW27	MDZIRNPRVJEHHX-UHFFFAOYSA-N	O=C(O)c1cccc(Nc2ccc(C(F)(F)F)cc2)c1	1284180-11-5	AKR1C3 inhibitor
OD-07-NJ52	MEEJEEVTIVAOJP-UHFFFAOYSA-N	N#CC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1	193542-65-3	CCR1 antagonist;Chemokine US28 Receptor Inverse Agonists
DF-80-BU28	MEICIUGVENCLKP-UHFFFAOYSA-N	COc1ccc(-c2c(C)oc3c(-n4nc(C)nc4C)c(C)nn23)c(C)c1	1207258-55-6	CRF-1 receptor antagonist;CRF1 Antagonists
CF-56-LO98	METKIMKYRPQLGS-UHFFFAOYSA-N	CC(C)NCC(O)COc1ccc(CC(N)=O)cc1	106020-65-9	beta1-Adrenoceptor Antagonists
IA-48-KI53	MEYYEMQDVMMNNR-UHFFFAOYSA-N	CC(=O)c1cc2c(=O)c3c(C(=O)O)c(O)c(O)cc3oc2c(C(C)=O)c1-c1coc2cc(O)c(O)c(C(=O)O)c2c1=O	133293-89-7	semaphorin inhibitor
BD-39-KG21	MEZLKOACVSPNER-GFCCVEGCSA-N	C#CCN(C)[C@H](C)Cc1ccccc1	102741-42-4	MAO-B Inhibitors
AA-84-PX05	MFCJVWFYIKEHSF-UHFFFAOYSA-N	CCC(CC)n1c(=O)ccc2cnc([S+](C)[O-])nc21		
ZD-43-CS43	MFESEDFKTIAUHD-UHFFFAOYSA-N	O=C1Nc2c(Cl)ccc(Cl)c2C2(CCCCC2)N1		PDE7 gene inhibitor
BA-02-RI19	MFFMDFFZMYYVKS-SECBINFHSA-N	N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F	1169707-31-6	Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors
VB-89-RG34	MFKQRFCQVDRBIH-AREMUKBSSA-N	C[C@@](N)(CCc1ccc(C(=O)CCc2ccc(-c3ccccc3)cc2)cc1)COP(=O)(O)O		Lysophospholipid Receptor Agonists
AF-33-HJ54	MFKWLGOHFQBVAA-UHFFFAOYSA-N	O=C(NC1CCCCC1)c1cn(CCN2CCOCC2)c2cc(Cl)ccc2c1=O	913534-05-1	CNR2 agonist
CC-07-DV77	MFKZGAAAKCDLHM-UHFFFAOYSA-N	CCOc1cnccc1-c1nc2c(c(CC)nn2C2CCCC2)c(=O)[nH]1	158020-82-7	Phosphodiesterase PDE11A Inhibitors;Phosphodiesterase V (PDE5A) Inhibitors
WF-31-RY78	MFWNKCLOYSRHCJ-UHFFFAOYSA-N	CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2	107007-99-8	5-HT3 receptor antagonist
ID-30-ST90	MGAJKGJCXBAMOD-LLVKDONJSA-N	C[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(F)cc1		
ED-93-KF69	MGJUIYJDXXKQJS-UHFFFAOYSA-N	NCCC12CC3CC(CC(O)(C3)C1)C2		
IB-87-IU44	MGSRCZKZVOBKFT-UHFFFAOYSA-N	Cc1ccc(C(C)C)c(O)c1		
UB-40-KU41	MHDXPUHCAAORBI-PAPYEOQZSA-N	CCNC(=O)[C@@H]1C[C@H](n2cnc3c(N)nc(Nc4ccccc4)nc32)[C@@H](O)[C@H]1O		
KD-86-AJ75	MHENZDOHQIFURA-UHFFFAOYSA-N	CNS(=O)(=O)c1cc(C)ccc1C=C1c2ccccc2CCc2ccccc21	710339-96-1	Glucocorticoid Receptor (GR) Antagonists;Mineralocorticoid Receptor (MR) Antagonists
YB-79-DM48	MHFRGQHAERHWKZ-UHFFFAOYSA-O	CCCCCCCCCCCCCCCCCCOCC(COP(=O)(O)OCC[N+](C)(C)C)OC	130157-42-5	Lipid Homeostasis Modulator;Membrane Metabolism Inhibitor;Angiogenesis Inhibitors;CoA-Independent Transacyclase (CoA-IT) Inhibitors;Lipid Homeostasis Modulator;Membrane Metabolism Inhibitor;Angiogenesis Inhibitors;CoA-Independent Transacyclase (CoA-IT) Inhibitors
UB-30-TL20	MHNSICQXIMKCDK-UHFFFAOYSA-N	Cc1ccc(Sc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c(C)c1		
KE-04-OV29	MHOOPNKRBMHHEC-NSCUHMNNSA-N	C/C=C/C1=CC(=O)C(O)C1O		
DD-54-MA35	MIBCJEHHQRRSRL-UHFFFAOYSA-N	Cn1cc(-c2ccn3c(C(=O)Nc4cc(C(=O)NCCN5CCCC5(C)C)ccc4F)cnc3c2)cn1	1426531-23-8	PDGFR kinase inhibitor
QC-90-PV99	MIDUFIRTIFUTQA-UHFFFAOYSA-N	O=c1cc(CN2CCOCC2)occ1OCCCCCSc1ccnc2cc(C(F)(F)F)ccc12	754239-64-0	Angiogenesis Inhibitors;Rac1 GTPase Inhibitors
BE-37-IC77	MIJYXULNPSFWEK-GTOFXWBISA-N	CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1	508-02-1	Insulin Secretagogues;Secretory Phospholipase A2 (sPLA2) Inhibitors;LDL Antioxidants;G-Protein Coupled Bile Acid Receptor 1 Agonists;Protein Tyrosine Phosphatase PTP-1B Inhibitors
ND-54-NO97	MIJYXULNPSFWEK-KDQGZELNSA-N	CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1		
LB-14-EI63	MIQPIUSUKVNLNT-UHFFFAOYSA-N	Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1	1246816-93-2	COMT Inhibitors
HB-36-FN80	MJDJFIONJBJENE-UHFFFAOYSA-N	N#Cc1ccc(-c2ccc(OCCN(O)C=O)cc2)cc1		
AD-86-XL96	MJIHNNLFOKEZEW-UHFFFAOYSA-N	Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1	103577-45-3	H+/K+-ATPase Inhibitors
AA-12-VW53	MJQMRGWYPNIERM-HNNXBMFYSA-N	C[C@@]1(c2cc(-c3cncnc3)c(F)cc2F)CCSC(N)=N1	1194044-20-6	BACE1 gene inhibitor
AB-25-XU75	MJRGSRRZKSJHOE-UHFFFAOYSA-N	Cc1noc(NS(=O)(=O)c2cccc3c(N(C)C)cccc23)c1C	1215703-04-0	EDNRA antagonist;Endothelin ETA Receptor Antagonists
AA-57-CF49	MJVAVZPDRWSRRC-UHFFFAOYSA-N	CC1=CC(=O)c2ccccc2C1=O	130-37-0	Oxidative stress inducer;Vitamin K3;Cell Division Cycle CDC25 Phosphatase Inhibitors
OC-15-PM40	MJYFVDNMTKLGTH-UHFFFAOYSA-N	CN(C)C(=O)c1ccc(Cn2c(C(=O)O)cc3c(Br)cc(Sc4ccc(Cl)c(Cl)c4)cc32)cc1		
HB-43-TI61	MKPLKVHSHYCHOC-AHTXBMBWSA-N	CC(C)OC(=O)CCC/C=C\\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O	157283-68-6	Prostanoid FP Agonists
YE-46-YA12	MKRGNKRNZLHINT-UHFFFAOYSA-N	COc1ccc(-c2nc3c(C(N)=O)cccc3[nH]2)cc1	181135-48-8	Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors
NB-24-VE53	MKTAGSRKQIGEBH-SSDOTTSWSA-N	Clc1ccc(OC[C@H]2CCN2)cn1	198283-73-7	Nicotinic Receptor Agonists
CB-03-EP53	MKWFJPZMYHPQIA-UHFFFAOYSA-N	N=C(N)NC(=N)Nc1ccccc1Cl	137588-53-5	5-HT3 receptor agonist
BA-07-GC72	MKXKFYHWDHIYRV-UHFFFAOYSA-N	CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1	13311-84-7	Androgen Receptor Antagonists
AD-77-UF99	MLCQSMIPJLUCJS-PXDATVDWSA-N	O[C@@H]1CCN(c2nccc(-c3cccc(-c4cnc5ccc(N6CCC[C@@H]6c6cccc(F)c6)nn45)n3)n2)C1	1196546-32-3	TRKA Inhibitors;ALK Inhibitors;TRKB Inhibitors
FA-88-II68	MLDXOTJSBITMBI-UHFFFAOYSA-N	COC(CC(=O)c1cc2c3c(c(N)cc(NC(C)=O)c3n1)N=C2)OC		
AA-14-VK39	MLJVGAYSVYMPSB-MSUKGTQXSA-N	CC1=C(C)C(=O)C(C(C)(C)CC(=O)N(CCCCSC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2O)Cc2cccc(-c3ccc(Cl)cc3)c2)=C(C)C1=O		
CB-86-ME74	MLKXDPUZXIRXEP-MFOYZWKCSA-N	CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\\c1ccc([S+](C)[O-])cc1	32004-68-5	ABCC1 Expression Enhancers;ABCC3 Expression Enhancers;Non-Steroidal Antiinflammatory Drugs;NF-kappaB (NFKB) Activation Inhibitors
BA-40-IU73	MLLQJNIKDWEEFT-UHFFFAOYSA-N	Nc1nccc(Oc2ccc3c(C(=O)Nc4cccc(C(F)(F)F)c4)cccc3c2)n1	861875-60-7	Inhibitors of Signal Transduction Pathways;Protein Kinase Inhibitors
AB-17-LS35	MMFMUVGWJMYXRK-UHFFFAOYSA-N	O=C(O)CCCCCc1c(-c2cccnc2)[nH]c2ccccc12		Prostanoid TP Antagonists
CE-96-JE44	MMPAULQSJLVKHP-UHFFFAOYSA-N	Clc1cccc(-c2nnnn2Cc2cccnc2)c1Cl	899431-18-6	P2X7 Receptor Antagonists
S0-EE-Y9JI	MMYRYMMKMUTPBB-UHFFFAOYSA-N	CCCCCCC(=O)c1cc(-c2ccc(CC(=O)O)cc2)c2nccn2c1		Serine Palmitoyl Transferase inhibitor
HD-62-KE69	MNDBXUUTURYVHR-UHFFFAOYSA-N	O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1	162401-32-3	Phosphodiesterase IV Inhibitors
DC-98-CP35	MNENNUUKHSBOKZ-BEOVBFIISA-N	CC(C)c1ccc2c(c1)[C@@H](NC[C@@H](O)[C@@H]1C[C@H](C)CCCCCCCCC(=O)N(C)[C@@H](C)C(=O)N1)CC(C)(C)O2	1146544-18-4	beta-Secretase 1 (BACE1) Inhibitors;Cathepsin D Inhibitors
CB-82-BV25	MNFGRMAJNGDXMU-CONSDPRKSA-N	CC(=O)N[C@@H](Cc1ccc(CP(=O)(O)O)cc1)C(=O)NC1(C(=O)N[C@@H](CC(N)=O)C(=O)NCCCc2cccc3ccccc23)CCCCC1		Grb2 SH2 Domain Inhibitors
BD-22-KS33	MNHDDERDSNZCCK-UHFFFAOYSA-N	CN1CCN2c3ccccc3Cn3cccc3C2C1	71576-40-4	ADRA2A antagonist
JE-11-UD64	MNHDKMDLOJSCGN-UHFFFAOYSA-N	COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1	192384-87-5	Dopamine D3 Agonists
AC-10-PK69	MNJVRJDLRVPLFE-UHFFFAOYSA-N	Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1	202409-33-4	Cyclooxygenase-2 Inhibitors;Non-Steroidal Antiinflammatory Drugs
KD-54-IS22	MNPXTRXFUMGQLK-UHFFFAOYSA-N	O=C(Nc1nnc(-c2ccco2)o1)c1cc(-c2ccccc2)nc2ccccc12	851095-32-4	STAT-3 Inhibitors
AA-61-KE62	MOBYSLOKLMGQHM-UHFFFAOYSA-N	COCCOc1cncc(Nc2nc(-c3cccc(C#N)c3)c(-n3cncn3)s2)n1		Adenosine A2B Antagonists;Adenosine A3 Antagonists
DA-08-XJ96	MODNMLYGANOZDZ-UHFFFAOYSA-N	CC(=O)Nc1sc2c(c1-c1nc3ccccc3s1)CNC2		Apurinic/Apyrimidinic Endonuclease 1 (Apex1) Inhibitors
JE-22-JR20	MOFIOVCNCFPDJY-LBPRGKRZSA-N	COc1ccccc1CNC(=O)c1cc(C(F)(F)F)nn1-c1csc(CNC(=O)[C@H](C)N)c1	1051927-74-2	Coactivator Associated Arginine Methyltransferase 1 (CARM1 PRMT4) Inhibitors
OD-56-KP44	MOHDDECYHGSHBH-UHFFFAOYSA-N	NC(=O)c1ccccc1NC(=O)c1cccc([N+](=O)[O-])c1		
TE-25-NH87	MOOPBYUCHZCDPA-BUHFOSPRSA-N	O=C(/C=C/c1ccccc1Cc1ccc2ccccc2c1)NS(=O)(=O)c1cccs1		Prostanoid EP3 Antagonists
KB-24-RB56	MOTZDAYCYVMXPC-UHFFFAOYSA-N	CCCCCCCCCCCCOS(=O)(=O)O		
EE-62-XB72	MOYKHGMNXAOIAT-JGWLITMVSA-N	O=[N+]([O-])O[C@H]1CO[C@H]2[C@@H]1OC[C@H]2O[N+](=O)[O-]	54650-95-2	Natriuretic peptide receptor A agonist
BE-86-FY67	MPDGHEJMBKOTSU-YKLVYJNSSA-N	CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12	107420-91-7	11-beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Inhibitors;11-beta-Hydroxysteroid Dehydrogenase Type 2 (11beta-HSD2) Inhibitors;17beta-Hydroxysteroid Dehydrogenase Type 3 (17beta-HSD3) Inhibitors
KD-17-MR02	MPDMMSRZEHOFPA-UHFFFAOYSA-N	Cc1noc(C)c1CCn1nnc(-c2ccc(OC(F)(F)F)cc2)c1CCl		MGMT gene inhibitor
WE-48-PP43	MPEAULRVUBBAGO-VQTJNVASSA-N	CCn1cnc2c(Nc3ccc(S(=O)(=O)N4CCCCC4)cc3)nc(N[C@@H]3CCCC[C@@H]3C(N)=O)nc21		Protein Kinase Inhibitors
GB-50-PK29	MPHPHYZQRGLTBO-UHFFFAOYSA-N	CCCC1C(=O)N2C(N(C)C)=Nc3ccc(C)cc3N2C1=O	13539-59-8	Xanthine Oxidase Inhibitors;Non-Steroidal Antiinflammatory Drugs
AE-13-CX28	MPUQHZXIXSTTDU-QXGSTGNESA-N	NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O	1160295-21-5	NEDD8-Activating Enzyme (NAE) Inhibitors
RA-27-ST16	MPYLDWFDPHRTEG-PAAYLBSLSA-N	C[C@]12CC/C(=N\\OCCN)C[C@@H]1C(=O)C[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12	203737-93-3	Na+/K+-ATPase Inhibitors;SERCA2a Activator;Na+/K+-ATPase Inhibitors;SERCA2a Activator
AC-71-VV28	MPZNLZJMWPDRGB-UHFFFAOYSA-N	CCc1cnc(N2CCC(Oc3ccc(CC4CCN(S(C)(=O)=O)CC4)cc3Cl)CC2)nc1	1190979-58-8	GPR119 agonist
HA-17-MS45	MQBZVUNNWUIPMK-UHFFFAOYSA-N	O=C(Nc1ccc([N+](=O)[O-])cc1O)Nc1ccccc1Br	182498-32-4	CXCR2 antagonist
IE-75-ZC91	MQGPSCMMNJKMHQ-UHFFFAOYSA-N	O=c1cc(-c2ccccc2)oc2cc(O)ccc12	6665-86-7	Cytochrome P450 CYP1A1 Inhibitors
AB-72-EP76	MQIMZDXIAHJKQP-UHFFFAOYSA-N	C=Cc1cc(O)cc2nc(-c3ccc(O)c(F)c3)oc12	524684-52-4	Estrogen Receptor (ER) beta Agonists
AB-96-XV75	MQJKPEGWNLWLTK-UHFFFAOYSA-N	Nc1ccc(S(=O)(=O)c2ccc(N)cc2)cc1		
FE-19-OW54	MQOBSOSZFYZQOK-UHFFFAOYSA-N	CC(C)(Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1)C(=O)O		
CA-43-YM01	MQODFJBDUZVWDH-UHFFFAOYSA-N	Nc1nc(N2CCN(S(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12		NPY5R antagonist
DA-20-OX15	MQQNFDZXWVTQEH-UHFFFAOYSA-N	N=C(N)Nc1ccc(C(=O)Oc2ccc3cc(C(=N)N)ccc3c2)cc1	80251-32-7	Tryptase Inhibitors
EF-84-QW37	MQSXZQXHIJMNAF-UHFFFAOYSA-N	Cc1cc(O)c2c(c1)C(=O)c1c(c(O)cc(O)c1-c1c(O)cc(O)c3c1C(=O)c1cc(C)cc(O)c1C3=O)C2=O	131233-49-3	Glucagon Receptor (GCGR) Antagonists
CB-44-FA25	MQUQNUAYKLCRME-INIZCTEOSA-N	Cc1ccc(S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)CCl)cc1		
BA-69-TQ80	MQUYTXDAVCOCMX-UHFFFAOYSA-N	NS(=O)(=O)c1nn2cc(-c3ccccc3)nc2s1	63735-71-7	Apoptosis Inhibitors;Stress-Activated Protein (SAP/Jun) Kinase Inhibitors;Heat Shock Protein 70 (hsp70) Inducers;Apoptosis Inhibitors;Stress-Activated Protein (SAP/Jun) Kinase Inhibitors;Heat Shock Protein 70 (hsp70) Inducers
PF-39-DY68	MQZIGYBFDRPAKN-QISQUURKSA-N	CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)C(=O)C(O)CC2(C)C)C(C)(C)CC(O)C1=O		
BC-80-FK74	MQZNUFXSYVZICW-UHFFFAOYSA-N	CCCN(CC1CC1)c1nc(C)nc2c1c(C)c(C)n2-c1c(C)cc(C)c2nsnc12	736174-23-5	CRF1 Antagonists
OB-71-IZ36	MRAFQBWAGNWURO-UHFFFAOYSA-N	Cc1cccc(Oc2c[nH]c(=O)[nH]c2=O)c1	66047-04-9	Lyn Kinase Activators
NA-29-UI75	MRAMUVZVDBOPEH-JOCHJYFZSA-N	O=C(c1ccc(N2CCOCC2)cc1)N1CCC[C@@H](N(C(=O)CCl)c2ccccc2)C1		covalent modifier of catalytic cysteine of pro-CASP8
AB-14-GQ48	MRAUNPAHJZDYCK-BYPYZUCNSA-N	N/C(=N\\[N+](=O)[O-])NCCC[C@H](N)C(=O)O	1015842-89-3	Nitric Oxide Synthase Inhibitors
DD-38-BM78	MRBBFOWSPXHYQT-FCXRPNKRSA-N	COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)on2)ccc1O	114380-40-4	beta-Amyloid (Abeta) Aggregation Inhibitors;Cyclooxygenase-1 Inhibitors;Cyclooxygenase-2 Inhibitors;Free Radical Scavengers
AA-18-BW97	MRBDMNSDAVCSSF-UHFFFAOYSA-N	Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1	249607-96-3	alpha-Adrenoceptor Antagonists
ND-07-WN37	MRFOPLWJZULAQD-SWGQDTFXSA-N	Nc1ccc(/C=C/C(=O)NCc2cc3cc(-c4ccc(C(=O)N5CCC(F)(F)CC5)cc4)cc(-c4ccc(F)cc4)c3o2)cn1	1643913-93-2	Allosteric inhibitor that degrades PAK4
BB-99-UN48	MRHOGORWIALJOI-UHFFFAOYSA-N	Cc1c(CC(C)C)nc(-c2ccco2)n1-c1c(Cl)cccc1Cl		
EE-47-TB79	MRMCPDJLTSLWGF-OPXMRZJTSA-N	COc1ccc(CCNC(=O)[C@@H]2[C@H]3C[C@H]3CN2C(=O)NCc2cccc3ccc(Cl)cc23)cc1	1093652-34-6	Kallikrein 7 Inhibitors
BC-50-TK39	MRUSUGVVWGNKFE-MRXNPFEDSA-N	CCCCCCCCc1cccc(NC(=O)[C@H](N)COP(=O)(O)O)c1	449173-19-7	Lysophospholipid edg1 (S1P1) Receptor Antagonists;Lysophospholipid edg3 (S1P3) Receptor Antagonists;Lysophospholipid edg6 (S1P4) Receptor Agonists;Lysophospholipid edg8 (S1P5) Receptor Partial Agonists
JA-95-PQ25	MSCCTZZBYHQMQJ-AZAGJHQNSA-N	Cc1c(C)c2c(c(C)c1OC(=O)c1cccnc1)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2		
S0-EE-XGEL	MSFPLTWUFWOKBX-IFXJQAMLSA-N	Cc1nnc2c3ccccc3c(N[C@@H](C)[C@H](c3ccccc3)N(C)C)nn12		KAT2B, KAT2A inhibitor
CA-44-WJ06	MSHZHSPISPJWHW-PVDLLORBSA-N	CO[C@@H]1[C@H](OC(=O)NC(=O)CCl)CC[C@]2(CO2)[C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C	129298-91-5	Methionine Aminopeptidase-2 (MetAP2) Inhibitors;Angiogenesis Inhibitors
BB-63-AW70	MSJODEOZODDVGW-UHFFFAOYSA-N	N=c1[nH]c2ccc(Cl)cc2c2nc(-c3ccco3)nn12	104615-18-1	Adenosine Receptor Antagonists
BD-85-IA32	MSTOPLWRMNGDRS-INIZCTEOSA-N	CCc1cc(NC(=O)N[C@H](CO)CCN2CC(Oc3ccc(Cl)cc3)C2)n(C)n1		Chemokine CCR3 Antagonists
EE-49-CD29	MTCFGRXMJLQNBG-UWTATZPHSA-N	N[C@H](CO)C(=O)O	13095-79-9	NMDA Glycine-Site Agonists
DC-43-KF54	MTFDMQASMMCFHB-UHFFFAOYSA-N	O=C(O)CNS(=O)(=O)c1ccc2ccccc2c1	92740-48-2	Aldose Reductase Inhibitors
EA-84-SC49	MTKCOKFSICWGPP-UHFFFAOYSA-N	Nc1cccc(C(=O)c2sc(Nc3ccccc3)nc2N)c1		CDK inhibitor
XE-55-GK99	MTKHCEFATKQYMK-UHFFFAOYSA-N	CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccc(OS(=O)(=O)C(F)(F)F)cc32)CC1		Drugs Acting on Dopamine Receptors;Drugs Acting on 5-Hydroxytryptamine Receptors;Drugs Acting on Adrenoceptors;Drugs Acting on Dopamine Receptors;Drugs Acting on 5-Hydroxytryptamine Receptors;Drugs Acting on Adrenoceptors
TF-29-QU48	MTVMVQKGJODTNB-IHCZHZLTSA-N	COc1cc2c(cc1OC(C)C)C(c1ccc(Cl)cc1)N(c1cnc(N(C)C[C@H]3CC[C@H](N4CC(=O)N(C)C4)CC3)cn1)C(=O)C2		
DB-54-GQ68	MUAICZWSFWUFNA-INIZCTEOSA-N	C[C@H](NCc1ccc2c(c1)[nH]/c(=N\\C(=O)c1ccc(-c3cn[nH]c3)s1)n2CC(C)(C)O)C(C)(C)C	1149753-56-9	ITK (EMT) Kinase Inhibitors;IL-4 Production Inhibitors;IL-2 Production Inhibitors
BE-13-XC52	MUCVVURUYXBTPX-UHFFFAOYSA-N	O=c1[nH]c2c(Cc3nnn[nH]3)c3ccccc3n2c2ccccc12	391670-52-3	NAD+ ADP-Ribosyltransferase (poly(ADP-ribose)polymerase| PARP) Inhibitors
DB-33-HZ87	MUFJHYRCIHHATF-UHFFFAOYSA-N	O=C(O)CC1CC(c2ccccc2)=NO1	6501-72-0	Cytokine Modulators
IC-18-TY61	MUOKSQABCJCOPU-UHFFFAOYSA-N	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12	1009820-21-6	Casein Kinase II (CK2) Inhibitors
GB-45-YG91	MUXFZBHBYYYLTH-UHFFFAOYSA-N	CC(C(=O)O)c1ccc2c(c1)CC(=O)c1ccccc1S2	1166864-09-0	Cyclooxygenase (COX) Inhibitors;Non-Steroidal Antiinflammatory Drugs
DE-42-QB97	MVAWJSIDNICKHF-UHFFFAOYSA-N	CC(=O)NCCc1c[nH]c2ccc(O)cc12		
BB-49-OQ60	MVCOAUNKQVWQHZ-UHFFFAOYSA-N	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1	1283526-53-3	SAPK2 (p38beta) Inhibitors;Inhibitors of Signal Transduction Pathways;p38 MAPK Inhibitors
LB-54-MZ19	MVCQKIKWYUURMU-UHFFFAOYSA-N	CCCCCCCCCCCCCCCCOc1nc2ccc(C)cc2c(=O)o1	282526-98-1	Triacylglycerol Lipase (Hormone-Sensitive Lipase) Inhibitors;Pancreatic Triacylglycerol Lipase Inhibitors
ED-05-KX67	MVSJKTQQXQNEHK-PXLXIMEGSA-N	Oc1ccc(/C=N/N(Cc2ccccc2)Cc2ccccc2)cc1		Glucose-6-phosphatase Inhibitors
GD-08-JL45	MVSMTXJIJKVMLF-ITWZMISCSA-N	Cc1ccc(-c2sc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c2-c2ccc(F)cc2)cc1		
KC-45-DZ26	MVWWLCCKVBTYTD-UHFFFAOYSA-N	Nc1c(O)ccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O	1547162-41-3	CRBN neomorph;E3 ligase inhibitor
DA-67-HS65	MWDJHBRCBQFLAW-UHFFFAOYSA-N	NCc1ccnc(C(=O)NCc2ccccc2)c1		LOXL2 inhibitor
PC-85-EL52	MWDVCHRYCKXEBY-LBPRGKRZSA-N	C[C@H](NC(=O)CNC(=O)c1cccc(Cl)c1)c1ccccc1	1802326-66-4	potent and selective agonist of hGPR139 with an EC50 = 16 nM;GPR139 inhibitor
OB-20-LP90	MWIASLNTAGRGGA-OTALZHNTSA-N	Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(CC2NC(=O)[C@@H](N)CCS(C)(=O)=O)C3(C)C)CC1		OXTR antagonist
OF-19-JH77	MWKJCJFYJWIFLL-UHFFFAOYSA-N	NC(=O)CNC(COCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(c1ccccc1)c1ccccc1	148034-30-4	TACR1 antagonist
DB-67-IP73	MWLSOWXNZPKENC-UHFFFAOYSA-N	CC(c1cc2ccccc2s1)N(O)C(N)=O	111406-87-2	5-Lipoxygenase inhibitor;5-Lipoxygenase Inhibitors;Leukotriene Synthesis Inhibitors
GC-03-VV12	MWOOGOJBHIARFG-UHFFFAOYSA-N	COc1cc(C=O)ccc1O		
QB-99-OU03	MWPYFGLASMUYAV-GUBZILKMSA-N	CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C#N		Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors
NC-28-YK77	MXDUNVCRYHRLPR-WUFINQPMSA-N	Cc1cc2cc(n1)NCCCCc1cccc(c1)C[C@@H]([C@H](O)CNC1(c3cc(C(C)(C)C)ccn3)CC1)NC2=O		
BF-27-HP68	MXGWDBFUMHUPTG-SKZNYKRCSA-N	C=C1NC(=O)[C@@H](C)NC(=O)CNC(=O)[C@H](Cc2c[nH]c3cccc(OC)c23)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)c2csc(n2)[C@@H](C)NC(=O)CN(C)C1=O		GFM1 inhibitor;Apoptosis Inducers;Proteasome Inhibitors
CD-21-MI27	MXHRCPNRJAMMIM-SHYZEUOFSA-N	O=c1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]1		
AB-07-KC02	MXUSGDMIHGLCNC-HNNXBMFYSA-N	N#Cc1cc(F)cc(Oc2ccc(S(=O)(=O)C(F)F)c3c2CC(F)(F)[C@H]3O)c1		HIF2A/EPAS1 inhibitor
CC-68-YZ44	MXWDSZWTBOCWBK-UHFFFAOYSA-N	CN(C)c1ccc(C(=O)NCCCCCCC(=O)NO)cc1	251456-60-7	Histone Deacetylase (HDAC) Inhibitors
AC-21-IE62	MXWHMTNPTTVWDM-NXOFHUPFSA-N	CC(/C=N/NC(=N)N)=N\\NC(=N)N	13922-04-8	Polyamine Biosynthesis Inhibitors;S-Adenosyl-L-methionine Decarboxylase Inhibitors
WC-22-DS16	MXWNYMNWSAHNDN-UHFFFAOYSA-N	Cc1ccc(S(=O)(=O)c2nnn3c2nc(NC(C)c2ccccc2)c2sccc23)cc1		
CB-97-LV32	MXXWOMGUGJBKIW-YPCIICBESA-N	O=C(/C=C/C=C/c1ccc2c(c1)OCO2)N1CCCCC1	147030-08-8	ACAT Inhibitors;MAO-A Inhibitors;MAO-B Inhibitors
IC-99-JZ46	MXYUKLILVYORSK-HBMCJLEFSA-N	CN1[C@@H](CC(=O)c2ccccc2)CCC[C@H]1C[C@H](O)c1ccccc1	134-63-4	Dopamine Receptor Modulators;alpha4beta2 nicotinic acid receptor partial agonist
IA-35-KC86	MXYUKLILVYORSK-HKBOAZHASA-N	CN1[C@@H](C[C@H](O)c2ccccc2)CCC[C@H]1CC(=O)c1ccccc1		
AC-53-RC32	MXYZRWQQCYFNLZ-VXKWHMMOSA-N	N#C[C@H](CCc1ccccc1)NC(=O)[C@H](CC1CCCCC1)NC(=O)N1CCOCC1		
GC-21-AN18	MYKJVLTXPNIGOV-KTKRTIGZSA-N	CCN(C/C=C\\c1ccc(C2CCCCC2)c(Cl)c1)C1CCCCC1	132173-06-9	sigma1 Receptor Ligands;sigma2 Receptor Ligands
EC-87-ZB49	MYKOWOGZBMOVBJ-UHFFFAOYSA-N	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21	1173022-21-3	calcium/calmodulin-dependent protein kinase inhibitor
AD-89-LX67	MYMBRLBXPADVCH-IUNQSVEYSA-N	CCC[C@H](NC(=O)[C@@H]1C[C@@]2(CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN(CC)C1)C1CCCCC1)C(C)(C)C)C(C)(C)C21CCC1)C(=O)C(=O)NC1CC1		
CA-56-VE74	MYSWGUAQZAJSOK-UHFFFAOYSA-N	O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O		
MB-83-RV32	MYTRGTBDVGKKRO-UHFFFAOYSA-N	O=C(NCC(=O)N1CCCCC1)Nc1ccc2nnsc2c1	1426152-53-5	PRMT3;allosteric PRMT3 inhibitor
HB-24-GP45	MYZPKVPIILDSSN-UHFFFAOYSA-N	Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCCN1		5-HT1D Agonists
JF-79-OI50	MZAGXDHQGXUDDX-JSRXJHBZSA-N	CC/C(=C\\C(=N\\O)C(N)=O)C(C)[N+](=O)[O-]	163180-49-2	Nitric Oxide Donors;Soluble Guanylyl Cyclase (sGC) Activators;Nitric Oxide Donors;Soluble Guanylyl Cyclase (sGC) Activators
IA-50-ET40	MZDYABXXPZNUCT-UHFFFAOYSA-N	CCCN(CCC)CC1CCCCN1CCNC(=O)N1c2ccccc2C(=O)Nc2cccnc21	118290-27-0	dual CHRM2/CHRM4 antagonist
DF-75-JD89	MZHFJNUVTFIFDX-SJORKVTESA-N	CCCC[C@H](CN(O)C=O)C(=O)N1CCC[C@H]1C(=O)Nc1cc(CC)ccn1		Peptide Deformylase (PDF) Inhibitors
RA-23-IX31	MZKQCJZDYJDDML-WNJJXGMVSA-N	Cc1ccc(NC(=O)[C@H]2CCCN(C(=O)c3ccccc3Cl)[C@H]2c2ccc(NC3CCCC3)cc2)cc1C(F)(F)F	1346623-19-5	C5a Antagonists
HF-25-LA47	MZRVIHRERYCHBL-HNNXBMFYSA-N	Cn1nc(C(C)(C)C)cc1C(=O)N[C@@H](Cc1cccc(Cl)c1)C(=O)NCC#N	225120-65-0	Cathepsin L Inhibitors
BA-60-DR11	MZYNHNDFHWNIIU-INIZCTEOSA-N	O=C(COc1ccc(CO)cc1)N1CC[C@H](Oc2ccccc2C(F)(F)F)C1	1111078-63-7	SCD inhibitor
SA-40-VR29	NAPHUBPIUWHFCT-UHFFFAOYSA-N	NC(CCc1ccccc1)P(=O)(O)O	89537-16-6	
CE-15-DU45	NAUWTFJOPJWYOT-UHFFFAOYSA-N	Fc1ccc(C(OCCN2CCN(CCCc3ccccc3)CC2)c2ccc(F)cc2)cc1	110872-73-6	Dopamine Reuptake Inhibitors
AA-42-XZ05	NAXBGVSFGBQHDO-UHFFFAOYSA-N	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCN(CCO)CC4)cn3)nc2n1C1CCCC1	1211440-85-5	CDK4 Inhibitors
EA-98-NW07	NAXSRXHZFIBFMI-UHFFFAOYSA-N	O=C(O)Cc1cccc(OCCCN(Cc2cccc(C(F)(F)F)c2Cl)CC(c2ccccc2)c2ccccc2)c1	405911-09-3	Liver X Receptor (LXR) Agonists;ABCA1 Expression Enhancers
DE-90-RU43	NBBJQUGYDBWHDI-UHFFFAOYSA-N	NC1CCc2c(Br)cccc2CC1=O	1023619-94-4	Membrane Alanine Aminopeptidase (Aminopeptidase N) Inhibitors
LE-60-VC29	NBEOSAFVNPGHAS-UHFFFAOYSA-N	O=C(NCc1ccc(Cl)cc1Cl)C1CC(=O)N(Cc2ccccc2)C1	851269-75-5	P2X7 Receptor Antagonists
CE-66-GR30	NBHPRWLFLUBAIE-UHFFFAOYSA-N	O=C(NCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1)c1ccc(F)cc1	59831-65-1	Dopamine Receptor Antagonists;Phospholipase D2 (PLD2) Inhibitors
CD-12-NI84	NBKGUPAYHLZPHD-UHFFFAOYSA-N	CCOCCOCCOCCCCCNC(=O)NC12CC3CC(CC(C3)C1)C2		Soluble Epoxide Hydrolase Inhibitors
ED-32-VE54	NBOMNTLFRHMDEZ-UHFFFAOYSA-N	O=C(O)c1ccccc1S		
AW-15-2439	NBQUWOCIFFHZTM-UHFFFAOYSA-N	N=c1[nH]c(-c2cccc3ccccc23)cs1	56503-96-9	5-HT2B Antagonists
GF-84-NF76	NBYATBIMYLFITE-UHFFFAOYSA-N	CCCCCCCCCC[Si](C)(C)CCC(=O)NC(Cc1ccc(C)cc1)c1ccccc1	78934-83-5	ACAT Inhibitors
JE-13-EV67	NCDZFGJFTFXHIW-UHFFFAOYSA-N	N#CC1(NC(=O)CNC(=O)Cc2nc3ccc(-c4ccccc4)cc3s2)CC1	1221924-74-8	Endothelial Lipase (EL) Inhibitors
IE-17-LV02	NCKLQXXBRWCYMA-FQEVSTJZSA-N	CC[C@@]1(c2ccccc2)C2=C(CC(C)(C)CC2=O)Nc2n[nH]cc21		
AE-85-KE62	NCNRHFGMJRPRSK-MDZDMXLPSA-N	O=C(/C=C/c1cccc(S(=O)(=O)Nc2ccccc2)c1)NO	414864-00-9	HDACs;Apoptosis Inducers;Histone Deacetylase 1 (HDAC1) Inhibitors;Histone Deacetylase 2 (HDAC2) Inhibitors;Angiogenesis Inhibitors
UD-07-US73	NCRSWJPOFRASIF-HMMYKYKNSA-N	C/C1=C\\C(C)C(C)OC(=O)CC(c2ccc(O)cc2)NC(=O)C(Cc2c[nH]c3ccccc23)N(C)C(=O)C(C)NC(=O)C(C)C1		Actin stabilizer
GF-57-MY04	NCTLNAWWXKBSSW-IYARVYRRSA-N	CC(C)(C)OC(=O)NC[C@H]1CC[C@H](CNS(=O)(=O)c2ccc3ccccc3c2)CC1	192323-14-1	Acetyl-CoA Carboxylase 2 (ACC2) Inhibitors
BD-45-WH14	NCZYSQOTAYFTNM-UHFFFAOYSA-N	Cc1c(C(=O)Nc2cccc(C(F)(F)F)c2)cc(-c2ccccc2)n1CCCN1CCOCC1	883031-03-6	TRPV4 gene inhibitor
LB-90-DC89	NDAUXUAQIAJITI-GFCCVEGCSA-N	CC(C)(C)NC[C@@H](O)c1ccc(O)c(CO)c1		
AB-71-VZ28	NDAUXUAQIAJITI-UHFFFAOYSA-N	CC(C)(C)NCC(O)c1ccc(O)c(CO)c1	148563-15-9	beta2-Adrenoceptor Agonists
DD-23-QZ62	NDDAHWYSQHTHNT-UHFFFAOYSA-N	CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1	26807-65-8	Carbonic Anhydrase Type VII Inhibitors
KA-71-CQ35	NDEVFXJRZJJZDG-UHFFFAOYSA-N	CC(C)(C)c1ccc(S(=O)(=O)n2c(C(=O)O)cc3cc(Cl)ccc32)cc1	1046151-58-9	CCR9 chemokine antagonist
VF-07-NP76	NDIKFKQBWGMLCA-DEOSSOPVSA-N	Cc1noc(C)c1Cn1cc(C#N)c2cc(Oc3ccc(NC(=O)[C@@H]4CCCN4)cc3)ccc21		inhibition of PFKFB3 leads to inhibition of glycolysis;PFKFB3 inhibitor
DB-41-SH04	NDMDQWQVLLPKLR-JOCHJYFZSA-N	O=C(O)C[C@@H](CC1CCCC1)C(=O)N(c1nc(-c2ccccc2-c2ccc(N3CCCC3=O)nc2)cs1)C1CC1	1229364-35-5	Free Fatty Acid Receptor 2 (FFAR2|  GPR43) Ligands;FFAR2 agonist;Free Fatty Acid Receptor 2 (FFAR2|  GPR43) Ligands;FFAR2 agonist
CF-35-NN63	NDPBMCKQJOZAQX-UHFFFAOYSA-N	COc1ccc(S(=O)(=O)Nc2nc(-c3cccc([N+](=O)[O-])c3)cs2)cc1OC	199666-03-0	Kynurenine 3-Monooxygenase Inhibitors
AB-09-JN93			1533426-72-0	
JC-24-MC69	NEKZEBMUYCZCTC-UHFFFAOYSA-N	O=C(N1CCCC1)n1cc(-c2ccc(-c3ccccc3)cc2)nn1	1312782-40-3	Acylaminoacyl peptidase inhibitor
PA-40-NS72	NENPYTRHICXVCS-YNEHKIRRSA-N	CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](N)[C@H]1NC(C)=O		
DC-88-RF46	NEQSWPCDHDQINX-MRXNPFEDSA-N	CS(=O)(=O)c1ccc([C@@H](CC2CCCC2)C(=O)Nc2nccs2)cc1	599164-57-5	Glucokinase Activators;Glucose Lowering Agents
BF-52-HF07	NETXMUIMUZJUTB-UHFFFAOYSA-N	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1	1044870-39-4	BRD2/3/4/T BET familiy inhibitor;APOA1 Expression Enhancers;BRD4 inhibitor
BC-03-OQ01	NEZONWMXZKDMKF-UHFFFAOYSA-N	CC(C)=CCC(O)C1=CC(=O)c2c(O)ccc(O)c2C1=O	11019-15-1	Apoptosis Inducers;TNF Expression Inhibitors;Non-Steroidal Antiinflammatory Drugs;Angiogenesis Inhibitors;Drugs Acting on Chemokine Receptors
AE-28-WC14	NFACJZMKEDPNKN-UHFFFAOYSA-N	COP(=O)(OC)C(O)C(Cl)(Cl)Cl	26373-97-7	Butyrylcholinesterase Inhibitors
IB-23-AO00	NFBCSWGEYDCCDW-UHFFFAOYSA-N	Cc1cccc(Nc2ncnc3ccc(N)cc23)c1	153436-70-5	Tyrosine Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Tyrosine Kinase Inhibitors;Inhibitors of Signal Transduction Pathways
EA-95-YN88	NFEQFEDSWINARK-KBPBESRZSA-N	CC(C)CN[C@H]1CS(=O)(=O)C[C@@H]1S(=O)(=O)c1ccc(Cl)cc1		
KD-68-JH25	NFHRQQKPEBFUJK-HSZRJFAPSA-N	CN1C(=O)[C@@H](NC(=O)c2cc3ccccc3[nH]2)N=C(c2ccccc2)c2ccccc21	103420-77-5	CCK1 (CCKA) Antagonists
EE-99-ZM45	NFIXBCVWIPOYCD-UHFFFAOYSA-N	CCN(CC)CCOc1ccc(Cc2ccccc2)cc1	1185241-83-1	Estrogen Receptor (ER) Antagonists;Histamine Receptor Antagonists
AE-34-SK19	NFLZAWLLXDSRBZ-UHFFFAOYSA-N	Cc1c(S(=O)(=O)Nc2cccc(C(=O)O)c2)sc2ccc(Cl)cc12	1365719-41-0	6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3 (PFKFB3) Inhibitors
AB-11-QV43	NFOLAKWLEGGBTA-UHFFFAOYSA-N	CCOc1c(OC)ccc2cc(C(=O)Nc3ccc(C(C)(C)N)cc3)c(=O)oc12		S1PR1 agonist
AC-77-BC52	NGAIXAHLIFBQTF-UHFFFAOYSA-N	CC(C)CC1C(=O)NC(=N)N1c1nc(NC(=N)N)nc(Nc2ccccc2)n1		
DA-45-PU65	NGBFQHCMQULJNZ-UHFFFAOYSA-N	Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1	56211-40-6	Drugs Acting on Potassium Channels
BF-05-EV13	NGBKFLTYGSREKK-PMACEKPBSA-N	CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](C=O)Cc1ccccc1	756485-04-8	Calpain Inhibitors
EB-09-OC36	NGHOLYJTSCBCGC-VAWYXSNFSA-N	O=C(/C=C/c1ccccc1)OCc1ccccc1	103-41-3	17beta-Hydroxysteroid Dehydrogenase (17beta-HSD)  Inhibitors
AE-69-CH29	NGNALWDRPKNJGR-UHFFFAOYSA-N	O=C(O)C1=CCCN(CCON=C(c2ccccc2)c2ccccc2)C1	145645-62-1	GAT-1 Inhibitors
AB-09-YX02	NGSWKAQJJWESNS-ZZXKWVIFSA-N	O=C(O)/C=C/c1ccc(O)cc1		
AD-39-QQ00	NGVMVBQRKZPFLB-YFKPBYRVSA-N	CSC(=N)NCCC[C@H](N)C(=O)O	156719-39-0	Nitric Oxide Synthase Inhibitors
HA-32-YH61	NHFIAAAMCYVRIW-UHFFFAOYSA-N	COc1ccc(C2CC(c3c(O)cc(C)oc3=O)=NCCS2)c(OC)c1	257292-29-8	P-Selectin Inhibitors
QB-87-TC65	NHJSWORVNIOXIT-UHFFFAOYSA-N	COc1cc(OC)cc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1	192705-79-6	Tyrosine Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Basic Fibroblast Growth Factor (bFGF;FGF2) Inhibitors;Angiogenesis Inhibitors
AA-02-FS13	NHOWLEZFTHYCTP-UHFFFAOYSA-N	NNCc1ccccc1		
AD-51-BB90	NHUHCSRWZMLRLA-UHFFFAOYSA-N	Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C	127-69-5	Endothelin Receptor Antagonists
CD-03-QC42	NHVRIDDXGZPJTJ-UHFFFAOYSA-N	CP(=O)(O)CCCN	127729-35-5	GABA(B) Agonists;GABBR1 agonist
KD-30-SM33	NHZMQXZHNVQTQA-UHFFFAOYSA-N	Cc1ncc(CO)c(CN)c1O		
DC-61-QV78	NIAOXEKTWMHVEO-UHFFFAOYSA-N	CC[n+]1c(/C=C/C=C2\\N(C)c3ccccc3C2(C)C)sc2ccccc21	108527-83-9	SIRT2 inhibitor
SA-53-XG95	NICHJJOSEXYBED-AMGIVPHBSA-N	CC(C)C[C@H](NC(=O)CCN(C)C)c1cc(Cl)ccc1N1CCN(C(=O)[C@H](C)Cc2ccc(Cl)cc2)CC1		Melanocortin MC4 Receptor Antagonists
AE-95-KU30	NIDVDYQCGWISJZ-UHFFFAOYSA-N	Cn1c(=O)c2c(ncn2CCN2CCN(c3ccccc3Cl)CC2)n(C)c1=O	1254041-13-8	Potassium Channel Activators;Phosphodiesterase Inhibitors;Guanylate Cyclase Activators
BE-68-LK29	NIJJYAXOARWZEE-UHFFFAOYSA-N	CCCC(CCC)C(=O)O	1069-66-5	Histone Deacetylase 1 (HDAC1) Inhibitors;GABAergic Transmission Enhancers
DE-52-BS63	NIVBGOGCJSMNMG-KRWDZBQOSA-N	CCN1c2ccc(F)cc2N=C(N[C@H]2CCN(C(=O)NC(C)(C)C)C2)c2cc(Cl)ccc21		PAK1 gene inhibitor
DE-46-NH51	NJIBWEPWTWDEJU-UHFFFAOYSA-N	COc1ccc(C2CCC(=O)C2)cc1OC1CCCC1		
HB-51-FH64	NJQHZBRWPXRTIW-UHFFFAOYSA-N	O=C(O)c1ccc(Nc2nc(Cl)nc(Cl)n2)cc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12		Deoxyribonuclease (DNase) gamma Inhibitors
HD-85-AJ28	NJXZWIIMWNEOGJ-WEWKHQNJSA-N	COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3ccccc3OC)(N3C[C@H](O)C[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1	352276-92-7	DNA-Directed RNA Polymerase Inhibitors
HC-18-NB46	NJYPALQXNVNJOH-UHFFFAOYSA-N	COc1ccc2c(CCNC(C)=O)c[nH]c2c1		
AC-74-ZA35	NJZHEQOUHLZCOX-FTLRAWMYSA-N	Fc1cc(F)c2c(c1)[C@H]1C=CC[C@H]1C(c1cccnc1)N2	1139889-93-2	Golgi-Specific Brefeldin A-Resistance Guanine Nucleotide Exchange Factor 1 (GBF1) Inhibitors
AE-37-MC27	NKANXQFJJICGDU-QPLCGJKRSA-N	CC/C(=C(\\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1	10540-29-1	Selective Estrogen Receptor Modulator (SERM)
HC-95-WQ65	NKHAVTQWNUWKEO-NSCUHMNNSA-N	COC(=O)/C=C/C(=O)O		
CA-56-GE89	NKRAIOQPSBRMOV-NRMKKVEVSA-N	C#C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1n1ccc2c(N)ncnc21		
BC-82-PP66	NKUDGJUBIVEDTF-FYJGNVAPSA-N	C/C(=N\\NC(=O)c1cccc(S(=O)(=O)N2CCOCC2)c1)c1cc(Cl)ccc1O	1423715-09-6	KDM1A (LSD1) inhibitor;KDM1A inhibitor
NC-52-AG88	NLCKCKYSUHCUDR-HJWRWDBZSA-N	O=C(/C=C\\C(=O)Nc1cccc(Cl)c1)Nc1ccc(Cl)cc1		XPO1 (CRM1) inhibitor
MA-88-CA03	NLIIKGCVOJPMQB-UHFFFAOYSA-N	Oc1ccc(C2COc3cc(O)c(O)cc3C2)cc1		
WC-16-IR43	NLKQTNGJKCBXMU-MDZDMXLPSA-N	O=C(/C=C/c1ccc(CNCCc2cnc3ccccc3c2)cc1)NO		Histone Deacetylase (HDAC) Inhibitors
KB-92-MK13	NMCXSWNTABUZSU-UHFFFAOYSA-N	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1NC1CCCCCC1		Tpl-2/Cot (MAP3K8) Kinase Inhibitors;TNF-alpha Production Inhibitors
DA-83-IZ87	NMEKVOIWAJHKSG-REYBDVSVSA-N	CCOCCOc1ccc2c(COc3cccc4[nH]c(C(=O)N[C@H]5CC[C@](O)(CCN6CC[C@H](O)[C@@H](C)C6)CC5)cc34)coc2c1		Chemokine CCR2 (MCP-1 Receptor) Antagonists;Chemokine CCR5 Antagonists
GD-46-OD81	NMFLMLJPBJHWSE-UHFFFAOYSA-N	c1cc(N2CCCCC2)ccc1OC12CC3CC(CC(C3)C1)C2		
CD-84-FJ21	NMIRAZSAZYNODX-UHFFFAOYSA-N	Cc1[nH]c(=O)c(C#N)cc1-c1ccc(C#N)cc1		
AD-30-OK99	NMTKJEZOWHRAQY-UHFFFAOYSA-N	COc1ccc2cncc(Cc3nc4c([nH]3)c(=O)n(C)c(=O)n4CC(C)C)c2c1		Phosphodiesterase V (PDE5A) Inhibitors
QF-71-QI30	NMUMGBKBHOJAQD-UHFFFAOYSA-N	CN(C)c1ccc(C(=O)NCCCCCCCC(=O)NO)cc1		Histone Deacetylase (HDAC) Inhibitors
DF-00-DK69	NMUSYJAQQFHJEW-KVTDHHQDSA-N	N=c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(O)n1	1401238-97-8	DNMT1;Antimetabolites;Apoptosis Inducers;DNA Methyltransferase (DNMT) Inhibitors;DNMT1;Antimetabolites;Apoptosis Inducers;DNA Methyltransferase (DNMT) Inhibitors
FB-67-PL18	NNACHAUCXXVJSP-UHFFFAOYSA-N	Clc1ccc(CCCOCCCN2CCCCC2)cc1	362665-56-3	Histamine H3 Receptor Inverse Agonists;Histamine H3 Receptor Antagonists
AA-99-HG96	NNAIYOXJNVGUOM-UHFFFAOYSA-N	CCNC(=O)N1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1	75529-73-6	5-HT2A Antagonists;Dopamine D2 Antagonists;5-HT2A Antagonists;Dopamine D2 Antagonists
IA-84-ES37	NNDATQSUZGLGQT-FZMZJTMJSA-N	CN1CCC[C@H]2c3cccc4[nH]cc(c34)C[C@@H]21		
BB-50-CR51	NNKGSGUFNSCAOR-UHFFFAOYSA-N	Cc1cc2c(cn1)cc(-c1cc(Nc3noc(-c4ccccn4)n3)ccc1C)c(=O)n2C	1185280-04-9	KIT (C-KIT) Inhibitors
KD-50-WP70	NNRSVGLUJAPMQD-UHFFFAOYSA-N	N=C(N)Nc1ccc(Cl)c(Cl)c1	112677-24-4	5-HT3 Receptor agonist;Cell Adhesion Inhibitors
JB-74-LJ21	NNUFRZJZOXVZIT-FQEVSTJZSA-N	N#Cc1ccc(-c2ccc(C[C@@H](C#N)NC(=O)C3(N)CCOCC3)cc2)cc1	1254318-44-9	cathepsin C (DPP1) inhibitor
EE-35-XA42	NODBJFYQYVUCCT-UHFFFAOYSA-N	COc1ccc(CCC(=O)Nc2cccc3ccc(C)nc23)cc1		
CA-90-TK74	NOEGNKMFWQHSLB-UHFFFAOYSA-N	O=Cc1ccc(CO)o1	67-47-0	Binds to hemoglobin, increases oxygen affinity thereby reducing sickling of cells
BA-60-RH02	NOHQEAFAESMMDX-UHFFFAOYSA-N	CC(C)(C)c1nc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)c3ccccc23)c2c(N)nccn12	1589527-65-0	IRE1 RNase Allosteric Inhibitor
VA-11-NO89	NOOBQTYVTDBXTL-UHFFFAOYSA-N	NS(=O)(=O)c1nc2ccc(O)cc2s1	1348093-27-5	Carbonic anhydrase type I inhibitor;carbonic anhydrase type II inhibitor;Carbonic anhydrase type I inhibitor;carbonic anhydrase type II inhibitor
HF-33-KS15	NOOLISFMXDJSKH-KXUCPTDWSA-N	CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O	114376-98-6	TRPM8 (TRP-p8;CMR1) Agonists
HB-79-CT92	NORNNMHDCZHPNP-UHFFFAOYSA-N	S=c1[nH]nc(Cc2ccccc2)n1-c1ccccc1	22478-90-6	Neutral Sphingomyelinase (N-SMase) Inhibitors
DD-71-LY65	NOYPYLRCIDNJJB-UHFFFAOYSA-N	COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC	251301-18-5	Antimetabolites;Dihydrofolate Reductase (DHFR) Inhibitors
QA-30-EV79	NOZIJMHMKORZBA-KJCUYJGMSA-N	CCCCCCO[C@@H](C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(/C=C(\\C)C(=O)O)c(Cl)c3)n2)c1OC	1110766-97-6	Signal Transduction Modulators;Thrombopoietin Receptor (c-MPL) agonist
FF-08-DP35	NPFDWHQSDBWQLH-QZTJIDSGSA-N	Cc1ccc(-c2ncccn2)c(C(=O)N2C[C@H](COc3ccc(F)cn3)CC[C@H]2C)c1	1088991-73-4	Orexin 1 receptor antagonist, Orexin 2 receptor antagonist
QA-27-XW03	NPJVGQHTXJHUEL-UHFFFAOYSA-N	CC(=O)N1c2ccccc2C(Nc2ccccc2)CC1C		
PE-86-SC73	NPUXORBZRBIOMQ-RUZDIDTESA-N	Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CN3CCC[C@@H]3CO)cc2)c1	1415562-82-1	SPHK1 inhibitor
JF-14-JC89	NQQBNZBOOHHVQP-UHFFFAOYSA-N	Nc1nnc(Sc2ncc([N+](=O)[O-])s2)s1	40045-50-9	SAPK1c (JNK1) Inhibitors
GA-97-UL18	NQWXHRRWWPCDAJ-BRJLIKDPSA-N	CCc1cc(O)cc2c(/C=N/NC(=N)NCCc3ccc(Cl)cc3)c[nH]c12		RXFP3 agonist
DD-17-HS50	NRHUXQVZPSEKDF-UHFFFAOYSA-N	COc1cccc(F)c1CNc1ccc(-c2cccnc2C)c2nncn12		EED gene inhibitor
BD-32-GI59	NRJSHVPDELFHKB-UHFFFAOYSA-N	CCc1cc2cc(OCCO)c(OC)cc2c(-c2cc(OC(C)C)cc(OC(C)C)c2)n1		Phosphodiesterase IV Inhibitors
PA-80-RV09	NSCPCMXKWUFFNL-UHFFFAOYSA-N	CCCCCCCCCC(O)(P(=O)(O)O)P(=O)(O)O	2809-23-6	
DE-24-AX80	NSDYPYMREQWLNC-UHFFFAOYSA-N	Cc1ccc(CCc2cnc3c(N)nc4ccccc4c3c2)c(C)c1	1186635-48-2	TLR7 Receptor Agonists;TLR8 Receptor Agonists
TA-34-CK62	NSMRMZWAHUBRPG-UHFFFAOYSA-N	NC(=O)CCNc1cc(-c2ccnc(Nc3cccc(Cl)c3)n2)ccn1		CDK1 Inhibitors
EC-12-AY12	NSMXQKNUPPXBRG-SECBINFHSA-N	C[C@@H](O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O		
IB-78-AY41	NSQNZEUFHPTJME-UHFFFAOYSA-N	NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(Cl)cc2)cc1	170569-86-5	Cyclooxygenase-2 Inhibitors
OC-59-JO99	NSSHPRGGTPKDER-RISCZKNCSA-N	COCC#CCOc1ccc(C(=O)N[C@H](C(=O)NO)[C@@H](C)N)cc1		
AC-36-FB52	NSWZIIRKLUDMHN-IIUQYHHOSA-N	CCC[C@H](NC(=O)[C@@H]1C[C@@]2(CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1CCCCN1C(C)C)C1CCCCC1)C(C)(C)C)C(C)(C)C21CCC1)C(=O)C(=O)NC1CC1		
AB-09-AD74	NTAVPKUNVZRIQP-ICSRJNTNSA-N	Cc1cc(C)n(-c2cc(-c3cnc4ccc(N[C@H]5CCC[C@H](O)C5)cn34)ccn2)n1	1146615-30-6	Activin Receptor Like Kinase 5 (ALK5 TbetaR-I) Inhibitors
NC-85-PZ41	NTCCRGGIJNDEAB-IRXDYDNUSA-N	CC(C)C[C@H](N[C@@H](Cc1cncn1Cc1cc(Cl)cc(Cl)c1)C(=O)O)C(=O)O	1315337-39-3	Angiotensin-I Converting Enzyme-Related Carboxypeptidase (ACE2) Inhibitors
JC-86-PD41	NTCCRGGIJNDEAB-SJORKVTESA-N	CC(C)C[C@@H](N[C@@H](Cc1cncn1Cc1cc(Cl)cc(Cl)c1)C(=O)O)C(=O)O	305335-31-3	angiotensin I converting enzyme 2 inhibitor
CB-92-VC05	NTDFYGSSDDMNHI-UHFFFAOYSA-N	CC[S+]([O-])c1nc(-c2cccc(OCc3ccccc3)c2)cc(C(F)(F)F)n1	1371569-69-5	covalent positive allosteric modulator of GLP1R
RA-02-OJ95	NTHMDFGHOCNNOE-ZJUUUORDSA-N	CSC[C@H]1CN(Cc2c[nH]c3c(N)ncnc23)C[C@@H]1O		Methylthioadenosine Phosphorylase (MTAP) Inhibitors
KB-39-DB68	NTINAJCDYRYMML-UHFFFAOYSA-N	COc1ccc(C(=O)C(=O)c2ccccc2)cc1	22711-21-3	Carboxylesterase Inhibitors
AB-82-EP26	NTPLIHVIDFWRGV-UHFFFAOYSA-N	CN1CCC(O)(c2cn(-c3ccnc(NC4CCCC4)n3)c(-c3cccc(C(F)(F)F)c3)n2)CC1		p38alpha MAPK Inhibitors
CA-23-CC52	NTXBDULODNTCKP-UHFFFAOYSA-N	COc1ccc(Nc2nc(C(=O)N3CCc4ccccc4C3)cs2)cc1	736945-96-3	TRPC6 Antagonists;TRPC3 Antagonists
HA-81-VN33	NTYJJOPFIAHURM-UHFFFAOYSA-N	NCCc1c[nH]cn1	117932-92-0	NADPH Oxidase Inhibitors;Histamine Receptor Agonists;NADPH Oxidase Inhibitors;Histamine Receptor Agonists
PD-11-LM65	NUFNQYOELLVIPL-UHFFFAOYSA-N	O=C(O)c1cc(Oc2ccc(C(F)(F)F)cc2Cl)ccc1[N+](=O)[O-]		
CF-61-OL44	NUPGBBOOIBGQDL-UHFFFAOYSA-N	Cc1cc(-c2ccccc2)nc2cc(C(=O)Nc3cccc(O)c3)nn12	312634-95-0	Phosphodiesterase PDE11A Inhibitors
MF-17-BD63	NUTDKFGHUBYHFK-UHFFFAOYSA-N	CC(=O)Nc1nc(C)c(-c2csc(Nc3cccnc3)n2)s1	860619-25-6	Phosphatidylinositol 3-Kinase gamma (PI3Kgamma) Inhibitors
SE-15-AV21	NUUSUAWULNXMGF-UHFFFAOYSA-N	O=C(Nc1ccc(Cl)c(Cl)c1)Nc1ccc2nnsc2c1	1257423-87-2	Eukaryotic Translation Initiation Factor 2-alpha Kinase 1 (HRI) Activators
JA-79-II25	NVAHQQYCEWEDKM-UHFFFAOYSA-N	Cn1c(=O)n(C2CCN(CCCn3nc(-c4ccc(C(F)(F)F)cc4)c4c3CCN(S(C)(=O)=O)C4)CC2)c2cc(Cl)ccc21	400797-24-2	Cathepsin S Inhibitors
VF-20-LY76	NVNSXBXKNMWKEJ-UHFFFAOYSA-N	O=C1C(=Cc2ccc(-c3ccccc3[N+](=O)[O-])o2)C(=O)N(c2ccccc2)C(=S)N1c1ccccc1	313649-08-0	Omi/HtrA2 Inhibitor
FB-62-GL41	NVOWFSVQTZTXSO-UHFFFAOYSA-N	O=C(O)c1cccc(-c2nc(-c3ccc(Cl)cc3)no2)c1		Nurr1 Receptor Activators
AE-13-WW30	NVYPANNIKFKQTB-UHFFFAOYSA-N	CN1C2CC(OC(=O)c3c[nH]c4ccccc34)CC1C1OC12	122732-06-3	5-HT3 Antagonists
GC-42-SY57	NVYQUIXKTUPQLY-VIFPVBQESA-N	CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)Nc1nnc(S)s1		
UA-39-TN76	NWBJAUFHPXRBKI-QMMMGPOBSA-N	CC(=N)NCCSC[C@](C)(N)C(=O)O	364067-16-3	Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Inositol Monophosphatase Inhibitors;Nitric Oxide Synthase Inhibitors;Signal Transduction Modulators
TE-87-FM14	NWFVLACQZHHSMZ-HNNXBMFYSA-N	Nc1nc(-c2ccccc2)cc(-c2ccc(C[C@H](N)C(=O)O)cc2)n1		
KE-74-OZ09	NXCSEAQOKPSNJV-UHFFFAOYSA-N	Cc1cc(Cl)ccc1CN(Cc1ccc(Cl)cc1)Cc1ccc([N+](=O)[O-])s1	1438071-12-5	REV-ERB agonist
BD-85-OV63	NXFFJDQHYLNEJK-CYBMUJFWSA-N	CS(=O)(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3	571170-77-9	Prostanoid DP (DP1) Antagonists
BA-51-DL54	NXFIEIXVSJMOQL-UHFFFAOYSA-N	Cc1cc2[nH]ncc2cc1-c1ccccc1C(F)(F)F	1613505-14-8	TRPA1 antagonist
EF-92-OO68	NXNGLEYSIAXGCL-UHFFFAOYSA-N	CNc1nc(SC)ncc1CO	17759-30-7	CDK Inhibitors
WA-36-EE47	NYAKHMNXWJGORW-UHFFFAOYSA-N	NCC1(CCNC(=O)Nc2ccc3cnccc3c2)CCCCC1		Allosteric PRMT3 inhibitor
FD-44-AD67	NYBZCKAQIIPSDS-UHFFFAOYSA-N	COc1ccc(-c2c(C)nn3c(C(F)(F)F)cc(C)nc23)c(F)c1F		
BE-45-VH04	NYDXWCQDYMSMIW-UHFFFAOYSA-N	CCOC(=O)c1ccncc1NCc1ccccc1		
FD-79-KT27	NYJGMJFBEVSQNN-CNRHASOASA-N	C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(ccc([C@H]3C[C@@H](N(C)C)[C@H](O)[C@@H](C)O3)c1O)C2=O	60227-09-0	Protein Kinase B (PKB/Akt) Inhibitors
LA-31-YT57	NYQXVKFKGJZIOC-UHFFFAOYSA-N	O=c1[nH]c2ccc(Cl)cc2c2nc(-c3ccccc3F)nn12	104615-04-5	GABA(A) BZ Site Receptor Antagonists
FA-94-QJ71	NYXDSXZBPWSAFA-UHFFFAOYSA-N	O=S(=O)(Nc1ccc(O)c(-c2c(O)ccc3ccccc23)c1)c1cccs1		Heat Shock Protein 90 (hsp90) Inhibitors
HA-82-OO58	NZCRJKRKKOLAOJ-XRCRFVBUSA-N	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\\C=C\\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C	80621-81-4	Inhibitor of transcription by by binding to the β-subunit of bacterial RNA polymerase, also activator of NR1I2
AD-23-AN14	NZHGWWWHIYHZNX-CSKARUKUSA-N	COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC	053902-12-8	IL-10 Production Enhancers;IL-2 Production Inhibitors;IL-4 Modulators;Indoleamine 2,3-dioxygenase Activators;Signal Transduction Modulators;TNF-alpha Production Inhibitors;IFN-gamma Production Inhibitors;Urate Transporter 1 (URAT1) Inhibitors
ME-62-IQ37	NZLDBNPKNBCGEN-UHFFFAOYSA-N	c1ccc2nc(COc3cccc4ccccc34)ccc2c1	110033-17-5	Lipoxygenase Inhibitors;Antiinflammatory Drugs;Lipoxygenase Inhibitors;Antiinflammatory Drugs
JC-53-YE56	NZOONKHCNQFYCI-UHFFFAOYSA-N	CC(C)(C)Sc1c(CC(C)(C)C(=O)O)n(Cc2ccc(Cl)cc2)c2ccc(OCc3ccc4ccccc4n3)cc12		
TA-36-PC58	NZRBRJQYGLEINZ-UHFFFAOYSA-N	N#Cc1c(-c2cc(OCc3ccccc3)cc(OCc3ccccc3)c2)cc(-c2cc(Cl)ccc2O)[nH]c1=O	1453835-43-2	Survivin Dimerization Inhibitors
KF-37-OX16	OAGYIOQZUSMRQV-UHFFFAOYSA-N	CC(=O)Nc1nc(-c2cccc(C)c2)c(-c2ccncc2)s1		Inhibitors of Signal Transduction Pathways;Adenosine A3 Antagonists;p38 MAPK Inhibitors;TNF-alpha Production Inhibitors
AA-47-MP58	OAIGRGDPMHLUJB-UHFFFAOYSA-N	CC1(OC(=O)N2CCC(COc3ccc(N4CCN(S(C)(=O)=O)CC4)nc3)CC2)CC1	1134104-96-3	
FC-82-WB67	OAIJSZIZWZSQBC-GYZMGTAESA-N	CC(C)=CCC/C(C)=C/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C=C(\\C)CCC=C(C)C		
WC-82-YS26	OAOCGQNMPOSYNM-UHFFFAOYSA-N	Cc1cccc(-c2nc(-c3cncc(-c4ccccc4C)c3)c3cc[nH]c3n2)n1		
BB-85-NU70	OAVGBZOFDPFGPJ-UHFFFAOYSA-N	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1	1058706-31-2	Protein Kinase PKC beta Inhibitors;Protein Kinase PKC theta Inhibitors;Protein Kinase PKC delta Inhibitors;Protein Kinase PKC alpha Inhibitors;Protein Kinase PKC epsilon Inhibitors
HB-72-BR75	OAVYVUXOTKQIRA-FUFSCUOVSA-N	CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C(=O)Nc2ccc(-c3ccccc3)cc2)C1		CXCR3 antagonist
AA-39-ZQ15	OBKXEAXTFZPCHS-UHFFFAOYSA-N	O=C(O)CCCc1ccccc1	1262970-43-3	Apoptosis Inducers;Histone Deacetylase (HDAC) Inhibitors
BA-66-BL56	OBTSACXGWYGCPK-UHFFFAOYSA-N	O=C(Nc1cc(O)cc(-c2cccs2)c1)Nc1ccc2ccccc2c1	1680196-54-6	frizzled-4 anatagonist
AA-89-HG56	OBWGMKKHCLHVIE-UHFFFAOYSA-N	CN1CCN(C2=Nc3cc(F)ccc3Cc3ccccc32)CC1	67121-76-0	Dopamine D2 Antagonists;5-HT2A Antagonists
PD-70-VS77	OBWNLXZLIGARLU-OUKQBFOZSA-N	CC(C)(C)c1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1		
CA-66-GI09	OBWOHJWFRIKFRD-UHFFFAOYSA-N	C=CCn1nc(-c2ccc(OC)c(OC)c2)c2cccc(C(F)(F)F)c21	1227290-29-0	Aryl hydrocarbon receptor modulator
OC-55-QZ56	OBYGAPWKTPDTAS-OCAPTIKFSA-N	C[C@H]([C@H](C)N1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1		
TE-15-RO34	OBZCWUUQSDVACZ-UHFFFAOYSA-N	Cc1cc(NC(=O)c2ccc3c(c2)CCNC3)nn1Cc1cc(Cl)ccc1OCC1CC1	1103260-94-1	SCD gene inhibitor
IA-35-VT87	OCBMECSFDVUYQN-ROUUACIJSA-N	COC[C@H](C)Oc1cc(O[C@@H](C)Cc2ccccc2)cc(C(=O)Nc2ccc(C(=O)O)cn2)c1	851884-87-2	Glucokinase Activators;Glucose Lowering Agents
TF-04-RX73	OCCJXNOZISGUGT-UHFFFAOYSA-N	Cc1nc2cnc3ccc(C#Cc4cccnc4)cc3c2n1-c1ccc(CCC#N)cc1		
BD-50-HU68	OCJYIGYOJCODJL-UHFFFAOYSA-N	Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1	1104-22-9	PCYT2 inhibitor
PF-59-CY33	OCQPKQVXUZWWQU-UHFFFAOYSA-N	COc1ncc(-c2ccc3ncc4c(c3c2)n(-c2cn(C(C)C)nc2C)c(=O)n4C)c(OC)n1		dual mTOR PI3K inhibitor
QD-13-FQ44	ODCKPUDNMNCWMR-UHFFFAOYSA-N	Cc1ccc2[nH]c3nc(O)nc-3cc2c1C	124886-01-7	Phosphodiesterase III Inhibitors
BF-97-LS55	ODEYARCPHPFZOJ-KFWWJZLASA-N	O=CN(O)C[C@@H](CC1CCC1)C(=O)N1C[C@H](F)C[C@H]1C(=O)Nc1cccn[n+]1[O-]		Peptide Deformylase (PDF) Inhibitors
AA-85-LB25	ODKNJVUHOIMIIZ-RRKCRQDMSA-N	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F	136353-77-0	Pyrimidine Antagonists
FB-56-SR65	ODKSFYDXXFIFQN-BYPYZUCNSA-N	N=C(N)NCCC[C@H](N)C(=O)O		
DD-36-YH76	ODPGGGTTYSGTGO-UHFFFAOYSA-N	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1	630124-46-8	Flt3 (FLK2/STK1) Inhibitors;Inhibitors of Signal Transduction Pathways
AB-07-WP43	ODQWQRRAPPTVAG-BOPFTXTBSA-N	CN(C)CC/C=C1/c2ccccc2COc2ccccc21	1229-29-4	Histamine H1 Receptor Antagonists;Histamine H2 Receptor Antagonists;5-HT Reuptake Inhibitors;Norepinephrine Reuptake Inhibitors
AB-85-YK41	ODUOJXZPIYUATO-UHFFFAOYSA-N	CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1	81110-73-8	Neprilysin (Enkephalinase, Neutral Endopeptidase, NEP) Inhibitors
DE-30-EA70	ODXQFEWQSHNQNI-UHFFFAOYSA-N	O=C(O)C(=O)c1cn(Cc2ccccc2)c2ccc(-c3ccc(OC(F)(F)F)cc3)cc12	393105-53-8	Plasminogen Activator Inhibitor (PAI-1) Inhibitors
TE-26-XS06	ODZBBRURCPAEIQ-PIXDULNESA-N	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1/C=C/Br	69304-47-8	Heat Shock Protein 27 (hsp27) Inhibitors;Reverse Transcriptase Inhibitors;Heat Shock Protein 27 (hsp27) Inhibitors;Reverse Transcriptase Inhibitors
FD-09-BQ45	OEBPANQZQGQPHF-UHFFFAOYSA-N	Cn1c(NCCN(CCO)CCCc2ccc([N+](=O)[O-])cc2)cc(=O)n(C)c1=O	130636-43-0	Potassium Channel Blockers;K(V)11.1 (erg1) Channel Blockers
BD-17-LT43	OEDGERSSZUMLBI-UHFFFAOYSA-N	CCS(=O)(=O)c1ccc(S(=O)(=O)NC)cc1Nc1cc(Nc2ccc(Cl)cn2)ncn1	1316059-00-3	Tnni3 kinase inhibitor
DA-27-BW40	OEDSFMUSNZDJFD-UHFFFAOYSA-N	CCNC(=O)c1cc2c(-c3cc(C(C)(C)O)ccc3Oc3c(C)cc(F)cc3C)cn(C)c(=O)c2[nH]1		BET inhibitor BD2 selective
RA-57-TJ22	OELFLUMRDSZNSF-BRWVUGGUSA-N	CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1	105816-04-4	K(ir) 6.2/SUR1 Blockers;Insulin Secretagogues
AF-76-AY17	OESNKOKTKJVMIR-WSBQPABSSA-N	CC(C)(C#N)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C	149281-19-6	Steroid 5alpha-Reductase Inhibitors
RB-74-JO32	OEXMNSOPAKOPEF-UHFFFAOYSA-N	CC(=O)Nc1ccc(Cc2ccc(NC(C)=O)cc2)cc1		
ID-30-NC19	OEYYOVRNPJSWTO-IBGZPJMESA-N	CC(C)N1CCC[C@H]1CNC(=O)c1cn(C2CCCC2)c(=O)c2c1c1ccccc1n2C		GLP-1 receptor agonist
JC-75-LJ73	OEZAIJNKVSSLFH-QZHFEQFPSA-N	CC[C@H](C)COc1ccc([C@H](CO)NC(=O)[C@H]2C[C@@H]2c2cccs2)cc1	1286280-32-7	GPR88 agonist
BE-42-WI29	OFBIFZUFASYYRE-UHFFFAOYSA-N	CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2	78755-81-4	GABA(A) BZ Site Receptor Antagonists
EC-56-YK73	OFEZSBMBBKLLBJ-BAJZRUMYSA-N	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)C[C@H]1O	73-03-0	PAPOLA gene inhibitor
AF-23-HJ84	OFGZKSUTEKHHAS-UHFFFAOYSA-N	CCOc1cc(CN2CCC(Nc3nc4cc(S(N)(=O)=O)ccc4o3)CC2)cc(OCC)c1N		Somatostatin SRIF1B (sst5) Antagonists
FA-47-JB44	OFHXXBRBGWUOHR-NYYWCZLTSA-N	COc1ccc(C(=O)N2CCN(C(=O)/C=C/c3ccc(Br)cc3)CC2)cc1	1599432-08-2	GPR183 antagonist
IB-80-NT15	OFQCVYOFPPDYDD-XIFFEERXSA-N	CN(C)CCNC(=O)C1=C[C@@]2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2	388598-00-3	Vasopressin (AVP) V1a Antagonists
AB-16-PO08	OFVLGDICTFRJMM-WESIUVDSSA-N	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12	115074-43-6	Antibiotic;30S Ribosomal Protein Inhibitors;Protein Arginine Deiminase Inhibitors
JB-55-CM55	OFWGHMAISKOSQV-UHFFFAOYSA-N	O=C1Nc2c(Cl)cc(-c3ccccc3)cc2C2(CCCCC2)N1		PDE7A gene inhibitor
TE-32-AC63	OFWWWKWUCDUISA-UHFFFAOYSA-N	Cc1cc2c(cc1N1C(=O)c3cccc4c(CCCO)ccc(c34)C1=O)n(C)c(=O)n2C		Bromodomain inhibitor
AB-68-SC09	OFYVIGTWSQPCLF-UHFFFAOYSA-N	Cc1ccc(C23CNCC2C3)cc1	66504-75-4	NMDA Antagonists;Norepinephrine Transporter (NET) Inhibitors;Serotonin Transporter (SERT) Inhibitors
IA-23-DB04	OFZJKCQENFPZBH-UHFFFAOYSA-N	O=C(Nc1nc(-c2cc(Cl)cs2)c(N2CCN(C3CCCCC3)CC2)s1)c1cnc(N2CCC(C(=O)O)CC2)c(Cl)c1	570406-98-3	Signal Transduction Modulators;Thrombopoietin Receptor (TpoR) Agonists
AF-80-QK39	OGAKLTJNUQRZJU-UHFFFAOYSA-N	OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1	19-11-4	Muscarinic M1 Receptor Ligands;Muscarinic M3 Receptor Ligands;Muscarinic M4 Receptor Ligands
FE-64-KC49	OGHNVEJMJSYVRP-UHFFFAOYSA-N	COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12	107741-96-8	beta1-Adrenoceptor Antagonists
IA-14-WP20	OGQICQVSFDPSEI-UHFFFAOYSA-N	CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1	118292-40-3	Retinoid RARgamma Agonists;Ornithine Decarboxylase Inhibitors;Retinoid RARbeta Agonists
LF-50-IZ49	OGSPWJRAVKPPFI-UHFFFAOYSA-N	NCCCC(O)(P(=O)(O)O)P(=O)(O)O	121268-17-5	Protein Tyrosine Phosphatase (PTP) Inhibitors;Farnesyl Pyrophosphate Synthase Inhibitors;Protein Tyrosine Phosphatase (PTP) Inhibitors;Farnesyl Pyrophosphate Synthase Inhibitors
MA-42-XG98	OGZLSMWTACJBSH-UHFFFAOYSA-N	CN1CCN(C2=Nc3cc(Cl)c(O)cc3Nc3ccccc32)CC1		
DA-85-SU90	OHAXNCGNVGGWSO-UHFFFAOYSA-N	O=C(Nc1ccc(Cl)cc1)c1cc2ccccc2cc1O	92-78-4	Cyclic AMP Response Element-Binding Protein (CREB) Inhibitors
AC-92-HS43	OHCQJHSOBUTRHG-KGGHGJDLSA-N	C=C[C@@]1(C)CC(=O)[C@]2(O)[C@@]3(C)[C@@H](O)CCC(C)(C)[C@@H]3[C@H](O)[C@H](OC(C)=O)[C@@]2(C)O1	64657-11-0	Adenylate Cyclase Activators
DC-97-ZB69	OHFLESATPONDTK-UHFFFAOYSA-N	N#CCC(c1cccc(Cl)c1)c1c[nH]c2c(=O)[nH]c(N)nc12	139367-69-4	Purine-Nucleoside Phosphorylase Inhibitors
JC-95-LT07	OHNPMEHVPMTGTH-UHFFFAOYSA-N	Cc1cccc(C)c1-c1noc(C)c1NC(=O)OCc1c(F)cccc1Cl	1104461-51-9	Nav1.7 ( PN1/hNE-Na) Sodium Channel Blockers
TF-36-BS66	OHOZGQXXXVZLBJ-NBOCEFNVSA-N	C[C@H](CO)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	10162-98-8	Cholesterol Biosynthesis Inhibitors; Delta(24)-Sterol Reductase (DHCR24) Inhibitors
AD-02-XI19	OHUZYICHQJQNNX-UHFFFAOYSA-N	CN(C)c1ccc(NC(=O)Nc2ccnc3cccnc23)cc1		Orexin 1 receptor antagonist
AB-84-PK04	OHVGZODROPSVRZ-UHFFFAOYSA-N	COc1cccc(F)c1CNc1ccc(-c2cnc(C)nc2C)c2nncn12		EED gene inhibitor
AC-82-PZ00	OIGHTPDWPMLMGT-UHFFFAOYSA-N	c1cc2c3c(c1)c1c(n3CCNC2)CCCC1	57756-45-3	5-HT2C Agonists;HTR2C agonist
CA-06-FY97	OILHAXASEUKARN-UHFFFAOYSA-N	CC1(OC(=O)N2CCC(COc3cnc(N4CCN(S(=O)(=O)CCCN5CCC5)CC4=O)cn3)CC2)CC1	1134107-73-5	Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119) Ligands
S0-EE-YLU9	OINGHOPGNMYCAB-INIZCTEOSA-N	CC(C)NC(=O)N1CC[C@H](NC2=Nc3cc(F)ccc3N(CC(F)F)c3ccc(Cl)cc32)C1		PAK1 inhibitor
BA-52-FW03	OIRDTQYFTABQOQ-KQYNXXCUSA-N	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	142796-17-6	Adenosine Receptor Agonists
SA-01-QC36	OIXABFWKYOZLGQ-QGZVFWFLSA-N	COC(=O)c1ccnc(-c2cn([C@@H]3CCCN(C(=O)c4ccccc4)C3)nn2)c1		KDM2A inhibitor
FE-10-KQ78	OJCKRNPLOZHAOU-MNKIFKDHSA-N	C[C@@H]1C[C@H](C)C[C@H](C)[C@@H](O)CC(=O)O[C@H]([C@@H]2CCC[C@H]2C(=O)O)C/C=C\\\\C=C(/C#N)[C@H](O)[C@@H](C)C1		Translation inhibitor;TARS inhibitor;angiogenesis inhibitor
HF-73-FS05	OJHLJXROBUJUPQ-UHFFFAOYSA-N	CNc1nc2nc3c1[nH]c(=O)n3Cc1cccc(c1)OCCOCCO2		NUDT1 Inhibitor;NUDT1 inhibitor
JA-82-EV20	OJHMDRZMENMQFP-UHFFFAOYSA-N	Nc1c(C(=O)c2ccccc2)sc2[nH]c(=O)c(C(=O)O)cc12	439946-22-2	Ubiquitin C-terminal Hydrolase L1 (UCH-L1) Inhibitors;Inhibitor of Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4)
YE-55-YX75	OJLOPKGSLYJEMD-ZRDIBKRKSA-N	CCCCC(C)(O)C/C=C/C1C(O)CC(=O)C1CCCCCCC(=O)OC		PTGER2 agonist;PTGER3 agonist;PTGER4 agonist
KD-44-PB06	OJOVBVONXDWCFW-CBHOWOPOSA-N	CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC1=O		
HA-75-LT22	OJPLJFIFUQPSJR-INIZCTEOSA-N	CC(C)(C(=O)NCC(F)(F)C(F)(F)F)C(=O)N[C@@H]1C(=O)Nc2ccccc2-c2ccccc21	847925-91-1	gamma-Secretase Inhibitors;Drugs Acting on Notch Receptors
LA-21-GQ75	OJQMKCBWYCWFPU-UHFFFAOYSA-N	CC(C)N(CCCCOCC(=O)O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1	475085-57-5	PTGIR agonist;Prostacyclin agonist
HE-80-BQ08	OKJDLRMQHZRYOZ-UHFFFAOYSA-N	NCCCn1c2c(c3ccc([N+](=O)[O-])cc3c1=O)C(=O)c1ccc(O)cc1-2		Dual Top1, TDP1 inhibitors
WD-73-QC55	OKPNYGAWTYOBFZ-UHFFFAOYSA-N	O=C(O)c1cc(O)c2c3nc4ccccc4oc-3cc(=O)c2n1		
FE-67-IO55	OKSSCZFPRININV-UHFFFAOYSA-N	Cn1cc(C2=C(c3nc(N4CCNC5(CC5)C4)cc4ccccc34)C(=O)NC2=O)c2ccccc21		
IF-08-GY16	OKVCTOBWIAGOMR-ACCUITESSA-N	COc1cc(/C=C/C(=O)CCCCc2ccccc2)ccc1O	81840-57-5	Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Tyrosinase Inhibitors;IL-1 Inhibitors;Antioxidants;TNF-alpha Production Inhibitors
ED-15-OX47	OLHQOJYVQUNWPL-UHFFFAOYSA-N	[H]/N=C(\\N)SCCCN(C)C	23256-33-9	HRH2 agonist
AC-45-YY00	OLHSUYVYCWVXTG-UHFFFAOYSA-N	CNc1ncc(-n2nc(N)c3cc(F)c(-c4ccc(O)c5ccccc45)cc32)c(Cl)c1C		
BB-21-XL84	OLIKCJUMYWSDIV-UHFFFAOYSA-N	Cc1oc2ccccc2c1Cc1cc(I)c(OCC(=O)O)c(I)c1	147030-48-6	Antithyroid Drugs
AD-45-DA82	OLNTVTPDXPETLC-XPWALMASSA-N	O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1	163222-33-1	Niemann-Pick C1-like protein 1 (NPC1L1) Inhibitors;Cholesterol Absorption Inhibitors
MF-37-KQ09	OLPSAOWBSPXZEA-JIEICEMKSA-N	C[C@]12CC[C@H](O)CC1=C[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12	2487-48-1	Estrogen Receptor (ER) beta Ligands
BA-24-BX40	OLTZHXYLLRJLST-UHFFFAOYSA-N	Cc1ccc(C(=O)Cn2c3c(sc2=N)CCCC3)cc1	206983-57-5	
AB-71-NB55	OLWWIAFRNOFHTL-UHFFFAOYSA-N	CN1CCC(O)(c2nc(-c3ccc(F)cc3)c(-c3ccncc3)o2)CC1		TNF-alpha Release Inhibitors;p38 MAPK Inhibitors
IA-19-ET52	OLXZPDWKRNYJJZ-RRKCRQDMSA-N	Nc1ncnc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1		
FB-97-DI91	OLYYSDFIGRYMDS-UHFFFAOYSA-N	Clc1ccc(CN2CCN(c3cccc4[nH]ccc34)CC2)cc1Cl		
XD-60-SU16	OMHZFEWYVFWVLI-UHFFFAOYSA-N	O=C1C(=Cc2cccnc2)C(=O)c2ccccc21	31083-55-3	Ubiquitin Protein Ligase E3 Inhibitors
ZB-45-AK89	OMISHRJQMYQPMG-UHFFFAOYSA-N	O=C1CCC(N2Cc3cc(C4CCN(Cc5ccccc5)CC4)ccc3C2=O)C(=O)N1		
AA-01-PS31	OMJHHTRDBKAMSN-LLVKDONJSA-N	Nc1nc(N2CCC3(CC2)COC[C@H]3N)cnc1Sc1ccnc(N)c1Cl		SHP2 allosteric inhibitor
AE-61-UO01	OMKBGTGZWMRDAZ-OAQYLSRUSA-N	CN(C)c1ccc(-c2ccc(S(=O)(=O)N[C@@H](C(=O)O)C3CCN(C(=O)OC(C)(C)C)CC3)s2)cc1	458558-79-7	MMP-13 (Collagenase 3) Inhibitors
DB-80-QN16	OMOMUFTZPTXCHP-UHFFFAOYSA-N	CCCC(CCC)C(N)=O		
CD-16-KY17	OMTNUGOQXBZIDL-UHFFFAOYSA-N	O=C(O)c1ccc2cc(NCc3nc(-c4ccccc4Cl)cs3)ccc2c1	1050506-98-3	G Protein-Coupled Receptor GPR120 Agonists
CE-04-PX35	ONBSHRSJOPSEGS-INIZCTEOSA-N	CS(=O)(=O)c1ccc(Oc2cc(F)cc(C#N)c2)c2c1[C@H](O)C(F)(F)C2	1672665-49-4	HIF2a / Hif-2 alpha inhibitor (gene: EPAS1);HIF2A inhibitor (HIF-2 alpha inhibitor)
ND-33-UV62	ONDYALNGTUAJDX-UHFFFAOYSA-N	COc1cccc2c1c(O)c(C(=O)N(C)c1ccc(C(F)(F)F)cc1)c(=O)n2C	254964-60-8	S100A9 Inhibitors;Histone Deacetylase 4 (HDAC4) Inhibitors
OE-50-VB46	ONNGKMAEIWXVBI-UHFFFAOYSA-N	O=c1[nH]c2c(O)ccc(C(O)CNCCc3ccc(OCCCCc4ccccc4)cc3)c2s1	862594-14-7	beta2-Adrenoceptor Agonists
AD-33-YW85	ONNMDRQRSGKZCN-UHFFFAOYSA-N	CCCCP(=O)(O)CCCN		
BE-36-FY37	ONYFNWIHJBLQKE-ZETCQYMHSA-N	C/C(N)=N\\CCCC[C@H](N)C(=O)O	150403-89-7	Inducible Nitric Oxide Synthase (NOS-2) Inhibitors
BE-33-IM71	OODPPJDFRMJIDK-UHFFFAOYSA-N	Nc1nccc(Oc2ccc3c(C(=O)Nc4ccc(F)c(C(F)(F)F)c4)cccc3c2)n1	890128-04-8	VEGFR-2 (FLK-1/KDR) Inhibitors
EF-75-CQ05	OOGJQPCLVADCPB-HXUWFJFHSA-N	Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1	124937-51-5	Muscarinic M3 Antagonists
BC-09-XQ45	OONFNUWBHFSNBT-HXUWFJFHSA-N	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1	497839-62-0	Angiogenesis Inhibitors;EGFR (HER1;erbB1) Inhibitors;HER2 (erbB2) Inhibitors;Inhibitors of Signal Transduction Pathways;VEGFR-2 (FLK-1/KDR) Inhibitors
KE-07-JX81	OOPCWGWDZXXLFV-RVDMUPIBSA-N	CCN(CC)C(=O)/C=C(\\C)c1ccc(OCc2c(F)cccc2F)c(OCC(=O)O)c1		Leukotriene BLT (LTB4) Antagonists
DE-01-HO61	OOUGLTULBSNHNF-UHFFFAOYSA-N	O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1	775304-57-9	Putative translational readthrough (TRT) molecule;Nonsense Mutation Suppressors;modulator of translational readthrough
KE-68-FV64	OOWCDRLEANCOSL-UHFFFAOYSA-N	CC(C)(C)c1ccc(S(=O)(=O)n2ccc3cc(C#N)ccc32)cc1		CCR9 antagonist
GB-39-OF03	OOYBKKYAZSKAEJ-UHFFFAOYSA-N	Cc1c(SC#N)c(=O)n(-c2ccccc2)n1C	91397-05-6	CRF Receptor Antagonists
DE-09-HJ53	OPGVEUGCNGNPSX-OOQHNNQLSA-N	C=CC(O)(CC[C@@H](C)C1CCC2C3CC=C4C[C@@H](O)CC[C@]4(C)C3CC[C@@]21C)C(C)C		
BB-05-NK66	OPKZTANCWQVQNS-COIPROHOSA-O	O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)[C@](O)(c1ccccc1)C1CCCC1)C2)Nc1ccon1		
AC-14-JQ68	OPSRUAAFZJIVQO-INIZCTEOSA-N	CC(C)CC(=O)N[C@@H](CCCCNC(=O)c1ccc(C(=N)N)cc1)CC(=O)O		
AA-35-VH74	OQDPVLVUJFGPGQ-UHFFFAOYSA-N	c1cnc(N2CCN(Cc3ccc4c(c3)OCO4)CC2)nc1	1451048-94-4	Dopamine D2 Agonists;Dopamine D3 Agonists;alpha2-Adrenoceptor Antagonists
QF-00-CY91	OQGRFQCUGLKSAV-UHFFFAOYSA-N	O=C1CCC(NC(=O)Cc2ccccc2)C(=O)N1		
KC-43-HY29	OQLODOGGOMSJDF-MRXNPFEDSA-N	CCc1ccccc1-c1cccc2[nH]c(C(=O)NC[C@@H](N)C(=O)O)cc12		NMDA Glycine-Site Modulators;Lysophospholipid edg6 (S1P4) Receptor Agonists;NMDA Glycine-Site Modulators;Lysophospholipid edg6 (S1P4) Receptor Agonists
FA-36-VA24	OQPHGDVGVLRNQC-UHFFFAOYSA-N	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4ccnc(NC)n4)cc3)cc2C(F)(F)F)CC1		
AE-28-IQ88	OQQVFCKUDYMWGV-UHFFFAOYSA-N	OCc1ccc(-c2nn(Cc3ccccc3)c3ccccc23)o1	154453-18-6	Apoptosis Inhibitors;Hypoxia Inducible Factor 1-alpha (HIF-1alpha) Inhibitors;Guanylate Cyclase Activators;Angiogenesis Inhibitors;Apoptosis Inhibitors;Hypoxia Inducible Factor 1-alpha (HIF-1alpha) Inhibitors;Guanylate Cyclase Activators;Angiogenesis Inhibitors
JF-91-IG96	OQXGEGPDPXAQRC-UHFFFAOYSA-N	O=c1c2ccccc2sn1-c1cc(S(=O)(=O)N2CCOCC2)ccc1N1CCOCC1		
AC-57-ZF49	OQZOXHCRSXYSPM-UHFFFAOYSA-N	CSc1cc2c(cc1C(F)(F)F)N(C(=O)Nc1cccnc1)CC2	196965-14-7	5-HT2B Antagonists;5-HT2C Antagonists
HF-07-ER47	ORBYFAFBEOHNKJ-UHFFFAOYSA-N	c1cncc(Cc2c[nH]c3ccccc23)c1		
LB-03-WL18	ORFLZNAGUTZRLQ-ZMBVWFSWSA-N	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)C(C)C	258818-34-7	Zonulin Receptor Antagonists
AD-12-YF12	ORHBXUUXSCNDEV-UHFFFAOYSA-N	O=c1ccc2ccc(O)cc2o1	142044-47-1	Carbonic Anhydrase Type IX Inhibitors;Carbonic Anhydrase Type XII Inhibitors;Cyclooxygenase-2 Inhibitors;Antioxidants
DD-82-GV50	ORYHYYPNXPCWQU-OAGGEKHMSA-N	O=CN(O)C[C@@H](CC1CCCC1)C(=O)N1C[C@H](F)C[C@H]1C(=O)Nc1cccnn1		Peptide Deformylase (PDF) Inhibitors
XB-35-TO54	OSFZBGUNRGOXKG-UHFFFAOYSA-N	Cc1cc(=O)[nH]c2ccc(NC(=O)c3cccnc3N3CCOCC3)cc12		BET inhibitor BD1 selective
EC-98-KI28	OSJFVOAURBIGTC-SFDUFSHASA-N	CO[C@H]1[C@@H](O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		
AB-95-LH34	OSLWRSOLKHYZCC-UHFFFAOYSA-N	C=CC(=O)N1CC(Oc2c(N)ncnc2-c2cc(F)cc(NC(=O)c3ccc(C4CC4)cc3F)c2C)C1		Btk tyrosine kinase inhibitor;irreversible, covalent inhibitor of BTK
FC-85-OX77	OSUAIFHDIUGTQU-BPGUCPLFSA-N	CN1c2ccc(F)cc2C(O)CC12CCN(C(=O)NCc1ccc(F)c([C@@H](N)C(F)(F)F)c1)CC2		
CB-88-LG34	OSXFATOLZGZLSK-UHFFFAOYSA-N	COc1cc2nc(N3CCCN(C)CC3)nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC	1392399-03-9	EHMT1/2;DNA Methyltransferase (DNMT) Inhibitors;Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 (EHMT2| G9a) Inhibitors
GD-63-XB79	OTAINLPPBNSXTJ-LJQANCHMSA-N	C[C@@H](Nc1ncnc2[nH]c(-c3cccc(CN4CCN(C)CC4)c3)cc12)c1ccccc1		
EC-08-KS82	OTBXOEAOVRKTNQ-UHFFFAOYSA-N	O=C1CN2Cc3c(ccc(Cl)c3Cl)N=C2N1	58579-51-4	PDE3A inhibitor
DE-85-DO61	OTJHLDXXJHAZTN-BYPYZUCNSA-N	N[C@@H](CSCCB(O)O)C(=O)O	222638-67-7	Arginase, Inhibitors
CA-08-ON66	OTQCFKGHQGIJNY-UHFFFAOYSA-N	N#Cc1cc(COC(=O)N2CCC(NC(=O)CCCc3c[nH]nn3)CC2)cc(C(F)(F)F)c1	1613514-20-7	Autotaxin inhibitor
BB-87-SF89	OTSOOHRUMBRSHZ-UHFFFAOYSA-N	COCC[n+]1c2c(n(Cc3cnccn3)c1C)C(=O)c1ccccc1C2=O	355406-09-6	BIRC5 gene inhibitor
AA-75-JH89	OTTJIRVZJJGFTK-GOSISDBHSA-N	CCN(C(=O)CO)[C@@H]1CN(/C(=N\\C#N)Nc2cccc(OC(F)F)c2)N=C1c1ccc(Cl)c(Cl)c1		
OD-96-TZ83	OTTJIRVZJJGFTK-SFHVURJKSA-N	CCN(C(=O)CO)[C@H]1CN(/C(=N\\C#N)Nc2cccc(OC(F)F)c2)N=C1c1ccc(Cl)c(Cl)c1		SMYD2 inhibitor
YF-64-PQ11	OUBCNLGXQFSTLU-UHFFFAOYSA-N	O=C1CCCC(=O)C1C(=O)c1ccc(C(F)(F)F)cc1[N+](=O)[O-]	104206-65-7	4-Hydroxyphenylpyruvate Dioxygenase (4HPPD) Inhibitors
BF-51-OI57	OUDSBRTVNLOZBN-UHFFFAOYSA-N	Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1		
DC-81-PH69	OUKYUETWWIPKQR-UHFFFAOYSA-N	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1	379231-04-6	Src Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Abl Kinase Inhibitors
BE-90-YK54	OUONONTYGQGSHC-UHFFFAOYSA-N	CCCc1c(OC)ccc2cc(C(=O)Nc3ccc(CN)cc3)c(=O)oc12		Lysophospholipid edg1 (S1P1) Receptor Agonists
PC-86-EW46	OUQVKRKGTAUJQA-UHFFFAOYSA-N	O=C(O)CNC(=O)c1nc(Cl)c2ccccc2c1O	223387-75-5	EGLN1 gene inhibitor
KA-58-YE68	OURCBWJERHUWHH-UHFFFAOYSA-N	Nc1cccc(-c2ccc3c(=O)[nH]c(Nc4ccccc4)cc3c2)c1		Cdc25B dual specificity phosphatase inhibitor
CA-75-HA22	OUSFTKFNBAZUKL-UHFFFAOYSA-N	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1	345627-80-7	CDK7 Inhibitors;CDK2/Cyclin E Inhibitors;CDK9 Inhibitors
BC-38-UW37	OUYCCCASQSFEME-QMMMGPOBSA-N	N[C@@H](Cc1ccc(O)cc1)C(=O)O	1189756-47-5	Tyrosine hydroxylase inhibitor
AA-45-BL29	OUYCCCASQSFEME-UHFFFAOYSA-N	NC(Cc1ccc(O)cc1)C(=O)O		
AC-99-ZN13	OUZWUKMCLIBBOG-UHFFFAOYSA-N	CCOc1ccc2nc(S(N)(=O)=O)sc2c1	452-35-7	CA1 inhibitor;CA2 inhibitor;CA4 inhibitor;CA7 inhibitor
AC-60-EU98	OVCDSSHSILBFBN-UHFFFAOYSA-N	CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O	1021496-19-4	Histamine Methyltransferase Inhibitor;Antimalarial
AE-06-JY57	OVJDNZFLEREPKG-VPMCBBNJSA-N	C=C1NC(=O)[C@@H](CC)NC(=O)CNC(=O)[C@H](Cc2c[nH]c3cccc(OC)c23)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)c2csc(n2)[C@@H](C)NC(=O)CN(C)C1=O		Inhibitor of mitochondrial translation
BB-87-YF54	OVLZMNNJQMDMRO-UHFFFAOYSA-N	Cc1cccc(NC(=O)c2cc(C(F)(F)F)ccc2C(=O)O)n1		
IC-23-YE16	OVMDIFAQBUDXLQ-UHFFFAOYSA-N	O=C(Nc1cccc(Cl)c1)c1ccccc1NCc1ccncc1		
AF-99-HA02	OVPNQJVDAFNBDN-UHFFFAOYSA-N	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl	844442-38-2	CDK1/Cyclin B Inhibitors;Apoptosis Inducers;Inhibitors of Signal Transduction Pathways;CDK2/Cyclin A Inhibitors
HD-68-CB31	OVZWUDZIAAHNFG-HXUWFJFHSA-N	CN(C(=O)Cc1ccccc1)[C@H](CN1CCCC1)c1ccccc1	207452-97-9	
QA-34-PH05	OWBFCJROIKNMGD-BQYQJAHWSA-N	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1	1225497-78-8	Antagonist of Raf-Ras interaction
AC-95-TK81	OWEGWHBOCFMBLP-UHFFFAOYSA-N	CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n1ccnc1	38083-17-9	Cyp Enzyme Inducers;Antifungal
S0-EE-XNAL	OWFNCOMYPJMMPG-CIKNZCACSA-N	CC(=O)O[C@H]1[C@H](OC(C)(C)[C@H]2CC=C(C)CC2)O[C@H](C)[C@H](O)[C@@H]1OC(=O)C=C(C)C		SLC43A1 gene inhibitor
GD-11-LR18	OXKNHBBDOIMFFQ-UHFFFAOYSA-N	O=C(CN1CCN(C(=O)c2ccco2)CC1)Nc1cc(C(F)(F)F)ccc1Cl	899713-86-1	acyl protein thioesterase 1 inhibitor
LC-03-KY64	OXMCCMNQOLPNQU-RXFVIIJJSA-N	CC(C)c1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc2c(c1)NCCC2	1291094-93-3	SGLT-1 Inhibitors;SGLT-2 Inhibitors
FC-40-QD52	OXQXJYQSWZFDBB-WJTVCTBASA-N	O=C(O)[C@@H]1C[C@H]2C[C@@H](CN3CC(F)(F)C[C@H]3C(=O)O)CC[C@H]2CN1	317844-33-0	iGluR5 (GluK5) Antagonists
AE-78-XJ76	OYAVBDAJSOIJJO-UHFFFAOYSA-N	Cc1cc2c(cc1C#N)c(-c1cccc(N)c1C)cn2C1CCC(O)CC1		KDM1A/B
HD-29-PZ41	OYHFPCHGDAYEET-UHFFFAOYSA-N	O=C(c1ccncc1)n1[nH]c(=O)ccc1=O		
KA-72-WY22	OYHLRJGDELITAF-INIZCTEOSA-N	O=C(N[C@@H](Cc1ccccc1)C(=O)CCl)OCc1ccccc1	26049-94-5	ATG4B gene Inhibitor
AF-16-IB77	OYMNPJXKQVTQTR-UHFFFAOYSA-N	FC(F)(F)c1cccc(-c2noc(-c3cc(-c4ccccc4)c(C(F)(F)F)s3)n2)c1	256414-75-2	Lysophospholipid edg1 (S1P1) Receptor Agonists;S1PR1 agonist
AD-34-WD27	OYODEQFZAJVROF-UHFFFAOYSA-N	Brc1ccc2c(c1)CNCC2	17680-55-6	Phenylethanolamine N-methyltransferase inhibitor
AF-92-EP16	OYQDQTACBONCGH-VVDBAWRFSA-N	CC[C@H](NC(=O)[C@@H]1C[C@@H](OCc2ccc(Br)cc2F)CN1C(=O)[C@@H](CCC1CCNCC1)NS(C)(=O)=O)C(=O)c1nc2ccccc2o1		
GD-69-KC91	OYVAGSVQBOHSSS-WXFSZRTFSA-O	Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(OC(N)=O)C1O)c1c[nH]cn1		
XB-70-NK42	OZBSSKGBKHOLGA-UHFFFAOYSA-N	CC(=O)Nc1nc(C)c(S(=O)(=O)Nc2ccc(C(O)(C(F)(F)F)C(F)(F)F)cc2)s1	1335106-03-0	Retinoid RORalpha Inverse Agonists;Retinoid RORgamma Inverse Agonists
UA-25-LA05	OZDWAHBMLHXZTI-UHFFFAOYSA-N	NCCCCNS(=O)(=O)c1cccc2c(Cl)cccc12		
BA-74-WG29	OZOMQRBLCMDCEG-VIZOYTHASA-N	O=C1CN(/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1	1185234-99-4	Ryanodine 1 receptor antagonist;Ryanodine 2 receptor antagonist
JD-74-IP25	OZPFIJIOIVJZMN-SFHVURJKSA-N	CNC(=O)c1ccc2cc([C@@]3(O)CCn4cncc43)ccc2c1	566939-85-3	Androgen Biosynthesis Inhibitors;Cytochrome P450 CYP17 (17alpha-Hydroxylase/C17-20 Lyase) Inhibitors
QE-76-ST29	OZQDLJNDRVBCST-UHFFFAOYSA-N	Nc1cnn(C2OC(CO)C(O)C2O)c(=O)n1		
EC-07-ZB49	OZSMSRIUUDGTEP-UHFFFAOYSA-N	O=S(=O)(c1cccc2c(Cl)cccc12)N1CCCNCC1		
KE-06-DQ22	OZTRKLQNMQQBRN-UHFFFAOYSA-N	O=C(O)CCc1c(C(=O)O)[nH]c2cccc(I)c12		
GF-67-HH28	OZUQRMYHPWAQQC-QGPMSJSTSA-N	CN1C[C@H](CSc2ccccn2)C[C@@H]2Cc3c(O)cccc3C[C@H]21	149328-94-9	Dopamine D1 Antagonists;Dopamine D2 Agonists
FE-82-JV20	PAEBEUZTAPIOIO-UHFFFAOYSA-N	CC(C)c1c(NC(=O)Nc2ccc(Cl)cc2)c(=O)n(-c2ccccc2)n1C	903895-98-7	FPR1 agonist;FPR2 agonist
BD-36-VB52	PAFKTGFSEFKSQG-PAASFTFBSA-N	C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(n3cnc4ccccc43)=CC[C@@H]12	851983-85-2	Androgen Receptor Antagonists;Cytochrome P450 CYP17 (17alpha-Hydroxylase/C17-20 Lyase) Inhibitors
ID-37-UU19	PAHHAUMKNPHKKW-UHFFFAOYSA-N	O=c1ccc(Cc2nnc(Nc3cccc(C(F)(F)F)c3)c3ccccc23)c[nH]1		
BC-70-BH47	PAJMKGZZBBTTOY-ZFORQUDYSA-N	CCCCC[C@H](O)CC[C@@H]1[C@H]2Cc3cccc(OCC(=O)O)c3C[C@H]2C[C@H]1O	289480-64-4	Prostacyclin Analogs
AD-28-GJ71	PAOANWZGLPPROA-RQXXJAGISA-N	CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(CCC(=O)O)cc4)nc32)[C@H](O)[C@@H]1O	120225-54-9	Adenosine A2A Agonists
ZE-45-CG69	PAOKUSHJSBBJJF-UHFFFAOYSA-N	NS(=O)(=O)c1c(Nc2ccnc(Nc3cccc(OCCN4CCCCC4)c3)n2)ccc2c1OCCCO2		
BC-74-QN56	PAXGPAVOMLKKDQ-IIZJFRANSA-N	CC(N[C@H]1C[C@@H]1c1ccccc1)c1ccc2c(c1)OCCO2		Lysine-Dependent Demethylase 1A (LSD1) Inhibitors
LA-66-RT74	PAZXLRUFYLWCKB-UHFFFAOYSA-N	C#CCOc1ccc2nc(C(=O)c3ccc(C(C)C)cc3)nc(-c3ccc(C(C)C)cc3)c2c1		Parathyroid Hormone Secretion Stimulants
BD-01-RI07	PBBRWFOVCUAONR-UHFFFAOYSA-N	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21	172889-27-9	Src Kinase Inhibitors
SC-25-HE80	PBHDCPWPSOSGGD-UHFFFAOYSA-N	CCN1CCN(Cc2ccc(C(=O)Nc3ccc(C)c(NCc4cnc5[nH]ccc5c4OC)c3)cc2C(F)(F)F)CC1	1315329-35-1	DDR tyrosine kinase receptor inhibitor
AW-16-2259	PBJUNGYSMWLZLJ-UHFFFAOYSA-N	CN(C)CCCn1c(=S)[nH]c2ccc(Cl)cc2c1=O		NOX2 inhibitors
DF-93-BT88	PBZYAPZLINAHET-UHFFFAOYSA-N	CC(C)C(=O)NC(c1ccco1)c1ccc2cccnc2c1O		KDM4C inhibitor
AE-26-JY57	PCFKMZRPZATASD-UHFFFAOYSA-N	CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ccccc21		Neuropeptide Y5 (NPY Y5) Antagonists
AE-56-SL06	PCFQFTWDXDICMA-UHFFFAOYSA-N	Cc1cccc(-n2ncc(Br)c(Br)c2=O)c1	1035450-90-8	SOD1 gene inhibitor
CE-88-RJ81	PCHRYHSDDPPZBV-UHFFFAOYSA-N	CCn1cc(NC(=S)Nc2cc(Cl)ccc2OC)c(C(N)=O)n1		
FA-65-UA27	PCILYMWQEGDZQY-UHFFFAOYSA-N	CSc1nc(N)nc(SCC(=O)Nc2nc3ccccc3s2)c1C#N	339156-32-0	
ED-31-AA47	PCIWCYUKRZFCMF-UHFFFAOYSA-N	COc1cccc(C(=O)NC2CC3CCC(C2)N3Cc2ccccc2)c1OC	109021-66-1	DRD2 antagonist
BB-65-JH59	PCMHOSYCWRRHTG-UHFFFAOYSA-N	COc1ccnc(N2CCC3(CCCN(Cc4c[nH]c5ccccc45)C3=O)CC2)n1		
MB-46-BT89	PCMORTLOPMLEFB-ONEGZZNKSA-N	COc1cc(/C=C/C(=O)O)cc(OC)c1O	530-59-6	GABA(A) Receptor Agonists;Antioxidants;Alleviation of Cartilage Destruction
CE-02-FZ80	PCNJGBMWAZRVEA-UHFFFAOYSA-N	CC(C)c1ccccc1OC(=O)NCCc1ccc2ccccc2c1	1354359-53-7	KIAA1363 inhibitor;NCEH1 inhibitor;Cytokine Secretion Inhibitor
KE-28-MO72	PCWZOPQESBMYEI-UHFFFAOYSA-N	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nccn1-c1cc(NCCN(C)C)ncn1		
S0-EE-YGIT	PDFAUYXBJDPBCE-UHFFFAOYSA-N	Cc1nn(Cc2ccccc2Cl)c(C)c1CN(C)CC(O)COc1ccc(Cl)cc1	1227743-71-6	TLR-4 antagonist
JF-30-FW92	PDGUQPADGLCLCV-UHFFFAOYSA-N	Cc1nnc(Sc2nc3cc(Cl)c(Cl)cc3nc2C(F)(F)F)s1	281208-76-2	GLP-1 Receptor Agonists;Insulin Secretagogues
HD-47-RR92	PDOCBJADCWMDGL-UHFFFAOYSA-N	CN1CCN(c2ncc(-c3cc(Cl)cc(Cl)c3Cl)c(N)n2)CC1	130800-90-7	N-Type Calcium Channel (Ca(v) 2.2) Blockers;Glutamate Release Inhibitors;Nav1.2 (Brain Type II) Sodium Channel Blockers
AE-00-WU78	PDOCNPCPPLPXRV-UHFFFAOYSA-N	Nc1nc2cc(Cl)ccc2[nH]1	1018894-96-6	5-HT3 receptor ligand
NC-27-AD53	PDOQBOJDRPLBQU-QMMMGPOBSA-N	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1	935666-88-9	Jak2 Inhibitors
IE-47-KU59	PDWJALXSRRSUHR-LFYBBSHMSA-N	N=C(N)N/N=C/c1ccccc1Cl	13098-73-2	sustains UPR
AE-91-BF25	PEHSVUKQDJULKE-UHFFFAOYSA-N	N=C(N)SCCc1c[nH]cn1	102203-18-9	HRH3 agonist
GA-18-PV59	PENIBPKELSMGQC-ZSOIEALJSA-N	O=C1/C(=C/c2cc([N+](=O)[O-])ccc2O)Sc2ccccc21		Palmitoyl Acyltransferase Inhibitors
AD-16-HL96	PEOAVEOEVIQCMT-XWDGXJISSA-N	CC[C@H](C)[C@H]1C(=O)N[C@H](Cc2cc(Cl)c(O)c(Cl)c2)C(=O)N[C@@H](C(C)(C)O)C(=O)O[C@H](c2ccccc2)[C@H](C)/C=C/C=C(\\C)[C@H](OC)C[C@@H]2O[C@@]2(C)C(=O)N1C		Elongation factor 1 alpha 1 inhibitor
SB-74-OD45	PEYZZHBZAUNXCI-UHFFFAOYSA-N	CC(c1ccoc1)N(O)C(N)=O	123606-23-5	Leukotriene Synthesis Inhibitors;Lipoxygenase Inhibitors;Non-Steroidal Antiinflammatory Drugs
DA-35-ZK21	PFDUBQQHEHJNQX-UHFFFAOYSA-N	CN(C)C1CCN(c2ccc(N)cc2)CC1	211247-62-0	CDK Inhibitors
GE-28-EL65	PFDUUKDQEHURQC-UHFFFAOYSA-N	COc1cc(CC(N)C(=O)O)ccc1O		
DB-58-ZC04	PFHDWRIVDDIFRP-UHFFFAOYSA-N	CCC(CC)n1ccc2c(C(=O)NCc3c(C)cc(C)[nH]c3=O)cc(C#N)cc21	1418308-27-6	PRC2/EZH2
LB-49-UZ91	PFKBTYIOBXMJNI-UHFFFAOYSA-N	Cn1c(CN2CCN(c3ccccn3)CC2)nc2ccccc21		
AB-11-MO96	PFSDKYXWJQPNMW-UHFFFAOYSA-N	Clc1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1C2		Muscarinic M1 Agonists;5-HT2A Inverse Agonists;Dopamine D2 Agonists
GD-43-TP28	PFWVGKROPKKEDW-UHFFFAOYSA-N	CC(C)(C)NC(=O)c1ccc(Oc2cc(F)c(CC(=O)O)cc2Cl)c(NS(=O)(=O)c2ccc(C3CC3)cc2Cl)c1	1169483-24-2	CRTH2 Receptor Antagonists;Prostanoid DP (DP1) Antagonists
PC-68-DU31	PFZTXTPVKAGHPW-GOSISDBHSA-N	COc1cc(CCc2cc(NC(=O)c3ccc(N4CCN(C)[C@H](C)C4)cc3)n[nH]2)cc(OC)c1	1201670-87-2	FGFR1 Inhibitors;Angiogenesis Inhibitors
UC-68-LC67	PGGINYVNLNKQRD-UHFFFAOYSA-N	CN(c1ncnc2sc3c(c12)CCCC3)C1CC1	1356074-25-3	Known USP14 inhibitor
MD-92-LN15	PGGLRAWFUJMQBN-HXUWFJFHSA-N	O=c1cc(-c2ccnc(NC3CCOCC3)n2)ccn1[C@H](CO)c1ccc(Cl)c(F)c1	1453847-30-7	ERK1/2 inhibitor
CC-01-PR23	PGKXDIMONUAMFR-AREMUKBSSA-N	CC(=O)NC1(c2ccccc2)CCN(CC[C@H](CN(C)C(=O)c2ccccc2)c2ccc(Cl)c(Cl)c2)CC1	142001-63-6	Tachykinin NK2 Antagonists
IE-13-CP28	PGPHHJBZEGSUNE-JYRVWZFOSA-N	O=C1NC(Nc2ccccc2)=N/C1=C\\c1ccc2c(c1)OCO2		CLK1 protein kinase inhibitor
ZE-11-PR61	PGSKODUPOMCUEJ-DLBZAZTESA-N	CNC(=O)c1ccc2c(c1)nc(-c1ccccn1)n2[C@@H]1CCC[C@H](NC(=O)c2ccc(Br)s2)C1		BCAT2 inhibitor
BC-13-GC37	PHCCFIGNVNPMML-RPWUZVMVSA-N	COCCCOc1cc(C(=O)N(C[C@@H]2CNC[C@H]2Cc2ccccc2)C(C)C)ccc1OC		Renin Inhibitors
DE-30-UR76	PHEDXBVPIONUQT-RGYGYFBISA-N	CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(C)=O	11016-13-0	Protein kinase C alpha stimulator
DB-21-FY75	PHESISZXAITBIM-MRXNPFEDSA-N	O=C(Nc1cc(-c2cccc(NCC3CCOCC3)n2)c(Cl)cn1)[C@@H]1CCCNC1	1270070-30-8	CDK9 inhibitor
AC-55-XA97	PHEZJEYUWHETKO-UHFFFAOYSA-N	Cc1c(-c2ccc(-c3ccccc3F)cc2)nc2ccc(F)cc2c1C(=O)O	96187-53-0	Dihydroorotate Dehydrogenase (DHODH) Inhibitors
AC-93-QD45	PHGTYMRDHDEHLI-HIFRSBDPSA-N	O=C(N[C@H]1CCCC[C@H]1C(=O)O)c1cnn2c(O)cc(-c3ccccc3)nc12		
CD-75-QY45	PHHZKBMVRPULAW-UHFFFAOYSA-N	Cc1cc(-c2ccccc2)cc(C(=O)NNS(=O)(=O)c2ccccc2)c1F		
CD-54-FJ31	PHIQHXFUZVPYII-ZCFIWIBFSA-O	C[N+](C)(C)C[C@H](O)CC(=O)O	10017-44-4	Lipid Lowering Agents;Antioxidants;Fatty acid oxidation
PE-82-OK78	PHRCDWVPTULQMT-UHFFFAOYSA-N	COc1cccc2c1CCCC2CCCN1CCN(C2CCCCC2)CC1	172906-90-0	
AB-16-LY07	PHVGLTMQBUFIQQ-UHFFFAOYSA-N	CNCCC=C1c2ccccc2CCc2ccccc21	203784-52-5	K(ir) 4.1 Blockers
HD-08-BP45	PHWBOXQYWZNQIN-UHFFFAOYSA-N	Clc1ccccc1CN1CCc2sccc2C1	53885-35-1	P2Y12 (P2T) Antagonists
BE-81-QL64	PHXJVRSECIGDHY-UHFFFAOYSA-N	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12	1114544-31-8	Inhibitors of Signal Transduction Pathways;Bcr-Abl Kinase Inhibitors
AD-00-ZK94	PIAWQVCBQLTEIY-UHFFFAOYSA-N	CN1N=C(SCc2ccc(Cl)cc2Cl)Sc2c1cnn(C)c2=O	245728-44-3	
BF-13-HM71	PIBITIKJRIGPID-UHFFFAOYSA-N	CC(C)Oc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1	845812-90-0	ALK Inhibitors
DD-65-SA37	PIROHBFQHMKAPE-UHFFFAOYSA-N	CNc1nc(NCc2ccc(NC(=O)c3ccc(Cl)nc3)cc2)c2ccccc2n1	1039731-99-1	beta-Catenin Inhibitors
EC-07-OP38	PIZJXFFDKNDZOC-UHFFFAOYSA-N	CN1CCN(c2cnn(-c3ccc(Cl)cc3)c(=O)c2Oc2ccc(-c3ccccc3)cc2)CC1		Protein-Lysine 6-Oxidase Inhibitors
ND-57-WU44	PIZUEVNGSMOVGW-IKGGRYGDSA-N	O=C(O)[C@H]1NC[C@@H](OCc2ccc(-c3ccccc3)cc2)[C@@H]1O	1426535-04-7	Anti-ASCT2 (Neutral Amino Acid Transporter)
AC-19-TH24	PJDFLNIOAUIZSL-UHFFFAOYSA-N	C=CC(N)CCC(=O)O	1391054-02-6	GABA Aminotransferase Inhibitors
BB-64-EE60	PJSOHQYOAVQLMP-UHFFFAOYSA-N	Cc1cc(-c2cc(-c3cc(S(=O)(=O)NCC(C)(C)O)ccc3C)cnc2N)on1		Phosphatidylinositol 3-Kinase gamma (PI3Kgamma) Inhibitors
AA-67-TF79	PJVWKTKQMONHTI-UHFFFAOYSA-N	CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O	129-06-6	Vitamin K Epoxide Reductase (VKER, VKOR) Inhibitors
BA-18-SW37	PJZPDFUUXKKDNB-KNINVFKUSA-N	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)C[C@H]5/C=C\\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(C)C)n3)nc2c1		
GC-60-XQ43	PKCDDUHJAFVJJB-VLZXCDOPSA-N	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1	1356958-77-4	IGF-1R Inhibitors;Insulin Receptor Antagonists
WB-38-DZ32	PKOUAUWPBMZQCH-FQEVSTJZSA-N	O=C1C(=O)N(Cc2ccccc2)c2ccc(S(=O)(=O)N3CCC[C@H]3COc3ccccc3)cc21	220510-16-7	Apoptosis Inhibitors;Caspase 3 Inhibitors;Caspase 7 Inhibitors
YE-01-JU83	PKQYVFHRKFDVCH-UHFFFAOYSA-N	Cc1ccc(NC(=N)N)cc1	1187927-45-2	5-HT3 receptor agonist
IA-76-YQ42	PKVXVECJINENFT-UHFFFAOYSA-N	CC(C)CN(CC(=O)NO)S(=O)(=O)c1ccc(N(C)C)cc1		
JA-20-KM58	PKXWXXPNHIWQHW-RCBQFDQVSA-N	CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@@H]1C(=O)N(C)CCc2ccccc21	425386-60-3	gamma-Secretase Inhibitors;Antiamyloidogenic Agents
TE-42-FZ03	PLCABEYQFQSQDK-UHFFFAOYSA-N	Cc1cccc(OC2CCN3CC2OC3=S)c1C		
HA-53-FL63	PLHJCIYEEKOWNM-HHHXNRCGSA-N	Cn1cncc1[C@@](N)(c1ccc(Cl)cc1)c1ccc2c(c1)c(-c1cccc(Cl)c1)cc(=O)n2C	192185-68-5	Inhibitors of Signal Transduction Pathways;Farnesyltransferase (geranylgeranyl pyrophosphate synthase) Inhibitors
DB-55-UX87	PLOMPBOPGTUIOH-UHFFFAOYSA-N	O=C1CC(c2cccc(-n3ccnc3)c2)=Nc2ccc(C#Cc3ccc(F)cc3)cc2N1	335258-08-7	mgluR2 Antagonists
JD-87-KA71	PLSOFLNMARXGBD-UHFFFAOYSA-N	CCc1ncnc2ccc(CCc3cc(OC)ccc3OC)cc12		Antimitotic Drugs
EC-98-YS67	PLWROONZUDKYKG-DOFZRALJSA-N	CCCCC/C=C\\C/C=C\\C/C=C\\C/C=C\\CCCC(=O)C(F)(F)F	149301-79-1	Cytosolic Phospholipase A2 (cPLA2) Inhibitors
FD-29-MM50	PLYJYKAWZXEBFC-WDNCENIBSA-N	CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1cncc(C(=O)c2ccc(F)cc2)c1)C1CCCCC1	1005342-47-1	Inhibitor of Apoptosis Proteins (IAP) Inhibitors;Apoptosis Inducers
HB-09-OC16	PLZVUODDFCETGR-NSHDSACASA-N	O=C(NCC(=O)N1CCC[C@H]1B(O)O)c1ccc(I)cc1		
AC-96-OO08	PMATZTZNYRCHOR-CGLBZJNRSA-N	C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C	104250-72-8	binds to cyclophilin;Calcineurin inhibitor;Cyclophilin modulator;Cyclophilin D Inhibitors;Cyclphilin A Inhibitors
BA-71-BE32	PMBUDILHPXTDNY-UHFFFAOYSA-N	CCOC(=O)c1c(C)cc2nc(COC(=O)NCCO)n(-c3ccccc3S(=O)(=O)NC)c(=O)c2c1C	581106-09-4	Cannabinoid CB1 Agonists;Cannabinoid CB2 Agonists
ED-91-LY45	PMJIHLSCWIDGMD-UHFFFAOYSA-N	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1	865854-05-3	GSK3B gene inhibitor
DF-85-QA87	PMKJGGBYYNEYPA-UHFFFAOYSA-N	CC(CCCCC(=O)Nc1ccc(C(F)(F)F)cc1)NCCc1c[nH]cn1	103827-16-3	HRH1 agonist
PE-25-KB33	PMMQOFWSZRQWEV-RVTXXDJVSA-N	CC(=O)OC[C@@]1(C)[C@@H]2C[C@H](OC(C)=O)[C@@]3(C)Oc4cc(-c5cccnc5)oc(=O)c4[C@H](O)[C@@H]3[C@@]2(C)CC[C@@H]1OC(C)=O	147444-03-9	SOAT2 inhibitor;ACAT 2 Inhibitors
RB-34-TO07	PMPKMTDYPOAEEH-UHFFFAOYSA-N	CN(C)C(=O)Nc1ccc(CN2CCC(C(O)(c3ccc(C(F)(F)F)cc3)c3ccc(C(F)(F)F)cc3)CC2)cc1		EHMT2 inhibitor
SB-96-CM72	PMPXTMSUCDRGCA-PIJUOVFKSA-N	CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ncccn1		
AA-49-BD04	PMXCMJLOPOFPBT-HNNXBMFYSA-N	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1	212844-53-6	CDK1/Cyclin B Inhibitors;CDK2/Cyclin A Inhibitors;CDK2/Cyclin E Inhibitors;CDK4/Cyclin D1 Inhibitors;CDK5 Inhibitors;Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase (DYRK) Inhibitors
OE-89-FS84	PNDQJUVRRFIFTM-UHFFFAOYSA-N	Oc1ncnc2c1c(-c1ccccc1)cn2-c1ccc(Br)cc1	220835-18-7	Glycolysis pathway inhibitor
WB-54-WD35	PNFMVADNCOGWME-UHFFFAOYSA-N	CCN(CCN(C)C)C(=O)CNCc1cc(C(N)=O)ccn1		
SD-82-GT69	PNMYJIOQIAEYQL-UHFFFAOYSA-N	Nc1nc(NC2CC2)cc(-c2cccc(Cl)c2Cl)n1	1609960-31-7	NUDT1 gene inhibitor
YC-45-JD42	PNPSWKNCPDJKQN-UHFFFAOYSA-N	CCOC(=O)C(C)Oc1cccc2c(=O)n(CC(=O)NCc3ccco3)ccc12		
HD-90-HQ28	PNQSEVRUOUYXCQ-LLVKDONJSA-N	O=c1[nH]c2cnc(NC[C@@H]3CCNC3)nc2n1Cc1ccccc1OC(F)(F)F		PKC theta inhibitor
BC-26-LE04	PNVNVHUZROJLTJ-UHFFFAOYSA-N	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	540726-98-5	5-HT Reuptake Inhibitors;Norepinephrine Reuptake Inhibitors
AE-52-NW93	PNYRDVBFYVDJJI-UHFFFAOYSA-N	Cc1cn(CCN2CCN(c3ccccc3-c3cc(C#N)cc(C(=O)NCCCN4CCCC4)c3)CC2)c2ccccc12	1793053-37-8	SMYD2 / KMT3C;SMYD2 gene inhibitor
YB-79-RC04	POIHISOJGIBUNY-ZJWIQQFQSA-N	CCCc1c(OCC/C=C\\C=C\\[C@H](Sc2ccc3c(=O)cc(C(=O)O)oc3c2)[C@H](O)c2cccc(C)c2)ccc(C(C)=O)c1O		Leukotriene Antagonists;Phospholipase A2 (PLA2) Inhibitors
YC-83-VF72	POJDHMRFTXZJLR-UHFFFAOYSA-N	Cc1cc(C)c(Nc2ccc(-c3nccn3C)cc2C(N)=O)c(C)c1		
CE-72-SF92	POOOQPHNOURAEX-UHFFFAOYSA-N	Clc1ccc(-c2cn3c(n2)sc2ccccc23)cc1	7025-32-3	STAT-6 Inhibitors
YA-21-RR66	POXFWGOYGQTRMD-SECBINFHSA-N	CN[C@@H]1CCN(c2nc(N)nc3c2oc2ccc(Cl)cc23)C1		Histamine H4 Receptor Antagonists
GF-37-MB64	PPAIMZHKIXDJRN-FMDGEEDCSA-N	CCNC1=N[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]2S1	1009816-48-1	N-Acetyl-beta-D-Glucosaminidase (O-GlcNAcase, OGA) Inhibitors;OGLcNACase inhibitor
BD-15-VR68	PPGSCVIDQKFZTG-UHFFFAOYSA-N	Cc1cccc(-c2ccc(CNC(=O)CCCc3ccc4cccnc4n3)cc2)c1	1314795-68-0	Succinate Receptor 1 (SUCNR1, GPR91) Antagonists
JE-59-EI25	PPLNRTPNYCWODC-UHFFFAOYSA-N	O=C(Nc1ccc(Cl)cc1)c1cc2c(cc1O)[nH]c1ccccc12	132-61-6	Carboxylesterase Inhibitors
HD-99-BT62	PPONHQQJLWPUPH-JTQLQIEISA-N	CCN(C[C@H]1COC(N)=N1)c1ccccc1	1048346-74-2	Trace amine-associated receptor-1 agonist
AC-18-DC84	PQCAUHUKTBHUSA-UHFFFAOYSA-N	O=[N+]([O-])c1cccc2cn[nH]c12		
AD-42-OW73	PQCXVIPXISBFPN-UHFFFAOYSA-N	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1	264218-23-7	
GB-35-DG61	PQHLRGARXNPFCF-UHFFFAOYSA-N	O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cc(Cl)ccc1NS(=O)(=O)c1ccc(Cl)s1	254877-67-3	Guanylate Cyclase Activators
AE-28-LX10	PQLXHQMOHUQAKB-UHFFFAOYSA-O	CCCCCCCCCCCCCCCCOP(=O)(O)OCC[N+](C)(C)C	58066-85-6	Angiogenesis Inhibitors, proliferation inhibitor
DE-73-JX23	PQOOIERVZAXHBP-UHFFFAOYSA-N	O=C(c1ccc(C(=O)N2CCC(N3CCCC3)CC2)c(Nc2ccccc2)c1)N1CCC(N2CCCC2)CC1	1415800-43-9	L3MBTL3 inhibitor;L3MBTL3 reader domain inhibitor
OA-12-SU22	PQUGCKBLVKJMNT-UHFFFAOYSA-N	COc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(Cl)cc2)cc1	188817-13-2	Cyclooxygenase-1 Inhibitors;Non-Steroidal Antiinflammatory Drugs
EB-82-HZ30	PQZDYFRDRHRZGF-UHFFFAOYSA-N	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCN4CCCC4)c(C)c3)nc2c1		
AE-19-BK71	PRDFBSVERLRRMY-UHFFFAOYSA-N	CCOc1ccc(-c2nc3cc(-c4nc5cc(N6CCN(C)CC6)ccc5[nH]4)ccc3[nH]2)cc1	23491-52-3	BCL2L1 gene inhibitor
BE-85-CH49	PRRZDZJYSJLDBS-UHFFFAOYSA-N	O=C(O)C(=O)CBr	1113-59-3	HK2 inhibitor
CF-22-OS28	PRWKHTZWEGPOKB-UHFFFAOYSA-N	CCc1cncn1CC(O)(P(=O)(O)O)P(=O)(O)O	1159507-44-4	Farnesyl Pyrophosphate Synthase Inhibitors
DF-56-GR45	PSCXFXNEYIHJST-QPJJXVBHSA-N	O=C(O)C/C=C/c1ccccc1	1914-58-5	Peptidyl-Glycine alpha-Amidating Monooxygenase (PAM) Inhibitors
DA-29-ZD04	PSIFNNKUMBGKDQ-UHFFFAOYSA-N	CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1	114798-26-4	AGTR1 gene inhibitor
AB-46-GB72	PSKQVPLMVPZZPQ-UHFFFAOYSA-N	Cc1ccc(-n2c(Cc3ccccc3)nnc2SCC(=O)Nc2ccccc2Cl)cc1		N-Type Calcium Channel (Ca(v) 2.2) Blockers
BC-12-VG35	PSLXNEVDCJSLEL-UHFFFAOYSA-N	Cc1c(NC(=O)c2ccc(C(C)(C)O)cc2F)cc(F)cc1-c1ncnc2[nH]c(C3=CCOCC3)cc12	1418127-84-0	reversible BTK inhibitor
DE-62-MB57	PSTBXECIKAJFMC-UHFFFAOYSA-N	O=C(c1ccc(-c2ccncc2)cc1)N1CCN(S(=O)(=O)c2ccc3cc(Cl)ccc3c2)CC1	207798-71-8	Inhibitors of Blood Coagulation Pathways;Coagulation Factor Xa Inhibitors
HC-63-SV27	PSXOKXJMVRSARX-SCSAIBSYSA-N	O=S(=O)(N[C@H](CO)C(C(F)(F)F)C(F)(F)F)c1ccc(Cl)s1	769169-27-9	gamma-Secretase Inhibitors
DB-34-KT45	PSYDCPHNVFLHOA-UHFFFAOYSA-N	CC(C)(C)c1ncc(Nc2ncc(-c3ccc4ccncc4c3)c3ccccc23)cn1		Inhibitors of Signal Transduction Pathways;Raf kinase B Inhibitors
OB-77-XJ02	PSZDOEIIIJFCFE-OSQDELBUSA-N	CC1(C)CC[C@]2(CO)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1	118204-21-0	IL-6 Production Inhibitors;IL-1beta Production Inhibitors
BE-28-WW67	PTJGLFIIZFVFJV-UHFFFAOYSA-N	O=C(CCCCCCC(=O)Nc1cccnc1)NO	382180-17-8	Histone Deacetylase (HDAC) Inhibitors
TF-09-RD17	PTQXTEKSNBVPQJ-UHFFFAOYSA-N	CC(C)c1cc(C(C)C)c(CC(=O)NS(=O)(=O)Oc2c(C(C)C)cccc2C(C)C)c(C(C)C)c1	166518-60-1	ACAT Inhibitor
S0-EE-XFDA	PTWUMGQRIORASC-UHFFFAOYSA-N	O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)Nc1ccc(Br)cc1-c1nnn[nH]1		Bone Resorption Inhibitors;ClC-7 Channel Blockers
ZE-46-XH09	PUKBOVABABRILL-PDDLMNHVSA-N	Cc1ccc(NC(=O)[C@@H]2CCCN(C(=O)c3c(C)cccc3F)[C@@H]2c2ccc(NC3CCCC3)cc2)cc1C(F)(F)F		
BE-82-TS38	PUMYFTJOWAJIKF-UHFFFAOYSA-N	CN1C(=O)CN=C(c2ccc(Cl)cc2)c2cc(Cl)ccc21	14439-61-3	Peripheral Benzodiazepine Receptor (PBR) Agonists
DD-12-RF07	PURKAOJPTOLRMP-UHFFFAOYSA-N	CC(C)(C)c1cc(C(C)(C)C)c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O	1134822-00-6	CFTR Channel Activators
EF-62-IO23	PUWRZSGQAPPNEC-UHFFFAOYSA-N	O=c1[nH]c2cc(Cl)ccc2c(=O)cc1O		
IA-67-NA51	PUYWDEYOTNGQIY-UHFFFAOYSA-N	N#Cc1cccc(-c2nc(Nc3ccccn3)sc2-c2ccncn2)c1		Adenosine A2B Antagonists
FC-96-WR45	PVCTYSQBVIGZRU-KRWDZBQOSA-N	O=C(O)CCCN1CCC[C@H]1COc1ccc(Oc2ccc(Cl)cc2)cc1	929915-58-2	Leukotriene Synthesis Inhibitors;Leukotriene A4 Hydrolase Inhibitors
YC-57-OY42	PVDGZHKJXXVONO-INIZCTEOSA-N	O=C(O)C[C@@H]1Cc2ccc(OCCCNc3ccccn3)cc2CN(CC(F)(F)F)C1=O		Integrin alphavbeta3 (Vitronectin) Antagonists;Integrin alpha-V/beta-3 antagonist, integrin alpha-V/beta-5 antagonist
MD-86-UW46	PVEZXRBQAIFHCC-QSXCDPBRSA-N	CCCCCCCCCC(=O)Nc1cc(/C(C)=N/NC(=N)N)cc(/C(C)=N/NC(=N)N)c1		
BD-18-XC74	PVHUJELLJLJGLN-UHFFFAOYSA-N	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1	39562-70-4	L-Type Calcium Channel Blockers
RF-07-FC20	PVKNPGQAFNALOI-UHFFFAOYSA-N	Cc1ccc2c(c1)C=Cc1cc(C)ccc1C2c1cn(Cc2ccc(C(=O)Nc3nn[nH]n3)o2)c(=O)[nH]c1=S	216657-60-2	An antagonist of the P2Y2 Receptor, apparently first identified by AZ;P2RY2 antagonist
YA-85-VH07	PVQUVXVUIZZLMP-UHFFFAOYSA-N	COc1ccc(-n2ncc3cnc(Nc4cc(OC)c(OC)c(OCCCN5CCN(C)CC5)c4)nc32)cc1	1381930-17-1	TBK1 inhibitor
EA-00-QR36	PVXYYWORFYROCX-UHFFFAOYSA-N	Cc1c(F)c(N)cc(C(=O)Nc2cc(-c3ccc(NC(=O)CCCN)cc3)ccc2N2CCN(C)CC2)c1Cl		MLL1-WDR5                 Protein-protein interaction inhibitor
QA-50-YO37	PWDYHMBTPGXCSN-VCBMUGGBSA-N	C/C(=N\\NC(=N)N)c1cc(NC(=O)CCCCCCCCC(=O)Nc2cc(/C(C)=N/NC(=N)N)cc(/C(C)=N/NC(=N)N)c2)cc(/C(C)=N/NC(=N)N)c1	164301-51-3	inhibits TNF-alpha - proposed NO inhibitor and/or p38 MAPK pathway; proposed to act via vagus nerve
DA-21-GV88	PWTBZOIUWZOPFT-UHFFFAOYSA-N	Nc1nc(NCCc2ccc(O)cc2)nc2nc(-c3ccco3)nn12	139180-30-6	Adenosine A2A Antagonists;Adenosine A2B Antagonists
CB-55-AK76	PXGREUPWZAUELV-LJQANCHMSA-N	Cc1nn(C2CC2)c2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		Bromodomain inhibitor
BB-19-ZK81	PXHPPVLWNLIWNR-UHFFFAOYSA-N	S=c1[nH]nc(-c2cccnc2)n1Cc1ccccc1	129119-80-8	Dopamine beta-monooxygenase Inhibitors
AC-02-SI74	PXNBOFBSFXZTES-UHFFFAOYSA-N	N=C(N)Nc1cc(Cl)cc(Cl)c1	46113-33-1	5-HT3 Receptor agonist ligands
AF-60-GR11	PXRDIWAVNLQFBI-UHFFFAOYSA-N	N#Cc1cnc2cnc(NCCN3CCOCC3)cc2c1Nc1ccc(Cc2ccccc2)cc1		Tpl-2/Cot (MAP3K8) Kinase Inhibitors
CA-72-JV60	PXXJHWLDUBFPOL-UHFFFAOYSA-N	N=C(N)c1ccccc1	125772-71-6	
FA-71-UB40	PXXXIDKPNLGOEH-LJQANCHMSA-N	CCOC(=O)C[C@@H](Cc1ccc(-c2cccc(Cl)c2)cc1)NC(=O)CCC(=O)O		
LE-94-HL75	PXXYOLIWFSWZNP-UHFFFAOYSA-P	COc1cc2c3cc1Oc1cc(ccc1O)CC1c4c(cc(OC)c(O)c4Oc4ccc(cc4)CC3[N+](C)(C)CC2)CC[N+]1(C)C	1398-92-1	Relaxant;nicotinic acetylcholine receptor antagonist;Relaxant;nicotinic acetylcholine receptor antagonist
GB-81-GK41	PYEBKOFMWAMBFV-UHFFFAOYSA-O	CC[N+](CC)(CC)CC(=O)Nc1c(C)cccc1C	21306-56-9	BLMH gene inhibitor
IA-27-CK10	PYKJFEPAUKAXNN-UHFFFAOYSA-N	Cc1nc2c(OCc3ccccc3)cccn2c1CC#N	76081-98-6	Reversible H+/K+-ATPase Inhibitors
DE-60-SD92	PYZRQGJRPPTADH-UHFFFAOYSA-N	Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1		
AB-63-HD20	PZRHRDRVRGEVNW-UHFFFAOYSA-N	Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1	100286-97-3	Phosphodiesterase III Inhibitors
EE-26-UK38	PZZOEXPDTYIBPI-UHFFFAOYSA-N	O=C1c2ccccc2CCC1CNCCc1ccc(O)cc1	30007-39-7	ADRA1A antagonist;ADRA1B antagonist;ADRA1D antagonist;alpha-Adrenoceptor Antagonists
CB-40-DA30	QABUURICQJOWID-MRXNPFEDSA-N	CC[C@@H]1CCCCN1C(=O)c1cnc(Nc2ccc(C)nc2)c(Cl)c1	942510-68-1	mgluR5 Antagonists
BA-79-ZR48	QAIPRVGONGVQAS-DUXPYHPUSA-N	O=C(O)/C=C/c1ccc(O)c(O)c1	331-39-5	5-Lipoxygenase Inhibitors;HIV Integrase Inhibitors;Antioxidants
BC-72-DZ30	QANMHLXAZMSUEX-UHFFFAOYSA-N	c1coc(CNc2ncnc3[nH]cnc23)c1	177966-68-6	PINK1 agonist;IKBKAP mRNA splicing corrector;PINK1 agonist;IKBKAP mRNA splicing corrector
DE-82-SC55	QAOAOVKBIIKRNL-UHFFFAOYSA-N	CC(C)c1ccc2c(c1)c(SC(C)(C)C)c(CC(C)(C)C(=O)O)n2Cc1ccc(Cl)cc1	118414-82-7	PPAR Modulators;5-Lipoxygenase-Activating Protein (FLAP) Inhibitors;Leukotriene Synthesis Inhibitors
EB-28-HP05	QASFUMOKHFSJGL-LAFRSMQTSA-N	CC1=C2C[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]2CC[C@]12O[C@@H]1C[C@H](C)CN[C@H]1[C@H]2C	11051-96-0	Smo Receptor Antagonists;Hedgehog Signaling Inhibitors;Smo Receptor Antagonists;Hedgehog Signaling Inhibitors
CE-48-TP40	QAUVAHYHKLRJCQ-UHFFFAOYSA-N	COc1cccc(OC)c1OCCNCC1CSc2ccccc2O1	92642-94-9	alpha1-Adrenoceptor Antagonists
KE-37-MN32	QBAGBBYBQAYFBT-XDHOZWIPSA-N	COC(=O)NCCSSCCNC(=O)/C(Cc1ccc(O)c(Br)c1)=N/O	133991-69-2	Histone Deacetylase (HDAC) Inhibitors
MC-82-RG58	QBAOBDKNTDWTHR-YFVJMOTDSA-N	CC(C)=CCC/C(C)=C/CC/C(C)=C/CC(P(=O)(O)O)P(=O)(O)O	145572-63-0	Squalene Synthase Inhibitors
FA-95-HA77	QBKSWRVVCFFDOT-UHFFFAOYSA-N	Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O	1189561-66-7	Apoptosis Inducers;11beta-Hydroxysteroid Dehydrogenase (11beta-HSD) Inhibitors;Antimitotic Drugs;Bcl-xl Inhibitors;Steroid 5alpha-Reductase Inhibitors
AD-20-CH42	QBNZBMVRFYREHK-UHFFFAOYSA-N	COc1ccc(C2CC(c3ccccc3)=NN2c2ccc(S(N)(=O)=O)cc2)cc1	71203-35-5	CDC42 Rho GTPase inhibitor
FA-73-WF99	QBTUKQKTXYTWPD-UHFFFAOYSA-N	N#Cc1c2c(c3nncn3c1NCc1ccco1)CN(Cc1ccccc1)CC2		PRC2/EED;EED
AA-86-YY62	QCDFBFJGMNKBDO-UHFFFAOYSA-N	Oc1c(I)cc(Cl)c2cccnc12	130-26-7	Chelating Agents;Carbonic Anhydrase Inhibitors;Antiamyloidogenic Agents
BB-31-EB45	QCIJLRJBZDBVDB-UHFFFAOYSA-N	COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCC1)n(C)c(=O)n2C	900305-37-5	BRPF1B;BRPF1B inhibitor
JD-05-LJ73	QCUWBENZERHUIR-UHFFFAOYSA-N	COc1cc2c(cc1NS(=O)(=O)c1ccc3c(c1)CCCC3)n(C)c(=O)n2C		
KC-21-PG56	QCUXJYDZKNLRRS-UHFFFAOYSA-N	COc1ccc(CCN(CCC(=O)NO)S(=O)(=O)c2ccc(NC(=O)c3ccccc3)cc2)cc1	289638-64-8	Procollagen C Peptidase (BMP1) inhibitor;Mammalian Tolloid-like 1 Protein (TLL1) inhibitor;Mammalian Tolloid-like 2 Protein (TLL2) Inhibitor
AE-38-QT35	QDBVSOZTVKXUES-UHFFFAOYSA-N	CN(C)CCCNC(=O)c1ccc(-c2cc(O)c3ncccc3c2)cc1	1222800-79-4	KDM4E
BF-22-EP86	QDITZBLZQQZVEE-YBEGLDIGSA-N	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1	958852-01-2	Phosphatidylinositol 3-Kinase alpha (PI3Kalpha) Inhibitors
KC-10-GC29	QDKLRKZQSOQWJQ-SMDXAGPFSA-N	C=C(C)[C@@H](CC=C(C)C)C[C@@]12C[C@@H](CC=C(C)C)C(C)(C)[C@@](CC=C(C)C)(C(=O)C(C(=O)c3ccc(O)c(O)c3)=C1O)C2=O	147782-04-5	Apoptosis Inducers;Histone N-Acetyltransferase (HAT) Inhibitors;Antioxidants;Apoptosis Inducers;Histone N-Acetyltransferase (HAT) Inhibitors;Antioxidants
MF-04-HB41	QDMAKDIDFJTXEL-UHFFFAOYSA-N	Cc1c(C2CCN(CCc3ccccc3)CC2)noc1-c1ccc(Cl)cc1	156337-32-5	Dopamine D4 Antagonists;DRD4 antagonist;Dopamine D4 Antagonists;DRD4 antagonist
AA-01-JO26	QDPMHXUWMPNTEQ-UHFFFAOYSA-N	Nc1nc(O)c2[nH]cc(Cc3ccsc3)c2n1	132138-76-2	Purine-Nucleoside Phosphorylase Inhibitors
FD-20-OG99	QECBVZBMGUAZDL-SJMSETAHSA-N	CC(=C/C(C)C/C=C/C(C)=C/C(C)C(=O)C(C)C(O)C(C)C/C(C)=C/C(=O)O)/C=C/C1OC(=O)C=CC1C	87081-36-5	Exportin 1 inhibitor
AE-32-DP61	QECMENZMDBOLDR-AWEZNQCLSA-N	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(N)=O)c1nnc(C)n1-2	1446144-04-2	BRD4 gene inhibitor
VC-14-ND05	QEHVTUCLCBXQIC-UHFFFAOYSA-N	Oc1c(Cl)cc(Cl)cc1CNc1ccc2[nH]nnc2c1		
QE-76-HF95	QEJQEIIPZKQCNP-UHFFFAOYSA-N	CCC(CC)CC(=O)c1c(C(=O)OC)c(-c2ccc(OC)c(OC)c2)c2c(OC)c(OC)c(OC)cc2c1O	151165-96-7	Ileal sodium bile acid cotransporter inhibitor
BF-41-MV83	QELUYTUMUWHWMC-UHFFFAOYSA-N	CC1=NN(c2ccccc2)C(=O)C1		
QA-76-ZM47	QEPAXTJXHXPFJN-KRWDZBQOSA-N	CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CN(CCCc1ccccc1)CC(=O)O	1333227-66-9	IDE gene inhibitor
LE-22-UD71	QESHSZWKJULSAR-UHFFFAOYSA-N	O=c1[nH]c2ccc(C(F)(F)F)cc2c(-c2cc(Cl)ccc2O)c1CCO	275375-69-4	Large Conductance K(Ca) 1.1 (BK, maxi K+) Channel Activators
AC-77-VS60	QEVHRUUCFGRFIF-MDEJGZGSSA-N	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC	1263-94-1	Norepinephrine Uptake Inhibitor;Vesicular Monoamine Transporter 2 (VMAT2) Inhibitors
FE-19-SC91	QEYZDQKYDMAJAJ-UHFFFAOYSA-N	CN1CCN(Cc2ccc3c(ccn3S(=O)(=O)c3ccccc3)c2)CC1	1039308-16-1	5-HT6 Receptor Ligands
MD-92-KD16	QFHKRFKDFPXDHF-UHFFFAOYSA-N	Cc1cccc(C(C)C)c1CNC(=O)n1c(=O)c2cccc(C(=O)O)c2n1C		Triacylglycerol Lipase (Hormone-Sensitive Lipase) Inhibitors
WA-98-CM36	QFTXEYWITUUVIK-UHFFFAOYSA-N	COc1ccc(Cl)cc1C(=O)Nc1cc(Cl)ccc1O		BKca channel opener;KCNMA1 gene stimulator
GA-68-SS47	QFWCYNPOPKQOKV-UHFFFAOYSA-N	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N	167869-21-8	ERK1 Inhibitors;MEK1 Inhibitors;MEK2 Inhibitors;MKK4 Inhibitors
IC-42-HA09	QFWPJPIVLCBXFJ-UHFFFAOYSA-N	COCCOc1cnc(NS(=O)(=O)c2ccccc2)nc1	339-44-6	KCNJ1 gene inhibitor
FD-59-TC81	QFWVGKDFYOXTQO-UHFFFAOYSA-N	CCCCCCCCCCCC(OC(=O)C(CCCCN(O)C(C)=O)NC(=O)c1coc(-c2ccccc2O)n1)C(C)C(=O)NC1CCCCN(O)C1=O	863507-43-1	Muscarinic M3 Receptor Ligands;Muscarinic M4 Receptor Ligands
KA-14-VZ39	QFXKXRXFBRLLPQ-UHFFFAOYSA-N	c1ccc2c(c1)[I+]c1ccccc1-2	1010-76-0	Cytochrome P450 Inhibitors;NADPH Oxidase Inhibitors;Nitric Oxide Synthase Inhibitors;Xanthine Oxidase Inhibitors;Electron Transport Chain Inhibitor
BB-52-LF37	QGJUIPDUBHWZPV-SGTAVMJGSA-N	N#C[C@@H]1C[C@@H]2C[C@@H]2N1C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2	1073057-20-1	Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors
JA-57-AV27	QGNDVASWIHEXCL-AWEZNQCLSA-N	C[C@H]1CCCN1Cc1nc2cc(NC(=O)c3ccc4c(cnn4C)c3)ccc2[nH]1		
KF-73-PY04	QGQFNQWZHHSZIC-UHFFFAOYSA-N	Cc1[nH]c(CO)c(-c2ccc(Oc3ccc(OC(F)(F)F)cc3)cc2)c(=O)c1Cl	958457-44-8	P. falciparum Cytochrome b-c1 Complex (Complex III subunit 3) Inhibitors;Electron Transport Chain Inhibitors;P. falciparum Cytochrome b-c1 Complex (Complex III subunit 3) Inhibitors;Electron Transport Chain Inhibitors
FE-73-PS05	QGWHBHBJGPJINC-UHFFFAOYSA-N	O=C(NC1CCCc2ccccc21)c1ccc2c(c1)OCO2		TAS1R1 gene antagonist
RA-53-JG50	QGYRJLOWWHNQAD-ZDUSSCGKSA-N	C=CCCCCCCCCC(=O)N[C@H]1CCC(=O)NC1=O	284495-31-4	Broad Spectrum Chemokine Inhibitors (BSCI)
BB-77-QQ71	QGZYDVAGYRLSKP-UHFFFAOYSA-N	O=C(CCCCCCNC(=O)c1cnc(N(c2ccccc2)c2ccccc2)nc1)NO	1316214-52-4	HDAC6
ZE-37-PE19	QHCDWDRQLOZVDJ-UHFFFAOYSA-N	COc1c(Cl)cc2c([nH]c3cnccc32)c1Cl	361202-37-1	
AD-16-OE34	QHGUCRYDKWKLMG-UHFFFAOYSA-N	NCC(O)c1ccc(O)cc1		
KE-53-DB74	QHIMQNFBELRAKZ-UHFFFAOYSA-N	Cc1cc(N2CCOCC2)nc2ccc(NC(=O)c3ccco3)cc12		
HE-55-QD94	QHTHSHPGHBEQIG-UHFFFAOYSA-N	N#Cc1c(NC(=O)COc2ccccc2)sc2c1CCCC2		
QB-07-YT91	QIHBWVVVRYYYRO-ZDUSSCGKSA-N	C[C@H](NC(=O)CCc1nc2ccccc2c(=O)[nH]1)c1ccccc1	1445251-22-8	PARP3 inhibitor
AA-54-WG39	QIKYZXDTTPVVAC-UHFFFAOYSA-N	NC(=O)c1ccc(N)cc1		
AA-80-IA90	QINRQIZOBCQKAZ-UHFFFAOYSA-N	CCOC(=O)c1cnc(SC)nc1N	776-53-4	CDK Inhibitors
AB-87-II61	QITKCQWRUKVTKJ-YIXHJXPBSA-N	N=C(N)N/N=C/c1ccc(Cl)c(Cl)c1	72116-14-4	Neuropeptide FF Receptor 2 (NPFF2) Agonists
RA-63-FK60	QIXBOOVPFRZHQQ-UHFFFAOYSA-N	CCCCCCCCn1cc(CC(N)=O)c2cc(-c3cccc(C)c3)ccc21	851636-83-4	Isoprenylcysteine Carboxyl Methyltransferase Inhibitors
JA-98-CL60	QJBRZZUZDREZIP-UHFFFAOYSA-N	CC(=O)NC(CSC12CCC3(O)CC(C)=CC(=O)C3(O)C1(O)C(=O)c1cccc(O)c1C2=O)C(=O)O	136286-49-2	Endothelin Receptor Antagonists
DF-75-OU25	QJIMSJUUARCROQ-QFIPXVFZSA-N	COc1nc(Nc2cc(S(C)(=O)=O)ccc2N[C@@H](c2cccc3c2OC(F)(F)O3)c2ncccc2Cl)nc(N2CCNCC2)n1		
DD-49-YG96	QJJXYPPXXYFBGM-LFZNUXCKSA-N	C=CC[C@@H]1/C=C(\\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC	104987-11-3	Calcineurin inhibitor;FKBP12 gene modulator
AC-49-ZR23	QJQORSLQNXDVGE-UHFFFAOYSA-N	Cn1ccc2cc3c(cc21)CCN3C(=O)Nc1cccnc1	1197334-04-5	5-HT2B Antagonists;5-HT2C Antagonists;5-HT1A Receptor Partial Agonists
BC-13-OQ01	QJZRFPJCWMNVAV-HHHXNRCGSA-N	Cc1ccc(C(=O)N(CCCN)[C@@H](c2nc3cc(Cl)ccc3c(=O)n2Cc2ccccc2)C(C)C)cc1	336113-53-2	Antimitotic Drugs;Kinesin-Like Spindle Protein  KIF11 (KSP, Eg5) Inhibitors
CA-48-SW47	QKDDJDBFONZGBW-UHFFFAOYSA-N	S=C(NC1CCCCC1)N1CCC(c2c[nH]cn2)CC1	106243-16-7	Histamine H3 Receptor Inverse Agonists;Histamine H3 Receptor Antagonists
CE-37-MS25	QKFWYOZIIUVZRC-UHFFFAOYSA-N	CCCCN(Cc1cc(Cl)c(OC)c(OC)c1)c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1		Liver X Receptor (LXR) Ligands
MB-50-ZI28	QKILPYXMYOTNIL-SFHVURJKSA-N	Cc1cc(N2C(=O)c3nn(C)c(C)c3[C@@H]2c2ccc(Cl)cc2)cn(C)c1=O		
GF-90-DG49	QKKIWEILHCXECO-UHFFFAOYSA-N	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1	1229582-33-5	MAP3K11 gene inhibitor
HB-09-NP07	QKRVSWPBAOCWHY-UHFFFAOYSA-N	CSc1ncc(C=O)c(NC2CCCC2)n1	211245-64-6	CDK inhibitors
AE-39-DG66	QLJDJSOFNVSHNG-VMPITWQZSA-N	O=C(/C=C/c1ccc(CNCCc2c[nH]c3ccc(F)cc23)cc1)NO		Histone Deacetylase (HDAC) Inhibitors
BF-57-II91	QLLJNZNWZIPIAL-LDADJPATSA-N	CCCOc1c(-c2cccc3sc(/C(C)=C/C(=O)O)cc23)cc(C(C)C)cc1C(C)C		Retinoid RXRalpha Antagonists
CE-45-AD14	QLMMOGWZCFQAPU-UHFFFAOYSA-N	C#CCN(C)CC1=Cc2ccccc2Oc2ccccc21	181296-84-4	Apoptosis Inhibitors;Glyceraldehyde 3-phosphate Dehydrogenase (GAPDH) Inhibitors
DA-27-BW20	QLNAEPZXTGNWCX-UHFFFAOYSA-N	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)n2)s1		Inhibitor of Aurora
DA-69-UN88	QLOCSAUIBGQZLC-UHFFFAOYSA-N	COc1ccc2nc(NC(=O)COC(=O)CC(NC(=O)c3ccccc3)c3ccccc3)sc2c1		
HB-92-XE24	QLPHOXTXAKOFMU-WBVHZDCISA-N	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1	1227911-45-6	PDK1 inhibitor;PDK1/2 inhibitor
OC-14-JE88	QLXKHBNJTPICNF-QMCAAQAGSA-N	CCOC(=O)OC[C@H]1O[C@@H](Oc2ccccc2Cc2ccc(OC)cc2)[C@H](O)[C@@H](O)[C@@H]1O	408504-26-7	SGLT-2 Inhibitors
VD-41-XP62	QLXULUNLCRKWRD-UHFFFAOYSA-N	O=C(NNS(=O)(=O)c1ccccc1F)c1cc(F)cc(-c2ccccn2)c1		
CE-40-VU73	QLYKJCMUNUWAGO-GAJHUEQPSA-N	C[C@H](NC(=O)C(C)(C)Oc1ccc(C(F)(F)F)cn1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1	1204240-86-7	Cannabinoid CB1 Inverse Agonists
CB-82-PL01	QMBFDOJGIXJMAA-UHFFFAOYSA-N	CC(=O)N(C)c1ccc(Nc2nc(NC3CCC3)c3nc[nH]c3n2)cc1	749206-47-1	Syk Kinase Inhibitors
AA-81-CY65	QMCOPDWHWYSJSA-UHFFFAOYSA-N	CNC(=O)c1cc2c(cn1)[nH]c1ccccc12	78538-74-6	GABA(A) BZ Site Receptor Inverse Agonists
BC-25-VR48	QMCXVSJLYBVIHV-VXGBXAGGSA-N	C[C@@H]1CC(Nc2nccc(-c3c[nH]c4c(F)cccc34)n2)C[C@@H](C)N1		IKBKB inhibitor
PB-66-RW16	QMDKVNSQXPVCRD-RQNOJGIXSA-N	CNCCN(C)Cc1c[nH]nc1-c1ccc(O[C@H]2C[C@H](OCCC3CCOCC3)C2)cc1		PRMT6 inhibitor;PRMT6 gene inhibitor
AD-99-SN88	QMGUOJYZJKLOLH-UHFFFAOYSA-N	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21	133052-90-1	CDK4/Cyclin D1 Inhibitors;Leucine-Rich Repeat Kinase 2 (LRRK2;Dardarin) Inhibitors;Protein Kinase C (PKC) Inhibitors
JD-51-GD99	QMLALHXGVBGFIC-UHFFFAOYSA-N	COc1ccc2c(c1)CCc1c-2c2c(c3c4ccccc4n(CCO)c13)CNC2=O	263175-33-3	MAP3K11 gene inhibitor
JB-34-VI53	QMXFZMPBYFJYLO-UHFFFAOYSA-N	O=C(NCCN1CCC(n2c(=O)[nH]c3cc(F)ccc32)CC1)c1ccc(F)cc1	1150562-18-7	PLD1 inhibitor
JF-96-HH81	QNFWRHKLBLSSPB-MRXNPFEDSA-N	CC(C)(C)c1ccc(CC[C@@](O)(CC(=O)O)C(=O)O)cc1		inhibitor of sodium-coupled citrate transporter
JC-64-QI43	QNJVELOLCDKQBN-UHFFFAOYSA-N	CC(C)c1cc(Br)cc(C(C)C)c1O	2432-03-3	Nav1.2 (Brain Type II) Sodium Channel Blockers;Nav1.4 (SkM1) Sodium Channel Blockers
CC-46-CE74	QNKLFDFMOINNIW-UHFFFAOYSA-N	Cc1csc(Nc2cccc3ccccc23)n1	1957-01-3	Chemokine CCR4 Antagonists
FB-95-JD99	QNLSCNDZNSALTM-OYRHEFFESA-N	COc1cc2c(cc1N1C[C@@H](C)N[C@@H](C)C1)N(C(=O)c1ccc(-c3ccc(-c4noc(C)n4)cc3C)cc1)CC2	332397-72-5	5-HT1B Antagonists
CC-56-MO03	QNMZWFNNJMGJPU-UHFFFAOYSA-N	Nc1nccc(-c2c[nH]c3ccccc23)n1		
IB-42-HL06	QNTASHOAVRSLMD-FCARAQADSA-N	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4=C/C(=N\\O)CC[C@]4(C)[C@H]3CC[C@]12C	22033-87-0	neuroprotective;Mitochondrial VDAC channel blocker
AC-74-UR36	QNZCBYKSOIHPEH-UHFFFAOYSA-N	COc1ccc(-n2nc(C(N)=O)c3c2C(=O)N(c2ccc(N4CCCCC4=O)cc2)CC3)cc1	503612-47-3	Known FactorXa inhibitor
PA-15-CP52	QODWZTUPLVMSQR-HZPDHXFCSA-N	CN1C(=O)[C@@H]2CN(S(=O)(=O)c3ccc4occc4c3)C[C@@H]2c2cnccc21		
CF-31-GE67	QOECJCJVIMVJGX-UHFFFAOYSA-N	COc1cc2c(NC3CCN(C(C)C)CC3)nc(C3CCCCC3)nc2cc1OCCCN1CCCC1	1255517-77-1	EHMT1/2;Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 (EHMT2| G9a) Inhibitors
AE-79-LG46	QOIGKGMMAGJZNZ-UHFFFAOYSA-N	CC1(C)CC(=O)N(CCCCN2CCN(c3ncccn3)CC2)C(=O)C1		
GB-16-NN30	QORLMYYHZLDYOR-UHFFFAOYSA-N	CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(Cl)ccc1-2	78756-33-9	Ligand of the GABAA receptor subtypes;Negative allosteric modulator of GABAA
RE-04-MV24	QOSIJVVNNGXEKE-INIZCTEOSA-N	O=C(O)C[C@H](Cc1ccc(C(F)(F)F)cc1)NC(=O)Cc1cccc(Cl)c1	1322598-09-3	GPR43 antagonist
RD-79-FH72	QOTXVUQRYGWKSW-UHFFFAOYSA-N	O=C(Nc1scc(-c2ccc(Cl)cc2)c1C(=O)O)c1ccc([N+](=O)[O-])o1		
BA-77-NI61	QOVKYBHJDNFWAP-UHFFFAOYSA-N	Cc1ccc(-c2cn3c(N4CCOCC4)cnc3cc2CN)c(Cl)c1		
GD-73-ZF64	QOWRADOKRZQCAQ-UHFFFAOYSA-N	NS(=O)(=O)c1ccc(CCNC(=S)Nc2ccccc2)cc1	10079-93-3	Carbonic anhydrase inhibitor
DD-77-GV27	QOYHHIBFXOOADH-UHFFFAOYSA-N	O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2	1841-19-6	Dopamine D2 Antagonists
EE-83-RW10	QOYROTCVRDQKJR-UHFFFAOYSA-N	CCOC(=O)C1(N(C(=O)CC)c2ccccc2)CCN(Cc2ccccc2)CC1	61085-74-3	Neuromedin U Receptor Modulators
FF-61-PA27	QPCDCPDFJACHGM-UHFFFAOYSA-N	O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O	1004765-76-7	Nitric Oxide Scavengers
OF-98-RK57	QPCVHQBVMYCJOM-UHFFFAOYSA-N	CCCOC(C(=O)OC1CCN(C)CC1)(c1ccccc1)c1ccccc1	54556-98-8	Muscarinic Antagonists
WB-47-FS93	QPGYAMIHXLCFTJ-UHFFFAOYSA-N	COc1nc(-c2ccc3c(c2)OCO3)n(-c2ccc(NC(=O)CSc3ccccc3)cc2)n1	853625-60-2	Cytohesin Inhibitors
BD-63-JC77	QPJOSVQNKZHDCK-UHFFFAOYSA-N	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)Oc1ccccc1		
DD-42-PC65	QPKKAIMODKGHRH-UHFFFAOYSA-N	CCN(Cc1cccc(-c2ccnc(Nc3cccc([N+](=O)[O-])c3)n2)c1)C(C)C		Antimitotic Drugs;Inhibitors of Signal Transduction Pathways;Aurora-A (ARK1) Kinase Inhibitors;Glycogen Synthase Kinase 3 beta (GSK-3beta| tau Protein Kinase I) Inhibitors;Cyclin-Dependent Kinase Inhibitors
YC-32-MB85	QPKROMNIEAEFQA-UHFFFAOYSA-N	O=C(N=c1[nH]c2ccccc2[nH]1)c1cccc([N+](=O)[O-])c1	301675-24-1	Inhibitors of Signal Transduction Pathways;Interleukin-1 Receptor-Associated Kinase (IRAK) Inhibitors;Inhibitors of Signal Transduction Pathways;Interleukin-1 Receptor-Associated Kinase (IRAK) Inhibitors
PC-44-DH10	QPLBGBUETBAFIV-LTOFHGMRSA-N	CC1=CC[C@]23O[C@@]2(C)CC[C@H]2C(CN(C)C)C(=O)O[C@@H]2[C@@H]13	188899-01-6	Inhibitors of Signal Transduction Pathways;Farnesyltransferase (geranylgeranyl pyrophosphate synthase) Inhibitors;Inhibitors of Signal Transduction Pathways;Farnesyltransferase (geranylgeranyl pyrophosphate synthase) Inhibitors
PD-14-CH80	QPTGWITYTSXRJB-UHFFFAOYSA-N	O=C1NC(=S)NC(=O)C1=Cc1cccc2ccccc12		
BC-48-WT15	QQHMKNYGKVVGCZ-UHFFFAOYSA-N	N=C1CCCN1Cc1[nH]c(=O)[nH]c(=O)c1Cl	183204-72-0	Thymidine Phosphorylase Inhibitors
HB-98-OB36	QQKKPWJFHBFCTH-UHFFFAOYSA-N	Cn1cc(C2=C(c3c4n(c5ccccc35)CCC(CN)C4)C(=O)NC2=O)c2ccccc21	131848-13-0	Protein Kinase C (PKC) Inhibitors
WB-92-FB15	QQNHTINEHANVJY-NSHDSACASA-N	N#C[C@@H]1CCCN1C(=O)CNC1CCCC1		Dipeptidyl Peptidase IX (DPP9| DPRP2) Inhibitors
JC-67-FV32	QQSPATQSWSHBGK-UHFFFAOYSA-N	NC(=O)c1cc2ncnc(N3CCC(CCN4CCCC4)CC3)c2s1	1431411-72-1	
BE-05-KR03	QQWUGDVOUVUTOY-UHFFFAOYSA-N	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1	761439-42-3	Inhibitors of Signal Transduction Pathways;ALK Inhibitors
FB-56-IR20	QRDAPCMJAOQZSU-KQQUZDAGSA-N	Cn1cc(/C=C/C(=O)c2cccc(F)c2)cc1/C=C/C(=O)NO	852475-26-4	Histone Deacetylase 2 (HDAC2) Inhibitors
MD-73-OU29	QRGQONAZHIKMGC-UHFFFAOYSA-N	CC1CCN(C(=O)Oc2ccc(Oc3ccccc3)cc2)CC1	136100-14-6	Lipase inhibitor
GE-77-FY84	QRKSBELIKLNLNV-UHFFFAOYSA-N	Cc1sc(-c2ccccn2)nc1OC(=O)c1ccc(F)cc1F		
AE-17-IZ62	QRVQVDZFHJHLSX-WSDLNYQXSA-N	COc1ccc(-c2cc(C(=O)N/N=C/c3cc(OC)c(OC)c(OC)c3)[nH]n2)cc1		
GE-34-TW62	QRYRORQUOLYVBU-VBKZILBWSA-N	CC(C)c1cc2c(c(O)c1O)[C@@]1(C(=O)O)CCCC(C)(C)[C@@H]1CC2	139236-75-2	PPARG agonist;Neurotrophic Factor Enhancers;Antioxidants;Triacylglycerol Lipase (Hormone-Sensitive Lipase) Inhibitors;Free Radical Scavengers
QA-25-HL62	QSENMPAGYMUVDE-UHFFFAOYSA-N	COc1cc2c(Nc3ccc(Sc4nccn4C)c(Cl)c3)c(C#N)cnc2cc1OCCCN1CCOCC1		Dual Specificity Mitogen-Activated Protein Kinase Kinase 1 (MAP2K1; MEK1) Inhibitors
DD-85-AN28	QSHGISMANBKLQL-OWJWWREXSA-N	C[C@H](NC(=O)Cc1cc(F)cc(F)c1)C(=O)N[C@@H]1C(=O)N(C)c2ccccc2-c2ccccc21	209984-56-5	Antiamyloidogenic Agents;gamma-Secretase Inhibitors;Notch Signaling Inhibitors;Antiamyloidogenic Agents;gamma-Secretase Inhibitors;Notch Signaling Inhibitors
DB-45-EH09	QSJWHWXROPOHCT-UHFFFAOYSA-N	C#CCSc1nc(NNC(N)=S)c(C#N)c(-c2cc(OC)c(OC)c(OC)c2)n1		LSD1 inhibitor
LD-47-RN92	QSTFOTXJPGATJP-UHFFFAOYSA-N	C#CCOc1ccc2c(c1)c(-c1ccc(C(C)C)cc1)nc(=O)n2CCC(C)(C)C		Calcium-Sensing Receptor (CaSR) Antagonists;Parathyroid Hormone Secretion Stimulants
ED-71-GA72	QSYLKMKIVWJAAK-UHFFFAOYSA-N	Cc1cc(Nc2ccc(NC(=O)c3ccc(Nc4ccnc5ccccc45)cc3)cc2)nc(N)n1	1020086-21-8	DNA Methyltransferase I Inhibitors
EF-46-LK88	QSYXPLNCWYFNQS-UHFFFAOYSA-N	CCOC(=O)C1=C(N)Oc2cc(O)ccc2C1c1ccccc1		
WD-26-LV83	QSZCDYHTHAAFAW-UHFFFAOYSA-N	COc1nc2cccnc2n1C1CC(Nc2nc3ccccc3s2)C1	1452553-40-0	Phoshodiesterase 10A Inhibitor
DF-74-MG39	QTCSXAUJBQZZSN-UHFFFAOYSA-N	CC(C)(CNC(=O)c1cccc(-c2noc(C(F)(F)F)n2)c1)c1coc(-c2ccccc2)n1	1314891-22-9	
WA-03-KC95	QTFKFJHTBIZRST-UHFFFAOYSA-N	Cc1cc(COC(=O)NC(C)(C)C)cc(C)n1	1198765-74-0	Leptin Receptor (OBR) Agonists
DD-55-SD64	QTNUWEKKZHSUQO-UHFFFAOYSA-N	O=C(O)c1ccc(-c2cc3cccnc3c(-c3cccc([N+](=O)[O-])c3)n2)cc1	207279-23-0	Phosphodiesterase IV Inhibitors
DE-48-FF01	QTOFVYOMOKYCEQ-UHFFFAOYSA-N	CC(C)CNc1nccn2c(-c3ccc(C(=O)NC4CC4)cc3)cnc12	1263420-68-3	TTK gene inhibitor
AB-73-ZX03	QTPDZKSJOIJEFW-QUCCMNQESA-N	O=C(N[C@@H]1CCC[C@](O)(C#Cc2cccc(Cl)c2)C1)c1cccnc1		mgluR5 Antagonists
AB-10-RE65	QTUJFHJUHDTZFB-UHFFFAOYSA-N	CN(c1ccc(-c2ccc(C#N)cc2O)nn1)C1CC(C)(C)NC(C)(C)C1	1562333-64-5	splicing modulator
BD-07-IW65	QTWVYUJFBIVOHT-JQHSSLGASA-N	O=c1[nH]c2c(O)ccc([C@H](O)CN[C@H]3CCC[C@@H]3OCc3ccccc3)c2s1		
BD-83-UC82	QTWVYUJFBIVOHT-SZMVWBNQSA-N	O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@@H]3OCc3ccccc3)c2s1	663925-02-8	ADRB2 agonist;ADRB2 gene stimulator
AD-41-WB70	QUNXSQHPYBFZQN-UHFFFAOYSA-N	Cc1ccc(Nc2nnc(-c3ccc4nc(-c5c(Cl)cccc5Cl)[nH]c4c3)o2)cn1	1137670-91-7	Diacylglycerol Acyltransferase type 1 (DGAT-1) Inhibitors
DA-86-GO43	QUSLYAPLTMMCFE-UHFFFAOYSA-N	CC(C)N1Cc2cc(S(C)(=O)=O)ccc2N(CCN2CC=C(c3c[nH]c4cc(F)ccc34)CC2)S1(=O)=O	271780-64-4	5-HT1B Antagonists;5-HT1D Antagonists;5-HT2A Antagonists;5-HT2B Antagonists;5-HT Reuptake Inhibitors
BD-85-AU55	QUVHZANTGRHKML-UHFFFAOYSA-N	CC(=O)NC1(c2ccc(CN3CCN(c4ncccn4)CC3)cc2)CC1		
BB-40-DA70	QUVNZVHUMJPPGC-KRWDZBQOSA-N	Cc1cc(F)c(-c2ccc(O[C@H]3CN4CCC3CC4)nn2)cc1F		
HC-20-JJ81	QUYLWAARGNSPMB-UHFFFAOYSA-N	C#CCOc1ccc2c(c1)c(-c1ccc(C(C)C)cc1)nc(=O)n2Cc1cccc(OCCO)n1		Calcium-Sensing Receptor (CaSR) Antagonists;Parathyroid Hormone Secretion Stimulants
HF-76-AK33	QUZLMKNNIUSREV-UHFFFAOYSA-N	O=C(c1ccc(F)cc1)N1CCc2nc(COc3ccccc3)oc2C1	1363281-27-9	GRM5 positive allosteric modulator
AB-83-EW00	QVAYTZAGDQIWMB-UHFFFAOYSA-N	CCCn1c(=O)c2c(ncn2C)n(CCC)c1=O		
BC-01-WO51	QVKGXWZEXPUJMY-AWEZNQCLSA-N	C[C@H](N)C(=O)NCCOC(=O)N(c1ccc(C(F)(F)F)cc1)c1nccc(-c2cccc(Cl)c2)n1		
TE-67-XP56	QVNZBDLTUKCPGJ-SHQCIBLASA-N	Cc1cc(COc2ccc([C@]3(N)CCN([C@H](CC(C)C)C(=O)NO)C3=O)cc2)c2ccccc2n1	611227-74-8	ADAM17 (TNF-alpha-Converting Enzyme (TACE) Inhibitors)
BC-02-WF67	QVZCXCJXTMIDME-UHFFFAOYSA-N	COc1cc(C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2)cc(OC)c1OC	20153-98-4	Adenosine Reuptake Inhibitor
TE-27-FF87	QWBVVOBWTNGNOF-UHFFFAOYSA-N	CC(C)(C)Cn1c(CN2C(=O)CC3(CCN(Cc4ccccc4)CC3)C2=O)cc2cnc(C#N)nc21		Cathepsin S Inhibitors;Cathepsin K Inhibitors
AD-45-YB25	QWCRAEMEVRGPNT-UHFFFAOYSA-N	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1	116753-41-4	5-HT1A Receptor Agonists;ADRA1B partial agonist
PA-39-SH87	QWFAMXAVDCZEBZ-UHFFFAOYSA-N	CC(C(=O)O)c1ccc2cc(OCc3ccc4ccccc4n3)ccc2c1	123016-15-9	Leukotriene Antagonists;Lipoxygenase Inhibitors;Non-Steroidal Antiinflammatory Drugs;Leukotriene Antagonists;Lipoxygenase Inhibitors;Non-Steroidal Antiinflammatory Drugs
AA-35-LB45	QWGDMFLQWFTERH-UHFFFAOYSA-N	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	14028-44-5	5-HT2A Antagonists;5-HT Reuptake Inhibitors;Norepinephrine Reuptake Inhibitors
DD-16-RV85	QWJLSBVZIPARSG-UHFFFAOYSA-N	COC(=O)c1c(NC(=O)CC2SC(=N)NC2=O)sc(C)c1C	405924-84-7	Secreted Frizzled-related Protein-1 (SFRP-1) Inhibitors
BE-59-WG31	QWQOWMCNZNPRMC-UHFFFAOYSA-N	Cc1cn(-c2cc(C(=O)Nc3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1	677704-46-0	Abl Kinase Inhibitors;Bcr-Abl Kinase Inhibitors;Inhibitors of Signal Transduction Pathways
BA-39-HG26	QXKHYNVANLEOEG-UHFFFAOYSA-N	COc1c2occc2cc2ccc(=O)oc12	12692-94-3	DNA-Damaging Drugs;Cytochrome P450 CYP1A2 Inhibitors
EF-61-NY75	QXOWLBKQZJYDBS-UHFFFAOYSA-N	CCc1ccc(-c2cnc(NCc3c(F)ccc4c3CCO4)n3cnnc23)c(C)n1		PRC2/EED
JA-62-XU82	QXQAFIAKTXDYFI-KRWDZBQOSA-N	N#CCNC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1		Cathepsin S Inhibitors;Cathepsin L Inhibitors;Cathepsin K Inhibitors
AB-28-BT90	QXQLIYVEURRKHO-UHFFFAOYSA-N	O=S(=O)(NCCCN1CCN(c2ccccc2F)CC1)c1cccc2cccnc12		Aquaporin 1 (AQP1) Inhibitors;Angiogenesis Inhibitors
AD-58-PW17	QXRSDHAAWVKZLJ-PVYNADRNSA-N	C/C(=C\\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1	152044-54-7	Apoptosis Inducers;Antimitotic Drugs;Microtubule-Stabilizing Agents;Apoptosis Inducers;Antimitotic Drugs;Microtubule-Stabilizing Agents
BB-14-KA05	QXWYKJLNLSIPIN-JGVFFNPUSA-N	N[C@H](C(=O)O)[C@H](O)c1ccc(O)c(O)c1	1260173-94-1	Norepinephrine Precursors
FD-28-EZ19	QXWZQTURMXZVHJ-UHFFFAOYSA-N	CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1	475086-01-2	Prostanoid IP Agonists
NC-01-ET52	QYTXJLQBSYAMGR-UHFFFAOYSA-N	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1C#N	1431540-99-6	lipid kinase inhibitor
EC-50-TX10	QYWNVGLKUUXOHE-UHFFFAOYSA-N	NCc1cc2ncc(C(=O)N3CCOCC3)n2cc1-c1ccc(Cl)cc1Cl		Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors
BA-34-BQ43	QYZOGCMHVIGURT-UHFFFAOYSA-N	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1	1218904-24-5	Aurora-B (ARK2) Kinase Inhibitors;Antimitotic Drugs;Inhibitors of Signal Transduction Pathways;Aurora-C (ARK3) Kinase Inhibitors
AD-56-VO78	QZAYGJVTTNCVMB-UHFFFAOYSA-N	NCCc1c[nH]c2ccc(O)cc12	1094000-36-8	Serotonin receptor agonist
KB-24-KS32	QZFSBPGOGMMRHP-UHFFFAOYSA-N	Cc1cc(OCC(=O)O)cc(C)c1-c1nc2ccc(C(=O)Nc3ccc4ccccc4n3)cc2[nH]1		
JA-23-QE71	QZGGATRCENWZPA-UHFFFAOYSA-N	CN1Cc2cc(Cl)ccc2-n2c(nnc2C2CCN(C(=O)c3ccc4cc[nH]c4c3)CC2)C1		AVPR1A antagonist
BC-40-TU13	QZKGUNQLVFEEBA-UHFFFAOYSA-N	CN1CCN(c2ccc(Nc3c4ccccc4nc4ccccc34)cc2)CC1	1259314-65-2	ADRA2C antagonist;alpha2C-Adrenoceptor Antagonists
AB-26-BE29	QZKOOEFIMWKZPK-UHFFFAOYSA-N	N=C(N)c1ccc2[nH]c(Cc3nc4cc(C(=N)N)ccc4[nH]3)nc2c1	74733-75-8	
AD-49-MG76	QZUDBNBUXVUHMW-UHFFFAOYSA-N	CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1	5786-21-0	Dopamine D4 Antagonists;5-HT2 Antagonists;ADRA1B gene inhibitor
UD-49-HQ53	QZUKGDYPSXQBSQ-VXKWHMMOSA-N	COc1cc([C@@H](O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)ncc1C#N	1255206-07-5	KCNJ1 gene inhibitor;KCNJ1 inhibitor
GC-61-BD64	QZVCTJOXCFMACW-UHFFFAOYSA-N	CC(COc1ccccc1)N(CCCl)Cc1ccccc1	102737-84-8	alpha-Adrenoceptor Antagonists
CE-00-EK89	QZYKIBMKWBKCBS-UHFFFAOYSA-N	COc1cc2c(cc1NS(=O)(=O)c1ccc(Cl)cc1)n(C)c(=O)n2C		
BB-16-BE49	QZZUEBNBZAPZLX-QFIPXVFZSA-N	CCc1cc2c(cc1CC)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2	1000160-87-1	beta2-Adrenoceptor Agonists
S0-EE-Y00Z	RANJJVIMTOIWIN-UHFFFAOYSA-N	CC(C)OC(=O)c1cn(Cc2c(F)cccc2F)c2sc(-c3ccc(NC(=O)C(C)C)cc3)c(CN(C)Cc3ccccc3)c2c1=O	192887-28-8	GnRH (LHRH) Antagonists
JB-08-BL30	RATFAFAWIWHLMR-UHFFFAOYSA-N	Cn1c(-c2ccccc2)c(-c2cn(CCC(=O)Nc3ccc(-c4ccccc4)cc3)nn2)c2cc(C(=O)O)c(O)cc21	1143579-78-5	Protein Tyrosine Phosphatase SHP-2 (PTP2C) Inhibitors
CC-61-KS26	RAVIZVQZGXBOQO-UHFFFAOYSA-N	CCC(C)N(C)C(=O)c1cc2ccccc2c(-c2ccccc2Cl)n1	85340-56-3	Peripheral Benzodiazepine Receptor (PBR) Antagonists;Pregnane X Receptor (PXR) Agonists;Constitutive Androstane Receptor (CAR) Antagonists
FF-35-JG06	RBKASMJPSJDQKY-RBFSKHHSSA-N	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN1CCN(c2cc(N3CCCC3)nc(N3CCCC3)n2)CC1	110101-66-1	Nitric Oxide Synthase Inhibitors;Lipid Peroxidation Inhibitors;Nitric Oxide Synthase Inhibitors;Lipid Peroxidation Inhibitors
CA-50-SD02	RBQOQRRFDPXAGN-UHFFFAOYSA-N	CCCn1cnc2c1c(=O)n(CCCCC(C)=O)c(=O)n2C	55242-55-2	Adenosine Reuptake Inhibitors
DB-80-CD47	RBTBFTRPCNLSDE-UHFFFAOYSA-N	CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1	1001913-24-1	Nitric Oxide Production Inhibitors;Tau Aggregation Inhibitors
AD-86-OB47	RCEFMOGVOYEGJN-UHFFFAOYSA-N	O=C1NC(c2cccc([N+](=O)[O-])c2)=CCN1c1ccccc1O	36945-98-9	TRPA1 Agonists;TRPM8 agonist;Induction of Brown Adipose Tissue (BAT) thermogenesis
CF-42-OS28	RCINICONZNJXQF-MZXODVADSA-N	CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O	1203669-79-7	Microtubule stabilizer
BE-69-RD44	RCSLEKLNDJJJLF-UHFFFAOYSA-N	CCOc1ccccc1NC(=O)c1ccccc1N[S@SP3](=O)(=O)C1CC1		MrgX1 PAM
GA-59-RW04	RDALZZCKQFLGJP-UHFFFAOYSA-N	Cc1cc2c(C(N)=O)cccc2n1-c1nc2c(c(NCc3ccccc3)n1)COCC2	1542705-92-9	p97 AAA ATPase inhibitor
EA-90-PK44	RDLIBCPWPNCFBW-UHFFFAOYSA-N	N=C(N)NC(=N)Nc1ccc2ccccc2c1	1215-36-7	5-HT3 receptoe agonist
AB-17-WP43	RDOIQAHITMMDAJ-UHFFFAOYSA-N	CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1	34552-83-5	mu-Opioid Agonists
KB-78-BE93	RDONXGFGWSSFMY-UHFFFAOYSA-N	CCS(=O)(=O)Nc1ccc(Oc2ccc(F)cc2F)c(-c2cn(C)c(=O)c3[nH]ccc23)c1	1445993-26-9	Bromodomain-Containing Protein 4 (Brd4, HUNK1) Inhibitors
DC-45-WU45	RDSACQWTXKSHJT-NSHDSACASA-N	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1	923032-36-4	MEK1 Inhibitors;MEK2 Inhibitors
AE-18-ZM98	RDSAUPRYZCQORM-BJTUFNSYSA-N	COc1ccc(C[C@H](C)CN2C[C@@H]3CCCC[C@@H]3[C@H](C(=O)N3CCN(c4ccc(F)c(F)c4)CC3)C2)cn1		Somatostatin srif1C (sst3) Antagonists
WB-82-EL69	RDSAUPRYZCQORM-KJMYBWGMSA-N	COc1ccc(C[C@@H](C)CN2C[C@H]3CCCC[C@H]3[C@@H](C(=O)N3CCN(c4ccc(F)c(F)c4)CC3)C2)cn1		
EE-98-PF86	RDSJJFGKRCBYRH-UHFFFAOYSA-N	c1ccc2c(N3CCNCC3)nc(-c3ccc4[nH]ncc4c3)nc2c1		Rho Kinase Inhibitors
GE-06-JX14	RDTVTSXTFYXNSG-HDNDNHAUSA-N	CC(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)N[C@@H]1CSSC[C@@H](C(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		SSTR2 antagonist
NE-93-AH13	REAXQOXPGHLTBE-UHFFFAOYSA-N	O=c1ccc(-c2cn[nH]c2)cn1-c1ccc(OC(F)(F)F)cc1		
FA-31-XR78	REBFVIFMSLOFLE-UHFFFAOYSA-N	O=C1Nc2ccc(C(=O)O)cc2/C1=N/Nc1cccc(C(=O)O)c1		
AB-82-ES53	REFJWTPEDVJJIY-UHFFFAOYSA-N	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12	117-39-5	
LF-33-KO15	REKSFCCYDQMSIN-UHFFFAOYSA-N	CC(C)n1cnc2c(NCc3cccc(C(F)(F)F)c3)ncnc21	1353867-91-0	Casein kinase-I alpha inhibitor;Casein kinase-I delta inhibitor
EE-59-HC06	RERPSPPBSSELBR-UHFFFAOYSA-N	NS(=O)(=O)N1CCc2ccccc2C1	15211-62-8	Carbonic Anhydrase Type II Inhibitors;Carbonic Anhydrase Type IX Inhibitors;Carbonic Anhydrase Type XIV Inhibitors
RB-80-II48	RESDJUDFKVEMNA-UHFFFAOYSA-N	COc1ccc(OC)c(-c2ccc3ncc4ncn(-c5ccccc5F)c4c3c2)c1		RET inhibitor
KB-48-GH25	REUBVRUCQDAYAF-UHFFFAOYSA-N	Cc1ccc(NC(=O)c2cc(-n3cc4ccc(C(=O)O)cc4n3)ccc2N2CCCCC2)cc1		
AA-48-XT80	REUIKJPCSZQCFD-UHFFFAOYSA-N	CCCn1c(-c2cnc(Nc3ccc(OC)cc3)c(Cl)c2)nc2ccccc21		
KA-54-QW27	REZGGXNDEMKIQB-UHFFFAOYSA-N	CCCOc1ccccc1-c1nc(=O)c2[nH]nnc2[nH]1	1110670-37-5	Phosphodiesterase V (PDE5A) Inhibitors;GPR35 agonist
IA-80-OW42	RFNNDNGXWCBNGK-VLJOUNFMSA-N	CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC	134447-97-5	Cathepsin B Inhibitors
AW-14-3219	RFTZQSZLGIQWEX-UHFFFAOYSA-N	CN1c2ccc(Cl)cc2N=C(N2CCNCC2)c2ccccc21		Muscarinic M1 Agonists;Dopamine D2 Agonists
KB-17-PN92	RFWGABANNQMHMZ-JUVTZQQOSA-N	C/C=C1\\C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)OC=C(C(=O)OC)C1CC(=O)OCCc1ccc(O)c(O)c1		
CF-57-GW25	RGCVKNLCSQQDEP-UHFFFAOYSA-N	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1	130-69-8	Dopamine Receptor Antagonists
FB-02-OL41	RGDHGNPUKLLPLT-UHFFFAOYSA-N	O=C1CCCN1c1cc([S@SP3](=O)(=O)Nc2ccc(F)cc2F)cc2c1N(C(=O)Nc1ccc(C(F)(F)F)cc1)CC2		MOGAT2 inhibitor
AB-62-TF27	RGELHKFJVUHNDT-FCEKVYKBSA-N	CS(=O)(=O)N[C@H](CCC1CCNCC1)C(=O)N1C[C@H](OCc2ccc(Cl)cc2)C[C@H]1C(=O)NCc1cc(Cl)ccc1CN		
ND-39-PO34	RGFKZORXYSZRTQ-UHFFFAOYSA-N	Cc1nc(NC(=N)N)nc2ccc3ccccc3c12	1028-27-9	
AA-88-PJ86	RGKVPYQYBUAAEH-UHFFFAOYSA-N	CCCn1c(-c2cnc(Nc3ccc(C)nc3)c(Cl)c2)nc2cccc(Cl)c21	1072929-61-3	mgluR5 Antagonists
AF-41-BY55	RGLYKWWBQGJZGM-ISLYRVAYSA-N	CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1	22610-99-7	Chloride Channel Blockers;Estrogen Receptor (ER) Agonists
CE-18-AP15	RGWSSTALGUXZMU-UHFFFAOYSA-N	CN(C)c1ccc(C(=O)NCCCCCC(=O)NO)cc1	193551-00-7	Histone Deacetylase (HDAC) Inhibitors
BE-73-KD75	RGXYYAZGELLKDA-UHFFFAOYSA-N	O=[N+]([O-])c1ccc(SCCCCCCO)c2nonc12	787634-60-0	Glutathione-S-Transferase P1 (GSTP1) Inhibitors
IF-06-KQ42	RGYQPQARIQKJKH-UHFFFAOYSA-N	CN(C)c1cccc(-c2c3c(=O)n(-c4ccccc4Cl)[nH]c3cc(=O)n2C)c1	1218942-37-0	NOX1, NOX4 inhibitor
AD-07-US30	RHMXXJGYXNZAPX-UHFFFAOYSA-N	Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O	518-82-1	Casein Kinase II (CK2) Inhibitors
HE-14-AT80	RIJLVEAXPNLDTC-UHFFFAOYSA-N	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1	1206101-20-3	
GE-58-RW27	RIKMMFOAQPJVMX-UHFFFAOYSA-N	Cc1cn[nH]c1		
OA-89-EE65	RIRYPMKEEPIRNS-UHFFFAOYSA-N	O=S(=O)(Nc1ccc(Cl)cc1NS(=O)(=O)c1ccc(OC(F)(F)F)cc1)c1ccc(OC(F)(F)F)cc1		
AD-66-NV75	RJBLYAOGZIACGS-ZDUSSCGKSA-N	Nc1ccc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1N1CCC[C@H](N)C1	1052709-60-0	Pim Kinase Inhibitors
CE-10-WA05	RJDZKYUVCPPOSE-UHFFFAOYSA-N	Cc1csc2c(Nc3ccc(C(N)=O)cc3OC3CCOC3)ncnc12		
VA-84-EQ91	RJEKXAIZCDVIHF-HYIHSTQNSA-N	C=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=C([C@@H](O)[C@H](OC(C)=O)[C@]12C)[C@@]1(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]1CC3)C(C)C		Elastase Inhibitors
DA-91-NR73	RJGBMEDATGRCEA-UHFFFAOYSA-N	CN(CCO)CCOC(=O)N(c1ccc(C(F)(F)F)cc1)c1nccc(-c2cccc(Cl)c2)n1		
HD-18-YL30	RJIWZDNTCBHXAL-UHFFFAOYSA-N	O=[N+]([O-])c1ccc(O)c2ncccc12	4008-48-4	Antibiotic;Chelator;Methionine Aminopeptidase-2 (MetAP2) Inhibitors;Angiogenesis Inhibitors
AC-71-HO46	RJKFOVLPORLFTN-LEKSSAKUSA-N	CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	137940-28-4	Progesterone Receptor Agonists
BF-00-PE90	RJLZHYQYYJPEOG-RIYZIHGNSA-N	COc1ccc(/C(C#N)=C/c2cccc(O)c2)cc1OC		Potassium Channel Activators;Breast Cancer-Resistant Protein (BCRP; ABCG2) Inhibitors
KE-41-JG66	RJTGOQWPPAHZBU-UHFFFAOYSA-N	N#Cc1ccc(NCCNc2ncc(-c3ncc[nH]3)c(-c3ccc(Br)cc3Cl)n2)nc1		
BB-44-SX65	RJURFGZVJUQBHK-IIXSONLDSA-N	Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O	50-76-0	RNA synthesis inhbitor;DNA-Directed RNA Polymerase Inhibitors;Transcription Inhibitors;RNA synthesis inhbitor;DNA-Directed RNA Polymerase Inhibitors;Transcription Inhibitors
NB-31-SG91	RJVANKLHHLOSMS-IZZDOVSWSA-N	COC(=O)CC/C(C)=C/Cc1c(OC)c(C)c2c(c1OC)C(=O)OC2		
HE-95-KK46	RJVLFQBBRSMWHX-DHUJRADRSA-N	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12	127191-97-3	P2X7 Receptor Antagonists;Calmodulin-Dependent Protein Kinase II (CaMK-II) Inhibitors;Calmodulin Antagonists;P2X7 Receptor Antagonists;Calmodulin-Dependent Protein Kinase II (CaMK-II) Inhibitors;Calmodulin Antagonists
AA-19-EX72	RJZFOZKSHAJVLQ-OLZOCXBDSA-N	Nc1nc(N)c(C(=O)/N=C2/NC[C@@H](CCCc3ccc(OC[C@@H](O)CO)cc3)N2)nc1Cl	1160939-59-2	
AD-09-MD49	RJZJEPYCJHLWQR-TUKIKUTGSA-N	CO[C@@H]1C(c2ccc(C#N)c(Cl)c2C)=NN2CC[C@H](O)[C@@H]12	1421375-26-9	Androgen receptor modulator
SE-91-VW19	RKEWSXXUOLRFBX-UHFFFAOYSA-N	CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1	706779-91-1	SELECTIVE inverse agonist on the serotonin receptor subtype 5-HT2A;HTR2A (5HT2A) inverse agonist;SELECTIVE inverse agonist on the serotonin receptor subtype 5-HT2A;HTR2A (5HT2A) inverse agonist
BA-26-GI09	RKFAZBXYICVSKP-AATRIKPKSA-N	C/C=C/c1cc(OC)c(OC)cc1OC	2883-98-9	Acetylcholinesterase Inhibitors;HMG-CoA Reductase Inhibitors
BB-48-VW67	RKKQUNNKTWJTLY-UHFFFAOYSA-N	CC(=O)N1CCN(c2ccc(OCc3cc4cnc(C#N)nc4n3CCC3CCCCC3)c(F)c2)CC1		Cathepsin S Inhibitors
GB-64-HC34	RKOUGZGFAYMUIO-RITPCOANSA-N	C=C1C[C@H](N)[C@H](C(=O)O)C1	156292-16-9	Isoleucyl-tRNA Synthetase Inhibitors
HE-59-VP02	RKQJIPUZTXRRRD-HHHXNRCGSA-N	C[C@@]1(Cc2ccc(-c3cncnc3)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(S(=O)(=O)N3CCNCC3)n21		Integrin alphaLbeta2 (LFA-1) Antagonists
AE-43-WW30	RKUNBYITZUJHSG-UHFFFAOYSA-N	CN1C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2	101-31-5	Muscarinic receptor antagonist
NE-55-KI60	RKWXKADYTDWZIJ-VIFPVBQESA-N	CNC(=O)[C@H](Cc1ccccc1)NC(=O)Nc1n[nH]c(=S)s1	198700-58-2	Matrix Metalloproteinase Inhibitors
AC-76-JB92	RLAJOHAIIACFAM-ZZXKWVIFSA-N	CN(C)CCOc1ccc(/C=C/c2cc(-c3cc4c(=O)[nH]cnc4[nH]3)ccn2)cc1		Aurora-A (ARK1) Kinase Inhibitors;MAPKAP-K2 (MK2) Inhibitors;Heat Shock Protein 27 (hsp27) Inhibitors;TNF-alpha Release Inhibitors
BF-81-LL19	RLAWWYSOJDYHDC-KSZLIROESA-N	NCCCC[C@H](N[C@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O	85955-59-5	Known ACE inhibitor
YF-57-HO38	RLFKILXOLJVUNF-UHFFFAOYSA-N	COCc1c(C(=O)OC(C)C)ncc2[nH]c3ccc(OCc4ccccc4)cc3c12	111841-85-1	GABA(A) BZ Site Receptor Partial Agonists
AB-38-CX25	RLJFTICUTYVZDG-UHFFFAOYSA-N	CSc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2	19728-88-2	
DC-49-EJ23	RLKRLNQEXBPQGQ-OZOXKJRCSA-N	N#Cc1ccc(O[C@@H]2c3ccccc3C[C@H]2N2CCC[C@@H](N)C2)c(Cl)c1	1333207-63-8	TRPC6 ion channel inhibitor
S0-EE-XZUM	RLRGPZGIQMEBLC-UHFFFAOYSA-N	O=c1[nH]cnc2c(-n3cc(CCN4CCC(c5cc(Cl)cc(Cl)c5)CC4)cn3)nccc12		
BD-48-JW52	RLXDINBVLLERRM-GOSISDBHSA-N	C[C@@H](Nc1ncnc2[nH]c(-c3ccc(CN4CCOCC4)cc3)cc12)c1ccccc1	497839-66-4	Receptor Tyrosine Kinase Inhibitors;Inhibitors of Signal Transduction Pathways
EF-99-HJ48	RMAMGGNACJHXHO-UHFFFAOYSA-N	CC(=O)c1cc([N+](=O)[O-])c(Sc2ccc(F)cc2F)s1	1247819-59-5	
TE-12-BW46	RMDYFILMTQCLCQ-JXMROGBWSA-N	O=C(/C=C/c1ccccc1Cl)N1CCN(Cc2ccc(F)cc2)CC1		Proteinase-Activated Receptor 1 (F2R; PAR1) Antagonist
AB-05-FB25	RMHMFHUVIITRHF-UHFFFAOYSA-N	CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc32)CC1	28797-61-7	Muscarinic M1 Antagonists
BC-43-HJ69	RMUCZJUITONUFY-UHFFFAOYSA-N	NNCCc1ccccc1	14847-47-3	MAO Inhibitors
JB-50-NM08	RMYKZOLKNAODDC-UHFFFAOYSA-N	CCCOc1ccc(C#Cc2ccc3c(c2)OCC(C)(C)CO3)cc1		Acetyl-CoA Carboxylase 2 (ACC2) Inhibitors
GC-49-HD44	RNAMYOYQYRYFQY-UHFFFAOYSA-N	COc1cc2c(NC3CCN(C(C)C)CC3)nc(N3CCC(F)(F)CC3)nc2cc1OCCCN1CCCC1	1481677-78-4	EHMT1/2
AC-86-KF37	RNEOHKZPZKEZCQ-UHFFFAOYSA-N	O=C(NCCc1nccs1)c1cnc2c(SSc3cccc4cc(C(=O)NCCc5nccs5)cnc34)cccc2c1		Proteasome inhibitor
EC-81-BA87	RNOJGTHBMJBOSP-UHFFFAOYSA-N	CC1(C2CCCC2)Cc2cc(OCC(=O)O)c(Cl)c(Cl)c2C1=O	53108-00-2	Chloride Channel Blockers
ED-80-NA90	RNPWPESLLCUROD-UHFFFAOYSA-N	O=[N+]([O-])c1ccc(N2CCC(O)CC2)cc1	79421-45-7	CDK Inhibitors
HD-27-CV87	RNSLRQNDXRSASX-UHFFFAOYSA-N	Cc1nn(C)c2nc(NNC(=O)Nc3cc(Cl)nc(Cl)c3)cc(C(C)C)c12	383150-41-2	S1PR2 antagonist;Lysophospholipid edg5 (S1P2) Receptor Antagonists
NE-24-ZO47	RNYPICBYZMHNQT-UHFFFAOYSA-N	COc1ccc(COc2nc(Br)cnc2NS(=O)(=O)c2ccc(C)cc2)cc1OCCN(C)C		Chemokine CCR4 Antagonists
AE-54-BN96	RNYUFDKLBWLNCR-UHFFFAOYSA-N	CCn1c(=O)ccc2cnc(SC)nc21	211244-82-5	CDK Inhibitors
AC-91-ME22	ROBVIMPUHSLWNV-CYBMUJFWSA-N	CC[C@]1(c2ccc(N)cc2)CCC(=O)NC1=O		
AA-74-OG49	ROBVIMPUHSLWNV-UHFFFAOYSA-N	CCC1(c2ccc(N)cc2)CCC(=O)NC1=O	125-84-8	Aromatase Inhibitors;Antiglucocorticoids
BB-75-XU05	RODXRVNMMDRFIK-UHFFFAOYSA-N	COc1cc2ccc(=O)oc2cc1O	92-61-5	Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Nicotinic Receptor Agonists;Acetylcholinesterase Inhibitors;LDL Antioxidants
JB-48-AO57	ROJNHXCKEQBZQP-FNRVNODHSA-N	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@H](CC(=O)OC)N(Cc4ccc(C(C)(C)O)cc4)C(=O)O3)[C@H]21		
RE-21-BF58	ROJNYKZWTOHRNU-UHFFFAOYSA-N	CNC(=O)Nc1ccc(OC)c(NC(=O)NC(=O)c2cc(F)c(F)cc2Cl)c1	648926-15-2	phosphorylase, glycogen, liver Inhibitor
AC-67-ZF49	RONZAEMNMFQXRA-UHFFFAOYSA-N	CN1CCN2c3ncccc3Cc3ccccc3C2C1	207516-99-2	5-HT2A Antagonists;5-HT3 Antagonists;alpha2-Adrenoceptor Antagonists
DC-50-QD52	ROSNVSQTEGHUKU-UHFFFAOYSA-N	O=C(NO)C1(CS(=O)(=O)c2ccc(Oc3ccc(Cl)cc3)cc2)CCOCC1	193022-04-7	MMP-12 (Macrophage Elastase) Inhibitors;MMP-13 (Collagenase 3) Inhibitors;MMP-14 (Membrane-Type Matrix Metalloproteinase 1) Inhibitors;MMP-2 (Gelatinase A) Inhibitors;MMP-3 (Stromelysin 1) Inhibitors;MMP-8 (Neutrophil Collagenase) Inhibitors;MMP-9 (Gelatinase B) Inhibitors;MMP-12 (Macrophage Elastase) Inhibitors;MMP-13 (Collagenase 3) Inhibitors;MMP-14 (Membrane-Type Matrix Metalloproteinase 1) Inhibitors;MMP-2 (Gelatinase A) Inhibitors;MMP-3 (Stromelysin 1) Inhibitors;MMP-8 (Neutrophil Collagenase) Inhibitors;MMP-9 (Gelatinase B) Inhibitors
HB-87-YY34	RPBMXJHQYJLPDN-UHFFFAOYSA-N	CC(=O)c1cc(-c2cc(C(=O)NC3CC3)ccc2C)c2ncccn12		BRD9/BRD7 inhibitor
BA-73-MC77	RPDFDSQFBCJTDY-GAQXSTBRSA-N	CC(C)Oc1cccc(CC(=O)N2CCC[C@](CC[N+]34CCC(c5ccccc5)(CC3)CC4)(c3ccc(Cl)c(Cl)c3)C2)c1	155418-05-6	Tachykinin NK1 Antagonists
JD-61-EG41	RPELAWNEKQODNO-UHFFFAOYSA-N	COc1ccccc1NS(=O)(=O)c1sc2ccc(Cl)cc2c1C		CDK5/p25 Inhibitors
CD-07-GB34	RPGDCRNUJYFGLT-UHFFFAOYSA-N	CC(CN)c1c[nH]c2ccc(O)cc12	22965-81-7	
AF-80-GK24	RPJPZDVUUKWPGT-RMMXNQGHSA-N	C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](C(C)CC)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C		
GD-17-GR17	RPJVKSSMOOHWAB-LBPRGKRZSA-N	N#C[C@@H]1CCCN1C(=O)CNCCNc1ccc(Cl)cn1		Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors
FB-29-KC76	RPMBYDYUVKEZJA-UHFFFAOYSA-N	COc1ccccc1CNCCCCCCNCCCCCCCCNCCCCCCNCc1ccccc1OC	104807-40-1	Muscarinic M2 Antagonists
CD-26-MB82	RPQZTTQVRYEKCR-WCTZXXKLSA-N	O=c1ncccn1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	3690-10-6	DNA Methyltransferase (DNMT) Inhibitors;Cytidine Deaminase (CDA) Inhibitors
BF-96-PY22	RPUTVAIXMBFZLI-NTCAYCPXSA-N	CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21		
LA-25-VT07	RPYWXZCFYPVCNQ-RVDMUPIBSA-N	COc1ccc(/C=C2\\CCCN=C2c2cccnc2)c(OC)c1	148372-04-7	Nicotinic alpha7 Partial Agonists
NB-53-OL78	RQCXKDWOCUJWQZ-UHFFFAOYSA-N	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12	214697-26-4	Adenylate kinase inhibitor
NB-89-OV56	RQFYFNAGNBUGFC-UHFFFAOYSA-N	COc1ccc(-c2ocnc2C(=O)NCCCn2cncn2)cc1Cl		GSK3a/b inhibitor
JA-74-VZ14	RQKXQCSEZPQBNZ-QSBCOWLBSA-N	C/C(=N\\NC(=O)[C@@H]1C(=O)NC[C@H]1c1ccccc1)c1cccc(Br)c1	1051487-82-1	PAR2 Agonists;F2RL1 agonist
KE-86-QG38	RQMVVBIHNXFXPW-UHFFFAOYSA-N	NCc1c(-c2ccc(Cl)cc2Cl)cn2c(N3CCSCC3)cnc2c1N		dipeptidyl-peptidase IV (DPP4) inhibitor;dipeptidyl-peptidase II (DPP7) inhibitor;Fibroblast Activation Protein alpha subunit (FAP) Inhibitor
S0-EE-Y79N	RQOKOKQQGKYASH-FPBOJHQQSA-N	O=C(/C=C/N1[C@H]2CC[C@@H]1c1ncnc(NC3CC3)c1C2)c1ccccc1O		N-Ac Lysine competitive SMARCA2/4 inhibitor
CE-18-CG29	RQQJJXVETXFINY-UHFFFAOYSA-N	N=C(N)NC(=O)c1nc(Cl)c(N2CCCCCC2)nc1N	1345839-29-3	GnRH (LHRH) Antagonists;Na+/H+ Exchanger (NHE) Inhibitors
WA-62-RP29	RQVLGMREYUFLPQ-UHFFFAOYSA-N	CNc1ccnc(Nc2ccc3cc(C)n(-c4ccccc4Oc4cnc5c(c4)ncn5C)c3c2)n1		Dot1L inhibitors
CA-98-SW47	RRGUKTPIGVIEKM-UHFFFAOYSA-N	O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1	1073608-02-2	Phosphodiesterase III Inhibitors
CE-99-NH84	RRKKJYBCPXAJAO-IBGZPJMESA-N	N=C(N)NCCC[C@H](NC(=O)COCC(c1ccccc1)c1ccccc1)C(=O)O	1140525-25-2	C3AR1 antagonist
BF-08-RW47	RRLCFCXRVBZHDG-UHFFFAOYSA-N	CN(C)CCc1c[nH]c2ccc(-c3ccccc3)cc12		5-HT1D Agonists;HTR1D agonist
AE-93-WW90	RRRUXBQSQLKHEL-UHFFFAOYSA-N	COc1ccc(C(=O)Nc2c(Cl)cncc2Cl)cc1OC1CCCC1	144035-83-6	Phosphodiesterase IV Inhibitors
AE-10-FH02	RRZVGDGTWNQAPW-UHFFFAOYSA-N	Cn1cc(CCn2cnc(-c3cnn(C)c3)c2-c2ccc(C#N)cc2)cn1	1665195-94-7	BAZ2A, BAZ2B dual inhibitor;Dual BAZ2A/BAZ2B inhibitor
GC-07-KH68	RSDOPYMFZBJHRL-UHFFFAOYSA-N	O=C1CCCN1CC#CCN1CCCC1	17360-35-9	Muscarinic receptor agonist
AB-17-ZZ77	RSEPBGGWRJCQGY-RBRWEJTLSA-N	CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C		
FE-58-ES32	RSKMQDIAPGOWDL-UHFFFAOYSA-N	Fc1ccc(Nc2nc(-c3ccccc3)cs2)cc1		
HE-16-PO98	RSMYFSPOTCDHHJ-GOSISDBHSA-N	COc1nnc2ccc(N3CCC(c4ccc(OCCN5CCN(C)C(=O)[C@H]5C)cc4)CC3)nn12		inhibitor of BRD4
FB-62-JY52	RSPDBEVKURKEII-ZCFIWIBFSA-N	O=c1[nH]c(=S)n(C[C@H]2CCCO2)c2nc[nH]c12	618913-30-7	Myeloperoxidase Inhibitors
FE-94-NQ13	RSQGZEAXODVTOL-UHFFFAOYSA-N	C#Cc1cnc2nc(O)n(C(CC)CC)c2n1	1005491-05-3	
CC-30-TN36	RSRUDTPYRBLHEO-UHFFFAOYSA-N	CN1CCc2cccc(Cl)c2CC1	73943-10-9	alpha2-Adrenoceptor Antagonists
YB-27-PO08	RSWGJHLUYNHPMX-ONCXSQPRSA-N	CC(C)C1=CC2=CC[C@@H]3[C@](C)(CCC[C@@]3(C)C(=O)O)[C@H]2CC1	10248-55-2	HSD11B1 expression inhibitor;Antibacterial;Antiinflammatory
AB-74-VK99	RTGDFNSFWBGLEC-SYZQJQIISA-N	COc1c(C)c2c(c(O)c1C/C=C(\\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2	1132748-21-0	Nicotinic Acid (Niacin;GPR109A;HM74A) Receptor Agonists;Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors
GC-28-YS77	RTGHTZYVGKKHJP-UHFFFAOYSA-N	Cc1nc(N2CCN(Cc3ccc(OC(F)(F)F)cc3)C2=O)sc1C(=O)NCc1ccccn1	1184957-40-1	SCD inhibitor
CC-84-QJ26	RTHCYVBBDHJXIQ-UHFFFAOYSA-N	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	100568-02-3	Sodium Channel  Blockers;Serotonin Transporter (SERT) Inhibitors
VF-49-KA00	RTHHSXOVIJWFQP-UHFFFAOYSA-N	Cc1cc(=O)oc2c(C=O)c(O)ccc12	14003-96-4	ERN1 gene inhibitor
AA-31-YE07	RTIXKCRFFJGDFG-UHFFFAOYSA-N	O=c1cc(-c2ccccc2)oc2cc(O)cc(O)c12	480-40-0	Apoptosis Inducers;Breast Cancer-Resistant Protein (BCRP;ABCG2) Inhibitors;Antiinflammatory Drugs;Antioxidants;Apoptosis Inducers;Breast Cancer-Resistant Protein (BCRP;ABCG2) Inhibitors;Antiinflammatory Drugs;Antioxidants
AE-19-XO96	RTJGVFANTDWUEG-UHFFFAOYSA-N	CC(C)c1cc(Cl)cc(C(C)C)c1NC(=O)NS(=O)(=O)c1cc(C(C)(C)O)co1		
FC-20-EQ58	RTKIYFITIVXBLE-WKWSCTOISA-N	CC(/C=C/C(=O)NO)=C\\C(C)C(=O)c1ccc(N(C)C)cc1	1208356-08-4	HDAC inhibitor
CF-81-DS26	RTRIXVOSRYRSBP-VXKWHMMOSA-N	c1ccc([C@@H]2CCC[C@@H]2N/C2=N/CCCCCCCCCCC2)cc1	40297-09-4	Adenylate Cyclase Inhibitors;Calcium Channel Blockers;Adenylate Cyclase Inhibitors;Calcium Channel Blockers
LC-42-WU67	RTRQQBHATOEIAF-UUOKFMHZSA-N	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1N	2627-69-2	AMP activated protein kinase stimulator;AMPK Activator;AMP activated protein kinase stimulator;AMPK Activator
NC-35-BF58	RTSVOIMXVOINRY-UHFFFAOYSA-N	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCCCC6)cc5)cnc34)ccnc2c1		
AD-92-AP11	RUDATBOHQWOJDD-BSWAIDMHSA-N	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	24404-86-2	11-beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Inhibitors;Farnesoid X Receptor (FXR) Agonists
ED-39-VX22	RUDATBOHQWOJDD-UZVSRGJWSA-N	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	108609-27-4	Nuclear Factor, Erythroid Derived 2, Like 2 (Nrf2) Activators;Antioxidants;AKR1C3 Inhibitor
FB-32-TL51	RUDQZAZYCMBBDU-SECBINFHSA-N	C[C@H](CN(C)C)NC(=O)c1ccc(-c2noc(C(F)(F)F)n2)cc1	1418292-63-3	HDAC4/5
OA-39-IH02	RUOKEQAAGRXIBM-GFCCVEGCSA-N	C#CCN[C@@H]1CCc2ccccc21	1204184-69-9	MAO-B Inhibitors
HF-01-QN73	RUTVRAJKELSHCC-UHFFFAOYSA-N	CC(C)n1nnc2cc(C(=O)O)ccc21	306935-41-1	Nicotinic Acid (Niacin;GPR109B;HM74) Receptor Agonists;GPR109B agonist
YA-78-MS95	RUWCWTXHTOBJIA-NHCUHLMSSA-N	CCCC[C@]1(CC)CS(=O)(=O)c2ccccc2[C@@H](c2ccccc2)N1	152802-07-8	Ileal Bile Acid Transporter (IBAT) Inhibitors
DA-80-IY83	RUZYUOTYCVRMRZ-UHFFFAOYSA-N	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC	137888-77-8	alpha1-Adrenoceptor Antagonists;Apoptosis Inducers
OA-51-KF88	RVGLGHVJXCETIO-UHFFFAOYSA-N	N#Cc1cc(NC(=O)C(=O)O)c(Cl)c(NC(=O)C(=O)O)c1	53882-12-5	
KE-93-TR02	RVKFQAJIXCZXQY-CBZIJGRNSA-N	C[C@]12CC[C@@H]3c4ccc(OS(N)(=O)=O)cc4CC[C@H]3[C@@H]1CCC2=O	148672-09-7	Estrogen Receptor (ER) Agonists;Steryl Sulfatase Inhibitors
BE-37-ZF44	RVMWIVNHZMXEHS-UWVGGRQHSA-N	COc1nc(N(CC(C)(C)F)c2cc(Cl)c(F)cc2F)cnc1C(=O)[C@H]1C[C@@H]1C(=O)O		
OB-22-TT14	RVOUDNBEIXGHJY-UHFFFAOYSA-N	O=C1NCCc2c(OCCCCN3CCCCC3)cccc21	129075-73-6	NAD+ ADP-Ribosyltransferase (poly(ADP-ribose)polymerase;PARP) Inhibitors;Influenza A virus RNA Promoter Binder
FC-35-BX82	RVYSEKGVPXFKBH-FRGIQLLGSA-N	C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](CC)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C		
GA-49-SZ11	RWNSISJNBAQNTF-NSHDSACASA-N	N[C@H](C(=O)N1CCCC1)C1CCCCC1		Dipeptidyl Peptidase VIII (DPP8) Inhibitors;Dipeptidyl Peptidase IX (DPP9| DPRP2) Inhibitors;Dipeptidyl Peptidase IV (CD26| DPP-IV| DP-IV) Inhibitors
S0-EE-Y6WJ	RWQUSQUPWBEBAN-UHFFFAOYSA-N	Nc1nc2ccc(-c3ccn(CC4CC4)c(=O)c3)cc2s1	1608501-54-7	PI4KA gene inhibitor
AC-73-DW50	RWTNPBWLLIMQHL-UHFFFAOYSA-N	CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1	1319714-86-7	Histamine H1 Receptor Antagonists
DA-88-JF21	RWVIMCIPOAXUDG-UHFFFAOYSA-N	O=[N+]([O-])c1cc2nc(O)c(O)nc2cc1[N+](=O)[O-]	1312992-24-7	
FC-97-EO10	RXGSYGWAACXBSV-NSOVKSMOSA-N	COCCCOc1cc(C(=O)N(C[C@@H]2CNC[C@H]2CN(C)C(=O)C2Cc3ccccc3C2)C(C)C)ccc1OC		
UD-20-ER54	RXGUTQNKCXHALN-BJMVGYQFSA-N	O=C(/C=C/c1ccc(O)cc1)NCCc1ccc(O)cc1	111129-11-4	uncompetitive inhibitor
BE-95-OR23	RXIUEIPPLAFSDF-CYBMUJFWSA-N	CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1	473727-83-2	Apoptosis Inducers;Chemokine CXCR1 (IL-8 alpha Receptor) Antagonists;Chemokine CXCR2  (IL-8 beta Receptor) Antagonists;Angiogenesis Inhibitors
FE-69-HJ93	RXIUMAOXORBRCY-UHFFFAOYSA-N	OCCNC1CCCc2c1[nH]c1ccc(-c3ccccc3)cc21	425399-05-9	CDC42 Rho GTPase inhibitor
RD-57-WQ44	RXRVCJFGSOVYLG-LLVKDONJSA-N	C[C@@H]1CN(c2cccnc2F)C(=O)c2cc(COc3ccc(Cl)cn3)nn21		selective mGlu3 NAM
IF-31-BQ95	RXVZJHDMMKTKDR-UHFFFAOYSA-N	C#CCOc1ccc2c(c1)c(-c1ccc(C(C)C)cc1)nc(=O)n2C(C)C	478963-79-0	Calcium-Sensing Receptor (CaSR) Antagonists;Parathyroid Hormone Secretion Stimulants
OE-68-FR64	RXXGGIYKMYOUPC-UHFFFAOYSA-N	CCc1cccc(CC)c1N1C(=O)Cc2ccccc2C1=O	202200-23-5	Puromycin-Sensitive Aminopeptidase Inhibitors
OB-78-PA58	RXXJCNMVVRGOJB-UHFFFAOYSA-O	COCCOCCOCCOCCOC(=O)OC[n+]1ccc(N/C(=N/C#N)NCCCCCCOc2ccc(Cl)cc2)cc1	432037-57-5	Glycerol-3-Phosphate Dehydrogenase (NAD+) Inhibitors;Inhibitory kappaB Kinase (IKK) Inhibitors;Nicotinamide Phosphoribosyltransferase (NMPRTase) Inhibitors;Signal Transduction Modulators;Glycerol-3-Phosphate Dehydrogenase (NAD+) Inhibitors;Inhibitory kappaB Kinase (IKK) Inhibitors;Nicotinamide Phosphoribosyltransferase (NMPRTase) Inhibitors;Signal Transduction Modulators
QE-87-XW53	RYBJORHCUPVNMB-UHFFFAOYSA-N	Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O	86197-47-9	Dopamine D1 Agonists;beta2-Adrenoceptor Agonists
HC-69-UG51	RYMZZMVNJRMUDD-HGQWONQESA-N	CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21	79902-63-9	HMG-CoA Reductase Inhibitors;HDL-Cholesterol Increasing Agents
AD-83-MW95	RYYVLZVUVIJVGH-UHFFFAOYSA-N	Cn1c(=O)c2c(ncn2C)n(C)c1=O	114303-55-8	Adenosine A2a receptor antagonist;Chitinase antagonist
AA-43-BW50	RZEKVGVHFLEQIL-UHFFFAOYSA-N	Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1	169590-42-5	Cyclooxygenase-2 Inhibitors;Angiogenesis Inhibitors;Cyclooxygenase-2 Inhibitors;Angiogenesis Inhibitors
DB-47-EV77	RZJQGNCSTQAWON-UHFFFAOYSA-N	CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1	162011-90-7	
HE-29-OW54	RZKDEGZIFSJVNA-IBGZPJMESA-N	C[C@H]1CN(Cc2ccc(CC(=O)N3CCC(Nc4cccc(F)c4)CC3)cc2)CCN1	923565-21-3	Motilin Receptor Agonists
DE-02-BL66	RZRPZWGIOOZIBE-UHFFFAOYSA-N	Clc1ccccc1CNCC1CCC(CNCc2ccccc2Cl)CC1	1245-84-7	Hedgehog pathway inhibitor;7-dehydrocholesterol reductase inhibitor
WF-76-NV73	RZRWBKKAFHXNEQ-UHFFFAOYSA-N	CS(=O)(=O)c1ccccc1S(=O)(=O)NO		activation for sGC, oxidation of sulfides for others
AC-40-KV26	RZTAMFZIAATZDJ-UHFFFAOYSA-N	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl	72509-76-3	Calcium Channel Blockers
IF-78-GO12	RZVAJINKPMORJF-UHFFFAOYSA-N	CC(=O)Nc1ccc(O)cc1	103-90-2	Cyclooxygenase-3 Inhibitors
RF-70-HE33			64232-83-3	
PD-26-DC63	SALVHVNECODMJP-GNUCVDFRSA-N	CC(C)=CCC/C(C)=C/CC/C(C)=C/CN1C(=O)c2cccc(O)c2Nc2c(O)cc(O)cc21	179981-40-9	Apoptosis Inducers;5-Lipoxygenase Inhibitors;Peripheral Benzodiazepine Receptor (PBR) Ligands;MAPK-Activated Protein Kinase Inhibitors
YD-32-RO91	SAPNXPWPAUFAJU-UHFFFAOYSA-N	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1		
HB-54-ZC59	SAULHIDXVGCWSE-UHFFFAOYSA-N	NC(=O)c1ccccc1Nc1cccc(OCCc2cccc(F)c2)c1	1382354-26-8	SIRT2 gene inhibitor
FF-32-LL81	SAVNTVHVERKVOD-UHFFFAOYSA-N	N=C(N)c1ccc(CNC(=O)c2cnn(Cc3ccccc3)c2)cc1		Kallikrein B (Plasma Kallikrein;KLKB1) Inhibitors
BE-25-UR78	SAYGKHKXGCPTLX-UHFFFAOYSA-N	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O	507475-17-4	IKK-2 (IKK-beta) Inhibitors
NE-29-VB58	SBJLJOFPWOYATP-XMMPIXPASA-N	CC(C)(N)CC(=O)N[C@@H]1CCc2ccccc2N(Cc2ccc(-c3ccccc3-c3nn[nH]n3)cc2)C1=O	145455-23-8	GHS Receptor Antagonists;GHSR agonist
CF-65-GU65	SBOKKVUBLNZTCT-OUKQBFOZSA-N	O=C(/C=C/c1nc2ccccc2[nH]1)c1c(O)nc2ccc(Cl)cc2c1-c1ccccc1	1233322-09-2	Apoptosis Inhibitors;PKB alpha/Akt1 Inhibitors
PC-87-OG75	SBVKGMIOZLHUCJ-UHFFFAOYSA-N	N#Cc1nc(-c2c(F)cccc2Cl)[nH]c1C#Cc1cccc(N)c1		
JC-02-ZR15	SBVMSMUUVDMKQT-UHFFFAOYSA-N	O=[N+]([O-])c1cc(S(=O)(=O)n2cc(CO)c3ccccc32)ccc1Cl	946413-49-6	Apoptosis Inducers;BCL2 Expression Inhibitors
CF-24-PH37	SCAZVAQQRCZSRZ-UHFFFAOYSA-N	CCOC(=O)Cc1c[nH]cn1	28782-45-8	IL-10 Production Enhancers
MA-64-FB16	SCGHPXZDNXFZTR-XJKSGUPXSA-N	Cn1nnc(-c2ccc([C@@H](C(=O)Nc3cnc(C(F)(F)F)cn3)[C@H]3CCC(F)(F)C3)cc2)n1		
BD-68-PM33	SCJXQZZYGYLKJG-CQSZACIVSA-N	CC[C@@H](N)CNc1ccnc(-c2cc(-c3cnn(C)c3)ccc2O)n1	1290629-45-6	protein kinase d inhibitor
SA-49-SD47	SCNILGOVBBRMBK-FJFSNTMWSA-N	Nc1nc(Nc2ccccc2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O		ADORA2A agonist;ADORA2B agonist
SD-69-QA40	SCQRJDHPTBHJPH-YFHOEESVSA-N	O=C1NC(=S)S/C1=C1/CCOc2ccc(F)cc21		Phosphatidylinositol 3-Kinase delta (PI3Kdelta) Inhibitors
CF-98-KM73	SCTZUZTYRMOMKT-UHFFFAOYSA-N	NC(=O)C(c1ccccc1)(c1ccc(F)cc1)c1ccc(F)cc1	289656-45-7	Intermediate Conductance K(Ca) 3.1 (IKCa1;Gardos channel, SK41, IK1) Channel Blockers
JD-44-KF86	SCULJPGYOQQXTK-OLRINKBESA-N	CC(=O)O[C@H]1[C@H]2O[C@]23[C@@H]2CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]2CC[C@]3(C)[C@H]1c1ccc(=O)oc1	36121-84-3	Cinobufagin, SMUT;Na+/K+-ATPase Inhibitors;Chloride Channel Activators
CF-03-QN99	SCVHJVCATBPIHN-SJCJKPOMSA-N	C[C@H](NC(=O)C(=O)Nc1ccccc1C(C)(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)COc1c(F)c(F)cc(F)c1F	254750-02-2	Apoptosis Inhibitors;Caspase Inhibitors
DE-57-JI61	SCVIEONTACSLJA-VZBZSUMNSA-N	CC/C(=C(/c1ccc(O)cc1)c1ccc(/C=C/C(=O)O)cc1)c1ccccc1	361203-06-7	Selective Estrogen Receptor Downregulators (SERDs)
MD-60-WI93	SCVSKBOXACFBBW-WGSAOQKQSA-N	COc1cc(Cc2nnc(N[C@H]3CC[C@H](C(C)C)CC3)c3ccccc23)ccn1		VEGFR-1 (Flt-1) Inhibitors;Inhibitors of Signal Transduction Pathways;Angiogenesis Inhibitors
HB-06-WU12	SDABUVHLPSIZEG-NBMRYCAZSA-N	CN1C(=O)[C@@]23C[C@](C)(C#N)[C@H](c4ccc5c(c4)OCO5)N2C(=O)[C@]1(C)SS3	1607798-23-1	induces concomitant H3K9me3 downregulation
DD-30-SX80	SDAPIJKUFXEZSO-UHFFFAOYSA-N	Oc1ccc(-c2cnc3ccc(NC4CCCCC4)nn23)cc1	1012345-10-6	Interleukin-1 Receptor-Associated Kinase (IRAK) Inhibitors
FA-12-QB17	SDGJBAUIGHSMRI-UHFFFAOYSA-N	CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1	1214265-58-3	inhibitor of NUAK1 and NUAK2
BD-84-ZR31	SDHTXBWLVGWJFT-UMXDBTPVSA-N	C=C1C(=O)[C@]23C(O)[C@H]1CC[C@H]2[C@@]12CO[C@]3(O)[C@@H](O)[C@@H]1C(C)(C)CC[C@@H]2O	28957-04-2	
FB-19-EX47	SDHXQALTNKXTMI-UHFFFAOYSA-N	O=C(c1cc(Cc2ccc(F)cc2)c(O)cc1O)N1Cc2ccccc2C1		
CF-17-PV42	SDJLVPMBBFRBLL-UHFFFAOYSA-N	CCN(CCCl)Cc1ccccc1Br	40616-75-9	Adrenergic Neuron Blockers
WB-44-AA73	SDKLWMXBZVGUHI-XPALAHHGSA-N	N=C(N)Nc1ccc(CNC(=O)N2CCN(C(=O)O[C@@H]3COC4C3OC[C@H]4OC(=O)N3CCN(C(=O)NCc4ccc(NC(=N)N)cc4)CC3)CC2)cc1	256649-36-2	Known Tryptase inhibitor
GB-51-MD79	SDMBRCRVFFHJKR-UHFFFAOYSA-N	CC(C)(CCCCOCCCCC(C)(C)C(=O)O)C(=O)O	183293-82-5	HDL-Cholesterol Increasing Agents;PPAR Agonists;HDL-Cholesterol Increasing Agents;PPAR Agonists
ND-86-GT24	SDTRYHWIXVHTLM-GFCCVEGCSA-N	Nc1nc2c(c(N3CC[C@@H](N)C3)n1)CCCc1ccccc1-2	1027330-97-7	HRH4 antagonist;Histamine H4 Receptor Antagonists
BF-10-IO69	SDUQYLNIPVEERB-QPPQHZFASA-N	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1	103882-84-4	Ribonucleotide Reductase inhibitor;DNA Damaging Agent
OD-30-JC39	SDYVNFZZVKLIRP-UHFFFAOYSA-N	CCCSC(=O)CCc1ccc(O)c(O)c1		NFE2L2 stimulator/agonist
BE-42-IC00	SDZRWUKZFQQKKV-CAPWMPRDSA-N	C=C1[C@@H](C)[C@H]2[C@H](Cc3ccccc3)NC(=O)[C@]23C(OC(C)=O)/C=C/[C@@](C)(O)C(=O)[C@@H](C)C/C=C/[C@H]3[C@@H]1O	22144-77-0	actin polymerization
YB-83-AS93	SEAKDKTVXBDRHV-UHFFFAOYSA-N	Cn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21	133052-89-8	CDK4/Cyclin D1 Inhibitors;CDK2/Cyclin E Inhibitors;Protein Kinase C (PKC) Inhibitors
FB-16-FK53	SEBQSRWAJBFZHB-UHFFFAOYSA-N	COc1ccc(C2=CC(=O)NC2)cc1OC1CCCC1		Phosphodiesterase IV Inhibitors;TNF-alpha Production Inhibitors
FD-65-VN78	SEDLHXUKMNCOMZ-UHFFFAOYSA-N	Cc1cccc(CNC(=O)n2nnc3ccccc32)c1	934701-74-3	Endothelial Lipase (EL) Inhibitors
FF-46-IE04	SEGYOKHGGFKMCX-UHFFFAOYSA-N	O=C(Oc1ccc([N+](=O)[O-])cc1)N1CCC(C(O)(c2ccc3c(c2)OCO3)c2ccc3c(c2)OCO3)CC1	1101854-58-3	Monoacylglycerol Lipase Inhibitors;Monoglyceride lipase inhibitor
EC-87-ZE76	SEPJQQWQYNEMDL-UHFFFAOYSA-N	N=C(N)c1ccc2cc(OC(=O)c3ccccc3)ccc2c1		Complement C1s subcomponent inhibitor;Factor XIa Inhibitor
PA-84-RB96	SEQBBDLZUXJXRX-KRWDZBQOSA-N	Cn1nc(C[C@@H]2CCN(C(=O)C3CC3)C2)n(-c2ccc(-c3ccc4occc4c3)cc2)c1=O		
SA-31-VB03	SETVRSKZJJWOPA-FLDGXQSCSA-N	CC(/C=C/[C@@]1(C)[C@H](C)CCC(=O)[C@@H]1C)=C\\Cc1c(O)c(Cl)c(C)c(C=O)c1O	26166-39-2	AP-1 Inhibitors;Electron Transport Chain Inhibitors;AP-1 Inhibitors;Electron Transport Chain Inhibitors
GA-68-KC29	SEUHNFHNNANEAJ-DTZQCDIJSA-N	O=C(Cn1c(=O)ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]2O)c1=O)c1ccccc1		P2Y6 Receptors
CA-70-EK39	SFDROHXKTATJBI-UHFFFAOYSA-N	CC1(C)CN=C(N2CCN(c3ncnc4sc(CC(F)(F)F)cc34)CC2)S1	1454920-20-7	Inhibitor of MEN1 (Menin);MEN1 inhibitor
AC-76-BB72	SFLSHLFXELFNJZ-QMMMGPOBSA-N	NC[C@H](O)c1ccc(O)c(O)c1	108341-18-0	alpha-Adrenoceptor Agonists;beta-Adrenoceptor Agonists;alpha-Adrenoceptor Agonists;beta-Adrenoceptor Agonists
CB-77-KL88	SFLSHLFXELFNJZ-UHFFFAOYSA-N	NCC(O)c1ccc(O)c(O)c1	104655-07-4	alpha-Adrenoceptor Antagonists
KB-05-VJ83	SFNLLCUAISZNRV-UHFFFAOYSA-N	O=C(NC(=O)c1c(F)cccc1Cl)NC1c2ccccc2-c2ccccc21	1186372-20-2	PPIA gene inhibitor
IE-02-TR35	SFRQIPRTNYHJHP-QHCPKHFHSA-N	O=C(NCc1ccc(F)cc1)N1CCN2C(=O)OC(c3ccccc3)(c3ccccc3)[C@@H]2C1	847555-75-3	NPSR1 antagonist
TA-19-GU13	SFXXRVSPZSOREJ-UHFFFAOYSA-N	CCOc1nc(N)nc2[nH]cnc12		
AE-11-VB80	SFYISUPIFOZKLQ-DYVFJYSZSA-N	C[C@@H](O)[C@H](NC(=O)c1ccc(C#Cc2ccccc2)cc1)C(=O)NO		
AB-12-IS33	SGDBTWWWUNNDEQ-LBPRGKRZSA-N	N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O		
JB-75-NC66	SGEIEGAXKLMUIZ-XUVDNFPMSA-N	[O-][n+]1cccc(/C(Cl)=N/OC[C@H](O)CN2CCCCC2)c1	289893-25-0	HSP70 co-inducer or chaperone
IB-67-WH43	SGIKDIUCJAUSRD-QMMMGPOBSA-N	Cc1cc(C(=O)O)ccc1[C@H](N)C(=O)O	198419-91-9	mgluR1 Antagonists
BF-44-RX10	SGKXHMJBGTURGB-UHFFFAOYSA-N	Cc1c(NC(=O)c2noc3c2CCCc2cc(OC(F)(F)F)ccc2-3)c(=O)n(-c2ccccc2F)n1C		SMAD-1 inhibitor;SMURF1 inhibitor
BE-09-HN23	SGPMJRPYYIJZPC-JYAZKYGWSA-N	CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(N)=O	171436-38-7	F2RL1 agonist
BD-27-CC87	SGRYPYWGNKJSDL-UHFFFAOYSA-N	CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1	68302-57-8	Mediator Release Inhibitors
AA-20-DK54	SGTNSNPWRIOYBX-UHFFFAOYSA-N	COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC	152-11-4	Dopamine D2 Antagonists;L-Type Calcium Channel Blockers;Calcium Channel Blockers
AB-15-FB25	SGUAFYQXFOLMHL-UHFFFAOYSA-N	CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(=N)O)c1	32780-40-8	alpha-Adrenoceptor Antagonists;beta-Adrenoceptor Antagonists
HB-79-CZ36	SGXXNSQHWDMGGP-IZZDOVSWSA-N	CN/C(=C\\[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1	1246833-99-7	Histamine H2 Receptor Antagonists
BC-54-ON71	SGYJGGKDGBXCNY-ZDIDWYTNSA-N	CC1(C)NC(=O)[C@H](CCCCCC(=O)C2CO2)NC(=O)[C@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC1=O	53342-16-8	Reported to be a general HDAC inhibitor
DE-22-JV30	SHGAZHPCJJPHSC-XFYACQKRSA-N	CC1=C(/C=C/C(C)=C/C=C/C(C)=C\\C(=O)O)C(C)(C)CCC1	4759-48-2	Retinoid RAR Agonists
AB-32-WM54	SHGAZHPCJJPHSC-YCNIQYBTSA-N	CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1	124510-04-9	Retinoid RORbeta Ligands
AB-70-GR31	SHGAZHPCJJPHSC-ZVCIMWCZSA-N	CC1=C(/C=C/C(C)=C\\C=C\\C(C)=C\\C(=O)O)C(C)(C)CCC1	124510-04-9	ABCA1 Expression Enhancers;Retinoid RAR Agonists;Retinoid RXR Agonists
AE-95-HR68	SHHUPGSHGSNPDB-UHFFFAOYSA-N	O=C(COc1ccc(C(=O)c2ccccc2)cc1)NC1CCN(Cc2ccccc2)CC1	924416-43-3	Adiponectin Receptor 1 (ADIPOR1) and Adiponectin Receptor 2 (ADIPOR2) Agonist.
WA-90-HU51	SHLGKPQMNGQNAT-UHFFFAOYSA-N	CCCCCc1nc2ccccc2c(O)c1C(=O)O		Histone N-Acetyltransferase (HAT) Inhibitors
XD-40-HA98	SHLJSRZKHPHFBY-XYPYZODXSA-N	NC(=O)c1nc(-c2cccnc2)nc2c1[nH]c(=O)n2[C@H]1CC[C@H](O)CC1		IKK-2 (IKK-beta) Inhibitors;;Mammalian Target of Rapamycin (mTOR;FRAP1) Inhibitors
DE-40-RX20	SHRITMLAKAATEW-UHFFFAOYSA-O	CS(=O)(=O)NNC(=O)c1ccc[n+](CC(=O)c2cccs2)c1		
CA-31-EL19	SHWNKRPMUBFWKE-UHFFFAOYSA-N	O=S(=O)(c1ccc2c(c1)OCCO2)N1CCN(S(=O)(=O)c2c(F)cccc2F)CC1	1186654-00-1	Activator of human pyruvate kinase M2
AE-21-GE72	SHZKQBHERIJWAO-AATRIKPKSA-N	O=C(O)/C=C/c1ccc(Cn2ccnc2)cc1	130952-46-4	Thromboxane Synthase Inhibitors
GB-88-ZP20	SILHYVDKGHXGBL-UHFFFAOYSA-N	Cc1c(F)cccc1CCCCOc1ccc(C#Cc2ccc(F)c3c(CCCC(=O)O)c(C)n(CCCC(=O)O)c23)cc1	1232861-58-3	Dual CysLT1 and CysLT2 antagonist
CA-68-SW47	SISOFUCTXZKSOQ-ZHACJKMWSA-N	Cc1cccc(/C=C/c2ccccc2)n1	6266-99-5	mgluR5 Antagonists
XE-29-LT20	SJAPSPJRTQCDNO-UHFFFAOYSA-N	Oc1noc2cc(Cl)ccc12	61977-29-5	D-Amino Acid Oxidase (DAAO) Inhibitors
GF-19-OF53	SJBWUBBLOZYBMP-UHFFFAOYSA-N	Cc1cccc(C#Cc2cccc(C(F)(F)F)c2)n1	823198-86-3	GRM5 antagonist
DB-73-KP48	SJCJCASJIVJOFT-KYJUHHDHSA-N	CCc1ccc(C(=O)N(C[C@@H]2CNC[C@H]2CN(C(=O)CC2CCN(C(C)=O)CC2)C2CC2)C(C)C)cc1OCCCOC		renin (REN) inhibitor
HC-16-SU62	SJDDOCKBXFJEJB-MOKWFATOSA-N	CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)c1ccc(N)c(Cl)c1)C(C)(C)C	273404-37-8	Caspase 1 (IL-1beta Converting Enzyme) Inhibitors
EA-92-CV45	SJDOMIRMMUGQQK-UHFFFAOYSA-N	COc1ccccc1N1CCN(CCCCN2C(=O)c3ccccc3C2=O)CC1	102392-05-2	5-HT1A Receptor Antagonists;ADRA2A antagonist;5-HT1A Receptor Antagonists;ADRA2A antagonist
JF-15-IJ23	SJGLLGFHNAVMQI-XMMPIXPASA-N	CC(C)(O)CNC(=O)c1ccc([C@]2(c3ccc(-c4cnc(N)cn4)cc3)CCCO2)cn1		ALOX5AP gene inhibitor
AD-41-ZI07	SJRVJRYZAQYCEE-UHFFFAOYSA-N	CCc1c(-c2ccccc2)c(-c2ccccc2)nn1-c1ccccc1-c1cccc(OCC(=O)O)c1	300657-03-8	Adypocyte Fatty Acid Binding Protein (A-FABP;FABP4;FABPaP2) Inhibitors
DC-99-NQ50	SJUTWXCXWZYBEM-UHFFFAOYSA-N	Cc1nc(N2CCN(Cc3ccc(C(F)(F)F)cc3)C2=O)sc1C(=O)NCc1cccnc1	1072803-00-9	SCD inhibitor
CB-99-NG16	SJVQHLPISAIATJ-ZDUSSCGKSA-N	C[C@H](Nc1ncnc2[nH]cnc12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1	1201438-56-3	lipid kinase inhibitor
IA-38-XE73	SKAYRDVTMVVMKL-SXGWCWSVSA-N	Clc1ccc(/C(=C/n2cncn2)OC2CCCCC2)c(Cl)c1		mgluR2 Antagonists;mgluR3 Antagonists
CE-96-GH46	SKBXAZQJXDJNFI-RMKNXTFCSA-N	COc1ccc2[nH]cc(CCNCc3ccc(/C=C/C(=O)NO)cc3)c2c1		Histone Deacetylase (HDAC) Inhibitors
LD-00-HM58	SKFRRNOLFFQBQU-AOOOYVTPSA-N	C[C@@H]1CN(c2ncc(-c3cccc(Cl)c3Cl)c(N)n2)C[C@H](C)N1		Nav1.8 (SNS/PN3) Sodium Channel Blockers
MA-67-FQ44	SKYWIMYOGAWOMB-IRXDYDNUSA-N	N=C(N)NCCC[C@H](NC(=O)c1ccc2ccccc2c1O)C(=O)N1CCC[C@H]1C(N)=O	178925-65-0	
BD-18-FM58	SKYYWSWIUKISCX-UHFFFAOYSA-N	O=C(O)CCNCc1ccc2sc(-c3ccc(-c4ccccc4)c(C(F)(F)F)c3)cc2c1	820240-77-5	Lysophospholipid edg1 (S1P1) Receptor Agonists;S1PR1 agonist
FE-22-JV50	SLJSXZAVVKCTHT-LZQZEXGQSA-N	CC(=O)c1nc(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NCc2cccc(Cl)c2F)n2ccccc12		Known FactorD inhibitor
WD-62-UB45	SLMGIUOAZCYKPE-UHFFFAOYSA-N	O=P(O)(O)C(NCc1ccccc1)c1ccccc1	25881-35-0	prostatic acid phosphatase inhibitor
WE-76-XH29	SLPOZBYDRWPSBE-UHFFFAOYSA-N	O=C(O)c1cc2cc(O)ccc2oc1=O	56437-16-2	Apoptosis Inducers;Caspase 3 Activators;Caspase 9 Activators;Apoptosis Inducers;Caspase 3 Activators;Caspase 9 Activators
OC-12-KT94	SLPWZBSWUHLVRY-UHFFFAOYSA-N	O=c1c2c(n(-c3cccc(Cl)c3)c3ncccc13)CCCC2	110545-79-4	Lipoxygenase Inhibitors;Mediator Release Inhibitors
ED-99-XG61	SLUINPGXGFUMLL-UHFFFAOYSA-N	O=C(O)c1ccccc1C(=O)Nc1ccc(-c2ccccc2)cc1	4727-31-5	Chondrogenesis activator
BE-70-YH17	SLXTWXQUEZSSTJ-UHFFFAOYSA-N	Cc1cc2c(cc1C1(c3ccc(C(=O)O)cn3)CC1)C(C)(C)CCC2(C)C	153559-76-3	ABCA1 Expression Enhancers;Angiogenesis Inhibitors;Antiinflammatory Drugs;Insulin Sensitizers;Retinoid RXR Agonists
OC-10-FB51	SMGITBMVMHVVNN-BFHYXJOUSA-N	CNC(=O)[C@@H](NC(=O)[C@H](c1ccc(F)cc1)[C@H](CO)C(=O)NO)C(C)(C)C		
FC-31-HE22	SMGZHCSEIBBFEJ-UHFFFAOYSA-N	Cc1nc2ccccc2n1S(=O)(=O)c1ccc(F)cc1	324777-01-7	Aldehyde dehydrogenase 3 inhibitor
TC-32-HZ53	SMILIUISKUMIEU-UHFFFAOYSA-N	CC(=O)Nc1ccccc1OCC(=O)N1CCN(Cc2ccc(F)cc2)CC1C		CCR1 antagonist
S0-EE-Y737	SMOJVTPALLWLKJ-LJQANCHMSA-N	O=C1Nc2ccc(-c3ccn[nH]3)cc2[C@](CNC(=O)c2ccc(F)cc2)(C(F)(F)F)O1	1141877-98-6	Long Chain Fatty Acid Elongase 6 Inhibitor
OB-06-WW76	SMTZFNFIKUPEJC-UHFFFAOYSA-N	CC(=O)OCC(=O)NCCCOc1cccc(CN2CCCCC2)c1	78628-28-1	HRH2 antagonist
FB-51-DL49	SMYUEWYXIKCMEA-UHFFFAOYSA-N	Cc1ccc(OC2CCN(c3ncnc4ccc(F)cc34)CC2)cn1		Positive allosteric modulators (PAMs) of the muscarinic acetylcholine
KC-15-HM70	SNFYYXUGUBUECJ-UHFFFAOYSA-N	CCC(CC)C(c1ccc(Nc2nc3ccccc3s2)cc1)n1cncn1	201410-53-9	An inhibitor of CYP26
AC-29-ZR23	SNICXCGAKADSCV-JTQLQIEISA-N	CN1CCC[C@H]1c1cccnc1	104062-50-2	Nicotinic alpha7 Partial Agonists
AD-51-FB60	SNJMEUDNDRSJAS-UHFFFAOYSA-N	NCCC12CC3CC(CC(C3)C1)C2		
EA-25-VD74	SNKZJIOFVMKAOJ-UHFFFAOYSA-N	NCCCS(=O)(=O)O	14650-46-5	beta-Amyloid (Abeta) Aggregation Inhibitors;Antiamyloidogenic Agents
NF-19-JL47	SNMCWIDCSPHZRD-UHFFFAOYSA-N	COc1c(C)c(C(=O)c2ccc(N)c(C(=O)O)c2)n2ccccc12	848318-25-2	Allosteric inhibitor binding extracellular domain
PC-62-AQ92	SNOFOFWXVIPRIY-AMGIVPHBSA-N	COCCNC(=O)[C@@H]1C[C@@H](Sc2nc3ccccc3[nH]2)CN1Cc1ccc2c(c1)Cc1ccccc1-2		Inhibitor of pyrimidine biosynthesis
AC-54-UG49	SNTQPLDRUZOSDP-UHFFFAOYSA-N	CCCC(C(=O)OCCN(CC)CC)(c1ccccc1)c1ccccc1	302-33-0	Neuronal Nitric Oxide Synthase Inhibitors;Cytochrome P450 Inhibitors;Potassium Channel Blockers
SB-92-FF15	SOACFIGORGRGQQ-NSHDSACASA-N	N#C[C@@H]1CCCN1C(=O)CNC1(CO)CCCC1		Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors
AB-00-IL62	SOJUSNIBPPMLCC-UHFFFAOYSA-N	Nc1ncc2c(n1)CC(c1ccco1)CC2=O	299442-43-6	Adenylate Cyclase Type V Inhibitors
EB-09-GW59	SONNWYBIRXJNDC-UHFFFAOYSA-N	CNCC(O)c1cccc(O)c1	1477-63-0	alpha-Adrenoceptor Antagonists
AB-61-VZ28	SONNWYBIRXJNDC-VIFPVBQESA-N	CNC[C@H](O)c1cccc(O)c1	1228015-39-1	alpha1A-Adrenoceptor Ligands;alpha1-Adrenoceptor Agonists
HB-09-RP77	SOYCMDCMZDHQFP-UHFFFAOYSA-N	Nc1c(CC(=O)O)cccc1C(=O)c1ccccc1	51579-82-9	Non-Steroidal Antiinflammatory Drugs
EB-52-HZ20	SOYKEARSMXGVTM-HNNXBMFYSA-N	CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1	113-92-8	Histamine Receptor Antagonists
TC-67-HF87	SPCKGPWTPMVBTL-UHFFFAOYSA-N	COc1ncnc2ccc(-c3cnc(Nc4ccc(C(C)(C)C)cc4)c4ccccc34)cc12		
IB-14-YP50	SPDQRCUBFSRAFI-DOMZBBRYSA-N	C[C@@H]1COCCN1c1cc(=O)n2c(n1)N(Cc1cncc(Cl)c1)[C@H](C(F)(F)F)CC2	1523406-39-4	VPS34 inhibitor
GE-77-CO40	SPHRJZBOFYIKMC-UHFFFAOYSA-N	C#CCOC(=O)C1=CCCN(C)C1	116511-28-5	CHRM2 agonist;CHRM3 agonist;CHRM4 agonist;CHRM5 agonist
HD-09-QF83	SPLDGZVGTOKENR-UZLBHIALSA-N	O=C(N[C@@H]1CCC[C@](O)(C#Cc2cccc(Cl)c2)C1)c1cccc(Cl)n1		mgluR5 Antagonists
FC-05-ID99	SPMVMDHWKHCIDT-UHFFFAOYSA-N	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC	475108-18-0	VEGFR-1 (Flt-1) Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;VEGFR-3 (FLT4) Inhibitors;Angiogenesis Inhibitors
CB-46-FO63	SPMXWAZPSFLJAG-UHFFFAOYSA-N	c1cncc(C(c2c[nH]c3ccccc23)c2c[nH]c3ccccc23)c1	21182-11-6	MMP-8 (Neutrophil Collagenase) Inhibitors
JA-26-YQ32	SPPTWHFVYKCNNK-FQEVSTJZSA-N	O=C(O)c1ccc(NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)c2ccccc2)cc1	37106-97-1	Pancreatic trypsin inhibitor
DB-92-FB02	SPUYFKBFURBLKE-UHFFFAOYSA-N	COc1ccc(N2CCN(Cc3cc4cnc(C#N)nc4n3CC(C)(C)C)CC2)c(OC)c1		Cathepsin K Inhibitors
WC-38-CZ02	SPYRWZPHRPACGG-UHFFFAOYSA-N	Cc1cccc(C#Cc2cc(CO)cc(CO)c2)n1		
CC-21-IE22	SQCOAXUEBSJCGO-SFHVURJKSA-N	Cc1cc(S(=O)(=O)Nc2cccc(-c3cc(C)c(C(=O)N[C@@H](C)C(=O)O)c(C)c3)c2)c(C)cc1Cl		S1PR1 antagonist
FE-82-MY37	SQIQIYYPWAELAC-UHFFFAOYSA-N	CC(C)n1cnc2cc(C(=O)O)ccc21		
ZB-28-SS80	SQKKJGJKDLZZHB-UHFFFAOYSA-N	Cc1ccc(CNS(=O)(=O)c2cc(-c3cn(CC(=O)O)cc3C#N)cc(C(F)(F)F)c2)o1		GPR44 antagonist
BB-79-GA42	SQVXWIUVAILQRH-UHFFFAOYSA-N	COc1ccc(-c2cc(=O)c3ccc(O)cc3o2)cc1		
AC-55-GO91	SQWAXHGWLCYBIN-UHFFFAOYSA-N	CC(=O)Nc1nc(C)c(-c2ccc(S(C)(=O)=O)c(-n3ccnc3)c2)s1	593959-35-4	lipid kinase inhibitor;Phosphatidylinositol 3-Kinase (PI3K) Inhibitors
AD-72-OW33	SRKDCGUSWAONMJ-HSZRJFAPSA-N	CC(C)(C#N)c1cc(COc2ccccc2CC(=O)O)cc(-c2ccc3c(c2)[C@H](N)CO3)c1		
CB-44-RT90	SRPNQDXRVRCTNK-UHFFFAOYSA-N	CC(C)(C)C(=O)NCCCC(=O)O	69542-93-4	CRF Receptor Antagonists
GE-77-IH08	SRVUGPYWYLBZNI-UHFFFAOYSA-N	O=[N+]([O-])c1cccc(-c2nc(-c3ccccc3)cc3cccnc23)c1		
NF-07-NX76	SRVXSISGYBMIHR-UHFFFAOYSA-N	Cc1cnc(C(CC(=O)O)c2cc(Cl)cc(-c3cccc(CC(N)=O)c3)c2)s1		Cathepsin A inhibitor
LD-50-SF36	STCVFKBRXOEQRF-YBEGLDIGSA-N	Clc1cccc(Cl)c1/C(=C/n1cncn1)OC1CCCCCC1	246852-46-0	GRM2 antagonist
BE-73-IJ64	STEPVHGLTKMRIT-SFHVURJKSA-N	CC1(OC(=O)N2CCC(COc3cnc(N4CCN(S(=O)(=O)[C@H]5CCNC5)CC4=O)cn3)CC2)CC1		
AD-43-WX13	STFYSQROIBDKFP-DZGCQCFKSA-N	N=C1N[C@H]2n3c(c(Br)c4ccccc43)C(=O)N3CCC[C@]23N1		Proteasome beta-5 subunit inhibitor
OE-04-VO07	STKOFLRHQQCLDD-UHFFFAOYSA-N	COCCn1c(-c2ccc(C(C)C)cc2)nc2c(C(F)(F)F)c(Cc3cccnc3[S+](C)[O-])cc(OC)c21		Calcium-Sensing Receptor (CaSR) Antagonists
SC-64-CU21	STNHMRPSFGWNKM-UHFFFAOYSA-N	COc1cc2c(cc1NS(=O)(=O)c1cccc(C#N)c1)n(C)c(=O)n2C		
EA-79-PC76	STRAIBOPIVXLQO-UHFFFAOYSA-N	Nc1nc(N)c(F)c(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)c1F		p38 MAPK Inhibitors
TC-25-NY68	STUOLYLKGJYHJO-KTIWRFAQSA-N	Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](N2Cc3ccccc3C2=O)C(C)(C)C)cc1	1448188-03-1	
HA-36-VD41	SUAJDOQSUKIRNA-KRWDZBQOSA-N	N[C@@H](CCCCNC(=O)OCc1ccc([N+](=O)[O-])cc1)C(=O)N1CCCCC1		Dipeptidyl Peptidase IX (DPP9| DPRP2) Inhibitors
CC-86-IO63	SUDAHWBOROXANE-SECBINFHSA-N	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F	391209-97-5	MEK Inhibitor
CF-32-LB77	SUGVYNSRNKFXQM-XRHWURSXSA-N	Cc1ccc(Cn2nc(C(=O)N[C@@H]3C(C)(C)[C@@H]4CC[C@@]3(C)C4)cc2-c2ccc(Cl)c(C)c2)cc1	192703-06-3	Cannabinoid CB2 Inverse Agonists;ACAT Inhibitors
ZC-88-KS25	SUMOJNFXYBYLBS-UHFFFAOYSA-N	CC(C)(C)c1ccc(Nc2ncc(-c3ccc4cnccc4c3)c3ccccc23)cc1		
ZC-47-HL31	SUVDDDNQVVLBRP-UHFFFAOYSA-N	N#CC1CCC(C2CCCc3cncn32)CC1		Cytochrome P450 11B2 (Aldosterone Synthase) Inhibitors;Cytochrome P450 CYP11B1 (Steroid 11-beta Hydroxylase) Inhibitors;Aromatase Inhibitors
BC-88-KT45	SVENPFFEMUOOGK-SDNWHVSQSA-N	N#C/C(=C\\c1ccc(-c2cc(Cl)ccc2Cl)o1)C(=O)Nc1cccc2ncccc12	304896-28-4	SIRT2;SIRT inhibitor NAD dependent
AA-58-BW57	SVJMLYUFVDMUHP-UHFFFAOYSA-N	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1	102993-22-6	Adrenergic receptor modulator;Calcium Channel Blockers;Adrenergic receptor modulator;Calcium Channel Blockers
HD-91-YX62	SVSYJTYGPLVUOZ-UHFFFAOYSA-N	N#Cc1c(-c2ccccc2)cc(-c2cc(Br)ccc2O)[nH]c1=O		
FE-23-WP33	SWIBQBGATKMFJX-ULKXQASOSA-N	C[C@@H](C(=O)N(Cc1cccc(O)c1F)C1Cc2ccccc2C1)N1CCc2ccccc2[C@@H]1c1ccccc1Cl	610298-05-0	C5AR1 antagonist
AD-15-VR38	SWJZCZVBMMEFSO-BOACMQGQSA-N	Cc1sc(C2CCNCC2)nc1CC(=O)N1C[C@H](OCc2ccc(Cl)cc2)C[C@H]1C(=O)N[C@@H](CCCCN)C(=O)c1nc2ccccc2o1		trypsin inhibitor;Matriptase (ST14) inhibitor;Plasma Kallikrein (KLKB1) inhibitor;Prostasin (PRSS8) Inhibitor
AE-02-OC25	SWUARLUWKZWEBQ-VQHVLOKHSA-N	O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccccc1		
GF-02-ER50	SWXOUTZSPTXSOB-UHFFFAOYSA-N	N=C(N)SCCSC(=N)N		
DE-03-NP53	SXBNYFIWCPCCIK-PCKJKUOASA-N	CC(C)[C@@]12C[C@@H](OC(=O)[C@H](C)O)[C@@](C)(O1)[C@@H]1CC[C@@H](C)[C@H]1[C@@H]2OC(=O)/C=C/c1ccccc1		
SC-17-WW78	SXHHURZUIGDYAR-QGZVFWFLSA-N	C[C@@H]1CCCN1c1cc(C2(C#N)CCN(C)CC2)cc(Nc2cc(C#N)ccn2)n1		MAP3K12 (DLK) Inhibitors
CB-73-HZ47	SXIIFTDRVOJBPT-MOPGFXCFSA-N	CC(C)(C)C[C@H](NC(=O)N1CCOCC1)C(=O)N[C@H](C#N)COCc1ccccc1		Cathepsin S Inhibitors
FC-64-QJ96	SXKMCHGAAJTXPZ-UHFFFAOYSA-N	COc1ccc(CC(=O)Nc2ccc(N3CCN(C(=O)Nc4c(Cl)cc(CN5CCCC5)cc4Cl)CC3)cc2)cc1	1092067-85-0	Diacylglycerol Acyltransferase type 1 (DGAT-1) Inhibitors
GE-68-FZ64	SXKPGYKPQPYJER-UHFFFAOYSA-N	CN1c2ccc([N+](=O)[O-])cc2N=C(c2ccc(C(=O)O)cc2)c2cc3c(cc21)C(C)(C)CCC3(C)C	188844-34-0	Retinoid RXR Antagonists
TB-06-VB30	SXNJFOWDRLKDSF-STROYTFGSA-N	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C	755038-65-4	pan PLK inhibitor
GD-46-BU97	SYFOWOGMCQAORD-UHFFFAOYSA-N	CC(C)(C)c1ccc(CC(=O)NCc2ccc3c(c2)CN(C2CCC(=O)NC2=O)C3=O)cc1		
IC-71-AQ35	SYIVDRTWCRQIBC-UHFFFAOYSA-N	CCCCNS(N)(=O)=O	42731-63-5	Carbonic anhydrase inhibitor
KD-38-KY71	SYKKEBRXRXCNEC-AYSLTRBKSA-N	N=C(N)N/N=C/c1ccc(Cl)c(C(F)(F)F)c1		NPFFR2 agonist, GIRK 1/4 blocker
FE-68-DZ79	SYKLNLIUTCAYCR-UHFFFAOYSA-N	NS(=O)(=O)NCc1ccccc1	14101-58-7	Carbonic anhydrase inhibitor
AE-09-SG21	SYTBZMRGLBWNTM-SNVBAGLBSA-N	C[C@@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1	5104-49-4	gamma-Secretase Inhibitors;NF-kappaB (NFKB) Modulators;Antiamyloidogenic Agents
AB-92-LS83	SYTBZMRGLBWNTM-UHFFFAOYSA-N	CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1	1185133-81-6	
GA-30-HJ41	SYTQCBZULZYSSV-UHFFFAOYSA-N	N#CC1(CCCN2CCC(O)(c3ccc(F)cc3)CC2)c2ccccc2CSc2ccccc21	99756-28-2	Antiinflammatory Drugs;Chemokine CCR1 Antagonists
HA-08-IL05	SYZSSLLFRVDRHL-QPJJXVBHSA-N	COc1ccc(/C=C/CCCCOc2ccc(C(=O)c3cccc(C(=O)O)c3)cc2CCC(=O)O)cc1	117423-74-2	Leukotriene Antagonists;Leukotriene BLT (LTB4) Antagonists
GA-07-NB64	SZFPYBIJACMNJV-UHFFFAOYSA-O	CCCCCCCCCCCCCCCCCCOP(=O)(O)OC1CC[N+](C)(C)CC1	157716-52-4	Apoptosis Inducers;Protein Kinase B (PKB/Akt) Inhibitors;Apoptosis Inducers;Protein Kinase B (PKB/Akt) Inhibitors
ID-12-CA39	SZSHJTJCJOWMHM-UHFFFAOYSA-N	Cc1nc(OCCCCCN2CCCCC2)cc(-c2ccc(F)cc2)n1	178429-67-9	Sodium Channel  Blockers;Calcium Channel Blockers;Nitric Oxide Synthase Inhibitors
AC-40-PV46	SZZHBDYOLFEVKI-UHFFFAOYSA-N	CN(C)C(=O)Cc1c(C(=O)O)n(Cc2cccc3ccccc23)c2ccc(F)cc12		Known Chymase inhibitor
AB-40-HA80	TTWJBBZEZQICBI-UHFFFAOYSA-N	CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC	2576-84-3	Dopamine Receptor Antagonists
S0-EE-X3ZZ	TTYKUKSFWHEBLI-DLBZAZTESA-N	CC(C)S(=O)(=O)N[C@H]1COC[C@H]1Oc1ccc(-c2ccc(C#N)s2)cc1	1258963-59-5	
BB-56-DB67	TUCIOBMMDDOEMM-RIYZIHGNSA-N	N#C/C(=C\\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1	133550-30-8	Jak3 Inhibitors;STAT-3 Inhibitors;Jak2 Inhibitors;Antiinflammatory Drugs
AE-87-GP03	TULJLCAZHLOETP-UHFFFAOYSA-N	O=c1c2c(COCc3ccccc3)n(Cc3cnccn3)c(=O)cc2[nH]n1-c1ccccc1Cl	1218814-52-8	NADPH Oxidase Inhibitors
DA-33-BM26	TUOZJWZCVIRDKO-UHFFFAOYSA-N	COc1cc2nc(-c3ccc(N4CCN(C)CC4)cc3)nc(NCCN3CCOCC3)c2cc1OC	1093135-60-4	TLR9 Receptor Antagonists;TLR7 Receptor Antagonists;TLR8 Receptor Antagonists
EC-82-LV30	TUVCWJQQGGETHL-UHFFFAOYSA-N	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1	371935-74-9	Mammalian Target of Rapamycin (mTOR;FRAP1) Inhibitors;Phosphatidylinositol 3-Kinase alpha (PI3Kalpha) Inhibitors;Phosphatidylinositol 3-Kinase beta (PI3Kbeta) Inhibitors;Phosphatidylinositol 3-Kinase delta (PI3Kdelta) Inhibitors;Phosphatidylinositol 3-Kinase gamma (PI3Kgamma) Inhibitors
DC-70-EK34	TVNSCKMVODVWRS-UHFFFAOYSA-N	CC(C)(O)Cn1nc(-c2ccccc2)c2c(Cl)c(-c3ccccc3)nnc21	1404506-35-9	CLRN stabilizer
JB-35-RC26	TVRCRTJYMVTEFS-ICGCPXGVSA-N	CC(C)[C@H](N)C(=O)O[C@@H]1[C@@H](CO)O[C@@H](n2ccc(N)nc2=O)[C@]1(C)O		
GD-82-CS38	TVTXCJFHQKSQQM-LJQIRTBHSA-N	COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F	1229705-06-9	Mdm2 p53-binding protein inhibitor
AB-08-HT45	TVURRHSHRRELCG-UHFFFAOYSA-N	Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1	1092382-99-4	Dopamine D1 Agonists
JC-63-DO70	TWAWPCMBTNHLQB-CONSDPRKSA-N	CN(Cc1ccccc1)C(=O)[C@H](Cc1ccc2ccccc2c1)N(C)C(=O)[C@@H]1CCCN1c1nc(=O)c2ccccc2[nH]1		Tachykinin NK1 Antagonists
GF-05-GQ05	TWKGDKPYCBTGHU-UHFFFAOYSA-N	Cc1csc2c1c(=O)n(O)c(=O)n2Cc1ccccc1		FEN1 endonuclease inhibitor
PD-40-ZV44	TWQYWUXBZHPIIV-UHFFFAOYSA-N	O=C(NCC1CCOCC1)c1cnc(Nc2ccc(Cl)cc2Cl)nc1C(F)(F)F	666260-75-9	Cannabinoid CB2 Agonists
DC-84-CJ21	TWWFAXQOKNBUCR-UHFFFAOYSA-N	O=C(Cc1ccccc1)Nc1nc2ccc(Cl)cc2c2nc(-c3ccco3)nn12	183721-15-5	ADORA3 antagonist
DC-98-RF46	TWWNJXWEOLLKJT-UHFFFAOYSA-N	N#Cc1cccc(-c2nc(C3CCC(C(=O)O)CC3)cc3cccnc23)c1		
TE-76-FI57	TXCIYDFKXAEUNM-UUWRZZSWSA-N	CN(C)CC[C@H](CSc1cccc(Cl)c1)Nc1ccc(S(=O)(=O)Nc2ncnc3c2CCN(C2CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC2)C3)cc1S(=O)(=O)C(F)(F)F	1274802-77-5	BCL2 gene inhibitor;Apoptosis Inducers
HF-79-EC41	TXEBNKKOLVBTFK-UHFFFAOYSA-N	C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1	1538604-68-0	FGFR4 inhibior
HA-29-PM90	TXEIIPDJKFWEEC-UHFFFAOYSA-N	O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1	137464-18-7	Transthyretin tetramer stabilizer
FA-89-PW29	TXGKRVFSSHPBAJ-JKSUJKDBSA-N	NC(=O)c1cnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc(-n2nccn2)c1	1370261-96-3	
JD-62-HR05	TXJZRSRTYPUYRW-NQIIRXRSSA-N	COC(=O)c1ccc([C@H]2c3[nH]c4ccccc4c3C[C@H](C(=O)OC)N2C(=O)CCl)cc1		GPX4 covalent inhibitor
GC-74-QF56	TXODBIOSWNNKJM-UHFFFAOYSA-N	Oc1c(Br)cc(Br)cc1-c1cc(Br)cc(Br)c1O		
CC-98-YC44	TXQKSMSLZVKQBI-UHFFFAOYSA-N	O=C(O)C1CCCN(CCC=C(c2ccccc2)c2ccccc2)C1	85375-15-1	GAT-1 Inhibitors
RC-47-HT31	TXUIRLUAKARNPD-XMMPIXPASA-N	CCN(CC)C(=O)[C@@H]1CCCN(C2CCN(C(=O)c3c4ccccc4cc4ccccc34)CC2)C1		Acetyl-CoA Carboxylase 1 (ACC1) Inhibitors;Acetyl-CoA Carboxylase 2 (ACC2) Inhibitors
KA-62-FE69	TXZPMHLMPKIUGK-UHFFFAOYSA-N	COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)CN(C)C(=O)N2	1403764-72-6	BRD2/3/4/T BET familiy inhibitor
BA-10-WH72	TXZRKKQUOSAZKF-UHFFFAOYSA-N	CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(Cl)cc2C(O)c2ccncc2)cc1		Chemokine CCR9 Receptor Ligands
KA-37-GD83	TYJGETBDTFVKAB-UHFFFAOYSA-N	O=C(Cc1ccccc1Nc1c(Cl)cccc1Cl)OCCOCCO		
LF-92-IK63	TYLTZPAGUBOPCU-UHFFFAOYSA-N	Cc1ccccc1-n1c(Cn2nc(-c3ccc(O)c(F)c3)c3c(N)ncnc32)nc2cccc(C)c2c1=O		Phosphatidylinositol 3-Kinase delta (PI3Kdelta) Inhibitors;Phosphatidylinositol 3-Kinase gamma (PI3Kgamma) Inhibitors
AC-80-DI95	TYMRLRRVMHJFTF-UHFFFAOYSA-N	NCc1ccc(S(N)(=O)=O)cc1	12001-72-8	Carbonic anhydrase inhibitor
JD-02-GA59	TYMWQUJQZNTYGF-YDZHTSKRSA-N	COc1ccc2[nH]cc(/C=N/NC(=N)NCCc3ccccc3)c2c1		
MD-03-GH73	TYNLGDBUJLVSMA-UHFFFAOYSA-N	CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O	112118-18-0	IL-1 Inhibitors
QB-34-NU46	TYYPSMSPMUMLJB-QGPMSJSTSA-N	Cc1ccnc(SC[C@@H]2C[C@@H]3Cc4c(O)cccc4C[C@H]3N(C)C2)n1		
BE-16-VM54	TZFNLOMSOLWIDK-JTQLQIEISA-N	C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O	1426847-87-1	Dopa decarboxylase inhibitor
AE-63-ST43	TZJUVVIWVWFLCD-UHFFFAOYSA-N	O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ncccn2)CC1	92589-98-5	HTR1A agonist;5-HT1A Receptor Agonists;ADRA1B gene modulator
NA-22-BX39	TZUYDLKHNQUNKS-UHFFFAOYSA-N	Cc1occ2c1C(=O)c1c(O)ccc(O)c1C2	150045-18-4	ELAVL1 gene inhibitor
BC-31-JL64	TZXKOCQBRNJULO-UHFFFAOYSA-N	Cc1c(O)c(=O)ccn1C		
FC-58-QS77	TZYSLHTWOJFPSJ-UHFFFAOYSA-N	COc1nc(Br)cnc1NS(=O)(=O)c1ccc(Cl)s1	548792-80-9	CCR4 antagonist
BC-10-SB73	TZZISDZOBASIEO-UHFFFAOYSA-N	Cc1ccc(C(N)=O)cc1Nc1nccc(-c2cn(C(C)C)c3cnccc23)n1	1221153-14-5	NFkappaB-inducing kinase (NIK;MAP3K14) Inhibitors
LC-83-NR62	UACUZULRKJKTHE-CZYKHXBRSA-N	O=C(NO)[C@@H](NCC1CC1)[C@@H](Cc1cccc(O)c1)C(=O)N[C@H]1c2ccccc2C[C@H]1O		Aggrecanase Inhibitors
GB-73-QS80	UAJYCSUKECWQFQ-UHFFFAOYSA-N	CC(C)(C)c1ccc(C(=O)Nc2cccc(S(N)(=O)=O)c2)cc1		Carbonic anhydrase inhibitor
BA-46-RB17	UAMIBPKKKLTAKG-BQYQJAHWSA-N	CCc1nc2c(C)cc(C)nc2n1Cc1ccc(/C=C/CN2CCN(C(C)C)CC2)cc1	1197879-16-5	GPR4 antagonist;G Protein-Coupled Receptor GPR4 Antagonists
UE-78-EW35	UBCVYEFSXHCFPK-UHFFFAOYSA-N	CN1CCC(c2c(-c3ccccc3)[nH]c3ccccc23)CC1		HTR2A antagonist
BC-22-OI74	UBHJFPVTEATUFS-UHFFFAOYSA-N	COc1cc(OC)cc(C(=O)Nc2ccc(Cl)c(-c3nc4cc(N(C)C)ccc4[nH]3)c2)c1	496794-70-8	Hedgehog Signaling Inhibitors
ZD-15-SG14	UBNXLZMXWUQSCB-UHFFFAOYSA-N	COc1c(OC)c(C=O)c2c(OC)c(-c3c(C)cc4c(C(C)C)c(OC)c(OC)c(C=O)c4c3OC)c(C)cc2c1C(C)C		
FA-10-SN61	UBPYILGKFZZVDX-UHFFFAOYSA-N	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl	380843-75-4	Abl Kinase Inhibitors;Apoptosis Inducers;Bcr-Abl Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Src Kinase Inhibitors;STAT-5 Inhibitors
TA-82-BQ12	UBQFTTUFRSSOHE-UHFFFAOYSA-N	CCCCCCOC(=O)c1cc(O)c(=O)c2c(O)c(O)c(OC)cc2c1	1416324-85-0	TLR1/2 complex inhibitor
AB-21-CI37	UBQYURCVBFRUQT-UHFFFAOYSA-N	CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN		
IB-39-YI25	UBRKDAVQCKZSPO-UHFFFAOYSA-N	CCN(CC)CC1CCCCN1CC(=O)N1c2ccccc2C(=O)Nc2cccnc21	100158-38-1	CHRM2 antagonist;Muscarinic M2 Antagonists
OC-23-QX66	UBXDWYFLYYJQFR-UHFFFAOYSA-N	COc1c(O)cc(C(=O)O)cc1O	4319-02-2	Free Radical Scavengers;NF-kappaB (NFKB) Activation Inhibitors
DC-47-KV62	UCFGDBYHRUNTLO-QHCPKHFHSA-N	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1	119413-54-6	DNA Topoisomerase I Inhibitors
EE-08-SZ54	UCGPWBGSZPBDQD-UHFFFAOYSA-N	COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(CN4CCN(C)CC4)cn3)c3nccnc23)c1F	1197331-38-6	FGFR3 Inhibitors;Angiogenesis Inhibitors
DD-48-MZ39	UCHDVTOVFHVWOS-UHFFFAOYSA-N	O=C(O)c1sccc1SCc1ccc(Cl)c(Cl)c1		
CA-57-TC62	UCHDWCPVSPXUMX-TZIWLTJVSA-N	CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1	1124196-02-6	Leukotriene CysLT1 (LTD4) Antagonists
SB-29-ZH97	UCKYOOZPSJFJIZ-XVKVHKPRSA-N	O=C1NC(O)CCN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	18771-50-1	CDA gene inhibitor
CA-67-XI76	UCTWMZQNUQWSLP-SECBINFHSA-N	CNC[C@@H](O)c1ccc(O)c(O)c1		
AD-51-LE62	UCTWMZQNUQWSLP-UHFFFAOYSA-N	CNCC(O)c1ccc(O)c(O)c1	104655-05-2	alpha-Adrenoceptor Antagonists
EA-73-WI86	UCTWMZQNUQWSLP-VIFPVBQESA-N	CNC[C@H](O)c1ccc(O)c(O)c1	104655-05-2	Adrenergic Agonists
KC-32-GO33	UCYSSYGGXOFJKK-UHFFFAOYSA-N	CCc1c(-c2ccc(C(=O)NC)nc2)cnc(N)c1-c1ccc(O)cc1		
BD-78-MJ16	UDMBCSSLTHHNCD-KQYNXXCUSA-N	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O	13270-66-1	nucleotide;AMPK activator;nucleotide;AMPK activator
UD-16-YL39	UEIXZMRXRYKEIL-UHFFFAOYSA-N	Nc1nccnc1C(=O)Nc1cc(C(=O)c2ccccc2)ccc1N1CCNCC1		
AD-72-MJ27	UEJJHQNACJXSKW-UHFFFAOYSA-N	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	1012310-87-0	DDB1-CRBN modulator;Angiogenesis Inhibitors;TNF-alpha Production Inhibitors
GF-15-LT47	UEMQPCYDWCSVCU-UHFFFAOYSA-N	COc1cc(C#N)ccc1S(=O)(=O)Nc1ccc2c(c1)cc(C)c(=O)n2C		BRPFs;Bromodomain inhibitor
GB-98-IZ84	UFAFCKVYKJIJTR-INIZCTEOSA-N	COc1cc(C(=O)O)c(NC(=O)N[C@@H](C)c2ccccc2OC)cc1OCCCC(C)C		C5 complement protein inhibitor
IC-61-PQ10	UFGBGFMPBMEVMI-UHFFFAOYSA-N	Cc1cc(=O)oc2cc(OS(N)(=O)=O)ccc12	136167-05-0	Steryl Sulfatase Inhibitors
CD-25-PY50	UFSKUSARDNFIRC-UHFFFAOYSA-N	Cc1ccc(NC(=O)C2(c3ccc4c(c3)OC(F)(F)O4)CC2)nc1-c1cccc(C(=O)O)c1	1160221-26-0	Specific stabilization of CFTR MSD1, specifically TMD1.
GB-96-WX99	UFTXCRWHCXBQKN-UHFFFAOYSA-N	N=C(N)/N=c1/[nH]c2c(s1)CCCCC2		NPFFR1 antagonist
AD-30-TH52	UGCRBILAPBGGAB-UHFFFAOYSA-N	COc1ccc(-c2ccncc2)cc1-c1ccc2nonc2c1		Phosphodiesterase PDE4D Inhibitors;TNF-alpha Production Inhibitors
AF-20-MK39	UGJMXCAKCUNAIE-UHFFFAOYSA-N	NCC1(CC(=O)O)CCCCC1	1185039-20-6	Calcium Channels (Voltage-Gated) alpha2/delta-1 Subunit Ligands;Calcium Channels (Voltage-Gated) alpha2/delta-2 Subunit Ligands
KA-09-PB43	UGLLZXSYRBMNOS-UHFFFAOYSA-N	NS(=O)(=O)c1ccc2c(c1)CNCC2	31404-61-2	
KC-87-DN47	UGMPOJSWOINMDE-UHFFFAOYSA-N	Nc1cc2c(cn1)[nH]c1ccccc12	114819-72-6	CCKAR antagonist
FA-16-KA99	UGOYTHLEFQMHQH-UHFFFAOYSA-N	CNc1cc(Oc2ccc(NC(=O)Nc3cc(CN4CCN(C(C)C)CC4)cc(C(F)(F)F)c3)cc2)ncn1		
BD-58-PW57	UGTJLJZQQFGTJD-UHFFFAOYSA-N	N#CC(C#N)=NNc1cccc(Cl)c1		
AD-27-JS45	UGYXPZQILZRKJJ-UHFFFAOYSA-N	Cc1[nH]cnc1CCN	36376-47-3	HRH4 agonist
DE-58-OW37	UHDGCWIWMRVCDJ-CCXZUQQUSA-N	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1	147-94-4	Antimetabolites;DNA Polymerase Inhibitors
DB-07-WB29	UHUQDQUVZJEUKR-UHFFFAOYSA-N	O=C(Nc1cc2ccccc2cn1)c1ccccc1NCc1ccncc1	267891-44-1	Angiogenesis Inhibitors;VEGFR Inhibitors;Angiogenesis Inhibitors;VEGFR Inhibitors
DF-57-FI46	UIAGMCDKSXEBJQ-UHFFFAOYSA-N	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1	1246815-36-0	Calcium channel inhibitor L-type
RA-42-CM42	UIARLYUEJFELEN-LROUJFHJSA-N	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		
AA-46-HS88	UIAYVIIHMORPSJ-UHFFFAOYSA-N	CN(C(=O)CCCOc1ccc2[nH]c(=O)ccc2c1)C1CCCCC1	68550-75-4	Phosphodiesterase III Inhibitors
KB-17-DU74	UIEBLUZPSFAFOC-UHFFFAOYSA-N	CCOC(=O)C1Cc2ccccc2CN1C(=O)c1ccc(SC)s1	1254944-66-5	REV-ERB anatagonist
CE-15-YU05	UIFFUZWRFRDZJC-SBOOETFBSA-N	CCCCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C	116095-18-2	Electron transport chain inhibitor;Cytochrome c reductase;Electron Transport Chain Inhibitors
DB-89-PT22	UIHKDOBBVHGTAQ-UHFFFAOYSA-N	CCN1C(=O)CC2(CCN(C)CC2)C1=O	19105-63-6	Muscarinic Agonists
CC-88-JZ09	UIUCUHMVFGOBTM-UHFFFAOYSA-N	Cc1ccc(NC(=O)c2ccc(CN3CCCC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		
BD-61-OO16	UIURJGHFUQVQKB-UHFFFAOYSA-N	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)NC(C)C)n1		Focal Adhesion Kinase (FAK) Inhibitors
BC-33-BM51	UIYYKSUHRZUEQP-VIFPVBQESA-N	CSc1ccc(Nc2c(C(=O)NOC[C@H](C)O)cc(F)c(=O)n2C)c(F)c1	934639-60-8	Mitogen-Activated Protein (MAP) Kinase Kinase (MEK) Inhibitors;Inhibitors of Signal Transduction Pathways
AC-63-OM41	UJBBWPQMJVUYPP-INIZCTEOSA-N	Cc1cccc(C[C@H](NC(=O)c2cc(C(C)(C)C)nn2C)C(=O)NCC#N)c1	225120-45-6	Cathepsin L Inhibitors
AB-63-UJ99	UJLAWZDWDVHWOW-YPMHNXCESA-N	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12	1259404-17-5	Jak1 tyrosine kinase inhibitor;Jak3 tyrosine kinase inhibitor
QB-42-MC63	UJNGIXKARARJGM-UHFFFAOYSA-N	C=CCN(C)Cc1ccc(-c2ccc(C(=O)c3ccccc3)cc2)cc1		Lanosterol Synthase Inhibitors
S0-EE-Y9YA	UJORPFQWUKFXIE-UHFFFAOYSA-N	CCOc1cc(F)c(Cn2nc(-c3ncc(OC)c(Nc4ccncc4)n3)c3c2CCC3)c(F)c1		BUB1 mitotic checkpoint serine/threonine kinase inhibitor
CE-04-HT15	UJTNRXYTECQKFO-QHCPKHFHSA-N	CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)[C@H](C(=O)OC)C(C)C	137863-17-3	AGTR1 antagonist
WC-88-EM46	UJVDJAPJQWZRFR-DHIUTWEWSA-N	CC(C)(N)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)NC=O	381231-18-1	FOS Expression Enhancers;GHS Receptor Agonists;Growth Hormone Secretagogues;Signal Transduction Modulators
FD-67-GI76	UJVLDDZCTMKXJK-WNHSNXHDSA-N	C[C@]12CCC(=O)C=C1C=C[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@@]21CCC(=O)O1	154738-42-8	Mineralocorticoid Receptor (MR) Antagonists
ED-43-XF39	UKHMZCMKHPHFOT-UHFFFAOYSA-N	Nc1ncnc2c1ncn2C1CCCO1	17318-31-9	Adenylate Cyclase Inhibitors
WC-33-YP46	UKIDQROHTFZLLK-UHFFFAOYSA-N	COCCN1CCN(CC(O)COc2c3c(c(-c4ccc5c(c4)OCO5)c4cc(OC)c(OC)cc24)C(=O)OC3)CC1		pan cancer cell killer;Notch pathway inhibitor;pan cancer cell killer;Notch pathway inhibitor
CB-73-ZP43	UKLKGWPUCHYHCT-KRWDZBQOSA-N	Cn1nc(C(C)(C)C)cc1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC#N	225120-42-3	cathepsin L (CTSL1) inhibitor
BB-17-GC12	UKMJWGFHXMGRNG-VZUYHUTRSA-O	CCCC[P+](CCCC)(CCCC)Cc1ccc(NC(=O)[C@@H](Cc2ccc3ccccc3c2)N/C(=N/C2CCCCC2)NC2CCCCC2)cc1		BDKRB2 antagonist
BD-41-DB55	ULDXWLCXEDXJGE-UHFFFAOYSA-N	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1	1032349-77-1	Protein Kinase B (PKB/Akt) Inhibitors;AKT inhibitor
CE-03-YQ91	ULEDNDFVPJDVMX-UHFFFAOYSA-N	c1cncc(-c2cnc3ccc(NCc4cccs4)nn23)c1		
FB-84-TJ61	ULFRLSNUDGIQQP-UHFFFAOYSA-N	CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12	144034-80-0	5-HT1B Agonists;5-HT1D Agonists
PE-68-QD35	ULFUJLFTRWWLPO-UHFFFAOYSA-N	CCOC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccccc2)cc1	1099644-42-4	TGFBR2 degrador
CC-01-ER18	ULGABHCZIJXUFO-UHFFFAOYSA-N	O=c1c(N2CCCC2)c(O)c2cccnc2n1-c1ccccc1		
AC-06-PO03	ULGZDMOVFRHVEP-RWJQBGPGSA-N	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O	114-07-8	Motilin Receptor Agonists;NF-kappaB (NFKB) Activation Inhibitors
JD-10-HM98	ULKIYKLTKXRBOD-UHFFFAOYSA-N	O=C(O)C(CP(=O)(O)O)c1ccccc1		Glutamate Carboxypeptidase II (NAALADase;NAAG Peptidase, FOLH1, PSMA) Inhibitors
CC-48-OM48	ULNXAWLQFZMIHX-UHFFFAOYSA-N	CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(-c2ccnc(N3CCN(C)CC3)c2)cc2c1cnn2C(C)C	1346704-33-3	PRC2/EZH2;EZH2 gene inhibitor
DA-62-QB27	ULSSJYNJIZWPSB-CVRXJBIPSA-N	C[C@H](NC(=O)[C@@H](O)c1cc(F)cc(F)c1)C(=O)N[C@@H]1C(=O)N(C)c2ccccc2-c2ccccc21	209984-57-6	gamma-Secretase Inhibitors;Antiamyloidogenic Agents
JA-12-YH01	ULUARQDPFVJPMB-UHFFFAOYSA-N	COc1ccc(Cn2cc(C(=O)NCc3c(C)cc(N)nc3C)cn2)cc1	1357950-47-0	Plasma Kallikrein (KLKB1) Inhibitor
DC-22-OP01	ULXXDDBFHOBEHA-CWDCEQMOSA-N	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1	1254955-21-9	Irreversible EGFR (HER1;erbB1) Inhibitors;HER2 (erbB2) Inhibitors;Inhibitors of Signal Transduction Pathways
NC-73-QU79	ULYONBAOIMCNEH-UHFFFAOYSA-N	COc1ccc(Cl)cc1C1(F)C(=O)Nc2cc(C(F)(F)F)ccc21	183720-28-7	Large Conductance K(Ca) 1.1 (BK, maxi K+) Channel Activators
ZD-09-WT25	UMGMHDFTFVVKHO-UHFFFAOYSA-N	Nc1ncc(-c2ccnc(NC3CCNCC3)n2)c(CC2CC2)n1		
HC-24-QF06	UMJJGDUYVQCBMC-UHFFFAOYSA-N	CCNCCCNCCCNCCCNCC	1044709-86-5	Antimetabolites;Ornithine Decarboxylase Inhibitors;S-Adenosyl-L-methionine Decarboxylase Inhibitors
IC-86-MA49	UMKHUSRDQFQHAK-RNJMTYCLSA-N	N=C(N)NCCC[C@H](NC(=O)C12CC3CC(CC(C3)C1)C2)C(=O)N[C@@H](Cc1ccccc1)C(N)=O	876310-60-0	Neuropeptide FF Receptor Antagonists
S0-EE-WIZB	UMOGNCVNHXWFIX-VIFPVBQESA-N	C[C@H](O)CNC(=O)c1ncc(S(=O)(=O)c2ccc(OC(F)(F)F)cc2)cc1N		
RD-66-DP49	UMQOTZCXVAMZNY-UHFFFAOYSA-N	Cn1c(=O)c(C(=O)NCC(=O)O)c(O)c2ccccc21		Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors;Prolyl 4-Hydroxylase Inhibitors;Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors;Prolyl 4-Hydroxylase Inhibitors
OF-28-PH15	UMQUQWCJKFOUGV-UHFFFAOYSA-N	CC(C)(C)NCC(O)COc1cccc2[nH]c(=O)[nH]c12	64208-32-8	beta3-Adrenoceptor Agonists
FE-92-ZL16	UMRRDXVUROEIKJ-JCXBGQGISA-N	CCN(CC)CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc(C(C)(C)C)cc1)C(=O)N[C@@H](CO)C(=O)OC		CDX4 gene inhibitor;CBX and CDY Kme inhibitor
EB-61-FU05	UMTDAKAAYOXIKU-UHFFFAOYSA-N	COc1ccccc1N1CCN(CC(C(=O)NC(C)(C)C)c2ccccc2)CC1	133025-23-7	5-HT1A Receptor Antagonists;ADRA1B gene modulator
DB-05-UK61	UMUPQWIGCOZEOY-JOCHJYFZSA-N	CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N1CCC2(CC1)CN(S(C)(=O)=O)c1ccccc12	159634-47-6	Growth Hormone Secretagogues
GD-33-XB49	UNFJLRCZNPDZMZ-UHFFFAOYSA-N	O=C1CN(Cc2ccccc2)S(=O)(=O)N1	612530-69-5	Protein Tyrosine Phosphatase SHP-2 (PTP2C) Inhibitors
SE-89-DO49	UNJUKEICOWKRIH-MGBGTMOVSA-N	COc1ccc(S(=O)(=O)N2Cc3cc(-c4ccc(C#N)o4)ccc3N(Cc3cncn3C)C[C@H]2Cc2ccc(OC(=O)NCc3ccccc3)cc2)cc1	1311269-25-6	Geranylgeranyl Transferase Type I (GGTase-I) Inhibitors;Rab GGTase Inhibitors
OC-21-IP52	UNLBPQBJPUFQQK-UHFFFAOYSA-N	O=C(Cc1ccc(NC(=O)Cc2ccccc2)cc1)NO		
AC-72-HZ80	UNQXIRZDOXDTMH-UHFFFAOYSA-N	CCS(=O)(=O)NCc1cncc(-c2c(C#N)c3ccc(Cl)cc3n2C)c1	1202550-93-3	Cytochrome P450 11B2 (Aldosterone Synthase) Inhibitors
DC-51-WE27	UNXVDXCOSNSFJO-VAMGGRTRSA-N	COC[C@@H](C)N[C@H]1CC[C@H](Nc2cc(-c3cncc(OCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		Transcription inhibitor;CDK9 inhibitor
KB-88-OR49	UOARKCQONVBSCH-RBUKOAKNSA-N	CCn1cnc2c(Nc3ccc(S(=O)(=O)NCC(C)C)cc3)nc(N[C@@H]3CCCC[C@@H]3C(N)=O)nc21		
FF-61-BU95	UOEJSOXEHKCNAE-UHFFFAOYSA-N	Cc1ccc(NC(=O)c2ccccc2)cc1Nc1nccc(-c2cccnc2)n1	152459-94-4	PDGFR Inhibitors;Angiogenesis Inhibitors
IA-67-CK10	UOXSNOOWASRNHS-UHFFFAOYSA-N	COc1cccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1		
JB-81-XD04	UPABQMWFWCMOFV-UHFFFAOYSA-N	c1ccc(CCNCc2ccccc2)cc1	3240-91-3	
SB-28-EJ14	UPCODGKQZAKIAC-UHFFFAOYSA-N	Nc1ccc(-c2cc3c(N4CCCc5ccccc54)ncnc3[nH]2)cc1		EGFR (HER1;erbB1) Inhibitors;Abl Kinase Inhibitors;Protein Kinase C (PKC) Inhibitors;EGFR (HER1;erbB1) Inhibitors;Abl Kinase Inhibitors;Protein Kinase C (PKC) Inhibitors
LE-43-AR77	UPHXPXYRKPCXHK-UHFFFAOYSA-N	O=C(CCCc1ccccc1)NO		
UC-80-UO92	UPJCYXIOWHZRLU-GQCTYLIASA-N	COc1ccc2[nH]c(C)c(/C=C/C(=O)c3ccncc3)c2c1	1363421-46-8	Methuosis inducer
BE-76-XL76	UPNAOLQUAQLVHO-GBLZOACLSA-N	NC(=O)n1cc(NC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NCc2cccc(Cl)c2F)c2cc(OCC(=O)O)ccc21		Complement Factor D (CFD) Inhibitor
HB-13-XB94	UPZWINBEAHDTLA-UHFFFAOYSA-N	Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1-c1ccc(F)cc1	1034442-21-1	MGLUR5 NAM
OE-84-HO42	UQHINZSKNAAVOZ-UHFFFAOYSA-N	OCCNc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12		Antimitotic Drugs;Aurora-A (ARK1) Kinase Inhibitors
AB-27-LS15	UQHKJRCFSLMWIA-UHFFFAOYSA-N	Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21	125313-65-7	Non-Steroidal Antiinflammatory Drugs;Protein Kinase C (PKC) Inhibitors
AD-39-JN68	UQIUWUJYJBQZBY-UHFFFAOYSA-N	Cc1ncc(-c2cc(-c3cc(S(=O)(=O)NCC(C)(C)O)ccc3C)cnc2N)o1		PI3 kinase p85 regulatory subunit gamma inhibitor
AC-54-FR31	UQRORFVVSGFNRO-UTINFBMNSA-N	CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO	134282-77-2	SGLT-3 Activators;Pharmacological Chaperones;alpha-Glucosidase Inhibitors;Ceramide Glucosyltransferase Inhibitors
AD-43-XJ59	UQRORFVVSGFNRO-XFWSIPNHSA-N	CCCCN1C[C@H](O)[C@@H](O)[C@@H](O)[C@H]1CO	141206-42-0	Ceramide Glucosyltransferase Inhibitors
VF-06-RV33	UQXBDKCUDUINDD-UHFFFAOYSA-N	Cc1c(Cc2ccc(Cl)cc2)c(=O)oc2cc(OCc3nn[nH]n3)cc(OCc3nn[nH]n3)c12		
HC-76-SY22	UQZVCDCIMBLVNR-TWYODKAFSA-N	CS(=O)(=O)NC(=O)CCC/C=C\\C[C@H]1C(=O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc1ccccc1		
AC-33-YJ09	URATWWKSRAPWRM-UHFFFAOYSA-N	COCCN(C)c1cc2n(c(=O)n1)CCc1cc(OC)ccc1-2		Inhibitors of Signal Transduction Pathways;MAPKAP-K2 (MK2) Inhibitors
RB-80-RO52	UREBDLICKHMUKA-CXSFZGCWSA-N	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	1050677-47-8	Antiinflammatory Drugs
AF-07-LS35	UREJDUPKGMFJRU-UHFFFAOYSA-N	S=C(NCCCc1c[nH]cn1)NCCCN(Cc1ccc(Cl)c(Cl)c1)c1ccc(Br)cn1	199522-35-5	Somatostatin srif2B (sst4) Agonists
MD-03-NA01	URFCJEUYXNAHFI-UHFFFAOYSA-N	O=C1CC(c2ccccc2)Oc2cc(O)cc(O)c21	480-39-7	Androgen Receptor Ligands;Steroid 5alpha-Reductase Inhibitors;Androgen Receptor Ligands;Steroid 5alpha-Reductase Inhibitors
DD-67-EC82	URKOMYMAXPYINW-UHFFFAOYSA-N	OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1	111974-69-7	alpha1-Adrenoceptor Antagonists
PA-09-IB98	URRVADSRTAEFCN-UHFFFAOYSA-N	CC(C)Oc1ccc(-n2cc(-c3cccc(Cl)c3)ccc2=O)cc1		
FA-23-LP18	URUHKHGBRNTPGA-UHFFFAOYSA-N	Nc1cc(-c2ccccc2)nc2ccccc12	111273-28-0	N-Type Calcium Channel (Ca(v) 2.2) Blockers
ZB-33-MZ40	URWCXPXBBITYLR-UHFFFAOYSA-N	CNc1cc(-c2cccc(Cl)c2Cl)nc(N)n1	1609960-30-6	NUDT1 gene inhibitor
GB-92-JY12	URWYQGVSPQJGGB-DHUJRADRSA-N	COc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12	743461-65-6	Muscarinic M3 receptor antagonist, Beta 2 adrenoceptor agonist
AE-15-KH69	USEMRPYUFJNFQN-UHFFFAOYSA-N	Cc1cc(NC2CCCCC2)nc(-n2nc(C)cc2C)n1	73029-73-9	Small Conductance SK(Ca) 2.3 (SK3, SKCa3, hKCa3) Channel Activators
CB-68-GZ09	USFUFHFQWXDVMH-UHFFFAOYSA-N	Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1	152239-46-8	HTR2B antagonist
BB-65-SY95	USGGSIVMQBZIHX-UHFFFAOYSA-N	NS(=O)(=O)c1ccc(NS(=O)(=O)c2ccc(F)cc2)cc1		Carbonic anhydrase inhibitor
GF-46-LK68	USGVVEIZVFGZSW-OAHLLOKOSA-N	CC[C@@H](Nc1c(Nc2ccc(Cl)c(S(=O)(=O)Nc3ccncc3)c2O)c(=O)c1=O)c1ccc(C)o1	1228575-09-4	CXCR2 antagonist
YF-12-EY30	USNOFOHMTMYBSM-QWAKEFERSA-N	CC(C)C[C@H](NC(=O)C(CS)CCc1ccccc1)C(=O)Nc1ccccc1		Collagenase Inhibitors
BA-29-GH49	USUWIEBBBWHKNI-KHIFEHGGSA-N	Cc1cc(-n2nc3c(c2-n2ccn(-c4ccc5c(cnn5C)c4F)c2=O)[C@H](C)N(C(=O)c2cc4cc([C@H]5CCOC(C)(C)C5)ccc4n2[C@@]2(c4noc(=O)[nH]4)C[C@@H]2C)CC3)cc(C)c1F		
IE-44-GZ79	USWLOKMMUTWFMD-UHFFFAOYSA-N	c1cc(-c2sc(-c3ccncc3)c(-c3ccncc3)c2-c2ccncc2)ccn1	143222-43-9	Hedgehog Signaling Inhibitors
ME-47-CY39	USZAGAREISWJDP-UHFFFAOYSA-N	N#Cc1ccc(Oc2ccc3c(c2)COB3O)cc1	1073669-75-6	PDE4 inhibitor use for topical application
UE-99-BK94	UTAJHKSGYJSZBR-UHFFFAOYSA-N	COc1ccccc1C(=O)Nc1cccc(NC(=O)c2cccc(C)c2)c1	947914-18-3	KCNK3 gene inhibitor
UA-56-RO11	UTBSBSOBZHXMHI-CABCVRRESA-N	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CCCC[C@H]3N)nc21		CDK inhibitor
FB-68-SI43	UTKDFELPCDMAME-UHFFFAOYSA-N	O=C(NCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1)c1cc2ccccc2[nH]1		
CC-93-RP38	UTNUDOFZCWSZMS-YFHOEESVSA-N	C/C(O)=C(\\C#N)C(=O)Nc1ccc(C(F)(F)F)cc1	108605-62-5	Dihydroorotate Dehydrogenase (DHODH) Inhibitors
SB-94-ZA83	UTOXGQNLFXWCMS-QGZVFWFLSA-N	CS(=O)(=O)N1CCC(c2noc([C@H](CCCC3CCCCC3)CC(=O)NO)n2)CC1		Procollagen C-Proteinase Inhibitors
IE-46-VU57	UTZAFVPPWUIPBH-QSLRECBCSA-N	C/C=C/C(=O)N1C(=O)OC[C@@H]1Cc1ccccc1	133812-16-5	RKIP-RAF1 interaction inhibitor
LD-98-CY91	UUCCOLYYQJSQJL-UHFFFAOYSA-N	CCN1CCN(c2cc(C)c3cc(NC(=O)COc4ccc(Cl)cc4)ccc3n2)CC1		Melanin-Concentrating Hormone MCH-R1 (SLC-1) Receptor Ligands
GA-06-UU42	UUDAMDVQRQNNHZ-UHFFFAOYSA-N	Cc1o[nH]c(=O)c1CC(N)C(=O)O	110592-37-5	
CB-59-FD39	UUDYZUDTQPLDDP-UHFFFAOYSA-N	O=C(Nc1cc(NC(=O)c2ccccc2)c(C(=O)O)cc1C(=O)O)c1ccccc1	70553-45-6	iGluR5 (GluK5) Antagonists
KF-00-NW62	UUFFVQSTMWBCOG-UHFFFAOYSA-N	COc1ccc(Cn2c(NCc3cccnc3N)nc(=O)n(Cc3ccc(OC)cc3)c2=O)cc1		Prokineticin 1 Receptor (PKR1) Antagonist
BD-99-DU20	UUKJKGJWLSRNNK-UHFFFAOYSA-N	O=c1oc(-c2ccco2)nc2ccccc12	20492-07-3	Elastase inhibitor
DE-73-EF24	UULIGRNKXHCLQN-WGSAOQKQSA-N	Nc1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12	192322-50-2	NPY5R antagonist;Neuropeptide Y5 (NPY Y5) Antagonists;Reduced Feeding in mice
BE-28-QT65	UUMKQZVEZSXWBY-HNNXBMFYSA-N	O=P(O)(O)CN[C@@H](Cc1ccc(-c2ccccc2)cc1)c1nn[nH]n1	154116-31-1	Endothelin-Converting Enzyme (ECE) Inhibitors;Neprilysin (Enkephalinase, Neutral Endopeptidase, NEP) Inhibitors
BB-52-UP66	UUOJIACWOAYWEZ-UHFFFAOYSA-N	Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1	62658-63-3	beta1-Adrenoceptor Antagonists
GF-81-MU70	UUQMNUMQCIQDMZ-UHFFFAOYSA-N	CNCCc1ccccn1	133206-34-5	Histamine H3 Receptor Antagonists;Histamine H1 Receptor Agonists
GB-81-UN03	UUSGLQSMBGQHMR-UHFFFAOYSA-N	Nc1cc(-c2cccs2)nc2ccccc12		
EE-64-WM03	UUSJIECFMYLBBU-UHFFFAOYSA-N	N=C(N)c1cccc(-c2cccc(C(=N)N)n2)n1	144205-77-6	Antimetabolites;S-Adenosyl-L-methionine Decarboxylase Inhibitors
CB-07-WI76	UUTKICFRNVKFRG-WDSKDSINSA-N	O=C1CC[C@@H](C(=O)N2CSC[C@H]2C(=O)O)N1		
QC-32-ZC28	UUVJYYBXBRFJPI-UHFFFAOYSA-N	CN(CCCCP(=O)(O)O)Cc1cc([N+](=O)[O-])cc2[nH]c(=O)c(=O)[nH]c12		
DE-29-MT22	UVIQSJCZCSLXRZ-UBUQANBQSA-N	CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cccnc4)=CC[C@@H]32)C1	154229-18-2	Androgen Biosynthesis Inhibitors;Cytochrome P450 CYP17 (17alpha-Hydroxylase/C17-20 Lyase) Inhibitors
AC-95-MR73	UVKZSORBKUEBAZ-UHFFFAOYSA-N	CN1CCN(C(c2ccccc2)c2ccccc2)CC1	303-25-3	Drugs Acting on Histamine Receptors
FD-79-TC61	UVPYXZGUFFMABH-UHFFFAOYSA-N	CNc1cc(Nc2nccc(Nc3ccc4c(c3S(N)(=O)=O)OCCO4)n2)ccc1C		ALK Inhibitors;ZAP70 Kinase Inhibitors
EC-84-CC24	UVSVTDVJQAJIFG-VURMDHGXSA-N	C/C(O)=C(\\C#N)C(=O)Nc1cc(Br)ccc1Br	244240-24-2	Inhibitors of Signal Transduction Pathways;Bruton's Tyrosine Kinase (BTK) Inhibitors
PA-60-HV24	UVSWWUWQVAQPJR-UHFFFAOYSA-N	COc1ccc(CCN2CCN(CCCc3ccccc3)CC2)cc1OC	165377-43-5	Acetylcholine Release Enhancers;sigma1 Receptor Agonists
DC-11-AR68	UVTGPXVPTNTUDR-URLMMPGGSA-N	Cc1cc(C)cc(C(=O)N(C)[C@H](Cc2ccc(-c3ccno3)cc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)c1	169545-68-0	EDNRB gene inhibitor
AB-23-MN29	UVTNFZQICZKOEM-UHFFFAOYSA-N	CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C	1216989-88-6	Antiarrhythmic agent;Sodium Channel Blocker
HE-84-RW47	UVVWQQKSNZLUQA-UHFFFAOYSA-N	CCCCCCCC(=O)c1c(O)cc(O)cc1CC(=O)OCC	321661-62-5	NR4A1 gene stimulator
AE-14-NN26	UWKQSNNFCGGAFS-XIFFEERXSA-N	CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC	100286-90-6	DNA Topoisomerase I Inhibitors
GD-27-UE16	UWQXWOJVNASZLI-UHFFFAOYSA-N	CC1=C(C(=O)Nc2ccccc2C)C(c2cccc([N+](=O)[O-])c2)C2=C(CCCC2=O)N1	506417-09-0	GPR41 agonist
DA-46-KH36	UWYZHKAOTLEWKK-UHFFFAOYSA-N	c1ccc2c(c1)CCNC2		
ME-64-LE18	UXCGGTCHSALBPY-UGSOOPFHSA-N	C[C@H]1[C@H]2c3ccccc3Cc3ccccc3N2CN1C	124097-52-5	ADRA2B antagonist
AC-17-PC87	UXGJAOIJSROTTN-UHFFFAOYSA-N	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1	516480-79-8	
TC-94-QN39	UXIPFQUBOVWAQW-UEBLJOKOSA-N	CN1CCCC[C@H]1CCc1ccccc1NC(=O)/C=C/c1ccccc1		
WC-95-BX35	UXNUAPAXTLFKIZ-TWGQIWQCSA-N	COC1=Nc2cc(Cl)ccc2/C(=C/C(=O)O)c2sc(Cl)cc21		
GA-43-FL03	UXOWGYHJODZGMF-QORCZRPOSA-N	COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC	1327153-71-8	Renin Inhibitors
HF-51-NR28	UXRKUKRXVWJFER-UHFFFAOYSA-N	Cc1[nH]c2ccccc2c1CCNC(=O)c1ccccc1F	442633-00-3	ARP2/3 Complex inhibitor
AC-21-PO16	UXUNKAVQAKRKEX-UHFFFAOYSA-N	NS(=O)(=O)Oc1ccc2c(c1)oc1c3ccccc3oc(=O)c21		
UA-06-UV98	UXXQOJXBIDBUAC-UHFFFAOYSA-N	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1	1227636-17-0	Flt3 (FLK2/STK1) Inhibitors;PDGFRbeta Inhibitors;KIT (C-KIT) Inhibitors;Angiogenesis Inhibitors
RA-86-LI22	UYBRROMMFMPJAN-UHFFFAOYSA-N	CCOC(=O)Nc1cc(-c2ccc(C)c(NS(C)(=O)=O)c2)nn2c(C)nnc12		
SE-29-ZA15	UYFZCWXRMHSLTC-UHFFFAOYSA-N	CCc1ccc(S(=O)(=O)c2nnn3c2nc(NCc2cccs2)c2sccc23)cc1	892742-76-6	Urea transporter inhibitor
EA-43-FS10	UYHFMGYGNYTVEP-ACCUITESSA-N	COc1ccc(/C=C/C(=O)CCCCc2ccccc2)cc1O		
BD-25-SA37	UYJNQQDJUOUFQJ-UHFFFAOYSA-N	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl	761437-28-9	Focal Adhesion Kinase (FAK) Inhibitors;IGF-1R Inhibitors
OC-40-XI13	UYJZZVDLGDDTCL-UHFFFAOYSA-N	CN(C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1	344458-15-7	NAD+ ADP-Ribosyltransferase (poly(ADP-ribose)polymerase PARP) Inhibitors;poly(ADP-ribose) Glycohydrolase (PARG) Inhibitors
IC-43-CV07	UYMHTIAWIYFUIJ-MHHIJSAWSA-N	CCOc1ccc2c(COc3cccc4[nH]c(C(=O)N[C@H]5CC[C@](O)(CCN6CC[C@H](O)[C@@H](C)C6)CC5)cc34)coc2c1		
AA-32-DP01	UYUHRKLITDJEHB-UHFFFAOYSA-N	COc1ccc(N(C(=O)Nc2c(C)cccc2C)c2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)c(OC)c1		SIK1 gene inhibitor
OB-75-VS99	UYZWTXQOSZVCEP-UHFFFAOYSA-N	NC(=O)c1ccc(Nc2ncnc3ccsc23)c(OC2CCOC2)c1	952521-84-5	MAPK-Interacting Kinase (MNK) Inhibitors
ME-77-XX06	UZBCFQXJIATIPJ-UHFFFAOYSA-N	Nc1nc(NCCC#CCCNS(=O)(=O)c2cccc3ccccc23)nc2ccccc12		
BB-72-TP61	UZDFSRHIULMBOE-UHFFFAOYSA-N	COc1ccc(C(=O)Nc2c(-c3cccc4ccccc34)c(=O)c3ccccc3n2C)cc1		
CD-97-ZV62	UZIATSFXNVOVFE-OAHLLOKOSA-N	CC(C)Oc1ccc(F)c(-c2cnc(N)c(C(=O)Nc3cnccc3N3CCC[C@@H](C(=O)O)C3)n2)c1		DYRK-1 alpha protein kinase inhibitor
HC-16-VX59	UZMWVMXNKZSFIP-UHFFFAOYSA-N	O=C(Cn1c2ccccc2c2c(N3CCCC3)nc(N3CCCC3)nc21)N1CCCC1	214212-38-1	Mediator Release Inhibitors;IL-5 Production Inhibitors
KD-00-UJ81	UZQIOQVHUUAJOZ-UHFFFAOYSA-N	O=c1[nH]c(Nc2ccccc2)cc2ccccc12		
CA-16-ZL71	VAAUVRVFOQPIGI-SPQHTLEESA-N	CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nc(=O)c(=O)[nH]n3C)CS[C@H]12)c1csc(N)n1	104376-79-6	Antibacterial;Antibiotic;organic anion transporter inhibitor
QB-69-QH67	VAKCXGDNXZOYKE-UHFFFAOYSA-N	COc1ccc(C2CC(c3ccc(Cl)cc3)=NN2C(=O)c2nc3ccccc3s2)cc1		TOP2A catalytic inhibitor
AA-58-JC44	VAYJLOGCWOXMAS-UHFFFAOYSA-N	COc1cc(C(=O)N(C(C)C)C(C)C)ccc1OCCCCCOc1ccc(C(=N)N)cc1	146957-32-6	Leukotriene BLT (LTB4) Antagonists
GE-47-OO30	VAZAPHZUAVEOMC-UHFFFAOYSA-N	CC(=O)Nc1ccc(C(=O)Nc2ccccc2N)cc1	112522-64-2	HDAC 1/2/3
DA-56-CH26	VBIYDORVDCFKHM-UHFFFAOYSA-N	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		Interleukin-1 Receptor-Associated Kinase (IRAK) Inhibitors
AB-01-UY50	VBWVJJZYUPVDPN-UHFFFAOYSA-N	O=C(CCCN1CCc2[nH]c3ccc(F)cc3c2C1)c1ccc(F)cc1	31540-62-2	HTR1 modulator;ADRA1B antagonist
JF-93-EL43	VCACXGULTWUFOL-ZYHUDNBSSA-N	Nc1nc(N2CCC3(CC2)C[C@H](O)C[C@H]3N)cnc1Sc1ccnc(Cl)c1Cl		SHP2 inhibitor
IC-72-HR20	VCKPUUFAIGNJHC-UHFFFAOYSA-N	Nc1c(O)cccc1C(=O)CC(N)C(=O)O		
DD-15-VH74	VCKUSRYTPJJLNI-UHFFFAOYSA-N	COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC	141269-45-6	PGK1 activator;alpha1-Adrenoceptor Antagonists
FC-71-PK06	VCPMZDWBEWTGNW-UHFFFAOYSA-N	O=C(CC(c1ccccc1)c1ccccc1)N1CCN(C(c2ccccc2)c2ccccc2)CC1	41332-24-5	N-Type Calcium Channel (Ca(v) 2.2) Blockers
CC-20-ZO24	VCRGLZYPNNAVRP-JTQLQIEISA-N	CC1(C)CCC(NC(=O)[C@@H](N)CCC(=O)O)CC1	163000-63-3	NMDA Glycine-Site Modulators;Norepinephrine Reuptake Inhibitors
DC-08-KP05	VCXNFMLRLDZWTK-SDZGCHGRSA-N	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCCCCCCCCc2ccc(OC[C@@H](O)CNC(C)(C)C)c3cc(C#N)[nH]c23)[C@@H]1c1cccc2nonc12		Calcium Channel Blockers;beta-Adrenoceptor Antagonists;Calcium Channel Blockers;beta-Adrenoceptor Antagonists
FA-79-WC91	VDDALHSBRYGZDW-UHFFFAOYSA-N	Cn1cc(C2=C(c3nc(N4CCNC5(CC5)C4)nc4ccccc34)C(=O)NC2=O)c2ccccc21		Protein Kinase C (PKC) Inhibitors
IF-92-OK68	VDDZMXQAZJMGPK-UHFFFAOYSA-N	CCOC(=O)c1cnc(SC)nc1NC	76360-82-2	CDK Inhibitors
PB-34-EE63	VDHAWDNDOKGFTD-MRXNPFEDSA-N	C[C@@H](NCCCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12	1025064-29-2	Calcium-Sensing Receptor (CaSR) Agonists
CB-83-LF14	VDPYORASPBMPQL-LBPRGKRZSA-N	CC(C)OCCCNCC(=O)N1CCC[C@H]1C#N		Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors
HE-27-FR27	VDWFDMKVYHLWRD-UHFFFAOYSA-N	O=C1CCCC2=C1C(c1cccc(Br)c1)Nc1ccc3ccccc3c12		Rho C GTPase Inhibitors
AD-98-UM13	VEFKMPXOOGXXSQ-UHFFFAOYSA-N	Cc1ccc2c(c1)nc(N1CCNCC1)n2Cc1ccccc1		5-HT3 Antagonists
MF-31-FM25	VEJBANJNCNEZHG-CQSZACIVSA-N	CNC(=S)Nc1cccc(-c2cc3c(N[C@H](C)c4ccccc4)ncnc3[nH]2)c1		
SD-61-RL57	VEPKQEUBKLEPRA-UHFFFAOYSA-N	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl	209410-46-8	P38 alpha MAP kinase inhibitor
MB-48-VA23	VETFGCIOWGTLKG-UHFFFAOYSA-N	CN1CC(c2ccccc2)OC2(CCN(Cc3ccccc3)CC2)N1	387883-97-8	Vascular adhesion molecule antagonists
JB-76-JD86	VEZNOACNEPSKKA-UHFFFAOYSA-N	Cc1cc(N)ncc1CNC(=O)c1cnn(Cc2ccccc2)c1		
CF-87-AS90	VFBGXTUGODTSPK-BAQGIRSFSA-N	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1	608512-97-6	PKR Inhibitor
GB-37-WI36	VFCRKLWBYMDAED-REWPJTCUSA-N	CCC[C@H](N[C@H]1CCc2cc(F)cc(F)c2C1)C(=O)Nc1cn(C(C)(C)CNCC(C)(C)C)cn1	1290543-63-3	Apoptosis Inducers;gamma-Secretase Inhibitors
EE-83-WF69	VFFZWMWTUSXDCB-ZDUSSCGKSA-N	N#Cc1ccc(NCCNCC(=O)N2CCC[C@H]2C#N)nc1	207556-62-5	Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors
KA-62-IU97	VFIDUCMKNJIJTO-CZUORRHYSA-N	Cc1ccc(OC[C@@H](O)[C@@H](C)NC(C)C)c2c1CCC2	72795-19-8	ADRB2 antagonist
AF-18-FX20	VFIZBHJTOHUOEK-UHFFFAOYSA-N	CCSC(=N)N	1071-37-0	Nitric Oxide Synthase Inhibitors
GF-93-DV47	VFMMPHCGEFXGIP-UHFFFAOYSA-N	O=c1cc(-c2ccccc2)oc2c1ccc1ccccc12	604-59-1	Breast Cancer-Resistant Protein (BCRP;ABCG2) Inhibitors;Nuclear Factor, Erythroid Derived 2, Like 2 (Nrf2) Activators
KA-53-KV02	VFPSHYIQSHKAFX-UHFFFAOYSA-N	O=S(=O)(c1ccccc1)c1nnn2c1nc(NCC1CCCO1)c1sccc12	892730-09-5	HTR6 antagonist;5-HT6 Antagonists
BC-51-ME52	VFTRKSBEFQDZKX-UHFFFAOYSA-N	c1ccc2c(Cc3c[nH]c4ccccc34)c[nH]c2c1	1968-05-4	Androgen Receptor Antagonists;Indoleamine 2,3-dioxygenase Inhibitors;Aryl Hydrocarbon Receptor (AhR) Agonists
AA-72-QI84	VGEREEWJJVICBM-UHFFFAOYSA-N	O=C(CCc1ccc(O)cc1)c1c(O)cc(O)cc1O	60-82-2	VCAM1 Expression Inhibitors;ICAM1 Expression Inhibitors;Antioxidants
CE-23-HP88	VGFALHATLLBXIT-UHFFFAOYSA-N	COc1ccc(NC(=N)N)cc1	112677-02-8	5-HT3 agonist
AE-71-CB15	VGGGPCQERPFHOB-RDBSUJKOSA-N	CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O	100992-60-7	Leukotriene A4 Hydrolase Inhibitors;Membrane Alanine Aminopeptidase (Aminopeptidase N) Inhibitors
TA-57-FF07	VGGJJTAZYLMEPD-JIYUALFRSA-N	C[C@@H](NS(C)(=O)=O)C(=O)N1C[C@H](OCc2ccc(Cl)cc2)C[C@H]1C(=O)N[C@@H](CCCCN)C(=O)c1nc2ccccc2o1		
CE-52-XV55	VGIGHGMPMUCLIQ-UHFFFAOYSA-N	O=S1(=O)c2cccc3cccc(c23)N1CCCN1CCN(c2ccc(F)cc2)CC1	127625-29-0	Dopamine D4 Antagonists;5-HT2A Antagonists
AE-85-LR48	VGIQUSQBXZXBGW-UHFFFAOYSA-N	CCN(CC)CCN(Cc1ccc(-c2ccc(C(F)(F)F)cc2)cc1)C(=O)Cn1cc(Cc2cnn(C)c2)c(=O)nc1SCc1ccc(F)cc1	304694-39-1	Lipoprotein Associated Phospholipase A2 (Lp-PLA2) Inhibitors;Signal Transduction Modulators
AA-97-XP63	VGKDLMBJGBXTGI-SJCJKPOMSA-N	CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21	219736-80-8	5-HT Reuptake Inhibitors
BC-78-NC89	VGPDHSJTCIECIM-QFQXNSOFSA-N	C[N@@+]1(CCCc2ccccc2)CCC[C@@H](OC(=O)C(O)(c2cccs2)c2cccs2)C1		Muscarinic M1 Antagonists;Muscarinic M2 Antagonists;Muscarinic M3 Antagonists
FD-80-EG54	VGUSQKZDZHAAEE-UHFFFAOYSA-N	Cc1ccc(C(=O)NC2CC2)cc1-n1ncc(C(=O)c2cccc(C#N)c2)c1N	836683-15-9	p38 MAPK Inhibitors
ZD-74-FC07	VGWSIOJGIHCFHY-UHFFFAOYSA-N	N=C(NC1CCCCC1)SCC1=CSC2=NCCN12		
HD-41-DX72	VHBBMEXIWWKUNY-MRVPVSSYSA-N	C[C@@H]1OCC2(CCN(C)CC2)O1		Cholinergics
DD-42-DB72	VHBBMEXIWWKUNY-QMMMGPOBSA-N	C[C@H]1OCC2(CCN(C)CC2)O1	104925-22-6	CHRM1 agonist
WD-26-EB85	VHBFFQKBGNRLFZ-UHFFFAOYSA-N	O=c1cc(-c2ccccc2)oc2ccccc12	11091-19-3	Cytochrome P450 CYP1A1 Inhibitors
S0-EE-WNJ9	VHBWMURBYGDRGO-LBPRGKRZSA-N	CNC(=O)c1cc(C(=O)Nc2cn[nH]c2)cc([C@@H](C)c2ccccc2)n1		
IC-27-TE11	VHDOJOVCAVZTRK-UHFFFAOYSA-N	Nc1ncnc2ccc(-c3cc(F)cc(NC(=O)CN4CCCC4)c3)nc12		MAP4K4 inhibitor
CD-47-BV87	VHGCDTVCOLNTBX-QGZVFWFLSA-N	CNCC[C@@H](Oc1ccccc1C)c1ccccc1	1027094-45-6	Norepinephrine Transporter (NET) Inhibitors
DE-28-BW67	VHOLZGILMFEDGK-UHFFFAOYSA-N	CN(C)c1ccc(CN(CC(=O)NO)S(=O)(=O)c2ccc(OCC3CC3)cc2)cc1		
GF-53-OL28	VHYTVSSUVKUYOG-UHFFFAOYSA-N	COc1ccc(Br)c(-c2nc3ccccc3c(=O)o2)c1		Inhibitors of Blood Coagulation Pathways;Coagulation Factor VIIa Inhibitors
ZA-63-AC60	VIBHJPDPEVVDTB-UHFFFAOYSA-N	Cc1onc(C(=O)N2CCN(C(c3ccc(Cl)cc3)c3ccc(Cl)cc3)CC2)c1[N+](=O)[O-]	1360705-96-9	
EE-61-NU30	VIDUBYQATATWPE-UHFFFAOYSA-N	Fc1ccc(C2(CCCN3Cc4ccccc4C3)OCCO2)cc1		5-HT7 Antagonists
NC-06-IT89	VILCJCGEZXAXTO-UHFFFAOYSA-N	NCCNCCNCCN	105821-86-1	Chelating Agents;Telomerase Inhibitors
FA-28-MT45	VJGGHXVGBSZVMZ-QIZQQNKQSA-N	O=C(O)CCC/C=C\\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(Cl)c2)[C@H](O)C[C@@H]1O	100786-10-5	PTGFR agonist
LD-39-FL02	VJJPUSNTGOMMGY-NBJJDLTASA-N	COc1cc([C@@H]2c3cc4c(cc3C(O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)C3COC(=O)[C@@H]32)OCO4)cc(OC)c1O		
BA-02-RG00	VJMAUIORXGDTDJ-UHFFFAOYSA-N	Cc1nc(-c2ccc(C(=O)Nc3c(C(C)C)nc4oc(C)c(C)n4c3=O)nc2)ccc1F		
AA-71-XO01	VJQALSOBHVEJQM-QAQDUYKDSA-N	COCCO[C@H]1CC[C@H](Nc2cc(=O)n(C)c3ccc(-c4cncs4)cc23)CC1		CD38 gene inhibitor;CD38 inhibitor
FF-86-NH56	VJXBYUITQBTTQM-DSRNDQRRSA-N	CC[C@H](C)[C@H]1NC(=O)[C@H]2CSSCC/C=C/[C@H](CC(=O)N[C@H](CCSC)C(=O)N2)OC(=O)C[C@@H]1O	1278522-67-0	HDAC inhibitor (no hydroxamic acid)
WA-80-EA43	VJXQOGGTCICSAP-GASCZTMLSA-N	COc1ccc(N2C[C@@H](C)N[C@@H](C)C2)nc1NS(=O)(=O)c1ccc(-c2ccc(C)o2)c(F)c1	952289-48-4	GHS Receptor Agonists
GD-66-LN30	VKGVZBMIHDQODH-UHFFFAOYSA-N	O=c1[nH]c2ccccc2n1CCCCN1CCN(c2cccc(Cl)c2)CC1		5-HT1A Receptor Antagonists;5-HT2A Antagonists
BD-23-MT28	VKHAHZOOUSRJNA-GCNJZUOMSA-N	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C	122742-25-0	Androgen Receptor Ligands;Glucocorticoid Receptor (GR) Antagonists;Internal Ribosomal Entry Site (IRES) Inhibitors;Progesterone Receptor Antagonists
GC-32-SH41	VKUYLANQOAKALN-LJQANCHMSA-N	COc1ccc(S(=O)(=O)N(Cc2ccccc2)[C@H](CC(C)C)C(=O)NO)cc1		
YC-11-LU43	VKWDUXSHPJACHQ-DHDCSXOGSA-N	CC(C)(CO)CNS(=O)(=O)c1ccc(N/C=C2\\C(=O)Nc3ccc4ncsc4c32)cc1	222035-75-8	Tyrosine Kinase Inhibitors;CDK1 Inhibitors;CDK2 Inhibitors
ME-11-OJ38	VKWNJVPLPUSCAV-JFTHPGNVSA-N	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)O)NC1=O		Anti-CD4
AD-21-WS76	VLCDMPCNKPJKLX-UHFFFAOYSA-N	Cc1c(Nc2ccc(Br)cc2F)c(C(=O)NOCC2CC2)c2n(c1=O)CCC2		
DD-55-AU25	VLCYCQAOQCDTCN-UHFFFAOYSA-N	NCCCC(N)(C(=O)O)C(F)F	67037-37-0	Ornithine Decarboxylase Inhibitors
SA-31-AZ46	VLIHQHQPGAWJCM-UHFFFAOYSA-N	O=C1CCc2cc(S(=O)(=O)Nc3ccc(F)c(Cl)c3)c(F)cc2N1	1346113-84-5	Pyruvate Kinase Isozyme M2 (PKM2) Activators
RF-05-PV01	VLPRXFLUVHYBBT-VAWYXSNFSA-N	CN1CCN(/C=C2\\CCn3c2nc(=O)c2c(Cl)cccc23)CC1		SMARCA2/4 inhibitor
EC-40-DQ58	VLQTUNDJHLEFEQ-KGENOOAVSA-N	COC(=O)/C=C/c1cccc(N(Cc2ccc(-c3ccc(N(C)C)cc3)cc2)C(=O)C2CCCCC2)c1	574013-66-4	Farnesoid X-receptor agonist
OE-34-NH10	VLULRUCCHYVXOH-UHFFFAOYSA-N	Cc1ccccc1CN1C(=O)C2=C(CCN(Cc3ccccc3)C2)N2CCN=C12	1342897-86-2	TIC10 inactivates Akt and ERK and induces TRAIL expression
QB-35-FO29	VLVARFGYPATFQX-ULQDDVLXSA-N	CC(C)C[C@H](NC(=O)[C@@H](S)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O		MMP-12 (Macrophage Elastase) Inhibitors
YC-06-WA22	VMJSEWCRPGCNOF-UHFFFAOYSA-N	O=C1CCON1CC#CCN1CCCC1		Muscarinic M1 Agonists;Muscarinic M2 Agonists;Muscarinic M3 Agonists
GC-54-IZ89	VMKPCENEHPIWJT-DOPYIHRPSA-N	CCOC(=O)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C)C(=O)COC(=O)c1c(Cl)cccc1Cl		Caspase 1 (IL-1beta Converting Enzyme) Inhibitors;Non-Steroidal Antiinflammatory Drugs
BA-59-QN98	VMMKGVRPILDZML-UHFFFAOYSA-N	COc1ccc2c(c1)C(c1ccc(F)cc1)=C(CN1CCCC1)CO2	1370544-73-2	
XD-18-IF89	VMSLCPKYRPDHLN-OAQYLSRUSA-N	CC(C)=CCC1=C(O)[C@](O)(CC=C(C)C)C(=O)C(C(=O)CC(C)C)=C1O	23510-81-8	Antioxidants;AP-1 Inhibitors;Apoptosis Inducers;Cyclooxygenase-2 Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Antioxidants;AP-1 Inhibitors;Apoptosis Inducers;Cyclooxygenase-2 Inhibitors;NF-kappaB (NFKB) Activation Inhibitors
BB-84-DG64	VMXJXAKTOFJSGO-IBGZPJMESA-N	COC[C@@H]1CCCN1c1ncc(C(F)(F)F)cc1CN(Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1nnn(C)n1		
BA-46-AB67	VMXUWOKSQNHOCA-UKTHLTGXSA-N	CN/C(=C\\[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1	128345-62-0	Histamine H2 Receptor Antagonists
AE-90-RS19	VMZMNAABQBOLAK-DBILLSOUSA-N	NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O	396091-73-9	Somatostatin SRIF1B (sst5) inhibitor
AF-48-FX20	VNFPBHJOKIVQEB-UHFFFAOYSA-N	Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1	117829-71-7	Intermediate Conductance K(Ca) 3.1 (IKCa1;Gardos channel, SK41, IK1) Channel Blockers;Lanosterol 14alpha-demethylase Inhibitors;Angiogenesis Inhibitors
EF-75-JG46	VNICFCQJUVFULD-UHFFFAOYSA-N	c1ccc2c(N3CCNCC3)cccc2c1	104113-71-5	
GA-16-IU17	VOASEWXFCTZRDF-UHFFFAOYSA-N	COc1c(C)cnc(Cn2cc(C#CCC(C)(C)O)c3c(Cl)nc(N)nc32)c1C	911397-80-3	Hsp90 inhibitor
CE-77-JB44	VODUCDWVPSEMSZ-UHFFFAOYSA-N	CN1CCN(C(=O)C2CCN([S@SP3](=O)(=O)c3ccc(NCC(c4ccccc4)c4ccccc4)c(C(=O)N4CCOCC4)c3)CC2)CC1	312722-60-4	Bradykinin B1 Antagonists
XA-40-AD40	VOEDRUGFNJEWGQ-VMPITWQZSA-N	COC(=O)C/C=C/c1ccccc1	24891-74-5	
FF-89-KK36	VOEWWLDOPMSCGF-CGIBVWHJSA-N	COC(=O)Nc1ccc(-c2cc([C@H](CC(=O)OC(C)(C)C)NC(=O)/C=C/c3cc(Cl)ccc3-n3cnnn3)n[nH]c2=O)cc1	1187647-57-9	Known FactorXI inhibitor
AC-50-TU13	VOJUXHHACRXLTD-UHFFFAOYSA-N	O=C(O)c1cc(O)c2ccccc2c1O	31519-22-9	Tau Aggregation Inhibitors
CC-42-ZV45	VOROEQBFPPIACJ-BYPYZUCNSA-N	N[C@@H](CCCP(=O)(O)O)C(=O)O		
EA-39-WW34	VOROEQBFPPIACJ-SCSAIBSYSA-N	N[C@H](CCCP(=O)(O)O)C(=O)O	76326-31-3	NMDA Antagonists
SF-48-KT63	VORWCQRDADUXEU-UHFFFAOYSA-N	NS(=O)(=O)Nc1ccc(S(N)(=O)=O)cc1		
AD-55-HH69	VOSNNSVWVJFJCR-UHFFFAOYSA-N	O=C(C(=O)c1ccccc1Cl)c1ccccc1Cl	21854-95-5	Carboxylesterase Inhibitors
AA-14-DQ28	VOXZDWNPVJITMN-ZBRFXRBCSA-N	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O		
EE-16-RH01	VOYCNOJFAJAILW-CAMHOICYSA-N	CSCC[C@H](N)C(=O)N[C@@]1(C(=O)O)CS(=O)(=O)[C@H]2[C@H](C(=O)O)[C@H]21	1026791-63-8	mgluR2 Agonists;mgluR3 Agonists
PA-25-OV46	VOZMMIFGJRFSNT-ZHACJKMWSA-N	Cc1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(N)=O)cc1		
ID-07-YY69	VOZQNHXBROFVMB-UHFFFAOYSA-N	CCc1nnc(NC(=O)CSc2nc(N)nc(SC)c2C#N)s1	339156-78-4	
HB-49-VZ71	VPBYZLCHOKSGRX-UHFFFAOYSA-N	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl	286370-15-8	Angiogenesis Inhibitors;Inhibitors of Signal Transduction Pathways;VEGFR-2 (FLK-1/KDR) Inhibitors;Angiogenesis Inhibitors;Inhibitors of Signal Transduction Pathways;VEGFR-2 (FLK-1/KDR) Inhibitors
FD-05-QX72	VPCWGBLXOCIIMU-WCQYABFASA-N	Nc1nccc(Sc2cnc(N3CCC4(CC3)C[C@@H](O)C[C@H]4N)cn2)c1Cl		SHP2 inhibitor
KF-18-RY71	VPEOEBSAJZUAHP-UHFFFAOYSA-N	Cc1cnc(Nc2cccc(S(C)(=O)=O)c2)nc1-c1cccc2[nH]ccc12	1036033-55-2	CDK gene inhibitor
S0-EE-X3XU	VPHJABWIKCBGMC-UHFFFAOYSA-N	CCCCN1CCC(N(Cc2ccccc2)C(=O)Nc2ccc(Cl)c(Cl)c2)CC1		
OB-41-EW79	VPHPQNGOVQYUMG-UHFFFAOYSA-N	COc1cccc(N(C)C(=S)Oc2ccc3c(c2)CCCC3)n1	88678-31-3	Fungal Squalene Monooxygenase Inhibitors
AD-90-PA45	VPJXQGSRWJZDOB-UHFFFAOYSA-O	C[N+](C)(C)CCOC(N)=O	2260-51-7	Cholinergics
GA-23-VF89	VPRPMBXDNMGHMB-UHFFFAOYSA-N	CCc1ccc(S(=O)(=O)c2nnn3c2nc(NC(C)C)c2sccc23)cc1		
AF-73-HJ84	VPXHZKTZYQIZFD-NYVOZVTQSA-N	O=C(NCc1cccnc1)[C@@H]1[C@H]2C[C@H]2CN1C(=O)NCc1cccc2ccc(Cl)cc12	1093652-33-5	Kallikrein-related Peptidase 7 (KLK7) Inhibitor
AC-59-ZD79	VQAYFKKCNSOZKM-IOSLPCCCSA-N	CNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		
ZD-93-FI44	VQHKDCUXFKNNMT-ODCIPOBUSA-O	CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1	202796-41-6	CCR3 antagonist
EB-34-KW22	VQHUQHAPWMNBLP-UHFFFAOYSA-N	COP(=O)(OC)OC(c1ccc(Cl)cc1)P(=O)(OC)OC	76541-72-5	PPARgamma Antagonists
FB-49-NW04	VQQRBBFRJRBWPF-UHFFFAOYSA-N	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4ccnc(N)n4)cc3)cc2C(F)(F)F)CC1	853299-52-2	Flt3 (FLK2/STK1) Inhibitors
DB-86-XL71	VQQVWGVXDIPORV-UHFFFAOYSA-N	O=C1c2ccccc2-n2c1nc1ccccc1c2=O	13220-57-0	5-Lipoxygenase Inhibitors;Hepatocyte Growth Factor (HGF) Antagonists;Cyclooxygenase-2 Inhibitors
JD-95-WC21	VQTHMGSYEABTGU-UHFFFAOYSA-N	O=c1c2ccccc2nc(-c2ccccc2O)n1CCc1ccccc1	691378-24-2	Calcium-Sensing Receptor (CaSR) Antagonists;Parathyroid Hormone Secretion Stimulants
DC-28-NF06	VRBKIVRKKCLPHA-UHFFFAOYSA-N	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	82752-99-6	5-HT2A Antagonists;5-HT Reuptake Inhibitors;ADRA1B gene modulator
BD-81-LB65	VRQMAABPASPXMW-HDICACEKSA-N	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@@H](C)N[C@@H](C)C4)cc3)[nH]n2)cc(OC)c1	1035270-39-3	FGFR1 gene inhibitor
IC-79-JZ26	VRUAXQODZDRLMI-UHFFFAOYSA-N	NC(=O)c1sc(-c2ccc(F)cc2)cc1N		
UA-20-YK17	VRUHOUHYPBCHJF-DVOMOZLQSA-N	C[C@@H]1CN(C(=O)[C@@](C)(O)C(F)(F)F)[C@@H](C)CN1Cc1ccccc1		Pyruvate Dehydrogenase Kinase (PDHK;PDK) Inhibitors
FD-86-NE74	VRVJKILQRBSEAG-LFPIHBKWSA-N	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CREBBP/ EP300 KAT inhibitor
VA-48-RJ44	VRYZCEONIWEUAV-UHFFFAOYSA-N	Cc1cc(C)cc(C(=O)NOCCCCCC(=O)NO)c1	1418033-25-6	HDAC 4/5
BE-31-XV38	VSJKWCGYPAHWDS-FQEVSTJZSA-N	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1	72517-83-0	topoisomerase I
AB-47-BS00	VSNHCAURESNICA-UHFFFAOYSA-N	NC(=O)NO	127-07-1	Nitric oxide donor;Ribonucleoside-Diphosphate Reductase Inhibitors;Antimetabolites
LF-85-QP07	VSOXJMQZOPRPGI-UHFFFAOYSA-N	Cc1sc2ncnc(SCC(=O)O)c2c1C	296262-16-3	Palmitoleoyl-Protein Carboxylesterase NOTUM Inhibitors
AB-71-UV73	VSQILWJHLPJYGP-ZDUSSCGKSA-N	N[C@@H](CC(=O)O)Cn1nnc(-c2ccc(Oc3ccc(Cl)cc3)cc2)n1		inhibitor of leukotriene A4 hydrolase
CF-61-EH59	VSWBSWWIRNCQIJ-HUUCEWRRSA-N	CN1C[C@@H]2c3ccccc3Oc3ccc(Cl)cc3[C@H]2C1	1412458-61-7	Dopamine D1 Antagonists;Dopamine D2 Antagonists;5-HT2 Antagonists
DB-78-NM13	VSWPGAIWKHPTKX-UHFFFAOYSA-N	Cc1scc2c1N(C(=O)CN1CCN(C)CC1)c1ccccc1NC2=O	127519-18-0	CHRM1 antagonist
DB-24-CQ08	VSXMVEPPUGCFEO-UHFFFAOYSA-N	OCc1cn(Cc2cccnc2)c2ccccc12		
CD-84-BU23	VSZGPKBBMSAYNT-RRFJBIMHSA-N	CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1		
CE-03-PW65	VTAARTQTOOYTES-RGDLXGNYSA-N	N[C@@]1(C(=O)O)CC[C@H]2[C@H](C(=O)O)[C@H]21	176199-48-7	GRM2 agonist;GRM3 agonist
CB-31-UO16	VTGBZWHPJFMTKS-UHFFFAOYSA-N	CCc1ccc(OCc2ccccc2C(=O)Nc2ccc3nc(C)cc(N)c3c2)cc1	244218-51-7	OPRL1 gene inhibitor;OPRM1 gene inhibitor
BF-04-NQ13	VTLDSEYLZYWTPA-UHFFFAOYSA-N	CC1(C)CCc2cc(OC(=O)c3ccccc3)c(N3CC(=O)NS3(=O)=O)cc2C1		
DA-01-GV68	VUFJQKBHTFYYMV-SIKRGNPESA-N	CCOCc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@H](O)[C@@H](C)C3)ccc2F)c(F)c1		
LE-81-PG11	VUIITYLFSAXKIQ-UHFFFAOYSA-N	CNCCN1CCC(c2cc(CN(C)C(=O)c3cccc(Oc4ccccc4)c3)ccn2)CC1		inhibitor of PRMT4
AC-67-TM11	VUIRVWPJNKZOSS-UHFFFAOYSA-N	Cc1cnc(-c2ccccc2C(C)C)nc1NCc1ccc(-n2ccnn2)cc1	1572414-83-5	USP1–UAF1 inhibitor
AC-05-MR83	VUUCDNZACXXJSO-UHFFFAOYSA-N	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4c(F)cccc4F)s3)cc2)CC1	223784-70-1	CDK4 Inhibitors
AF-30-GH67	VUVUVNZRUGEAHB-CYBMUJFWSA-N	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12	1300031-49-5	BRD2/3/4/T BET familiy inhibitor;BRD4 gene inhibitor
GD-72-XO18	VVOXDJYPDCSQMI-UHFFFAOYSA-N	CC1(C)Oc2cc(O)ccc2C2C1=CCn1c(=O)n(-c3ccccc3)c(=O)n12	908568-01-4	HMGB2 gene inhibitor
ME-16-XW76	VVSOHUNZJUMVHS-UHFFFAOYSA-N	O=C(CCCN1CCC(NC(=O)c2ccccc2)CC1)c1ccccc1	57368-81-7	alpha1-Adrenoceptor Antagonists
S0-EE-YEKU	VVWGPQZBDQVQRC-RMKNXTFCSA-N	O=C(/C=C/c1cncc(F)c1)c1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		EIF4G gene inhibitor
S0-EE-Y6LH	VVZZHFMLRHJXTO-RXVVDRJESA-N	Cc1cnc(C(=O)N[C@H]2CCOC[C@@H]2O)cc1Cc1ccc(-c2cscn2)cc1		M1 postive allosteric modulator
BE-92-TW08	VWAGKEVPPOVJMV-GEVRCRHISA-N	CC1=C(C#N)C(/C=N/N(C)c2ncc(C(F)(F)F)cc2Cl)CC(=O)N1		Niemann-Pick C1-like protein 1 (NPC1L1) Inhibitors;ABCA1 Expression Inhibitors;HMGCS2 Expression Enhancers;Cholesterol Absorption Inhibitors
EB-28-ZJ41	VWFCHDSQECPREK-LURJTMIESA-N	Nc1ccn(C[C@@H](CO)OCP(=O)(O)O)c(=O)n1		
MD-09-FE75	VWIWOPFCNLLGBQ-UHFFFAOYSA-N	[O-][S+](CC1(O)CCN(CCc2c[nH]c3ccc(F)cc23)CC1)c1ccccc1		TACR2 antagonist
CB-80-CK24	VWSFKHFDPRSPLA-UHFFFAOYSA-N	Cc1nc(NCc2ccco2)c2c3c(sc2n1)CCC3		
ZE-13-SI09	VWVYLBIQWASACG-UHFFFAOYSA-N	NC(CC1CCCCC1)P(=O)(O)O	137619-55-7	Leucine Aminopeptidase inhibitor
S0-EE-Y96T	VWWVDRUMIVMLNJ-HNNXBMFYSA-N	CCCn1c(NC(=O)[C@H]2CCCN(c3cnccn3)C2)nc2ccccc21		Selective allosteric inhibitor for HSPA1A/Hsp70i
AF-19-KN63	VWXRQYYUEIYXCZ-OBIMUBPZSA-N	CCOc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1	90779-69-4	Oxytocin (OT) Antagonists
LB-68-SH80	VXDAVYUFYPFGDX-ATFAPYMMSA-N	CC(=O)N1C[C@H](O)C[C@H]1C(=O)NC(CCCNC(=N)N)C(=O)c1nc2ccccc2s1	287182-52-9	Trypsin Inhibitors;Tryptase Inhibitors
FE-21-KA82	VXDKQRWTOJFQKH-BJZITVGISA-N	O=C(C[C@@H](Cc1cccc(O)c1)C(=O)N[C@H]1c2ccccc2C[C@H]1O)NO		Aggrecanase Inhibitors
BC-32-DI69	VXHFXQCYIMKVIG-UHFFFAOYSA-N	CC(C)c1oc2c3c(ccc2c(=O)c1-c1ccc(Cl)cc1)NCCO3		
JB-63-NV02	VXMOONUMYLCFJD-XADRRFQNSA-N	COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@H]2CCN(Cc3ccccc3)C2)C1c1cccc([N+](=O)[O-])c1		
CE-70-KX45	VYCMAAOURFJIHD-PJNXIOHISA-N	CC(C)C[C@@H]1NC(=O)[C@@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC1=O	136553-81-6	Endothelin ETA Receptor Antagonists
MD-51-EC81	VYOCYWDJTQRZLC-KCDKBNATSA-N	C[C@@H]1NC[C@@H](O)[C@H](O)[C@@H]1O	210174-73-5	
FB-52-MO63	VYUMPVZHBZSNFA-SFGWMHHMSA-N	CS(=O)(=O)N[C@H](CCC1CCNCC1)C(=O)N1C[C@H](OCc2ccc(Cl)cc2)C[C@H]1C(=O)N[C@@H](CCCCN)C(=O)c1nc2ccccc2o1	959423-27-9	trypsin inhibitor;Matriptase (ST14) inhibitor;Plasma Kallikrein (KLKB1) inhibitor;Prostasin (PRSS8) Inhibitor
JF-84-QZ64	VYXPSMUFCGRWJC-UHFFFAOYSA-N	CC(C)(O)C(O)Cc1cc(O)ccc1O	171812-79-6	Neutral Sphingomyelinase (N-SMase) Inhibitors;Antiinflammatory Drugs
HE-34-NJ16	VYYRFBRPGFAPCM-UHFFFAOYSA-N	FC(F)(F)c1ccc2c(c1)N(CCCN1CCNCC1)c1ccccc1S2	2804-16-2	Apoptosis Inducers;Caspase 3 Activators;Caspase 8 Activators;Caspase 9 Activators;Serotonin Antagonists
KE-28-DL25	VYZAPHKISNXMSJ-UHFFFAOYSA-N	COC(=O)c1ccc(Cn2c(=O)c(=O)n(C(C)C)c3ccc(C(F)(F)F)cc32)cc1		Phosphodiesterase PDE4B Inhibitors
LB-58-KL25	VZAFGXCWAWRULT-UONOGXRCSA-N	CN1C[C@H](Nc2cnn(C)c(=O)c2Br)C[C@H](c2ccccc2)C1		KAT2A, KAT2B inhibitor
AC-74-BQ48	VZGHGFHSYRBRMS-UHFFFAOYSA-N	COc1cc(C(=O)N(C(C)C)C(C)C)ccc1OCCCCCOc1ccc(C(=N)NC(=O)c2ccccc2)cc1	146978-29-2	Leukotriene Antagonists;Leukotriene BLT (LTB4) Antagonists;Non-Steroidal Antiinflammatory Drugs;Leukotriene Antagonists;Leukotriene BLT (LTB4) Antagonists;Non-Steroidal Antiinflammatory Drugs
HC-26-PX74	VZHSVWPBQJLEAE-AREMUKBSSA-N	Cc1oc(-c2ccc(Cl)cc2)nc1COc1cccc(C(C)(C)C(=O)N2c3ccccc3C[C@@H]2C(=O)O)c1		
BD-80-SK69	VZJHQHUOVIDRCF-UHFFFAOYSA-N	CC1(C)CCCC2(C)C(CO)C3CCC2C31	1139-17-9	UGT2B7 gene inhibitor
WF-20-QN39	VZMLEMYJUIIHNF-QURGRASLSA-N	CCC(=O)Oc1ccc(/C(CC)=C(\\CC)c2ccc(OC(=O)CC)cc2)cc1	130-80-3	Estrogen Receptor Agonist
GD-07-UH23	VZWSTBKRBWNPMR-UHFFFAOYSA-N	CC(C)c1ccc(OCC(=O)Nc2ccccc2C(=O)O)cc1		Nicotinic Acid (Niacin;GPR109A;HM74A) Receptor Agonists
CB-69-DJ58	VZXMZMJSGLFKQI-ABVWVHJUSA-N	O=C(O)[C@H]1CN(C/C=C/P(=O)(O)O)CCN1	117414-74-1	NMDA Antagonists
AE-36-GL26	VZYBFPCKRNEWKJ-UHFFFAOYSA-N	O=C(Nc1ccc2ccccc2n1)c1ccc2cc(-c3c(Cl)cccc3Cl)[nH]c2c1		
XC-61-SE50	WAAWETUDFSIYSD-UHFFFAOYSA-N	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1	1240308-45-5	selective agonist of sphingosine-1-phosphate receptor 5 (S1PR5)
FF-06-MO73	WAEXFXRVDQXREF-UHFFFAOYSA-N	O=C(CCCCCCC(=O)Nc1ccccc1)NO	1227736-21-1	HDACs;Apoptosis Inducers;Histone Deacetylase 1 (HDAC1) Inhibitors;Histone Deacetylase 2 (HDAC2) Inhibitors;Histone Deacetylase 6 (HDAC6) Inhibitors;Histone Deacetylase 3 (HDAC3) Inhibitors;Inhibitor;HDACs;Apoptosis Inducers;Histone Deacetylase 1 (HDAC1) Inhibitors;Histone Deacetylase 2 (HDAC2) Inhibitors;Histone Deacetylase 6 (HDAC6) Inhibitors;Histone Deacetylase 3 (HDAC3) Inhibitors;Inhibitor
AB-17-DF74	WAFJKVGCIWVHQC-UHFFFAOYSA-N	O=C(CCCCCc1ccc(-c2ccccc2)cc1)OCc1ccc2c(c1)OCO2	1643657-35-5	Monoacylglycerol Lipase inhibitor
DA-11-GV88	WAFNZAURAWBNDZ-UHFFFAOYSA-N	CCCCCCCCCCC(C)(C)C(=O)Nc1c(OC)cc(OC)cc1OC	114289-47-3	ACAT Inhibitors
S0-EE-YNU4	WALDOGJQTYJBFG-AATRIKPKSA-N	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(CN3CCOCC3)n2)ccc2[nH]ccc12		PKC theta inhibitor
AF-71-GL94	WAOBCCBUTHNTFO-UHFFFAOYSA-N	Cc1ccc(Cl)cc1N(CC(=O)Nc1c(F)cccc1F)S(C)(=O)=O		
MC-69-RB13	WAOQONBSWFLFPE-VIFPVBQESA-N	CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC	104953-11-9	Dopamine D2 Antagonists;Dopamine D3 Antagonists
GB-94-XG34	WAPBQFRODQBNJI-UHFFFAOYSA-N	COc1ccc2nc(-c3cccs3)nc(NN3C(=O)C=C(C)C3=O)c2c1		AP-1 Inhibitors;Cytokine Production Inhibitors;NF-kappaB (NFKB) Activation Inhibitors
CB-37-NM86	WAPUAZWMCBAXGP-UHFFFAOYSA-N	Cn1nc(-c2ccc(C(=O)N3CCC(O)CC3)s2)cc1C(F)(F)F	947540-06-9	Novel and Selective Monoamine Oxidase B Inhibitors
AF-19-OG56	WAZOFYYWAQHTQZ-UHFFFAOYSA-N	C=CC(=O)Nc1ccc(S(=O)(=O)N2CCN(C(=O)C3CCCC3)CC2)cc1	1306720-78-4	Tissue transglutaminase inhibitor
BC-14-CG34	WBBVZYXTIGTZTN-UHFFFAOYSA-N	CC(C)Oc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)NC2CCC2)n1		
NA-30-HS87	WBKCKEHGXNWYMO-UHFFFAOYSA-N	CCOC(=O)CCNc1cc(N2CCc3ccccc3CC2)nc(-c2ccccn2)n1	1373423-53-0	pan-KDM6 family (KDM6A / KDM6B / UTY);Histone demethylation inhibitors;KDM6A gene inhibitor, KDM6B gene inhibitor
RD-35-DE45	WBLVOWHFRUAMCP-UHFFFAOYSA-N	COc1ccc(C(=O)NCc2cc(C(C)C)no2)cc1OC1CCN(C)CC1	1649450-12-3	SLC5A7 gene inhibitor
AA-29-ZN08	WBQNJPBYOGNEQC-UHFFFAOYSA-N	CCn1nnc(CCNC(=O)Nc2nc(C)c(-c3ccc(S(C)(=O)=O)c(F)c3)s2)n1		Phosphatidylinositol 3-Kinase gamma (PI3Kgamma) Inhibitors
GA-53-SC22	WBWFIUAVMCNYPG-BQYQJAHWSA-N	Cn1c(=O)c2c(nc(/C=C/c3cccc(Cl)c3)n2C)n(C)c1=O	147700-11-6	Adenosine A2A Antagonists;MAO-B Inhibitors
DF-11-IL69	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N	Nc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c[nH]c2[nH]1	1006872-74-7	de novo synthesis inhibitor;Antimetabolites;DHFR inhibitor
RF-57-OJ02	WBYNZQXAAWPAGR-UHFFFAOYSA-N	CC(C)Oc1cc(Cl)ccc1CNc1cc(-c2ccccc2)nc2ncnn12		GPR3 inverse agonist
S0-EE-Y97N	WCDLCPLAAKUJNY-UHFFFAOYSA-N	c1cc(N2CCOCC2)ccc1-c1cnc2c(-c3cn[nH]c3)cnn2c1	1435615-18-1	ALK2 inhibitor
FD-46-HV00	WCGUUGGRBIKTOS-PDADFLJVSA-N	C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CCC4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12		
EF-64-HJ41	WCGXJPFHTHQNJL-UHFFFAOYSA-N	CCc1cc(C(C)=O)c(O)cc1OCCCCCC(C)(C)c1nn[nH]n1	117690-79-6	LTB4R2 antagonist
AD-31-PI82	WCIGMFCFPXZRMQ-UHFFFAOYSA-N	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1	1285515-21-0	LRRK2 gene inhibitor
BE-87-TM66	WCJRDLYNOVMUTE-UHFFFAOYSA-N	COCCn1cc(C(=O)N2CCC(c3cc(CN)ccc3F)CC2)c2c(OC(F)(F)F)ccc(F)c21	1208976-99-1	Known Tryptase inhibitor
FC-52-RL51	WCQNUEKQADFUPV-UHFFFAOYSA-N	COc1nn2cc(-c3c(CO)n(Cc4ccccc4Cl)c4ccc(OC(F)(F)F)cc34)nc2s1		PAR4 antagonist
PA-93-BD53	WCUZTSOTIQHYNL-UFYCRDLUSA-N	CC[C@H](N)C(=O)NNC(=O)N[C@@H](CCc1ccccc1)C(=O)N[C@@H](Cc1cccc(F)c1)C(N)=O		Cathepsin C (Dipeptidyl Peptidase I) Inhibitors
CB-32-EI69	WDDPHFBMKLOVOX-AYQXTPAHSA-N	Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F	123318-82-1	DNA Polymerase Inhibitors;Ribonucleoside-Diphosphate Reductase Inhibitors
DC-02-OP01	WDEABJKSGGRCQA-UHFFFAOYSA-N	CC1=C(C)C(=O)C(CCCCC#CCCCC#CCO)=C(C)C1=O	80809-81-0	Lipoxygenase Inhibitors
JB-41-UN43	WDGJSLVWUQWGTB-CDZUIXILSA-N	Nc1ccc(C[C@H](NS(=O)(=O)c2cnccc2N[C@@H](Cc2ccccc2)CN2CCOCC2)C(=O)N2CCC(CCF)CC2)cc1		Inhibitors of Blood Coagulation Pathways;Thrombin Inhibitors
EB-85-JN83	WDHCLDUKGHLEOU-MRXNPFEDSA-N	NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1		
KE-18-XY06	WDKXLLJDNUBYCY-UHFFFAOYSA-N	CNCCc1ccc(OC(=O)C(C)C)c(OC(=O)C(C)C)c1	66195-31-1	Dopamine D1 Agonists
JF-62-LU77	WDPFJWLDPVQCAJ-UHFFFAOYSA-N	CCN(CC)CCN(Cc1ccc(-c2ccc(C(F)(F)F)cc2)cc1)C(=O)Cn1c(SCc2ccc(F)cc2)nc(=O)c2c1CCC2	356057-34-6	Lipoprotein Associated Phospholipase A2 (Lp-PLA2) Inhibitors
AE-05-HA92	WDQGZGQWBRMQPY-UHFFFAOYSA-N	CN1CCN(C2=Nc3ccccc3Cn3c2cc2ccccc23)CC1	101226-25-9	GnRH (LHRH) Antagonists;Mediator Release Inhibitors
OD-03-CA36	WDWWXLHZTZFIDA-UHFFFAOYSA-N	C=CC(=O)Nc1ccc2ncn(-c3cncc(Nc4c(C)cccc4Cl)n3)c2c1		
JE-27-XK20	WDZCUPBHRAEYDL-GZAUEHORSA-N	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\\C=C\\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C	61379-65-5	DNA-Directed RNA Polymerase Inhibitors
NF-64-RE03	WECRLAZSZWCWDE-UHFFFAOYSA-N	CCCCCCCCOc1c(Br)cc(CNCCCP(=O)(O)O)cc1OC		Lysophospholipid edg1 (S1P1) Receptor Agonists;Lysophospholipid edg8 (S1P5) Receptor Agonists
EA-00-RN06	WEOIHIYCKWSSBW-UHFFFAOYSA-N	N=C(N)/N=C(\\N)Nc1cccc([N+](=O)[O-])c1	10441-20-0	5-HT3 receptor agonist
FE-36-XA09	WEUJYFZQFFQFND-UHFFFAOYSA-N	Nc1n[nH]c2nc(N3CCCCC3)c3c(c12)CCN(Cc1ccccc1)C3	371227-84-8	ADAM17 (TNF-alpha-Converting Enzyme (TACE) Inhibitors);MMP-13 (Collagenase 3) Inhibitors;MMP-1 (Interstitial Collagenase) Inhibitors;MMP-2 (Gelatinase A) Inhibitors;MMP-3 (Stromelysin 1) Inhibitors;MMP-9 (Gelatinase B) Inhibitors;BRS3 agonist
FE-76-CA29	WEVYNIUIFUYDGI-UHFFFAOYSA-N	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1	778270-11-4	Bcr-Abl Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Bcr-Abl Kinase Inhibitors;Inhibitors of Signal Transduction Pathways
QA-81-IM40	WEXCGGWTIDNVNT-UHFFFAOYSA-N	COc1cc2nc(N3CCCC3)nc(NCCCCCN3CCCC3)c2cc1OC	1620401-82-2	
ZD-85-ID22	WEXZHJRBQNKEKT-UHFFFAOYSA-N	Oc1c(F)cc(-c2cnccc2-c2ccc(F)cc2)cc1F		
S0-EE-YEL3	WFDHLKUQFQCHKF-UHFFFAOYSA-N	CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CNC(=O)c5cccc(F)c5)cc4)c3n2)c1	1313880-28-2	allosteric AKT inhbitor
AD-53-VC77	WFJQCQNBWDAYSK-AWEZNQCLSA-N	C[C@H]1Cc2c(ncnc2Oc2ccc3c(ccn3C(=O)Nc3cc(C4(C)CC4)[nH]n3)c2)CN1	1229450-18-3	VEGFR-2 (FLK-1/KDR) Inhibitors
MC-92-JU67	WFLMIJKKTIOYSO-UHFFFAOYSA-N	C=CCc1c(N(C)c2ccc(C(=O)O)cc2)nc(-c2ccccc2)nc1C(F)(F)F		
BF-61-BY15	WFMNAESJUUOVOL-RBZFPXEDSA-N	C[C@H]1[C@H](Oc2ccc(-c3ccc4[nH]ccc4c3)nn2)C2CCN1CC2		
JC-99-EF33	WFOVEDJTASPCIR-UHFFFAOYSA-N	Cn1c(CNc2cccc(C(=O)NCc3ccccc3C(F)(F)F)c2)nnc1-c1ccncc1		beta adrenergic receptor kinase 1 and 2
CD-80-ZD47	WFPUBEDBBOGGIQ-UHFFFAOYSA-N	Clc1ccc2c(c1Cl)CNCC2	57987-77-6	
JA-17-JV87	WFWLQNSHRPWKFK-UHFFFAOYSA-N	O=c1[nH]c(=O)n(C2CCCO2)cc1F	1189456-27-6	Cytochrome P450 CYP2A6 inhibitor
EE-77-XO60	WFZVSYFCDKGJEM-CRAIPNDOSA-N	CN1CC(CSc2nc3cccnc3s2)=C[C@@H]2Cc3c(O)cccc3C[C@H]21		
PE-49-CB03	WGABOZPQOOZAOI-UHFFFAOYSA-N	COc1cc(C(=O)N(CCCc2ccccc2)Cc2ccc(CC(=O)O)cc2)cc(OC)c1C		LPA1 antagonist
AE-73-KX58	WGFOBBZOWHGYQH-MXHNKVEKSA-N	CCCCC(F)(F)[C@@]1(O)CC[C@H]2[C@@H](CC(=O)[C@@H]2CCCCCCC(=O)O)O1	136790-76-6	ClC-2 Channel Activators
MB-53-WO35	WGGYUVUKVGFUEL-QHCPKHFHSA-N	CC(C)C(=O)N1CCN(c2nc(NC3COC3)cc(C(=O)NC[C@H](O)CN3CCc4ccccc4C3)n2)CC1	1616395-11-9	PRMT5 inhibitor
EA-61-RR63	WGJYLOIXFLBOHT-UHFFFAOYSA-N	O=C(O)CCc1cc(Cl)c(-c2nc3ccc(C(=O)Nc4ccc5ccccc5n4)cc3[nH]2)c(Cl)c1	1189057-31-5	Diacylglycerol Acyltransferase type 1 (DGAT-1) Inhibitors
JA-85-CW09	WGUCZWYLSKPURM-UHFFFAOYSA-N	CNc1nc(SC)ncc1C=O	185040-32-8	CDK Inhibitors
KC-26-JQ92	WHMXDBPHBVLYRC-OFVILXPXSA-N	CC(C)Oc1ccc(C(=O)N[C@H](CNC(=O)CN(C)C)Cc2ccc(-c3cn4cccc([C@H](C)O)c4n3)cc2)cc1Cl	1088965-37-0	Centromere protein E inhibitor
BD-69-GX17	WHSIXKUPQCKWBY-IOSLPCCCSA-N	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	24386-93-4	Adenosine kinase inhibitor
AA-46-GL76	WHTVZRBIWZFKQO-UHFFFAOYSA-N	CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12	117399-83-4	Thiamine uptake inhibitor;Apoptosis Inducers;Thiamine uptake inhibitor;Apoptosis Inducers
IC-98-UO17	WHUUTDBJXJRKMK-GSVOUGTGSA-N	N[C@H](CCC(=O)O)C(=O)O	11070-68-1	
IF-31-RN78	WHXMKTBCFHIYNQ-SECBINFHSA-N	C[C@@H]1CC(=O)NN=C1c1ccc(NN=C(C#N)C#N)cc1	131741-08-7	Troponin C slow skeletal muscle stabilizer;Calcium sensitizer;K(ATP) Channel Activators;Nitric Oxide (NO) Production Inhibitors
LC-57-RH78	WIGIZIANZCJQQY-RUCARUNLSA-N	CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O	93479-97-1	K(ATP) Channel Blockers
CA-00-AR16	WILMXUAKQKGGCC-DJKKODMXSA-N	CC(Sc1nc2ccccc2[nH]1)C(=O)N/N=C/c1cc(Br)ccc1O	330676-02-3	soluble adenylyl cyclase inhibitor
BB-09-GD09	WINHZLLDWRZWRT-ATVHPVEESA-N	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\\C(=O)Nc3ccc(F)cc32)c1C	1126641-10-8	
BF-44-HD37	WIQRRFQGIHYYTD-UHFFFAOYSA-N	Cc1cc2c(cn1)cc(-c1cc(Nc3noc(-c4ccc(Cl)cc4)n3)ccc1C)c(=O)n2C	1185279-60-0	PDGFRalpha Inhibitors;PDGFRbeta Inhibitors;KIT (C-KIT) Inhibitors;Angiogenesis Inhibitors
AE-15-HA32	WJBHHTPFTVKZCV-CVEARBPZSA-N	CC1(C)Oc2ccc(C#N)cc2[C@@H](OC2=CC(=O)CC2)[C@@H]1O		
NC-52-HX69	WJBLNOPPDWQMCH-MBPVOVBZSA-N	C=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5	1228646-70-5	kappa-Opioid Antagonists
BC-15-MR23	WJEOLQLKVOPQFV-UHFFFAOYSA-N	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1	790299-79-5	Inhibitors of Signal Transduction Pathways;FGFR3 Inhibitors;KIT (C-KIT) Inhibitors;Angiogenesis Inhibitors
IC-37-QU39	WJIGGYYSZBWCGC-MRXNPFEDSA-N	NCC[C@@H](O)c1cccc(OCC2CCCCC2)c1	1141777-14-1	Retinoid Isomerohydrolase (RPE65) Inhibitors
RB-48-AN54	WJQBOBGVBBZLJU-HNNXBMFYSA-N	O=C(N[C@H]1CCCc2c1[nH]c1ccc(Cl)cc21)c1ccccn1		
RD-64-KA33	WJQBOBGVBBZLJU-OAHLLOKOSA-N	O=C(N[C@@H]1CCCc2c1[nH]c1ccc(Cl)cc21)c1ccccn1	827591-02-6	Inhibitor of pyrimidine biosynthesis
WD-75-LK69	WJSPZKYFHWWSDK-OAQYLSRUSA-N	N#Cc1ccc(-c2cnc3ccc(N4CCCC[C@@H]4c4cccc(F)c4)nn23)cc1		
NB-17-SQ59	WJUGGKGTCAVATA-UHFFFAOYSA-N	C1=C(c2ccc(CN3CCCCC3)cc2)N2CCN=C2c2ccccc21	115621-95-9	Platelet-Activating Factor Receptor (PAFR) Antagonists
DE-97-IV02	WJUNQSYQHHIVFX-UHFFFAOYSA-N	CCNC(=O)c1cc2c(-c3cc(OCCN4CCCC4)c(Cl)cc3Cl)nc(N)nc2s1	847559-80-2	Heat Shock Protein 90 (hsp90) Inhibitors
DA-40-HO94	WJVYZVMUDBIEES-CYBMUJFWSA-N	C[C@@H]1Cn2ncc(C3CCN(S(C)(=O)=O)CC3)c2CN1c1cc(Cl)nc2[nH]ccc12		ATR gene inhibitor
GF-58-OL90	WJXSWCUQABXPFS-UHFFFAOYSA-N	Nc1c(O)cccc1C(=O)O	4920-81-4	Aldehyde Dehydrogenase Inhibitor
AD-91-LE02	WKGXYQFOCVYPAC-UHFFFAOYSA-N	NC(=O)OCC(COC(N)=O)c1ccccc1	1177501-39-1	GABA(A) Receptor Modulators
HD-89-HC56	WKKAVTNXNVPCCN-HSZRJFAPSA-N	O=C(c1cnn2cc(Br)ccc12)N1CCN(C(=O)c2ccc(Br)cc2)[C@@H](c2ccc(Cl)cc2)C1		
AA-24-UO04	WKNFADCGOAHBPG-UHFFFAOYSA-N	CN1CCC(c2c[nH]c3ccc(O)cc23)CC1	1197333-54-2	HTR1E agonist;HTR1F agonist
BC-94-GN01	WKSAUQYGYAYLPV-UHFFFAOYSA-N	CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1	19085-09-7	Pharmacological Chaperones;Dihydrofolate Reductase (DHFR) Inhibitors
EB-56-HU77	WKSHMJCYWFOADB-UHFFFAOYSA-N	CN(C(=O)Oc1nsnc1N1CCOCC1)C1CCCCCCC1		ABHD6 Inhibitor
AF-89-AD94	WKZLNEWVIAGNAW-UHFFFAOYSA-N	NCCc1c[nH]c2ccc(C(N)=O)cc12	74885-09-9	
GD-98-WZ24	WLJNZVDCPSBLRP-UHFFFAOYSA-N	O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O	108626-78-4	G Protein-Coupled Receptor GPR35 Agonists
GA-79-DW49	WLKOCYWYAWBGKY-CPNJWEJPSA-N	CCN(CC)c1ccc(/C=N/NC(=O)c2ccc(O)cc2)cc1	95167-41-2	Estrogen-Related Receptor beta (ERRbeta, ERR2) Agonists;Estrogen-Related Receptor gamma (ERRgamma) Agonists
DD-23-ZC57	WLMZTKAZJUWXCB-PKJMTWSGSA-N	CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@H](O)C3O)c2n1	34983-48-7	P2RY1 agonist;P2RY12 agonist;P2RY13 agonist
CE-57-KI16	WLQXBRYTQYYCMW-REWPJTCUSA-N	Cc1ncc(F)cc1NC(=O)C[C@H](C(=O)N[C@@H]1C(=O)N2CC3(CC3)CN2C(=O)c2ccccc21)C1CC1		SPPL2A Inhibitor
HC-01-CN33	WLSORBAAVBPTGJ-UHFFFAOYSA-N	N#Cc1cccc(-c2csc(Nc3cc(F)ccc3O)n2)c1		
YA-39-ZW92	WLVCZYGIAIOYFH-UHFFFAOYSA-N	CN1CCN(c2nc3ccccc3c3c2CCCC3)CC1		5-HT3 receptor antagonist
EA-67-FY34	WMBWREPUVVBILR-NQIIRXRSSA-N	O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1	107965-88-8	Enoyl-(acyl-carrier protein) Reductase Fabl Inhibitors;Antioxidants;PPARalpha Agonists
AE-52-FP96	WMCBPITWUUHVJB-UHFFFAOYSA-N	O=S(=O)(c1ccc(Cl)cc1)N1CCCC1c1cccs1		GRM1 antagonist
GA-28-SS67	WMFBXKZFGHSRHI-UHFFFAOYSA-N	COC(=O)c1c(-c2c(Cl)cccc2Cl)noc1-c1cnn(-c2cccc(Cl)c2)c1C(F)(F)F	1357266-65-9	Inhibitor of pyrimidine biosynthesis
UF-85-NE30	WMKCDURBDLAZMQ-UHFFFAOYSA-N	COc1cc(Oc2ccccn2)ccc1-c1cc2c(cc1F)ncc1nc(CO)n(C3CCN(CC#N)CC3)c12		
AD-29-IG16	WMKGGPCROCCUDY-PHEQNACWSA-N	O=C(/C=C/c1ccccc1)/C=C/c1ccccc1	32005-36-0	N-Myristoyltransferase 1 (NMT1) Inhibitors
CC-55-CD84	WNKKYPQIDFAOCU-UHFFFAOYSA-N	COc1ccc(-c2ccc(-c3ccnc(NC4CC(C)(C)NC(C)(C)C4)n3)s2)cc1		Inhibitory kappaB Kinase (IKK) Inhibitors;Inhibitors of Signal Transduction Pathways;Inhibitory kappaB Kinase (IKK) Inhibitors;Inhibitors of Signal Transduction Pathways
AD-11-FZ23	WNMJYKCGWZFFKR-UHFFFAOYSA-N	COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC	1100050-87-0	alpha1-Adrenoceptor Antagonists
DD-33-XP23	WNUBXSUKNMGDHX-UHFFFAOYSA-N	C#CCOc1ccc2c(c1)c(-c1ccc(C(C)C)cc1)nc(=S)n2Cc1cccc(OCCO)c1		Calcium-Sensing Receptor (CaSR) Antagonists;Parathyroid Hormone Secretion Stimulants
CB-38-AW77	WNWPRKWIJGVALY-UHFFFAOYSA-N	Cc1ccc2ccc(C(Nc3ccccn3)c3sccc3C)c(O)c2n1	430462-25-2	Apoptosis Inducers;Caspase Activators;Mcl-1 Inhibitors
OB-15-UL37	WOAGSQCIFSCNIH-ZETCQYMHSA-N	CCN(Cc1cc([N+](=O)[O-])cc2[nH]c(=O)c(=O)[nH]c12)[C@H](C)P(=O)(O)O		
DC-17-ZB19	WOFGKOQKJKFJLB-UHFFFAOYSA-N	COCCCc1cc(-c2c[nH]c3cc(C(=O)c4ccc(Cl)c(S(N)(=O)=O)c4)ccc23)ccn1	1189544-84-0	MMP-13 (Collagenase 3) Inhibitors;MMP-2 (Gelatinase A) Inhibitors
AA-66-PC55	WOUDPYBESPZALS-UHFFFAOYSA-N	O=C1Cc2c([nH]c3ccncc23)-c2ccccc2N1	1244029-68-2	Glycogen Synthase Kinase 3 (GSK-3) Inhibitors;CDK9/Cyclin T1 Inhibitors
ED-32-JY57	WOYZHFHQSIRZAK-UHFFFAOYSA-N	Cc1ccccc1NCC1=NCCN1	67084-28-0	α2-Adrenoceptors
BC-56-CP81	WOZSCQDILHKSGG-UHFFFAOYSA-N	CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c(N)ncnc21)OCOC(=O)C(C)(C)C		
AA-66-YY32	WPGUWABWNUSPMW-UHFFFAOYSA-N	COC(=O)c1c2n(c3ccccc13)Cc1ccccc1N1CCN(C)CC21	115313-22-9	5-HT2A Antagonists
DF-57-BL63	WPHIEFHDFQKSGI-UUOWRZLLSA-N	N#Cc1ccc(C[C@@]23C[C@H](NC(=O)CCC(N)=O)CN2C(=O)N(c2cc(Cl)cc(Cl)c2)C3=O)cc1		Cell Adhesion Inhibitors;Integrin alphaLbeta2 (LFA-1) Antagonists;Tachykinin NK1 Antagonists
WF-96-ME07	WPHXYKUPFJRJDK-AHWVRZQESA-N	COc1cccc(CN(C(=O)CC(C)(C)C)[C@H]2C[C@@H](C(=O)N3CCNCC3)N(Cc3ccc4c(c3)OCO4)C2)c1	334998-36-6	Smo Receptor Antagonists;Hedgehog Signaling Inhibitors;Smo Receptor Antagonists;Hedgehog Signaling Inhibitors
DD-08-BT45	WPNJAUFVNXKLIM-UHFFFAOYSA-N	COc1nc(C)nc(Cl)c1NC1=NCCN1	1008754-16-2	Imidazoline I1 Receptor Agonists
BA-29-OX17	WPOLKWXCMWKIMW-UHFFFAOYSA-N	CCNCC(=O)N1CCC(c2cc(OC)c(Nc3nc(Nc4ccccc4S(=O)(=O)C(C)C)n4nccc4n3)cc2C)CC1	1190116-60-9	ALK Inhibitors
BA-53-FM66	WPSURGXSNWIBBJ-BJKOFHAPSA-N	COCCCOc1cc(C(=O)N(C[C@@H]2CNC[C@H]2NS(=O)(=O)Cc2ccccc2)C(C)C)ccc1OC		REN inhibitor
FA-80-DR66	WPTTVJLTNAWYAO-KPOXMGGZSA-N	COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@]4(C)C=C(C#N)C(=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2	218600-53-4	Angiogenesis Inhibitors;Antiinflammatory Drugs;Apoptosis Inducers;Bcl-2 Inhibitors;Glutathione Reductase (NADPH) Activators;Heme Oxygenase Activators;IKK-1 (IKK-alpha) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Nitric Oxide Production Inhibitors;Nuclear Factor, Erythroid Derived 2, Like 2 (Nrf2) Activators;PPARgamma Agonists
CB-55-GX92	WPVRNXUYVXQXPY-YFAYRSKXSA-N	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@H]3C[C@@H](O)CC(=O)N3Cc3ccc4c(CO)c(OC)ccc4c3)[C@H]21		LFA-1/ICAM-1 Interaction Inhibitors
AE-32-UP21	WPYWMXNXEZFMAK-UHFFFAOYSA-N	O=C(O)CCCCN(CCc1ccccc1OCc1ccc(CCc2ccccc2)cc1)Cc1ccc(C(=O)O)cc1	329773-35-5	Soluble guanylate cyclase activator;Soluble Guanylyl Cyclase (sGC) Activators
LD-37-JE11	WQAGVQVBDHOHRD-UHFFFAOYSA-N	Cc1c[nH]c2ncnc(-c3ccc(NC(=O)N(CCO)c4ccccc4)cc3)c12	1219728-20-7	Limk1 inhibitor
DA-35-DU85	WQAVPPWWLLVGFK-VTNASVEKSA-N	COc1ccc(C[C@H](NC(=O)[C@H](C)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@@]2(C)CO2)cc1	960374-59-8	Immunoproteasome Inhibitors
KA-29-AB08	WQBLEMAGSGUUGW-UHFFFAOYSA-N	Nc1cc(-c2ccnc(Nc3cccc(Cl)c3)n2)ccn1	164658-61-1	CDK1 Inhibitors
CC-31-VS31	WQFWISDSLGGPCP-JAILNELLSA-N	CS(=O)(=NC#N)c1ccc(-c2ccc(-c3nc4[nH]c(O[C@@H]5CO[C@H]6[C@@H]5OC[C@H]6O)nc4cc3Cl)cc2)cc1		AMP activated protein kinase alpha 1 stimulator
DA-10-HD17	WQINSVOOIJDOLJ-UHFFFAOYSA-N	O=C(O)CN1C(=O)c2ccccc2C1=O		
MC-30-BS07	WQLBIRHATOKWMC-BZSNNMDCSA-N	CCCC(CCC)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C=O)CCCNC(=N)N		
FE-75-VG41	WQOVUXDYBFHIHS-WBANQOEISA-N	C[N@+]1(CCOc2ccccc2)CC[C@H](OC(=O)C(O)(c2cccs2)c2cccs2)CC1		Muscarinic M3 Antagonists
DE-59-OT87	WQTKNBPCJKRYPA-OAQYLSRUSA-N	CCOc1ccc(-n2c([C@@H](C)N(Cc3cccnc3)C(=O)Cc3ccc(OC(F)(F)F)cc3)nc3ncccc3c2=O)cc1	473719-41-4	Chemokine CXCR3 Antagonists
BA-09-PG96	WRHJCJHWJSQAHY-UHFFFAOYSA-N	O=c1c2c[nH]c3ccccc3c-2nn1-c1ccccc1	77779-60-3	GABA(A) BZ Site Receptor Antagonists;Non-Steroidal Antiinflammatory Drugs;GABA(A) BZ Site Receptor Antagonists;Non-Steroidal Antiinflammatory Drugs
JA-46-LK88	WRIVUQGWNCNNGS-UHFFFAOYSA-N	O=C1C(=O)c2c(C(=O)c3ccccc3)coc2-c2ccccc21		Inhibitors of Signal Transduction Pathways;CDC25A Inhibitors;CDC25B Inhibitors;CDC25C Inhibitors;Inhibitors of Signal Transduction Pathways;CDC25A Inhibitors;CDC25B Inhibitors;CDC25C Inhibitors
DB-93-SW55	WRKPZSMRWPJJDH-UHFFFAOYSA-N	Cc1ccc2nc(NC(=O)CSc3nc4c(c(=O)n3-c3ccccc3)SCC4)sc2c1	686770-61-6	porcupine inhibitor
BD-46-RY02	WRNKIDLXXXIELU-IEBWSBKVSA-N	CN1Cc2ccccc2[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21	100999-26-6	Dopamine D1 Agonists
AE-22-QI24	WRNXUQJJCIZICJ-UHFFFAOYSA-N	Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(N(C)C)c3ccccc32)cc1	137975-06-5	Vasopressin (AVP) V2 Antagonists
DA-78-WW87	WROHEWWOCPRMIA-UHFFFAOYSA-N	CNC(=O)c1ccc(Oc2ccc3c(c2)CCN(C2CCC2)CC3)nc1	720690-73-3	Histamine H3 Receptor Inverse Agonists;Histamine H3 Receptor Antagonists
BE-82-MI84	WRUUGTRCQOWXEG-UHFFFAOYSA-N	NCCC(O)(P(=O)(O)O)P(=O)(O)O	1159812-33-5	Farnesyl Pyrophosphate Synthase Inhibitors
ZA-84-ZC97	WRWCAQNPEXYGJK-PKNBQFBNSA-N	CC1(C)CCC(C)(C)c2cc(C3CCCc4oc(/C=C/C(=O)O)cc43)ccc21	503620-39-1	Retinoid RXRalpha Agonists
AB-73-SW45	WSEQXVZVJXJVFP-UHFFFAOYSA-N	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	207559-01-1	5-HT Reuptake Inhibitors
AB-86-GB42	WSLWDYFVQCTRRJ-UHFFFAOYSA-N	CNC(=O)c1cccc(-c2ccn3c(-c4ccnc(-c5ccc(F)cc5)c4)cnc3c2)c1	1146612-65-8	ALK5 inhibitor
AF-40-QU33	WSUXACNDZSQZBC-IERDGZPVSA-N	O=C(Nc1ccc(C(=O)N2CCC[C@H]3CCCC[C@@H]32)cc1)c1ccc(F)cc1		11-beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Inhibitors
LA-09-SS14	WSWXSQNYFMZUDP-KSSFIOAISA-N	CCCCCCCC(=O)N[C@H](c1cccc(OC)c1)[C@H](C)OP(=O)(O)O	289052-51-3	cPLA2a activator;IL-10 Production Enhancers;TNF-alpha Production Inhibitors;cPLA2a activator;IL-10 Production Enhancers;TNF-alpha Production Inhibitors
AA-98-PM63	WTDRDQBEARUVNC-LURJTMIESA-N	N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O	122769-74-8	Dopamine Precursors
GE-63-WI86	WTDWVLJJJOTABN-UHFFFAOYSA-N	CNC(=O)c1c(-c2ccc(F)cc2)oc2cc(N(CCO)S(C)(=O)=O)c(C3CC3)cc12		
TC-59-QN21	WTLRWOHEKQGKDS-UHFFFAOYSA-N	NS(=O)(=O)c1c(Cl)ccc(NC(=O)Nc2cccc(Cl)c2Cl)c1O	276700-41-5	Chemokine CXCR2  (IL-8 beta Receptor) Antagonists
BE-07-BZ97	WTMNOOVMFFBHSN-DJUMBFHZSA-N	CN1CC(c2ccccc2)C2(CCCN(C(=O)[C@@H](COCc3ccccc3)NC(=O)C(C)(C)N)C2)C1=O	1415234-44-4	
AB-02-TI14	WTNCKLVOKCXDAU-CYBMUJFWSA-N	C[C@@](O)(C(=O)Nc1ccc(S(=O)(=O)N2CCNCC2)cc1Cl)C(F)(F)F		Pyruvate Dehydrogenase Kinase (PDHK;PDK) Inhibitors
BE-27-XF09	WTQWDNIIFGEBSZ-WGBDABJCSA-N	C[C@H]1CCCC[C@H]2C(=O)C=C[C@H](O)[C@@H]2CC(=O)O1	643747-04-0	tat Inhibitors;bacterial DNA Primase Inhibitors
MF-11-EW49	WUADCCWRTIWANL-UHFFFAOYSA-N	COc1ccc(-c2coc3cc(O)cc(O)c3c2=O)cc1	491-80-5	Androgen Receptor Antagonists;Steroid 5alpha-Reductase Inhibitors;PPARalpha Agonists;PPARgamma Agonists
PD-74-GP60	WUJVPELCYCESAP-UHFFFAOYSA-N	O=C(O)CC1CCC2(CC1)CCN(c1cc(OC(F)(F)F)ccc1Cl)CC2	1599477-75-4	GPR120 agonist
AC-37-OZ52	WUNPTEURMBNIKG-UHFFFAOYSA-N	CCN1CCN(Cc2ccc(NC(=O)c3ccc(-c4c(F)c(OC)cc(OC)c4Cl)c4nccnc34)nc2)CC1	1197331-39-7	FGFR3 gene inhibitor
KA-63-FH23	WUPXZZWTHIZICK-UHFFFAOYSA-N	COc1cccc(-c2cn(-c3ccc(CCN4CCC(O)CC4)cc3)c3ncnc(N)c23)c1	234772-64-6	Src Kinase Inhibitors
CB-13-OP88	WURBFLDFSFBTLW-UHFFFAOYSA-N	O=C(C(=O)c1ccccc1)c1ccccc1	103852-36-4	Carboxylesterase Inhibitors
UF-55-NA30	WUTVVUYVJVXZMW-UHFFFAOYSA-N	Nc1cccc(-c2nc3c(Nc4cccc(O)c4)ncnc3o2)c1		
YD-59-WM48	WUTYZMFRCNBCHQ-UHFFFAOYSA-N	CC1OC2(CS1)CN1CCC2CC1	107220-28-0	CHRM1 agonist
DA-33-CW45	WVHMNCOFPWFUMF-UHFFFAOYSA-N	CC(C)Nc1nc(Nc2ccccc2)nc(-c2ccccc2)n1	1446506-78-0	IDH2 mutant inhibitor
BC-34-IH52	WVIPVRJNDZWQGP-UHFFFAOYSA-N	Cc1cc2[nH]c(=O)cc(C)c2cc1NC(=O)c1cc(S(=O)(=O)N(C)C)ccc1N1CCOCC1		bET inhibitor BD1 selective
GA-56-IU17	WVLHHLRVNDMIAR-IBGZPJMESA-N	NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]1CCCc2cccnc21	558441-90-0	CXCR4 antagonist, HIV attachment inhibitor
DE-59-HQ30	WVQLWTIRBNXQMX-BZNIZROVSA-N	NC(=O)n1cc(NC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)c2F)c2ccccc21		Complement Factor D (CFD) Inhibitor
AE-67-DS75	WVRBXBROEPXZHF-SANMLTNESA-N	O=C1COc2c(cccc2[C@@H](O)CNCCN(C(=O)CCNCCc2ccc(Cl)c(Cl)c2)C2CCCCC2)N1		SMYD2 gene inhibitor;SMYD2 inhibitor
BD-10-ZH17	WVTUDMXKOFCUFN-XMMPIXPASA-N	O=C(O)COc1cccc(CN2CCC[C@@H]2c2nc(-c3ccccc3)c(-c3ccccc3)o2)c1		Prostanoid IP Agonists
FA-10-DN36	WVVXBPKOIZGVNS-UHFFFAOYSA-N	CC(=O)NCCc1c(Cc2ccccc2)[nH]c2ccccc12	117946-91-5	Melatonin MT2 Antagonists
CF-82-AS63	WVYADZUPLLSGPU-UHFFFAOYSA-N	O=C(Oc1ccccc1C(=O)O)c1ccccc1O	552-94-3	inhibition of p300-induced Tau acetylation;Non-Steroidal Antiinflammatory Drugs;NF-kappaB (NFKB) Activation Inhibitors
GE-97-UL88	WVZQZRVDIMHSMC-UHFFFAOYSA-N	CN1c2ccc(F)cc2C(=O)CC12CCN(C(=O)NCc1ccc(F)cc1)CC2		
CE-73-JW90	WWEQTPOWISSFHS-UHFFFAOYSA-N	O=C(Nc1ccc(N2CCOCC2)cc1)c1n[nH]c2ccccc12	660822-84-4	Inhibitors of Signal Transduction Pathways;CDK2 Inhibitors
PD-05-HV36	WWFLLNOJGAOPHX-SMSORMJASA-N	O=C(NC1CCN(C[C@@H]2CCCN3CCCC[C@H]23)CC1)c1cc2c(OCc3coc4ccc(Cl)cc34)cccc2[nH]1		Chemokine CCR2 (MCP-1 Receptor) Antagonists
FC-58-KP35	WWQTWEWAPUCDDZ-QGZVFWFLSA-N	Cc1noc(-c2ccc(-c3ccc(CC(=O)O)cc3)cc2)c1NC(=O)O[C@H](C)c1ccccc1Cl	1228690-19-4	LPAR1 antagonist
ME-73-FK70	WWRAFPGUBABZSD-UHFFFAOYSA-N	Nc1ccc2oc(=O)ccc2c1I	137881-27-7	NAD+ ADP-Ribosyltransferase (poly(ADP-ribose)polymerase| PARP) Inhibitors
EC-42-WE14	WWVANQJRLPIHNS-ZKWXMUAHSA-N	N=C1N[C@H]2[C@H](CS[C@H]2CCCCC(=O)O)N1	13395-35-2	Inducible Nitric Oxide Synthase (NOS-2) Inhibitors;Neuronal Nitric Oxide Synthase Inhibitors
QC-15-WY38	WWXDWPFSZVAXNZ-LGMDPLHJSA-N	O=C1Nc2ccccc2/C1=C/Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1		TRKA Inhibitors
BE-64-ZN31	WXCXUHSOUPDCQV-UHFFFAOYSA-N	CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F	915087-33-1	Androgen Receptor Antagonists
EC-72-RE74	WXRGFPHDRFQODR-ICLZECGLSA-N	CC(C)N(CCCNC(=O)Nc1ccc(C(C)(C)C)cc1)C[C@H]1O[C@@H](n2ccc3c(N)ncnc32)[C@H](O)[C@@H]1O	1338466-77-5	Dot1L / KMT4;Histone methyltransferase inhibitors
EA-50-GQ38	WXTMDXOMEHJXQO-UHFFFAOYSA-N	O=C(O)c1cc(O)ccc1O		
BC-97-SZ42	WXUORZWCMOOXRS-DEOSSOPVSA-N	COc1cc(Nc2ccc3c(n2)O[C@H](c2ccccc2)CN(C)C3)ccc1-n1cnc(C)c1	1255700-29-8	Known Gamma secretase modulator
SA-32-CC58	WXUWYRZLSHTUDA-UHFFFAOYSA-N	c1cnc2[nH]cc(-c3ccnc(NC4CCNCC4)n3)c2c1		CDK inhibitors
NF-53-AH73	WXXSNCNJFUAIDG-UHFFFAOYSA-N	COC(=O)N(C)c1c(N)nc(-c2nn(Cc3ccccc3F)c3ncccc23)nc1N	625115-55-1	Guanylate Cyclase Activators
CA-66-FY97	WXYLMESQOULMTG-UHFFFAOYSA-N	CC(=O)Nc1ccc(Cl)cc1-c1ccc(-n2c(=N)n(Cc3cccc4[nH]ccc34)c3ccc(F)cc32)cn1		
AA-11-RO46	WYQIPCUPNMRAKP-UHFFFAOYSA-O	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21	114719-57-2	CDK6 Inhibitors;DNA-Intercalating Drugs;CDK4/Cyclin D1 Inhibitors;CDC25B Inhibitors
BB-43-YQ76	WYWIFABBXFUGLM-UHFFFAOYSA-N	Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1	1491-59-4	alpha1A-Adrenoceptor Agonists;alpha2A(2D)-Adrenoceptor Agonists
BA-41-VY30	WYWNEDARFVJQSG-UHFFFAOYSA-N	Cc1[nH]c2ccc(O)cc2c1CCN	78263-90-8	
SA-28-ZT78	WZBNEZWCNKUOSM-VOTSOKGWSA-N	O=C(/C=C/c1c(C(=O)O)[nH]c2cc(Cl)cc(Cl)c12)Nc1ccccc1	153436-22-7	NMDA Glycine-Site Antagonists
GA-04-JM33	WZFNBQBUDJACCD-ZSYWEHCUSA-N	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)[C@@H]2CC[C@H](/C=C/1C)ON2c1ccccc1	892494-07-4	FK506-Binding Protein 52 (FKBP52) Inhibitors;L-Type Calcium Channel Blockers;Neurotrophic Agents;Signal Transduction Modulators
EF-16-GV25	WZJKPXZLQTXALB-UHFFFAOYSA-N	C[N+](C)(C)CCC(=O)c1cccc2ccccc12	115066-04-1	Chemokine-like Receptor 1 (CMKLR1, CHEMR23) Antagonists;ChAT inhibitor;Aldehyde dehydrogenase 1 inhibitor
AC-43-ZC52	WZJSIHGOLMMBAL-MRXNPFEDSA-N	CCCN1CCc2cccc3c2[C@H]1Cc1cccc(O)c1-3	114033-65-7	Dopamine D2 Receptor Ligands;Dopamine D1 Receptor Ligands;Dopamine D3 Receptor Ligands
QC-12-DW06	WZMVQZJKOVPVGZ-UHFFFAOYSA-N	COc1cc(C(=O)N2CCC(CCN3CCC(C(N)=O)(c4ccccc4)CC3)(c3ccc(Cl)c(Cl)c3)C2)cc(OC)c1OC	167261-47-4	Tachykinin NK1 Antagonists;Tachykinin NK2 Antagonists
DA-33-NF79	WZXHSWVDAYOFPE-UHFFFAOYSA-N	COc1cc(Br)c2oc(C3CCNCC3)cc2c1	63638-90-4	MAO-A Inhibitors
BF-95-KA82	XAMYAYIMCKELIP-FQEVSTJZSA-N	CCCCCCCC[C@H](SCCCCCC)C(=O)Nc1c(SC)cc(C)nc1SC	135025-12-6	SOAT-1 inhibitor
XC-13-LW13	XANVKORFTYYQCZ-UHFFFAOYSA-N	N#Cc1sc2nc(-c3cccs3)cc(-c3ccccc3)c2c1N		
DA-48-IP75	XASIMHXSUQUHLV-UHFFFAOYSA-N	CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(N=C(N)N)cc2)cc1	59721-28-7	Known Trypsin inhibitor
WD-97-SF27	XASXTBSHBDYHAT-JOCHJYFZSA-N	Cc1ncccc1-c1c(Cl)sc2ccc(NC(=O)NCC(=O)NCCCN(C)[C@@H]3CCCN(c4ncnc5[nH]ccc45)C3)cc12		
CE-38-KX20	XAUDJQYHKZQPEU-KVQBGUIXSA-N	Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1	105597-46-4	DNMT1;Antimetabolites;DNA Methyltransferase (DNMT) Inhibitors
DE-99-OT37	XBBDACCLCFWBSI-ZETCQYMHSA-N	COC(=O)[C@@H](N)Cc1ccc(O)c(O)c1	1421-65-4	Dopamine Precursors
BB-82-TP51	XBEQSQDCBSKCHJ-UHFFFAOYSA-N	Fc1ccccc1-c1nc2ccn(Cc3ccc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)nn3)cc-2n1		
NA-16-OJ70	XBJHBEQDHSREQB-QHCPKHFHSA-N	COc1ncc(-c2nc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1	1448867-13-7	Mdm2 p53-binding protein inhibitor
YC-80-XX73	XBJWOGLKABXFJE-UHFFFAOYSA-N	CCOC(=O)N1CSCC1C(=O)O	127657-29-8	Elastase Inhibitors
CC-17-HI11	XBNSDTLFWKORGH-UHFFFAOYSA-N	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		Phosphatidylinositol 3-Kinase delta (PI3Kdelta) Inhibitors
NB-61-FT12	XBPYTDZHCNJRBY-UHFFFAOYSA-N	O=C(NCCc1c[nH]c2ccccc12)c1ccccc1O	31384-98-2	L-Type Calcium Channel Blockers;Sodium Channel  Blockers;Potassium Channel Modulators
EA-12-SS08	XBVOXAWRUIZEMG-WKILWMFISA-N	Nc1ncc(C#Cc2ccc(Cl)cc2)c(N[C@H]2CC[C@H](O)CC2)n1	393856-87-6	Nerve Growth Factor (NGF) Enhancers;Tenogenic;Nerve Growth Factor (NGF) Enhancers;Tenogenic
BC-21-EB65	XCCTYIAWTASOJW-XVFCMESISA-N	O=c1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)[nH]1	27821-45-0	P2Y6 purinoceptor antagonist
SE-76-JI27	XCHAQSBFCMITMW-OAQYLSRUSA-N	CN(C(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@H](CCNC(=O)c1ccccn1)Cc1ccccc1	1238070-12-6	Orexin OX-2 Antagonists
KF-38-DH25	XCKWRUGRUFVXGC-NTEUORMPSA-N	CC(=O)Nc1ccc(/C=C/C(=O)NCC(=O)N(C)c2ccc(Cl)c(COc3cccc4ccc(C)nc34)c2Cl)cn1	167838-64-4	Antiinflammatory Drugs;Bradykinin B2 Antagonists
AA-72-JP86	XDAOLTSRNUSPPH-XMMPIXPASA-N	C[C@]1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)Cn2cc([N+](=O)[O-])nc2O1		
ZB-16-BR73	XDHBUMNIQRLHGO-UKTHLTGXSA-N	C/C(=N\\NC(=S)N1CCC1)c1ccccn1	71555-25-4	p53 tumor suppressor protein inhibitor
GD-51-SU60	XDHNQDDQEHDUTM-XJKSCTEHSA-N	CO/C1=C\\C(C)=C\\[C@@H](C)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@H](OC)[C@@H]([C@@H](C)[C@@H](O)[C@H](C)[C@@]2(O)C[C@@H](O)[C@H](C)[C@@H](C(C)C)O2)OC1=O	116764-51-3	v-ATPase inhibitor
JC-26-DD86	XDHONXIOZAUYDB-UHFFFAOYSA-N	Cc1ccc(-c2cnc3nc(C(=O)CCCCCc4ccccc4)oc3c2)cc1		dual diacyglycerol lipase alpha and beta reversible inhibitor
HC-97-OH18	XDHYXZYJYANQCH-UHFFFAOYSA-N	CC(C)Nc1nc(Nc2ccccc2)nc(Nc2ccccc2)n1		KCNH voltage-gated potassium channel-3 inhibitor
DC-87-HI21	XDJCLCLBSGGNKS-UHFFFAOYSA-N	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4ncn[nH]4)cc23)c1	1438391-30-0	SAPK1 (JNK) Inhibitors;Inhibitors of Signal Transduction Pathways
VA-06-DB75	XDLYKKIQACFMJG-WKILWMFISA-N	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1	1013101-36-4	Mammalian Target of Rapamycin (mTOR;FRAP1) Inhibitors;Phosphatidylinositol 3-Kinase (PI3K) Inhibitors
AE-11-BF25	XDRYMKDFEDOLFX-UHFFFAOYSA-N	N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1		
VC-79-JG59	XDYLTMJUGCWWIL-RGEXLXHISA-N	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc32)c1C		PYK2 inhibitor
DB-21-FY25	XEAOPVUAMONVLA-QGZVFWFLSA-N	NC(=O)[C@@H](CCC(F)(F)F)N(Cc1ccc(-c2ncon2)cc1F)S(=O)(=O)c1ccc(Cl)cc1	1146699-66-2	gamma-Secretase Inhibitors
CA-40-KX35	XEAQIWGXBXCYFX-BQYQJAHWSA-N	COC1=CC(=O)OC(/C=C/c2ccccc2)C1	1635-33-2	Sodium Channel  Blockers;Calcium Channel Modulators;advanced lipoxidation endproduct inhibitors;Sodium Channel  Blockers;Calcium Channel Modulators;advanced lipoxidation endproduct inhibitors
FA-16-HR75	XEEQGYMUWCZPDN-DOMZBBRYSA-N	O[C@@H](c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)[C@H]1CCCCN1	147368-41-0	Antimalarial;Pannexin 1 (PANX1) Inhibitors
BD-68-ZT55	XEFQLINVKFYRCS-UHFFFAOYSA-N	Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl		
SB-26-NB80	XEPVNVXTIBRSPO-UHFFFAOYSA-N	NC1=NN(c2ccc(Cl)cc2)C(c2ccccc2)C1	83959-28-8	D-Amino Acid Oxidase (DAAO) Inhibitors
UD-78-YQ06	XERATECPNBWJFP-UHFFFAOYSA-N	O=C(O)Cn1nnc(-c2ccc(CN(CCCCOc3ccc(CN4CCCC4)cc3)CCc3ccccc3)cc2)n1		Tip60 (KAT5) inhibitor
IB-59-SI50	XEWAXQQWHKCUTB-JLHYYAGUSA-N	O=C(/C=C/c1ccc(CNCCc2c[nH]c3ccc(OCc4ccccc4)cc23)cc1)NO		Histone Deacetylase (HDAC) Inhibitors
AB-21-MV93	XEYBRNLFEZDVAW-ARSRFYASSA-N	CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\\CCCC(=O)O	363-24-6	
YD-38-CI01	XEZGQZRJNWWNJR-UHFFFAOYSA-N	COc1cc(N)c(Cl)cc1C(=O)OCCN1CCCC1		HTR4 agonist
DD-85-KU00	XFBAMRWEUKVTJU-UHFFFAOYSA-N	CCCCCCC(=O)N1CCc2c(c(-c3ccc(C(C)(C)C(=O)O)cc3)nn2C)C1		Serine Palmitoyl Transferase inhibitor
FA-43-TP28	XFDJYSQDBULQSI-UHFFFAOYSA-N	CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O	113-07-5	
NE-95-RP07	XFFITGBWVLQNCD-UHFFFAOYSA-N	CC(C)c1cccc(C(C)C)c1NC(=O)Nc1ccc(Sc2ccc([N+](=O)[O-])cc2)cc1	228544-65-8	Lipid Lowering Agents;ACAT Inhibitors;Lipid Lowering Agents;ACAT Inhibitors
AA-15-HO31	XFILPEOLDIKJHX-QYZOEREBSA-N	CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)[C@H](CSc1cccs1)C(=O)NO	130370-60-4	Angiogenesis Inhibitors;Matrix Metalloproteinase Inhibitors;Angiogenesis Inhibitors;Matrix Metalloproteinase Inhibitors
DF-00-BU08	XFMZYCHKCPPZQW-HXUWFJFHSA-N	CN(C)C[C@@H](OC(=O)N1Cc2c(n[nH]c2NC(=O)c2ccc(F)cc2)C1(C)C)c1ccccc1	1026898-98-5	PAK4 gene inhibitor
MA-25-RP17	XFPKKPUAPZGFCK-UHFFFAOYSA-N	Cc1cccc2c(CCSc3nnc(-c4ccc5ccccc5n4)n3CCCCN)c[nH]c12		Somatostatin SRIF1A (sst2) Agonists;Somatostatin SRIF1B (sst5) Agonists
AC-98-QW77	XFWLTFZLLXVKDY-WAYWQWQTSA-N	CCNCCCNC/C=C\\CNCCCNCC		
YA-92-YO01	XFWZBMTTXLUWKW-YIUHCBHRSA-N	CO[C@H]1OC(=O)C=C2C1=C[C@H]1OC(=O)[C@@]3(C)CCC[C@@]2(C)[C@@H]13		
FE-06-GR60	XGAKLPIDELWBDY-LJQANCHMSA-N	C[C@@H]1CN(c2nnc(Cc3ccccc3)c3ccc(C#N)cc23)CCN1c1ccc(C#N)cn1	1610536-42-9	S1P lyase inhibitor
AA-92-NW83	XGCZRGJUCNQVCO-XFAJEYMZSA-N	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@H](CC(=O)NC)N(Cc4ccc(O)c(OC)c4)C(=O)O3)[C@H]21		LFA-1/ICAM-1 Interaction Inhibitors
QB-88-PG52	XGGBVRLLWXYLJS-UHFFFAOYSA-N	O=c1oc(OCc2ccccc2)nc2ccccc12	107717-51-1	Cathepsin G inhibitor
AD-30-TH82	XGOYIMQSIKSOBS-UHFFFAOYSA-N	Cc1ccc2c(=O)c3cccc(CC(=O)O)c3oc2c1C	117570-53-3	Mouse STING agonist;Interferon Inducers;Vascular Disrupting Agents (VDA)
SF-52-LP14	XGUFMAUYGBDFJS-PTRLVYDZSA-N	C[C@@H]1CCC2C(C)(C)[C@H](O)[C@H](O)C[C@]2(C)[C@@]12Cc1c(O)cc(C=O)c(C(=O)O)c1O2		Complement Inhibitors
AA-80-XK94	XGVJFFSPCYBCEY-UHFFFAOYSA-N	CN(c1nnc(-c2c(O)c3ccccc3n(C)c2=O)s1)C1CC(C)(C)NC(C)(C)C1		splicing modulator
BA-56-QV45	XHBVYDAKJHETMP-UHFFFAOYSA-N	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1	1219168-18-9	AMPK Inhibitor
SC-02-RZ08	XHKRPARFGAVJRB-LQGKIZFRSA-N	C(=N/NC1=NCCN1)\\c1ccc(/C=N/NC2=NCCN2)cc1		CXCR4 antagonist
SF-32-RC78	XHOUYEFJMAJKSB-UHFFFAOYSA-N	CC(C)CCOc1cccc(C2C(C(=O)c3ccc4c(c3)CC(C)O4)=C(O)C(=O)N2c2nc3ccc(F)cc3s2)c1		MAP3K5 gene inhibitor
OE-31-YC41	XHQASCCMERNXCT-UHFFFAOYSA-N	CC(C)N(NC(=O)c1ccccc1)C(=O)COc1c(F)cc(F)cc1-c1ccccc1OC(F)(F)F		Diacylglycerol Acyltransferase (DGAT) Inhibitors
RA-14-EK87	XHQUDHNMFAUGFT-UHFFFAOYSA-N	COc1ccc2c(c1)OC(=O)N(c1ccc(O)cc1)C2		
OD-28-MX63	XIDPLDHLNCWZQE-UHFFFAOYSA-N	CNCCC1CCc2ccccc2C1c1ccccc1		HTR2C antagonist
FA-72-JL16	XIFVEJXUSTTZKD-UHFFFAOYSA-N	Cc1cc(=O)[nH]c(-n2nc(C)cc2C)n1	65004-42-4	Divalent Metal Transporter 1 (DMT1; DCT1; Nramp2) Inhibitors
BF-34-DG44	XIKRQPKFOKKGGW-LCYFTJDESA-N	COC1=Cc2ccccc2/C(=C/C(=O)O)c2ccsc21		
AE-59-ZQ55	XILNRORTJVDYRH-HKUYNNGSSA-N	COc1ccc(-n2nnnc2C(F)(F)F)cc1CN[C@H]1CCCN[C@H]1c1ccccc1	168266-51-1	Tachykinin NK1 Antagonists
MF-62-JR25	XIQVNETUBQGFHX-UHFFFAOYSA-N	CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1	119579-36-1	Muscarinic Antagonists
GE-54-IF41	XJBCFFLVLOPYBV-UHFFFAOYSA-N	CC(C)(Cc1ccccc1)NCC(O)c1ccc(O)c(NS(C)(=O)=O)c1	37000-20-7	beta2-Adrenoceptor Agonists;beta3-Adrenoceptor Agonists
AD-43-EQ11	XJCBUMMVPAJQKC-KRWDZBQOSA-N	CCOc1cc([C@H](C)N2CCc3c(CN(C)C)cc(Cn4ccnc4NC)cc3C2=O)ncc1F		
CE-37-XI06	XJCLYGZLMYHFCN-UHFFFAOYSA-N	Cc1cc(C)c(Nc2cccc3c(C)n[nH]c(=O)c23)c(C)c1	1072157-13-1	S1PR5 agonist
S0-EE-XXLY	XJFPWEGWVPIYIH-NSHDSACASA-N	O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)N[C@H]1CCN(c2ccc3nncn3n2)C1		CDK8 inhibitor
AD-55-WK61	XJGOPYWCSIEHLX-UHFFFAOYSA-N	CC(C)(C)c1ccc(Nc2ncc(Cc3ccncc3)c3ccccc23)cc1	258851-00-2	RAF Inhibitor
FA-10-KQ78	XJGVXQDUIWGIRW-UHFFFAOYSA-N	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1	1977-10-2	Dopamine D4 Receptor Ligands;Dopamine D2 Antagonists;Dopamine D1 Receptor Ligands;Dopamine D3 Receptor Ligands;5-HT2 Antagonists
ED-25-BD54	XJJYJNMNYDNXNO-UHFFFAOYSA-N	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		MAPKAP-K2 (MK2) Inhibitors;TNF-alpha Production Inhibitors
BC-86-PL11	XJLATMLVMSFZBN-VYDXJSESSA-N	CCCCC[C@H](CC(=O)NO)C(=O)N[C@H](C(=O)N1CCC[C@H]1CO)C(C)C	13434-13-4	Mitochondrial Translation Inhibitors;Peptide Deformylase (PDF) Inhibitors;Membrane Alanine Aminopeptidase (Aminopeptidase N) Inhibitors
BA-97-CI76	XJQRRXDTQMFSPX-POXKQJJMSA-O	O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)[C@](O)(c1ccccc1)C1CCCCC1)C2)Nc1ccon1		
IE-05-JN93	XKBSPAZCFAIBJL-OAHLLOKOSA-N	CN(C)[C@@H]1CCN(c2cc(-c3ccccc3)nc3ccnn23)C1		MRGPRX2 agonist
AC-95-MU00	XKLMZUWKNUAPSZ-UHFFFAOYSA-N	COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1	1080496-58-7	Sodium Channel  Blockers
EC-18-TF61	XKPJTOHUPQWSOJ-HSZRJFAPSA-N	CCN(CC)Cc1ccc(C(=O)N(CCc2ccccc2OC)[C@@H]2CCNC2)cc1	947303-87-9	Site-1 Protease (S1P) Inhibitors
BB-20-UU03	XKTFQMCPGMTBMD-FYHMSGCOSA-N	CO/C(=C/C(N)=O)[C@H](C)[C@H](/C=C/c1csc(-c2csc([C@@H](C)/C=C/C=C/C(C)C)n2)n1)OC	76706-55-3	cytochrome c reductase;Electron Transport Chain Inhibitors
JC-05-CC41	XKWVLGMVINJGLP-MRXNPFEDSA-N	CN([C@@H]1CCc2c(c3ccccc3n2CCC(=O)O)C1)S(=O)(=O)c1ccc(F)cc1		
AF-79-OK66	XLOGLWKOHPIJLV-UHFFFAOYSA-N	CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1		RIPK2 inhibitor
KF-70-DC09	XLVOWGDFXAVSFE-UHFFFAOYSA-N	CSc1ncc(CO)c(N)n1	588-36-3	CDK Inhibitors
GB-19-AP57	XLWJPQQFJNGUPA-UHFFFAOYSA-N	CC(C)(CO)Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1		
EC-27-RY89	XLYOFNOQVPJJNP-UHFFFAOYSA-N	O		
AD-11-RL84	XLZSBGWFJTXBDS-UHFFFAOYSA-N	CNC(=O)c1cc(Oc2ccc3c(c2)nc(Nc2ccc(Br)cc2)n3C)ccn1	611213-70-8	Raf kinase B Inhibitors;Raf kinase C Inhibitors
AC-31-AY35	XMAWUPHYEABFDR-UHFFFAOYSA-N	O=C(C(=O)c1ccc(Cl)cc1)c1ccc(Cl)cc1	3457-46-3	Carboxylesterase Inhibitors
AB-39-ED84	XMAYWYJOQHXEEK-OZXSUGGESA-N	CC(=O)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1	65277-42-1	Antifungal;CYP inhibitor;Antifungal;CYP inhibitor
AF-81-JB15	XMAYWYJOQHXEEK-ZEQKJWHPSA-N	CC(=O)N1CCN(c2ccc(OC[C@@H]3CO[C@@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1		
CE-69-FD64	XMBSZPZJLPTFMV-UHFFFAOYSA-N	Cc1nn(C)c(C)c1NS(=O)(=O)c1c(Cl)cc(-c2ccnc(N3CCNCC3)c2)cc1Cl	1215010-55-1	N-Myristoyltransferase Inhibitors
CC-08-JZ09	XMBYWWHLSMXSPA-VNKDHWASSA-N	C=C1C=C(CCC(=O)O)C(=O)OC1/C=C/C=C/C	1097679-78-1	Apoptosis Inhibitors;IL-4 Production Inhibitors;IL-2 Production Inhibitors
QE-35-YE15	XMCZXGQXIWYWIH-UHFFFAOYSA-N	CC(C)(C)c1ccc(Nc2nnc(Cc3ccc(=O)[nH]c3)c3ccccc23)cc1		
JD-90-SN16	XMMAOXMYUGQGJD-UHFFFAOYSA-N	COc1ccc2nc3ccc(Cl)cc3c(SCCCN)c2c1		
UB-83-HM84	XMQRFWOHEPJZPS-JHUFMRCFSA-N	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C(C)(C)C		
NC-39-KP22	XMVAWGSQPHFXKU-UHFFFAOYSA-N	Cc1nn(C)c(COc2ccc(N3CCN(S(=O)(=O)N(C)C)CC3)cc2)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)n(CCN3CCOCC3)c12	1668553-26-1	Mcl-1 inhibitor
BB-51-ML99	XMWVPWJKPMQVJW-UHFFFAOYSA-N	OCc1cn(Cc2ccccn2)c2ccccc12		SULT1A1 prodrug
CE-36-UR55	XMXMKWBRPQAPEB-FMIVXFBMSA-N	C/C(=C\\c1ccc(Cc2cccnc2)cc1)C(=O)O	74427-50-2	Thromboxane Synthase Inhibitors
AE-03-MJ64	XNAWXFHJMUGSMC-UHFFFAOYSA-N	COc1ccc(-c2nc(COc3ccc(OCC(=O)O)c(C)c3)sc2-c2ccc(OC(F)(F)F)cc2)cn1	870521-57-6	PPARdelta Agonists
GB-10-QG19	XNEWILNREVDHDJ-UHFFFAOYSA-N	COCCn1c(-c2ccc(C(C)C)cc2)nc2c(C(F)(F)F)c(Cc3cccnc3S(C)(=O)=O)cc(OC)c21	952057-39-5	Calcium-Sensing Receptor (CaSR) Antagonists;Parathyroid Hormone Secretion Stimulants
MF-20-QI53	XNHZXMPLVSJQFK-UHFFFAOYSA-O	Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCOCC4)cc2)CCC3)cc1	229005-80-5	Chemokine CXCR3 Antagonists;HIV Attachment Inhibitors;Chemokine CCR5 Antagonists
GD-59-OG21	XNKLLVCARDGLGL-JGVFFNPUSA-N	Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O		
FC-03-PM86	XNOPRXBHLZRZKH-DSZYJQQASA-N	CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O	50-56-6	OXTR agonist
KA-35-YF58	XNUCDMDHVWJDIP-UHFFFAOYSA-N	O=S(=O)(Nc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c2ccccc12)c1ccc(Cl)cc1	167321-71-3	Carboxylesterase Inhibitors
AA-18-GQ83	XNUGHKFWLZXJDH-UHFFFAOYSA-N	CN(C)CCCCCNC(=O)c1cc(-c2cccs2)on1		
ID-31-AD14	XNVWWDGUTCSRJU-UHFFFAOYSA-N	COc1ccc(-c2cnn3ccc(NCCCN4CCOCC4)nc23)cc1OC		
CC-09-YG11	XNWDRALEEPGBHB-UHFFFAOYSA-N	NC(=O)c1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCNCC2)c1	1201673-28-0	Protein Kinase D (PKD) Inhibitors
NB-48-NL30	XOAHEZUFENTGII-UHFFFAOYSA-N	CCNC(=O)c1ccc(Cn2nc(-c3ccc(C#N)cc3)cc2C)cc1		
RC-08-UN34	XOGPWGKZPAAIHN-UHFFFAOYSA-N	N#Cc1ccc(C2CCn3cncc32)cc1		
SD-12-UF05	XOIYZMDJFLKIEI-UHFFFAOYSA-N	NS(=O)(=O)Oc1ccccc1	19792-91-7	Carbonic anhydrase inhibitor
UF-27-HS98	XOKJUSAYZUAMGJ-WOUKDFQISA-N	N#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12	606-58-6	
ED-28-RW52	XONOYNOZMFMROO-UHFFFAOYSA-N	N#Cc1cc(-c2ccccc2F)c2nncn2c1NCc1ccco1		PRC2/EED;EED gene inhibitor
AF-73-ON54	XPCFTKFZXHTYIP-PMACEKPBSA-N	CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O	109010-10-8	Angiotensin-I Converting Enzyme (ACE) Inhibitors
CC-90-FE70	XPEIJWZLPWNNOK-UHFFFAOYSA-N	OB(O)c1ccc(-c2ccccc2)cc1	5122-94-1	Carbonic Anhydrase Type I Inhibitors;Carbonic Anhydrase Type II Inhibitors;Carbonic Anhydrase Type IX Inhibitors;Carbonic Anhydrase Type XII Inhibitors
CE-04-OJ56	XPQIPUZPSLAZDV-UHFFFAOYSA-N	NCCc1ccccn1		
ZB-62-QB90	XPRDUGXOWVXZLL-UHFFFAOYSA-N	COc1cccc(-c2ccc(NC(=O)C3=C(C(=O)O)CCC3)c(F)c2)c1	717824-30-1	Anti-IL-17;Dihydroorotate Dehydrogenase (DHODH) Inhibitors
ED-22-QV85	XPRZIORDEVHURQ-UHFFFAOYSA-N	Cc1nnsc1C(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2C(F)(F)F)cc1	223499-30-7	Calcium channel inhibitor;TRPM4 agonist;IL-5 Production Inhibitors;Calcium Release-Activated Channels (CRAC) Blockers;TRPM4 Agonists;IL-4 Production Inhibitors;IL-2 Production Inhibitors
DB-74-HJ91	XQGZSYKGWHUSDH-UHFFFAOYSA-N	O=C(O)c1ccc(OCCn2ccnc2)cc1	103735-00-8	Thromboxane Synthase Inhibitors
AB-30-CR11	XQVVPGYIWAGRNI-JOCHJYFZSA-N	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1	755038-02-9	Antimitotic Drugs;Polo-like Kinase-1 (Plk-1) Inhibitors
JF-30-FM28	XQYASZNUFDVMFH-CQSZACIVSA-N	C[C@@H]1CN(Cc2ccc(F)cc2)CCN1C(=O)COc1ccc(Cl)cc1NC(N)=O	217645-70-0	Chemokine CCR1 Antagonists
AC-17-PI61	XQYZDYMELSJDRZ-UHFFFAOYSA-N	COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC	132-40-1	Phosphodiesterase PDE10A Inhibitors
KE-97-MN12	XRASPMIURGNCCH-UHFFFAOYSA-N	O=P(O)(O)C(O)(Cn1ccnc1)P(=O)(O)O	118072-93-8	Angiogenesis Inhibitors
AA-98-FJ71	XRCFXMGQEVUZFC-UHFFFAOYSA-N	COc1ccc(C2C(=O)c3ccccc3C2=O)cc1	117-37-3	gamma carboxylation inhibitor
AC-50-FR41	XRFHWSYKRFEPRA-CYBMUJFWSA-N	COc1cncc(-c2cc(F)ccc2[C@H]2Cc3nc(N)nc(C)c3C(=O)N2)n1		Heat Shock Protein 90 (hsp90) Inhibitors
AC-73-GJ74	XRKYMMUGXMWDAO-UHFFFAOYSA-N	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1	587871-26-9	ATM Kinase Inhibitors;DNA Repair Inhibitors
HB-55-NJ83	XRMUPVMLIVXXAW-UHFFFAOYSA-N	Cc1c(CC(=O)O)c2cccnc2n1S(=O)(=O)c1ccc(F)c(C#N)c1		CRTH2 Receptor Antagonists
QF-41-QW99	XRPSUWYWZUQALB-UHFFFAOYSA-N	CCOc1ccc2c(-c3cccc(F)c3)nn(CC(=O)N(C)c3ccc4nc(C)oc4c3)c(=O)c2c1		CFTR corrector
HE-29-ZP52	XRWIDXUNUCQCLH-JOCHJYFZSA-N	Cc1oc(-c2ccccc2)nc1COc1cccc(C(C)(C)C(=O)N2CCC[C@@H]2C(=O)O)c1		
CB-48-WM43	XRXDAJYKGWNHTQ-UHFFFAOYSA-N	c1ccc2nc(N3CCNCC3)ccc2c1	1245646-84-7	5-HT3 receptor agonist selective against 5-HT1B
DD-73-IP88	XRYJULCDUUATMC-CYBMUJFWSA-N	C[C@@H](Nc1ncnc2[nH]c(-c3ccc(O)cc3)cc12)c1ccccc1	1350639-79-0	EGFR (HER1;erbB1) Inhibitors;HER2 (erbB2) Inhibitors;Inhibitors of Signal Transduction Pathways
AB-21-VE32	XSBJQWNBBMWICJ-UHFFFAOYSA-N	CN(c1ccc(-c2ccc(-c3cn[nH]c3)cc2O)nn1)C1CC(C)(C)NC(C)(C)C1	1562333-92-9	Splicing modulator
IC-91-IX22	XSHQBIXMLULFEV-UHFFFAOYSA-N	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21	221243-82-9	Extracellular-Regulated Kinase (ERK) Inhibitors;EphB4 Inhibitors;Angiogenesis Inhibitors;Extracellular-Regulated Kinase (ERK) Inhibitors;EphB4 Inhibitors;Angiogenesis Inhibitors
BF-53-AT13	XSOMTMVYQGTMOC-UHFFFAOYSA-N	CNC(=O)c1ccnc(NC(=O)N2CCC3(CCc4cccc(Cl)c4O3)CC2)c1	1247733-46-5	scd inhibitor
GA-47-MH68	XSYJUVKQRPLTAU-BKMGADMVSA-N	CO[C@@H](C(=O)N[C@H]1CC[C@@H](OC(=O)C2CCCCC2)CNC1=O)[C@H](O)[C@@H](O)[C@H](O)/C=C/C(C)(C)C	270902-51-7	Methionine Aminopeptidase-1 (MetAP1) Inhibitors;Methionine Aminopeptidase-2 (MetAP2) Inhibitors
HA-22-CY42	XTDZQFNXZCQIIJ-UHFFFAOYSA-N	CCNc1cc(-c2ccc3ncc4c(c3c2)n(-c2cn(CC)nc2C)c(=O)n4C)cnc1COC		dual mTOR/PI3K inhibitor
YF-77-FV50			524923-88-4	
HB-29-DM15	XTKGXPFBKPYFDW-UHFFFAOYSA-N	N=C(N)Nc1ccc(C(=O)Oc2ccc(CC(=O)O)cc2)cc1		
ND-03-LH88	XTKLTGBKIDQGQL-UHFFFAOYSA-N	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F	1372540-25-4	PI3Kbeta inhibitor
BF-49-QA17	XTKUZTBZRIJTFR-UHFFFAOYSA-N	FC(F)(F)c1ccc(Nc2nccc(-c3cccc(Cl)c3)n2)cc1		
HC-10-FJ51	XTLUDINLEUZFDI-UHFFFAOYSA-N	Cc1cc(C)c(S(=O)(=O)Nc2ccc(O)c(-c3c(O)ccc4ccccc34)c2)cc1C		
FA-66-LB92	XUKUURHRXDUEBC-KAYWLYCHSA-N	CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O	110862-48-1	HMG-CoA Reductase Inhibitors
ID-31-PA82	XUSDVLHKNBOGJY-FYYLOGMGSA-N	CCCCCCCCCCCCCC(=O)N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1	35922-06-6	Apoptosis Inducers;Ceramidase Inhibitors
CF-24-KQ98	XUSKJHCMMWAAHV-SANMLTNESA-N	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccc(O)cc1c2[Si](C)(C)C(C)(C)C	220913-32-6	DNA-Intercalating Drugs;DNA Topoisomerase I Inhibitors
OE-78-TD20	XUWLAGNFLUARAN-CHQNGUEUSA-N	C=CCN(CC=C)[C@@H](Cc1ccc(O)cc1)C(=O)NC(C)(C)C(=O)NC(C)(C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O	92535-15-4	delta-Opioid Inverse Agonists
IE-04-SI43	XUZWTJRGKMQTGI-UHFFFAOYSA-N	CC(C)(C)c1nc(Nc2nnc(Cc3ccncc3)c3ccccc23)sc1C#N		Drugs Acting on Estrogen Receptors (ER);Glucocorticoid Receptor (GR) Antagonists;Androgen Receptor Antagonists;Mineralocorticoid Receptor (MR) Antagonists
AE-09-IN08	XVECMUKVOMUNLE-UHFFFAOYSA-N	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12	865362-74-9	ERK1 Inhibitors;ERK2 Inhibitors
IC-28-HS37	XVECNLUKQDKOST-UHFFFAOYSA-N	CCCS(=O)(=O)c1nc(NC2CC2)cc(-c2ccc3c(ccn3C3CC(C)(C)NC(C)(C)C3)c2)n1		CECR2 inhibitor;CECR2 inhbitor
CE-25-VD54	XVHTYXUNNDYUPK-MRXNPFEDSA-N	COc1ccccc1[C@@H]1CCN(Cc2ccc3c(c2)OCCO3)C1	352312-63-1	alpha2-Adrenoceptor Antagonists
PB-59-HH22	XVMFFIALWXXWPW-UHFFFAOYSA-N	O=C(NCc1cccnc1)c1ccc(CNS(=O)(=O)c2ccc(F)cc2)cc1		NR2A Antagonists
LD-69-TV81	XVOIIUGMYVACGS-UHFFFAOYSA-N	CCCc1c(OCCCOc2cc(O)c(C(C)=O)cc2CC)ccc2c1OC(C(=O)O)CC2	156005-50-4	Leukotriene Antagonists;Leukotriene BLT (LTB4) Antagonists
CA-88-FC74	XVVBHKGQHJECBA-UHFFFAOYSA-N	CC(C)N1CCN(c2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CC1	1211441-71-2	CDK4 Inhibitors
ID-32-NA94	XVWPFYDMUFBHBF-CLOONOSVSA-N	COC(=O)[C@H](CC(C)C)NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1cccc2ccccc12	1217457-86-7	Farnesyl Transferase Inhibitors;Geranylgeranyl Transferase Type I (GGTase-I) Inhibitors
LC-19-SF48	XVYLNHVEAOOEGI-CURLCGPBSA-N	OC[C@H]1[C@@H](O)[C@H](O)[C@@H](O)CN1CCCCCOCC12CC3CC(CC(C3)C1)C2	1203659-60-2	Glucosylceramidase inhibitor
HC-89-WQ85	XWAONOGAGZNUSF-UHFFFAOYSA-N	Fc1ccc(-n2cc(CCCCN3CCC4(CC3)OCc3ccccc34)c3ccccc32)cc1	147817-50-3	
HF-39-BC66	XWLOYAAKIFUZDU-UHFFFAOYSA-N	Nc1ncc(C(=O)NC2CC2)c2ccc(-c3cccc(F)c3)nc12	1449276-86-1	MAP4K4 inhibitor
WF-85-JN16	XWNSOVPLENXWNU-UHFFFAOYSA-N	Cc1c(OC(C)c2ccc(CC(C)C)cc2)ccc(C(=O)Nc2ccccc2OCCCC(=O)O)c1C	119347-91-0	Steroid 5alpha-Reductase Inhibitors
AC-35-JA42	XWTYSIMOBUGWOL-UHFFFAOYSA-N	CC(C)(C)NCC(O)c1cc(O)cc(O)c1	1164563-86-3	beta2-Adrenoceptor Agonists
BA-60-DK24	XWVBOPKUSVZZPJ-UHFFFAOYSA-N	O=C(O)C1CCC(c2cc3cccnc3c(-c3cccc(F)c3)n2)CC1	524734-30-3	Phosphodiesterase IV Inhibitors
CC-07-LB64	XWZHCDCMXBLZFJ-UHFFFAOYSA-N	O=c1oc2cc(O)ccc2c2c1CCCCC2		
FC-19-RM40	XXJWYDDUDKYVKI-UHFFFAOYSA-N	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1	288383-20-0	VEGFR-1 (Flt-1) Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;Inhibitors of Signal Transduction Pathways;VEGFR-3 (FLT4) Inhibitors;Angiogenesis Inhibitors
BC-15-EL49	XXLAEKOWCYJOKK-UHFFFAOYSA-N	Oc1cccc(-c2nc(N3CCOCC3)c3sccc3n2)c1	371943-05-4	Phosphatidylinositol 3-Kinase alpha (PI3Kalpha) Inhibitors;Phosphatidylinositol 3-Kinase beta (PI3Kbeta) Inhibitors
KF-09-GB83	XXPANQJNYNUNES-CQSZACIVSA-N	CN1Cc2c(N)cccc2[C@@H](c2ccccc2)C1		
CC-14-WK34	XXPANQJNYNUNES-UHFFFAOYSA-N	CN1Cc2c(N)cccc2C(c2ccccc2)C1	118184-50-2	Dopamine Reuptake Inhibitors;Norepinephrine Reuptake Inhibitors
EB-47-BB89	XXSDLQLNIVFIJI-UHFFFAOYSA-N	Nc1ncc(-c2ccnc(Nc3ccncc3)n2)c(CC2CC2)n1	1383716-40-2	Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 (PIK3C3;Vps34) Inhibitors
CE-36-KR60	XXSMGPRMXLTPCZ-UHFFFAOYSA-N	CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12		
IB-94-WM88	XXUFNNVFZFVKGP-UHFFFAOYSA-N	CCOC(=O)N1CCN(C(=O)Cn2sc3nc(C)cc(C)c3c2=O)CC1	902589-96-2	DTYMK inhibitor
CE-58-XJ66	XXUPXHKCPIKWLR-JHUOEJJVSA-N	CCCCCCCC(=O)CC[C@@H]1[C@@H](C/C=C\\CCCC(=O)OC(C)C)[C@@H](O)C[C@H]1O		
AC-35-CK01	XXVLKDRPHSFIIB-UHFFFAOYSA-N	CN(C)CCN1C(=O)c2cccc3cc([N+](=O)[O-])cc(c23)C1=O		
LB-11-CG51	XYFPWWZEPKGCCK-UHFFFAOYSA-N	C=CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1	936563-87-0	Bruton's Tyrosine Kinase (BTK) Inhibitors
BE-27-CS60	XYKWNRUXCOIMFZ-UHFFFAOYSA-N	COc1ccc(-n2nc(CCC(=O)N(C)O)cc2-c2ccc(Cl)cc2)cc1	103475-41-8	Cyclooxygenase (COX) Inhibitors;Lipoxygenase Inhibitors;NF-kappaB (NFKB) Activation Inhibitors
KD-42-UK08	XYNNEMHCLNODBL-UHFFFAOYSA-N	Cc1ccc(C(=O)N2CC3CNCC(C2)O3)cc1NC(=O)CC12CC3CC(CC(C3)C1)C2		P2X7 Receptor Antagonists
BA-50-HH67	XYNPYHXGMWJBLV-VXPJTDKGSA-N	C[C@H]1CC[C@]2(NC1)O[C@H]1C[C@H]3[C@@H]4CC[C@H]5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C		
UC-52-SS41	XYRDHZXSQUWVCD-UHFFFAOYSA-N	CCC(OC)(c1cccc(OCc2ccc3ccccc3c2)c1)c1nccs1	129424-08-4	Leukotriene Synthesis Inhibitors;Lipoxygenase Inhibitors;Non-Steroidal Antiinflammatory Drugs
EC-41-PH99	XYSLUZSLUPHDCY-UHFFFAOYSA-N	Cc1cc(Nc2nc(Nc3cc(C(F)(F)F)c(C4CCN(CC(N)=O)CC4)cc3F)ncc2Cl)n[nH]1		
RE-97-MC55	XYUYSDBKGVJSKN-UHFFFAOYSA-N	CN(C)CCCn1nc(C2=C(c3cn(-c4ccc5ccccc5c4)c4ccccc34)C(=O)NC2=O)c2ccccc21		Inhibitors of Signal Transduction Pathways;Protein Kinase PKC beta Inhibitors;Angiogenesis Inhibitors
EF-52-ML96	XZIZUQSOFMLIIR-CQSZACIVSA-N	c1ccc2c(c1)CCC[C@H]2Nc1nc2ccccc2[nH]1	875755-24-1	
EF-74-KW12	XZTUSOXSLKTKJQ-CESUGQOBSA-N	C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C3=CC(=O)OC3)CC[C@]12O	143-62-4	Cardiac glycoside
PA-15-CI45	XZVPTVGMYKLOAB-HEAIWPOISA-N	CCOC(=O)C(O)C(O)C(Cc1ccc(-c2cc(Cl)cc(Cl)c2)cc1)NC(=O)[C@H](C)N	1431562-48-9	Ubiquitin-Conjugating Enzyme E2 R1 (CDC34) Inhibitors
UF-14-LK87	XZWYZXLIPXDOLR-UHFFFAOYSA-N	CN(C)C(=N)N=C(N)N	1115-70-4	inhibitor of mitochondrial complex I of the electron transport chain;AMP-Activated Protein Kinase (AMPK) Activators;MTTP Inhibitor;mitochondrial repiratory chain 1 inhibitors;adenine deaminase inhibitor;GPD2 gene modulator
BB-69-YQ35	XZYRDNUZENBYFI-UHFFFAOYSA-N	Nc1c[n+](N2CCOCC2)no1	16142-27-1	Nitric Oxide Donors
CB-73-MJ69	XZZHOJONZJQARN-UHFFFAOYSA-N	O=C(O)c1c[nH]c2c(ccc3cccnc32)c1=O	331830-20-7	HIF prolyl hydroxylase-1 inhibitor
CC-44-MG29	XZZOJFOFCDHYRX-UHFFFAOYSA-N	CN1CC2(CNC(=O)c3c2[nH]c2c3CCc3cnc(-c4ccccc4F)cc3-2)C1	1105659-16-2	MAPKAP-K2 (MK2) Inhibitors
BA-51-NO76	YACHGFWEQXFSBS-GKUACYEYSA-N	CCC(=C/C(C)C/C=C/C(C)=C/C(C)C(=O)C(C)C(O)C(C)C/C(C)=C/C(=O)O)/C=C/C1OC(=O)C=CC1C		XPO1 (CRM1) inhibitor
VE-23-IJ47	YADWCLRVZMIWHF-UHFFFAOYSA-N	FC(F)(F)c1cccc(Nc2nccc(-c3nccs3)n2)c1		
FB-30-CD67	YAFQFNOUYXZVPZ-UHFFFAOYSA-N	Clc1cccc(CNC2=Nc3ccccc3NC23CCNCC3)c1		
AC-78-GT35	YAKSFKRNONBMDV-GOSISDBHSA-N	CCCOc1ccc2cc(CC[C@@](C)(N)CO)ccc2c1		
GA-89-ZT62	YAOAMZOGXBMLFQ-UHFFFAOYSA-N	N=C(N)NCCCCCCCN	150333-69-0	DHPS inhibitor
CD-47-YL43	YAORIDZYZDUZCM-UHFFFAOYSA-N	c1ccc(C2CC2)c(OCC2=NCCN2)c1	40600-13-3	ADRA1B agonist;ADRA1D agonist
AB-01-NB05	YASAKCUCGLMORW-UHFFFAOYSA-N	CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1	1217260-35-9	Insulin Sensitizers;PPARgamma Agonists
BA-86-YY52	YASBOGFWAMXINH-JSGCOSHPSA-N	CN1CC[C@H]2CN3CCc4cccc(c43)[C@H]2C1		5-HT2B Antagonists;5-HT2C Antagonists
UC-20-ZV24	YAWWQIFONIPBKT-FQEVSTJZSA-N	CCCC[C@@]1(C2CCCC2)Cc2cc(OCC(=O)O)c(Cl)c(Cl)c2C1=O	81166-47-4	Erythrocyte Cl- transport system inhibitor
AB-16-HE44	YAZSBRQTAHVVGE-UHFFFAOYSA-N	Nc1ccccc1S(N)(=O)=O	1348915-35-4	Carbonic anhydrase inhibitor
OA-45-SS39	YBAJVMDZJITCEZ-WMZHIEFXSA-N	COc1ccc([C@@H]2C[C@H](C(F)(F)F)n3nc(-c4ccc(C(=O)N5CCNCC5)cc4)cc3N2)cc1OC		Toll-like receptor 7, toll-like receptor 8
CD-13-QZ32	YBKDMLFWQHJAMJ-UHFFFAOYSA-N	O=C(CCCCCNC(=O)c1ccc(OCc2ccccc2)cc1)NO		Histone Deacetylase (HDAC) Inhibitors
OB-83-EA66	YBKFCWABWAQJTN-VQTJNVASSA-N	CC(=O)N1CSC[C@@H]1C(=O)N[C@@H](Cc1ccc(OCc2c(Cl)cccc2Cl)cc1)C(=O)O	217478-98-3	Cell Adhesion Inhibitors;Integrin alpha4beta1 (VLA-4) Antagonists
IC-60-AG74	YBMGNDPBARCLFT-UHFFFAOYSA-N	COc1ccc(C2C(C#N)=C(N)OC3=C2C(=O)CC(c2cccc4ccccc24)C3)cc1	1118460-77-7	SLC1A3 - EAAT1/GLAST inhibitor
EF-22-PB37	YBNROIWEBSZURX-UHFFFAOYSA-N	COCC(=O)N(CC(N)=O)c1nc(NCc2ccc(C(F)(F)F)cc2)c2ncn(C)c2n1	206275-65-2	Glycogen Synthase Kinase 3 (GSK-3) Inhibitors
GE-40-GQ38	YBPIBGNBHHGLEB-UHFFFAOYSA-N	Nc1ccc(C(=O)Nc2cccc(-c3nc(N4CCOCC4)c4oc5ncccc5c4n3)c2)cn1	371942-69-7	PIKFYVE gene inhibitor;Apoptosis-independent
IE-46-OA29	YBSDQTBCNYWBMX-ONEGZZNKSA-N	Fc1ccc2c(/C=C/c3cccnc3)c[nH]c2c1	163239-22-3	Tryptophan 2,3 dioxygenase inhibitor
LA-99-FV41	YBSJFWOBGCMAKL-UHFFFAOYSA-N	Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21	211914-51-1	Known Thrombin inhibitor
CA-42-YI34	YBTIDKMFVSZULE-HOTGVXAUSA-N	Nc1nc(=O)n([C@H]2CC[C@H](NC(=O)c3cc(-c4cc5ccccc5s4)ccn3)C2)cc1F	1034174-88-3	DCK gene inhibitor;Deoxycytidine kinase-1 inhibitor
TF-77-DW08	YBTRRYYNHWVJLG-UHFFFAOYSA-N	CCN(CC)C(=O)CCC1(c2ccc(Cl)cc2)c2c(OC)cccc2-c2nccn21	1227197-32-1	NPSR1 antagonist;Neuropeptide S Receptor 1 (NPSR1) Antagonists
BA-31-AB30	YBWLTKFZAOSWSM-UHFFFAOYSA-N	COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C)cn2)nc(-c2ccncc2)nc1OC	290815-26-8	Endothelin ETA Receptor Antagonists
CC-72-ZV25	YBZBAKCPGGZDTH-UHFFFAOYSA-N	c1ccc(CC(NC2=NCCS2)c2ccccc2)cc1	1058720-68-5	alpha2A(2D)-Adrenoceptor Agonists;alpha2B-Adrenoceptor Agonists
AB-09-NX37	YCAACZFPADQMAR-UHFFFAOYSA-N	COCCOCc1ccc(-c2cc3onc(-c4ccccc4)c3c(=O)n2C)cc1		Nuclear Receptor Subfamily 4 Group A Member 2 (NR4A2, NURR1) Agonists
CC-41-SI77	YCHGQICUQDEGMP-UHFFFAOYSA-N	Cc1c(C(=O)Nc2c(C)n(C)n(-c3ccccc3F)c2=O)noc1-c1ccc(C2CC2)cc1Cl		SMAD-1 inhibitor;SMURF1 inhibitor
AA-22-FS33	YCOYDOIWSSHVCK-UHFFFAOYSA-N	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1	212141-51-0	Angiogenesis Inhibitors;Aromatase Inhibitors;Inhibitors of Signal Transduction Pathways;KIT (C-KIT) Inhibitors;PDGFRbeta Inhibitors;VEGFR-1 (Flt-1) Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;VEGFR-3 (FLT4) Inhibitors
SA-87-MW08	YCTGZMYVONHILF-DNUNIWOASA-N	COCCCCOc1ccccc1C(=O)NC[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCCC1CCN(C(C)=O)CC1)C(C)C)C(C)C		Renin Inhibitor
GF-72-OO48	YCXFHPUBGMMWJQ-UHFFFAOYSA-N	Cc1cccc(NC(=O)NC2N=C(c3ccccc3)c3ccccc3N(CC(=O)c3ccccc3C)C2=O)c1		
FA-57-CO50	YDBCEBYHYKAFRX-UHFFFAOYSA-N	COc1ccc(NC(=O)c2ccc(-c3ccc(-c4noc(C)n4)cc3C)cc2)cc1N1CCN(C)CC1	1049739-35-6	HTR1D antagonist
BA-74-EG74	YDBLKRPLXZNVNB-UHFFFAOYSA-N	Cc1cc(SCc2sc(-c3ccc(C(F)(F)F)cc3)nc2C)ccc1OCC(=O)O	317318-70-0	Insulin Sensitizers;PPARdelta Agonists
BD-73-TX58	YDEUKNRKEYICTH-UHFFFAOYSA-N	Nc1ccc(O)c2ncccc12	13207-66-4	Apoptosis Inducers;Proteasome Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Apoptosis Inducers;Proteasome Inhibitors;NF-kappaB (NFKB) Activation Inhibitors
HB-77-UY14	YDPMMWAOCCOULO-JBRSBNLGSA-N	CO[C@H]1CNC[C@@H](OCC2CCC(F)(F)CC2)[C@@H]1Nc1ncc(-c2cncc(C)c2)c2cc(C)c(=O)[nH]c12		inhibitor of ATAD2 bromodomain;N-Ac Lysine competitive ATAD2A/B inhibitor
MF-41-QM60	YDYSCRZHYWLSPQ-INIZCTEOSA-N	N[C@@H](CCCCNC(=O)OCc1ccc([N+](=O)[O-])cc1)C(=O)N1CCCC1	136259-18-2	Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors
CB-13-ZM96	YDYXDRNASMJPTJ-UHFFFAOYSA-N	Cc1cc(Nc2nc(Nc3cc(C)c(C4CCN(C5CC5)CC4)cc3F)ncc2Cl)n[nH]1		
DA-83-VJ09	YDZNRNHKJQTGCG-UHFFFAOYSA-N	O=C(O)c1ccc2ccccc2c1-c1c(C(=O)O)ccc2ccccc12	18531-96-9	CDC-Like Kinase 4 (CLK4) Inhibitors
BB-75-JK26	YECJXONJMOAUGJ-UHFFFAOYSA-N	CSc1nc(N)nc(SCC(=O)n2nc(C)cc2C)c1C#N	311812-74-5	
AB-96-JV50	YEEZWCHGZNKEEK-UHFFFAOYSA-N	COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12	107753-78-6	Leukotriene CysLT1 (LTD4) Antagonists
CC-16-ZE49	YEJCDKJIEMIWRQ-UHFFFAOYSA-N	O=C1N(c2ccccc2)c2ccccc2C1(Cc1ccncc1)Cc1ccncc1	105431-72-9	Acetylcholine Release Enhancers
HD-95-OT07	YEMXHRPEHMDPDD-JXFKEZNVSA-N	C[C@H](NC(=O)O[C@@H](CC1CCCCC1)C(=O)N1CCOCC1)C(=O)c1nc2ccccc2o1		highly selective inhibitor of cathepsin S;Cathepsin S Inhibitors
XC-12-SL04	YEQJVHQCUDMXFG-FHZYATBESA-N	CC(C)(O)CC[C@H](C[C@H](O)[C@H](Cc1cccc(F)c1)NC(=O)c1cnc2ccccc2n1)C(N)=O	212790-31-3	Chemokine CCR1 Antagonists
JD-10-HW02	YEQJVHQCUDMXFG-JWNTYJGQSA-N	CC(C)(O)CC[C@@H](C[C@@H](O)[C@H](Cc1cccc(F)c1)NC(=O)c1cnc2ccccc2n1)C(N)=O		
JD-01-RA07	YEUGJDPRUKBRDK-UHFFFAOYSA-N	Cc1cc(C)nc(NS(=O)(=O)c2ccc(NCc3ccccc3C)cc2)n1	491600-31-8	alpha2B-Adrenoceptor Antagonists
LB-24-DV44	YEVLSUSEISXRDN-VOTSOKGWSA-N	O=c1[nH]cnc2[nH]c(-c3ccnc(/C=C/C4CCCCC4)c3)cc12		
AE-38-EW02	YEYAKZXEBSVURO-UHFFFAOYSA-N	CCN(CC)CCNC(=O)c1ccc(N)c(Cl)c1	891-60-1	Apoptosis Inducers;NF-kappaB (NFKB) Activation Inhibitors;5-HT3 antagonist;Apoptosis Inducers;NF-kappaB (NFKB) Activation Inhibitors;5-HT3 antagonist
AA-91-XV98	YEZNLOUZAIOMLT-UHFFFAOYSA-N	Cc1c(Cl)cccc1Nc1ccccc1C(=O)O		
AE-32-NZ70	YFDNXWTWDPWCOC-GQCTYLIASA-N	Cc1nnn(Cc2cc(C(F)(F)F)ccc2/C=C/C(=O)N2CCC(c3nnc(C)o3)CC2)n1		Autotaxin inhibitor
AE-62-QI94	YFDSDRDMDDGDFC-HOQQKOLYSA-N	CC(C)C[C@H](O)[C@H](O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1cscn1)NC(=O)[C@H](Cc1ccccc1)CS(=O)(=O)N1CCN(C)CC1	138742-43-5	Renin Inhibitors
FA-56-WH26	YFHRCLAKZBDRHN-MRXNPFEDSA-N	CC(C)(NC(=O)O[C@@H]1CN2CCC1CC2)c1csc(-c2ccc(F)cc2)n1	1401090-53-6	
GD-23-GS20	YFIAGILPWYUJOO-UHFFFAOYSA-N	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCC(O)C4)ccc3n2)c1		Inhibitors of Signal Transduction Pathways;Rho Kinase 1 (ROCK 1;p160-ROCK) Inhibitors;Rho Kinase 2 (ROCK 2;ROCKalpha) Inhibitors
AE-66-YB82	YFUXWHLSMLQHNR-UHFFFAOYSA-N	N/C(=N\\C(=O)c1nc(Cl)c(N)nc1N)NCCCCNC(=O)c1ccc(C(=O)NCCCCN/C(N)=N/C(=O)c2nc(Cl)c(N)nc2N)cc1		Epithelial Sodium Channels (ENaC) Blockers
EB-72-SO78	YGCWTLJXPQFPEQ-UHFFFAOYSA-N	CN(C)CC1=C(c2cccnc2)c2ccccc2C1		mu-Opioid Receptor Ligands;5-HT Reuptake Inhibitors;Norepinephrine Reuptake Inhibitors
LE-80-BM08	YGEPYVAQKIHLFY-FYWRMAATSA-N	CCCCCCCCOc1c(OC)cc(/C=C/C(=O)N2CCN(c3ccc(C)c(C)c3)CC2)cc1OC	214265-97-1	
LF-27-NX16	YGIDGBAHDZEYMT-MQFIMZJJSA-N	OC[C@H]1O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4cccc(F)c4)nn3)[C@H]2O)[C@H](O)[C@@H](n2cc(-c3cccc(F)c3)nn2)[C@H]1O	1450824-22-2	Galectin 3 Inhibitors;Galectin-3 inhibitor
AB-00-HA50	YGSDEFSMJLZEOE-UHFFFAOYSA-N	O=C(O)c1ccccc1O		
AC-75-LR63	YGURPIQSTIMWPG-UHFFFAOYSA-N	O=C(c1ccccc1)N1CCC(N(C(=O)CCl)c2ccccc2)CC1		covalent modifier of catalytic cysteine of pro-CASP8 and pro-CASP10
VE-28-FM71	YGXIELIREXEJQN-UHFFFAOYSA-N	O=C1N=C(N2CCCCC2)CN1c1ccc(Cl)cc1	188116-08-7	GABA(A) BZ Site Receptor Partial Agonists
ND-27-UQ99	YHCNHDIDECZSCA-AGHHOFFYSA-N	CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3ccc(O)c(Br)c3)[C@@H]2O)c1	1292799-14-4	beta-Secretase 1 (BACE1) Inhibitors;beta-Secretase 2 (BACE2) Inhibitors;Cathepsin E Inhibitors
AF-23-RM26	YHFUDIOQQYJGOQ-UHFFFAOYSA-N	O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1cc[n+]([O-])cc1		Angiogenesis Inhibitors;VEGFR Inhibitors
YB-54-ET23	YHHFKWKMXWRVTJ-OQKWZONESA-N	Clc1ccc(N/N=C(\\c2ccccc2)c2ccccn2)nc1	199596-05-9	JMJD2 Histone Demethylase Inhibitor
UB-76-QL04	YHWLQRCELGIAGV-UHFFFAOYSA-N	COCCNc1cc(-n2ncnc2Nc2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc2C)ncn1		
AA-07-BW60	YHXISWVBGDMDLQ-UHFFFAOYSA-N	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	108375-13-9	MAO-A Inhibitors
GD-48-HM23	YIDDLAAKOYYGJG-UHFFFAOYSA-N	Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1	1448428-04-3	MAP3K5 inhibitor
CD-59-PT17	YILJWHUIUCRKEU-UHFFFAOYSA-N	CCCCc1nc2cccnc2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1	133052-30-9	Angiotensin Receptor Antagonists
JB-14-TF61	YIQPUIGJQJDJOS-UHFFFAOYSA-N	c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1	110078-46-1	Chelating Agents;Chemokine CXCR4 (SDF-1 Receptor) Antagonists;HIV Attachment Inhibitors;CXCR4 antagonist
GC-09-XF08	YIUBSFCQATYQJB-VCMDLEIESA-N	CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@H](Cc1ccccc1)C(=O)O		Bradykinin B1 Agonists
DB-42-FS68	YJDYDFNKCBANTM-QCWCSKBGSA-N	C/C=C/C[C@@H](C)C(=O)[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C		
SA-43-QT61	YJFKVTUXWSYLEL-UHFFFAOYSA-N	S=c1[nH]c(-c2cc(Cl)ccc2Cl)nn1Cc1ccccc1		Chemokine CXCR2  (IL-8 beta Receptor) Antagonists
VA-92-QP54	YJGVMLPVUAXIQN-HAEOHBJNSA-N	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC	118627-04-6	CASP3 activator;apoptosis inhibitor;IGF1R inhibitor;IGF-1R Inhibitors;Caspase 3 Activators;Apoptosis Inducers
DA-10-GX45	YJGVMLPVUAXIQN-XVVDYKMHSA-N	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC	11016-28-7	
FE-99-RJ28	YJJLUDGRBLUWTF-LBPRGKRZSA-N	C[C@H](N)C(=O)NCc1cccc(-n2nc(C(F)(F)F)cc2-c2nnc(-c3ccccc3Cl)o2)c1		CARM1 / PRMT4 inhbitor;CARM1 inhibitor
OC-25-TL77	YJXMVZWBSKFEBU-UHFFFAOYSA-N	COC(=O)c1sccc1NC(=O)Cc1ccccc1		
BE-65-HV88	YJYPHIXNFHFHND-UHFFFAOYSA-N	COc1ccc2cccc(CCNC(C)=O)c2c1	1176316-99-6	melatonergic antidepressant;5-HT2C Antagonists;Melatonin MT1 Agonists;Melatonin MT2 Agonists
HA-50-AT10	YKDZBRSWSREMEA-YWWLSZNVSA-N	C[C@]12CCC(=O)C=C1C[C@@H](Sc1ccccc1)C1C2CC[C@@]2(C)C1CC[C@@]21CCC(=O)O1		17beta-Hydroxysteroid Dehydrogenase Type 2 (17beta-HSD2) Inhibitors
AF-76-FL46	YKGYIDJEEQRWQH-UHFFFAOYSA-N	CCOC(=O)c1ccc(OC(=O)CCCCCN=C(N)N)cc1	39492-01-8	AP-1 Inhibitors;Tryptase Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;MATE1 Inhibitors;AP-1 Inhibitors;Tryptase Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;MATE1 Inhibitors
AB-98-HT45	YKPUWZUDDOIDPM-SOFGYWHQSA-N	COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O	404-86-4	Vanilloid receptor agonist
VC-30-QH05	YKPUWZUDDOIDPM-VURMDHGXSA-N	COc1cc(CNC(=O)CCCC/C=C\\C(C)C)ccc1O	25775-90-0	TRPV1 (Vanilloid VR1 Receptor) Agonists
AE-19-ZK31	YKPYIPVDTNNYCN-INIZCTEOSA-N	CC1(C)SCCN(S(=O)(=O)c2ccc(Oc3ccncc3)cc2)[C@H]1C(=O)NO	1435779-45-5	MMP-2 (Gelatinase A) Inhibitors;MMP-9 (Gelatinase B) Inhibitors;Angiogenesis Inhibitors;MMP-2 (Gelatinase A) Inhibitors;MMP-9 (Gelatinase B) Inhibitors;Angiogenesis Inhibitors
KB-77-BA46	YKRHGHVJNYCHEN-UHFFFAOYSA-N	Cc1ccc(C(=O)NC2CC2)cc1-n1ncc(C(=O)c2ccccc2)c1N	836682-64-5	p38 MAPK Inhibitors
BD-40-EK64	YKROJXPZFTZLDK-UHFFFAOYSA-N	CC(C)(C)c1cc(C(C(=O)O)c2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)cc(C(C)(C)C)c1O	15534-92-6	LDL Antioxidants
AC-51-PY60	YKYCELLZOAVFCT-UHFFFAOYSA-N	Cc1ccc(S(=O)(=O)Nc2nnc(-c3ccccc3)s2)cc1	19948-89-1	Kynurenine 3-Monooxygenase Inhibitors
AB-42-AI99	YLFMCMWKHSDUCT-UHFFFAOYSA-N	O=c1[nH]c2cc(C(F)(F)F)ccc2n1-c1cc(C(F)(F)F)ccc1O	153587-01-0	Large Conductance K(Ca) 1.1 (BK, maxi K+) Channel Activators
CB-01-MR53	YLFZHHDVRSYTKT-NRFANRHFSA-N	CCOCc1cc(OC)c(-c2ccc(C[C@H](NC(=O)c3c(F)cccc3F)C(=O)O)cc2)c(OC)c1	402567-16-2	Integrin alpha4beta7 (LPAM-1) Antagonists;Integrin alpha4beta1 (VLA-4) Antagonists
WF-24-LG17	YLGBZXMOCLUOKZ-QFIPXVFZSA-N	N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NC1CCN(Cc2c[nH]c3ccccc23)CC1		
AB-09-PR28	YLJREFDVOIBQDA-UHFFFAOYSA-N	Nc1c2c(nc3ccccc13)CCCC2	1684-40-8	Acetylcholinesterase Inhibitors;Butyrylcholinesterase Inhibitors
ED-11-BL19	YLPZTDCVMOWRPZ-CVEARBPZSA-N	Cn1cc(CNc2cc(OC[C@H]3C[C@@H]3c3ccccn3)nc3ccnn23)cn1		PDE10A gene inhibitor
BC-91-YI62	YLUUOWHPDIWHBD-UHFFFAOYSA-N	O=C(CN1CCC(n2c(=O)[nH]c3cc(-c4nnn[nH]4)ccc32)CC1)c1ccc(Cl)cc1	1037834-87-9	Serine Palmitoyltransferase (SPT) Inhibitors
DB-68-AC34	YMFDSPVIOOOQTH-HXUWFJFHSA-N	CN1CCN(c2cc(N3CCC[C@@H](C(=O)NCCc4ccc(C#N)cc4)C3)nc(C(F)(F)F)n2)CC1	1595144-49-2	GPBAR1 agonist
FA-77-LS25	YMIKAQYPFQWUEM-UHFFFAOYSA-N	CSc1sc(-c2cc[nH]n2)c2c1C(=O)CC(C)(C)C2	207307-44-6	Ligand of the GABAA alpha5 receptor subtype
AC-97-KP88	YMQHMPUWBKBXEA-UHFFFAOYSA-N	COc1ccc(Nc2cc(-c3cccc(O)c3)nc(N3CCOCC3)n2)cn1	701243-21-2	Phosphatidylinositol 3-Kinase delta (PI3Kdelta) Inhibitors;Phosphatidylinositol 3-Kinase alpha (PI3Kalpha) Inhibitors
BA-37-NF64	YMTINGFKWWXKFG-UHFFFAOYSA-N	CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1	49562-28-9	APOA1 Expression Enhancers;PPARalpha Agonists
CA-96-UO48	YNANGXWUZWWFKX-UHFFFAOYSA-N	COc1ccc(C(=O)C(=O)c2ccc(OC)cc2)cc1	1226-42-2	Carboxylesterase Inhibitors
LA-24-RZ79	YNCHESVKDKRUDJ-SJSRKZJXSA-N	OC[C@H]1O[C@@H](c2ccc(C3CC3)c(Cc3ccc4c(c3)OCCO4)c2)[C@H](O)[C@@H](O)[C@@H]1O	1291094-71-7	SGLT-1 Inhibitors;SGLT-2 Inhibitors
BC-37-HI51	YNGFNKUXMJZNCR-UHFFFAOYSA-N	Cc1nccn1-c1sc(Nc2cnccn2)nc1-c1cccc(C#N)c1	431040-19-6	Adenosine A2B Antagonists;Adenosine A3 Antagonists
AC-28-RT00	YNIGIJNKAURBRK-CPJSRVTESA-N	CC(C)(C)[C@H](c1nc(-c2cc(F)ccc2F)cn1Cc1ccccc1)N(CC[C@H](N)CF)C(=O)CO	1161925-41-2	Antimitotic Drugs;Kinesin-Like Spindle Protein (KSP, Eg5) Inhibitors
UF-27-OP66	YNKICMROKLRBAY-UHFFFAOYSA-N	Clc1ccc(-c2n[nH]c3ccc(-c4nnn[nH]4)cc23)cc1		SAPK1a (JNK2) Inhibitors
GD-56-YA39	YNLOODBDGBLPCM-UHFFFAOYSA-N	Cc1cc(CCC(=O)O)cc(C)c1-c1nc2ccc(C(=O)Nc3ccc4ccccc4n3)cc2[nH]1	1021165-30-9	DGAT1 gene inhibitor
IE-19-LI00	YNQONPYZDIKVFM-UHFFFAOYSA-N	O=C1NC(=O)C(c2cn(CCCO)c3ccccc23)=C1c1c[nH]c2ccccc12	170364-27-9	Protein Kinase C (PKC) Inhibitors
CB-75-PH34	YNUAEEJQYHYLMS-UHFFFAOYSA-N	O=C1c2cc(-c3ccc(OC(F)(F)F)cc3)ccc2OCCN1Cc1ncccn1	1443211-72-0	Nav1.5 channel inhibitor
BC-43-PD20	YNXYTOJEFCKHEM-UHFFFAOYSA-N	COCCNC(=O)c1cccc(-c2cccc3cc(Cc4cc(F)cc(Cl)c4)sc23)c1	1207965-40-9	GPR52 agonist
DC-72-IB32	YNZXWQJZEDLQEG-UHFFFAOYSA-N	COc1cc2c(N)nc(N3CCN(C(=O)OCC(C)(C)O)CC3)nc2c(OC)c1OC	35795-16-5	alpha-Adrenoceptor Antagonists
XB-75-YN01	YOGVFFRGTMXMRZ-UHFFFAOYSA-N	CC(C)COC1CCN2CC1OC2=O		Cathepsin B Inhibitors
FF-14-JG89	YOIDHZBOHMNTNP-UHFFFAOYSA-N	Cc1ccc(S(=O)(=O)NC(=O)Nc2ccc(Cl)cc2)cc1	3955-50-8	Tumor NADH Oxidase (tNOX) Inhibitors
BB-89-HE42	YOLTZIVRJAPVPH-UHFFFAOYSA-N	Brc1cc2c(cc1C1Nc3ccccc3C3C=CCC31)OCO2	1005086-82-7	GPER antagonist
OE-78-XD40	YONLFQNRGZXBBF-UHFFFAOYSA-N	O=C(OC(C(=O)O)C(OC(=O)c1ccccc1)C(=O)O)c1ccccc1	100632-52-8	Dopamine D3 Antagonists
BD-02-US28	YOPFAMROKXHVCQ-UHFFFAOYSA-N	Cc1c(CC(=O)O)c2cccnc2n1Cc1ccc(S(C)(=O)=O)cc1	872365-16-7	Angiogenesis Inhibitors;Apoptosis Inducers;Nicotinamide Phosphoribosyltransferase (NMPRTase) Inhibitors
BA-19-VU85	YOSHYTLCDANDAN-UHFFFAOYSA-N	CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1	138402-11-6	Angiotensin AT1 Antagonists
AD-32-RF17	YOVGCKBDPOHLAV-CNIHBODFSA-N	CCOC[C@@H](CC(C)C)NC(=O)[C@@H]1CNC[C@H](C(=O)N(c2ccc(C(C)C)cn2)C2CC2)[C@@H]1O	1093955-02-2	Renin Inhibitors;direct renin inhibitor
HA-82-XO48	YOYDGKNKZANQBG-UHFFFAOYSA-N	Clc1ccc2[nH]c3cnccc3c2c1	30684-46-9	
HC-94-AQ98	YOZBGTLTNGAVFU-UHFFFAOYSA-N	Cc1nc(C(=O)NCC(=O)O)c(O)c2ccc(Oc3ccccc3)cc12	808118-40-3	hypoxia-inducible factor prolyl hydroxylase inhibitor
BB-45-NH69	YPELFRMCRYSPKZ-UHFFFAOYSA-N	CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1	112885-41-3	5-HT4 Agonists
CE-20-VA70	YPHMISFOHDHNIV-FSZOTQKASA-N	C[C@@H]1C[C@@H]([C@H](O)CC2CC(=O)NC(=O)C2)C(=O)[C@@H](C)C1	1154-57-0	Translation Inhibitor;Glycogen Synthase Kinase 3 beta (GSK-3beta;tau Protein Kinase I) Inhibitors;Translation Inhibitor;Glycogen Synthase Kinase 3 beta (GSK-3beta;tau Protein Kinase I) Inhibitors
IC-05-AW29	YPIQVCUJEKAZCP-UHFFFAOYSA-N	CC(C)OC(=O)C(C(=O)OC(C)C)=C1SC=CS1		
S0-EE-YFUH	YPPSMYLMSKHYAY-UHFFFAOYSA-N	Cc1ccc2cc(-c3c(C)ccc(C(=O)c4c(-c5ccccc5)n(C)n(-c5ccccc5)c4=O)c3N)ccc2n1		PERK kinase inhibitor
JC-76-VX29	YPRWYZSUBZXORL-UHFFFAOYSA-N	O=[N+]([O-])c1ccc2c(c1)CNCC2	1198285-38-9	phenylethanolamine N-methyltransferase inhibitor
BB-33-HC27	YQABUUDNACVDEO-UHFFFAOYSA-N	CNC(=O)c1c(NCC2CCC3(CCC3)CC2)nc(C#N)nc1OCCO		Cathepsin S Inhibitors
DB-88-VW47	YQNRVGJCPCNMKT-LFVJCYFKSA-N	C=CCc1cccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)c1O	315183-21-2	Apoptosis Inducers;Procaspase 3 Activators
WE-41-YO44	YQPLKJCBEOVDBS-UHFFFAOYSA-N	N=C(N)Nc1ccc(CNC(=O)NC23CC4CC(CC(C4)C2)C3)cc1	282718-42-7	Urokinase (u-PA) Inhibitors;Angiogenesis Inhibitors
AF-64-CQ08	YQUVCSBJEUQKSH-UHFFFAOYSA-N	O=C(O)c1ccc(O)c(O)c1	1225528-47-1	Apoptosis Inhibitors;Dihydroorotate Dehydrogenase (DHODH) Inhibitors;Antioxidants;beta-Amyloid (Abeta) Protein Neurotoxicity Inhibitors
EC-62-HO43	YQYVFVRQLZMJKJ-UHFFFAOYSA-N	CC1C2Cc3ccc(O)cc3C1(C)CCN2CC1CC1	3572-80-3	Opioid agonist-antagonists
IA-95-KW09	YRCPIXCRSAKRGM-UHFFFAOYSA-N	COc1cc(C(=O)NS(=O)(=O)c2ccccc2)ccc1Cn1ncc2ccc(NC(=O)OC3CCCC3)cc21	104448-53-5	Leukotriene Antagonists
BA-88-HT15	YRDHKIFCGOZTGD-UHFFFAOYSA-N	CN1C(=O)c2sccc2N(C)c2nc(Nc3ccc(S(N)(=O)=O)cc3)ncc21		MST1/2 inhibitor
CD-18-RM48	YREYEVIYCVEVJK-UHFFFAOYSA-N	COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C	117976-89-3	H+/K+-ATPase Inhibitors
MB-32-LQ97	YRGYYQCOWUULNF-UHFFFAOYSA-N	Cc1cc(O)[nH]c(=O)c1C#N	40401-47-6	Uridine Phosphorylase Inhibitors
UC-58-DM11	YRVIKLBSVVNSHF-JTQLQIEISA-N	Cc1ncccc1OC[C@@H]1CCCN1	161417-03-4	Nicotinic Receptor Partial Agonists
CC-49-CQ25	YSBGRVXJEMSEQY-DEOSSOPVSA-N	Cn1c(SCC(=O)N2CCC[C@H]2C(=O)Nc2ccccc2-c2ccccc2)nc2ccccc21	916141-36-1	Orexin OX-1 Antagonists;Orexin OX-2 Antagonists
CB-36-QH71	YSGSJSXBWTXSSX-DTQAZKPQSA-N	CCN(CC)C(=O)/C=C(\\C)c1ccc(Oc2ccccc2)c(OCC(=O)O)c1		
TC-45-JH72	YSSBJODGIYRAMI-IAGOWNOFSA-N	O[C@@H]1CCCC[C@H]1N1CCC(c2ccccc2)CC1	112709-59-8	
GA-94-KZ19	YSTVFDAKLDMYCR-NDEPHWFRSA-N	Cc1cc(Cn2cnc3c2C[C@@H](C(=O)O)N(C(=O)C(c2ccccc2)c2ccccc2)C3)ccc1N(C)C	130663-39-7	AGTR2 antagonist
GE-25-DQ65	YSUBLPUJDOWYDP-UHFFFAOYSA-N	CCOc1ccc(Oc2ccc(OCc3cc(F)ccc3F)cc2)c(N)c1	223104-29-8	Na+/Ca2+ Exchanger type 1 (NCX1) Inhibitors
FB-12-UL66	YSXKPIUOCJLQIE-UHFFFAOYSA-N	OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2	1235-82-1	Anticholinergics
TB-55-WY28	YTRNLFYTHYWDAU-KDOFPFPSSA-N	O=C(O)C[C@@]1(O)C[C@@H](CCCCCCc2ccc(Cl)cc2Cl)OC1=O		ATP citrate lyase inhibitor
WB-48-EF24	YUCMWAUBTFDJIZ-CTYIDZIISA-N	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](O)CC3)nc21		Tyrosine Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Protein Kinase C (PKC) Inhibitors
EC-17-VB09	YUGRWLHLWREHAP-UHFFFAOYSA-N	c1ccc(-c2cc(-c3ccccc3)c(N3CCN(c4ncccn4)CC3)nn2)cc1		
IE-70-HC14	YUJFUSDUQKTNNX-UHFFFAOYSA-N	Cc1cccc2c(CC3C(=O)N(CCCCCN)C(=O)N3S(=O)(=O)c3ccc(Oc4ccc(O)c(Cl)c4)c(C(=O)N(C)C)c3)c[nH]c12	373381-21-6	SSTR2 agonist
MB-67-UU04	YULHJGMZULHTCR-UHFFFAOYSA-N	Cc1nc2ccc(S(=O)(=O)N3CCC(n4c(-c5ccncc5F)nc5cccnc54)CC3)cc2o1		CFTR Modulator
PC-18-VX23	YULUCECVQOCQFQ-UHFFFAOYSA-N	NCC(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1	1471979-81-3	PDK1 inhibitor
HC-40-TX80	YUMYYTORLYHUFW-MSKIIMLESA-N	CC(C)C[C@H](NC(=O)N1CCOCC1)C(=O)N[C@H](/C=C/S(=O)(=O)c1ccccc1)CCc1ccccc1		Cathepsin S Inhibitors
QF-45-KI95	YUNQZQREIHWDQT-UHFFFAOYSA-N	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C	919973-83-4	BRPF1B and BRPF2 inhibitor
DF-00-BX35	YUTLWCQIOXIPAP-UHFFFAOYSA-N	COc1ccccc1-c1cc(Nc2ccc(C)c(NS(C)(=O)=O)c2)ncn1		CDK inhibitor
FA-52-OO58	YUUGYIUSCYNSQR-LBPRGKRZSA-N	C[C@H](Oc1ccc(S(C)(=O)=O)cc1C(=O)N1CCN(c2ncc(C(F)(F)F)cc2F)CC1)C(F)(F)F	845614-11-1	glycine reuptake inhibitor
ZA-18-VC47	YVBSNHLFRIVWFQ-UHFFFAOYSA-N	O=C(C1CC1)N1CCN(Cn2sc3ccccc3c2=O)CC1	877963-94-5	
IB-87-ZR37	YVEHAXKUSUDPMN-UHFFFAOYSA-N	CCOc1ccc(-n2c(SCc3ccc(Cl)cc3)nc3ccc(Cl)cc32)cc1		Free Fatty Acid Receptor 1 (FFAR1;GPR40) Antagonists
QE-04-BY06	YVIJPELUPZUEJX-UHFFFAOYSA-N	COc1ccc(N2CCN(C(=O)c3cc4c(s3)-c3ccccc3S(=O)(=O)C4)CC2)cc1	890819-86-0	LYPLA2 gene inhibitor
AB-16-SB72	YVPGZQLRPAGKLA-UHFFFAOYSA-N	Cc1cc(C(N)=O)ccc1-n1c(CCC(=O)O)ccc1-c1ccc(-n2ccnc2)cc1	1208315-24-5	Alcohol Dehydrogenase class-3 (GSNOR;ADH5) Inhibitors
FF-59-KC06	YVWGGGGMRDLOGA-GOSISDBHSA-N	Cc1cccc(S(=O)(=O)N2CCC[C@@H]2CCN2CCC(C)CC2)c1	201038-58-6	ADRA1B gene modulator;5-HT7 Antagonists
DC-23-UM36	YWDAJLXJSLKKPA-UHFFFAOYSA-N	Cc1ncc(-c2ccc3ncc4c(c3c2)n(-c2cn(C)nc2C)c(=O)n4C)cc1OC(C)C	1257547-40-2	Mammalian Target of Rapamycin (mTOR;FRAP1) Inhibitors;PI3K inhibitors
DD-08-NW42	YWEGXZZAORIRQR-UHFFFAOYSA-N	COc1ccc2nc3[nH]nc(C)c3c(NCCOCCO)c2c1	171927-40-5	NUDT1 inhibitor;Ras/Rac transformation blocker
S0-EE-Y96U	YWGYNGCRVZLMCS-UHFFFAOYSA-N	O=C(Nc1cnccc1Cl)N1CCN(Cc2ccc3c(c2)OC(F)(F)O3)CC1	1346528-50-4	FAAH inhibitor
ED-35-ZX52	YWJXCIXBAKGUKZ-HJJNZUOJSA-N	COc1c(O)cc2c(c1O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1OC2=O	108032-11-7	Protein Tyrosine Phosphatase PTP-1B Inhibitors
AA-98-HX85	YWRDIVXHYHFOLT-UHFFFAOYSA-N	C=CC(=O)Nc1ccc(S(=O)(=O)N2CCCC2)cc1		
DF-00-NA25	YWTXVPSLMQXXRD-UHFFFAOYSA-N	N#Cc1nc(-c2c(F)cccc2Cl)[nH]c1-c1ccc(C#Cc2ccccc2)nc1	1254167-24-2	Microsomal Prostaglandin E2 Synthase-1 (mPGES-1) Inhibitors
HE-17-FY34	YWXXGUXRTABXPV-UHFFFAOYSA-N	Cc1nc(N2CCN(Cc3ccc(C(F)(F)F)cc3)C2=O)sc1C(N)=O	1184955-92-7	SCD inhibitor
IE-30-KW32	YWYNFBNIDCUJSP-UHFFFAOYSA-N	COc1ccc(Cl)cc1/N=C(\\S)NCCO		
ZD-18-MI26	YXHLPJQQPOMPGE-UHFFFAOYSA-N	Cc1ccccc1N(C)C(=O)c1ccc([S+]([O-])c2nccs2)c([N+](=O)[O-])c1	217438-17-0	Calcitonin Gene-Related Peptides (CGRP) Antagonists
DF-13-OP48	YXULTTUNHKOFRS-MRXNPFEDSA-N	CCCCCOc1ccc(CC[C@@](C)(N)CO)cc1		
GC-29-JC76	YXZOFIJALCWGSK-UHFFFAOYSA-N	Cc1noc(C)c1NC(=O)Nc1ccc(N2CCN(C(c3ccccc3)c3ccccc3)CC2)c(C#N)c1	1141883-77-3	Neuropeptide Y2 (NPY Y2) Antagonists
YE-57-WY37	YYCJNZZPQLMVIW-UHFFFAOYSA-N	O=C(NCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1)c1ccccc1F		
CD-55-ZN88	YYQUWEHEBOMRPH-NYUBLWNDSA-N	CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC1=O	137813-35-5	Integrin binder;Integrin alphavbeta3 (Vitronectin) Antagonists
FF-31-BR08	YYTHPXHGWSAKIZ-UHFFFAOYSA-N	Clc1ccc(-c2csc(NN=C3CCCC3)n2)cc1	357649-93-5	Histone N-Acetyltransferase (HAT) Inhibitors
AF-76-BV30	YZQLWPMZQVHJED-UHFFFAOYSA-N	CCC(CC)CC1(C(=O)Nc2ccccc2SC(=O)C(C)C)CCCCC1	211513-37-0	Cholesteryl Ester Transfer Protein (CETP) Inhibitors
DA-33-IZ67	YZRLVRHBPHBXFV-KYJUHHDHSA-N	CN(Cc1ccccc1)C(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@@H]1CCCN1c1nc(=O)c2ccccc2[nH]1		Tachykinin Antagonists
LA-44-KW22	YZRXTIGAQRIAEX-XMMPIXPASA-N	CC(C)(C)Cc1[nH]nc2c1[C@](C)(c1ccccc1)C1=C(CC(C)(C)CC1=O)N2		
AA-45-SU80	YZTJYBJCZXZGCT-UHFFFAOYSA-N	c1ccc(N2CCNCC2)cc1		
AA-35-QK71	YZZVIKDAOTXDEB-JTQLQIEISA-N	NCc1c[nH]c(=S)n1[C@H]1CCc2c(F)cc(F)cc2C1	170151-24-3	Dopamine-β-hydroxylase inhibitor
BE-71-AV63	ZAIULUYKQLVQFH-UHFFFAOYSA-N	Nc1ccccc1NC(=O)CCCCCC(=O)Nc1ccccc1	537034-15-4	HDACs
GA-13-WB79	ZAUAJRUCLHZWIT-UHFFFAOYSA-N	COc1cccc(Oc2c(Cl)ncnc2NS(=O)(=O)c2ccc(C(C)(C)C)cc2)c1		
BC-10-OR76	ZBBXLAORWSJJJE-UHFFFAOYSA-N	COC(=O)C#Cc1cc([N+](=O)[O-])cc(OCc2ccccc2)c1N		
BA-86-AL61	ZBNZXTGUTAYRHI-UHFFFAOYSA-N	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1	302962-49-8	Src Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Bruton's Tyrosine Kinase (BTK) Inhibitors;Bcr-Abl Kinase Inhibitors
NC-62-VG98	ZBUCZBCUBSTXQF-UHFFFAOYSA-N	Cc1cc(C)c(Nc2ccc(Cl)cc2C(N)=O)c(C)c1	1085386-98-6	Lysophospholipid edg1 (S1P1) Receptor Agonists;Lysophospholipid edg6 (S1P4) Receptor Agonists;Lysophospholipid edg8 (S1P5) Receptor Agonists
BE-48-TM93	ZBVKEHDGYSLCCC-UHFFFAOYSA-N	CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccccc2)=C(C)C1=O	103185-78-0	Prostanoid TP Antagonists
PA-57-TT36	ZCKKHYXUQFTBIK-MDZDMXLPSA-N	CCOC(=O)/C=C1/SC(N2CCCCC2)C(=O)N1C	73-09-6	Drugs Acting on Potassium Channels
MC-60-AC74	ZCMFEWUYBFMLIN-UHFFFAOYSA-N	O=C(O)c1cc2cc(O)c(O)cc2c(C(=O)c2ccc(O)c(O)c2)n1	374620-70-9	IGFBP1-6 Inhibitor
RD-90-DS77	ZCOLJUOHXJRHDI-CMWLGVBASA-N	O=c1c(-c2ccc(O)cc2)coc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc(O)c12		
FA-92-JL46	ZCQOSCDABPVAFB-UHFFFAOYSA-N	O=C(O)c1ccccc1Nc1ccc(CCc2ccc(Cl)c(Cl)c2)cc1	313674-97-4	Voltage-Gated K(V)11.1 (erg1) Channel Activators;Antiamyloidogenic Agents
NB-73-PA21	ZCUKWEROAITMTR-UHFFFAOYSA-N	Cc1cc(OCc2nc(-c3ccc(OC(C)C)cc3)c(-c3ccc(C(F)(F)F)cc3)s2)ccc1OCC(=O)O		
CA-68-KG29	ZCURBFFRNVPIAS-CYBMUJFWSA-N	CCCCCC(=O)N1C[C@@H](CCl)c2c1cc(O)c1ccccc21	1446715-27-0	covalent inhibitor of ALDH1A1
AE-65-LV28	ZCVMWBYGMWKGHF-UHFFFAOYSA-N	CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1		
LF-14-KL05	ZCZQCKJQIGWLFR-UHFFFAOYSA-N	Nc1c2c(nc3ccccc13)N(Cc1ccccc1)CC2	135882-37-0	Urotensin II receptor inhibitor
FB-39-CW59	ZDCPYKDNLZEPSX-UHFFFAOYSA-N	CCCS(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2OC)ncc1Cl		Focal Adhesion Kinase (FAK) Inhibitors
CC-04-WK34	ZDIGNSYAACHWNL-UHFFFAOYSA-N	CN(C)CCC(c1ccc(Br)cc1)c1ccccn1	132-21-8	Histamine Receptor Antagonists
KC-36-DK23	ZDNGJXBUEQNFBQ-GCJKJVERSA-N	COc1cc([C@@H](CC(=O)O)c2ccc(C)c(CN3C[C@@H](C)Oc4ccccc4S3(=O)=O)c2)cc2nnn(C)c12		Inhibitor of KEAP1-Nrf2 PPI
AA-99-PN83	ZDNOQFYOJHNBGG-JOCHJYFZSA-N	CC[C@@H]1C(=O)N(C)c2cnc(N(C)c3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		
HA-42-TE64	ZDOTZEDNGNPOEW-UHFFFAOYSA-N	O=c1c(O)c(-c2ccc(O)cc2)oc2c(O)c(O)cc(O)c12	527-95-7	ODC1 gene inhibitor
AA-82-RM29	ZDQSOHOQTUFQEM-NURRSENYSA-N	CC[C@@H]1/C=C(\\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC	104987-12-4	Calcineurin inhibitor;FKBP12 gene modulator;Calcineurin inhibitor;FKBP12 gene modulator
ZB-09-RC84	ZEGAKOAYQRABCU-UHFFFAOYSA-N	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)cc(C(F)(F)F)n2)CC1		Protein Kinase C (PKC) Inhibitors;IL-2 Production Inhibitors
HC-15-LT47	ZEOWFBDZQYSYSD-HXUWFJFHSA-N	Cc1oc(-c2ccc(C(F)(F)F)cc2)nc1CSc1ccc(S(=O)(=O)N2CCC[C@@H]2C(=O)O)cc1		
TC-36-AL79	ZEUITGRIYCTCEM-KRWDZBQOSA-N	CNCC[C@H](Oc1cccc2ccccc12)c1cccs1	116539-58-3	Norepinephrine Transporter (NET) Inhibitors;Serotonin Transporter (SERT) Inhibitors
AB-31-VZ28	ZEWQUBUPAILYHI-UHFFFAOYSA-N	CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1	117-89-5	Dopamine D2 Antagonists;Nav1.4 (SkM1) Sodium Channel Blockers;Nav1.7 ( PN1/hNE-Na) Sodium Channel Blockers
FB-86-IO73	ZEXHXVOGJFGTRX-UHFFFAOYSA-N	Cc1ncc([N+](=O)[O-])n1CCOC(=O)NC(Nc1ncccn1)C(Cl)(Cl)Cl	300815-04-7	CDC20 inhibitor
AA-67-FZ57	ZEZPDHKACVMMCD-UHFFFAOYSA-N	C1=C(CS/C(=N\\C2CCCCC2)NC2CCCCC2)N2CCN=C2S1	864677-52-1	Chemokine CXCR4 (SDF-1 Receptor) Antagonists;HIV Attachment Inhibitors
GB-21-FN58	ZFCPCFWCBDYWAI-UHFFFAOYSA-N	O=C(O)CSc1nsc(SCC(=O)O)n1		Lck Kinase SH2 domain Inhibitors
AA-79-SX47	ZFGXZJKLOFCECI-UHFFFAOYSA-N	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1	1177741-83-1	Sphingosine Kinase Inhibitors;Apoptosis Inducers
DB-34-QA60	ZFLJHSQHILSNCM-UHFFFAOYSA-N	c1nc2c(NC3CCCCC3)nc(Nc3ccc(N4CCOCC4)cc3)nc2[nH]1	656820-32-5	Aurora-B (ARK2) Kinase Inhibitors;Antimitotic Drugs;Aurora-A (ARK1) Kinase Inhibitors;Adenosine A3 Antagonists;Differentiation Inhibitors
BB-58-LW82	ZFLWDHHVRRZMEI-UHFFFAOYSA-N	COC(=O)C1=C(C)NC(C)=C([N+](=O)[O-])C1c1ccccc1C(F)(F)F		
AE-36-TF52	ZFOMCSNUEHMROO-UHFFFAOYSA-N	COc1ccc2nc3ccc(OC)cc3c(SCCCN)c2c1	184582-62-5	Serine/Threonine Kinase Haspin (Gsg2) Inhibitors;Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 2 (DYRK2) Inhibitors
NB-80-IM48	ZFOPNBKVZKKGAZ-UHFFFAOYSA-N	Fc1ccccc1-n1cnc2cnc3ccc(-c4ccncc4)cc3c21		
EB-97-AV17	ZFRNOTZQUGWMQN-UHFFFAOYSA-N	O=C(O)c1ccccc1Nc1ccccc1C(=O)O		
OA-10-PB21	ZFZPJDFBJFHYIV-UHFFFAOYSA-N	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2nsc3ccccc23)CC1	87691-91-6	alpha1-Adrenoceptor Antagonists
LA-10-VZ79	ZGBGPEDJXCYQPH-UHFFFAOYSA-N	Cc1ccc(NC(=O)c2cccc(C(C)(C)C#N)c2)cc1Nc1ccc2ncn(C)c(=O)c2c1	878739-06-1	Apoptosis Inducers;Inhibitors of Signal Transduction Pathways;Raf kinase B Inhibitors;Raf kinase C Inhibitors
OE-75-WF43	ZGCGVCMUJCQTAY-UHFFFAOYSA-N	Cc1nc(N2CC(C)NC(C)C2)ncc1-c1cnc(NCc2c(F)ccc3c2CCO3)n2cnc(C#N)c12		
CB-02-XL81	ZGLXUQQMLLIKAN-SVIJTADQSA-N	COc1cc([C@@H]2c3cc4c(cc3C[C@H]3COC(=O)[C@@H]32)OCO4)cc(OC)c1OC	100348-38-7	Cyclooxygenase-2 Inhibitors;Non-Steroidal Antiinflammatory Drugs;Angiogenesis Inhibitors
AB-71-CI37	ZGLXUQQMLLIKAN-SVIJTADQSA-N	COc1cc([C@@H]2c3cc4c(cc3C[C@H]3COC(=O)[C@@H]32)OCO4)cc(OC)c1OC	100348-38-7	Cyclooxygenase-2 Inhibitors;Non-Steroidal Antiinflammatory Drugs;Angiogenesis Inhibitors
AC-42-SI74	ZGQHOOMVABRSSX-UHFFFAOYSA-N	CN(C)C(=O)On1nnc2ccccc21	39968-13-3	Triacylglycerol Lipase (Hormone-Sensitive Lipase) Inhibitors
HE-01-ND39	ZGSHVWAJDGRIKT-OALUTQOASA-N	CC(C)C[C@H](S)C(=O)NC1(C(=O)N[C@@H](Cc2ccc(-c3cccs3)nc2)C(=O)O)CCCC1		Endothelin-Converting Enzyme (ECE) Inhibitors
WA-45-ZD47	ZGSTVUAZFACDLH-GOSISDBHSA-N	COc1ccc(S(=O)(=O)N(Cc2ccccc2)[C@@H](C(=O)NO)C(C)C)cc1	161313-73-1	Leukocyte Elastase Inhibitors
HD-33-CS00	ZGSXEXBYLJIOGF-ALFLXDJESA-N	O=C(Nc1cccc2cccnc12)c1ccc(N2C(=O)[C@@H]3[C@H](C2=O)[C@@H]2C=C[C@H]3C2)cc1	1127442-82-3	Wnt Signaling Inhibitors
CB-93-YZ07	ZGUGJATZUQXKMC-SDLFDTCQSA-N	C=CC[C@@H]1/C=C(\\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](OC(=O)Nc4ccc(CC(=O)OC)cc4)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC		FKBP12 gene modulator;TLR7 Receptor Agonists;TLR8 Receptor Agonists;Calcineurin inhibitor;FKBP12 gene modulator;TLR7 Receptor Agonists;TLR8 Receptor Agonists;Calcineurin inhibitor
TA-10-KH35	ZGZGUAKCJRZXRV-UHFFFAOYSA-N	CN1CCN(C2=C(Cl)C(=O)N(c3ccc(Cl)c(Cl)c3)C2=O)CC1	370572-36-4	
LE-55-RW34	ZHSMSTRJUILSME-XTCLZLMSSA-N	Cc1nccn1CC1CCc2c(c3ccccc3n2C)/C1=N/OC(=O)c1ccc(Br)s1		Cyclooxygenase-1 Inhibitors;Cyclooxygenase-2 Inhibitors;TNF-alpha Production Inhibitors
GA-09-TM90	ZHXNIYGJAOPMSO-UHFFFAOYSA-N	COc1cc(C)c(Sc2cnc(NC(=O)c3ccc(CNC(C)C(C)(C)C)cc3)s2)cc1C(=O)N1CCN(C(C)=O)CC1	439575-02-7	ITK (EMT) Kinase Inhibitors
YE-45-AD07	ZIQDXXULVSAWND-UHFFFAOYSA-N	O=C(NC1CCCc2ccccc21)c1ccc(-c2ccc(F)cc2)nc1	1185126-05-9	Prostaglandin synthase inhibitor
HF-91-IU60	ZIQFYVPVJZEOFS-UHFFFAOYSA-N	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccc(CO)c3)nc21	185039-91-2	Src Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Abl Kinase Inhibitors;Bcr-Abl Kinase Inhibitors;Src Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Abl Kinase Inhibitors;Bcr-Abl Kinase Inhibitors
FC-88-AJ86	ZIUSSTSXXLLKKK-KOBPDPAPSA-N	COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O		
ED-87-UE76	ZIWFCOIGUNPHPM-HKUYNNGSSA-N	COc1ccc(OC(F)(F)F)cc1CN[C@H]1CCCN[C@H]1c1ccccc1	145742-28-5	Neurokinin 1 receptor antagonist;Tachykinin NK1 Antagonists
CE-44-KU68	ZIXDDEATQSBHHL-BEFAXECRSA-N	CSCC[C@H](NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1ccccc1)C(=O)O	1217471-51-6	Farnesyltransferase (geranylgeranyl pyrophosphate synthase) Inhibitors;Inhibitors of Signal Transduction Pathways
CA-84-IJ41	ZJAWVBLMRPEUPW-UHFFFAOYSA-N	N=C(N)NC(=N)Nc1ccc(Cl)c(Cl)c1	15233-34-8	5-HT3 Receptor agonist;Cell Adhesion Inhibitors
GB-45-CJ58	ZJIUEDYXZUIMNV-UHFFFAOYSA-N	Clc1ccc2c(c1)CCNCC2	25174-38-3	5-HT2C Agonists
BD-98-TG79	ZJJXGWJIGJFDTL-UHFFFAOYSA-N	Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1	172964-66-8	K(ATP) Channel Blockers
AD-51-SS86	ZJLXSIPWULUCRJ-UHFFFAOYSA-N	c1ccc(-c2c(-c3ccc(OCCN4CCCC4)cc3)[nH]c3ncnc(NCC4SCCS4)c23)cc1	1026493-77-5	ACK tyrosine kinase inhibitor
CF-79-FU20	ZJQHPWUVQPJPQT-UHFFFAOYSA-N	NCc1cc(=O)[nH]o1	18174-72-6	GABA A receptor agonist
AE-42-HT01	ZJVFLBOZORBYFE-UHFFFAOYSA-N	CC(C)C(=O)c1c(C(C)C)nn2ccccc12	050847-11-5	TLR4 (LPS) Receptor Antagonists;Leukotriene CysLT1 (LTD4) Antagonists;Phosphodiesterase Inhibitors;Mediator Release Inhibitors
AA-68-OJ16	ZJXHODMMACVLQQ-NEPJUHHUSA-N	C[C@@H]1COCCN1c1nc(N2CCOC[C@@H]2C)nc2sc(-c3cc[nH]n3)nc12		
HD-22-GO73	ZJXIUGNEAIHSBI-IBGZPJMESA-N	Cc1nc(C(=O)N2CCCC[C@H]2CNC(=O)c2cccc3occc23)c(-c2ccc(F)cc2)s1	380899-24-1	Orexin Receptor Antagonists
UB-90-TA33	ZKCDJRHDZOHNGR-UHFFFAOYSA-N	CC(C)(C)c1nc(Nc2nnc(Cc3cncc(F)c3)c3ccccc23)sc1C#N		
HB-16-NO83	ZKFQEACEUNWPMT-UHFFFAOYSA-N	CC1=C(C(=O)OC(C)C)C(c2cccc([N+](=O)[O-])c2)C(C(=O)OC2CN(C(c3ccccc3)c3ccccc3)C2)=C(N)N1	123524-52-7	Calcium Channel Blockers
KC-17-YN77	ZKFVOZCCAXQXBU-UHFFFAOYSA-N	O=C(NC12CC3CC(CC(C3)C1)C2)c1cnc2ccccc2n1	226878-01-9	mgluR1 Antagonists;mgluR5 Antagonists
PA-75-VS64	ZKIQFLSGMMYCGS-SANMLTNESA-N	N[C@@H](CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2ccccc2C1		Known DPP8, DPP9 inhibitor
S0-EE-X9LZ	ZKIRTFGYQVXNGL-UHFFFAOYSA-N	C=CCn1cc(C(=O)N(C)C2CCN(c3cc(-c4cccc(OC)c4)ncn3)CC2)c2cc[nH]c2c1=O		Inhibitor of CERC2
GA-32-TO88	ZKUIDNFBWWVULC-UHFFFAOYSA-N	NS(=O)(=O)c1ccc(NC(=O)CN2CCOCC2)cc1	91533-01-6	Carbonic Anhydrase Type I Inhibitors;Carbonic Anhydrase Type II Inhibitors;Carbonic Anhydrase Type IX Inhibitors
LA-57-ZX71	ZKXZLIFRWWKZRY-KRWDZBQOSA-N	O=C(NC[C@H](O)CN1CCc2ccccc2C1)c1cc(NC2COC2)ncn1	1616391-65-1	SAM-cooperative (uncompetitive) inhibition of methyltransferase function;Epizyme SAM cooperative PRMT5 inhibitor (aka EPZ01566 / GSK3235025);PRMT5 gene inhibitor
BB-94-HN41	ZKYBMZOPYZKVKJ-UHFFFAOYSA-N	Cc1c(NC(=O)c2noc3c2CCCc2cc(OC(F)(F)F)ccc2-3)c(=O)n(C2CCCCC2)n1C		SMAD-1 inhibitor
AE-36-JB67	ZKZXNDJNWUTGDK-NSCUHMNNSA-N	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12	127243-85-0	cAMP-Dependent Protein Kinase (PKA) Inhibitors;Protein Kinase B (PKB/Akt) Inhibitors;Voltage-Gated K(V) Channel Blockers
AA-17-RC87	ZLENJXHJTDYRCQ-UHFFFAOYSA-N	COc1ccc(-c2ccc(C(=O)Nc3ccc4c(c3)CCC(CN(C)C)C4)cc2)cc1		MCHR1 antagonist
AD-94-EX35	ZLHZLMOSPGACSZ-NSHDSACASA-N	O=[N+]([O-])c1cn2c(n1)OC[C@@H](OCc1ccc(OC(F)(F)F)cc1)C2		
AD-42-VF57	ZLIAJZQKKBOFJR-WOUKDFQISA-N	CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O)[C@@H](O)[C@H]3O)c2n1	164992-25-0	P2RY12 (P2T) Antagonists
CD-91-BY60	ZLQBZYKAQQWOTK-UHFFFAOYSA-N	O=C(NNS(=O)(=O)c1ccccc1C(F)(F)F)c1cc2cc(Cl)ccc2o1	406191-34-2	Branched amino acid aminotransferase 1 inhibitor
RE-44-GR79	ZLUOAFAJSUPHOG-UHFFFAOYSA-N	CS(=O)(=O)c1ccccc1-c1ccc(NC(=O)c2cc(C(F)(F)F)nn2-c2cccc(CN)c2)c(F)c1	209957-47-1	Coagulation Factor Xa Inhibitors;Inhibitors of Blood Coagulation Pathways
AA-22-UI44	ZLUZDKXBTNQWOL-MDZDMXLPSA-N	O=C(/C=C/c1ccc(CNCCc2c[nH]c3ccccc23)cc1)NO	404951-52-6	HDAC inhibitor
QA-24-ZK07	ZLVMAMIPILWYHQ-INIZCTEOSA-N	CCOC(=O)Oc1ccc(CCNC(=O)[C@H](CCSC)NC(C)=O)cc1OC(=O)OCC	74639-40-0	Dopamine Receptor Agonists;Dopamine Precursors;Dopamine Receptor Agonists;Dopamine Precursors
XD-54-WU31	ZMJBYMUCKBYSCP-CVYQJGLWSA-N	O=C(O)C[C@@](O)(C(=O)O)[C@H](O)C(=O)O	1007119-75-6	ATP citrate lyase inhibitor
NC-11-BC71	ZMNWFTYYYCSSTF-SOAUALDESA-N	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		IL-2 Production Inhibitors;Inhibitors of Signal Transduction Pathways;Lck Kinase Inhibitors
FB-98-HM88	ZMWQOLGHIDQXCJ-UHFFFAOYSA-N	CC(CN1CCOCC1)Nc1ccc2cc(-n3cnc4cnc5cnc(-c6ccncc6)cc5c43)ccc2n1		Cot kinase inhibitor
WC-54-BJ14	ZMXBIIQMSGOIRZ-RCZVLFRGSA-N	Cc1cc(C)n(-c2cccc([C@H](CC(=O)O)CN3CC[C@@H](CCc4ccc5c(n4)NCCC5)C3)c2)n1		ITGB6 antagonist
OA-46-YF15	ZMZRKOASUWINDA-VEABSNGSSA-N	CC(C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@H](C=O)CC(=O)O		Apoptosis Inhibitors;Caspase 3 Inhibitors;Caspase 8 Inhibitors
AD-66-NO48	ZNNLBTZKUZBEKO-UHFFFAOYSA-N	COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1	10238-21-8	K(ATP) Channel Blockers
ZC-74-FT18	ZNRAIJHKWVDFLC-UHFFFAOYSA-N	COc1ccc(CNC(=O)c2cc(-c3cncc(C)c3)cnc2-c2cccc(F)c2)nc1OC	1112850-42-6	Orexin 2 receptor antagonist
UC-21-PY73	ZNXOKLWCOWOECF-UHFFFAOYSA-N	COc1cccc(Oc2c(NS(=O)(=O)c3ccc(C(C)(C)C)cc3)ncnc2OCCO)c1	150725-87-4	Endothelin Receptor Antagonists
UA-17-QS18	ZOEXTTOBTGLDTJ-CGAIIQECSA-N	Nc1ccc(CN2C(=O)C(N[C@@H](CCC3CCCCC3)C(=O)O)CCc3ccccc32)cc1		AGTR2 antagonist
AD-26-SL71	ZOTHAEBAWXWVID-HXEFRTELSA-N	CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(C(=O)NCCNC(=O)NC4CCN(c5ccccn5)CC4)nc32)[C@H](O)[C@@H]1O	380221-63-6	Adenosine A2A Agonists
JD-79-ZS29	ZPANWZBSGMDWON-UHFFFAOYSA-N	Oc1ccc2ccccc2c1Cc1c(O)ccc2ccccc12	1096-84-0	Antiamyloidogenic Agents
BC-63-DM76	ZPBFSCZQRXZGLG-DHZHZOJOSA-N	Cc1ccc(C)n1-c1ccc(/C=C/C(=O)N(C)O)cc1		
ZD-27-QL96	ZPGVLDQXMSGLHG-UHFFFAOYSA-N	Nc1ccc(N2CCCC(CO)C2)cc1	211247-50-6	CDK Inhibitors
DF-32-MM89	ZPLQIPFOCGIIHV-UHFFFAOYSA-N	O=c1cc(O)c(Cl)c[nH]1	103766-25-2	Dihydropyrimidine Dehydrogenase Inhibitors
AC-53-OM41	ZPMNHBXQOOVQJL-UHFFFAOYSA-N	COCCCN1CCC(NC(=O)c2cc(Cl)c(N)c3c2OCC3)CC1	179474-80-7	5-HT4 Agonists
JC-47-KK95	ZPTIDFIDKRDHIP-UHFFFAOYSA-N	CN1c2ccc(C#N)cc2N=C(c2ccc(C(=O)O)c(F)c2)c2cc3c(cc21)C(C)(C)CCC3(C)C		
S0-EE-Y6YC	ZPVUIOVIUFJGHO-UHFFFAOYSA-N	Cc1ccc(CNC(=O)Nc2cccc(F)c2)cc1NC(=O)c1cnc2ccccn12		DDR2 inhibitor
CB-62-TB77	ZPXRQFLATDNYSS-BJMVGYQFSA-N	COC(=O)CC/C(C)=C/Cc1c(O)c2c(c(C)c1OC)COC2=O	24243-40-1	Inosine 5'-Monophosphate Dehydrogenase Type II (IMPDH II) Inhibitors;Inosine 5'-Monophosphate Dehydrogenase Type I (IMPDH I) Inhibitors
DD-64-ET45	ZQENOOAKMIIQNI-DYLHXGEVSA-N	C[C@H]1CN([C@@H](C)CN2CCC(NC(=O)c3cc4c(OCC5CCC5)cccc4[nH]3)CC2)CC[C@@H]1O		Chemokine CCR2 (MCP-1 Receptor) Antagonists
LE-33-GL18	ZQGHKUXYQHDKBP-UHFFFAOYSA-N	CC(C)(C)c1ccc(S(=O)(=O)Nc2ccsc2C(=O)O)cc1	1111300-51-6	Chemokine CCR9 Receptor Antagonists
GB-69-YC71	ZQWBOKJVVYNKTL-AUEPDCJTSA-N	Clc1ccc(-c2nc3sccn3c2/C=N/OCc2ccc(Cl)c(Cl)c2)cc1	338404-52-7	Constitutive Androstane Receptor (CAR) Agonists
NE-92-EU87	ZRHWCAFAIHTQKD-KRWDZBQOSA-N	COC(=O)N1C(=O)[C@](c2ccccc2)(C2CCCC2)N1C(=O)OC	1073529-41-5	Protein Phosphatase Methylesterase 1 Inhibitor
AW-13-3788	ZRPJJBLGKLVADE-UHFFFAOYSA-N	CN(C)CCC=C(c1ccccc1)c1ccccc1	28916-83-8	Nav1.2 (Brain Type II) Sodium Channel Blockers
AD-20-YO14	ZRPZPNYZFSJUPA-UHFFFAOYSA-N	C=CC(=O)N1CCN(c2ncnc3c(F)c(-c4c(O)cccc4F)c(Cl)cc23)CC1		
QC-78-XX98	ZSBOMTDTBDDKMP-OAHLLOKOSA-N	Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O	1246610-75-2	Dipeptidyl Peptidase IV (CD26;DPP-IV;DP-IV) Inhibitors
AF-10-BU38	ZSHHRBYVHTVRFK-UHFFFAOYSA-N	NS(=O)(=O)c1cc(C(=O)O)c(Cl)cc1Cl	2736-23-4	Carbonic Anhydrase Type I Inhibitors;Carbonic Anhydrase Type II Inhibitors
LB-76-JJ80	ZSOZYBIDCNHWSW-UHFFFAOYSA-N	O=C1c2ccccc2CN1C1CCN(CCC(c2ccccc2)c2ccccc2)CC1	163268-23-3	Microsomal Triglyceride Transfer Protein (MTTP) Inhibitors;ApoB Secretion Inhibitors
DA-42-BI19	ZSPJYUOSWBXBCK-ZDUSSCGKSA-N	COc1ccc(-c2[nH]c(NC(=O)[C@@H](C)c3ccc(Cl)cc3)nc2C)cc1S(=O)(=O)CCO		PI4Kb inhibitor
FE-21-KA32	ZSUFQZNGDIXQAD-CABCVRRESA-N	CC1(C)Oc2ccc(C(F)(F)C(F)(F)F)cc2[C@@H](N2CCCCC2=O)[C@@H]1O		
S0-EE-WJKI	ZTQLCNOQWGSELY-UHFFFAOYSA-N	Cn1c(=O)c2c(nc(S(C)(=O)=O)n2C)n(CC#Cc2cccc(O)c2)c1=O		
FD-48-ZP65	ZTQXZKHEMCRFEP-UHFFFAOYSA-N	O=c1c2cc(F)ccc2sn1-c1ccccc1	1306638-12-9	PMI Inhibitor
UE-13-LK75	ZTUJNJAKTLHBEX-UHFFFAOYSA-N	CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1	1242156-23-5	reversible BTK inhibitor
VF-12-MF80	ZTYHZMAZUWOXNC-UHFFFAOYSA-N	N#Cc1c(N)nc(SCC(N)=O)c(C#N)c1-c1ccc(OCC2CC2)cc1	910487-58-0	Adenosine A2B Agonists
BB-93-VT73	ZUEBVBPVXLQMQR-UHFFFAOYSA-N	O=C(O)C(CS)Cc1ccccc1	69734-01-6	
BC-22-DS93	ZUIQDOUMMXDZTF-UHFFFAOYSA-N	CCN1c2ccc(C#N)cc2N=C(c2ccc(C(=O)O)c(F)c2)c2cc3c(cc21)C(C)(C)CCC3(C)C	951220-02-3	Retinoid RXRalpha Antagonists
AA-34-SG19	ZUMPSVPHCDJCMD-UHFFFAOYSA-N	CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)CC1(C(=O)O)CCCC1	137882-98-5	Angiotensin AT1 Antagonists
XC-65-XN91	ZUOMBFMTDPEMAZ-UHFFFAOYSA-N	CCCNc1ccc(C(=O)O)cn1	861045-08-1	GPR109A agonist
MD-51-HM45	ZUPGHKKHKOINAJ-UHFFFAOYSA-N	O=C(c1ccccc1)N1CCN(C(=O)c2cc3nc(-c4ccccc4)cc(C(F)(F)F)n3n2)CC1		
JF-08-NB76	ZUQIFHLBPBLRRM-QPJJXVBHSA-N	NS(=O)(=O)c1ccc(NC(=S)N2CCN(C/C=C/c3ccccc3)CC2)cc1		CTNNBIP1 gene inhibitor
VA-19-EX85	ZURNBNBFNSFMLM-UUWRZZSWSA-N	CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ncnc3c2CCN(C2CCN(Cc4cc(F)ccc4-c4ccc(Cl)cc4)CC2)C3)cc1S(=O)(=O)C(F)(F)F	1274802-67-3	Apoptosis Inducers;Bcl-2 Inhibitors
S0-EE-WH3B	ZUWUBCCXJATTTE-UHFFFAOYSA-N	CS(=O)(=O)c1ccc(-c2nn(-c3ccc(C#N)cc3)cc2C(=O)Nc2cccc(F)c2)cc1		
BE-07-XI66	ZVHMJDWHTKULHY-ZDUSSCGKSA-N	CCc1nnc(NC(=O)N[C@H](CO)CCN2CC(Oc3ccc(Cl)cc3)C2)s1		Chemokine CCR3 Antagonists
FB-24-UT80	ZVHNDZWQTBEVRY-UHFFFAOYSA-N	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1	1056634-68-4	Jak2 Inhibitors;Jak1 Inhibitors;Tyk2 Inhibitors
AC-28-IT60	ZVLLYAWRICTPLZ-GOSISDBHSA-N	Nc1nc(N2CCC3(CCC[C@H]3N)CC2)cnc1Sc1cccc(NC(=O)c2c(O)nc3ccccn3c2=O)c1Cl		SHP2 allosteric inhibitor
AB-44-GQ28	ZVNYJIZDIRKMBF-UHFFFAOYSA-N	COc1ccc(C(=O)N2CCN(c3ccc4c(c3)CCC(=O)N4)CC2)cc1OC	81840-15-5	Apoptosis Inducers;CDKN1A Expression Enhancers;Transitional Endoplasmic Reticulum ATPase (VCP, p97) Inhibitors
BE-03-XC62	ZVPDNRVYHLRXLX-UHFFFAOYSA-N	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1	172889-26-8	Apoptosis Inducers;Src Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Abl Kinase Inhibitors;Apoptosis Inducers;Src Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Abl Kinase Inhibitors
AF-06-ME04	ZVQUCWXZCKWZBP-CQSZACIVSA-N	COc1cccc([C@@H](C)NCCCc2ccccc2Cl)c1	148717-49-1	Calcium-Sensing Receptor (CaSR) Agonists
BB-77-IG67	ZVTPIBKKYCMLDF-ZDUSSCGKSA-N	COc1ncc(NC(=O)Nc2cnc3ccc(C#N)cc3c2N2CCOC[C@@H]2C)cc1Cl		
GC-67-AH43	ZVVCSBSDFGYRCB-UHFFFAOYSA-N	CCCc1c(OCCCOc2ccc(C(C)=O)c(OC)c2CCC)ccc2c1OC(C(=O)O)CC2	120072-59-5	Leukotriene Antagonists;Leukotriene BLT (LTB4) Antagonists
IF-75-AJ33	ZVYIJXLMBWCGHP-UHFFFAOYSA-N	CCOC(=O)C1CSC(Cc2ccc(OCc3ccc([N+](=O)[O-])cc3)cc2)N1	415697-08-4	Sodium calcium exchanger 1 inhibitor
BF-02-QT56	ZWAOHEXOSAUJHY-ZIYNGMLESA-N	C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O	003094-09-5	Pyrimidine Antagonists;Apoptosis Inducers;Thymidylate Synthase Inhibitors
BD-74-LH52	ZWEMGIQYCJPRLW-UHFFFAOYSA-N	O=C(OC(C(F)(F)F)C(F)(F)F)N1CC(c2ccn(-c3ccccc3)n2)C1		
FE-37-OS90	ZWKJWVSEDISQIS-UHFFFAOYSA-N	Cn1c2cc([S+](C)[O-])sc2c2cnn(Cc3cccc(N)c3)c(=O)c21	1221186-53-3	Pyruvate kinase 2 stimulator
YA-00-OG62	ZWUKNHQASDKHCT-LLVKDONJSA-N	COC(=O)c1ccc(NC(=O)[C@@](C)(O)C(F)(F)F)c(Cl)c1	243982-48-1	Pyruvate Dehydrogenase Kinase (PDHK;PDK) Inhibitors
EA-22-SB72	ZWVZORIKUNOTCS-OAQYLSRUSA-N	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NC[C@@H](O)c4cccc(Cl)c4)cc[nH]c3=O)nc12	468740-43-4	IGF-1R Inhibitors
FD-88-CF51	ZXERDUOLZKYMJM-ZWECCWDJSA-N	CC[C@H]1[C@@H](O)[C@@H]2[C@H](CC[C@]3(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]23)[C@@]2(C)CC[C@@H](O)C[C@@H]12	459789-99-2	activates FXR directly in the liver and increases FGF19 hormone levels via intestinal FXR activation;Farnesoid X Receptor (FXR) Agonists
FD-85-SX37	ZXGGCBQORXDVTE-UMCMBGNQSA-N	N#Cc1ccc(COC[C@H]2O[C@@H](n3c(NCc4ccc(Cl)c(Cl)c4)nc4c(N)ncnc43)[C@H](O)[C@@H]2O)cc1	1134156-31-2	Heat Shock Protein 70 (hsp70) Inhibitors
XD-68-MP63	ZXICHDGQTHXJKH-UHFFFAOYSA-N	FC(F)(F)c1cccc(Nc2nc(-c3ccc(Cl)cc3)cs2)c1		
JB-72-IH66	ZXMXAOYWSLZLQM-NZNGGYBSSA-N	CCC(C)[C@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccno1)C(=O)N1CCC2(CCc3ccccc32)CC1	1252806-86-2	Proteinase activated receptor 2 (PAR2) partial agonist
DB-20-QK39	ZXPHIYQTYJUUQW-FIBWVYCGSA-N	COc1cc(C(=O)N2C[C@@H](n3cc(C4CC4)nn3)C[C@H]2C(=O)NCC(c2ccccc2)c2ccccc2)ccc1CN		Trypsin Inhibitor
BB-37-LS05	ZXRVKCBLGJOCEE-UHFFFAOYSA-N	O=c1[nH]oc2c1CCNC2	64603-91-4	GABA(A) Receptor Partial Agonists;Selective GABAA-delta agonist
GB-90-UG49	ZXUYYZPJUGQHLQ-UHFFFAOYSA-N	OC(CCCN1CCN(c2ncc(F)cn2)CC1)c1ccc(F)cc1	105565-55-7	NMDA Antagonists;sigma Receptor Antagonists;NMDA Antagonists;sigma Receptor Antagonists
DF-03-OP38	ZXVIXEYQZIGLDG-UHFFFAOYSA-N	O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)c1ccccc1NCc1cc[n+]([O-])cc1		
OE-41-RC56	ZYDXPXBPARYTSC-UHFFFAOYSA-N	CCOc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)cc1		
AC-93-OJ74	ZZIALNLLNHEQPJ-UHFFFAOYSA-N	O=c1oc2cc(O)ccc2c2oc3cc(O)ccc3c12	479-13-0	Estrogen Receptor (ER) alpha Ligands;Estrogen Receptor (ER) beta Ligands;AGE Inhibitors (Maillard's Reaction Inhibitors)
HD-96-GX64	ZZIVMEREMOBTBA-UHFFFAOYSA-N	COC(=O)c1ccc(NC(=O)c2c(Cl)ccc(Cl)c2OC)cc1		
CD-29-EG36	ZZKNRXZVGOYGJT-VKHMYHEASA-N	O=C(O)C[C@H](NC(=O)CP(=O)(O)O)C(=O)O	51321-79-0	Antimetabolites;Aspartate Carbamoyltransferase Inhibitors
JB-14-ZM03	ZZUBHVMHNVYXRR-UHFFFAOYSA-N	Oc1ccc(C2=Cc3ccc(O)cc3OC2)cc1	81267-65-4	Apoptosis Inducers;Inhibitors of Signal Transduction Pathways;BIRC4 Expression Inhibitors;Sphingosine Kinase Inhibitors;Tumor NADH Oxidase (tNOX) Inhibitors;Apoptosis Inducers;Inhibitors of Signal Transduction Pathways;BIRC4 Expression Inhibitors;Sphingosine Kinase Inhibitors;Tumor NADH Oxidase (tNOX) Inhibitors
AD-89-ID99	ZZUFCTLCJUWOSV-UHFFFAOYSA-N	NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl	106391-48-4	Antidiuretic
AC-51-WE57	ZZVUWRFHKOJYTH-UHFFFAOYSA-N	CN(C)CCOC(c1ccccc1)c1ccccc1	110491-04-8	Histamine H1 Receptor Antagonists
JF-12-EH36	ZZXIRFDFHJBYCS-UHFFFAOYSA-N	CC1(C)CCn2cncc2C1c1ccc(C#N)cc1		Cytochrome P450 11B2 (Aldosterone Synthase) Inhibitors;Cytochrome P450 CYP11B1 (Steroid 11-beta Hydroxylase) Inhibitors
SB-29-AN01	ZZYMTFSRMGVTHN-MLGOLLRUSA-N	C[C@@H]1CN(C(=O)[C@@](C)(O)C(F)(F)F)CCN1C(=O)OCc1ccccc1		Pyruvate Dehydrogenase Kinase (PDHK;PDK) Inhibitors
GA-88-CF36	ZZZYHIMVKOHVIH-VILODJCFSA-N	COC(=O)[C@@]12OC[C@]34[C@H]([C@@H](O)[C@@H]1O)[C@@]1(C)CC(=O)C(O)=C(C)[C@@H]1C[C@H]3OC(=O)[C@H](OC(=O)C=C(C)C)[C@@H]24		
